data_5m9z_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 5m9z _Structure_validation_residue.Date_analyzed 2017-07-28 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.387 0 N-CA-C 112.565 -0.214 . . . . 3.77 112.565 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 549' ' ' LYS . . . . . . . . . . . . . 32.5 mmmt -70.8 143.72 51.06 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 110.038 -0.356 . . . . 6.2 110.038 178.089 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 550' ' ' TYR . . . . . 0.49 ' CE1' HG13 ' A' ' 583' ' ' VAL . 23.8 p90 -125.97 159.73 31.89 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 109.29 -0.633 . . . . 3.22 109.29 177.015 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 551' ' ' VAL . . . . . . . . . . . . . 52.6 t -118.33 133.37 65.35 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.021 0 N-CA-C 108.723 -0.843 . . . . 2.01 108.723 177.48 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 552' ' ' VAL . . . . . 0.569 ' HA ' ' O ' ' A' ' 582' ' ' TRP . 60.8 t -65.2 130.59 30.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 109.499 -0.556 . . . . 1.8 109.499 179.374 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 553' ' ' VAL . . . . . 0.59 HG21 ' CD1' ' A' ' 584' ' ' TRP . 66.0 t -59.0 121.37 54.6 Favored Pre-proline 0 CA--C 1.519 -0.243 0 O-C-N 123.618 0.574 . . . . 1.63 110.681 -175.608 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 554' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 553' ' ' VAL . 31.9 Cg_exo . . . . . 0 N--CA 1.464 -0.219 0 C-N-CA 123.041 2.494 . . . . 2.2 112.786 -177.404 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 560' ' ' MET . . . . . 0.455 ' HG3' HG12 ' A' ' 553' ' ' VAL . 1.8 mpt? . . . . . 0 N--CA 1.466 0.346 0 N-CA-C 112.397 0.518 . . . . 2.98 112.397 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 561' ' ' ALA . . . . . 0.455 ' HA ' ' O ' ' A' ' 571' ' ' VAL . . . -144.5 152.67 40.93 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.015 0.436 . . . . 1.46 111.33 -178.659 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 33.4 p90 -142.76 151.7 41.52 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.219 -0.66 . . . . 1.35 109.219 170.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 563' ' ' LYS . . . . . . . . . . . . . 3.6 tppp? -88.8 117.98 28.17 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 109.269 -0.641 . . . . 2.71 109.269 -178.49 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 564' ' ' CYS . . . . . 0.417 ' O ' ' HA ' ' A' ' 568' ' ' LYS . 41.7 t -68.26 112.96 12.45 Favored Pre-proline 0 C--O 1.223 -0.316 0 N-CA-C 109.578 -0.527 . . . . 0.41 109.578 179.035 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 565' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_exo -71.77 -18.21 28.66 Favored 'Trans proline' 0 CA--C 1.527 0.162 0 C-N-CA 122.747 2.298 . . . . 1.0 113.299 -174.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 566' ' ' ILE . . . . . . . . . . . . . 26.4 mt -89.18 -38.32 11.15 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 N-CA-C 112.211 0.448 . . . . 1.54 112.211 -172.233 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 567' ' ' CYS . . . . . 0.466 ' SG ' ' OE2' ' A' ' 569' ' ' GLU . 28.6 p -127.74 1.21 6.09 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.512 -0.475 . . . . 0.7 111.65 178.67 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 568' ' ' LYS . . . . . 0.417 ' HA ' ' O ' ' A' ' 564' ' ' CYS . 54.3 mtpt 70.9 31.72 2.55 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 114.576 1.324 . . . . 3.19 114.576 163.782 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 569' ' ' GLU . . . . . 0.466 ' OE2' ' SG ' ' A' ' 567' ' ' CYS . 0.0 OUTLIER -95.72 149.38 21.55 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 108.605 -0.887 . . . . 3.34 108.605 170.173 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 570' ' ' THR . . . . . . . . . . . . . 57.0 m -84.02 117.06 23.16 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 109.045 -0.724 . . . . 1.43 109.045 172.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 571' ' ' VAL . . . . . 0.493 HG21 ' CE1' ' A' ' 596' ' ' HIS . 34.1 t -84.89 116.56 28.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-O 120.976 0.417 . . . . 1.39 111.108 -174.214 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 23.7 p -107.03 159.24 16.44 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.748 -0.66 . . . . 2.17 109.768 177.191 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . -130.5 155.68 21.24 Favored Glycine 0 N--CA 1.442 -0.926 0 C-N-CA 119.925 -1.131 . . . . 2.2 111.732 -178.233 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 574' ' ' VAL . . . . . 0.479 ' O ' HG23 ' A' ' 583' ' ' VAL . 40.5 t -118.0 148.44 20.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 109.838 -0.43 . . . . 3.64 109.838 -174.215 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 575' ' ' TYR . . . . . 0.456 ' HA ' ' HA ' ' A' ' 582' ' ' TRP . 47.6 t80 -84.22 119.46 25.06 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.797 -0.446 . . . . 3.53 109.797 178.147 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 576' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -95.84 113.38 25.0 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.97 0.414 . . . . 3.34 110.04 176.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 577' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -70.43 -22.69 62.69 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.42 -0.809 . . . . 5.59 112.074 -175.262 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 578' ' ' GLU . . . . . . . . . . . . . 15.8 tp10 -74.82 -46.39 36.98 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 121.023 -0.271 . . . . 5.11 110.854 -179.233 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 579' ' ' SER . . . . . . . . . . . . . 74.0 p -82.34 -20.96 36.27 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.111 0.482 . . . . 3.7 110.608 176.013 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 580' ' ' GLY . . . . . . . . . . . . . . . 79.54 20.21 69.45 Favored Glycine 0 N--CA 1.447 -0.578 0 CA-C-N 115.667 -0.697 . . . . 2.89 112.5 175.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 581' ' ' GLU . . . . . 0.433 ' OE1' ' HA ' ' A' ' 581' ' ' GLU . 8.7 mm-40 -138.1 160.26 39.85 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.24 0.543 . . . . 3.19 111.048 -177.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 582' ' ' TRP . . . . . 0.569 ' O ' ' HA ' ' A' ' 552' ' ' VAL . 80.3 m95 -79.55 137.84 37.29 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.609 -0.723 . . . . 2.63 109.361 174.322 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 583' ' ' VAL . . . . . 0.49 HG13 ' CE1' ' A' ' 550' ' ' TYR . 19.9 m -116.53 132.43 66.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 N-CA-C 113.667 0.988 . . . . 1.67 113.667 -172.122 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 584' ' ' TRP . . . . . 0.59 ' CD1' HG21 ' A' ' 553' ' ' VAL . 31.2 m0 -113.31 102.71 10.6 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 108.17 -1.048 . . . . 2.74 108.17 162.387 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 585' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.32 154.15 18.03 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.884 -0.327 . . . . 4.27 110.869 -176.212 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 586' ' ' ASN . . . . . . . . . . . . . 22.6 m-20 56.23 43.73 26.11 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 108.615 -0.884 . . . . 1.72 108.615 -170.112 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 587' ' ' THR . . . . . . . . . . . . . 34.3 m -133.98 141.13 47.16 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.098 -0.955 . . . . 1.22 110.513 -176.019 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 588' ' ' ILE . . . . . . . . . . . . . 12.7 tt -141.58 149.41 20.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.358 -0.383 . . . . 1.34 110.095 -178.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 589' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -97.73 122.65 41.08 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.887 -0.412 . . . . 1.35 109.887 177.246 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 590' ' ' VAL . . . . . . . . . . . . . 35.4 t -124.64 118.44 53.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 N-CA-C 109.761 -0.459 . . . . 1.3 109.761 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 591' ' ' ASN . . . . . . . . . . . . . 3.7 t30 55.58 40.99 31.12 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.418 -0.81 . . . . 2.03 110.988 177.458 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . 85.41 5.13 85.34 Favored Glycine 0 CA--C 1.52 0.365 0 C-N-CA 120.86 -0.686 . . . . 0.62 113.778 174.455 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 593' ' ' LYS . . . . . . . . . . . . . 56.0 mttp -127.84 144.89 51.08 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 117.363 0.582 . . . . 3.3 110.958 177.481 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 594' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -91.25 132.94 35.8 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.277 0.561 . . . . 2.29 110.711 -179.516 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 595' ' ' PHE . . . . . . . . . . . . . 72.0 m-85 -132.95 156.32 47.5 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.299 -0.864 . . . . 2.2 108.962 178.441 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 596' ' ' HIS . . . . . 0.493 ' CE1' HG21 ' A' ' 571' ' ' VAL . 11.3 m170 -60.98 126.97 29.3 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 108.384 -0.969 . . . . 0.76 108.384 167.775 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 597' ' ' SER . . . . . . . . . . . . . 23.2 t -65.15 -29.31 70.14 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.859 -0.609 . . . . 1.59 109.986 -177.506 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 598' ' ' THR . . . . . . . . . . . . . 2.6 m -66.8 -39.18 87.67 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 115.522 -0.763 . . . . 1.93 110.707 178.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 599' ' ' CYS . . . . . . . . . . . . . 86.1 m -74.68 -32.82 62.31 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.527 -0.76 . . . . 0.81 112.152 -174.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 600' ' ' TYR . . . . . . . . . . . . . 73.9 t80 -57.06 -34.68 68.5 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.928 0.394 . . . . 2.65 111.471 -172.337 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 601' ' ' HIS . . . . . . . . . . . . . 14.6 m-70 -61.91 -26.82 68.4 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.786 -0.643 . . . . 5.16 112.361 -177.221 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 602' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.49 -29.13 65.57 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 121.117 0.484 . . . . 3.85 110.13 -178.646 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 603' ' ' THR . . . . . . . . . . . . . 92.2 m . . . . . 0 C--N 1.326 -0.423 0 CA-C-N 115.841 -0.618 . . . . 3.3 110.811 -178.311 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.512 -0.147 0 N-CA-C 113.274 0.07 . . . . 3.77 113.274 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 549' ' ' LYS . . . . . 0.632 ' HD2' ' N ' ' A' ' 549' ' ' LYS . 6.5 mptt -81.29 150.35 28.56 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.379 0.609 . . . . 6.2 111.467 178.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 550' ' ' TYR . . . . . 0.492 ' CE1' HG12 ' A' ' 583' ' ' VAL . 16.6 p90 -111.19 161.88 15.52 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 114.92 -1.036 . . . . 3.22 110.072 -174.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 551' ' ' VAL . . . . . . . . . . . . . 84.9 t -118.08 133.28 65.38 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 N-CA-C 109.181 -0.674 . . . . 2.01 109.181 177.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 552' ' ' VAL . . . . . . . . . . . . . 59.1 t -63.92 134.66 28.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.725 -0.67 . . . . 1.8 109.815 -179.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 553' ' ' VAL . . . . . 0.59 HG22 ' CD1' ' A' ' 584' ' ' TRP . 86.3 t -60.07 121.01 55.78 Favored Pre-proline 0 N--CA 1.454 -0.233 0 O-C-N 123.618 0.574 . . . . 1.63 111.108 -176.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 554' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 553' ' ' VAL . 16.6 Cg_exo . . . . . 0 N--CA 1.461 -0.431 0 C-N-CA 123.167 2.578 . . . . 2.2 112.561 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 560' ' ' MET . . . . . . . . . . . . . 67.0 mtm . . . . . 0 C--O 1.235 0.294 0 N-CA-C 111.703 0.261 . . . . 2.98 111.703 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 561' ' ' ALA . . . . . . . . . . . . . . . -145.39 157.96 43.93 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.364 -0.38 . . . . 1.46 110.54 178.387 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 35.0 p90 -153.33 158.39 41.48 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.736 -0.468 . . . . 1.35 109.736 174.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 563' ' ' LYS . . . . . . . . . . . . . 5.2 tppp? -89.43 127.32 35.82 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 110.191 -0.3 . . . . 2.71 110.191 179.215 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 564' ' ' CYS . . . . . 0.666 ' O ' ' HA ' ' A' ' 568' ' ' LYS . 47.7 t -71.02 114.44 27.23 Favored Pre-proline 0 C--O 1.222 -0.355 0 N-CA-C 109.48 -0.563 . . . . 0.41 109.48 175.493 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 565' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_exo -72.21 -18.8 26.6 Favored 'Trans proline' 0 CA--C 1.528 0.208 0 C-N-CA 122.978 2.452 . . . . 1.0 113.887 -174.424 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 566' ' ' ILE . . . . . 0.417 HD11 ' HB ' ' A' ' 603' ' ' THR . 65.9 mt -91.85 -55.14 6.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 112.191 0.441 . . . . 1.54 112.191 -172.019 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 567' ' ' CYS . . . . . 0.454 ' SG ' ' OE2' ' A' ' 569' ' ' GLU . 29.5 p -106.68 -6.35 17.94 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.251 -0.579 . . . . 0.7 111.043 178.584 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 568' ' ' LYS . . . . . 0.666 ' HA ' ' O ' ' A' ' 564' ' ' CYS . 99.4 mttt 70.98 32.92 2.22 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 114.64 1.348 . . . . 3.19 114.64 165.569 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 569' ' ' GLU . . . . . 0.454 ' OE2' ' SG ' ' A' ' 567' ' ' CYS . 0.0 OUTLIER -96.44 136.19 37.28 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 108.806 -0.813 . . . . 3.34 108.806 168.098 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 570' ' ' THR . . . . . . . . . . . . . 57.3 m -68.41 118.24 11.22 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.203 -0.453 . . . . 1.43 110.182 -179.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 571' ' ' VAL . . . . . 0.523 HG21 ' CE1' ' A' ' 596' ' ' HIS . 21.6 t -89.7 116.55 31.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 116.15 -0.477 . . . . 1.39 110.935 -175.66 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 29.2 p -115.18 161.37 18.52 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 109.011 -0.737 . . . . 2.17 109.011 173.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . -128.27 154.41 19.92 Favored Glycine 0 N--CA 1.437 -1.285 0 C-N-CA 119.468 -1.349 . . . . 2.2 111.089 -179.494 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 574' ' ' VAL . . . . . 0.421 ' O ' HG22 ' A' ' 583' ' ' VAL . 49.0 t -115.47 142.46 28.49 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-O 120.922 0.391 . . . . 3.64 110.308 -171.557 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 575' ' ' TYR . . . . . . . . . . . . . 45.3 t80 -79.96 118.93 22.15 Favored 'General case' 0 N--CA 1.443 -0.787 0 N-CA-C 109.568 -0.53 . . . . 3.53 109.568 175.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 576' ' ' ASP . . . . . . . . . . . . . 27.9 t0 -90.92 109.11 20.33 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.192 -0.669 . . . . 3.34 109.192 178.018 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 577' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -70.57 -23.9 62.68 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 115.008 -0.996 . . . . 5.59 111.309 -175.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 578' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -77.09 -34.2 56.91 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.149 -0.478 . . . . 5.11 111.056 -175.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 579' ' ' SER . . . . . . . . . . . . . 77.5 p -98.77 -20.66 16.78 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.351 0.595 . . . . 3.7 110.553 176.207 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 580' ' ' GLY . . . . . . . . . . . . . . . 80.43 28.04 49.54 Favored Glycine 0 N--CA 1.448 -0.506 0 CA-C-N 115.497 -0.774 . . . . 2.89 113.46 177.225 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 581' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -140.91 161.2 38.39 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 117.195 0.498 . . . . 3.19 111.48 178.15 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 582' ' ' TRP . . . . . . . . . . . . . 81.6 m95 -84.93 134.28 34.26 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.743 -0.466 . . . . 2.63 109.743 176.508 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 583' ' ' VAL . . . . . 0.492 HG12 ' CE1' ' A' ' 550' ' ' TYR . 15.6 m -115.84 136.63 52.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 N-CA-C 112.61 0.596 . . . . 1.67 112.61 -172.415 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 584' ' ' TRP . . . . . 0.59 ' CD1' HG22 ' A' ' 553' ' ' VAL . 18.9 m0 -113.59 104.42 12.23 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.478 -0.783 . . . . 2.74 108.982 165.758 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 585' ' ' LYS . . . . . 0.488 ' HG2' ' OD1' ' A' ' 586' ' ' ASN . 0.0 OUTLIER -88.77 151.25 22.51 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.639 0.257 . . . . 4.27 111.262 -175.137 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 586' ' ' ASN . . . . . 0.557 ' O ' ' HA ' ' A' ' 596' ' ' HIS . 8.0 m120 53.51 43.0 31.85 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 123.196 0.598 . . . . 1.72 110.019 -174.121 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 587' ' ' THR . . . . . . . . . . . . . 53.2 m -128.91 140.46 51.66 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.021 0.439 . . . . 1.22 111.425 -173.377 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 588' ' ' ILE . . . . . . . . . . . . . 14.8 tt -142.4 150.27 18.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.855 -0.611 . . . . 1.34 109.682 178.056 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 589' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -104.4 119.65 39.44 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.47 -0.567 . . . . 1.35 109.47 176.353 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 590' ' ' VAL . . . . . . . . . . . . . 58.5 t -125.37 117.41 49.6 Favored 'Isoleucine or valine' 0 C--O 1.239 0.552 0 CA-C-N 115.831 -0.622 . . . . 1.3 110.374 178.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 591' ' ' ASN . . . . . . . . . . . . . 95.0 m-20 57.36 45.8 19.4 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.379 -0.828 . . . . 2.03 112.172 176.538 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . 82.06 7.4 87.89 Favored Glycine 0 N--CA 1.45 -0.429 0 CA-C-N 115.927 -0.579 . . . . 0.62 112.329 173.318 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 593' ' ' LYS . . . . . 0.636 ' HZ1' ' HB2' ' A' ' 593' ' ' LYS . 8.1 mtmp? -129.97 137.86 50.54 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.823 0.344 . . . . 3.3 111.182 -177.557 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 594' ' ' TYR . . . . . . . . . . . . . 79.2 m-85 -94.21 132.38 38.83 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.016 -0.538 . . . . 2.29 110.567 179.514 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 595' ' ' PHE . . . . . . . . . . . . . 71.8 m-85 -138.41 159.35 42.28 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.013 -0.736 . . . . 2.2 109.013 177.053 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 596' ' ' HIS . . . . . 0.654 ' HB2' ' SG ' ' A' ' 599' ' ' CYS . 24.4 m170 -63.52 129.44 40.19 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 107.599 -1.26 . . . . 0.76 107.599 165.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 597' ' ' SER . . . . . . . . . . . . . 2.9 m -58.7 -32.41 69.14 Favored 'General case' 0 CA--C 1.519 -0.214 0 CA-C-O 121.577 0.703 . . . . 1.59 109.783 178.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 598' ' ' THR . . . . . . . . . . . . . 81.8 m -59.46 -39.9 85.14 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 114.573 -1.194 . . . . 1.93 110.534 173.606 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 599' ' ' CYS . . . . . 0.667 ' HA ' ' HG2' ' A' ' 602' ' ' GLU . 83.6 m -74.82 -34.99 62.45 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.969 -0.56 . . . . 0.81 112.329 -179.258 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 600' ' ' TYR . . . . . . . . . . . . . 79.6 t80 -61.01 -35.57 77.19 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 109.161 -0.681 . . . . 2.65 109.161 -179.142 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 601' ' ' HIS . . . . . . . . . . . . . 27.8 t60 -68.09 -42.99 79.52 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 115.581 -0.736 . . . . 5.16 110.288 177.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 602' ' ' GLU . . . . . 0.667 ' HG2' ' HA ' ' A' ' 599' ' ' CYS . 13.8 pt-20 -70.91 -33.74 70.84 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 111.863 0.32 . . . . 3.85 111.863 -176.447 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 603' ' ' THR . . . . . 0.417 ' HB ' HD11 ' A' ' 566' ' ' ILE . 15.3 t . . . . . 0 C--N 1.326 -0.434 0 O-C-N 122.167 -0.333 . . . . 3.3 111.243 -179.028 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.289 0 N-CA-C 113.593 0.197 . . . . 3.77 113.593 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 549' ' ' LYS . . . . . . . . . . . . . 29.6 mtpt -81.01 138.89 36.02 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.107 0.48 . . . . 6.2 110.473 177.447 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 550' ' ' TYR . . . . . 0.545 ' CE1' HG11 ' A' ' 583' ' ' VAL . 16.4 p90 -111.46 161.72 15.84 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.167 -0.924 . . . . 3.22 109.279 178.535 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 551' ' ' VAL . . . . . 0.506 HG13 ' HE1' ' A' ' 594' ' ' TYR . 57.4 t -116.47 133.52 62.79 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.992 0 N-CA-C 109.19 -0.67 . . . . 2.01 109.19 177.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 552' ' ' VAL . . . . . . . . . . . . . 48.3 t -67.89 130.72 33.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.912 -0.585 . . . . 1.8 110.361 -177.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 553' ' ' VAL . . . . . 0.628 HG21 ' CD1' ' A' ' 584' ' ' TRP . 64.1 t -59.2 122.61 64.72 Favored Pre-proline 0 C--N 1.328 -0.34 0 O-C-N 123.902 0.751 . . . . 1.63 111.048 -177.545 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 554' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_exo . . . . . 0 N--CA 1.461 -0.391 0 C-N-CA 122.706 2.271 . . . . 2.2 111.442 176.709 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 560' ' ' MET . . . . . . . . . . . . . 57.4 mtt . . . . . 0 N--CA 1.469 0.503 0 CA-C-O 121.585 0.707 . . . . 2.98 110.259 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 561' ' ' ALA . . . . . . . . . . . . . . . -144.21 161.18 39.54 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.048 -0.978 . . . . 1.46 110.517 -174.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 30.8 p90 -136.59 164.31 28.5 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 108.02 -1.104 . . . . 1.35 108.02 171.373 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 563' ' ' LYS . . . . . . . . . . . . . 29.2 ttpt -112.17 122.0 46.51 Favored 'General case' 0 C--N 1.32 -0.704 0 C-N-CA 120.399 -0.52 . . . . 2.71 110.675 -177.542 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 564' ' ' CYS . . . . . 0.416 ' HA ' ' HD3' ' A' ' 565' ' ' PRO . 44.2 t -74.39 111.91 14.91 Favored Pre-proline 0 N--CA 1.453 -0.322 0 CA-C-N 115.48 -0.782 . . . . 0.41 109.624 -178.49 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 565' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 564' ' ' CYS . 15.2 Cg_exo -72.34 -21.66 22.79 Favored 'Trans proline' 0 CA--C 1.528 0.202 0 C-N-CA 123.128 2.552 . . . . 1.0 113.843 -174.206 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 566' ' ' ILE . . . . . . . . . . . . . 18.4 mt -71.9 -39.19 66.93 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 CA-C-O 121.059 0.457 . . . . 1.54 110.476 -173.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 567' ' ' CYS . . . . . 0.599 ' SG ' ' HG3' ' A' ' 569' ' ' GLU . 27.4 p -129.81 2.53 4.9 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.873 -0.603 . . . . 0.7 112.534 -174.5 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 568' ' ' LYS . . . . . . . . . . . . . 52.5 mtpt 71.16 30.81 2.58 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 113.425 0.898 . . . . 3.19 113.425 175.047 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 569' ' ' GLU . . . . . 0.599 ' HG3' ' SG ' ' A' ' 567' ' ' CYS . 46.2 mt-10 -85.59 132.84 34.1 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 120.515 -0.474 . . . . 3.34 110.277 176.486 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 570' ' ' THR . . . . . . . . . . . . . 49.2 m -84.42 116.12 22.9 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 108.317 -0.994 . . . . 1.43 108.317 166.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 571' ' ' VAL . . . . . . . . . . . . . 12.7 t -98.08 116.29 40.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 115.947 -0.57 . . . . 1.39 110.856 -171.398 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 27.5 p -104.26 160.71 14.65 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.594 -0.73 . . . . 2.17 109.474 178.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . -128.66 157.18 21.36 Favored Glycine 0 N--CA 1.439 -1.114 0 C-N-CA 119.896 -1.145 . . . . 2.2 111.912 -176.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 574' ' ' VAL . . . . . . . . . . . . . 60.3 t -111.66 145.86 17.3 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-O 121.004 0.43 . . . . 3.64 110.231 -172.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 575' ' ' TYR . . . . . . . . . . . . . 45.3 t80 -78.52 118.49 20.7 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 108.917 -0.772 . . . . 3.53 108.917 174.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 576' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -91.66 102.76 15.39 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 109.154 -0.684 . . . . 3.34 109.154 -179.113 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 577' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -68.56 -23.0 64.45 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.276 -0.42 . . . . 5.59 111.635 -176.147 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 578' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -65.74 -43.98 87.35 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.409 -0.36 . . . . 5.11 110.603 -178.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 579' ' ' SER . . . . . . . . . . . . . 72.0 p -95.9 -20.61 18.64 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.109 0.48 . . . . 3.7 111.504 176.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 580' ' ' GLY . . . . . . . . . . . . . . . 80.71 21.38 63.93 Favored Glycine 0 N--CA 1.452 -0.244 0 CA-C-N 116.01 -0.541 . . . . 2.89 112.886 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 581' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -133.09 157.56 44.98 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.728 0.299 . . . . 3.19 110.597 179.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 582' ' ' TRP . . . . . 0.448 ' HB2' ' HB ' ' A' ' 553' ' ' VAL . 76.3 m95 -79.85 137.11 36.85 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.478 -0.328 . . . . 2.63 110.194 178.151 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 583' ' ' VAL . . . . . 0.545 HG11 ' CE1' ' A' ' 550' ' ' TYR . 20.5 m -118.81 141.48 38.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 113.251 0.834 . . . . 1.67 113.251 -173.409 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 584' ' ' TRP . . . . . 0.628 ' CD1' HG21 ' A' ' 553' ' ' VAL . 28.1 m0 -113.43 104.56 12.41 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 114.997 -1.001 . . . . 2.74 108.621 164.225 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 585' ' ' LYS . . . . . 0.487 ' HD2' ' CB ' ' A' ' 550' ' ' TYR . 10.9 mmmm -89.17 152.35 21.66 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.696 0.284 . . . . 4.27 110.491 -176.337 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 586' ' ' ASN . . . . . 0.416 ' O ' ' HA ' ' A' ' 596' ' ' HIS . 1.1 m-20 55.24 42.77 30.15 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 115.911 -0.586 . . . . 1.72 109.648 -173.601 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 587' ' ' THR . . . . . . . . . . . . . 53.3 m -126.33 140.23 52.68 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.114 0.483 . . . . 1.22 110.878 -175.491 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 588' ' ' ILE . . . . . 0.588 ' HB ' ' HG ' ' A' ' 597' ' ' SER . 14.3 tt -137.25 145.3 29.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.832 -0.622 . . . . 1.34 109.644 179.785 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 589' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -103.17 121.14 42.04 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.064 0.459 . . . . 1.35 109.999 178.636 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 590' ' ' VAL . . . . . 0.683 HG13 ' HH ' ' A' ' 600' ' ' TYR . 43.5 t -131.6 127.65 59.6 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 115.594 -0.73 . . . . 1.3 109.662 -179.843 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 591' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 59.63 33.26 21.93 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 121.947 0.88 . . . . 2.03 110.451 179.297 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . 77.78 9.82 86.64 Favored Glycine 0 N--CA 1.449 -0.436 0 CA-C-N 115.64 -0.709 . . . . 0.62 112.327 179.316 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 593' ' ' LYS . . . . . . . . . . . . . 70.1 mmtt -123.35 144.57 49.37 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 110.185 -0.302 . . . . 3.3 110.185 -175.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 594' ' ' TYR . . . . . 0.506 ' HE1' HG13 ' A' ' 551' ' ' VAL . 99.1 m-85 -96.28 134.27 39.6 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.878 0.37 . . . . 2.29 111.162 -177.2 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 595' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -139.18 162.66 34.42 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.681 -0.69 . . . . 2.2 109.631 178.258 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 596' ' ' HIS . . . . . 0.429 ' HB2' ' HB2' ' A' ' 599' ' ' CYS . 24.6 m170 -68.17 128.78 37.8 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 108.951 -0.759 . . . . 0.76 108.951 169.4 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 597' ' ' SER . . . . . 0.588 ' HG ' ' HB ' ' A' ' 588' ' ' ILE . 4.6 m -63.26 -36.42 83.61 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-O 121.467 0.651 . . . . 1.59 109.474 178.519 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 598' ' ' THR . . . . . . . . . . . . . 96.3 m -63.69 -44.76 92.74 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 114.704 -1.134 . . . . 1.93 111.188 177.225 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 599' ' ' CYS . . . . . 0.654 ' O ' ' HG2' ' A' ' 602' ' ' GLU . 83.3 m -76.45 -31.98 58.16 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.564 0.579 . . . . 0.81 112.564 -176.157 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 600' ' ' TYR . . . . . 0.683 ' HH ' HG13 ' A' ' 590' ' ' VAL . 87.5 t80 -57.03 -36.45 70.48 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.647 0.61 . . . . 2.65 112.647 -169.219 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 601' ' ' HIS . . . . . . . . . . . . . 18.5 m170 -64.17 -26.71 68.65 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 112.801 0.667 . . . . 5.16 112.801 -174.4 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 602' ' ' GLU . . . . . 0.654 ' HG2' ' O ' ' A' ' 599' ' ' CYS . 11.9 pt-20 -70.12 -23.48 63.03 Favored 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 120.313 -0.555 . . . . 3.85 111.077 -178.445 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 603' ' ' THR . . . . . . . . . . . . . 85.0 m . . . . . 0 C--N 1.328 -0.338 0 CA-C-O 121.31 0.576 . . . . 3.3 109.774 177.347 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.447 0 N-CA-C 112.504 -0.239 . . . . 3.77 112.504 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 549' ' ' LYS . . . . . 0.437 ' HD3' ' HA ' ' A' ' 549' ' ' LYS . 31.0 mmtp -76.13 150.86 37.14 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.615 0.721 . . . . 6.2 111.429 179.014 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 550' ' ' TYR . . . . . 0.58 ' CE1' HG12 ' A' ' 583' ' ' VAL . 46.9 p90 -114.81 162.97 16.17 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 114.594 -1.185 . . . . 3.22 110.761 -170.375 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 551' ' ' VAL . . . . . . . . . . . . . 60.5 t -117.03 134.01 61.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 N-CA-C 108.681 -0.859 . . . . 2.01 108.681 175.228 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 552' ' ' VAL . . . . . 0.592 ' HA ' ' O ' ' A' ' 582' ' ' TRP . 60.4 t -62.57 135.36 27.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.094 -0.503 . . . . 1.8 110.508 -176.622 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 553' ' ' VAL . . . . . 0.551 HG21 ' CD1' ' A' ' 584' ' ' TRP . 92.4 t -59.34 120.62 49.74 Favored Pre-proline 0 N--CA 1.455 -0.194 0 CA-C-N 116.034 -0.53 . . . . 1.63 110.464 -178.405 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 554' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 553' ' ' VAL . 33.5 Cg_exo . . . . . 0 C--O 1.232 0.21 0 C-N-CA 123.653 2.902 . . . . 2.2 113.043 -178.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 560' ' ' MET . . . . . . . . . . . . . 1.9 mpt? . . . . . 0 N--CA 1.467 0.421 0 N-CA-C 112.059 0.392 . . . . 2.98 112.059 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 561' ' ' ALA . . . . . 0.492 ' HA ' ' O ' ' A' ' 571' ' ' VAL . . . -144.64 154.71 43.09 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.918 0.39 . . . . 1.46 111.486 -177.634 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 34.5 p90 -141.58 159.83 41.41 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 108.884 -0.784 . . . . 1.35 108.884 170.467 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 563' ' ' LYS . . . . . . . . . . . . . 23.3 tptm -99.87 122.52 42.94 Favored 'General case' 0 C--N 1.32 -0.713 0 C-N-CA 120.98 -0.288 . . . . 2.71 110.702 -176.066 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 564' ' ' CYS . . . . . 0.48 ' HB3' ' HG2' ' A' ' 569' ' ' GLU . 49.5 t -77.38 114.72 43.07 Favored Pre-proline 0 C--N 1.326 -0.425 0 N-CA-C 109.912 -0.403 . . . . 0.41 109.912 178.102 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 565' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 564' ' ' CYS . 13.4 Cg_exo -69.42 -28.85 26.37 Favored 'Trans proline' 0 C--N 1.343 0.263 0 C-N-CA 122.998 2.465 . . . . 1.0 113.539 -173.053 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 566' ' ' ILE . . . . . . . . . . . . . 51.9 mt -72.01 -55.62 12.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 121.005 0.431 . . . . 1.54 111.577 -175.537 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 567' ' ' CYS . . . . . 0.494 ' SG ' ' OE2' ' A' ' 569' ' ' GLU . 26.7 p -107.47 2.3 24.11 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 112.262 0.467 . . . . 0.7 112.262 -174.186 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 568' ' ' LYS . . . . . . . . . . . . . 44.8 mmtm 67.34 28.7 7.81 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 115.921 -0.581 . . . . 3.19 112.186 171.117 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 569' ' ' GLU . . . . . 0.494 ' OE2' ' SG ' ' A' ' 567' ' ' CYS . 17.4 pt-20 -99.5 135.51 40.8 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.705 -0.398 . . . . 3.34 110.35 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 570' ' ' THR . . . . . . . . . . . . . 88.5 m -80.66 119.1 22.85 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.649 -0.5 . . . . 1.43 109.649 174.154 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 571' ' ' VAL . . . . . 0.492 ' O ' ' HA ' ' A' ' 561' ' ' ALA . 11.7 t -92.27 116.72 34.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 116.179 -0.464 . . . . 1.39 111.039 -174.861 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 27.8 p -107.67 159.07 16.75 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 116.1 -0.5 . . . . 2.17 109.889 176.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . -130.79 155.78 21.37 Favored Glycine 0 N--CA 1.442 -0.939 0 C-N-CA 119.868 -1.158 . . . . 2.2 111.835 179.496 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 574' ' ' VAL . . . . . . . . . . . . . 23.9 t -114.09 149.96 16.26 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 N-CA-C 109.761 -0.459 . . . . 3.64 109.761 -175.148 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 575' ' ' TYR . . . . . . . . . . . . . 54.1 t80 -82.02 119.18 23.67 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 108.717 -0.846 . . . . 3.53 108.717 174.335 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 576' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -90.57 106.36 18.45 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 109.12 -0.696 . . . . 3.34 109.12 -178.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 577' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -69.36 -21.8 63.78 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.956 -0.565 . . . . 5.59 111.965 -176.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 578' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -67.6 -44.76 77.32 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.974 0.416 . . . . 5.11 110.527 -177.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 579' ' ' SER . . . . . . . . . . . . . 70.1 p -96.29 -23.67 16.56 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.281 0.562 . . . . 3.7 111.119 176.202 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 580' ' ' GLY . . . . . . . . . . . . . . . 81.81 31.48 32.48 Favored Glycine 0 CA--C 1.522 0.477 0 CA-C-N 115.497 -0.774 . . . . 2.89 113.018 -178.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 581' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -138.15 152.52 48.77 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 116.855 0.327 . . . . 3.19 110.675 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 582' ' ' TRP . . . . . 0.592 ' O ' ' HA ' ' A' ' 552' ' ' VAL . 80.5 m95 -76.8 136.69 38.97 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 109.639 -0.504 . . . . 2.63 109.639 176.411 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 583' ' ' VAL . . . . . 0.58 HG12 ' CE1' ' A' ' 550' ' ' TYR . 19.1 m -116.0 131.55 68.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 N-CA-C 113.502 0.927 . . . . 1.67 113.502 -173.118 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 584' ' ' TRP . . . . . 0.551 ' CD1' HG21 ' A' ' 553' ' ' VAL . 17.8 m0 -114.49 103.0 10.6 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 108.497 -0.927 . . . . 2.74 108.497 162.835 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 585' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.98 151.21 22.95 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.066 0.46 . . . . 4.27 111.991 -173.426 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 586' ' ' ASN . . . . . . . . . . . . . 18.9 m-20 52.68 41.7 31.46 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 115.23 -0.896 . . . . 1.72 110.192 -174.474 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 587' ' ' THR . . . . . . . . . . . . . 32.5 m -120.34 141.0 50.46 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.015 -0.539 . . . . 1.22 110.789 -177.132 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 588' ' ' ILE . . . . . . . . . . . . . 11.7 tt -137.98 141.54 38.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 N-CA-C 109.671 -0.492 . . . . 1.34 109.671 179.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 589' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -97.23 120.87 38.38 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.306 -0.628 . . . . 1.35 109.306 177.812 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 590' ' ' VAL . . . . . . . . . . . . . 61.9 t -127.17 118.2 49.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.634 -0.712 . . . . 1.3 110.549 179.653 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 591' ' ' ASN . . . . . . . . . . . . . 62.8 t30 58.62 38.91 25.11 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 115.459 -0.791 . . . . 2.03 111.617 176.112 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . 86.08 5.49 83.12 Favored Glycine 0 N--CA 1.45 -0.421 0 CA-C-N 115.86 -0.609 . . . . 0.62 113.17 175.344 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 593' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -128.74 139.75 52.06 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.917 0.389 . . . . 3.3 111.151 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 594' ' ' TYR . . . . . . . . . . . . . 85.1 m-85 -91.26 129.82 37.2 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.966 -0.561 . . . . 2.29 110.478 -179.218 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 595' ' ' PHE . . . . . . . . . . . . . 63.8 m-85 -135.0 162.9 31.13 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.896 -0.593 . . . . 2.2 109.682 177.235 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 596' ' ' HIS . . . . . 0.487 ' HB2' ' SG ' ' A' ' 599' ' ' CYS . 30.5 m170 -70.68 129.36 38.93 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.68 -0.489 . . . . 0.76 109.68 172.436 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 597' ' ' SER . . . . . . . . . . . . . 23.0 t -65.47 -30.47 71.25 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.783 -0.644 . . . . 1.59 109.598 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 598' ' ' THR . . . . . . . . . . . . . 1.8 m -66.52 -42.42 87.32 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 115.464 -0.789 . . . . 1.93 110.333 175.063 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 599' ' ' CYS . . . . . 0.487 ' SG ' ' HB2' ' A' ' 596' ' ' HIS . 78.6 m -73.83 -27.45 61.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.069 -0.969 . . . . 0.81 111.906 -178.778 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 600' ' ' TYR . . . . . . . . . . . . . 79.7 t80 -56.0 -35.29 66.64 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.696 0.284 . . . . 2.65 110.98 -174.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 601' ' ' HIS . . . . . . . . . . . . . 31.2 m170 -62.74 -28.13 69.75 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.006 0.432 . . . . 5.16 111.01 178.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 602' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -70.81 -38.37 73.3 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.018 -0.537 . . . . 3.85 110.924 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 603' ' ' THR . . . . . . . . . . . . . 10.3 t . . . . . 0 C--N 1.327 -0.392 0 CA-C-O 121.203 0.525 . . . . 3.3 110.599 -176.594 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.509 -0.321 0 CA-C-O 120.915 0.175 . . . . 3.77 113.064 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 549' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -80.18 132.72 35.95 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.135 0.493 . . . . 6.2 110.559 179.392 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 550' ' ' TYR . . . . . 0.454 ' HB3' ' HD2' ' A' ' 585' ' ' LYS . 39.0 p90 -111.18 160.56 16.82 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.58 -0.737 . . . . 3.22 109.29 174.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 551' ' ' VAL . . . . . . . . . . . . . 70.2 t -117.72 133.36 64.75 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 N-CA-C 108.708 -0.849 . . . . 2.01 108.708 178.137 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 552' ' ' VAL . . . . . 0.576 ' HA ' ' O ' ' A' ' 582' ' ' TRP . 74.4 t -64.86 131.67 30.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.994 -0.548 . . . . 1.8 110.487 -178.291 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 553' ' ' VAL . . . . . 0.6 HG21 ' CD1' ' A' ' 584' ' ' TRP . 65.9 t -59.04 123.33 68.76 Favored Pre-proline 0 C--O 1.235 0.319 0 CA-C-N 116.073 -0.512 . . . . 1.63 110.08 178.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 554' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_exo . . . . . 0 CA--C 1.529 0.241 0 C-N-CA 122.967 2.445 . . . . 2.2 112.577 -177.275 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 560' ' ' MET . . . . . . . . . . . . . 41.7 mtm . . . . . 0 C--O 1.235 0.298 0 CA-C-O 120.67 0.271 . . . . 2.98 110.947 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 561' ' ' ALA . . . . . . . . . . . . . . . -142.84 145.78 33.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.098 0.475 . . . . 1.46 112.231 -173.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 27.0 p90 -136.17 164.7 27.44 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 107.4 -1.333 . . . . 1.35 107.4 172.427 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 563' ' ' LYS . . . . . . . . . . . . . 35.5 ttmt -105.48 133.0 50.96 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 119.589 -0.844 . . . . 2.71 111.157 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 564' ' ' CYS . . . . . 0.428 ' O ' ' HA ' ' A' ' 568' ' ' LYS . 34.6 t -71.97 114.1 26.08 Favored Pre-proline 0 C--O 1.222 -0.385 0 CA-C-N 115.085 -0.961 . . . . 0.41 109.385 178.468 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 565' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -67.02 -30.79 38.45 Favored 'Trans proline' 0 CA--C 1.53 0.285 0 C-N-CA 122.588 2.192 . . . . 1.0 113.942 -172.613 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 566' ' ' ILE . . . . . . . . . . . . . 32.8 mt -71.61 -56.27 10.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.815 0.34 . . . . 1.54 111.53 -172.47 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 567' ' ' CYS . . . . . 0.53 ' SG ' ' HG3' ' A' ' 569' ' ' GLU . 28.5 p -108.05 0.71 21.91 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.99 0.424 . . . . 0.7 111.339 -177.604 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 568' ' ' LYS . . . . . 0.428 ' HA ' ' O ' ' A' ' 564' ' ' CYS . 52.7 mttp 67.57 30.56 6.6 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 113.145 0.795 . . . . 3.19 113.145 171.389 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 569' ' ' GLU . . . . . 0.53 ' HG3' ' SG ' ' A' ' 567' ' ' CYS . 35.7 mt-10 -77.96 133.44 38.03 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.78 -0.452 . . . . 3.34 109.78 171.85 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 570' ' ' THR . . . . . . . . . . . . . 52.8 m -76.16 117.31 17.73 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 108.68 -0.859 . . . . 1.43 108.68 167.278 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 571' ' ' VAL . . . . . . . . . . . . . 23.5 t -94.77 116.93 37.32 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-N 116.59 -0.277 . . . . 1.39 110.894 -172.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 24.1 p -111.89 159.59 18.21 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.748 -0.66 . . . . 2.17 109.536 175.532 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . -130.82 155.1 21.05 Favored Glycine 0 N--CA 1.442 -0.938 0 C-N-CA 119.933 -1.127 . . . . 2.2 111.799 -178.129 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 574' ' ' VAL . . . . . 0.429 ' O ' HG21 ' A' ' 583' ' ' VAL . 35.4 t -113.04 149.54 15.44 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 N-CA-C 109.614 -0.513 . . . . 3.64 109.614 -176.081 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 575' ' ' TYR . . . . . 0.506 ' HA ' ' HA ' ' A' ' 582' ' ' TRP . 59.8 t80 -83.76 119.41 24.78 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.593 0.235 . . . . 3.53 110.43 177.071 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 576' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -92.01 105.67 17.86 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.199 0.523 . . . . 3.34 110.024 175.236 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 577' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -63.87 -23.94 67.55 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.39 -0.823 . . . . 5.59 111.153 -178.184 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 578' ' ' GLU . . . . . . . . . . . . . 13.4 tt0 -72.25 -46.58 55.37 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.911 -0.586 . . . . 5.11 111.216 -174.422 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 579' ' ' SER . . . . . . . . . . . . . 75.7 p -87.54 -15.97 35.98 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.965 0.412 . . . . 3.7 110.743 175.102 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 580' ' ' GLY . . . . . . . . . . . . . . . 80.04 15.24 79.32 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 121.07 -0.586 . . . . 2.89 112.697 177.379 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 581' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -135.09 154.53 51.64 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.023 0.439 . . . . 3.19 110.596 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 582' ' ' TRP . . . . . 0.599 ' HB2' ' HB ' ' A' ' 553' ' ' VAL . 77.3 m95 -71.88 148.2 46.35 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.913 -0.585 . . . . 2.63 109.96 176.673 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 583' ' ' VAL . . . . . 0.452 HG11 ' CE1' ' A' ' 550' ' ' TYR . 15.8 m -121.58 133.33 68.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 112.975 0.731 . . . . 1.67 112.975 -174.881 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 584' ' ' TRP . . . . . 0.6 ' CD1' HG21 ' A' ' 553' ' ' VAL . 27.0 m0 -110.31 103.79 12.5 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 108.262 -1.014 . . . . 2.74 108.262 162.868 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 585' ' ' LYS . . . . . 0.454 ' HD2' ' HB3' ' A' ' 550' ' ' TYR . 14.4 mmmm -82.08 152.0 26.78 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.877 0.37 . . . . 4.27 111.127 -175.312 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 586' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 54.76 41.9 31.57 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 115.424 -0.807 . . . . 1.72 109.632 -176.844 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 587' ' ' THR . . . . . . . . . . . . . 49.3 m -120.91 140.52 51.71 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.19 0.519 . . . . 1.22 110.628 -175.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 588' ' ' ILE . . . . . 0.739 ' HB ' ' HG ' ' A' ' 597' ' ' SER . 15.1 tt -139.67 143.61 30.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.606 -0.725 . . . . 1.34 109.924 -177.812 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 589' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -96.22 119.56 34.92 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.351 -0.611 . . . . 1.35 109.351 175.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 590' ' ' VAL . . . . . . . . . . . . . 27.3 t -128.36 120.75 53.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.253 -0.885 . . . . 1.3 109.343 179.028 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 591' ' ' ASN . . . . . . . . . . . . . 16.9 m120 59.36 34.66 22.9 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 121.175 0.512 . . . . 2.03 111.21 -179.004 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . 79.56 13.91 81.93 Favored Glycine 0 N--CA 1.445 -0.748 0 C-N-CA 120.981 -0.628 . . . . 0.62 112.15 177.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 593' ' ' LYS . . . . . . . . . . . . . 46.7 mmtm -123.58 139.81 53.63 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.747 0.308 . . . . 3.3 110.535 -176.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 594' ' ' TYR . . . . . . . . . . . . . 75.5 m-85 -90.62 122.51 33.47 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.304 -0.407 . . . . 2.29 110.466 179.089 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 595' ' ' PHE . . . . . . . . . . . . . 44.8 m-85 -133.15 163.87 28.3 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.771 -0.65 . . . . 2.2 110.058 178.588 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 596' ' ' HIS . . . . . . . . . . . . . 32.1 m170 -71.55 128.06 34.59 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.742 -0.836 . . . . 0.76 108.742 170.093 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 597' ' ' SER . . . . . 0.739 ' HG ' ' HB ' ' A' ' 588' ' ' ILE . 8.6 m -64.15 -29.99 71.08 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.159 -0.473 . . . . 1.59 110.277 -179.732 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 598' ' ' THR . . . . . . . . . . . . . 4.7 t -67.37 -38.91 85.51 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 115.376 -0.829 . . . . 1.93 110.968 179.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 599' ' ' CYS . . . . . . . . . . . . . 77.3 m -77.35 -34.64 55.1 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.954 -0.566 . . . . 0.81 112.495 -175.179 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 600' ' ' TYR . . . . . 0.402 ' O ' HG23 ' A' ' 603' ' ' THR . 85.0 t80 -56.75 -33.65 66.79 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 120.898 0.38 . . . . 2.65 111.92 -170.091 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 601' ' ' HIS . . . . . . . . . . . . . 28.7 m170 -59.74 -27.21 66.3 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 112.427 0.529 . . . . 5.16 112.427 -175.314 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 602' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -70.06 -31.08 68.51 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.734 0.302 . . . . 3.85 110.794 -176.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 603' ' ' THR . . . . . 0.402 HG23 ' O ' ' A' ' 600' ' ' TYR . 3.2 t . . . . . 0 CA--C 1.533 0.302 0 C-N-CA 120.55 -0.46 . . . . 3.3 111.66 -174.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.508 -0.351 0 N-CA-C 112.127 -0.389 . . . . 3.77 112.127 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 549' ' ' LYS . . . . . 0.414 ' HA ' ' HD3' ' A' ' 549' ' ' LYS . 71.3 mmtt -71.91 132.55 44.51 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.003 0.43 . . . . 6.2 110.871 -179.521 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 550' ' ' TYR . . . . . . . . . . . . . 21.2 p90 -125.66 159.63 31.73 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.232 -0.894 . . . . 3.22 109.286 177.588 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 551' ' ' VAL . . . . . . . . . . . . . 57.5 t -118.81 132.69 67.96 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 N-CA-C 109.073 -0.714 . . . . 2.01 109.073 177.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 552' ' ' VAL . . . . . 0.501 ' HA ' ' O ' ' A' ' 582' ' ' TRP . 67.9 t -65.19 127.04 25.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 109.642 -0.503 . . . . 1.8 109.642 178.668 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 553' ' ' VAL . . . . . 0.658 HG21 ' CD1' ' A' ' 584' ' ' TRP . 61.8 t -59.92 120.99 55.11 Favored Pre-proline 0 C--N 1.329 -0.313 0 O-C-N 123.495 0.497 . . . . 1.63 110.834 -176.238 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 554' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_exo . . . . . 0 N--CA 1.461 -0.406 0 C-N-CA 122.785 2.323 . . . . 2.2 111.764 178.907 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 560' ' ' MET . . . . . . . . . . . . . 2.0 mpt? . . . . . 0 N--CA 1.465 0.323 0 CA-C-O 121.355 0.598 . . . . 2.98 109.935 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 561' ' ' ALA . . . . . . . . . . . . . . . -145.36 161.95 38.41 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.394 -0.821 . . . . 1.46 111.722 -171.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 31.0 p90 -142.82 155.03 44.73 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 107.781 -1.192 . . . . 1.35 107.781 170.117 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 563' ' ' LYS . . . . . . . . . . . . . 78.7 tttt -99.15 120.83 40.15 Favored 'General case' 0 C--N 1.32 -0.715 0 C-N-CA 120.193 -0.603 . . . . 2.71 110.536 -176.254 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 564' ' ' CYS . . . . . . . . . . . . . 42.8 t -64.7 117.29 36.8 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 115.412 -0.813 . . . . 0.41 111.944 -174.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 565' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_exo -68.72 -22.01 37.93 Favored 'Trans proline' 0 CA--C 1.531 0.358 0 C-N-CA 123.128 2.552 . . . . 1.0 113.085 -179.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 566' ' ' ILE . . . . . 0.518 HG23 ' HB3' ' A' ' 599' ' ' CYS . 36.0 mm -74.47 -42.25 49.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 120.714 0.293 . . . . 1.54 111.569 -177.041 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 567' ' ' CYS . . . . . . . . . . . . . 28.8 p -123.56 0.9 8.86 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 111.923 0.342 . . . . 0.7 111.923 -174.172 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 568' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? 62.13 27.95 16.83 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.84 -0.618 . . . . 3.19 112.008 176.425 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 569' ' ' GLU . . . . . 0.41 ' HA ' ' OE1' ' A' ' 569' ' ' GLU . 6.3 mm-40 -107.37 137.4 45.49 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 116.298 -0.41 . . . . 3.34 110.463 177.637 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 570' ' ' THR . . . . . . . . . . . . . 37.4 m -69.24 123.91 22.41 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.76 -0.655 . . . . 1.43 110.396 -179.257 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 571' ' ' VAL . . . . . 0.421 HG22 ' CE1' ' A' ' 596' ' ' HIS . 18.0 t -96.62 115.41 35.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 116.376 -0.374 . . . . 1.39 110.087 -179.827 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 23.6 p -106.72 159.22 16.38 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 116.053 -0.521 . . . . 2.17 110.325 178.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . -130.35 155.73 21.23 Favored Glycine 0 N--CA 1.44 -1.084 0 C-N-CA 119.921 -1.133 . . . . 2.2 111.384 -178.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 574' ' ' VAL . . . . . 0.462 ' O ' HG23 ' A' ' 583' ' ' VAL . 41.2 t -111.85 147.2 15.88 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 N-CA-C 109.644 -0.502 . . . . 3.64 109.644 -172.503 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 575' ' ' TYR . . . . . 0.475 ' HA ' ' HA ' ' A' ' 582' ' ' TRP . 48.8 t80 -82.33 121.49 26.76 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.507 -0.553 . . . . 3.53 109.507 174.668 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 576' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -89.59 108.54 19.73 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.046 -0.724 . . . . 3.34 109.046 179.45 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 577' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -69.68 -23.03 63.39 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.417 -0.81 . . . . 5.59 111.816 -172.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 578' ' ' GLU . . . . . . . . . . . . . 45.4 tt0 -74.87 -48.35 25.38 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 121.044 -0.262 . . . . 5.11 110.858 -178.156 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 579' ' ' SER . . . . . . . . . . . . . 74.0 p -85.64 -19.16 31.38 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.019 0.438 . . . . 3.7 111.187 179.32 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 580' ' ' GLY . . . . . . . . . . . . . . . 79.13 22.36 65.72 Favored Glycine 0 N--CA 1.448 -0.535 0 CA-C-N 115.926 -0.579 . . . . 2.89 112.818 178.554 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 581' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -135.17 152.34 51.5 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.876 0.37 . . . . 3.19 110.8 -178.394 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 582' ' ' TRP . . . . . 0.501 ' O ' ' HA ' ' A' ' 552' ' ' VAL . 74.5 m95 -78.8 144.78 34.76 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.742 -0.663 . . . . 2.63 110.013 177.778 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 583' ' ' VAL . . . . . 0.462 HG23 ' O ' ' A' ' 574' ' ' VAL . 26.7 m -124.14 134.3 66.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 N-CA-C 112.719 0.637 . . . . 1.67 112.719 -175.001 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 584' ' ' TRP . . . . . 0.658 ' CD1' HG21 ' A' ' 553' ' ' VAL . 27.8 m0 -109.5 101.98 10.88 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 108.799 -0.815 . . . . 2.74 108.799 162.761 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 585' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.62 152.68 21.26 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.644 -0.253 . . . . 4.27 110.904 -177.217 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 586' ' ' ASN . . . . . . . . . . . . . 10.4 m120 55.34 46.22 23.9 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 109.385 -0.598 . . . . 1.72 109.385 -170.615 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 587' ' ' THR . . . . . . . . . . . . . 28.6 m -135.69 140.68 44.63 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.012 -0.54 . . . . 1.22 110.593 -177.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 588' ' ' ILE . . . . . . . . . . . . . 15.0 tt -141.9 146.49 22.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.305 -0.407 . . . . 1.34 110.404 -179.423 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 589' ' ' GLU . . . . . 0.41 ' HB2' ' CE2' ' A' ' 594' ' ' TYR . 33.4 tt0 -94.54 119.84 33.84 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.829 -0.434 . . . . 1.35 109.829 174.722 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 590' ' ' VAL . . . . . . . . . . . . . 61.3 t -125.49 121.57 60.58 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 N-CA-C 109.491 -0.559 . . . . 1.3 109.491 178.392 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 591' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 58.2 33.71 23.42 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.083 -0.508 . . . . 2.03 111.425 -179.231 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . 84.67 -1.58 88.74 Favored Glycine 0 N--CA 1.45 -0.378 0 CA-C-N 115.797 -0.638 . . . . 0.62 113.114 177.511 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 593' ' ' LYS . . . . . . . . . . . . . 70.5 mmtt -114.49 146.22 40.95 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.782 0.325 . . . . 3.3 111.254 -179.145 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 594' ' ' TYR . . . . . 0.41 ' CE2' ' HB2' ' A' ' 589' ' ' GLU . 80.4 m-85 -98.16 127.45 44.11 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.207 -0.451 . . . . 2.29 111.46 -176.198 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 595' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -135.13 162.53 32.24 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.531 -0.759 . . . . 2.2 109.704 177.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 596' ' ' HIS . . . . . 0.421 ' CE1' HG22 ' A' ' 571' ' ' VAL . 10.3 m170 -61.29 128.79 38.07 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.42 -0.585 . . . . 0.76 109.42 171.403 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 597' ' ' SER . . . . . . . . . . . . . 47.7 t -64.55 -29.57 70.6 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.244 -0.65 . . . . 1.59 109.244 176.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 598' ' ' THR . . . . . . . . . . . . . 5.2 m -67.98 -45.98 72.63 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-O 121.64 0.734 . . . . 1.93 110.233 175.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 599' ' ' CYS . . . . . 0.518 ' HB3' HG23 ' A' ' 566' ' ' ILE . 74.6 m -74.67 -30.67 61.67 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.376 -0.829 . . . . 0.81 112.566 -174.618 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 600' ' ' TYR . . . . . 0.478 ' O ' HG21 ' A' ' 603' ' ' THR . 85.0 t80 -57.47 -36.08 71.0 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.045 0.45 . . . . 2.65 110.762 -174.644 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 601' ' ' HIS . . . . . . . . . . . . . 41.2 m170 -66.59 -28.47 68.53 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.213 -0.449 . . . . 5.16 111.546 179.447 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 602' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -63.56 -32.75 74.31 Favored 'General case' 0 CA--C 1.52 -0.192 0 CA-C-O 120.686 0.279 . . . . 3.85 110.315 -175.884 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 603' ' ' THR . . . . . 0.478 HG21 ' O ' ' A' ' 600' ' ' TYR . 13.0 t . . . . . 0 N--CA 1.45 -0.473 0 CA-C-O 121.065 0.459 . . . . 3.3 110.713 -178.028 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.326 0 N-CA-C 112.546 -0.222 . . . . 3.77 112.546 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 549' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -67.46 149.51 50.12 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.368 0.604 . . . . 6.2 110.67 177.04 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 550' ' ' TYR . . . . . 0.55 ' HB3' ' HD3' ' A' ' 585' ' ' LYS . 9.5 p90 -124.29 160.29 28.35 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.331 -0.849 . . . . 3.22 110.947 -173.403 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 551' ' ' VAL . . . . . . . . . . . . . 96.9 t -118.95 133.19 66.61 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 N-CA-C 108.704 -0.85 . . . . 2.01 108.704 172.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 552' ' ' VAL . . . . . 0.542 ' HA ' ' O ' ' A' ' 582' ' ' TRP . 47.4 t -65.34 131.74 31.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 116.238 -0.437 . . . . 1.8 110.112 -178.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 553' ' ' VAL . . . . . 0.673 HG23 ' CD1' ' A' ' 584' ' ' TRP . 26.3 t -63.56 120.99 67.62 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.249 -0.432 . . . . 1.63 109.967 -179.677 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 554' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_exo . . . . . 0 C--O 1.231 0.171 0 C-N-CA 122.959 2.44 . . . . 2.2 113.025 -177.323 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 560' ' ' MET . . . . . . . . . . . . . 81.5 mtp . . . . . 0 N--CA 1.466 0.341 0 CA-C-O 121.168 0.509 . . . . 2.98 110.682 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 561' ' ' ALA . . . . . . . . . . . . . . . -145.82 162.2 38.23 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.897 -0.592 . . . . 1.46 109.89 -177.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 35.1 p90 -138.5 145.97 41.42 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 120.437 -0.505 . . . . 1.35 110.022 173.172 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 563' ' ' LYS . . . . . . . . . . . . . 50.2 tptt -88.62 111.18 21.61 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 116.134 -0.484 . . . . 2.71 110.06 -178.575 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 564' ' ' CYS . . . . . 0.412 ' HA ' ' HD3' ' A' ' 565' ' ' PRO . 42.4 t -68.72 112.09 10.25 Favored Pre-proline 0 C--N 1.333 -0.145 0 N-CA-C 109.183 -0.673 . . . . 0.41 109.183 179.266 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 565' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 564' ' ' CYS . 15.4 Cg_exo -71.57 -17.77 29.69 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 123.042 2.494 . . . . 1.0 111.751 -175.293 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 566' ' ' ILE . . . . . . . . . . . . . 45.6 mt -80.16 -51.9 15.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.233 -0.894 . . . . 1.54 111.044 -175.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 567' ' ' CYS . . . . . . . . . . . . . 28.9 p -105.12 -1.7 25.21 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.363 -0.381 . . . . 0.7 111.237 -176.572 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 568' ' ' LYS . . . . . . . . . . . . . 35.6 mtmm 65.41 22.54 11.95 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 112.646 0.61 . . . . 3.19 112.646 174.48 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 569' ' ' GLU . . . . . . . . . . . . . 15.9 mm-40 -105.81 135.26 47.56 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.654 0.264 . . . . 3.34 110.479 177.064 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 570' ' ' THR . . . . . . . . . . . . . 49.2 m -75.54 126.08 30.29 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.508 -0.552 . . . . 1.43 109.508 177.059 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 571' ' ' VAL . . . . . . . . . . . . . 16.2 t -100.42 115.26 41.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 116.511 -0.313 . . . . 1.39 110.888 -175.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 24.6 p -105.3 161.83 13.96 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.022 -0.733 . . . . 2.17 109.022 174.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . -127.6 154.0 19.46 Favored Glycine 0 N--CA 1.436 -1.305 0 C-N-CA 119.134 -1.508 . . . . 2.2 111.68 -179.012 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 574' ' ' VAL . . . . . . . . . . . . . 44.5 t -111.32 145.14 17.94 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 CA-C-O 120.898 0.38 . . . . 3.64 110.059 -171.1 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 575' ' ' TYR . . . . . . . . . . . . . 38.7 t80 -76.93 118.44 19.52 Favored 'General case' 0 N--CA 1.439 -1.021 0 N-CA-C 108.956 -0.757 . . . . 3.53 108.956 174.177 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 576' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -89.72 96.95 10.92 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 108.469 -0.938 . . . . 3.34 108.469 -177.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 577' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -63.66 -22.73 67.06 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.53 -0.759 . . . . 5.59 111.907 -175.164 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 578' ' ' GLU . . . . . . . . . . . . . 19.0 mm-40 -66.14 -43.52 86.84 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.182 -0.463 . . . . 5.11 110.547 -179.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 579' ' ' SER . . . . . . . . . . . . . 68.3 p -100.46 -19.72 16.1 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.045 -0.525 . . . . 3.7 111.696 -179.599 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 580' ' ' GLY . . . . . . . . . . . . . . . 80.66 30.49 39.62 Favored Glycine 0 CA--C 1.524 0.6 0 CA-C-N 115.85 -0.614 . . . . 2.89 113.264 179.28 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 581' ' ' GLU . . . . . 0.487 ' CD ' ' HH ' ' A' ' 550' ' ' TYR . 17.3 pt-20 -139.07 156.44 47.17 Favored 'General case' 0 C--N 1.326 -0.442 0 O-C-N 122.304 -0.527 . . . . 3.19 110.682 179.837 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 582' ' ' TRP . . . . . 0.572 ' HB3' ' HB ' ' A' ' 553' ' ' VAL . 90.2 m95 -82.04 134.26 35.34 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.512 -0.551 . . . . 2.63 109.512 176.241 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 583' ' ' VAL . . . . . . . . . . . . . 33.5 m -123.0 134.03 67.33 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 N-CA-C 113.793 1.034 . . . . 1.67 113.793 -173.666 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 584' ' ' TRP . . . . . 0.673 ' CD1' HG23 ' A' ' 553' ' ' VAL . 33.5 m0 -113.85 103.76 11.51 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 107.893 -1.151 . . . . 2.74 107.893 161.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 585' ' ' LYS . . . . . 0.55 ' HD3' ' HB3' ' A' ' 550' ' ' TYR . 35.3 mmtp -81.56 142.67 32.62 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.777 -0.369 . . . . 4.27 110.768 -175.84 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 586' ' ' ASN . . . . . . . . . . . . . 22.1 m-20 55.23 50.0 16.02 Favored 'General case' 0 CA--C 1.516 -0.335 0 CA-C-N 115.38 -0.827 . . . . 1.72 109.889 -178.292 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 587' ' ' THR . . . . . . . . . . . . . 41.1 m -125.03 141.41 52.14 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.907 -0.588 . . . . 1.22 109.965 -179.417 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 588' ' ' ILE . . . . . 0.525 ' HB ' ' HG ' ' A' ' 597' ' ' SER . 12.9 tt -140.57 144.21 27.71 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 N-CA-C 109.841 -0.429 . . . . 1.34 109.841 -178.801 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 589' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -96.78 119.13 34.69 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 108.68 -0.859 . . . . 1.35 108.68 176.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 590' ' ' VAL . . . . . . . . . . . . . 56.3 t -125.1 118.83 54.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.997 -0.547 . . . . 1.3 109.989 -178.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 591' ' ' ASN . . . . . . . . . . . . . 12.3 m120 58.1 36.57 26.05 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.932 -0.577 . . . . 2.03 112.334 176.326 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . 86.57 6.65 80.18 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 121.194 -0.527 . . . . 0.62 113.682 175.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 593' ' ' LYS . . . . . . . . . . . . . 27.8 mtpp -129.1 146.39 51.06 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 117.204 0.502 . . . . 3.3 110.933 176.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 594' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -91.16 133.97 34.92 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.895 -0.593 . . . . 2.29 110.836 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 595' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -139.12 160.46 39.73 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.829 -0.623 . . . . 2.2 109.716 176.362 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 596' ' ' HIS . . . . . 0.742 ' HB2' ' SG ' ' A' ' 599' ' ' CYS . 37.7 m80 -67.16 130.5 43.32 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.314 -0.995 . . . . 0.76 108.314 169.229 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 597' ' ' SER . . . . . 0.525 ' HG ' ' HB ' ' A' ' 588' ' ' ILE . 11.4 m -60.75 -31.88 71.19 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.283 -0.417 . . . . 1.59 110.252 179.471 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 598' ' ' THR . . . . . . . . . . . . . 3.6 t -69.22 -35.23 75.97 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.397 0.618 . . . . 1.93 110.33 174.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 599' ' ' CYS . . . . . 0.742 ' SG ' ' HB2' ' A' ' 596' ' ' HIS . 91.2 m -73.98 -29.58 62.05 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.819 -0.628 . . . . 0.81 112.595 -176.162 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 600' ' ' TYR . . . . . . . . . . . . . 43.9 t80 -57.26 -35.0 69.2 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.125 -0.695 . . . . 2.65 109.125 -178.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 601' ' ' HIS . . . . . . . . . . . . . 45.4 m-70 -74.7 -41.16 60.71 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.638 -0.71 . . . . 5.16 111.814 176.15 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 602' ' ' GLU . . . . . 0.695 ' HG2' ' HA ' ' A' ' 599' ' ' CYS . 22.5 pt-20 -67.81 -25.72 65.71 Favored 'General case' 0 N--CA 1.467 0.411 0 O-C-N 122.094 -0.379 . . . . 3.85 110.87 -176.65 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 603' ' ' THR . . . . . . . . . . . . . 14.1 t . . . . . 0 CA--C 1.533 0.309 0 N-CA-C 111.994 0.368 . . . . 3.3 111.994 -179.639 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.452 0 N-CA-C 111.141 -0.784 . . . . 3.77 111.141 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 549' ' ' LYS . . . . . 0.425 ' HA ' ' HD3' ' A' ' 549' ' ' LYS . 37.1 mmtm -73.18 147.39 44.81 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-O 121.673 0.749 . . . . 6.2 111.061 179.82 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 550' ' ' TYR . . . . . 0.482 ' CE1' HG12 ' A' ' 583' ' ' VAL . 29.2 p90 -124.76 162.18 24.81 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 114.764 -1.107 . . . . 3.22 109.703 -175.73 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 551' ' ' VAL . . . . . 0.425 HG13 ' HE1' ' A' ' 594' ' ' TYR . 96.3 t -117.39 133.61 63.62 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 N-CA-C 109.016 -0.735 . . . . 2.01 109.016 175.863 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 552' ' ' VAL . . . . . 0.499 ' HA ' ' O ' ' A' ' 582' ' ' TRP . 56.9 t -62.99 132.15 28.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.928 -0.578 . . . . 1.8 109.802 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 553' ' ' VAL . . . . . 0.596 HG23 ' CD1' ' A' ' 584' ' ' TRP . 65.8 t -60.79 120.67 55.35 Favored Pre-proline 0 C--N 1.33 -0.247 0 O-C-N 123.74 0.65 . . . . 1.63 111.505 -175.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 554' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo . . . . . 0 N--CA 1.462 -0.331 0 C-N-CA 123.194 2.596 . . . . 2.2 111.939 176.169 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 560' ' ' MET . . . . . 0.515 ' HB3' HG13 ' A' ' 553' ' ' VAL . 65.3 mtt . . . . . 0 C--O 1.236 0.366 0 CA-C-O 121.553 0.692 . . . . 2.98 110.119 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 561' ' ' ALA . . . . . . . . . . . . . . . -144.98 161.73 38.65 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 115.279 -0.873 . . . . 1.46 110.902 -175.214 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 33.8 p90 -150.06 163.7 37.47 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 107.796 -1.187 . . . . 1.35 107.796 173.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 563' ' ' LYS . . . . . . . . . . . . . 7.7 ttmm -106.63 126.33 52.14 Favored 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 119.44 -0.904 . . . . 2.71 109.935 179.12 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 564' ' ' CYS . . . . . . . . . . . . . 48.6 t -69.3 112.06 10.62 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 115.523 -0.762 . . . . 0.41 109.601 -178.5 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 565' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -70.67 -29.9 18.87 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 123.318 2.678 . . . . 1.0 113.686 -173.525 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 566' ' ' ILE . . . . . . . . . . . . . 26.8 mt -70.74 -34.84 58.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.308 -0.405 . . . . 1.54 111.184 -172.497 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 567' ' ' CYS . . . . . 0.502 ' SG ' ' OE2' ' A' ' 569' ' ' GLU . 28.7 p -129.07 3.61 5.27 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 112.855 0.687 . . . . 0.7 112.855 -175.257 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 568' ' ' LYS . . . . . . . . . . . . . 61.9 mmtt 71.21 30.21 2.68 Favored 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 113.028 0.751 . . . . 3.19 113.028 175.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 569' ' ' GLU . . . . . 0.502 ' OE2' ' SG ' ' A' ' 567' ' ' CYS . 45.2 mt-10 -90.11 131.71 35.82 Favored 'General case' 0 N--CA 1.468 0.448 0 O-C-N 121.953 -0.467 . . . . 3.34 110.662 176.794 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 570' ' ' THR . . . . . . . . . . . . . 47.2 m -75.7 117.85 17.9 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 108.917 -0.772 . . . . 1.43 108.917 164.558 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 571' ' ' VAL . . . . . 0.413 HG22 ' CE1' ' A' ' 596' ' ' HIS . 20.2 t -100.66 116.49 44.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 120.808 0.337 . . . . 1.39 111.344 -172.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 33.4 p -110.41 160.01 16.97 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.908 -0.587 . . . . 2.17 109.914 176.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . -129.8 155.03 20.74 Favored Glycine 0 N--CA 1.442 -0.929 0 C-N-CA 119.761 -1.209 . . . . 2.2 111.875 -178.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 574' ' ' VAL . . . . . 0.463 ' O ' HG22 ' A' ' 583' ' ' VAL . 27.6 t -120.39 148.82 23.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-O 120.757 0.313 . . . . 3.64 110.234 -172.549 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 575' ' ' TYR . . . . . . . . . . . . . 66.2 t80 -83.69 119.14 24.41 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.5 -0.318 . . . . 3.53 110.261 177.079 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 576' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -94.99 114.23 26.02 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.772 -0.455 . . . . 3.34 109.772 178.133 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 577' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -69.21 -23.41 63.89 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.122 -0.49 . . . . 5.59 112.231 -174.347 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 578' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -74.7 -41.41 60.26 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.002 0.43 . . . . 5.11 110.773 -177.276 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 579' ' ' SER . . . . . . . . . . . . . 67.7 p -86.31 -25.58 25.37 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.228 -0.442 . . . . 3.7 110.938 176.46 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 580' ' ' GLY . . . . . . . . . . . . . . . 80.28 15.98 77.29 Favored Glycine 0 N--CA 1.451 -0.348 0 CA-C-N 115.865 -0.607 . . . . 2.89 112.584 179.006 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 581' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 -130.74 161.12 32.39 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.863 0.363 . . . . 3.19 110.386 -178.492 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 582' ' ' TRP . . . . . 0.499 ' O ' ' HA ' ' A' ' 552' ' ' VAL . 76.1 m95 -83.04 134.42 35.03 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.38 -0.6 . . . . 2.63 109.38 175.108 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 583' ' ' VAL . . . . . 0.482 HG12 ' CE1' ' A' ' 550' ' ' TYR . 16.9 m -113.17 133.63 58.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 N-CA-C 113.487 0.921 . . . . 1.67 113.487 -171.753 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 584' ' ' TRP . . . . . 0.596 ' CD1' HG23 ' A' ' 553' ' ' VAL . 29.0 m0 -108.44 101.35 10.54 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.114 -1.069 . . . . 2.74 108.114 161.154 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 585' ' ' LYS . . . . . 0.434 ' HD2' ' H ' ' A' ' 585' ' ' LYS . 0.0 OUTLIER -76.4 145.66 39.23 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.415 -0.357 . . . . 4.27 111.211 -174.281 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 586' ' ' ASN . . . . . . . . . . . . . 32.3 m-20 48.85 50.3 17.78 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 115.668 -0.696 . . . . 1.72 110.37 -179.692 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 587' ' ' THR . . . . . . . . . . . . . 45.5 m -127.1 142.72 51.45 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.674 -0.694 . . . . 1.22 109.948 -178.436 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 588' ' ' ILE . . . . . . . . . . . . . 13.3 tt -139.35 147.77 24.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 109.476 -0.564 . . . . 1.34 109.476 179.601 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 589' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -103.1 121.86 43.48 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.124 0.487 . . . . 1.35 109.799 178.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 590' ' ' VAL . . . . . . . . . . . . . 64.8 t -134.54 130.91 53.97 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.621 0 CA-C-N 115.537 -0.756 . . . . 1.3 109.144 178.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 591' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 59.19 33.24 22.63 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 121.391 0.615 . . . . 2.03 110.77 178.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . 77.22 11.92 85.08 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.937 -0.649 . . . . 0.62 112.487 178.332 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 593' ' ' LYS . . . . . . . . . . . . . 34.1 mmtp -126.42 139.68 53.07 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.777 0.322 . . . . 3.3 110.533 -178.057 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 594' ' ' TYR . . . . . 0.425 ' HE1' HG13 ' A' ' 551' ' ' VAL . 95.0 m-85 -89.85 132.06 35.46 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 116.067 -0.515 . . . . 2.29 110.273 177.695 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 595' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -134.94 154.63 51.63 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 108.914 -0.773 . . . . 2.2 108.914 175.405 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 596' ' ' HIS . . . . . 0.413 ' CE1' HG22 ' A' ' 571' ' ' VAL . 26.9 m170 -62.34 128.13 34.6 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 108.446 -0.946 . . . . 0.76 108.446 169.733 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 597' ' ' SER . . . . . . . . . . . . . 31.0 t -63.3 -29.96 71.18 Favored 'General case' 0 C--N 1.322 -0.592 0 O-C-N 123.701 0.626 . . . . 1.59 109.852 -177.274 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 598' ' ' THR . . . . . . . . . . . . . 1.8 t -67.09 -41.54 86.16 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 115.715 -0.675 . . . . 1.93 110.776 175.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 599' ' ' CYS . . . . . . . . . . . . . 74.2 m -75.82 -31.88 59.57 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.892 -0.595 . . . . 0.81 111.574 -177.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 600' ' ' TYR . . . . . . . . . . . . . 72.4 t80 -57.03 -33.1 66.86 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.038 -0.528 . . . . 2.65 112.067 -173.566 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 601' ' ' HIS . . . . . . . . . . . . . 33.7 m170 -58.46 -26.4 63.33 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 112.781 0.66 . . . . 5.16 112.781 -173.276 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 602' ' ' GLU . . . . . . . . . . . . . 3.0 pp20? -62.1 -30.54 71.08 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-O 120.949 0.404 . . . . 3.85 110.849 -178.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 603' ' ' THR . . . . . . . . . . . . . 1.1 m . . . . . 0 CA--C 1.537 0.469 0 CA-C-O 120.981 0.42 . . . . 3.3 111.161 -177.138 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.519 0.328 0 N-CA-C 113.676 0.231 . . . . 3.77 113.676 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 549' ' ' LYS . . . . . . . . . . . . . 28.8 mtpp -81.1 142.24 33.5 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 117.247 0.524 . . . . 6.2 110.931 177.393 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 550' ' ' TYR . . . . . 0.44 ' CE1' HG13 ' A' ' 583' ' ' VAL . 24.9 p90 -116.35 159.97 21.17 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.066 -0.716 . . . . 3.22 109.066 176.246 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 551' ' ' VAL . . . . . 0.742 HG13 ' HE1' ' A' ' 594' ' ' TYR . 39.9 t -119.97 136.58 56.59 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 N-CA-C 109.154 -0.684 . . . . 2.01 109.154 176.735 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 552' ' ' VAL . . . . . 0.559 ' HA ' ' O ' ' A' ' 582' ' ' TRP . 62.9 t -66.33 133.63 30.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 110.449 -0.204 . . . . 1.8 110.449 -178.796 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 553' ' ' VAL . . . . . 0.626 HG22 ' CD1' ' A' ' 584' ' ' TRP . 80.7 t -61.99 120.99 62.54 Favored Pre-proline 0 C--N 1.331 -0.227 0 CA-C-N 116.228 -0.442 . . . . 1.63 111.254 -177.386 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 554' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' A' ' 553' ' ' VAL . 7.1 Cg_exo . . . . . 0 N--CA 1.46 -0.483 0 C-N-CA 122.871 2.381 . . . . 2.2 112.45 179.19 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 560' ' ' MET . . . . . . . . . . . . . 2.1 mpt? . . . . . 0 C--O 1.234 0.266 0 CA-C-O 121.239 0.543 . . . . 2.98 110.311 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 561' ' ' ALA . . . . . . . . . . . . . . . -144.32 151.15 38.95 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 115.622 -0.717 . . . . 1.46 110.036 -176.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 45.9 p90 -128.2 150.27 50.09 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 110.015 -0.365 . . . . 1.35 110.015 177.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 563' ' ' LYS . . . . . 0.448 ' HE3' ' O ' ' A' ' 568' ' ' LYS . 47.5 tptt -89.6 113.81 25.3 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.001 -0.74 . . . . 2.71 109.001 -178.513 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 564' ' ' CYS . . . . . . . . . . . . . 47.1 t -62.56 113.55 9.29 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 116.461 -0.336 . . . . 0.41 110.902 -175.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 565' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -67.65 -27.95 38.03 Favored 'Trans proline' 0 CA--C 1.53 0.284 0 C-N-CA 123.074 2.516 . . . . 1.0 112.778 -176.026 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 566' ' ' ILE . . . . . . . . . . . . . 42.8 mt -71.73 -38.15 65.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 111.969 0.359 . . . . 1.54 111.969 -174.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 567' ' ' CYS . . . . . . . . . . . . . 28.5 p -129.2 1.08 5.18 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.427 0.528 . . . . 0.7 112.427 -174.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 568' ' ' LYS . . . . . 0.448 ' O ' ' HE3' ' A' ' 563' ' ' LYS . 50.3 mtpt 66.27 30.93 8.85 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 121.055 0.455 . . . . 3.19 111.753 176.105 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 569' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -105.67 135.23 47.46 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.003 -0.544 . . . . 3.34 110.933 179.215 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 570' ' ' THR . . . . . . . . . . . . . 41.4 m -71.1 118.78 14.32 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.331 -0.395 . . . . 1.43 110.598 179.217 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 571' ' ' VAL . . . . . 0.639 HG21 ' CE1' ' A' ' 596' ' ' HIS . 16.9 t -97.25 116.22 39.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 120.722 0.296 . . . . 1.39 110.635 -178.649 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 22.7 p -108.78 157.88 18.16 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.129 -0.487 . . . . 2.17 110.599 179.381 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 573' ' ' GLY . . . . . 0.466 ' HA3' ' HD1' ' A' ' 584' ' ' TRP . . . -131.24 156.06 21.61 Favored Glycine 0 N--CA 1.44 -1.069 0 N-CA-C 111.061 -0.816 . . . . 2.2 111.061 178.265 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 574' ' ' VAL . . . . . 0.519 ' O ' HG23 ' A' ' 583' ' ' VAL . 25.6 t -116.66 147.68 19.88 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 CA-C-O 120.8 0.334 . . . . 3.64 110.111 -172.9 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 575' ' ' TYR . . . . . . . . . . . . . 59.5 t80 -78.28 120.51 23.15 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.684 -0.487 . . . . 3.53 109.684 175.268 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 576' ' ' ASP . . . . . . . . . . . . . 15.4 t0 -91.16 114.67 27.25 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.071 0.462 . . . . 3.34 110.275 -179.333 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 577' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -66.98 -23.31 65.93 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.491 -0.777 . . . . 5.59 111.144 -179.574 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 578' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -75.83 -48.51 21.27 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.444 -0.344 . . . . 5.11 111.083 -174.192 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 579' ' ' SER . . . . . . . . . . . . . 75.4 p -87.37 -24.41 24.25 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.295 0.569 . . . . 3.7 110.8 177.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 580' ' ' GLY . . . . . . . . . . . . . . . 80.26 23.04 61.73 Favored Glycine 0 N--CA 1.447 -0.626 0 CA-C-N 115.407 -0.815 . . . . 2.89 111.86 -177.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 581' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -131.16 160.02 36.0 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.882 0.372 . . . . 3.19 110.157 -179.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 582' ' ' TRP . . . . . 0.559 ' O ' ' HA ' ' A' ' 552' ' ' VAL . 76.5 m95 -82.09 135.43 35.31 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.846 -0.427 . . . . 2.63 109.846 176.634 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 583' ' ' VAL . . . . . 0.519 HG23 ' O ' ' A' ' 574' ' ' VAL . 20.0 m -112.86 131.6 63.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 N-CA-C 112.775 0.657 . . . . 1.67 112.775 -174.841 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 584' ' ' TRP . . . . . 0.626 ' CD1' HG22 ' A' ' 553' ' ' VAL . 15.9 m0 -105.01 102.99 12.46 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 108.943 -0.762 . . . . 2.74 108.943 164.074 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 585' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.5 151.62 19.6 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.391 -0.822 . . . . 4.27 111.43 -175.248 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 586' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 53.27 41.15 32.15 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 115.521 -0.763 . . . . 1.72 109.026 -172.314 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 587' ' ' THR . . . . . . . . . . . . . 36.1 m -128.86 140.83 51.51 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.492 -0.776 . . . . 1.22 110.203 -175.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 588' ' ' ILE . . . . . 0.552 ' HB ' ' HB3' ' A' ' 597' ' ' SER . 12.5 tt -131.52 144.37 37.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 N-CA-C 109.228 -0.656 . . . . 1.34 109.228 178.047 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 589' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -106.57 120.06 40.94 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.254 0.55 . . . . 1.35 109.847 178.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 590' ' ' VAL . . . . . . . . . . . . . 54.9 t -128.16 120.37 53.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.262 -0.881 . . . . 1.3 109.995 -179.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 591' ' ' ASN . . . . . . . . . . . . . 2.3 t30 59.23 40.68 21.21 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 115.969 -0.56 . . . . 2.03 111.1 177.217 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . 78.82 10.06 86.52 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.94 -0.647 . . . . 0.62 112.4 175.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 593' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -126.28 144.3 50.84 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-O 121.174 0.512 . . . . 3.3 110.981 -178.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 594' ' ' TYR . . . . . 0.742 ' HE1' HG13 ' A' ' 551' ' ' VAL . 97.5 m-85 -101.29 135.13 43.27 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.784 -0.644 . . . . 2.29 110.725 -177.848 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 595' ' ' PHE . . . . . . . . . . . . . 59.9 m-85 -139.55 158.24 44.46 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 108.548 -0.908 . . . . 2.2 108.548 177.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 596' ' ' HIS . . . . . 0.639 ' CE1' HG21 ' A' ' 571' ' ' VAL . 15.4 m170 -61.18 127.03 29.52 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.341 -0.985 . . . . 0.76 108.341 168.661 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 597' ' ' SER . . . . . 0.552 ' HB3' ' HB ' ' A' ' 588' ' ' ILE . 8.7 p -66.37 -29.31 69.46 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.068 0.461 . . . . 1.59 109.879 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 598' ' ' THR . . . . . . . . . . . . . 1.1 t -69.0 -32.48 72.07 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 115.273 -0.876 . . . . 1.93 109.93 176.321 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 599' ' ' CYS . . . . . 0.448 ' SG ' ' HB2' ' A' ' 596' ' ' HIS . 84.9 m -78.82 -29.06 44.56 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 113.81 1.041 . . . . 0.81 113.81 -179.323 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 600' ' ' TYR . . . . . 0.445 ' O ' HG21 ' A' ' 603' ' ' THR . 87.3 t80 -54.64 -35.98 64.06 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 113.678 0.992 . . . . 2.65 113.678 -164.304 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 601' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -60.22 -25.15 65.41 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 112.267 0.469 . . . . 5.16 112.267 -177.415 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 602' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -61.7 -38.19 86.94 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 120.981 0.419 . . . . 3.85 111.357 179.188 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 603' ' ' THR . . . . . 0.445 HG21 ' O ' ' A' ' 600' ' ' TYR . 11.5 t . . . . . 0 C--O 1.236 0.352 0 CA-C-N 116.483 -0.326 . . . . 3.3 111.344 -177.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.455 0 N-CA-C 111.754 -0.538 . . . . 3.77 111.754 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 549' ' ' LYS . . . . . . . . . . . . . 9.1 mtmp? -68.91 149.78 48.49 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.896 -0.409 . . . . 6.2 109.896 177.358 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 550' ' ' TYR . . . . . 0.489 ' CE1' HG12 ' A' ' 583' ' ' VAL . 38.0 p90 -114.75 160.21 19.67 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 115.941 -0.572 . . . . 3.22 110.402 -176.087 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 551' ' ' VAL . . . . . . . . . . . . . 65.5 t -117.76 133.76 63.5 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 N-CA-C 108.493 -0.928 . . . . 2.01 108.493 175.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 552' ' ' VAL . . . . . 0.617 ' HA ' ' O ' ' A' ' 582' ' ' TRP . 28.3 t -61.95 134.88 27.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 116.315 -0.402 . . . . 1.8 110.08 -177.573 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 553' ' ' VAL . . . . . 0.577 HG22 ' CD1' ' A' ' 584' ' ' TRP . 89.0 t -61.6 119.19 44.96 Favored Pre-proline 0 N--CA 1.451 -0.411 0 N-CA-C 109.648 -0.501 . . . . 1.63 109.648 -179.688 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 554' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo . . . . . 0 N--CA 1.46 -0.458 0 C-N-CA 122.878 2.385 . . . . 2.2 112.779 -178.509 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 560' ' ' MET . . . . . . . . . . . . . 56.9 mtm . . . . . 0 N--CA 1.469 0.478 0 CA-C-O 120.787 0.327 . . . . 2.98 111.317 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 561' ' ' ALA . . . . . . . . . . . . . . . -145.55 156.63 43.81 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.199 -0.455 . . . . 1.46 111.485 -176.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 24.1 p90 -141.9 156.77 45.5 Favored 'General case' 0 C--O 1.225 -0.218 0 N-CA-C 108.131 -1.063 . . . . 1.35 108.131 172.306 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 563' ' ' LYS . . . . . 0.513 ' HA ' ' HA ' ' A' ' 570' ' ' THR . 36.5 ttmt -99.83 128.04 45.95 Favored 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 119.752 -0.779 . . . . 2.71 110.444 -178.773 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 564' ' ' CYS . . . . . . . . . . . . . 50.0 t -72.12 118.05 63.77 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 115.834 -0.621 . . . . 0.41 110.395 179.275 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 565' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -72.13 -27.62 16.69 Favored 'Trans proline' 0 CA--C 1.531 0.372 0 C-N-CA 123.026 2.484 . . . . 1.0 114.209 -173.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 566' ' ' ILE . . . . . 0.437 HD13 ' HB3' ' A' ' 599' ' ' CYS . 71.2 mt -82.2 -52.36 13.67 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 N-CA-C 112.271 0.471 . . . . 1.54 112.271 -172.257 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 567' ' ' CYS . . . . . . . . . . . . . 29.5 p -104.59 0.82 29.0 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 121.063 0.459 . . . . 0.7 110.787 -179.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 568' ' ' LYS . . . . . . . . . . . . . 28.3 mtpp 69.93 29.27 4.0 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 113.623 0.971 . . . . 3.19 113.623 166.091 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 569' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -101.39 132.96 46.7 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.669 -0.412 . . . . 3.34 110.18 175.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 570' ' ' THR . . . . . 0.513 ' HA ' ' HA ' ' A' ' 563' ' ' LYS . 55.8 m -70.82 118.4 13.55 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.517 -0.549 . . . . 1.43 109.517 173.21 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 571' ' ' VAL . . . . . . . . . . . . . 22.4 t -91.02 116.18 31.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-O 121.0 0.428 . . . . 1.39 110.539 -176.389 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 30.6 p -106.68 159.5 16.16 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.504 -0.771 . . . . 2.17 109.068 175.122 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . -129.76 154.66 20.56 Favored Glycine 0 N--CA 1.439 -1.107 0 C-N-CA 119.689 -1.243 . . . . 2.2 111.599 -178.366 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 574' ' ' VAL . . . . . 0.434 ' O ' HG22 ' A' ' 583' ' ' VAL . 22.6 t -114.25 151.9 15.98 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 N-CA-C 109.874 -0.417 . . . . 3.64 109.874 -175.061 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 575' ' ' TYR . . . . . . . . . . . . . 39.8 t80 -83.73 122.47 28.68 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 116.29 -0.413 . . . . 3.53 110.077 176.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 576' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -91.31 112.85 24.94 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 108.674 -0.861 . . . . 3.34 108.674 175.121 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 577' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -69.73 -35.56 75.1 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.38 -0.827 . . . . 5.59 112.524 -169.035 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 578' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -75.39 -35.51 61.04 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.881 -0.328 . . . . 5.11 111.566 -174.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 579' ' ' SER . . . . . . . . . . . . . 77.1 p -82.53 -24.69 33.95 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.92 0.39 . . . . 3.7 110.486 179.228 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 580' ' ' GLY . . . . . . . . . . . . . . . 80.66 20.66 65.56 Favored Glycine 0 N--CA 1.452 -0.285 0 CA-C-N 115.574 -0.739 . . . . 2.89 112.914 177.147 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 581' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -145.85 154.8 42.38 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.845 0.355 . . . . 3.19 111.072 179.545 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 582' ' ' TRP . . . . . 0.617 ' O ' ' HA ' ' A' ' 552' ' ' VAL . 64.9 m95 -77.34 150.78 35.14 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.088 -0.506 . . . . 2.63 110.509 -177.833 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 583' ' ' VAL . . . . . 0.489 HG12 ' CE1' ' A' ' 550' ' ' TYR . 21.4 m -123.9 133.04 70.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 113.564 0.95 . . . . 1.67 113.564 -173.285 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 584' ' ' TRP . . . . . 0.577 ' CD1' HG22 ' A' ' 553' ' ' VAL . 24.1 m0 -116.2 103.79 10.87 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 114.854 -1.066 . . . . 2.74 108.566 164.124 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 585' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -87.25 150.2 24.06 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 120.419 -0.513 . . . . 4.27 111.136 -175.003 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 586' ' ' ASN . . . . . . . . . . . . . 14.1 m120 54.37 41.29 32.05 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 115.545 -0.752 . . . . 1.72 110.495 -175.101 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 587' ' ' THR . . . . . . . . . . . . . 44.3 m -119.76 142.53 48.47 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.756 -0.656 . . . . 1.22 110.341 -177.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 588' ' ' ILE . . . . . . . . . . . . . 15.3 tt -133.75 148.19 30.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 N-CA-C 109.424 -0.584 . . . . 1.34 109.424 -179.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 589' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -115.33 118.75 34.13 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.519 -0.548 . . . . 1.35 109.519 177.901 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 590' ' ' VAL . . . . . . . . . . . . . 44.0 t -125.14 118.84 54.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.505 -0.77 . . . . 1.3 110.019 -177.439 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 591' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 58.2 36.99 26.19 Favored 'General case' 0 C--O 1.235 0.306 0 O-C-N 123.482 0.489 . . . . 2.03 111.864 177.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . 85.66 8.41 80.18 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.967 -0.635 . . . . 0.62 113.271 174.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 593' ' ' LYS . . . . . . . . . . . . . 60.1 mttm -125.55 139.76 53.33 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.158 0.504 . . . . 3.3 111.461 178.55 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 594' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -93.67 133.28 37.19 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.165 -0.925 . . . . 2.29 110.784 -178.385 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 595' ' ' PHE . . . . . . . . . . . . . 81.2 m-85 -139.98 160.14 40.59 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.194 -0.912 . . . . 2.2 108.896 177.262 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 596' ' ' HIS . . . . . 0.52 ' HB3' HG23 ' A' ' 598' ' ' THR . 9.3 m170 -66.32 128.69 37.12 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 108.579 -0.897 . . . . 0.76 108.579 167.849 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 597' ' ' SER . . . . . . . . . . . . . 40.2 t -61.71 -32.48 72.7 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.8 -0.637 . . . . 1.59 109.696 -178.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 598' ' ' THR . . . . . 0.52 HG23 ' HB3' ' A' ' 596' ' ' HIS . 11.1 t -67.82 -35.33 78.41 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-N 115.332 -0.849 . . . . 1.93 110.091 177.637 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 599' ' ' CYS . . . . . 0.583 ' HA ' ' HB3' ' A' ' 602' ' ' GLU . 72.7 m -76.13 -31.98 58.9 Favored 'General case' 0 N--CA 1.457 -0.091 0 N-CA-C 112.228 0.455 . . . . 0.81 112.228 -179.048 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 600' ' ' TYR . . . . . . . . . . . . . 71.1 t80 -67.37 -36.26 80.99 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.009 -0.737 . . . . 2.65 109.009 -178.355 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 601' ' ' HIS . . . . . . . . . . . . . 64.5 t60 -72.48 -32.06 65.9 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.134 -0.939 . . . . 5.16 109.656 174.135 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 602' ' ' GLU . . . . . 0.583 ' HB3' ' HA ' ' A' ' 599' ' ' CYS . 0.7 OUTLIER -61.83 -37.59 85.02 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 115.463 -0.79 . . . . 3.85 111.745 177.475 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 603' ' ' THR . . . . . . . . . . . . . 14.5 t . . . . . 0 C--N 1.324 -0.542 0 N-CA-C 112.391 0.515 . . . . 3.3 112.391 -173.157 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.284 0 N-CA-C 112.998 -0.041 . . . . 3.77 112.998 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 549' ' ' LYS . . . . . . . . . . . . . 89.1 mttt -80.26 144.08 33.17 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.954 0.407 . . . . 6.2 110.342 174.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 550' ' ' TYR . . . . . 0.513 ' HH ' ' CD ' ' A' ' 581' ' ' GLU . 30.2 p90 -118.5 161.03 20.69 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 108.649 -0.871 . . . . 3.22 108.649 179.495 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 551' ' ' VAL . . . . . . . . . . . . . 62.7 t -118.24 133.18 65.87 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.971 0 N-CA-C 109.485 -0.561 . . . . 2.01 109.485 177.706 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 552' ' ' VAL . . . . . 0.459 ' HA ' ' O ' ' A' ' 582' ' ' TRP . 33.1 t -67.97 126.04 26.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-O 120.666 0.27 . . . . 1.8 110.549 -177.61 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 553' ' ' VAL . . . . . 0.649 HG22 ' CD1' ' A' ' 584' ' ' TRP . 47.3 t -61.91 126.37 87.1 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 115.828 -0.624 . . . . 1.63 111.415 -176.145 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 554' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 553' ' ' VAL . 16.5 Cg_exo . . . . . 0 C--O 1.233 0.27 0 C-N-CA 123.0 2.467 . . . . 2.2 111.464 175.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 560' ' ' MET . . . . . . . . . . . . . 4.5 mpp? . . . . . 0 N--CA 1.467 0.404 0 N-CA-C 111.935 0.346 . . . . 2.98 111.935 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 561' ' ' ALA . . . . . . . . . . . . . . . -144.29 145.75 32.2 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.314 -0.403 . . . . 1.46 110.08 178.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 44.5 p90 -137.42 155.32 49.49 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.315 -0.402 . . . . 1.35 109.938 178.224 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 563' ' ' LYS . . . . . . . . . . . . . 13.9 tppt? -90.01 125.55 35.43 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.771 0.32 . . . . 2.71 110.33 -179.354 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 564' ' ' CYS . . . . . . . . . . . . . 40.6 t -63.57 114.78 14.32 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 115.908 -0.587 . . . . 0.41 109.596 176.121 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 565' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -69.8 -17.61 37.3 Favored 'Trans proline' 0 CA--C 1.527 0.164 0 C-N-CA 122.588 2.192 . . . . 1.0 113.157 -172.498 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 566' ' ' ILE . . . . . 0.446 HG22 ' HG2' ' A' ' 602' ' ' GLU . 55.5 mt -81.48 -44.33 20.43 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 N-CA-C 111.807 0.299 . . . . 1.54 111.807 -176.832 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 567' ' ' CYS . . . . . 0.494 ' SG ' ' HG3' ' A' ' 569' ' ' GLU . 27.9 p -129.8 1.83 4.89 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.447 0.536 . . . . 0.7 112.447 -174.044 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 568' ' ' LYS . . . . . . . . . . . . . 40.0 mtmt 68.08 30.77 5.74 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 113.433 0.901 . . . . 3.19 113.433 173.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 569' ' ' GLU . . . . . 0.494 ' HG3' ' SG ' ' A' ' 567' ' ' CYS . 32.7 mt-10 -80.17 135.8 36.36 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 108.932 -0.766 . . . . 3.34 108.932 169.635 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 570' ' ' THR . . . . . . . . . . . . . 90.1 m -78.31 117.88 19.97 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 109.083 -0.71 . . . . 1.43 109.083 170.753 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 571' ' ' VAL . . . . . . . . . . . . . 39.6 t -90.03 116.12 30.8 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 N-CA-C 110.008 -0.368 . . . . 1.39 110.008 -178.492 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 32.0 p -115.19 158.0 22.87 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.984 -0.553 . . . . 2.17 110.017 179.753 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . -130.07 155.11 20.85 Favored Glycine 0 N--CA 1.436 -1.318 0 C-N-CA 120.05 -1.071 . . . . 2.2 111.529 178.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 574' ' ' VAL . . . . . . . . . . . . . 42.2 t -115.87 147.56 19.18 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 N-CA-C 109.63 -0.507 . . . . 3.64 109.63 -173.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 575' ' ' TYR . . . . . . . . . . . . . 51.5 t80 -83.76 118.32 23.83 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 108.82 -0.807 . . . . 3.53 108.82 173.26 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 576' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -95.71 107.05 19.23 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.033 -0.729 . . . . 3.34 109.033 178.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 577' ' ' GLU . . . . . . . . . . . . . 38.3 mp0 -68.56 -23.3 64.48 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.824 -0.625 . . . . 5.59 111.943 -173.567 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 578' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -76.05 -34.7 59.63 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.603 0.239 . . . . 5.11 111.256 -177.525 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 579' ' ' SER . . . . . . . . . . . . . 67.5 p -93.75 -23.42 18.2 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.097 0.475 . . . . 3.7 110.546 175.512 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 580' ' ' GLY . . . . . . . . . . . . . . . 80.44 26.81 53.71 Favored Glycine 0 N--CA 1.449 -0.462 0 CA-C-N 115.608 -0.723 . . . . 2.89 112.929 176.449 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 581' ' ' GLU . . . . . 0.513 ' CD ' ' HH ' ' A' ' 550' ' ' TYR . 10.9 pt-20 -145.87 161.6 39.63 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 117.16 0.48 . . . . 3.19 111.421 -179.69 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 582' ' ' TRP . . . . . 0.508 ' CB ' ' HB ' ' A' ' 553' ' ' VAL . 80.4 m95 -83.93 139.12 32.79 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-N 115.887 -0.597 . . . . 2.63 110.37 177.605 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 583' ' ' VAL . . . . . 0.409 HG22 ' O ' ' A' ' 583' ' ' VAL . 26.6 m -121.04 130.15 74.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 N-CA-C 112.971 0.73 . . . . 1.67 112.971 -174.773 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 584' ' ' TRP . . . . . 0.649 ' CD1' HG22 ' A' ' 553' ' ' VAL . 14.7 m0 -104.82 103.5 13.11 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 108.605 -0.887 . . . . 2.74 108.605 162.835 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 585' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -94.83 153.75 17.58 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.637 -0.711 . . . . 4.27 111.241 -175.334 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 586' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 55.56 40.75 31.14 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 108.799 -0.815 . . . . 1.72 108.799 -170.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 587' ' ' THR . . . . . . . . . . . . . 26.6 m -134.88 141.45 46.34 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.393 -0.821 . . . . 1.22 110.396 -173.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 588' ' ' ILE . . . . . 0.401 HG21 ' HA ' ' A' ' 597' ' ' SER . 13.7 tt -141.58 148.92 20.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 109.665 -0.494 . . . . 1.34 109.665 -179.552 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 589' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -94.34 118.7 32.01 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.93 0.395 . . . . 1.35 110.016 176.209 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 590' ' ' VAL . . . . . . . . . . . . . 59.9 t -126.5 127.25 70.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.888 -0.596 . . . . 1.3 109.451 179.488 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 591' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 59.46 37.25 23.11 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-O 121.554 0.692 . . . . 2.03 110.313 -179.689 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . 73.42 12.04 80.03 Favored Glycine 0 C--N 1.333 0.364 0 CA-C-N 115.588 -0.733 . . . . 0.62 112.952 177.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 593' ' ' LYS . . . . . . . . . . . . . 46.3 mtmt -127.74 143.45 51.14 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.861 0.362 . . . . 3.3 110.372 -177.005 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 594' ' ' TYR . . . . . . . . . . . . . 56.0 m-85 -86.59 125.51 33.86 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.955 0.407 . . . . 2.29 110.853 -178.696 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 595' ' ' PHE . . . . . . . . . . . . . 63.7 m-85 -136.41 160.49 38.57 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.634 -0.712 . . . . 2.2 110.044 179.593 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 596' ' ' HIS . . . . . . . . . . . . . 4.2 m170 -62.34 127.16 30.02 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.476 -0.565 . . . . 0.76 109.476 172.664 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 597' ' ' SER . . . . . 0.401 ' HA ' HG21 ' A' ' 588' ' ' ILE . 31.8 t -66.55 -32.04 73.14 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.849 -0.614 . . . . 1.59 109.776 179.45 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 598' ' ' THR . . . . . . . . . . . . . 13.0 t -69.13 -35.19 76.12 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 115.274 -0.875 . . . . 1.93 110.356 179.714 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 599' ' ' CYS . . . . . . . . . . . . . 73.4 m -75.92 -29.73 58.49 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.596 -0.729 . . . . 0.81 112.591 -176.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 600' ' ' TYR . . . . . 0.45 ' O ' HG21 ' A' ' 603' ' ' THR . 71.0 t80 -54.54 -31.73 56.93 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.868 0.366 . . . . 2.65 111.763 -172.559 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 601' ' ' HIS . . . . . . . . . . . . . 12.6 m170 -59.43 -27.29 65.91 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 111.927 0.343 . . . . 5.16 111.927 -179.425 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 602' ' ' GLU . . . . . 0.446 ' HG2' HG22 ' A' ' 566' ' ' ILE . 1.1 pp20? -70.18 -32.83 70.94 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 120.906 -0.317 . . . . 3.85 111.384 -175.389 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 603' ' ' THR . . . . . 0.45 HG21 ' O ' ' A' ' 600' ' ' TYR . 11.4 t . . . . . 0 C--N 1.329 -0.305 0 CA-C-O 120.922 0.391 . . . . 3.3 110.977 -176.77 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.506 0 N-CA-C 112.381 -0.288 . . . . 3.77 112.381 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 549' ' ' LYS . . . . . . . . . . . . . 31.3 mmmt -80.65 137.11 36.32 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 121.113 0.482 . . . . 6.2 110.491 177.528 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 550' ' ' TYR . . . . . . . . . . . . . 49.9 p90 -109.6 159.77 16.82 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 108.405 -0.961 . . . . 3.22 108.405 176.194 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 551' ' ' VAL . . . . . . . . . . . . . 55.1 t -117.17 133.21 64.63 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.106 0 N-CA-C 109.033 -0.729 . . . . 2.01 109.033 179.632 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 552' ' ' VAL . . . . . 0.712 ' HA ' ' O ' ' A' ' 582' ' ' TRP . 39.1 t -66.98 130.09 32.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.972 -0.558 . . . . 1.8 109.612 -179.122 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 553' ' ' VAL . . . . . 0.593 HG23 ' CD1' ' A' ' 584' ' ' TRP . 59.1 t -59.0 119.44 38.09 Favored Pre-proline 0 N--CA 1.452 -0.342 0 O-C-N 123.409 0.443 . . . . 1.63 110.016 -176.655 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 554' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 553' ' ' VAL . 33.0 Cg_exo . . . . . 0 N--CA 1.459 -0.552 0 C-N-CA 122.945 2.43 . . . . 2.2 112.132 -178.192 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 560' ' ' MET . . . . . . . . . . . . . 4.3 mpp? . . . . . 0 N--CA 1.465 0.312 0 CA-C-O 120.843 0.354 . . . . 2.98 111.907 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 561' ' ' ALA . . . . . . . . . . . . . . . -144.75 155.24 43.43 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 116.258 -0.428 . . . . 1.46 110.817 -176.317 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 29.3 p90 -138.7 164.59 29.14 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.413 -0.588 . . . . 1.35 109.413 174.38 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 563' ' ' LYS . . . . . . . . . . . . . 21.9 tptm -103.06 125.07 49.63 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 109.983 -0.377 . . . . 2.71 109.983 -178.446 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 564' ' ' CYS . . . . . . . . . . . . . 48.8 t -80.09 113.38 38.01 Favored Pre-proline 0 C--N 1.327 -0.412 0 N-CA-C 109.512 -0.551 . . . . 0.41 109.512 -179.663 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 565' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -71.88 -28.67 16.24 Favored 'Trans proline' 0 CA--C 1.528 0.217 0 C-N-CA 122.667 2.245 . . . . 1.0 113.954 -172.13 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 566' ' ' ILE . . . . . . . . . . . . . 28.5 mt -72.67 -37.7 56.59 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 CA-C-O 121.069 0.462 . . . . 1.54 111.671 -172.662 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 567' ' ' CYS . . . . . 0.58 ' SG ' ' HG3' ' A' ' 569' ' ' GLU . 27.8 p -127.43 1.27 6.29 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.534 -0.303 . . . . 0.7 111.567 -175.309 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 568' ' ' LYS . . . . . . . . . . . . . 29.1 mtpp 67.45 27.45 8.01 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 115.934 -0.576 . . . . 3.19 112.429 175.272 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 569' ' ' GLU . . . . . 0.58 ' HG3' ' SG ' ' A' ' 567' ' ' CYS . 51.1 mt-10 -79.07 136.43 37.16 Favored 'General case' 0 CA--C 1.516 -0.336 0 N-CA-C 109.944 -0.391 . . . . 3.34 109.944 174.692 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 570' ' ' THR . . . . . . . . . . . . . 47.4 m -87.99 116.58 26.26 Favored 'General case' 0 C--N 1.314 -0.977 0 N-CA-C 107.835 -1.172 . . . . 1.43 107.835 171.736 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 571' ' ' VAL . . . . . 0.459 HG23 ' CE1' ' A' ' 596' ' ' HIS . 16.8 t -97.78 115.73 38.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 C-N-CA 120.668 -0.413 . . . . 1.39 110.962 -171.477 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 23.8 p -109.76 158.82 17.73 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 109.183 -0.673 . . . . 2.17 109.183 174.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . -131.21 155.15 21.16 Favored Glycine 0 N--CA 1.443 -0.896 0 C-N-CA 120.04 -1.076 . . . . 2.2 112.132 -178.2 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 574' ' ' VAL . . . . . . . . . . . . . 39.5 t -112.35 152.81 14.1 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 N-CA-C 109.432 -0.581 . . . . 3.64 109.432 -175.632 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 575' ' ' TYR . . . . . . . . . . . . . 50.7 t80 -84.52 119.84 25.64 Favored 'General case' 0 C--N 1.315 -0.891 0 N-CA-C 109.953 -0.388 . . . . 3.53 109.953 176.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 576' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -90.3 97.96 11.49 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 108.277 -1.009 . . . . 3.34 108.277 178.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 577' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -65.92 -22.85 66.53 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.354 -0.839 . . . . 5.59 111.851 -172.834 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 578' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -73.32 -48.09 37.25 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.014 0.435 . . . . 5.11 110.116 -178.27 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 579' ' ' SER . . . . . . . . . . . . . 74.5 p -84.05 -19.88 33.64 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.922 0.391 . . . . 3.7 111.023 178.109 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 580' ' ' GLY . . . . . . . . . . . . . . . 80.24 22.65 62.53 Favored Glycine 0 N--CA 1.449 -0.451 0 CA-C-N 115.795 -0.639 . . . . 2.89 112.266 179.048 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 581' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -130.59 147.83 52.31 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-O 121.32 0.581 . . . . 3.19 111.009 -177.274 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 582' ' ' TRP . . . . . 0.712 ' O ' ' HA ' ' A' ' 552' ' ' VAL . 88.4 m95 -72.05 143.82 48.97 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 108.591 -0.892 . . . . 2.63 108.591 168.815 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 583' ' ' VAL . . . . . 0.614 HG21 ' HE2' ' A' ' 585' ' ' LYS . 24.4 m -124.08 133.19 69.96 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 N-CA-C 113.679 0.992 . . . . 1.67 113.679 -174.493 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 584' ' ' TRP . . . . . 0.593 ' CD1' HG23 ' A' ' 553' ' ' VAL . 30.9 m0 -110.51 104.1 12.79 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 114.912 -1.04 . . . . 2.74 108.338 163.067 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 585' ' ' LYS . . . . . 0.614 ' HE2' HG21 ' A' ' 583' ' ' VAL . 66.9 mmtt -83.38 151.49 25.5 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-O 120.495 0.188 . . . . 4.27 110.611 -176.54 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 586' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 50.27 44.86 26.36 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 115.887 -0.597 . . . . 1.72 110.124 -175.517 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 587' ' ' THR . . . . . . . . . . . . . 75.3 m -125.83 140.94 52.25 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.15 -0.477 . . . . 1.22 110.679 -176.394 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 588' ' ' ILE . . . . . 0.447 ' HB ' ' HB3' ' A' ' 597' ' ' SER . 12.7 tt -136.05 146.13 29.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 N-CA-C 109.482 -0.562 . . . . 1.34 109.482 179.025 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 589' ' ' GLU . . . . . . . . . . . . . 46.2 tt0 -100.45 121.5 41.65 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.219 -0.66 . . . . 1.35 109.219 174.329 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 590' ' ' VAL . . . . . . . . . . . . . 52.7 t -124.35 118.19 52.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 109.947 -0.39 . . . . 1.3 109.947 -179.185 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 591' ' ' ASN . . . . . . . . . . . . . 60.0 t30 58.12 37.51 26.4 Favored 'General case' 0 C--N 1.328 -0.327 0 O-C-N 123.912 0.757 . . . . 2.03 110.852 178.67 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . 85.25 0.88 88.51 Favored Glycine 0 N--CA 1.452 -0.256 0 CA-C-N 115.844 -0.616 . . . . 0.62 113.718 176.462 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 593' ' ' LYS . . . . . . . . . . . . . 61.8 mttp -118.71 147.69 43.56 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 117.245 0.523 . . . . 3.3 111.104 -179.129 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 594' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -96.53 135.64 38.14 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.018 0.437 . . . . 2.29 111.219 -175.581 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 595' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 -143.87 155.02 43.96 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.337 -0.847 . . . . 2.2 109.322 178.57 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 596' ' ' HIS . . . . . 0.459 ' CE1' HG23 ' A' ' 571' ' ' VAL . 16.7 m170 -64.66 127.24 30.69 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 107.972 -1.121 . . . . 0.76 107.972 166.579 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 597' ' ' SER . . . . . 0.447 ' HB3' ' HB ' ' A' ' 588' ' ' ILE . 7.7 p -66.02 -32.02 73.26 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.043 0.449 . . . . 1.59 110.002 -178.906 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 598' ' ' THR . . . . . . . . . . . . . 97.1 m -61.12 -43.25 99.17 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.265 -0.879 . . . . 1.93 110.345 173.694 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 599' ' ' CYS . . . . . 0.512 ' O ' ' HB3' ' A' ' 602' ' ' GLU . 83.9 m -74.74 -30.46 61.51 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.779 -0.646 . . . . 0.81 111.289 -179.775 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 600' ' ' TYR . . . . . . . . . . . . . 88.0 t80 -59.28 -35.87 74.52 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.179 0.514 . . . . 2.65 109.908 177.572 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 601' ' ' HIS . . . . . . . . . . . . . 67.3 t60 -71.22 -29.51 65.23 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.811 -0.631 . . . . 5.16 110.506 176.562 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 602' ' ' GLU . . . . . 0.512 ' HB3' ' O ' ' A' ' 599' ' ' CYS . 2.0 tp10 -61.89 -37.21 83.74 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.923 -0.581 . . . . 3.85 111.149 178.639 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 603' ' ' THR . . . . . . . . . . . . . 12.3 t . . . . . 0 C--N 1.328 -0.343 0 CA-C-N 116.447 -0.342 . . . . 3.3 111.102 -179.05 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.5 0 N-CA-C 111.818 -0.513 . . . . 3.77 111.818 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 549' ' ' LYS . . . . . . . . . . . . . 68.4 mmtt -64.01 149.37 47.57 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-O 121.338 0.589 . . . . 6.2 111.085 178.813 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 550' ' ' TYR . . . . . . . . . . . . . 39.7 p90 -122.38 159.94 26.47 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.277 -0.874 . . . . 3.22 109.745 179.181 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 551' ' ' VAL . . . . . . . . . . . . . 60.6 t -118.15 133.35 65.21 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.925 0 N-CA-C 108.527 -0.916 . . . . 2.01 108.527 177.551 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 552' ' ' VAL . . . . . 0.641 ' HA ' ' O ' ' A' ' 582' ' ' TRP . 42.0 t -67.8 134.24 30.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 116.122 -0.49 . . . . 1.8 109.741 -177.426 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 553' ' ' VAL . . . . . 0.54 HG12 ' HB3' ' A' ' 560' ' ' MET . 63.2 t -59.46 121.68 58.57 Favored Pre-proline 0 C--N 1.325 -0.461 0 O-C-N 123.682 0.613 . . . . 1.63 111.391 -175.813 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 554' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 553' ' ' VAL . 31.6 Cg_exo . . . . . 0 C--N 1.343 0.272 0 C-N-CA 123.559 2.839 . . . . 2.2 112.607 179.148 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 560' ' ' MET . . . . . 0.54 ' HB3' HG12 ' A' ' 553' ' ' VAL . 60.1 mtt . . . . . 0 C--O 1.234 0.285 0 CA-C-O 120.912 0.387 . . . . 2.98 111.266 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 561' ' ' ALA . . . . . 0.409 ' HB1' HG22 ' A' ' 572' ' ' THR . . . -144.3 161.95 37.65 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 116.072 -0.513 . . . . 1.46 111.443 -177.627 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 31.2 p90 -143.83 153.06 41.97 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.968 -0.753 . . . . 1.35 108.968 173.242 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 563' ' ' LYS . . . . . 0.511 ' HA ' ' HA ' ' A' ' 570' ' ' THR . 16.0 tppt? -88.89 126.47 35.4 Favored 'General case' 0 C--N 1.317 -0.841 0 C-N-CA 120.705 -0.398 . . . . 2.71 110.189 177.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 564' ' ' CYS . . . . . 0.435 ' HA ' ' HD3' ' A' ' 565' ' ' PRO . 52.7 t -79.46 113.62 38.42 Favored Pre-proline 0 N--CA 1.451 -0.379 0 N-CA-C 109.444 -0.576 . . . . 0.41 109.444 174.62 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 565' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 564' ' ' CYS . 33.4 Cg_exo -63.38 -36.37 55.98 Favored 'Trans proline' 0 CA--C 1.528 0.206 0 C-N-CA 123.146 2.564 . . . . 1.0 113.896 -173.323 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 566' ' ' ILE . . . . . 0.438 HD11 ' HB3' ' A' ' 599' ' ' CYS . 60.3 mt -72.35 -37.81 59.25 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 N-CA-C 112.088 0.403 . . . . 1.54 112.088 -173.143 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 567' ' ' CYS . . . . . . . . . . . . . 29.6 p -113.15 0.76 15.04 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.536 -0.466 . . . . 0.7 111.82 -176.281 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 568' ' ' LYS . . . . . . . . . . . . . 99.4 mttt 66.03 11.63 7.89 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 113.181 0.808 . . . . 3.19 113.181 173.522 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 569' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -100.6 134.64 43.26 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.873 0.368 . . . . 3.34 110.971 179.216 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 570' ' ' THR . . . . . 0.511 ' HA ' ' HA ' ' A' ' 563' ' ' LYS . 45.8 m -74.13 128.96 36.87 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.5 -0.773 . . . . 1.43 109.617 177.863 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 571' ' ' VAL . . . . . . . . . . . . . 17.9 t -95.76 115.09 33.97 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 N-CA-C 109.568 -0.53 . . . . 1.39 109.568 178.424 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 572' ' ' THR . . . . . 0.409 HG22 ' HB1' ' A' ' 561' ' ' ALA . 24.4 p -106.24 160.41 15.37 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.66 -0.7 . . . . 2.17 109.438 177.103 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . -129.53 153.89 20.14 Favored Glycine 0 N--CA 1.44 -1.052 0 C-N-CA 119.352 -1.404 . . . . 2.2 112.405 -178.619 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 574' ' ' VAL . . . . . . . . . . . . . 58.5 t -122.57 148.13 26.42 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 CA-C-N 114.861 -0.67 . . . . 3.64 109.395 -172.714 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 575' ' ' TYR . . . . . . . . . . . . . 53.3 t80 -80.81 118.07 22.02 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 109.356 -0.609 . . . . 3.53 109.356 175.718 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 576' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -92.96 114.89 27.58 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 109.754 -0.461 . . . . 3.34 109.754 179.756 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 577' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -68.89 -22.72 64.16 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.511 -0.768 . . . . 5.59 112.13 -174.441 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 578' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -77.08 -48.13 18.65 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.509 -0.314 . . . . 5.11 111.723 -178.276 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 579' ' ' SER . . . . . . . . . . . . . 72.4 p -86.0 -21.82 27.61 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.878 0.37 . . . . 3.7 110.859 178.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 580' ' ' GLY . . . . . . . . . . . . . . . 80.19 17.29 74.54 Favored Glycine 0 C--N 1.331 0.285 0 C-N-CA 121.157 -0.544 . . . . 2.89 112.725 178.48 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 581' ' ' GLU . . . . . . . . . . . . . 20.7 mm-40 -122.42 152.24 40.43 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.921 0.391 . . . . 3.19 111.292 -176.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 582' ' ' TRP . . . . . 0.641 ' O ' ' HA ' ' A' ' 552' ' ' VAL . 84.5 m95 -77.51 130.38 36.9 Favored 'General case' 0 CA--C 1.512 -0.491 0 N-CA-C 107.451 -1.315 . . . . 2.63 107.451 165.245 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 583' ' ' VAL . . . . . . . . . . . . . 19.3 m -115.39 133.91 60.2 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.971 0 N-CA-C 113.958 1.096 . . . . 1.67 113.958 -169.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 584' ' ' TRP . . . . . 0.5 ' CD1' HG22 ' A' ' 553' ' ' VAL . 30.5 m0 -113.33 103.65 11.52 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 114.795 -1.093 . . . . 2.74 108.053 162.281 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 585' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.99 145.61 27.63 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.985 0.422 . . . . 4.27 111.774 -173.104 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 586' ' ' ASN . . . . . . . . . . . . . 12.3 m120 53.2 42.93 32.13 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.282 -0.872 . . . . 1.72 110.512 -176.613 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 587' ' ' THR . . . . . . . . . . . . . 57.9 m -115.38 142.46 46.66 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.0 0.428 . . . . 1.22 110.761 -176.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 588' ' ' ILE . . . . . . . . . . . . . 15.3 tt -137.38 150.19 25.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.58 -0.736 . . . . 1.34 109.396 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 589' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -111.13 122.73 48.62 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.098 -0.705 . . . . 1.35 109.098 176.908 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 590' ' ' VAL . . . . . . . . . . . . . 62.1 t -126.39 117.65 49.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 115.716 -0.675 . . . . 1.3 110.06 179.324 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 591' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 58.27 40.64 24.43 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 115.582 -0.735 . . . . 2.03 110.835 177.267 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . 79.98 13.67 81.81 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.91 -0.662 . . . . 0.62 112.592 176.036 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 593' ' ' LYS . . . . . . . . . . . . . 46.8 mtmt -128.47 139.92 52.08 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.036 0.446 . . . . 3.3 110.777 -178.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 594' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -94.9 134.88 37.06 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.054 -0.521 . . . . 2.29 111.064 -177.081 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 595' ' ' PHE . . . . . . . . . . . . . 62.7 m-85 -142.25 165.24 27.98 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.372 -0.831 . . . . 2.2 108.807 177.002 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 596' ' ' HIS . . . . . 0.687 ' HB2' ' SG ' ' A' ' 599' ' ' CYS . 24.9 m80 -68.79 130.11 41.88 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 108.273 -1.01 . . . . 0.76 108.273 166.641 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 597' ' ' SER . . . . . . . . . . . . . 40.1 t -60.83 -30.16 69.93 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.462 0.649 . . . . 1.59 109.81 179.361 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 598' ' ' THR . . . . . . . . . . . . . 93.7 m -66.39 -34.71 78.58 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.905 -1.043 . . . . 1.93 110.803 175.11 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 599' ' ' CYS . . . . . 0.687 ' SG ' ' HB2' ' A' ' 596' ' ' HIS . 75.8 m -74.77 -31.15 61.69 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.622 0.601 . . . . 0.81 112.622 -178.25 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 600' ' ' TYR . . . . . . . . . . . . . 86.0 t80 -61.8 -35.62 78.72 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 121.362 0.601 . . . . 2.65 109.842 -178.427 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 601' ' ' HIS . . . . . . . . . . . . . 78.7 t60 -66.72 -34.7 78.43 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.373 -0.83 . . . . 5.16 110.408 176.001 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 602' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -64.65 -36.57 84.69 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.145 -0.48 . . . . 3.85 110.927 179.847 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 603' ' ' THR . . . . . . . . . . . . . 15.4 t . . . . . 0 C--N 1.324 -0.507 0 CA-C-N 116.554 -0.293 . . . . 3.3 110.701 -179.266 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.418 0 N-CA-C 112.107 -0.397 . . . . 3.77 112.107 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 549' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -64.28 132.49 50.39 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.056 0.455 . . . . 6.2 110.125 176.558 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 550' ' ' TYR . . . . . 0.503 ' CE1' HG12 ' A' ' 583' ' ' VAL . 37.4 p90 -111.34 160.91 16.6 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.822 -0.626 . . . . 3.22 109.834 177.414 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 551' ' ' VAL . . . . . 0.511 HG11 ' HE1' ' A' ' 594' ' ' TYR . 52.9 t -118.53 133.26 65.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 N-CA-C 109.072 -0.714 . . . . 2.01 109.072 176.437 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 552' ' ' VAL . . . . . 0.72 ' HA ' ' O ' ' A' ' 582' ' ' TRP . 56.6 t -61.95 125.18 17.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 O-C-N 123.32 0.388 . . . . 1.8 110.287 -179.039 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 553' ' ' VAL . . . . . 0.677 HG21 ' CD1' ' A' ' 584' ' ' TRP . 66.6 t -58.91 120.41 46.32 Favored Pre-proline 0 C--N 1.33 -0.271 0 O-C-N 123.729 0.643 . . . . 1.63 111.495 -173.903 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 554' ' ' PRO . . . . . 0.45 ' HD3' ' HA ' ' A' ' 553' ' ' VAL . 7.2 Cg_exo . . . . . 0 N--CA 1.456 -0.697 0 C-N-CA 122.802 2.335 . . . . 2.2 112.06 175.78 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 560' ' ' MET . . . . . . . . . . . . . 62.1 mtt . . . . . 0 N--CA 1.468 0.471 0 CA-C-O 120.87 0.367 . . . . 2.98 110.797 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 561' ' ' ALA . . . . . . . . . . . . . . . -144.77 149.94 36.35 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.378 -0.373 . . . . 1.46 111.162 -173.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 26.8 p90 -133.69 164.01 28.17 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.572 -0.899 . . . . 1.35 108.572 173.605 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 563' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt -112.09 127.59 55.96 Favored 'General case' 0 C--N 1.323 -0.587 0 C-N-CA 120.456 -0.498 . . . . 2.71 110.772 -179.459 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 564' ' ' CYS . . . . . . . . . . . . . 53.4 t -73.77 113.9 27.28 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 115.416 -0.811 . . . . 0.41 109.797 -179.192 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 565' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -72.83 -19.91 23.15 Favored 'Trans proline' 0 N--CA 1.472 0.218 0 C-N-CA 122.965 2.443 . . . . 1.0 113.599 -175.633 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 566' ' ' ILE . . . . . 0.416 HD13 ' HB ' ' A' ' 603' ' ' THR . 37.7 mt -82.26 -37.86 14.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.255 -0.429 . . . . 1.54 111.616 -172.368 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 567' ' ' CYS . . . . . 0.476 ' SG ' ' OE2' ' A' ' 569' ' ' GLU . 27.9 p -129.32 5.86 5.27 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 112.22 0.452 . . . . 0.7 112.22 -179.319 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 568' ' ' LYS . . . . . . . . . . . . . 21.0 mmmt 72.82 30.59 1.72 Allowed 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 113.923 1.083 . . . . 3.19 113.923 167.346 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 569' ' ' GLU . . . . . 0.476 ' OE2' ' SG ' ' A' ' 567' ' ' CYS . 7.0 mt-10 -92.85 135.81 33.8 Favored 'General case' 0 N--CA 1.466 0.361 0 O-C-N 121.786 -0.571 . . . . 3.34 111.231 178.308 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 570' ' ' THR . . . . . . . . . . . . . 82.5 m -82.14 117.91 22.66 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 108.875 -0.787 . . . . 1.43 108.875 166.142 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 571' ' ' VAL . . . . . . . . . . . . . 21.3 t -103.13 123.27 56.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.951 0.405 . . . . 1.39 111.745 -170.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 24.5 p -108.94 160.96 15.59 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.87 -0.604 . . . . 2.17 110.33 177.672 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . -130.98 156.15 21.61 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.343 -0.932 . . . . 2.2 112.185 -177.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 574' ' ' VAL . . . . . 0.405 ' O ' HG22 ' A' ' 583' ' ' VAL . 21.8 t -112.26 149.61 14.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-O 120.888 0.375 . . . . 3.64 110.319 -173.117 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 575' ' ' TYR . . . . . . . . . . . . . 53.8 t80 -85.21 123.36 30.62 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.256 -0.429 . . . . 3.53 111.012 179.061 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 576' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -92.12 107.75 19.44 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.418 -0.586 . . . . 3.34 109.418 174.09 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 577' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -68.17 -26.98 66.03 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.037 -0.529 . . . . 5.59 112.424 -173.215 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 578' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -69.53 -47.95 62.06 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.76 0.314 . . . . 5.11 111.249 -178.409 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 579' ' ' SER . . . . . . . . . . . . . 77.1 p -83.31 -23.88 32.39 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.343 0.592 . . . . 3.7 110.578 -179.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 580' ' ' GLY . . . . . . . . . . . . . . . 79.17 18.4 74.5 Favored Glycine 0 N--CA 1.449 -0.499 0 CA-C-N 115.561 -0.745 . . . . 2.89 111.326 -176.714 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 581' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -123.32 138.85 54.52 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.295 0.569 . . . . 3.19 110.833 -176.036 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 582' ' ' TRP . . . . . 0.72 ' O ' ' HA ' ' A' ' 552' ' ' VAL . 83.7 m95 -71.45 141.06 50.25 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.975 -0.75 . . . . 2.63 108.975 173.221 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 583' ' ' VAL . . . . . 0.503 HG12 ' CE1' ' A' ' 550' ' ' TYR . 24.0 m -119.89 133.78 65.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 N-CA-C 113.352 0.871 . . . . 1.67 113.352 -173.933 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 584' ' ' TRP . . . . . 0.677 ' CD1' HG21 ' A' ' 553' ' ' VAL . 21.6 m0 -111.38 104.51 12.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.024 -0.989 . . . . 2.74 108.983 165.436 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 585' ' ' LYS . . . . . . . . . . . . . 26.2 mmmt -83.23 148.13 27.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.607 -0.269 . . . . 4.27 110.473 -175.041 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 586' ' ' ASN . . . . . . . . . . . . . 62.7 m-20 48.32 41.95 17.16 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 123.319 0.648 . . . . 1.72 110.337 -173.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 587' ' ' THR . . . . . . . . . . . . . 56.8 m -120.1 140.9 50.35 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.966 -0.561 . . . . 1.22 109.607 179.556 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 588' ' ' ILE . . . . . 0.428 HG21 ' HA ' ' A' ' 597' ' ' SER . 15.5 tt -135.66 146.22 30.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-O 120.927 0.394 . . . . 1.34 110.123 -178.707 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 589' ' ' GLU . . . . . 0.403 ' HA ' ' O ' ' A' ' 593' ' ' LYS . 1.8 tm-20 -103.23 121.16 42.12 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.213 -0.662 . . . . 1.35 109.213 175.373 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 590' ' ' VAL . . . . . . . . . . . . . 59.1 t -125.64 118.6 52.69 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 115.776 -0.647 . . . . 1.3 109.829 -179.56 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 591' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 58.78 36.9 25.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.676 0.751 . . . . 2.03 110.779 178.041 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . 85.85 6.59 82.35 Favored Glycine 0 N--CA 1.446 -0.647 0 CA-C-N 115.729 -0.669 . . . . 0.62 113.214 176.38 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 593' ' ' LYS . . . . . 0.403 ' O ' ' HA ' ' A' ' 589' ' ' GLU . 30.4 mmmt -120.85 139.29 53.38 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 117.02 0.41 . . . . 3.3 111.64 -179.046 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 594' ' ' TYR . . . . . 0.511 ' HE1' HG11 ' A' ' 551' ' ' VAL . 91.8 m-85 -93.55 124.05 37.28 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.86 -0.609 . . . . 2.29 111.092 -179.864 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 595' ' ' PHE . . . . . . . . . . . . . 47.9 m-85 -137.29 164.27 28.95 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.865 -0.607 . . . . 2.2 109.662 176.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 596' ' ' HIS . . . . . 0.705 ' HB2' ' SG ' ' A' ' 599' ' ' CYS . 29.3 m170 -61.58 129.83 43.0 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 108.927 -0.768 . . . . 0.76 108.927 168.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 597' ' ' SER . . . . . 0.428 ' HA ' HG21 ' A' ' 588' ' ' ILE . 33.4 t -64.24 -30.35 71.41 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.039 -0.528 . . . . 1.59 109.65 178.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 598' ' ' THR . . . . . . . . . . . . . 8.7 m -61.8 -38.85 89.64 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 115.307 -0.861 . . . . 1.93 110.488 175.403 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 599' ' ' CYS . . . . . 0.705 ' SG ' ' HB2' ' A' ' 596' ' ' HIS . 83.2 m -73.98 -28.52 61.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.302 -0.863 . . . . 0.81 112.672 -175.336 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 600' ' ' TYR . . . . . . . . . . . . . 70.0 t80 -55.94 -35.89 67.16 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 120.902 0.382 . . . . 2.65 110.963 -174.62 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 601' ' ' HIS . . . . . . . . . . . . . 43.5 m-70 -73.26 -39.35 65.48 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.453 -0.339 . . . . 5.16 111.232 -178.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 602' ' ' GLU . . . . . 0.644 ' HG2' ' O ' ' A' ' 599' ' ' CYS . 23.3 pt-20 -70.36 -35.5 73.59 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 120.709 0.29 . . . . 3.85 111.028 -177.438 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 603' ' ' THR . . . . . 0.416 ' HB ' HD13 ' A' ' 566' ' ' ILE . 13.0 t . . . . . 0 C--N 1.327 -0.387 0 C-N-CA 120.978 -0.289 . . . . 3.3 111.557 -175.225 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.136 0 N-CA-C 113.484 0.154 . . . . 3.77 113.484 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 549' ' ' LYS . . . . . . . . . . . . . 61.6 mttm -73.43 134.79 44.07 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.906 0.384 . . . . 6.2 110.588 176.218 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 550' ' ' TYR . . . . . . . . . . . . . 31.8 p90 -111.62 159.9 17.74 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.561 -0.745 . . . . 3.22 109.584 179.322 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 551' ' ' VAL . . . . . . . . . . . . . 59.2 t -117.94 131.9 69.34 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 N-CA-C 108.556 -0.905 . . . . 2.01 108.556 175.311 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 552' ' ' VAL . . . . . 0.559 ' HA ' ' O ' ' A' ' 582' ' ' TRP . 59.0 t -63.95 134.82 28.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 116.051 -0.522 . . . . 1.8 110.075 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 553' ' ' VAL . . . . . 0.572 HG21 ' CD1' ' A' ' 584' ' ' TRP . 86.0 t -58.84 121.72 56.55 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 115.677 -0.692 . . . . 1.63 110.05 -178.489 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 554' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_exo . . . . . 0 N--CA 1.462 -0.363 0 C-N-CA 122.791 2.327 . . . . 2.2 112.496 -176.523 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 560' ' ' MET . . . . . . . . . . . . . 3.8 mpp? . . . . . 0 C--O 1.237 0.419 0 CA-C-O 120.647 0.26 . . . . 2.98 111.28 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 561' ' ' ALA . . . . . 0.533 ' HA ' ' O ' ' A' ' 571' ' ' VAL . . . -144.66 145.7 31.88 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-O 121.045 0.45 . . . . 1.46 111.552 -176.628 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 33.1 p90 -135.92 149.22 48.87 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 107.791 -1.189 . . . . 1.35 107.791 169.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 563' ' ' LYS . . . . . 0.443 ' HA ' ' HA ' ' A' ' 570' ' ' THR . 72.1 tttt -93.3 119.99 33.07 Favored 'General case' 0 C--N 1.316 -0.859 0 C-N-CA 120.093 -0.643 . . . . 2.71 110.929 -176.07 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 564' ' ' CYS . . . . . 0.457 ' HA ' ' HD3' ' A' ' 565' ' ' PRO . 10.6 t -76.91 114.26 37.76 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-N 115.348 -0.842 . . . . 0.41 110.729 -178.626 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 565' ' ' PRO . . . . . 0.457 ' HD3' ' HA ' ' A' ' 564' ' ' CYS . 20.6 Cg_exo -70.48 -23.41 27.55 Favored 'Trans proline' 0 CA--C 1.534 0.487 0 C-N-CA 123.379 2.719 . . . . 1.0 113.35 -177.479 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 566' ' ' ILE . . . . . 0.465 HG23 ' HB3' ' A' ' 599' ' ' CYS . 26.7 mt -71.44 -37.64 65.46 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.364 0 N-CA-C 112.041 0.385 . . . . 1.54 112.041 -174.249 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 567' ' ' CYS . . . . . . . . . . . . . 29.2 p -124.34 2.06 8.43 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.805 0.336 . . . . 0.7 111.429 178.07 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 568' ' ' LYS . . . . . . . . . . . . . 29.4 mtpp 69.65 18.01 7.7 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 113.463 0.912 . . . . 3.19 113.463 171.798 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 569' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -107.85 136.37 47.69 Favored 'General case' 0 C--O 1.238 0.46 0 C-N-CA 120.373 -0.531 . . . . 3.34 111.332 178.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 570' ' ' THR . . . . . 0.443 ' HA ' ' HA ' ' A' ' 563' ' ' LYS . 35.5 m -68.18 125.99 28.12 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 115.015 -0.993 . . . . 1.43 110.925 -178.677 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 571' ' ' VAL . . . . . 0.533 ' O ' ' HA ' ' A' ' 561' ' ' ALA . 15.9 t -95.06 117.51 39.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 115.68 -0.691 . . . . 1.39 110.602 -176.891 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 572' ' ' THR . . . . . 0.513 HG23 ' HB2' ' A' ' 561' ' ' ALA . 25.6 p -109.17 158.62 17.63 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 109.619 -0.512 . . . . 2.17 109.619 176.589 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . -129.92 156.41 21.44 Favored Glycine 0 N--CA 1.443 -0.871 0 C-N-CA 120.305 -0.95 . . . . 2.2 111.777 -177.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 574' ' ' VAL . . . . . 0.444 ' O ' HG21 ' A' ' 583' ' ' VAL . 20.1 t -113.68 149.94 15.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-O 120.832 0.348 . . . . 3.64 110.227 -173.352 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 575' ' ' TYR . . . . . 0.424 ' HA ' ' HA ' ' A' ' 582' ' ' TRP . 39.6 t80 -80.61 123.84 28.48 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 109.276 -0.639 . . . . 3.53 109.276 174.383 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 576' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -90.97 105.49 17.86 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 108.434 -0.95 . . . . 3.34 108.434 175.574 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 577' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -67.09 -27.02 67.01 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.377 -0.829 . . . . 5.59 112.083 -170.602 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 578' ' ' GLU . . . . . . . . . . . . . 23.1 mp0 -75.15 -47.06 30.33 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.537 -0.301 . . . . 5.11 111.354 -179.452 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 579' ' ' SER . . . . . . . . . . . . . 75.2 p -83.12 -21.06 33.74 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.059 0.457 . . . . 3.7 111.295 -179.449 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 580' ' ' GLY . . . . . . . . . . . . . . . 80.23 20.49 67.03 Favored Glycine 0 N--CA 1.449 -0.46 0 CA-C-N 115.863 -0.608 . . . . 2.89 112.836 177.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 581' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -130.28 148.08 52.07 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.912 0.387 . . . . 3.19 110.752 -178.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 582' ' ' TRP . . . . . 0.559 ' O ' ' HA ' ' A' ' 552' ' ' VAL . 81.1 m95 -79.12 135.19 36.76 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.313 -0.625 . . . . 2.63 109.313 174.194 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 583' ' ' VAL . . . . . 0.444 HG21 ' O ' ' A' ' 574' ' ' VAL . 29.3 m -113.4 129.33 69.35 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 N-CA-C 112.987 0.736 . . . . 1.67 112.987 -172.594 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 584' ' ' TRP . . . . . 0.572 ' CD1' HG21 ' A' ' 553' ' ' VAL . 23.3 m0 -109.4 102.31 11.21 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 108.085 -1.08 . . . . 2.74 108.085 163.108 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 585' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.99 151.51 19.49 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 110.2 -0.296 . . . . 4.27 110.2 -173.428 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 586' ' ' ASN . . . . . 0.504 ' O ' ' HA ' ' A' ' 596' ' ' HIS . 2.2 m-20 55.95 42.33 28.83 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 121.214 0.53 . . . . 1.72 109.714 -173.311 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 587' ' ' THR . . . . . . . . . . . . . 30.2 m -124.41 141.42 52.1 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.359 -0.837 . . . . 1.22 110.439 -178.015 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 588' ' ' ILE . . . . . 0.563 ' HB ' ' HB3' ' A' ' 597' ' ' SER . 16.1 tt -139.98 147.92 23.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 116.255 -0.43 . . . . 1.34 109.877 177.928 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 589' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -100.62 119.08 38.03 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.453 -0.573 . . . . 1.35 109.453 176.653 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 590' ' ' VAL . . . . . . . . . . . . . 60.0 t -130.93 127.31 61.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.563 -0.744 . . . . 1.3 109.401 179.065 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 591' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 59.05 33.21 22.83 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 121.605 0.717 . . . . 2.03 110.384 179.068 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . 84.88 0.74 89.07 Favored Glycine 0 N--CA 1.45 -0.424 0 CA-C-N 115.795 -0.639 . . . . 0.62 113.303 175.815 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 593' ' ' LYS . . . . . . . . . . . . . 45.3 mmtm -121.35 148.06 44.86 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.056 0.455 . . . . 3.3 111.482 -178.305 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 594' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -92.89 132.76 36.75 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.566 -0.743 . . . . 2.29 110.576 179.597 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 595' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -136.55 162.58 32.72 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.292 -0.867 . . . . 2.2 108.766 177.529 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 596' ' ' HIS . . . . . 0.504 ' HA ' ' O ' ' A' ' 586' ' ' ASN . 21.9 m170 -66.86 125.05 24.7 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 107.743 -1.206 . . . . 0.76 107.743 167.178 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 597' ' ' SER . . . . . 0.563 ' HB3' ' HB ' ' A' ' 588' ' ' ILE . 2.1 p -67.77 -29.79 69.08 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.256 0.55 . . . . 1.59 109.884 177.501 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 598' ' ' THR . . . . . . . . . . . . . 25.6 m -63.84 -38.27 90.46 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.258 -0.883 . . . . 1.93 110.656 174.643 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 599' ' ' CYS . . . . . 0.47 ' SG ' ' HB2' ' A' ' 596' ' ' HIS . 73.6 m -75.14 -29.92 60.64 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.971 -0.559 . . . . 0.81 110.816 177.263 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 600' ' ' TYR . . . . . . . . . . . . . 92.4 t80 -55.62 -34.52 64.98 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.617 -0.719 . . . . 2.65 111.623 -174.598 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 601' ' ' HIS . . . . . . . . . . . . . 66.9 m170 -60.16 -32.51 71.12 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 112.459 0.541 . . . . 5.16 112.459 -176.343 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 602' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -72.61 -33.52 66.73 Favored 'General case' 0 CA--C 1.528 0.099 0 C-N-CA 120.118 -0.633 . . . . 3.85 110.966 -179.141 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 603' ' ' THR . . . . . . . . . . . . . 8.8 t . . . . . 0 C--O 1.235 0.3 0 C-N-CA 120.633 -0.427 . . . . 3.3 110.837 -177.564 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.387 0 N-CA-C 112.565 -0.214 . . . . 3.77 112.565 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 549' ' ' LYS . . . . . . . . . . . . . 32.5 mmmt -70.8 143.72 51.06 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 110.038 -0.356 . . . . 6.2 110.038 178.089 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 550' ' ' TYR . . . . . 0.49 ' CE1' HG13 ' A' ' 583' ' ' VAL . 23.8 p90 -125.97 159.73 31.89 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 109.29 -0.633 . . . . 3.22 109.29 177.015 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 551' ' ' VAL . . . . . . . . . . . . . 52.6 t -118.33 133.37 65.35 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.021 0 N-CA-C 108.723 -0.843 . . . . 2.01 108.723 177.48 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 552' ' ' VAL . . . . . 0.569 ' HA ' ' O ' ' A' ' 582' ' ' TRP . 60.8 t -65.2 130.59 30.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 109.499 -0.556 . . . . 1.8 109.499 179.374 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 553' ' ' VAL . . . . . 0.59 HG21 ' CD1' ' A' ' 584' ' ' TRP . 66.0 t -59.0 121.37 54.6 Favored Pre-proline 0 CA--C 1.519 -0.243 0 O-C-N 123.618 0.574 . . . . 1.63 110.681 -175.608 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 554' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 553' ' ' VAL . 31.9 Cg_exo -57.74 135.22 67.93 Favored 'Trans proline' 0 N--CA 1.464 -0.219 0 C-N-CA 123.041 2.494 . . . . 2.2 112.786 -177.404 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 555' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -91.65 -3.99 55.71 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.698 -0.683 . . . . 4.17 110.476 -179.262 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 21.6 p -86.43 -16.12 38.15 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.574 -0.739 . . . . 4.31 111.127 179.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 557' ' ' SER . . . . . . . . . . . . . 13.3 m -88.43 -41.14 12.98 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.179 -0.464 . . . . 3.39 110.701 179.112 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 558' ' ' GLN . . . . . . . . . . . . . 53.4 mt-30 68.76 -1.49 1.99 Allowed 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 115.396 -0.82 . . . . 5.62 113.013 175.599 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 559' ' ' ASP . . . . . . . . . . . . . 28.8 p-10 -105.7 -18.46 14.07 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.078 0.466 . . . . 3.23 110.429 176.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 560' ' ' MET . . . . . 0.455 ' HG3' HG12 ' A' ' 553' ' ' VAL . 1.8 mpt? 63.96 21.75 12.73 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 115.241 -0.891 . . . . 2.98 112.397 174.872 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 561' ' ' ALA . . . . . 0.455 ' HA ' ' O ' ' A' ' 571' ' ' VAL . . . -144.5 152.67 40.93 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.015 0.436 . . . . 1.46 111.33 -178.659 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 33.4 p90 -142.76 151.7 41.52 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.219 -0.66 . . . . 1.35 109.219 170.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 563' ' ' LYS . . . . . . . . . . . . . 3.6 tppp? -88.8 117.98 28.17 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 109.269 -0.641 . . . . 2.71 109.269 -178.49 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 564' ' ' CYS . . . . . 0.417 ' O ' ' HA ' ' A' ' 568' ' ' LYS . 41.7 t -68.26 112.96 12.45 Favored Pre-proline 0 C--O 1.223 -0.316 0 N-CA-C 109.578 -0.527 . . . . 0.41 109.578 179.035 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 565' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_exo -71.77 -18.21 28.66 Favored 'Trans proline' 0 CA--C 1.527 0.162 0 C-N-CA 122.747 2.298 . . . . 1.0 113.299 -174.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 566' ' ' ILE . . . . . . . . . . . . . 26.4 mt -89.18 -38.32 11.15 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 N-CA-C 112.211 0.448 . . . . 1.54 112.211 -172.233 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 567' ' ' CYS . . . . . . . . . . . . . 28.6 p -127.74 1.21 6.09 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.512 -0.475 . . . . 0.7 111.65 178.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 568' ' ' LYS . . . . . 0.417 ' HA ' ' O ' ' A' ' 564' ' ' CYS . 54.3 mtpt 70.9 31.72 2.55 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 114.576 1.324 . . . . 3.19 114.576 163.782 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 569' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -95.72 149.38 21.55 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 108.605 -0.887 . . . . 3.34 108.605 170.173 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 570' ' ' THR . . . . . . . . . . . . . 57.0 m -84.02 117.06 23.16 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 109.045 -0.724 . . . . 1.43 109.045 172.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 571' ' ' VAL . . . . . 0.493 HG21 ' CE1' ' A' ' 596' ' ' HIS . 34.1 t -84.89 116.56 28.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-O 120.976 0.417 . . . . 1.39 111.108 -174.214 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 23.7 p -107.03 159.24 16.44 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.748 -0.66 . . . . 2.17 109.768 177.191 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . -130.5 155.68 21.24 Favored Glycine 0 N--CA 1.442 -0.926 0 C-N-CA 119.925 -1.131 . . . . 2.2 111.732 -178.233 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 574' ' ' VAL . . . . . 0.479 ' O ' HG23 ' A' ' 583' ' ' VAL . 40.5 t -118.0 148.44 20.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 109.838 -0.43 . . . . 3.64 109.838 -174.215 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 575' ' ' TYR . . . . . 0.456 ' HA ' ' HA ' ' A' ' 582' ' ' TRP . 47.6 t80 -84.22 119.46 25.06 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.797 -0.446 . . . . 3.53 109.797 178.147 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 576' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -95.84 113.38 25.0 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.97 0.414 . . . . 3.34 110.04 176.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 577' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -70.43 -22.69 62.69 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.42 -0.809 . . . . 5.59 112.074 -175.262 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 578' ' ' GLU . . . . . . . . . . . . . 15.8 tp10 -74.82 -46.39 36.98 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 121.023 -0.271 . . . . 5.11 110.854 -179.233 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 579' ' ' SER . . . . . . . . . . . . . 74.0 p -82.34 -20.96 36.27 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.111 0.482 . . . . 3.7 110.608 176.013 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 580' ' ' GLY . . . . . . . . . . . . . . . 79.54 20.21 69.45 Favored Glycine 0 N--CA 1.447 -0.578 0 CA-C-N 115.667 -0.697 . . . . 2.89 112.5 175.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 581' ' ' GLU . . . . . 0.433 ' OE1' ' HA ' ' A' ' 581' ' ' GLU . 8.7 mm-40 -138.1 160.26 39.85 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.24 0.543 . . . . 3.19 111.048 -177.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 582' ' ' TRP . . . . . 0.569 ' O ' ' HA ' ' A' ' 552' ' ' VAL . 80.3 m95 -79.55 137.84 37.29 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.609 -0.723 . . . . 2.63 109.361 174.322 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 583' ' ' VAL . . . . . 0.49 HG13 ' CE1' ' A' ' 550' ' ' TYR . 19.9 m -116.53 132.43 66.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 N-CA-C 113.667 0.988 . . . . 1.67 113.667 -172.122 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 584' ' ' TRP . . . . . 0.59 ' CD1' HG21 ' A' ' 553' ' ' VAL . 31.2 m0 -113.31 102.71 10.6 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 108.17 -1.048 . . . . 2.74 108.17 162.387 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 585' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.32 154.15 18.03 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.884 -0.327 . . . . 4.27 110.869 -176.212 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 586' ' ' ASN . . . . . . . . . . . . . 22.6 m-20 56.23 43.73 26.11 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 108.615 -0.884 . . . . 1.72 108.615 -170.112 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 587' ' ' THR . . . . . . . . . . . . . 34.3 m -133.98 141.13 47.16 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.098 -0.955 . . . . 1.22 110.513 -176.019 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 588' ' ' ILE . . . . . . . . . . . . . 12.7 tt -141.58 149.41 20.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.358 -0.383 . . . . 1.34 110.095 -178.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 589' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -97.73 122.65 41.08 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.887 -0.412 . . . . 1.35 109.887 177.246 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 590' ' ' VAL . . . . . . . . . . . . . 35.4 t -124.64 118.44 53.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 N-CA-C 109.761 -0.459 . . . . 1.3 109.761 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 591' ' ' ASN . . . . . . . . . . . . . 3.7 t30 55.58 40.99 31.12 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.418 -0.81 . . . . 2.03 110.988 177.458 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . 85.41 5.13 85.34 Favored Glycine 0 CA--C 1.52 0.365 0 C-N-CA 120.86 -0.686 . . . . 0.62 113.778 174.455 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 593' ' ' LYS . . . . . . . . . . . . . 56.0 mttp -127.84 144.89 51.08 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 117.363 0.582 . . . . 3.3 110.958 177.481 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 594' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -91.25 132.94 35.8 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.277 0.561 . . . . 2.29 110.711 -179.516 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 595' ' ' PHE . . . . . . . . . . . . . 72.0 m-85 -132.95 156.32 47.5 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.299 -0.864 . . . . 2.2 108.962 178.441 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 596' ' ' HIS . . . . . 0.493 ' CE1' HG21 ' A' ' 571' ' ' VAL . 11.3 m170 -60.98 126.97 29.3 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 108.384 -0.969 . . . . 0.76 108.384 167.775 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 597' ' ' SER . . . . . . . . . . . . . 23.2 t -65.15 -29.31 70.14 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.859 -0.609 . . . . 1.59 109.986 -177.506 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 598' ' ' THR . . . . . . . . . . . . . 2.6 m -66.8 -39.18 87.67 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 115.522 -0.763 . . . . 1.93 110.707 178.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 599' ' ' CYS . . . . . . . . . . . . . 86.1 m -74.68 -32.82 62.31 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.527 -0.76 . . . . 0.81 112.152 -174.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 600' ' ' TYR . . . . . . . . . . . . . 73.9 t80 -57.06 -34.68 68.5 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.928 0.394 . . . . 2.65 111.471 -172.337 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 601' ' ' HIS . . . . . . . . . . . . . 14.6 m-70 -61.91 -26.82 68.4 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.786 -0.643 . . . . 5.16 112.361 -177.221 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 602' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.49 -29.13 65.57 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 121.117 0.484 . . . . 3.85 110.13 -178.646 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 603' ' ' THR . . . . . . . . . . . . . 92.2 m . . . . . 0 C--N 1.326 -0.423 0 CA-C-N 115.841 -0.618 . . . . 3.3 110.811 -178.311 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 701' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.512 -0.147 0 N-CA-C 113.274 0.07 . . . . 3.77 113.274 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 549' ' ' LYS . . . . . 0.632 ' HD2' ' N ' ' A' ' 549' ' ' LYS . 6.5 mptt -81.29 150.35 28.56 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.379 0.609 . . . . 6.2 111.467 178.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 550' ' ' TYR . . . . . 0.492 ' CE1' HG12 ' A' ' 583' ' ' VAL . 16.6 p90 -111.19 161.88 15.52 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 114.92 -1.036 . . . . 3.22 110.072 -174.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 551' ' ' VAL . . . . . . . . . . . . . 84.9 t -118.08 133.28 65.38 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 N-CA-C 109.181 -0.674 . . . . 2.01 109.181 177.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 552' ' ' VAL . . . . . . . . . . . . . 59.1 t -63.92 134.66 28.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.725 -0.67 . . . . 1.8 109.815 -179.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 553' ' ' VAL . . . . . 0.59 HG22 ' CD1' ' A' ' 584' ' ' TRP . 86.3 t -60.07 121.01 55.78 Favored Pre-proline 0 N--CA 1.454 -0.233 0 O-C-N 123.618 0.574 . . . . 1.63 111.108 -176.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 554' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 553' ' ' VAL . 16.6 Cg_exo -64.22 138.06 59.44 Favored 'Trans proline' 0 N--CA 1.461 -0.431 0 C-N-CA 123.167 2.578 . . . . 2.2 112.561 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 555' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.41 -32.09 24.31 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.622 -0.717 . . . . 4.17 110.57 -178.413 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 19.0 p -82.15 6.88 15.11 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.398 -0.819 . . . . 4.31 112.329 -177.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 557' ' ' SER . . . . . 0.424 ' OG ' ' HB2' ' A' ' 554' ' ' PRO . 60.7 m -86.2 -2.78 58.68 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.952 -0.388 . . . . 3.39 109.952 174.143 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 558' ' ' GLN . . . . . . . . . . . . . 78.1 mm-40 68.65 -70.44 0.13 Allowed 'General case' 0 N--CA 1.465 0.305 0 O-C-N 123.987 0.804 . . . . 5.62 110.771 -178.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 559' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -94.77 146.27 24.3 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.544 -0.539 . . . . 3.23 109.544 177.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 560' ' ' MET . . . . . . . . . . . . . 67.0 mtm -92.12 29.59 1.6 Allowed 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 111.703 0.261 . . . . 2.98 111.703 -173.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 561' ' ' ALA . . . . . . . . . . . . . . . -145.39 157.96 43.93 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.364 -0.38 . . . . 1.46 110.54 178.387 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 35.0 p90 -153.33 158.39 41.48 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.736 -0.468 . . . . 1.35 109.736 174.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 563' ' ' LYS . . . . . . . . . . . . . 5.2 tppp? -89.43 127.32 35.82 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 110.191 -0.3 . . . . 2.71 110.191 179.215 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 564' ' ' CYS . . . . . 0.666 ' O ' ' HA ' ' A' ' 568' ' ' LYS . 47.7 t -71.02 114.44 27.23 Favored Pre-proline 0 C--O 1.222 -0.355 0 N-CA-C 109.48 -0.563 . . . . 0.41 109.48 175.493 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 565' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_exo -72.21 -18.8 26.6 Favored 'Trans proline' 0 CA--C 1.528 0.208 0 C-N-CA 122.978 2.452 . . . . 1.0 113.887 -174.424 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 566' ' ' ILE . . . . . 0.417 HD11 ' HB ' ' A' ' 603' ' ' THR . 65.9 mt -91.85 -55.14 6.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 112.191 0.441 . . . . 1.54 112.191 -172.019 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 567' ' ' CYS . . . . . . . . . . . . . 29.5 p -106.68 -6.35 17.94 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.251 -0.579 . . . . 0.7 111.043 178.584 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 568' ' ' LYS . . . . . 0.666 ' HA ' ' O ' ' A' ' 564' ' ' CYS . 99.4 mttt 70.98 32.92 2.22 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 114.64 1.348 . . . . 3.19 114.64 165.569 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 569' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -96.44 136.19 37.28 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 108.806 -0.813 . . . . 3.34 108.806 168.098 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 570' ' ' THR . . . . . . . . . . . . . 57.3 m -68.41 118.24 11.22 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.203 -0.453 . . . . 1.43 110.182 -179.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 571' ' ' VAL . . . . . 0.523 HG21 ' CE1' ' A' ' 596' ' ' HIS . 21.6 t -89.7 116.55 31.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 116.15 -0.477 . . . . 1.39 110.935 -175.66 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 29.2 p -115.18 161.37 18.52 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 109.011 -0.737 . . . . 2.17 109.011 173.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . -128.27 154.41 19.92 Favored Glycine 0 N--CA 1.437 -1.285 0 C-N-CA 119.468 -1.349 . . . . 2.2 111.089 -179.494 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 574' ' ' VAL . . . . . 0.421 ' O ' HG22 ' A' ' 583' ' ' VAL . 49.0 t -115.47 142.46 28.49 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-O 120.922 0.391 . . . . 3.64 110.308 -171.557 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 575' ' ' TYR . . . . . . . . . . . . . 45.3 t80 -79.96 118.93 22.15 Favored 'General case' 0 N--CA 1.443 -0.787 0 N-CA-C 109.568 -0.53 . . . . 3.53 109.568 175.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 576' ' ' ASP . . . . . . . . . . . . . 27.9 t0 -90.92 109.11 20.33 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.192 -0.669 . . . . 3.34 109.192 178.018 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 577' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -70.57 -23.9 62.68 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 115.008 -0.996 . . . . 5.59 111.309 -175.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 578' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -77.09 -34.2 56.91 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.149 -0.478 . . . . 5.11 111.056 -175.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 579' ' ' SER . . . . . . . . . . . . . 77.5 p -98.77 -20.66 16.78 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.351 0.595 . . . . 3.7 110.553 176.207 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 580' ' ' GLY . . . . . . . . . . . . . . . 80.43 28.04 49.54 Favored Glycine 0 N--CA 1.448 -0.506 0 CA-C-N 115.497 -0.774 . . . . 2.89 113.46 177.225 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 581' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -140.91 161.2 38.39 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 117.195 0.498 . . . . 3.19 111.48 178.15 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 582' ' ' TRP . . . . . . . . . . . . . 81.6 m95 -84.93 134.28 34.26 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.743 -0.466 . . . . 2.63 109.743 176.508 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 583' ' ' VAL . . . . . 0.492 HG12 ' CE1' ' A' ' 550' ' ' TYR . 15.6 m -115.84 136.63 52.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 N-CA-C 112.61 0.596 . . . . 1.67 112.61 -172.415 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 584' ' ' TRP . . . . . 0.59 ' CD1' HG22 ' A' ' 553' ' ' VAL . 18.9 m0 -113.59 104.42 12.23 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.478 -0.783 . . . . 2.74 108.982 165.758 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 585' ' ' LYS . . . . . 0.488 ' HG2' ' OD1' ' A' ' 586' ' ' ASN . 0.0 OUTLIER -88.77 151.25 22.51 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.639 0.257 . . . . 4.27 111.262 -175.137 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 586' ' ' ASN . . . . . 0.557 ' O ' ' HA ' ' A' ' 596' ' ' HIS . 8.0 m120 53.51 43.0 31.85 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 123.196 0.598 . . . . 1.72 110.019 -174.121 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 587' ' ' THR . . . . . . . . . . . . . 53.2 m -128.91 140.46 51.66 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.021 0.439 . . . . 1.22 111.425 -173.377 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 588' ' ' ILE . . . . . . . . . . . . . 14.8 tt -142.4 150.27 18.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.855 -0.611 . . . . 1.34 109.682 178.056 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 589' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -104.4 119.65 39.44 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.47 -0.567 . . . . 1.35 109.47 176.353 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 590' ' ' VAL . . . . . . . . . . . . . 58.5 t -125.37 117.41 49.6 Favored 'Isoleucine or valine' 0 C--O 1.239 0.552 0 CA-C-N 115.831 -0.622 . . . . 1.3 110.374 178.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 591' ' ' ASN . . . . . . . . . . . . . 95.0 m-20 57.36 45.8 19.4 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.379 -0.828 . . . . 2.03 112.172 176.538 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . 82.06 7.4 87.89 Favored Glycine 0 N--CA 1.45 -0.429 0 CA-C-N 115.927 -0.579 . . . . 0.62 112.329 173.318 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 593' ' ' LYS . . . . . 0.636 ' HZ1' ' HB2' ' A' ' 593' ' ' LYS . 8.1 mtmp? -129.97 137.86 50.54 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.823 0.344 . . . . 3.3 111.182 -177.557 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 594' ' ' TYR . . . . . . . . . . . . . 79.2 m-85 -94.21 132.38 38.83 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.016 -0.538 . . . . 2.29 110.567 179.514 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 595' ' ' PHE . . . . . . . . . . . . . 71.8 m-85 -138.41 159.35 42.28 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.013 -0.736 . . . . 2.2 109.013 177.053 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 596' ' ' HIS . . . . . 0.654 ' HB2' ' SG ' ' A' ' 599' ' ' CYS . 24.4 m170 -63.52 129.44 40.19 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 107.599 -1.26 . . . . 0.76 107.599 165.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 597' ' ' SER . . . . . . . . . . . . . 2.9 m -58.7 -32.41 69.14 Favored 'General case' 0 CA--C 1.519 -0.214 0 CA-C-O 121.577 0.703 . . . . 1.59 109.783 178.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 598' ' ' THR . . . . . . . . . . . . . 81.8 m -59.46 -39.9 85.14 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 114.573 -1.194 . . . . 1.93 110.534 173.606 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 599' ' ' CYS . . . . . 0.667 ' HA ' ' HG2' ' A' ' 602' ' ' GLU . 83.6 m -74.82 -34.99 62.45 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.969 -0.56 . . . . 0.81 112.329 -179.258 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 600' ' ' TYR . . . . . . . . . . . . . 79.6 t80 -61.01 -35.57 77.19 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 109.161 -0.681 . . . . 2.65 109.161 -179.142 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 601' ' ' HIS . . . . . . . . . . . . . 27.8 t60 -68.09 -42.99 79.52 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 115.581 -0.736 . . . . 5.16 110.288 177.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 602' ' ' GLU . . . . . 0.667 ' HG2' ' HA ' ' A' ' 599' ' ' CYS . 13.8 pt-20 -70.91 -33.74 70.84 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 111.863 0.32 . . . . 3.85 111.863 -176.447 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 603' ' ' THR . . . . . 0.417 ' HB ' HD11 ' A' ' 566' ' ' ILE . 15.3 t . . . . . 0 C--N 1.326 -0.434 0 O-C-N 122.167 -0.333 . . . . 3.3 111.243 -179.028 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 701' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.289 0 N-CA-C 113.593 0.197 . . . . 3.77 113.593 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 549' ' ' LYS . . . . . . . . . . . . . 29.6 mtpt -81.01 138.89 36.02 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.107 0.48 . . . . 6.2 110.473 177.447 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 550' ' ' TYR . . . . . 0.545 ' CE1' HG11 ' A' ' 583' ' ' VAL . 16.4 p90 -111.46 161.72 15.84 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.167 -0.924 . . . . 3.22 109.279 178.535 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 551' ' ' VAL . . . . . 0.506 HG13 ' HE1' ' A' ' 594' ' ' TYR . 57.4 t -116.47 133.52 62.79 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.992 0 N-CA-C 109.19 -0.67 . . . . 2.01 109.19 177.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 552' ' ' VAL . . . . . . . . . . . . . 48.3 t -67.89 130.72 33.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.912 -0.585 . . . . 1.8 110.361 -177.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 553' ' ' VAL . . . . . 0.628 HG21 ' CD1' ' A' ' 584' ' ' TRP . 64.1 t -59.2 122.61 64.72 Favored Pre-proline 0 C--N 1.328 -0.34 0 O-C-N 123.902 0.751 . . . . 1.63 111.048 -177.545 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 554' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_exo -59.9 142.78 99.22 Favored 'Trans proline' 0 N--CA 1.461 -0.391 0 C-N-CA 122.706 2.271 . . . . 2.2 111.442 176.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 555' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -47.86 -49.05 30.67 Favored 'General case' 0 C--O 1.235 0.319 0 O-C-N 123.608 0.567 . . . . 4.17 111.949 -171.57 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 22.8 p -108.17 -76.06 0.62 Allowed 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.959 -0.564 . . . . 4.31 111.879 -178.086 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 557' ' ' SER . . . . . . . . . . . . . 21.8 t 62.8 -84.63 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 109.509 -0.552 . . . . 3.39 109.509 -173.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 558' ' ' GLN . . . . . . . . . . . . . 13.0 mm100 -147.54 -84.13 0.11 Allowed 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 108.602 -0.888 . . . . 5.62 108.602 174.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 559' ' ' ASP . . . . . . . . . . . . . 20.9 p-10 -121.05 46.24 2.08 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.149 -0.932 . . . . 3.23 109.239 173.365 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 560' ' ' MET . . . . . . . . . . . . . 57.4 mtt 59.52 33.26 22.11 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 115.087 -0.96 . . . . 2.98 110.259 -174.297 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 561' ' ' ALA . . . . . . . . . . . . . . . -144.21 161.18 39.54 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.048 -0.978 . . . . 1.46 110.517 -174.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 30.8 p90 -136.59 164.31 28.5 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 108.02 -1.104 . . . . 1.35 108.02 171.373 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 563' ' ' LYS . . . . . . . . . . . . . 29.2 ttpt -112.17 122.0 46.51 Favored 'General case' 0 C--N 1.32 -0.704 0 C-N-CA 120.399 -0.52 . . . . 2.71 110.675 -177.542 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 564' ' ' CYS . . . . . 0.416 ' HA ' ' HD3' ' A' ' 565' ' ' PRO . 44.2 t -74.39 111.91 14.91 Favored Pre-proline 0 N--CA 1.453 -0.322 0 CA-C-N 115.48 -0.782 . . . . 0.41 109.624 -178.49 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 565' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 564' ' ' CYS . 15.2 Cg_exo -72.34 -21.66 22.79 Favored 'Trans proline' 0 CA--C 1.528 0.202 0 C-N-CA 123.128 2.552 . . . . 1.0 113.843 -174.206 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 566' ' ' ILE . . . . . . . . . . . . . 18.4 mt -71.9 -39.19 66.93 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 CA-C-O 121.059 0.457 . . . . 1.54 110.476 -173.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 567' ' ' CYS . . . . . 0.599 ' SG ' ' HG3' ' A' ' 569' ' ' GLU . 27.4 p -129.81 2.53 4.9 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.873 -0.603 . . . . 0.7 112.534 -174.5 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 568' ' ' LYS . . . . . . . . . . . . . 52.5 mtpt 71.16 30.81 2.58 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 113.425 0.898 . . . . 3.19 113.425 175.047 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 569' ' ' GLU . . . . . 0.599 ' HG3' ' SG ' ' A' ' 567' ' ' CYS . 46.2 mt-10 -85.59 132.84 34.1 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 120.515 -0.474 . . . . 3.34 110.277 176.486 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 570' ' ' THR . . . . . . . . . . . . . 49.2 m -84.42 116.12 22.9 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 108.317 -0.994 . . . . 1.43 108.317 166.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 571' ' ' VAL . . . . . . . . . . . . . 12.7 t -98.08 116.29 40.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 115.947 -0.57 . . . . 1.39 110.856 -171.398 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 27.5 p -104.26 160.71 14.65 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.594 -0.73 . . . . 2.17 109.474 178.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . -128.66 157.18 21.36 Favored Glycine 0 N--CA 1.439 -1.114 0 C-N-CA 119.896 -1.145 . . . . 2.2 111.912 -176.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 574' ' ' VAL . . . . . . . . . . . . . 60.3 t -111.66 145.86 17.3 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-O 121.004 0.43 . . . . 3.64 110.231 -172.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 575' ' ' TYR . . . . . . . . . . . . . 45.3 t80 -78.52 118.49 20.7 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 108.917 -0.772 . . . . 3.53 108.917 174.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 576' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -91.66 102.76 15.39 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 109.154 -0.684 . . . . 3.34 109.154 -179.113 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 577' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -68.56 -23.0 64.45 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.276 -0.42 . . . . 5.59 111.635 -176.147 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 578' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -65.74 -43.98 87.35 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.409 -0.36 . . . . 5.11 110.603 -178.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 579' ' ' SER . . . . . . . . . . . . . 72.0 p -95.9 -20.61 18.64 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.109 0.48 . . . . 3.7 111.504 176.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 580' ' ' GLY . . . . . . . . . . . . . . . 80.71 21.38 63.93 Favored Glycine 0 N--CA 1.452 -0.244 0 CA-C-N 116.01 -0.541 . . . . 2.89 112.886 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 581' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -133.09 157.56 44.98 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.728 0.299 . . . . 3.19 110.597 179.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 582' ' ' TRP . . . . . 0.448 ' HB2' ' HB ' ' A' ' 553' ' ' VAL . 76.3 m95 -79.85 137.11 36.85 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.478 -0.328 . . . . 2.63 110.194 178.151 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 583' ' ' VAL . . . . . 0.545 HG11 ' CE1' ' A' ' 550' ' ' TYR . 20.5 m -118.81 141.48 38.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 113.251 0.834 . . . . 1.67 113.251 -173.409 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 584' ' ' TRP . . . . . 0.628 ' CD1' HG21 ' A' ' 553' ' ' VAL . 28.1 m0 -113.43 104.56 12.41 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 114.997 -1.001 . . . . 2.74 108.621 164.225 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 585' ' ' LYS . . . . . 0.487 ' HD2' ' CB ' ' A' ' 550' ' ' TYR . 10.9 mmmm -89.17 152.35 21.66 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.696 0.284 . . . . 4.27 110.491 -176.337 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 586' ' ' ASN . . . . . 0.416 ' O ' ' HA ' ' A' ' 596' ' ' HIS . 1.1 m-20 55.24 42.77 30.15 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 115.911 -0.586 . . . . 1.72 109.648 -173.601 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 587' ' ' THR . . . . . . . . . . . . . 53.3 m -126.33 140.23 52.68 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.114 0.483 . . . . 1.22 110.878 -175.491 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 588' ' ' ILE . . . . . 0.588 ' HB ' ' HG ' ' A' ' 597' ' ' SER . 14.3 tt -137.25 145.3 29.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.832 -0.622 . . . . 1.34 109.644 179.785 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 589' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -103.17 121.14 42.04 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.064 0.459 . . . . 1.35 109.999 178.636 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 590' ' ' VAL . . . . . 0.683 HG13 ' HH ' ' A' ' 600' ' ' TYR . 43.5 t -131.6 127.65 59.6 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 115.594 -0.73 . . . . 1.3 109.662 -179.843 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 591' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 59.63 33.26 21.93 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 121.947 0.88 . . . . 2.03 110.451 179.297 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . 77.78 9.82 86.64 Favored Glycine 0 N--CA 1.449 -0.436 0 CA-C-N 115.64 -0.709 . . . . 0.62 112.327 179.316 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 593' ' ' LYS . . . . . . . . . . . . . 70.1 mmtt -123.35 144.57 49.37 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 110.185 -0.302 . . . . 3.3 110.185 -175.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 594' ' ' TYR . . . . . 0.506 ' HE1' HG13 ' A' ' 551' ' ' VAL . 99.1 m-85 -96.28 134.27 39.6 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.878 0.37 . . . . 2.29 111.162 -177.2 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 595' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -139.18 162.66 34.42 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.681 -0.69 . . . . 2.2 109.631 178.258 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 596' ' ' HIS . . . . . 0.429 ' HB2' ' HB2' ' A' ' 599' ' ' CYS . 24.6 m170 -68.17 128.78 37.8 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 108.951 -0.759 . . . . 0.76 108.951 169.4 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 597' ' ' SER . . . . . 0.588 ' HG ' ' HB ' ' A' ' 588' ' ' ILE . 4.6 m -63.26 -36.42 83.61 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-O 121.467 0.651 . . . . 1.59 109.474 178.519 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 598' ' ' THR . . . . . . . . . . . . . 96.3 m -63.69 -44.76 92.74 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 114.704 -1.134 . . . . 1.93 111.188 177.225 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 599' ' ' CYS . . . . . 0.654 ' O ' ' HG2' ' A' ' 602' ' ' GLU . 83.3 m -76.45 -31.98 58.16 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.564 0.579 . . . . 0.81 112.564 -176.157 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 600' ' ' TYR . . . . . 0.683 ' HH ' HG13 ' A' ' 590' ' ' VAL . 87.5 t80 -57.03 -36.45 70.48 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.647 0.61 . . . . 2.65 112.647 -169.219 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 601' ' ' HIS . . . . . . . . . . . . . 18.5 m170 -64.17 -26.71 68.65 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 112.801 0.667 . . . . 5.16 112.801 -174.4 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 602' ' ' GLU . . . . . 0.654 ' HG2' ' O ' ' A' ' 599' ' ' CYS . 11.9 pt-20 -70.12 -23.48 63.03 Favored 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 120.313 -0.555 . . . . 3.85 111.077 -178.445 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 603' ' ' THR . . . . . . . . . . . . . 85.0 m . . . . . 0 C--N 1.328 -0.338 0 CA-C-O 121.31 0.576 . . . . 3.3 109.774 177.347 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 701' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.447 0 N-CA-C 112.504 -0.239 . . . . 3.77 112.504 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 549' ' ' LYS . . . . . 0.437 ' HD3' ' HA ' ' A' ' 549' ' ' LYS . 31.0 mmtp -76.13 150.86 37.14 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.615 0.721 . . . . 6.2 111.429 179.014 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 550' ' ' TYR . . . . . 0.58 ' CE1' HG12 ' A' ' 583' ' ' VAL . 46.9 p90 -114.81 162.97 16.17 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 114.594 -1.185 . . . . 3.22 110.761 -170.375 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 551' ' ' VAL . . . . . . . . . . . . . 60.5 t -117.03 134.01 61.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 N-CA-C 108.681 -0.859 . . . . 2.01 108.681 175.228 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 552' ' ' VAL . . . . . 0.592 ' HA ' ' O ' ' A' ' 582' ' ' TRP . 60.4 t -62.57 135.36 27.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.094 -0.503 . . . . 1.8 110.508 -176.622 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 553' ' ' VAL . . . . . 0.551 HG21 ' CD1' ' A' ' 584' ' ' TRP . 92.4 t -59.34 120.62 49.74 Favored Pre-proline 0 N--CA 1.455 -0.194 0 CA-C-N 116.034 -0.53 . . . . 1.63 110.464 -178.405 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 554' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 553' ' ' VAL . 33.5 Cg_exo -57.31 143.24 94.29 Favored 'Trans proline' 0 C--O 1.232 0.21 0 C-N-CA 123.653 2.902 . . . . 2.2 113.043 -178.526 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 555' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -72.33 -15.1 61.88 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.446 -0.797 . . . . 4.17 110.341 179.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 23.7 p -104.67 22.06 15.74 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.454 -0.794 . . . . 4.31 110.779 177.408 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 557' ' ' SER . . . . . . . . . . . . . 29.0 t -74.3 149.75 40.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.848 -0.615 . . . . 3.39 110.763 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 558' ' ' GLN . . . . . . . . . . . . . 14.5 mm100 -90.69 89.3 7.46 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.112 -0.495 . . . . 5.62 109.952 -178.322 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 559' ' ' ASP . . . . . . . . . . . . . 10.8 t70 64.91 35.07 8.61 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 115.217 -0.902 . . . . 3.23 110.399 -179.233 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 560' ' ' MET . . . . . . . . . . . . . 1.9 mpt? 61.09 26.56 16.47 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 115.119 -0.946 . . . . 2.98 112.059 177.083 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 561' ' ' ALA . . . . . 0.492 ' HA ' ' O ' ' A' ' 571' ' ' VAL . . . -144.64 154.71 43.09 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.918 0.39 . . . . 1.46 111.486 -177.634 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 34.5 p90 -141.58 159.83 41.41 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 108.884 -0.784 . . . . 1.35 108.884 170.467 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 563' ' ' LYS . . . . . . . . . . . . . 23.3 tptm -99.87 122.52 42.94 Favored 'General case' 0 C--N 1.32 -0.713 0 C-N-CA 120.98 -0.288 . . . . 2.71 110.702 -176.066 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 564' ' ' CYS . . . . . 0.48 ' HB3' ' HG2' ' A' ' 569' ' ' GLU . 49.5 t -77.38 114.72 43.07 Favored Pre-proline 0 C--N 1.326 -0.425 0 N-CA-C 109.912 -0.403 . . . . 0.41 109.912 178.102 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 565' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 564' ' ' CYS . 13.4 Cg_exo -69.42 -28.85 26.37 Favored 'Trans proline' 0 C--N 1.343 0.263 0 C-N-CA 122.998 2.465 . . . . 1.0 113.539 -173.053 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 566' ' ' ILE . . . . . . . . . . . . . 51.9 mt -72.01 -55.62 12.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 121.005 0.431 . . . . 1.54 111.577 -175.537 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 567' ' ' CYS . . . . . . . . . . . . . 26.7 p -107.47 2.3 24.11 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 112.262 0.467 . . . . 0.7 112.262 -174.186 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 568' ' ' LYS . . . . . . . . . . . . . 44.8 mmtm 67.34 28.7 7.81 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 115.921 -0.581 . . . . 3.19 112.186 171.117 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 569' ' ' GLU . . . . . 0.48 ' HG2' ' HB3' ' A' ' 564' ' ' CYS . 17.4 pt-20 -99.5 135.51 40.8 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.705 -0.398 . . . . 3.34 110.35 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 570' ' ' THR . . . . . . . . . . . . . 88.5 m -80.66 119.1 22.85 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.649 -0.5 . . . . 1.43 109.649 174.154 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 571' ' ' VAL . . . . . 0.492 ' O ' ' HA ' ' A' ' 561' ' ' ALA . 11.7 t -92.27 116.72 34.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 116.179 -0.464 . . . . 1.39 111.039 -174.861 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 27.8 p -107.67 159.07 16.75 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 116.1 -0.5 . . . . 2.17 109.889 176.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . -130.79 155.78 21.37 Favored Glycine 0 N--CA 1.442 -0.939 0 C-N-CA 119.868 -1.158 . . . . 2.2 111.835 179.496 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 574' ' ' VAL . . . . . . . . . . . . . 23.9 t -114.09 149.96 16.26 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 N-CA-C 109.761 -0.459 . . . . 3.64 109.761 -175.148 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 575' ' ' TYR . . . . . . . . . . . . . 54.1 t80 -82.02 119.18 23.67 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 108.717 -0.846 . . . . 3.53 108.717 174.335 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 576' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -90.57 106.36 18.45 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 109.12 -0.696 . . . . 3.34 109.12 -178.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 577' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -69.36 -21.8 63.78 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.956 -0.565 . . . . 5.59 111.965 -176.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 578' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -67.6 -44.76 77.32 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.974 0.416 . . . . 5.11 110.527 -177.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 579' ' ' SER . . . . . . . . . . . . . 70.1 p -96.29 -23.67 16.56 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.281 0.562 . . . . 3.7 111.119 176.202 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 580' ' ' GLY . . . . . . . . . . . . . . . 81.81 31.48 32.48 Favored Glycine 0 CA--C 1.522 0.477 0 CA-C-N 115.497 -0.774 . . . . 2.89 113.018 -178.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 581' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -138.15 152.52 48.77 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 116.855 0.327 . . . . 3.19 110.675 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 582' ' ' TRP . . . . . 0.592 ' O ' ' HA ' ' A' ' 552' ' ' VAL . 80.5 m95 -76.8 136.69 38.97 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 109.639 -0.504 . . . . 2.63 109.639 176.411 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 583' ' ' VAL . . . . . 0.58 HG12 ' CE1' ' A' ' 550' ' ' TYR . 19.1 m -116.0 131.55 68.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 N-CA-C 113.502 0.927 . . . . 1.67 113.502 -173.118 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 584' ' ' TRP . . . . . 0.551 ' CD1' HG21 ' A' ' 553' ' ' VAL . 17.8 m0 -114.49 103.0 10.6 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 108.497 -0.927 . . . . 2.74 108.497 162.835 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 585' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.98 151.21 22.95 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.066 0.46 . . . . 4.27 111.991 -173.426 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 586' ' ' ASN . . . . . . . . . . . . . 18.9 m-20 52.68 41.7 31.46 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 115.23 -0.896 . . . . 1.72 110.192 -174.474 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 587' ' ' THR . . . . . . . . . . . . . 32.5 m -120.34 141.0 50.46 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.015 -0.539 . . . . 1.22 110.789 -177.132 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 588' ' ' ILE . . . . . . . . . . . . . 11.7 tt -137.98 141.54 38.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 N-CA-C 109.671 -0.492 . . . . 1.34 109.671 179.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 589' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -97.23 120.87 38.38 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.306 -0.628 . . . . 1.35 109.306 177.812 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 590' ' ' VAL . . . . . . . . . . . . . 61.9 t -127.17 118.2 49.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.634 -0.712 . . . . 1.3 110.549 179.653 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 591' ' ' ASN . . . . . . . . . . . . . 62.8 t30 58.62 38.91 25.11 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 115.459 -0.791 . . . . 2.03 111.617 176.112 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . 86.08 5.49 83.12 Favored Glycine 0 N--CA 1.45 -0.421 0 CA-C-N 115.86 -0.609 . . . . 0.62 113.17 175.344 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 593' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -128.74 139.75 52.06 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.917 0.389 . . . . 3.3 111.151 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 594' ' ' TYR . . . . . . . . . . . . . 85.1 m-85 -91.26 129.82 37.2 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.966 -0.561 . . . . 2.29 110.478 -179.218 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 595' ' ' PHE . . . . . . . . . . . . . 63.8 m-85 -135.0 162.9 31.13 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.896 -0.593 . . . . 2.2 109.682 177.235 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 596' ' ' HIS . . . . . 0.487 ' HB2' ' SG ' ' A' ' 599' ' ' CYS . 30.5 m170 -70.68 129.36 38.93 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.68 -0.489 . . . . 0.76 109.68 172.436 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 597' ' ' SER . . . . . . . . . . . . . 23.0 t -65.47 -30.47 71.25 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.783 -0.644 . . . . 1.59 109.598 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 598' ' ' THR . . . . . . . . . . . . . 1.8 m -66.52 -42.42 87.32 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 115.464 -0.789 . . . . 1.93 110.333 175.063 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 599' ' ' CYS . . . . . 0.487 ' SG ' ' HB2' ' A' ' 596' ' ' HIS . 78.6 m -73.83 -27.45 61.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.069 -0.969 . . . . 0.81 111.906 -178.778 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 600' ' ' TYR . . . . . . . . . . . . . 79.7 t80 -56.0 -35.29 66.64 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.696 0.284 . . . . 2.65 110.98 -174.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 601' ' ' HIS . . . . . . . . . . . . . 31.2 m170 -62.74 -28.13 69.75 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.006 0.432 . . . . 5.16 111.01 178.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 602' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -70.81 -38.37 73.3 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.018 -0.537 . . . . 3.85 110.924 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 603' ' ' THR . . . . . . . . . . . . . 10.3 t . . . . . 0 C--N 1.327 -0.392 0 CA-C-O 121.203 0.525 . . . . 3.3 110.599 -176.594 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 701' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.509 -0.321 0 CA-C-O 120.915 0.175 . . . . 3.77 113.064 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 549' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -80.18 132.72 35.95 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.135 0.493 . . . . 6.2 110.559 179.392 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 550' ' ' TYR . . . . . 0.454 ' HB3' ' HD2' ' A' ' 585' ' ' LYS . 39.0 p90 -111.18 160.56 16.82 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.58 -0.737 . . . . 3.22 109.29 174.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 551' ' ' VAL . . . . . . . . . . . . . 70.2 t -117.72 133.36 64.75 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 N-CA-C 108.708 -0.849 . . . . 2.01 108.708 178.137 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 552' ' ' VAL . . . . . 0.576 ' HA ' ' O ' ' A' ' 582' ' ' TRP . 74.4 t -64.86 131.67 30.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.994 -0.548 . . . . 1.8 110.487 -178.291 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 553' ' ' VAL . . . . . 0.6 HG21 ' CD1' ' A' ' 584' ' ' TRP . 65.9 t -59.04 123.33 68.76 Favored Pre-proline 0 C--O 1.235 0.319 0 CA-C-N 116.073 -0.512 . . . . 1.63 110.08 178.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 554' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_exo -56.18 136.58 75.96 Favored 'Trans proline' 0 CA--C 1.529 0.241 0 C-N-CA 122.967 2.445 . . . . 2.2 112.577 -177.275 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 555' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -90.23 143.76 26.47 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.817 -0.629 . . . . 4.17 110.132 -176.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 28.6 p 47.6 36.3 5.26 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 123.428 0.691 . . . . 4.31 111.997 -176.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 557' ' ' SER . . . . . . . . . . . . . 15.5 t -102.99 49.62 0.83 Allowed 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 116.091 -0.504 . . . . 3.39 110.04 -178.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 558' ' ' GLN . . . . . 0.868 ' HA ' HE21 ' A' ' 558' ' ' GLN . 0.0 OUTLIER 71.76 -63.5 0.42 Allowed 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 115.26 -0.882 . . . . 5.62 111.616 -179.953 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 559' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -143.68 -168.03 2.73 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.393 -0.595 . . . . 3.23 109.393 -177.488 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 560' ' ' MET . . . . . . . . . . . . . 41.7 mtm -115.62 15.28 16.58 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.67 0.271 . . . . 2.98 110.947 -173.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 561' ' ' ALA . . . . . . . . . . . . . . . -142.84 145.78 33.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.098 0.475 . . . . 1.46 112.231 -173.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 27.0 p90 -136.17 164.7 27.44 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 107.4 -1.333 . . . . 1.35 107.4 172.427 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 563' ' ' LYS . . . . . . . . . . . . . 35.5 ttmt -105.48 133.0 50.96 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 119.589 -0.844 . . . . 2.71 111.157 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 564' ' ' CYS . . . . . 0.428 ' O ' ' HA ' ' A' ' 568' ' ' LYS . 34.6 t -71.97 114.1 26.08 Favored Pre-proline 0 C--O 1.222 -0.385 0 CA-C-N 115.085 -0.961 . . . . 0.41 109.385 178.468 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 565' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -67.02 -30.79 38.45 Favored 'Trans proline' 0 CA--C 1.53 0.285 0 C-N-CA 122.588 2.192 . . . . 1.0 113.942 -172.613 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 566' ' ' ILE . . . . . . . . . . . . . 32.8 mt -71.61 -56.27 10.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.815 0.34 . . . . 1.54 111.53 -172.47 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 567' ' ' CYS . . . . . 0.53 ' SG ' ' HG3' ' A' ' 569' ' ' GLU . 28.5 p -108.05 0.71 21.91 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.99 0.424 . . . . 0.7 111.339 -177.604 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 568' ' ' LYS . . . . . 0.428 ' HA ' ' O ' ' A' ' 564' ' ' CYS . 52.7 mttp 67.57 30.56 6.6 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 113.145 0.795 . . . . 3.19 113.145 171.389 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 569' ' ' GLU . . . . . 0.53 ' HG3' ' SG ' ' A' ' 567' ' ' CYS . 35.7 mt-10 -77.96 133.44 38.03 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.78 -0.452 . . . . 3.34 109.78 171.85 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 570' ' ' THR . . . . . . . . . . . . . 52.8 m -76.16 117.31 17.73 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 108.68 -0.859 . . . . 1.43 108.68 167.278 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 571' ' ' VAL . . . . . . . . . . . . . 23.5 t -94.77 116.93 37.32 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-N 116.59 -0.277 . . . . 1.39 110.894 -172.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 24.1 p -111.89 159.59 18.21 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.748 -0.66 . . . . 2.17 109.536 175.532 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . -130.82 155.1 21.05 Favored Glycine 0 N--CA 1.442 -0.938 0 C-N-CA 119.933 -1.127 . . . . 2.2 111.799 -178.129 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 574' ' ' VAL . . . . . 0.429 ' O ' HG21 ' A' ' 583' ' ' VAL . 35.4 t -113.04 149.54 15.44 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 N-CA-C 109.614 -0.513 . . . . 3.64 109.614 -176.081 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 575' ' ' TYR . . . . . 0.506 ' HA ' ' HA ' ' A' ' 582' ' ' TRP . 59.8 t80 -83.76 119.41 24.78 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.593 0.235 . . . . 3.53 110.43 177.071 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 576' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -92.01 105.67 17.86 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.199 0.523 . . . . 3.34 110.024 175.236 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 577' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -63.87 -23.94 67.55 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.39 -0.823 . . . . 5.59 111.153 -178.184 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 578' ' ' GLU . . . . . . . . . . . . . 13.4 tt0 -72.25 -46.58 55.37 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.911 -0.586 . . . . 5.11 111.216 -174.422 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 579' ' ' SER . . . . . . . . . . . . . 75.7 p -87.54 -15.97 35.98 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.965 0.412 . . . . 3.7 110.743 175.102 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 580' ' ' GLY . . . . . . . . . . . . . . . 80.04 15.24 79.32 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 121.07 -0.586 . . . . 2.89 112.697 177.379 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 581' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -135.09 154.53 51.64 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.023 0.439 . . . . 3.19 110.596 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 582' ' ' TRP . . . . . 0.599 ' HB2' ' HB ' ' A' ' 553' ' ' VAL . 77.3 m95 -71.88 148.2 46.35 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.913 -0.585 . . . . 2.63 109.96 176.673 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 583' ' ' VAL . . . . . 0.452 HG11 ' CE1' ' A' ' 550' ' ' TYR . 15.8 m -121.58 133.33 68.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 112.975 0.731 . . . . 1.67 112.975 -174.881 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 584' ' ' TRP . . . . . 0.6 ' CD1' HG21 ' A' ' 553' ' ' VAL . 27.0 m0 -110.31 103.79 12.5 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 108.262 -1.014 . . . . 2.74 108.262 162.868 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 585' ' ' LYS . . . . . 0.454 ' HD2' ' HB3' ' A' ' 550' ' ' TYR . 14.4 mmmm -82.08 152.0 26.78 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.877 0.37 . . . . 4.27 111.127 -175.312 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 586' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 54.76 41.9 31.57 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 115.424 -0.807 . . . . 1.72 109.632 -176.844 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 587' ' ' THR . . . . . . . . . . . . . 49.3 m -120.91 140.52 51.71 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.19 0.519 . . . . 1.22 110.628 -175.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 588' ' ' ILE . . . . . 0.739 ' HB ' ' HG ' ' A' ' 597' ' ' SER . 15.1 tt -139.67 143.61 30.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.606 -0.725 . . . . 1.34 109.924 -177.812 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 589' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -96.22 119.56 34.92 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.351 -0.611 . . . . 1.35 109.351 175.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 590' ' ' VAL . . . . . . . . . . . . . 27.3 t -128.36 120.75 53.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.253 -0.885 . . . . 1.3 109.343 179.028 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 591' ' ' ASN . . . . . . . . . . . . . 16.9 m120 59.36 34.66 22.9 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 121.175 0.512 . . . . 2.03 111.21 -179.004 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . 79.56 13.91 81.93 Favored Glycine 0 N--CA 1.445 -0.748 0 C-N-CA 120.981 -0.628 . . . . 0.62 112.15 177.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 593' ' ' LYS . . . . . . . . . . . . . 46.7 mmtm -123.58 139.81 53.63 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.747 0.308 . . . . 3.3 110.535 -176.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 594' ' ' TYR . . . . . . . . . . . . . 75.5 m-85 -90.62 122.51 33.47 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.304 -0.407 . . . . 2.29 110.466 179.089 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 595' ' ' PHE . . . . . . . . . . . . . 44.8 m-85 -133.15 163.87 28.3 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.771 -0.65 . . . . 2.2 110.058 178.588 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 596' ' ' HIS . . . . . . . . . . . . . 32.1 m170 -71.55 128.06 34.59 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.742 -0.836 . . . . 0.76 108.742 170.093 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 597' ' ' SER . . . . . 0.739 ' HG ' ' HB ' ' A' ' 588' ' ' ILE . 8.6 m -64.15 -29.99 71.08 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.159 -0.473 . . . . 1.59 110.277 -179.732 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 598' ' ' THR . . . . . . . . . . . . . 4.7 t -67.37 -38.91 85.51 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 115.376 -0.829 . . . . 1.93 110.968 179.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 599' ' ' CYS . . . . . . . . . . . . . 77.3 m -77.35 -34.64 55.1 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.954 -0.566 . . . . 0.81 112.495 -175.179 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 600' ' ' TYR . . . . . 0.402 ' O ' HG23 ' A' ' 603' ' ' THR . 85.0 t80 -56.75 -33.65 66.79 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 120.898 0.38 . . . . 2.65 111.92 -170.091 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 601' ' ' HIS . . . . . . . . . . . . . 28.7 m170 -59.74 -27.21 66.3 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 112.427 0.529 . . . . 5.16 112.427 -175.314 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 602' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -70.06 -31.08 68.51 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.734 0.302 . . . . 3.85 110.794 -176.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 603' ' ' THR . . . . . 0.402 HG23 ' O ' ' A' ' 600' ' ' TYR . 3.2 t . . . . . 0 CA--C 1.533 0.302 0 C-N-CA 120.55 -0.46 . . . . 3.3 111.66 -174.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 701' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.508 -0.351 0 N-CA-C 112.127 -0.389 . . . . 3.77 112.127 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 549' ' ' LYS . . . . . 0.414 ' HA ' ' HD3' ' A' ' 549' ' ' LYS . 71.3 mmtt -71.91 132.55 44.51 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.003 0.43 . . . . 6.2 110.871 -179.521 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 550' ' ' TYR . . . . . . . . . . . . . 21.2 p90 -125.66 159.63 31.73 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.232 -0.894 . . . . 3.22 109.286 177.588 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 551' ' ' VAL . . . . . . . . . . . . . 57.5 t -118.81 132.69 67.96 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 N-CA-C 109.073 -0.714 . . . . 2.01 109.073 177.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 552' ' ' VAL . . . . . 0.501 ' HA ' ' O ' ' A' ' 582' ' ' TRP . 67.9 t -65.19 127.04 25.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 109.642 -0.503 . . . . 1.8 109.642 178.668 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 553' ' ' VAL . . . . . 0.658 HG21 ' CD1' ' A' ' 584' ' ' TRP . 61.8 t -59.92 120.99 55.11 Favored Pre-proline 0 C--N 1.329 -0.313 0 O-C-N 123.495 0.497 . . . . 1.63 110.834 -176.238 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 554' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_exo -60.93 135.91 62.38 Favored 'Trans proline' 0 N--CA 1.461 -0.406 0 C-N-CA 122.785 2.323 . . . . 2.2 111.764 178.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 555' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -82.06 -0.78 46.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.234 0.54 . . . . 4.17 110.858 -179.245 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 24.4 p -80.46 -27.81 37.79 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.773 -0.649 . . . . 4.31 110.278 174.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 557' ' ' SER . . . . . . . . . . . . . 44.5 t -81.05 109.03 15.22 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 115.478 -0.783 . . . . 3.39 109.795 177.557 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 558' ' ' GLN . . . . . . . . . . . . . 24.3 mt-30 -75.81 -1.44 25.17 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.052 0.453 . . . . 5.62 110.629 179.488 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 559' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -101.73 -18.61 15.74 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.612 -0.722 . . . . 3.23 110.679 176.331 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 560' ' ' MET . . . . . . . . . . . . . 2.0 mpt? 60.58 22.38 12.16 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 115.496 -0.775 . . . . 2.98 109.935 -173.396 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 561' ' ' ALA . . . . . . . . . . . . . . . -145.36 161.95 38.41 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.394 -0.821 . . . . 1.46 111.722 -171.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 31.0 p90 -142.82 155.03 44.73 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 107.781 -1.192 . . . . 1.35 107.781 170.117 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 563' ' ' LYS . . . . . . . . . . . . . 78.7 tttt -99.15 120.83 40.15 Favored 'General case' 0 C--N 1.32 -0.715 0 C-N-CA 120.193 -0.603 . . . . 2.71 110.536 -176.254 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 564' ' ' CYS . . . . . . . . . . . . . 42.8 t -64.7 117.29 36.8 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 115.412 -0.813 . . . . 0.41 111.944 -174.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 565' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_exo -68.72 -22.01 37.93 Favored 'Trans proline' 0 CA--C 1.531 0.358 0 C-N-CA 123.128 2.552 . . . . 1.0 113.085 -179.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 566' ' ' ILE . . . . . 0.518 HG23 ' HB3' ' A' ' 599' ' ' CYS . 36.0 mm -74.47 -42.25 49.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 120.714 0.293 . . . . 1.54 111.569 -177.041 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 567' ' ' CYS . . . . . . . . . . . . . 28.8 p -123.56 0.9 8.86 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 111.923 0.342 . . . . 0.7 111.923 -174.172 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 568' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? 62.13 27.95 16.83 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.84 -0.618 . . . . 3.19 112.008 176.425 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 569' ' ' GLU . . . . . 0.41 ' HA ' ' OE1' ' A' ' 569' ' ' GLU . 6.3 mm-40 -107.37 137.4 45.49 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 116.298 -0.41 . . . . 3.34 110.463 177.637 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 570' ' ' THR . . . . . . . . . . . . . 37.4 m -69.24 123.91 22.41 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.76 -0.655 . . . . 1.43 110.396 -179.257 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 571' ' ' VAL . . . . . 0.421 HG22 ' CE1' ' A' ' 596' ' ' HIS . 18.0 t -96.62 115.41 35.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 116.376 -0.374 . . . . 1.39 110.087 -179.827 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 23.6 p -106.72 159.22 16.38 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 116.053 -0.521 . . . . 2.17 110.325 178.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . -130.35 155.73 21.23 Favored Glycine 0 N--CA 1.44 -1.084 0 C-N-CA 119.921 -1.133 . . . . 2.2 111.384 -178.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 574' ' ' VAL . . . . . 0.462 ' O ' HG23 ' A' ' 583' ' ' VAL . 41.2 t -111.85 147.2 15.88 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 N-CA-C 109.644 -0.502 . . . . 3.64 109.644 -172.503 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 575' ' ' TYR . . . . . 0.475 ' HA ' ' HA ' ' A' ' 582' ' ' TRP . 48.8 t80 -82.33 121.49 26.76 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.507 -0.553 . . . . 3.53 109.507 174.668 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 576' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -89.59 108.54 19.73 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.046 -0.724 . . . . 3.34 109.046 179.45 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 577' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -69.68 -23.03 63.39 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.417 -0.81 . . . . 5.59 111.816 -172.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 578' ' ' GLU . . . . . . . . . . . . . 45.4 tt0 -74.87 -48.35 25.38 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 121.044 -0.262 . . . . 5.11 110.858 -178.156 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 579' ' ' SER . . . . . . . . . . . . . 74.0 p -85.64 -19.16 31.38 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.019 0.438 . . . . 3.7 111.187 179.32 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 580' ' ' GLY . . . . . . . . . . . . . . . 79.13 22.36 65.72 Favored Glycine 0 N--CA 1.448 -0.535 0 CA-C-N 115.926 -0.579 . . . . 2.89 112.818 178.554 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 581' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -135.17 152.34 51.5 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.876 0.37 . . . . 3.19 110.8 -178.394 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 582' ' ' TRP . . . . . 0.501 ' O ' ' HA ' ' A' ' 552' ' ' VAL . 74.5 m95 -78.8 144.78 34.76 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.742 -0.663 . . . . 2.63 110.013 177.778 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 583' ' ' VAL . . . . . 0.462 HG23 ' O ' ' A' ' 574' ' ' VAL . 26.7 m -124.14 134.3 66.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 N-CA-C 112.719 0.637 . . . . 1.67 112.719 -175.001 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 584' ' ' TRP . . . . . 0.658 ' CD1' HG21 ' A' ' 553' ' ' VAL . 27.8 m0 -109.5 101.98 10.88 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 108.799 -0.815 . . . . 2.74 108.799 162.761 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 585' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.62 152.68 21.26 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.644 -0.253 . . . . 4.27 110.904 -177.217 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 586' ' ' ASN . . . . . . . . . . . . . 10.4 m120 55.34 46.22 23.9 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 109.385 -0.598 . . . . 1.72 109.385 -170.615 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 587' ' ' THR . . . . . . . . . . . . . 28.6 m -135.69 140.68 44.63 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.012 -0.54 . . . . 1.22 110.593 -177.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 588' ' ' ILE . . . . . . . . . . . . . 15.0 tt -141.9 146.49 22.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.305 -0.407 . . . . 1.34 110.404 -179.423 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 589' ' ' GLU . . . . . 0.41 ' HB2' ' CE2' ' A' ' 594' ' ' TYR . 33.4 tt0 -94.54 119.84 33.84 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.829 -0.434 . . . . 1.35 109.829 174.722 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 590' ' ' VAL . . . . . . . . . . . . . 61.3 t -125.49 121.57 60.58 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 N-CA-C 109.491 -0.559 . . . . 1.3 109.491 178.392 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 591' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 58.2 33.71 23.42 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.083 -0.508 . . . . 2.03 111.425 -179.231 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . 84.67 -1.58 88.74 Favored Glycine 0 N--CA 1.45 -0.378 0 CA-C-N 115.797 -0.638 . . . . 0.62 113.114 177.511 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 593' ' ' LYS . . . . . . . . . . . . . 70.5 mmtt -114.49 146.22 40.95 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.782 0.325 . . . . 3.3 111.254 -179.145 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 594' ' ' TYR . . . . . 0.41 ' CE2' ' HB2' ' A' ' 589' ' ' GLU . 80.4 m-85 -98.16 127.45 44.11 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.207 -0.451 . . . . 2.29 111.46 -176.198 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 595' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -135.13 162.53 32.24 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.531 -0.759 . . . . 2.2 109.704 177.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 596' ' ' HIS . . . . . 0.421 ' CE1' HG22 ' A' ' 571' ' ' VAL . 10.3 m170 -61.29 128.79 38.07 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.42 -0.585 . . . . 0.76 109.42 171.403 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 597' ' ' SER . . . . . . . . . . . . . 47.7 t -64.55 -29.57 70.6 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.244 -0.65 . . . . 1.59 109.244 176.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 598' ' ' THR . . . . . . . . . . . . . 5.2 m -67.98 -45.98 72.63 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-O 121.64 0.734 . . . . 1.93 110.233 175.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 599' ' ' CYS . . . . . 0.518 ' HB3' HG23 ' A' ' 566' ' ' ILE . 74.6 m -74.67 -30.67 61.67 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.376 -0.829 . . . . 0.81 112.566 -174.618 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 600' ' ' TYR . . . . . 0.478 ' O ' HG21 ' A' ' 603' ' ' THR . 85.0 t80 -57.47 -36.08 71.0 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.045 0.45 . . . . 2.65 110.762 -174.644 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 601' ' ' HIS . . . . . . . . . . . . . 41.2 m170 -66.59 -28.47 68.53 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.213 -0.449 . . . . 5.16 111.546 179.447 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 602' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -63.56 -32.75 74.31 Favored 'General case' 0 CA--C 1.52 -0.192 0 CA-C-O 120.686 0.279 . . . . 3.85 110.315 -175.884 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 603' ' ' THR . . . . . 0.478 HG21 ' O ' ' A' ' 600' ' ' TYR . 13.0 t . . . . . 0 N--CA 1.45 -0.473 0 CA-C-O 121.065 0.459 . . . . 3.3 110.713 -178.028 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 701' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.326 0 N-CA-C 112.546 -0.222 . . . . 3.77 112.546 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 549' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -67.46 149.51 50.12 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.368 0.604 . . . . 6.2 110.67 177.04 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 550' ' ' TYR . . . . . 0.55 ' HB3' ' HD3' ' A' ' 585' ' ' LYS . 9.5 p90 -124.29 160.29 28.35 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.331 -0.849 . . . . 3.22 110.947 -173.403 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 551' ' ' VAL . . . . . . . . . . . . . 96.9 t -118.95 133.19 66.61 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 N-CA-C 108.704 -0.85 . . . . 2.01 108.704 172.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 552' ' ' VAL . . . . . 0.542 ' HA ' ' O ' ' A' ' 582' ' ' TRP . 47.4 t -65.34 131.74 31.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 116.238 -0.437 . . . . 1.8 110.112 -178.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 553' ' ' VAL . . . . . 0.673 HG23 ' CD1' ' A' ' 584' ' ' TRP . 26.3 t -63.56 120.99 67.62 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.249 -0.432 . . . . 1.63 109.967 -179.677 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 554' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_exo -57.03 135.88 73.4 Favored 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.959 2.44 . . . . 2.2 113.025 -177.323 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 555' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -104.52 -4.77 22.24 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.416 0.627 . . . . 4.17 110.059 175.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 24.2 p -86.05 -4.59 59.2 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.356 -0.838 . . . . 4.31 110.116 175.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 557' ' ' SER . . . . . . . . . . . . . 39.5 m -100.62 138.35 37.8 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 115.193 -0.912 . . . . 3.39 110.157 -179.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 558' ' ' GLN . . . . . . . . . . . . . 61.7 mt-30 -73.73 -35.24 65.04 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.618 -0.719 . . . . 5.62 109.549 178.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 559' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -107.3 109.67 21.5 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.188 -0.915 . . . . 3.23 109.402 172.024 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 560' ' ' MET . . . . . . . . . . . . . 81.5 mtp -80.45 39.7 0.47 Allowed 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 121.168 0.509 . . . . 2.98 110.682 -176.295 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 561' ' ' ALA . . . . . . . . . . . . . . . -145.82 162.2 38.23 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.897 -0.592 . . . . 1.46 109.89 -177.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 35.1 p90 -138.5 145.97 41.42 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 120.437 -0.505 . . . . 1.35 110.022 173.172 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 563' ' ' LYS . . . . . . . . . . . . . 50.2 tptt -88.62 111.18 21.61 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 116.134 -0.484 . . . . 2.71 110.06 -178.575 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 564' ' ' CYS . . . . . 0.412 ' HA ' ' HD3' ' A' ' 565' ' ' PRO . 42.4 t -68.72 112.09 10.25 Favored Pre-proline 0 C--N 1.333 -0.145 0 N-CA-C 109.183 -0.673 . . . . 0.41 109.183 179.266 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 565' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 564' ' ' CYS . 15.4 Cg_exo -71.57 -17.77 29.69 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 123.042 2.494 . . . . 1.0 111.751 -175.293 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 566' ' ' ILE . . . . . . . . . . . . . 45.6 mt -80.16 -51.9 15.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.233 -0.894 . . . . 1.54 111.044 -175.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 567' ' ' CYS . . . . . . . . . . . . . 28.9 p -105.12 -1.7 25.21 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.363 -0.381 . . . . 0.7 111.237 -176.572 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 568' ' ' LYS . . . . . . . . . . . . . 35.6 mtmm 65.41 22.54 11.95 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 112.646 0.61 . . . . 3.19 112.646 174.48 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 569' ' ' GLU . . . . . . . . . . . . . 15.9 mm-40 -105.81 135.26 47.56 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.654 0.264 . . . . 3.34 110.479 177.064 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 570' ' ' THR . . . . . . . . . . . . . 49.2 m -75.54 126.08 30.29 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.508 -0.552 . . . . 1.43 109.508 177.059 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 571' ' ' VAL . . . . . . . . . . . . . 16.2 t -100.42 115.26 41.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 116.511 -0.313 . . . . 1.39 110.888 -175.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 24.6 p -105.3 161.83 13.96 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.022 -0.733 . . . . 2.17 109.022 174.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . -127.6 154.0 19.46 Favored Glycine 0 N--CA 1.436 -1.305 0 C-N-CA 119.134 -1.508 . . . . 2.2 111.68 -179.012 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 574' ' ' VAL . . . . . . . . . . . . . 44.5 t -111.32 145.14 17.94 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 CA-C-O 120.898 0.38 . . . . 3.64 110.059 -171.1 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 575' ' ' TYR . . . . . . . . . . . . . 38.7 t80 -76.93 118.44 19.52 Favored 'General case' 0 N--CA 1.439 -1.021 0 N-CA-C 108.956 -0.757 . . . . 3.53 108.956 174.177 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 576' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -89.72 96.95 10.92 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 108.469 -0.938 . . . . 3.34 108.469 -177.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 577' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -63.66 -22.73 67.06 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.53 -0.759 . . . . 5.59 111.907 -175.164 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 578' ' ' GLU . . . . . . . . . . . . . 19.0 mm-40 -66.14 -43.52 86.84 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.182 -0.463 . . . . 5.11 110.547 -179.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 579' ' ' SER . . . . . . . . . . . . . 68.3 p -100.46 -19.72 16.1 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.045 -0.525 . . . . 3.7 111.696 -179.599 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 580' ' ' GLY . . . . . . . . . . . . . . . 80.66 30.49 39.62 Favored Glycine 0 CA--C 1.524 0.6 0 CA-C-N 115.85 -0.614 . . . . 2.89 113.264 179.28 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 581' ' ' GLU . . . . . 0.487 ' CD ' ' HH ' ' A' ' 550' ' ' TYR . 17.3 pt-20 -139.07 156.44 47.17 Favored 'General case' 0 C--N 1.326 -0.442 0 O-C-N 122.304 -0.527 . . . . 3.19 110.682 179.837 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 582' ' ' TRP . . . . . 0.572 ' HB3' ' HB ' ' A' ' 553' ' ' VAL . 90.2 m95 -82.04 134.26 35.34 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.512 -0.551 . . . . 2.63 109.512 176.241 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 583' ' ' VAL . . . . . . . . . . . . . 33.5 m -123.0 134.03 67.33 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 N-CA-C 113.793 1.034 . . . . 1.67 113.793 -173.666 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 584' ' ' TRP . . . . . 0.673 ' CD1' HG23 ' A' ' 553' ' ' VAL . 33.5 m0 -113.85 103.76 11.51 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 107.893 -1.151 . . . . 2.74 107.893 161.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 585' ' ' LYS . . . . . 0.55 ' HD3' ' HB3' ' A' ' 550' ' ' TYR . 35.3 mmtp -81.56 142.67 32.62 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.777 -0.369 . . . . 4.27 110.768 -175.84 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 586' ' ' ASN . . . . . . . . . . . . . 22.1 m-20 55.23 50.0 16.02 Favored 'General case' 0 CA--C 1.516 -0.335 0 CA-C-N 115.38 -0.827 . . . . 1.72 109.889 -178.292 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 587' ' ' THR . . . . . . . . . . . . . 41.1 m -125.03 141.41 52.14 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.907 -0.588 . . . . 1.22 109.965 -179.417 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 588' ' ' ILE . . . . . 0.525 ' HB ' ' HG ' ' A' ' 597' ' ' SER . 12.9 tt -140.57 144.21 27.71 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 N-CA-C 109.841 -0.429 . . . . 1.34 109.841 -178.801 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 589' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -96.78 119.13 34.69 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 108.68 -0.859 . . . . 1.35 108.68 176.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 590' ' ' VAL . . . . . . . . . . . . . 56.3 t -125.1 118.83 54.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.997 -0.547 . . . . 1.3 109.989 -178.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 591' ' ' ASN . . . . . . . . . . . . . 12.3 m120 58.1 36.57 26.05 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.932 -0.577 . . . . 2.03 112.334 176.326 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . 86.57 6.65 80.18 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 121.194 -0.527 . . . . 0.62 113.682 175.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 593' ' ' LYS . . . . . . . . . . . . . 27.8 mtpp -129.1 146.39 51.06 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 117.204 0.502 . . . . 3.3 110.933 176.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 594' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -91.16 133.97 34.92 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.895 -0.593 . . . . 2.29 110.836 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 595' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -139.12 160.46 39.73 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.829 -0.623 . . . . 2.2 109.716 176.362 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 596' ' ' HIS . . . . . 0.742 ' HB2' ' SG ' ' A' ' 599' ' ' CYS . 37.7 m80 -67.16 130.5 43.32 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.314 -0.995 . . . . 0.76 108.314 169.229 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 597' ' ' SER . . . . . 0.525 ' HG ' ' HB ' ' A' ' 588' ' ' ILE . 11.4 m -60.75 -31.88 71.19 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.283 -0.417 . . . . 1.59 110.252 179.471 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 598' ' ' THR . . . . . . . . . . . . . 3.6 t -69.22 -35.23 75.97 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.397 0.618 . . . . 1.93 110.33 174.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 599' ' ' CYS . . . . . 0.742 ' SG ' ' HB2' ' A' ' 596' ' ' HIS . 91.2 m -73.98 -29.58 62.05 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.819 -0.628 . . . . 0.81 112.595 -176.162 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 600' ' ' TYR . . . . . . . . . . . . . 43.9 t80 -57.26 -35.0 69.2 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.125 -0.695 . . . . 2.65 109.125 -178.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 601' ' ' HIS . . . . . . . . . . . . . 45.4 m-70 -74.7 -41.16 60.71 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.638 -0.71 . . . . 5.16 111.814 176.15 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 602' ' ' GLU . . . . . 0.695 ' HG2' ' HA ' ' A' ' 599' ' ' CYS . 22.5 pt-20 -67.81 -25.72 65.71 Favored 'General case' 0 N--CA 1.467 0.411 0 O-C-N 122.094 -0.379 . . . . 3.85 110.87 -176.65 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 603' ' ' THR . . . . . . . . . . . . . 14.1 t . . . . . 0 CA--C 1.533 0.309 0 N-CA-C 111.994 0.368 . . . . 3.3 111.994 -179.639 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 701' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.452 0 N-CA-C 111.141 -0.784 . . . . 3.77 111.141 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 549' ' ' LYS . . . . . 0.425 ' HA ' ' HD3' ' A' ' 549' ' ' LYS . 37.1 mmtm -73.18 147.39 44.81 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-O 121.673 0.749 . . . . 6.2 111.061 179.82 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 550' ' ' TYR . . . . . 0.482 ' CE1' HG12 ' A' ' 583' ' ' VAL . 29.2 p90 -124.76 162.18 24.81 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 114.764 -1.107 . . . . 3.22 109.703 -175.73 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 551' ' ' VAL . . . . . 0.425 HG13 ' HE1' ' A' ' 594' ' ' TYR . 96.3 t -117.39 133.61 63.62 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 N-CA-C 109.016 -0.735 . . . . 2.01 109.016 175.863 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 552' ' ' VAL . . . . . 0.499 ' HA ' ' O ' ' A' ' 582' ' ' TRP . 56.9 t -62.99 132.15 28.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.928 -0.578 . . . . 1.8 109.802 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 553' ' ' VAL . . . . . 0.596 HG23 ' CD1' ' A' ' 584' ' ' TRP . 65.8 t -60.79 120.67 55.35 Favored Pre-proline 0 C--N 1.33 -0.247 0 O-C-N 123.74 0.65 . . . . 1.63 111.505 -175.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 554' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo -70.15 138.16 35.94 Favored 'Trans proline' 0 N--CA 1.462 -0.331 0 C-N-CA 123.194 2.596 . . . . 2.2 111.939 176.169 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 555' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -72.81 -35.8 67.4 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.439 0.638 . . . . 4.17 110.283 179.298 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 23.1 p -94.81 85.07 4.32 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.537 -0.756 . . . . 4.31 111.565 -175.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 557' ' ' SER . . . . . . . . . . . . . 32.5 t -157.99 -100.76 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.613 -0.514 . . . . 3.39 109.613 176.204 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 558' ' ' GLN . . . . . . . . . . . . . 80.2 mt-30 -126.16 -136.76 0.26 Allowed 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.476 -0.564 . . . . 5.62 109.476 173.6 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 559' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -76.66 47.92 0.53 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.685 0.278 . . . . 3.23 110.408 178.291 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 560' ' ' MET . . . . . 0.515 ' HB3' HG13 ' A' ' 553' ' ' VAL . 65.3 mtt 58.11 29.6 18.09 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-O 121.553 0.692 . . . . 2.98 110.119 -172.514 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 561' ' ' ALA . . . . . . . . . . . . . . . -144.98 161.73 38.65 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 115.279 -0.873 . . . . 1.46 110.902 -175.214 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 33.8 p90 -150.06 163.7 37.47 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 107.796 -1.187 . . . . 1.35 107.796 173.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 563' ' ' LYS . . . . . . . . . . . . . 7.7 ttmm -106.63 126.33 52.14 Favored 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 119.44 -0.904 . . . . 2.71 109.935 179.12 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 564' ' ' CYS . . . . . . . . . . . . . 48.6 t -69.3 112.06 10.62 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 115.523 -0.762 . . . . 0.41 109.601 -178.5 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 565' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -70.67 -29.9 18.87 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 123.318 2.678 . . . . 1.0 113.686 -173.525 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 566' ' ' ILE . . . . . . . . . . . . . 26.8 mt -70.74 -34.84 58.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.308 -0.405 . . . . 1.54 111.184 -172.497 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 567' ' ' CYS . . . . . 0.463 ' SG ' ' HG3' ' A' ' 569' ' ' GLU . 28.7 p -129.07 3.61 5.27 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 112.855 0.687 . . . . 0.7 112.855 -175.257 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 568' ' ' LYS . . . . . . . . . . . . . 61.9 mmtt 71.21 30.21 2.68 Favored 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 113.028 0.751 . . . . 3.19 113.028 175.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 569' ' ' GLU . . . . . 0.463 ' HG3' ' SG ' ' A' ' 567' ' ' CYS . 45.2 mt-10 -90.11 131.71 35.82 Favored 'General case' 0 N--CA 1.468 0.448 0 O-C-N 121.953 -0.467 . . . . 3.34 110.662 176.794 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 570' ' ' THR . . . . . . . . . . . . . 47.2 m -75.7 117.85 17.9 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 108.917 -0.772 . . . . 1.43 108.917 164.558 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 571' ' ' VAL . . . . . 0.413 HG22 ' CE1' ' A' ' 596' ' ' HIS . 20.2 t -100.66 116.49 44.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 120.808 0.337 . . . . 1.39 111.344 -172.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 33.4 p -110.41 160.01 16.97 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.908 -0.587 . . . . 2.17 109.914 176.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . -129.8 155.03 20.74 Favored Glycine 0 N--CA 1.442 -0.929 0 C-N-CA 119.761 -1.209 . . . . 2.2 111.875 -178.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 574' ' ' VAL . . . . . 0.463 ' O ' HG22 ' A' ' 583' ' ' VAL . 27.6 t -120.39 148.82 23.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-O 120.757 0.313 . . . . 3.64 110.234 -172.549 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 575' ' ' TYR . . . . . . . . . . . . . 66.2 t80 -83.69 119.14 24.41 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.5 -0.318 . . . . 3.53 110.261 177.079 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 576' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -94.99 114.23 26.02 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.772 -0.455 . . . . 3.34 109.772 178.133 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 577' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -69.21 -23.41 63.89 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.122 -0.49 . . . . 5.59 112.231 -174.347 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 578' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -74.7 -41.41 60.26 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.002 0.43 . . . . 5.11 110.773 -177.276 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 579' ' ' SER . . . . . . . . . . . . . 67.7 p -86.31 -25.58 25.37 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.228 -0.442 . . . . 3.7 110.938 176.46 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 580' ' ' GLY . . . . . . . . . . . . . . . 80.28 15.98 77.29 Favored Glycine 0 N--CA 1.451 -0.348 0 CA-C-N 115.865 -0.607 . . . . 2.89 112.584 179.006 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 581' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 -130.74 161.12 32.39 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.863 0.363 . . . . 3.19 110.386 -178.492 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 582' ' ' TRP . . . . . 0.499 ' O ' ' HA ' ' A' ' 552' ' ' VAL . 76.1 m95 -83.04 134.42 35.03 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.38 -0.6 . . . . 2.63 109.38 175.108 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 583' ' ' VAL . . . . . 0.482 HG12 ' CE1' ' A' ' 550' ' ' TYR . 16.9 m -113.17 133.63 58.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 N-CA-C 113.487 0.921 . . . . 1.67 113.487 -171.753 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 584' ' ' TRP . . . . . 0.596 ' CD1' HG23 ' A' ' 553' ' ' VAL . 29.0 m0 -108.44 101.35 10.54 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.114 -1.069 . . . . 2.74 108.114 161.154 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 585' ' ' LYS . . . . . 0.434 ' HD2' ' H ' ' A' ' 585' ' ' LYS . 0.0 OUTLIER -76.4 145.66 39.23 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.415 -0.357 . . . . 4.27 111.211 -174.281 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 586' ' ' ASN . . . . . . . . . . . . . 32.3 m-20 48.85 50.3 17.78 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 115.668 -0.696 . . . . 1.72 110.37 -179.692 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 587' ' ' THR . . . . . . . . . . . . . 45.5 m -127.1 142.72 51.45 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.674 -0.694 . . . . 1.22 109.948 -178.436 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 588' ' ' ILE . . . . . . . . . . . . . 13.3 tt -139.35 147.77 24.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 109.476 -0.564 . . . . 1.34 109.476 179.601 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 589' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -103.1 121.86 43.48 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.124 0.487 . . . . 1.35 109.799 178.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 590' ' ' VAL . . . . . . . . . . . . . 64.8 t -134.54 130.91 53.97 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.621 0 CA-C-N 115.537 -0.756 . . . . 1.3 109.144 178.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 591' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 59.19 33.24 22.63 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 121.391 0.615 . . . . 2.03 110.77 178.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . 77.22 11.92 85.08 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.937 -0.649 . . . . 0.62 112.487 178.332 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 593' ' ' LYS . . . . . . . . . . . . . 34.1 mmtp -126.42 139.68 53.07 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.777 0.322 . . . . 3.3 110.533 -178.057 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 594' ' ' TYR . . . . . 0.425 ' HE1' HG13 ' A' ' 551' ' ' VAL . 95.0 m-85 -89.85 132.06 35.46 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 116.067 -0.515 . . . . 2.29 110.273 177.695 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 595' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -134.94 154.63 51.63 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 108.914 -0.773 . . . . 2.2 108.914 175.405 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 596' ' ' HIS . . . . . 0.413 ' CE1' HG22 ' A' ' 571' ' ' VAL . 26.9 m170 -62.34 128.13 34.6 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 108.446 -0.946 . . . . 0.76 108.446 169.733 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 597' ' ' SER . . . . . . . . . . . . . 31.0 t -63.3 -29.96 71.18 Favored 'General case' 0 C--N 1.322 -0.592 0 O-C-N 123.701 0.626 . . . . 1.59 109.852 -177.274 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 598' ' ' THR . . . . . . . . . . . . . 1.8 t -67.09 -41.54 86.16 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 115.715 -0.675 . . . . 1.93 110.776 175.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 599' ' ' CYS . . . . . . . . . . . . . 74.2 m -75.82 -31.88 59.57 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.892 -0.595 . . . . 0.81 111.574 -177.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 600' ' ' TYR . . . . . . . . . . . . . 72.4 t80 -57.03 -33.1 66.86 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.038 -0.528 . . . . 2.65 112.067 -173.566 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 601' ' ' HIS . . . . . . . . . . . . . 33.7 m170 -58.46 -26.4 63.33 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 112.781 0.66 . . . . 5.16 112.781 -173.276 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 602' ' ' GLU . . . . . . . . . . . . . 3.0 pp20? -62.1 -30.54 71.08 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-O 120.949 0.404 . . . . 3.85 110.849 -178.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 603' ' ' THR . . . . . . . . . . . . . 1.1 m . . . . . 0 CA--C 1.537 0.469 0 CA-C-O 120.981 0.42 . . . . 3.3 111.161 -177.138 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 701' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.519 0.328 0 N-CA-C 113.676 0.231 . . . . 3.77 113.676 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 549' ' ' LYS . . . . . . . . . . . . . 28.8 mtpp -81.1 142.24 33.5 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 117.247 0.524 . . . . 6.2 110.931 177.393 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 550' ' ' TYR . . . . . 0.44 ' CE1' HG13 ' A' ' 583' ' ' VAL . 24.9 p90 -116.35 159.97 21.17 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.066 -0.716 . . . . 3.22 109.066 176.246 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 551' ' ' VAL . . . . . 0.742 HG13 ' HE1' ' A' ' 594' ' ' TYR . 39.9 t -119.97 136.58 56.59 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 N-CA-C 109.154 -0.684 . . . . 2.01 109.154 176.735 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 552' ' ' VAL . . . . . 0.559 ' HA ' ' O ' ' A' ' 582' ' ' TRP . 62.9 t -66.33 133.63 30.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 110.449 -0.204 . . . . 1.8 110.449 -178.796 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 553' ' ' VAL . . . . . 0.626 HG22 ' CD1' ' A' ' 584' ' ' TRP . 80.7 t -61.99 120.99 62.54 Favored Pre-proline 0 C--N 1.331 -0.227 0 CA-C-N 116.228 -0.442 . . . . 1.63 111.254 -177.386 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 554' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' A' ' 553' ' ' VAL . 7.1 Cg_exo -69.1 137.43 37.36 Favored 'Trans proline' 0 N--CA 1.46 -0.483 0 C-N-CA 122.871 2.381 . . . . 2.2 112.45 179.19 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 555' ' ' GLU . . . . . 0.412 ' C ' ' H ' ' A' ' 557' ' ' SER . 41.3 mt-10 -89.94 -1.61 58.01 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.285 0.564 . . . . 4.17 109.883 176.106 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 23.2 p -81.88 40.5 0.61 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.728 0.775 . . . . 4.31 110.319 175.47 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 557' ' ' SER . . . . . 0.412 ' H ' ' C ' ' A' ' 555' ' ' GLU . 46.8 t -157.62 141.31 15.71 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-N 114.719 -1.128 . . . . 3.39 108.109 -177.37 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 558' ' ' GLN . . . . . 0.872 ' HA ' HE21 ' A' ' 558' ' ' GLN . 0.0 OUTLIER -78.48 -26.32 46.01 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.976 0.417 . . . . 5.62 110.284 -179.613 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 559' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -105.23 136.24 45.11 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.63 -0.714 . . . . 3.23 109.778 176.215 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 560' ' ' MET . . . . . . . . . . . . . 2.1 mpt? -83.8 18.45 1.98 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.239 0.543 . . . . 2.98 110.311 178.352 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 561' ' ' ALA . . . . . . . . . . . . . . . -144.32 151.15 38.95 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 115.622 -0.717 . . . . 1.46 110.036 -176.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 45.9 p90 -128.2 150.27 50.09 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 110.015 -0.365 . . . . 1.35 110.015 177.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 563' ' ' LYS . . . . . 0.448 ' HE3' ' O ' ' A' ' 568' ' ' LYS . 47.5 tptt -89.6 113.81 25.3 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.001 -0.74 . . . . 2.71 109.001 -178.513 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 564' ' ' CYS . . . . . . . . . . . . . 47.1 t -62.56 113.55 9.29 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 116.461 -0.336 . . . . 0.41 110.902 -175.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 565' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -67.65 -27.95 38.03 Favored 'Trans proline' 0 CA--C 1.53 0.284 0 C-N-CA 123.074 2.516 . . . . 1.0 112.778 -176.026 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 566' ' ' ILE . . . . . . . . . . . . . 42.8 mt -71.73 -38.15 65.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 111.969 0.359 . . . . 1.54 111.969 -174.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 567' ' ' CYS . . . . . . . . . . . . . 28.5 p -129.2 1.08 5.18 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.427 0.528 . . . . 0.7 112.427 -174.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 568' ' ' LYS . . . . . 0.448 ' O ' ' HE3' ' A' ' 563' ' ' LYS . 50.3 mtpt 66.27 30.93 8.85 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 121.055 0.455 . . . . 3.19 111.753 176.105 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 569' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -105.67 135.23 47.46 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.003 -0.544 . . . . 3.34 110.933 179.215 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 570' ' ' THR . . . . . . . . . . . . . 41.4 m -71.1 118.78 14.32 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.331 -0.395 . . . . 1.43 110.598 179.217 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 571' ' ' VAL . . . . . 0.639 HG21 ' CE1' ' A' ' 596' ' ' HIS . 16.9 t -97.25 116.22 39.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 120.722 0.296 . . . . 1.39 110.635 -178.649 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 22.7 p -108.78 157.88 18.16 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.129 -0.487 . . . . 2.17 110.599 179.381 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 573' ' ' GLY . . . . . 0.466 ' HA3' ' HD1' ' A' ' 584' ' ' TRP . . . -131.24 156.06 21.61 Favored Glycine 0 N--CA 1.44 -1.069 0 N-CA-C 111.061 -0.816 . . . . 2.2 111.061 178.265 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 574' ' ' VAL . . . . . 0.519 ' O ' HG23 ' A' ' 583' ' ' VAL . 25.6 t -116.66 147.68 19.88 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 CA-C-O 120.8 0.334 . . . . 3.64 110.111 -172.9 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 575' ' ' TYR . . . . . . . . . . . . . 59.5 t80 -78.28 120.51 23.15 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.684 -0.487 . . . . 3.53 109.684 175.268 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 576' ' ' ASP . . . . . . . . . . . . . 15.4 t0 -91.16 114.67 27.25 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.071 0.462 . . . . 3.34 110.275 -179.333 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 577' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -66.98 -23.31 65.93 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.491 -0.777 . . . . 5.59 111.144 -179.574 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 578' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -75.83 -48.51 21.27 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.444 -0.344 . . . . 5.11 111.083 -174.192 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 579' ' ' SER . . . . . . . . . . . . . 75.4 p -87.37 -24.41 24.25 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.295 0.569 . . . . 3.7 110.8 177.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 580' ' ' GLY . . . . . . . . . . . . . . . 80.26 23.04 61.73 Favored Glycine 0 N--CA 1.447 -0.626 0 CA-C-N 115.407 -0.815 . . . . 2.89 111.86 -177.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 581' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -131.16 160.02 36.0 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.882 0.372 . . . . 3.19 110.157 -179.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 582' ' ' TRP . . . . . 0.559 ' O ' ' HA ' ' A' ' 552' ' ' VAL . 76.5 m95 -82.09 135.43 35.31 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.846 -0.427 . . . . 2.63 109.846 176.634 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 583' ' ' VAL . . . . . 0.519 HG23 ' O ' ' A' ' 574' ' ' VAL . 20.0 m -112.86 131.6 63.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 N-CA-C 112.775 0.657 . . . . 1.67 112.775 -174.841 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 584' ' ' TRP . . . . . 0.626 ' CD1' HG22 ' A' ' 553' ' ' VAL . 15.9 m0 -105.01 102.99 12.46 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 108.943 -0.762 . . . . 2.74 108.943 164.074 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 585' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.5 151.62 19.6 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.391 -0.822 . . . . 4.27 111.43 -175.248 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 586' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 53.27 41.15 32.15 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 115.521 -0.763 . . . . 1.72 109.026 -172.314 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 587' ' ' THR . . . . . . . . . . . . . 36.1 m -128.86 140.83 51.51 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.492 -0.776 . . . . 1.22 110.203 -175.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 588' ' ' ILE . . . . . 0.552 ' HB ' ' HB3' ' A' ' 597' ' ' SER . 12.5 tt -131.52 144.37 37.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 N-CA-C 109.228 -0.656 . . . . 1.34 109.228 178.047 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 589' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -106.57 120.06 40.94 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.254 0.55 . . . . 1.35 109.847 178.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 590' ' ' VAL . . . . . . . . . . . . . 54.9 t -128.16 120.37 53.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.262 -0.881 . . . . 1.3 109.995 -179.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 591' ' ' ASN . . . . . . . . . . . . . 2.3 t30 59.23 40.68 21.21 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 115.969 -0.56 . . . . 2.03 111.1 177.217 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . 78.82 10.06 86.52 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.94 -0.647 . . . . 0.62 112.4 175.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 593' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -126.28 144.3 50.84 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-O 121.174 0.512 . . . . 3.3 110.981 -178.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 594' ' ' TYR . . . . . 0.742 ' HE1' HG13 ' A' ' 551' ' ' VAL . 97.5 m-85 -101.29 135.13 43.27 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.784 -0.644 . . . . 2.29 110.725 -177.848 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 595' ' ' PHE . . . . . . . . . . . . . 59.9 m-85 -139.55 158.24 44.46 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 108.548 -0.908 . . . . 2.2 108.548 177.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 596' ' ' HIS . . . . . 0.639 ' CE1' HG21 ' A' ' 571' ' ' VAL . 15.4 m170 -61.18 127.03 29.52 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.341 -0.985 . . . . 0.76 108.341 168.661 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 597' ' ' SER . . . . . 0.552 ' HB3' ' HB ' ' A' ' 588' ' ' ILE . 8.7 p -66.37 -29.31 69.46 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.068 0.461 . . . . 1.59 109.879 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 598' ' ' THR . . . . . . . . . . . . . 1.1 t -69.0 -32.48 72.07 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 115.273 -0.876 . . . . 1.93 109.93 176.321 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 599' ' ' CYS . . . . . 0.448 ' SG ' ' HB2' ' A' ' 596' ' ' HIS . 84.9 m -78.82 -29.06 44.56 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 113.81 1.041 . . . . 0.81 113.81 -179.323 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 600' ' ' TYR . . . . . 0.445 ' O ' HG21 ' A' ' 603' ' ' THR . 87.3 t80 -54.64 -35.98 64.06 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 113.678 0.992 . . . . 2.65 113.678 -164.304 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 601' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -60.22 -25.15 65.41 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 112.267 0.469 . . . . 5.16 112.267 -177.415 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 602' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -61.7 -38.19 86.94 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 120.981 0.419 . . . . 3.85 111.357 179.188 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 603' ' ' THR . . . . . 0.445 HG21 ' O ' ' A' ' 600' ' ' TYR . 11.5 t . . . . . 0 C--O 1.236 0.352 0 CA-C-N 116.483 -0.326 . . . . 3.3 111.344 -177.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 701' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.455 0 N-CA-C 111.754 -0.538 . . . . 3.77 111.754 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 549' ' ' LYS . . . . . . . . . . . . . 9.1 mtmp? -68.91 149.78 48.49 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.896 -0.409 . . . . 6.2 109.896 177.358 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 550' ' ' TYR . . . . . 0.489 ' CE1' HG12 ' A' ' 583' ' ' VAL . 38.0 p90 -114.75 160.21 19.67 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 115.941 -0.572 . . . . 3.22 110.402 -176.087 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 551' ' ' VAL . . . . . . . . . . . . . 65.5 t -117.76 133.76 63.5 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 N-CA-C 108.493 -0.928 . . . . 2.01 108.493 175.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 552' ' ' VAL . . . . . 0.617 ' HA ' ' O ' ' A' ' 582' ' ' TRP . 28.3 t -61.95 134.88 27.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 116.315 -0.402 . . . . 1.8 110.08 -177.573 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 553' ' ' VAL . . . . . 0.577 HG22 ' CD1' ' A' ' 584' ' ' TRP . 89.0 t -61.6 119.19 44.96 Favored Pre-proline 0 N--CA 1.451 -0.411 0 N-CA-C 109.648 -0.501 . . . . 1.63 109.648 -179.688 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 554' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -59.45 136.13 69.56 Favored 'Trans proline' 0 N--CA 1.46 -0.458 0 C-N-CA 122.878 2.385 . . . . 2.2 112.779 -178.509 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 555' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -78.36 -10.72 59.8 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.924 -0.769 . . . . 4.17 108.924 174.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 25.2 p -99.73 24.39 8.41 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 114.869 -1.06 . . . . 4.31 110.928 -179.621 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 557' ' ' SER . . . . . . . . . . . . . 73.8 p -95.64 179.02 5.28 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.13 -0.486 . . . . 3.39 110.513 -179.178 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 558' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -74.51 -73.12 0.25 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.993 0.425 . . . . 5.62 110.311 178.215 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 559' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -131.76 48.49 2.41 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.137 -0.483 . . . . 3.23 110.214 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 560' ' ' MET . . . . . . . . . . . . . 56.9 mtm 62.7 18.56 10.71 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 115.756 -0.656 . . . . 2.98 111.317 179.272 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 561' ' ' ALA . . . . . . . . . . . . . . . -145.55 156.63 43.81 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.199 -0.455 . . . . 1.46 111.485 -176.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 24.1 p90 -141.9 156.77 45.5 Favored 'General case' 0 C--O 1.225 -0.218 0 N-CA-C 108.131 -1.063 . . . . 1.35 108.131 172.306 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 563' ' ' LYS . . . . . 0.513 ' HA ' ' HA ' ' A' ' 570' ' ' THR . 36.5 ttmt -99.83 128.04 45.95 Favored 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 119.752 -0.779 . . . . 2.71 110.444 -178.773 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 564' ' ' CYS . . . . . . . . . . . . . 50.0 t -72.12 118.05 63.77 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 115.834 -0.621 . . . . 0.41 110.395 179.275 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 565' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -72.13 -27.62 16.69 Favored 'Trans proline' 0 CA--C 1.531 0.372 0 C-N-CA 123.026 2.484 . . . . 1.0 114.209 -173.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 566' ' ' ILE . . . . . 0.437 HD13 ' HB3' ' A' ' 599' ' ' CYS . 71.2 mt -82.2 -52.36 13.67 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 N-CA-C 112.271 0.471 . . . . 1.54 112.271 -172.257 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 567' ' ' CYS . . . . . . . . . . . . . 29.5 p -104.59 0.82 29.0 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 121.063 0.459 . . . . 0.7 110.787 -179.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 568' ' ' LYS . . . . . . . . . . . . . 28.3 mtpp 69.93 29.27 4.0 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 113.623 0.971 . . . . 3.19 113.623 166.091 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 569' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -101.39 132.96 46.7 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.669 -0.412 . . . . 3.34 110.18 175.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 570' ' ' THR . . . . . 0.513 ' HA ' ' HA ' ' A' ' 563' ' ' LYS . 55.8 m -70.82 118.4 13.55 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.517 -0.549 . . . . 1.43 109.517 173.21 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 571' ' ' VAL . . . . . . . . . . . . . 22.4 t -91.02 116.18 31.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-O 121.0 0.428 . . . . 1.39 110.539 -176.389 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 30.6 p -106.68 159.5 16.16 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.504 -0.771 . . . . 2.17 109.068 175.122 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . -129.76 154.66 20.56 Favored Glycine 0 N--CA 1.439 -1.107 0 C-N-CA 119.689 -1.243 . . . . 2.2 111.599 -178.366 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 574' ' ' VAL . . . . . 0.434 ' O ' HG22 ' A' ' 583' ' ' VAL . 22.6 t -114.25 151.9 15.98 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 N-CA-C 109.874 -0.417 . . . . 3.64 109.874 -175.061 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 575' ' ' TYR . . . . . . . . . . . . . 39.8 t80 -83.73 122.47 28.68 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 116.29 -0.413 . . . . 3.53 110.077 176.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 576' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -91.31 112.85 24.94 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 108.674 -0.861 . . . . 3.34 108.674 175.121 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 577' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -69.73 -35.56 75.1 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.38 -0.827 . . . . 5.59 112.524 -169.035 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 578' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -75.39 -35.51 61.04 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.881 -0.328 . . . . 5.11 111.566 -174.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 579' ' ' SER . . . . . . . . . . . . . 77.1 p -82.53 -24.69 33.95 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.92 0.39 . . . . 3.7 110.486 179.228 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 580' ' ' GLY . . . . . . . . . . . . . . . 80.66 20.66 65.56 Favored Glycine 0 N--CA 1.452 -0.285 0 CA-C-N 115.574 -0.739 . . . . 2.89 112.914 177.147 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 581' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -145.85 154.8 42.38 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.845 0.355 . . . . 3.19 111.072 179.545 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 582' ' ' TRP . . . . . 0.617 ' O ' ' HA ' ' A' ' 552' ' ' VAL . 64.9 m95 -77.34 150.78 35.14 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.088 -0.506 . . . . 2.63 110.509 -177.833 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 583' ' ' VAL . . . . . 0.489 HG12 ' CE1' ' A' ' 550' ' ' TYR . 21.4 m -123.9 133.04 70.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 113.564 0.95 . . . . 1.67 113.564 -173.285 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 584' ' ' TRP . . . . . 0.577 ' CD1' HG22 ' A' ' 553' ' ' VAL . 24.1 m0 -116.2 103.79 10.87 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 114.854 -1.066 . . . . 2.74 108.566 164.124 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 585' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -87.25 150.2 24.06 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 120.419 -0.513 . . . . 4.27 111.136 -175.003 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 586' ' ' ASN . . . . . . . . . . . . . 14.1 m120 54.37 41.29 32.05 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 115.545 -0.752 . . . . 1.72 110.495 -175.101 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 587' ' ' THR . . . . . . . . . . . . . 44.3 m -119.76 142.53 48.47 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.756 -0.656 . . . . 1.22 110.341 -177.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 588' ' ' ILE . . . . . . . . . . . . . 15.3 tt -133.75 148.19 30.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 N-CA-C 109.424 -0.584 . . . . 1.34 109.424 -179.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 589' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -115.33 118.75 34.13 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.519 -0.548 . . . . 1.35 109.519 177.901 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 590' ' ' VAL . . . . . . . . . . . . . 44.0 t -125.14 118.84 54.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.505 -0.77 . . . . 1.3 110.019 -177.439 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 591' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 58.2 36.99 26.19 Favored 'General case' 0 C--O 1.235 0.306 0 O-C-N 123.482 0.489 . . . . 2.03 111.864 177.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . 85.66 8.41 80.18 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.967 -0.635 . . . . 0.62 113.271 174.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 593' ' ' LYS . . . . . . . . . . . . . 60.1 mttm -125.55 139.76 53.33 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.158 0.504 . . . . 3.3 111.461 178.55 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 594' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -93.67 133.28 37.19 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.165 -0.925 . . . . 2.29 110.784 -178.385 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 595' ' ' PHE . . . . . . . . . . . . . 81.2 m-85 -139.98 160.14 40.59 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.194 -0.912 . . . . 2.2 108.896 177.262 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 596' ' ' HIS . . . . . 0.52 ' HB3' HG23 ' A' ' 598' ' ' THR . 9.3 m170 -66.32 128.69 37.12 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 108.579 -0.897 . . . . 0.76 108.579 167.849 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 597' ' ' SER . . . . . . . . . . . . . 40.2 t -61.71 -32.48 72.7 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.8 -0.637 . . . . 1.59 109.696 -178.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 598' ' ' THR . . . . . 0.52 HG23 ' HB3' ' A' ' 596' ' ' HIS . 11.1 t -67.82 -35.33 78.41 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-N 115.332 -0.849 . . . . 1.93 110.091 177.637 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 599' ' ' CYS . . . . . 0.583 ' HA ' ' HB3' ' A' ' 602' ' ' GLU . 72.7 m -76.13 -31.98 58.9 Favored 'General case' 0 N--CA 1.457 -0.091 0 N-CA-C 112.228 0.455 . . . . 0.81 112.228 -179.048 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 600' ' ' TYR . . . . . . . . . . . . . 71.1 t80 -67.37 -36.26 80.99 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.009 -0.737 . . . . 2.65 109.009 -178.355 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 601' ' ' HIS . . . . . . . . . . . . . 64.5 t60 -72.48 -32.06 65.9 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.134 -0.939 . . . . 5.16 109.656 174.135 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 602' ' ' GLU . . . . . 0.583 ' HB3' ' HA ' ' A' ' 599' ' ' CYS . 0.7 OUTLIER -61.83 -37.59 85.02 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 115.463 -0.79 . . . . 3.85 111.745 177.475 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 603' ' ' THR . . . . . . . . . . . . . 14.5 t . . . . . 0 C--N 1.324 -0.542 0 N-CA-C 112.391 0.515 . . . . 3.3 112.391 -173.157 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 701' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.284 0 N-CA-C 112.998 -0.041 . . . . 3.77 112.998 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 549' ' ' LYS . . . . . . . . . . . . . 89.1 mttt -80.26 144.08 33.17 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.954 0.407 . . . . 6.2 110.342 174.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 550' ' ' TYR . . . . . 0.513 ' HH ' ' CD ' ' A' ' 581' ' ' GLU . 30.2 p90 -118.5 161.03 20.69 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 108.649 -0.871 . . . . 3.22 108.649 179.495 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 551' ' ' VAL . . . . . . . . . . . . . 62.7 t -118.24 133.18 65.87 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.971 0 N-CA-C 109.485 -0.561 . . . . 2.01 109.485 177.706 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 552' ' ' VAL . . . . . 0.459 ' HA ' ' O ' ' A' ' 582' ' ' TRP . 33.1 t -67.97 126.04 26.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-O 120.666 0.27 . . . . 1.8 110.549 -177.61 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 553' ' ' VAL . . . . . 0.649 HG22 ' CD1' ' A' ' 584' ' ' TRP . 47.3 t -61.91 126.37 87.1 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 115.828 -0.624 . . . . 1.63 111.415 -176.145 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 554' ' ' PRO . . . . . 0.535 ' HB2' ' HB2' ' A' ' 557' ' ' SER . 16.5 Cg_exo -66.96 138.05 46.74 Favored 'Trans proline' 0 C--O 1.233 0.27 0 C-N-CA 123.0 2.467 . . . . 2.2 111.464 175.941 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 555' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -79.01 -30.96 44.52 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.013 0.435 . . . . 4.17 110.728 -176.037 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 39.3 p -94.9 30.93 1.96 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.355 0.597 . . . . 4.31 111.139 179.442 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 557' ' ' SER . . . . . 0.535 ' HB2' ' HB2' ' A' ' 554' ' ' PRO . 21.2 t -91.6 30.1 1.39 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.905 -0.589 . . . . 3.39 110.228 -178.854 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 558' ' ' GLN . . . . . . . . . . . . . 22.6 mt-30 62.11 -83.71 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 123.576 0.75 . . . . 5.62 111.636 -179.127 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 559' ' ' ASP . . . . . . . . . . . . . 16.5 p-10 -115.37 15.24 16.85 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.975 0.417 . . . . 3.23 110.927 -178.121 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 560' ' ' MET . . . . . . . . . . . . . 4.5 mpp? 61.8 23.98 14.19 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 115.239 -0.892 . . . . 2.98 111.935 174.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 561' ' ' ALA . . . . . . . . . . . . . . . -144.29 145.75 32.2 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.314 -0.403 . . . . 1.46 110.08 178.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 44.5 p90 -137.42 155.32 49.49 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.315 -0.402 . . . . 1.35 109.938 178.224 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 563' ' ' LYS . . . . . . . . . . . . . 13.9 tppt? -90.01 125.55 35.43 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.771 0.32 . . . . 2.71 110.33 -179.354 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 564' ' ' CYS . . . . . . . . . . . . . 40.6 t -63.57 114.78 14.32 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 115.908 -0.587 . . . . 0.41 109.596 176.121 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 565' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -69.8 -17.61 37.3 Favored 'Trans proline' 0 CA--C 1.527 0.164 0 C-N-CA 122.588 2.192 . . . . 1.0 113.157 -172.498 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 566' ' ' ILE . . . . . 0.446 HG22 ' HG2' ' A' ' 602' ' ' GLU . 55.5 mt -81.48 -44.33 20.43 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 N-CA-C 111.807 0.299 . . . . 1.54 111.807 -176.832 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 567' ' ' CYS . . . . . 0.494 ' SG ' ' HG3' ' A' ' 569' ' ' GLU . 27.9 p -129.8 1.83 4.89 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.447 0.536 . . . . 0.7 112.447 -174.044 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 568' ' ' LYS . . . . . . . . . . . . . 40.0 mtmt 68.08 30.77 5.74 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 113.433 0.901 . . . . 3.19 113.433 173.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 569' ' ' GLU . . . . . 0.494 ' HG3' ' SG ' ' A' ' 567' ' ' CYS . 32.7 mt-10 -80.17 135.8 36.36 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 108.932 -0.766 . . . . 3.34 108.932 169.635 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 570' ' ' THR . . . . . . . . . . . . . 90.1 m -78.31 117.88 19.97 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 109.083 -0.71 . . . . 1.43 109.083 170.753 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 571' ' ' VAL . . . . . . . . . . . . . 39.6 t -90.03 116.12 30.8 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 N-CA-C 110.008 -0.368 . . . . 1.39 110.008 -178.492 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 32.0 p -115.19 158.0 22.87 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.984 -0.553 . . . . 2.17 110.017 179.753 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . -130.07 155.11 20.85 Favored Glycine 0 N--CA 1.436 -1.318 0 C-N-CA 120.05 -1.071 . . . . 2.2 111.529 178.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 574' ' ' VAL . . . . . . . . . . . . . 42.2 t -115.87 147.56 19.18 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 N-CA-C 109.63 -0.507 . . . . 3.64 109.63 -173.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 575' ' ' TYR . . . . . . . . . . . . . 51.5 t80 -83.76 118.32 23.83 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 108.82 -0.807 . . . . 3.53 108.82 173.26 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 576' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -95.71 107.05 19.23 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.033 -0.729 . . . . 3.34 109.033 178.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 577' ' ' GLU . . . . . . . . . . . . . 38.3 mp0 -68.56 -23.3 64.48 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.824 -0.625 . . . . 5.59 111.943 -173.567 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 578' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -76.05 -34.7 59.63 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.603 0.239 . . . . 5.11 111.256 -177.525 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 579' ' ' SER . . . . . . . . . . . . . 67.5 p -93.75 -23.42 18.2 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.097 0.475 . . . . 3.7 110.546 175.512 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 580' ' ' GLY . . . . . . . . . . . . . . . 80.44 26.81 53.71 Favored Glycine 0 N--CA 1.449 -0.462 0 CA-C-N 115.608 -0.723 . . . . 2.89 112.929 176.449 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 581' ' ' GLU . . . . . 0.513 ' CD ' ' HH ' ' A' ' 550' ' ' TYR . 10.9 pt-20 -145.87 161.6 39.63 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 117.16 0.48 . . . . 3.19 111.421 -179.69 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 582' ' ' TRP . . . . . 0.508 ' CB ' ' HB ' ' A' ' 553' ' ' VAL . 80.4 m95 -83.93 139.12 32.79 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-N 115.887 -0.597 . . . . 2.63 110.37 177.605 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 583' ' ' VAL . . . . . 0.409 HG22 ' O ' ' A' ' 583' ' ' VAL . 26.6 m -121.04 130.15 74.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 N-CA-C 112.971 0.73 . . . . 1.67 112.971 -174.773 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 584' ' ' TRP . . . . . 0.649 ' CD1' HG22 ' A' ' 553' ' ' VAL . 14.7 m0 -104.82 103.5 13.11 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 108.605 -0.887 . . . . 2.74 108.605 162.835 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 585' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -94.83 153.75 17.58 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.637 -0.711 . . . . 4.27 111.241 -175.334 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 586' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 55.56 40.75 31.14 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 108.799 -0.815 . . . . 1.72 108.799 -170.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 587' ' ' THR . . . . . . . . . . . . . 26.6 m -134.88 141.45 46.34 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.393 -0.821 . . . . 1.22 110.396 -173.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 588' ' ' ILE . . . . . 0.401 HG21 ' HA ' ' A' ' 597' ' ' SER . 13.7 tt -141.58 148.92 20.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 109.665 -0.494 . . . . 1.34 109.665 -179.552 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 589' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -94.34 118.7 32.01 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.93 0.395 . . . . 1.35 110.016 176.209 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 590' ' ' VAL . . . . . . . . . . . . . 59.9 t -126.5 127.25 70.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.888 -0.596 . . . . 1.3 109.451 179.488 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 591' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 59.46 37.25 23.11 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-O 121.554 0.692 . . . . 2.03 110.313 -179.689 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . 73.42 12.04 80.03 Favored Glycine 0 C--N 1.333 0.364 0 CA-C-N 115.588 -0.733 . . . . 0.62 112.952 177.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 593' ' ' LYS . . . . . . . . . . . . . 46.3 mtmt -127.74 143.45 51.14 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.861 0.362 . . . . 3.3 110.372 -177.005 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 594' ' ' TYR . . . . . . . . . . . . . 56.0 m-85 -86.59 125.51 33.86 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.955 0.407 . . . . 2.29 110.853 -178.696 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 595' ' ' PHE . . . . . . . . . . . . . 63.7 m-85 -136.41 160.49 38.57 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.634 -0.712 . . . . 2.2 110.044 179.593 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 596' ' ' HIS . . . . . . . . . . . . . 4.2 m170 -62.34 127.16 30.02 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.476 -0.565 . . . . 0.76 109.476 172.664 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 597' ' ' SER . . . . . 0.401 ' HA ' HG21 ' A' ' 588' ' ' ILE . 31.8 t -66.55 -32.04 73.14 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.849 -0.614 . . . . 1.59 109.776 179.45 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 598' ' ' THR . . . . . . . . . . . . . 13.0 t -69.13 -35.19 76.12 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 115.274 -0.875 . . . . 1.93 110.356 179.714 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 599' ' ' CYS . . . . . . . . . . . . . 73.4 m -75.92 -29.73 58.49 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.596 -0.729 . . . . 0.81 112.591 -176.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 600' ' ' TYR . . . . . 0.45 ' O ' HG21 ' A' ' 603' ' ' THR . 71.0 t80 -54.54 -31.73 56.93 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.868 0.366 . . . . 2.65 111.763 -172.559 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 601' ' ' HIS . . . . . . . . . . . . . 12.6 m170 -59.43 -27.29 65.91 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 111.927 0.343 . . . . 5.16 111.927 -179.425 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 602' ' ' GLU . . . . . 0.446 ' HG2' HG22 ' A' ' 566' ' ' ILE . 1.1 pp20? -70.18 -32.83 70.94 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 120.906 -0.317 . . . . 3.85 111.384 -175.389 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 603' ' ' THR . . . . . 0.45 HG21 ' O ' ' A' ' 600' ' ' TYR . 11.4 t . . . . . 0 C--N 1.329 -0.305 0 CA-C-O 120.922 0.391 . . . . 3.3 110.977 -176.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 701' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.506 0 N-CA-C 112.381 -0.288 . . . . 3.77 112.381 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 549' ' ' LYS . . . . . . . . . . . . . 31.3 mmmt -80.65 137.11 36.32 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 121.113 0.482 . . . . 6.2 110.491 177.528 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 550' ' ' TYR . . . . . . . . . . . . . 49.9 p90 -109.6 159.77 16.82 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 108.405 -0.961 . . . . 3.22 108.405 176.194 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 551' ' ' VAL . . . . . . . . . . . . . 55.1 t -117.17 133.21 64.63 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.106 0 N-CA-C 109.033 -0.729 . . . . 2.01 109.033 179.632 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 552' ' ' VAL . . . . . 0.712 ' HA ' ' O ' ' A' ' 582' ' ' TRP . 39.1 t -66.98 130.09 32.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.972 -0.558 . . . . 1.8 109.612 -179.122 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 553' ' ' VAL . . . . . 0.593 HG23 ' CD1' ' A' ' 584' ' ' TRP . 59.1 t -59.0 119.44 38.09 Favored Pre-proline 0 N--CA 1.452 -0.342 0 O-C-N 123.409 0.443 . . . . 1.63 110.016 -176.655 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 554' ' ' PRO . . . . . 0.53 ' HB2' ' HB2' ' A' ' 557' ' ' SER . 33.0 Cg_exo -59.5 135.92 67.98 Favored 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 122.945 2.43 . . . . 2.2 112.132 -178.192 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 555' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -77.32 -21.57 53.23 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.64 -0.709 . . . . 4.17 110.031 179.341 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 21.5 p -89.56 3.53 52.2 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 115.382 -0.827 . . . . 4.31 110.835 176.241 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 557' ' ' SER . . . . . 0.53 ' HB2' ' HB2' ' A' ' 554' ' ' PRO . 15.5 t -98.03 120.07 37.77 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.047 -0.723 . . . . 3.39 109.047 175.162 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 558' ' ' GLN . . . . . . . . . . . . . 78.4 mm-40 -69.71 138.22 52.69 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.093 -0.503 . . . . 5.62 111.564 -174.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 559' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 68.34 6.0 5.07 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 115.341 -0.845 . . . . 3.23 112.204 175.787 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 560' ' ' MET . . . . . . . . . . . . . 4.3 mpp? 58.09 27.34 14.8 Favored 'General case' 0 N--CA 1.465 0.312 0 O-C-N 123.451 0.469 . . . . 2.98 111.907 176.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 561' ' ' ALA . . . . . . . . . . . . . . . -144.75 155.24 43.43 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 116.258 -0.428 . . . . 1.46 110.817 -176.317 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 29.3 p90 -138.7 164.59 29.14 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.413 -0.588 . . . . 1.35 109.413 174.38 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 563' ' ' LYS . . . . . . . . . . . . . 21.9 tptm -103.06 125.07 49.63 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 109.983 -0.377 . . . . 2.71 109.983 -178.446 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 564' ' ' CYS . . . . . . . . . . . . . 48.8 t -80.09 113.38 38.01 Favored Pre-proline 0 C--N 1.327 -0.412 0 N-CA-C 109.512 -0.551 . . . . 0.41 109.512 -179.663 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 565' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -71.88 -28.67 16.24 Favored 'Trans proline' 0 CA--C 1.528 0.217 0 C-N-CA 122.667 2.245 . . . . 1.0 113.954 -172.13 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 566' ' ' ILE . . . . . . . . . . . . . 28.5 mt -72.67 -37.7 56.59 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 CA-C-O 121.069 0.462 . . . . 1.54 111.671 -172.662 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 567' ' ' CYS . . . . . 0.58 ' SG ' ' HG3' ' A' ' 569' ' ' GLU . 27.8 p -127.43 1.27 6.29 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.534 -0.303 . . . . 0.7 111.567 -175.309 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 568' ' ' LYS . . . . . . . . . . . . . 29.1 mtpp 67.45 27.45 8.01 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 115.934 -0.576 . . . . 3.19 112.429 175.272 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 569' ' ' GLU . . . . . 0.58 ' HG3' ' SG ' ' A' ' 567' ' ' CYS . 51.1 mt-10 -79.07 136.43 37.16 Favored 'General case' 0 CA--C 1.516 -0.336 0 N-CA-C 109.944 -0.391 . . . . 3.34 109.944 174.692 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 570' ' ' THR . . . . . . . . . . . . . 47.4 m -87.99 116.58 26.26 Favored 'General case' 0 C--N 1.314 -0.977 0 N-CA-C 107.835 -1.172 . . . . 1.43 107.835 171.736 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 571' ' ' VAL . . . . . 0.459 HG23 ' CE1' ' A' ' 596' ' ' HIS . 16.8 t -97.78 115.73 38.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 C-N-CA 120.668 -0.413 . . . . 1.39 110.962 -171.477 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 23.8 p -109.76 158.82 17.73 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 109.183 -0.673 . . . . 2.17 109.183 174.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . -131.21 155.15 21.16 Favored Glycine 0 N--CA 1.443 -0.896 0 C-N-CA 120.04 -1.076 . . . . 2.2 112.132 -178.2 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 574' ' ' VAL . . . . . . . . . . . . . 39.5 t -112.35 152.81 14.1 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 N-CA-C 109.432 -0.581 . . . . 3.64 109.432 -175.632 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 575' ' ' TYR . . . . . . . . . . . . . 50.7 t80 -84.52 119.84 25.64 Favored 'General case' 0 C--N 1.315 -0.891 0 N-CA-C 109.953 -0.388 . . . . 3.53 109.953 176.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 576' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -90.3 97.96 11.49 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 108.277 -1.009 . . . . 3.34 108.277 178.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 577' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -65.92 -22.85 66.53 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.354 -0.839 . . . . 5.59 111.851 -172.834 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 578' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -73.32 -48.09 37.25 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.014 0.435 . . . . 5.11 110.116 -178.27 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 579' ' ' SER . . . . . . . . . . . . . 74.5 p -84.05 -19.88 33.64 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.922 0.391 . . . . 3.7 111.023 178.109 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 580' ' ' GLY . . . . . . . . . . . . . . . 80.24 22.65 62.53 Favored Glycine 0 N--CA 1.449 -0.451 0 CA-C-N 115.795 -0.639 . . . . 2.89 112.266 179.048 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 581' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -130.59 147.83 52.31 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-O 121.32 0.581 . . . . 3.19 111.009 -177.274 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 582' ' ' TRP . . . . . 0.712 ' O ' ' HA ' ' A' ' 552' ' ' VAL . 88.4 m95 -72.05 143.82 48.97 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 108.591 -0.892 . . . . 2.63 108.591 168.815 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 583' ' ' VAL . . . . . 0.614 HG21 ' HE2' ' A' ' 585' ' ' LYS . 24.4 m -124.08 133.19 69.96 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 N-CA-C 113.679 0.992 . . . . 1.67 113.679 -174.493 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 584' ' ' TRP . . . . . 0.593 ' CD1' HG23 ' A' ' 553' ' ' VAL . 30.9 m0 -110.51 104.1 12.79 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 114.912 -1.04 . . . . 2.74 108.338 163.067 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 585' ' ' LYS . . . . . 0.614 ' HE2' HG21 ' A' ' 583' ' ' VAL . 66.9 mmtt -83.38 151.49 25.5 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-O 120.495 0.188 . . . . 4.27 110.611 -176.54 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 586' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 50.27 44.86 26.36 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 115.887 -0.597 . . . . 1.72 110.124 -175.517 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 587' ' ' THR . . . . . . . . . . . . . 75.3 m -125.83 140.94 52.25 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.15 -0.477 . . . . 1.22 110.679 -176.394 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 588' ' ' ILE . . . . . 0.447 ' HB ' ' HB3' ' A' ' 597' ' ' SER . 12.7 tt -136.05 146.13 29.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 N-CA-C 109.482 -0.562 . . . . 1.34 109.482 179.025 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 589' ' ' GLU . . . . . . . . . . . . . 46.2 tt0 -100.45 121.5 41.65 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.219 -0.66 . . . . 1.35 109.219 174.329 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 590' ' ' VAL . . . . . . . . . . . . . 52.7 t -124.35 118.19 52.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 109.947 -0.39 . . . . 1.3 109.947 -179.185 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 591' ' ' ASN . . . . . . . . . . . . . 60.0 t30 58.12 37.51 26.4 Favored 'General case' 0 C--N 1.328 -0.327 0 O-C-N 123.912 0.757 . . . . 2.03 110.852 178.67 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . 85.25 0.88 88.51 Favored Glycine 0 N--CA 1.452 -0.256 0 CA-C-N 115.844 -0.616 . . . . 0.62 113.718 176.462 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 593' ' ' LYS . . . . . . . . . . . . . 61.8 mttp -118.71 147.69 43.56 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 117.245 0.523 . . . . 3.3 111.104 -179.129 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 594' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -96.53 135.64 38.14 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.018 0.437 . . . . 2.29 111.219 -175.581 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 595' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 -143.87 155.02 43.96 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.337 -0.847 . . . . 2.2 109.322 178.57 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 596' ' ' HIS . . . . . 0.459 ' CE1' HG23 ' A' ' 571' ' ' VAL . 16.7 m170 -64.66 127.24 30.69 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 107.972 -1.121 . . . . 0.76 107.972 166.579 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 597' ' ' SER . . . . . 0.447 ' HB3' ' HB ' ' A' ' 588' ' ' ILE . 7.7 p -66.02 -32.02 73.26 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.043 0.449 . . . . 1.59 110.002 -178.906 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 598' ' ' THR . . . . . . . . . . . . . 97.1 m -61.12 -43.25 99.17 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.265 -0.879 . . . . 1.93 110.345 173.694 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 599' ' ' CYS . . . . . 0.512 ' O ' ' HB3' ' A' ' 602' ' ' GLU . 83.9 m -74.74 -30.46 61.51 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.779 -0.646 . . . . 0.81 111.289 -179.775 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 600' ' ' TYR . . . . . . . . . . . . . 88.0 t80 -59.28 -35.87 74.52 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.179 0.514 . . . . 2.65 109.908 177.572 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 601' ' ' HIS . . . . . . . . . . . . . 67.3 t60 -71.22 -29.51 65.23 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.811 -0.631 . . . . 5.16 110.506 176.562 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 602' ' ' GLU . . . . . 0.512 ' HB3' ' O ' ' A' ' 599' ' ' CYS . 2.0 tp10 -61.89 -37.21 83.74 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.923 -0.581 . . . . 3.85 111.149 178.639 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 603' ' ' THR . . . . . . . . . . . . . 12.3 t . . . . . 0 C--N 1.328 -0.343 0 CA-C-N 116.447 -0.342 . . . . 3.3 111.102 -179.05 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 701' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.5 0 N-CA-C 111.818 -0.513 . . . . 3.77 111.818 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 549' ' ' LYS . . . . . . . . . . . . . 68.4 mmtt -64.01 149.37 47.57 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-O 121.338 0.589 . . . . 6.2 111.085 178.813 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 550' ' ' TYR . . . . . . . . . . . . . 39.7 p90 -122.38 159.94 26.47 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.277 -0.874 . . . . 3.22 109.745 179.181 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 551' ' ' VAL . . . . . . . . . . . . . 60.6 t -118.15 133.35 65.21 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.925 0 N-CA-C 108.527 -0.916 . . . . 2.01 108.527 177.551 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 552' ' ' VAL . . . . . 0.641 ' HA ' ' O ' ' A' ' 582' ' ' TRP . 42.0 t -67.8 134.24 30.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 116.122 -0.49 . . . . 1.8 109.741 -177.426 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 553' ' ' VAL . . . . . 0.54 HG12 ' HB3' ' A' ' 560' ' ' MET . 63.2 t -59.46 121.68 58.57 Favored Pre-proline 0 C--N 1.325 -0.461 0 O-C-N 123.682 0.613 . . . . 1.63 111.391 -175.813 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 554' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 553' ' ' VAL . 31.6 Cg_exo -58.74 143.13 99.1 Favored 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 123.559 2.839 . . . . 2.2 112.607 179.148 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 555' ' ' GLU . . . . . . . . . . . . . 19.9 tp10 -62.05 -38.36 88.45 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.165 -0.925 . . . . 4.17 111.094 -179.562 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 24.1 p -96.26 45.01 1.07 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.238 -0.437 . . . . 4.31 111.848 -176.68 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 557' ' ' SER . . . . . 0.576 ' OG ' ' HA ' ' A' ' 560' ' ' MET . 59.4 p -107.25 124.37 49.66 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.99 0.424 . . . . 3.39 110.438 179.003 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 558' ' ' GLN . . . . . . . . . . . . . 89.3 mt-30 -66.11 112.84 4.1 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.18 -0.463 . . . . 5.62 109.86 179.312 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 559' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 66.44 12.98 9.04 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 115.867 -0.606 . . . . 3.23 111.71 -177.467 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 560' ' ' MET . . . . . 0.576 ' HA ' ' OG ' ' A' ' 557' ' ' SER . 60.1 mtt 57.18 37.03 28.2 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 116.248 -0.433 . . . . 2.98 111.266 -179.789 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 561' ' ' ALA . . . . . 0.409 ' HB1' HG22 ' A' ' 572' ' ' THR . . . -144.3 161.95 37.65 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 116.072 -0.513 . . . . 1.46 111.443 -177.627 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 31.2 p90 -143.83 153.06 41.97 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.968 -0.753 . . . . 1.35 108.968 173.242 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 563' ' ' LYS . . . . . 0.511 ' HA ' ' HA ' ' A' ' 570' ' ' THR . 16.0 tppt? -88.89 126.47 35.4 Favored 'General case' 0 C--N 1.317 -0.841 0 C-N-CA 120.705 -0.398 . . . . 2.71 110.189 177.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 564' ' ' CYS . . . . . 0.435 ' HA ' ' HD3' ' A' ' 565' ' ' PRO . 52.7 t -79.46 113.62 38.42 Favored Pre-proline 0 N--CA 1.451 -0.379 0 N-CA-C 109.444 -0.576 . . . . 0.41 109.444 174.62 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 565' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 564' ' ' CYS . 33.4 Cg_exo -63.38 -36.37 55.98 Favored 'Trans proline' 0 CA--C 1.528 0.206 0 C-N-CA 123.146 2.564 . . . . 1.0 113.896 -173.323 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 566' ' ' ILE . . . . . 0.438 HD11 ' HB3' ' A' ' 599' ' ' CYS . 60.3 mt -72.35 -37.81 59.25 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 N-CA-C 112.088 0.403 . . . . 1.54 112.088 -173.143 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 567' ' ' CYS . . . . . . . . . . . . . 29.6 p -113.15 0.76 15.04 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.536 -0.466 . . . . 0.7 111.82 -176.281 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 568' ' ' LYS . . . . . . . . . . . . . 99.4 mttt 66.03 11.63 7.89 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 113.181 0.808 . . . . 3.19 113.181 173.522 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 569' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -100.6 134.64 43.26 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.873 0.368 . . . . 3.34 110.971 179.216 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 570' ' ' THR . . . . . 0.511 ' HA ' ' HA ' ' A' ' 563' ' ' LYS . 45.8 m -74.13 128.96 36.87 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.5 -0.773 . . . . 1.43 109.617 177.863 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 571' ' ' VAL . . . . . . . . . . . . . 17.9 t -95.76 115.09 33.97 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 N-CA-C 109.568 -0.53 . . . . 1.39 109.568 178.424 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 572' ' ' THR . . . . . 0.409 HG22 ' HB1' ' A' ' 561' ' ' ALA . 24.4 p -106.24 160.41 15.37 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.66 -0.7 . . . . 2.17 109.438 177.103 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . -129.53 153.89 20.14 Favored Glycine 0 N--CA 1.44 -1.052 0 C-N-CA 119.352 -1.404 . . . . 2.2 112.405 -178.619 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 574' ' ' VAL . . . . . . . . . . . . . 58.5 t -122.57 148.13 26.42 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 CA-C-N 114.861 -0.67 . . . . 3.64 109.395 -172.714 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 575' ' ' TYR . . . . . . . . . . . . . 53.3 t80 -80.81 118.07 22.02 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 109.356 -0.609 . . . . 3.53 109.356 175.718 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 576' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -92.96 114.89 27.58 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 109.754 -0.461 . . . . 3.34 109.754 179.756 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 577' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -68.89 -22.72 64.16 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.511 -0.768 . . . . 5.59 112.13 -174.441 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 578' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -77.08 -48.13 18.65 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.509 -0.314 . . . . 5.11 111.723 -178.276 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 579' ' ' SER . . . . . . . . . . . . . 72.4 p -86.0 -21.82 27.61 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.878 0.37 . . . . 3.7 110.859 178.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 580' ' ' GLY . . . . . . . . . . . . . . . 80.19 17.29 74.54 Favored Glycine 0 C--N 1.331 0.285 0 C-N-CA 121.157 -0.544 . . . . 2.89 112.725 178.48 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 581' ' ' GLU . . . . . . . . . . . . . 20.7 mm-40 -122.42 152.24 40.43 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.921 0.391 . . . . 3.19 111.292 -176.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 582' ' ' TRP . . . . . 0.641 ' O ' ' HA ' ' A' ' 552' ' ' VAL . 84.5 m95 -77.51 130.38 36.9 Favored 'General case' 0 CA--C 1.512 -0.491 0 N-CA-C 107.451 -1.315 . . . . 2.63 107.451 165.245 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 583' ' ' VAL . . . . . . . . . . . . . 19.3 m -115.39 133.91 60.2 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.971 0 N-CA-C 113.958 1.096 . . . . 1.67 113.958 -169.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 584' ' ' TRP . . . . . 0.5 ' CD1' HG22 ' A' ' 553' ' ' VAL . 30.5 m0 -113.33 103.65 11.52 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 114.795 -1.093 . . . . 2.74 108.053 162.281 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 585' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.99 145.61 27.63 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.985 0.422 . . . . 4.27 111.774 -173.104 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 586' ' ' ASN . . . . . . . . . . . . . 12.3 m120 53.2 42.93 32.13 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.282 -0.872 . . . . 1.72 110.512 -176.613 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 587' ' ' THR . . . . . . . . . . . . . 57.9 m -115.38 142.46 46.66 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.0 0.428 . . . . 1.22 110.761 -176.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 588' ' ' ILE . . . . . . . . . . . . . 15.3 tt -137.38 150.19 25.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.58 -0.736 . . . . 1.34 109.396 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 589' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -111.13 122.73 48.62 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.098 -0.705 . . . . 1.35 109.098 176.908 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 590' ' ' VAL . . . . . . . . . . . . . 62.1 t -126.39 117.65 49.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 115.716 -0.675 . . . . 1.3 110.06 179.324 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 591' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 58.27 40.64 24.43 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 115.582 -0.735 . . . . 2.03 110.835 177.267 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . 79.98 13.67 81.81 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.91 -0.662 . . . . 0.62 112.592 176.036 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 593' ' ' LYS . . . . . . . . . . . . . 46.8 mtmt -128.47 139.92 52.08 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.036 0.446 . . . . 3.3 110.777 -178.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 594' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -94.9 134.88 37.06 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.054 -0.521 . . . . 2.29 111.064 -177.081 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 595' ' ' PHE . . . . . . . . . . . . . 62.7 m-85 -142.25 165.24 27.98 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.372 -0.831 . . . . 2.2 108.807 177.002 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 596' ' ' HIS . . . . . 0.687 ' HB2' ' SG ' ' A' ' 599' ' ' CYS . 24.9 m80 -68.79 130.11 41.88 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 108.273 -1.01 . . . . 0.76 108.273 166.641 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 597' ' ' SER . . . . . . . . . . . . . 40.1 t -60.83 -30.16 69.93 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.462 0.649 . . . . 1.59 109.81 179.361 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 598' ' ' THR . . . . . . . . . . . . . 93.7 m -66.39 -34.71 78.58 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.905 -1.043 . . . . 1.93 110.803 175.11 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 599' ' ' CYS . . . . . 0.687 ' SG ' ' HB2' ' A' ' 596' ' ' HIS . 75.8 m -74.77 -31.15 61.69 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.622 0.601 . . . . 0.81 112.622 -178.25 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 600' ' ' TYR . . . . . . . . . . . . . 86.0 t80 -61.8 -35.62 78.72 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 121.362 0.601 . . . . 2.65 109.842 -178.427 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 601' ' ' HIS . . . . . . . . . . . . . 78.7 t60 -66.72 -34.7 78.43 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.373 -0.83 . . . . 5.16 110.408 176.001 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 602' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -64.65 -36.57 84.69 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.145 -0.48 . . . . 3.85 110.927 179.847 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 603' ' ' THR . . . . . . . . . . . . . 15.4 t . . . . . 0 C--N 1.324 -0.507 0 CA-C-N 116.554 -0.293 . . . . 3.3 110.701 -179.266 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 701' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.418 0 N-CA-C 112.107 -0.397 . . . . 3.77 112.107 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 549' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -64.28 132.49 50.39 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.056 0.455 . . . . 6.2 110.125 176.558 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 550' ' ' TYR . . . . . 0.503 ' CE1' HG12 ' A' ' 583' ' ' VAL . 37.4 p90 -111.34 160.91 16.6 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.822 -0.626 . . . . 3.22 109.834 177.414 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 551' ' ' VAL . . . . . 0.511 HG11 ' HE1' ' A' ' 594' ' ' TYR . 52.9 t -118.53 133.26 65.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 N-CA-C 109.072 -0.714 . . . . 2.01 109.072 176.437 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 552' ' ' VAL . . . . . 0.72 ' HA ' ' O ' ' A' ' 582' ' ' TRP . 56.6 t -61.95 125.18 17.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 O-C-N 123.32 0.388 . . . . 1.8 110.287 -179.039 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 553' ' ' VAL . . . . . 0.677 HG21 ' CD1' ' A' ' 584' ' ' TRP . 66.6 t -58.91 120.41 46.32 Favored Pre-proline 0 C--N 1.33 -0.271 0 O-C-N 123.729 0.643 . . . . 1.63 111.495 -173.903 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 554' ' ' PRO . . . . . 0.45 ' HD3' ' HA ' ' A' ' 553' ' ' VAL . 7.2 Cg_exo -72.4 136.91 27.21 Favored 'Trans proline' 0 N--CA 1.456 -0.697 0 C-N-CA 122.802 2.335 . . . . 2.2 112.06 175.78 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 555' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 -76.93 -15.35 59.7 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.593 -0.73 . . . . 4.17 110.055 179.357 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 22.7 p -84.43 -13.34 52.38 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.389 -0.823 . . . . 4.31 111.862 -177.71 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 557' ' ' SER . . . . . . . . . . . . . 47.2 m -80.68 78.07 7.46 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.615 -0.266 . . . . 3.39 111.532 -177.64 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 558' ' ' GLN . . . . . 0.426 ' HA ' ' OE1' ' A' ' 558' ' ' GLN . 10.4 mm-40 56.25 -89.66 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 123.512 0.725 . . . . 5.62 111.703 176.39 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 559' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -137.05 61.07 1.63 Allowed 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.022 -0.733 . . . . 3.23 109.022 176.784 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 560' ' ' MET . . . . . . . . . . . . . 62.1 mtt 62.22 24.63 14.68 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 115.273 -0.876 . . . . 2.98 110.797 -178.302 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 561' ' ' ALA . . . . . . . . . . . . . . . -144.77 149.94 36.35 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.378 -0.373 . . . . 1.46 111.162 -173.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 26.8 p90 -133.69 164.01 28.17 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.572 -0.899 . . . . 1.35 108.572 173.605 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 563' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt -112.09 127.59 55.96 Favored 'General case' 0 C--N 1.323 -0.587 0 C-N-CA 120.456 -0.498 . . . . 2.71 110.772 -179.459 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 564' ' ' CYS . . . . . . . . . . . . . 53.4 t -73.77 113.9 27.28 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 115.416 -0.811 . . . . 0.41 109.797 -179.192 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 565' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -72.83 -19.91 23.15 Favored 'Trans proline' 0 N--CA 1.472 0.218 0 C-N-CA 122.965 2.443 . . . . 1.0 113.599 -175.633 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 566' ' ' ILE . . . . . 0.416 HD13 ' HB ' ' A' ' 603' ' ' THR . 37.7 mt -82.26 -37.86 14.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.255 -0.429 . . . . 1.54 111.616 -172.368 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 567' ' ' CYS . . . . . . . . . . . . . 27.9 p -129.32 5.86 5.27 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 112.22 0.452 . . . . 0.7 112.22 -179.319 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 568' ' ' LYS . . . . . . . . . . . . . 21.0 mmmt 72.82 30.59 1.72 Allowed 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 113.923 1.083 . . . . 3.19 113.923 167.346 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 569' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -92.85 135.81 33.8 Favored 'General case' 0 N--CA 1.466 0.361 0 O-C-N 121.786 -0.571 . . . . 3.34 111.231 178.308 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 570' ' ' THR . . . . . . . . . . . . . 82.5 m -82.14 117.91 22.66 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 108.875 -0.787 . . . . 1.43 108.875 166.142 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 571' ' ' VAL . . . . . . . . . . . . . 21.3 t -103.13 123.27 56.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.951 0.405 . . . . 1.39 111.745 -170.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 24.5 p -108.94 160.96 15.59 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.87 -0.604 . . . . 2.17 110.33 177.672 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . -130.98 156.15 21.61 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.343 -0.932 . . . . 2.2 112.185 -177.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 574' ' ' VAL . . . . . 0.405 ' O ' HG22 ' A' ' 583' ' ' VAL . 21.8 t -112.26 149.61 14.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-O 120.888 0.375 . . . . 3.64 110.319 -173.117 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 575' ' ' TYR . . . . . . . . . . . . . 53.8 t80 -85.21 123.36 30.62 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.256 -0.429 . . . . 3.53 111.012 179.061 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 576' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -92.12 107.75 19.44 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.418 -0.586 . . . . 3.34 109.418 174.09 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 577' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -68.17 -26.98 66.03 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.037 -0.529 . . . . 5.59 112.424 -173.215 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 578' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -69.53 -47.95 62.06 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.76 0.314 . . . . 5.11 111.249 -178.409 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 579' ' ' SER . . . . . . . . . . . . . 77.1 p -83.31 -23.88 32.39 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.343 0.592 . . . . 3.7 110.578 -179.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 580' ' ' GLY . . . . . . . . . . . . . . . 79.17 18.4 74.5 Favored Glycine 0 N--CA 1.449 -0.499 0 CA-C-N 115.561 -0.745 . . . . 2.89 111.326 -176.714 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 581' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -123.32 138.85 54.52 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.295 0.569 . . . . 3.19 110.833 -176.036 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 582' ' ' TRP . . . . . 0.72 ' O ' ' HA ' ' A' ' 552' ' ' VAL . 83.7 m95 -71.45 141.06 50.25 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.975 -0.75 . . . . 2.63 108.975 173.221 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 583' ' ' VAL . . . . . 0.503 HG12 ' CE1' ' A' ' 550' ' ' TYR . 24.0 m -119.89 133.78 65.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 N-CA-C 113.352 0.871 . . . . 1.67 113.352 -173.933 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 584' ' ' TRP . . . . . 0.677 ' CD1' HG21 ' A' ' 553' ' ' VAL . 21.6 m0 -111.38 104.51 12.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.024 -0.989 . . . . 2.74 108.983 165.436 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 585' ' ' LYS . . . . . . . . . . . . . 26.2 mmmt -83.23 148.13 27.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.607 -0.269 . . . . 4.27 110.473 -175.041 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 586' ' ' ASN . . . . . . . . . . . . . 62.7 m-20 48.32 41.95 17.16 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 123.319 0.648 . . . . 1.72 110.337 -173.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 587' ' ' THR . . . . . . . . . . . . . 56.8 m -120.1 140.9 50.35 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.966 -0.561 . . . . 1.22 109.607 179.556 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 588' ' ' ILE . . . . . 0.428 HG21 ' HA ' ' A' ' 597' ' ' SER . 15.5 tt -135.66 146.22 30.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-O 120.927 0.394 . . . . 1.34 110.123 -178.707 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 589' ' ' GLU . . . . . 0.403 ' HA ' ' O ' ' A' ' 593' ' ' LYS . 1.8 tm-20 -103.23 121.16 42.12 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.213 -0.662 . . . . 1.35 109.213 175.373 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 590' ' ' VAL . . . . . . . . . . . . . 59.1 t -125.64 118.6 52.69 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 115.776 -0.647 . . . . 1.3 109.829 -179.56 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 591' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 58.78 36.9 25.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.676 0.751 . . . . 2.03 110.779 178.041 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . 85.85 6.59 82.35 Favored Glycine 0 N--CA 1.446 -0.647 0 CA-C-N 115.729 -0.669 . . . . 0.62 113.214 176.38 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 593' ' ' LYS . . . . . 0.403 ' O ' ' HA ' ' A' ' 589' ' ' GLU . 30.4 mmmt -120.85 139.29 53.38 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 117.02 0.41 . . . . 3.3 111.64 -179.046 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 594' ' ' TYR . . . . . 0.511 ' HE1' HG11 ' A' ' 551' ' ' VAL . 91.8 m-85 -93.55 124.05 37.28 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.86 -0.609 . . . . 2.29 111.092 -179.864 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 595' ' ' PHE . . . . . . . . . . . . . 47.9 m-85 -137.29 164.27 28.95 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.865 -0.607 . . . . 2.2 109.662 176.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 596' ' ' HIS . . . . . 0.705 ' HB2' ' SG ' ' A' ' 599' ' ' CYS . 29.3 m170 -61.58 129.83 43.0 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 108.927 -0.768 . . . . 0.76 108.927 168.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 597' ' ' SER . . . . . 0.428 ' HA ' HG21 ' A' ' 588' ' ' ILE . 33.4 t -64.24 -30.35 71.41 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.039 -0.528 . . . . 1.59 109.65 178.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 598' ' ' THR . . . . . . . . . . . . . 8.7 m -61.8 -38.85 89.64 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 115.307 -0.861 . . . . 1.93 110.488 175.403 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 599' ' ' CYS . . . . . 0.705 ' SG ' ' HB2' ' A' ' 596' ' ' HIS . 83.2 m -73.98 -28.52 61.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.302 -0.863 . . . . 0.81 112.672 -175.336 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 600' ' ' TYR . . . . . . . . . . . . . 70.0 t80 -55.94 -35.89 67.16 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 120.902 0.382 . . . . 2.65 110.963 -174.62 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 601' ' ' HIS . . . . . . . . . . . . . 43.5 m-70 -73.26 -39.35 65.48 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.453 -0.339 . . . . 5.16 111.232 -178.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 602' ' ' GLU . . . . . 0.644 ' HG2' ' O ' ' A' ' 599' ' ' CYS . 23.3 pt-20 -70.36 -35.5 73.59 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 120.709 0.29 . . . . 3.85 111.028 -177.438 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 603' ' ' THR . . . . . 0.416 ' HB ' HD13 ' A' ' 566' ' ' ILE . 13.0 t . . . . . 0 C--N 1.327 -0.387 0 C-N-CA 120.978 -0.289 . . . . 3.3 111.557 -175.225 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 701' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.136 0 N-CA-C 113.484 0.154 . . . . 3.77 113.484 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 549' ' ' LYS . . . . . . . . . . . . . 61.6 mttm -73.43 134.79 44.07 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.906 0.384 . . . . 6.2 110.588 176.218 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 550' ' ' TYR . . . . . . . . . . . . . 31.8 p90 -111.62 159.9 17.74 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.561 -0.745 . . . . 3.22 109.584 179.322 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 551' ' ' VAL . . . . . . . . . . . . . 59.2 t -117.94 131.9 69.34 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 N-CA-C 108.556 -0.905 . . . . 2.01 108.556 175.311 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 552' ' ' VAL . . . . . 0.559 ' HA ' ' O ' ' A' ' 582' ' ' TRP . 59.0 t -63.95 134.82 28.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 116.051 -0.522 . . . . 1.8 110.075 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 553' ' ' VAL . . . . . 0.572 HG21 ' CD1' ' A' ' 584' ' ' TRP . 86.0 t -58.84 121.72 56.55 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 115.677 -0.692 . . . . 1.63 110.05 -178.489 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 554' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_exo -55.65 135.89 71.55 Favored 'Trans proline' 0 N--CA 1.462 -0.363 0 C-N-CA 122.791 2.327 . . . . 2.2 112.496 -176.523 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 555' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -82.59 -6.32 59.28 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.979 -0.555 . . . . 4.17 110.2 -178.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 23.0 p -83.23 -6.39 59.46 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.567 -0.742 . . . . 4.31 111.037 179.111 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 557' ' ' SER . . . . . . . . . . . . . 32.6 t -109.02 143.1 38.75 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 115.977 -0.556 . . . . 3.39 110.28 -179.066 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 558' ' ' GLN . . . . . . . . . . . . . 27.5 mt-30 -100.31 5.3 44.49 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.089 -0.505 . . . . 5.62 110.229 177.199 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 559' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -133.05 120.55 21.47 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 108.938 -0.764 . . . . 3.23 108.938 176.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 560' ' ' MET . . . . . . . . . . . . . 3.8 mpp? -78.45 37.4 0.27 Allowed 'General case' 0 C--O 1.237 0.419 0 CA-C-N 116.587 -0.279 . . . . 2.98 111.28 -174.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 561' ' ' ALA . . . . . 0.533 ' HA ' ' O ' ' A' ' 571' ' ' VAL . . . -144.66 145.7 31.88 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-O 121.045 0.45 . . . . 1.46 111.552 -176.628 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 33.1 p90 -135.92 149.22 48.87 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 107.791 -1.189 . . . . 1.35 107.791 169.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 563' ' ' LYS . . . . . 0.443 ' HA ' ' HA ' ' A' ' 570' ' ' THR . 72.1 tttt -93.3 119.99 33.07 Favored 'General case' 0 C--N 1.316 -0.859 0 C-N-CA 120.093 -0.643 . . . . 2.71 110.929 -176.07 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 564' ' ' CYS . . . . . 0.457 ' HA ' ' HD3' ' A' ' 565' ' ' PRO . 10.6 t -76.91 114.26 37.76 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-N 115.348 -0.842 . . . . 0.41 110.729 -178.626 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 565' ' ' PRO . . . . . 0.457 ' HD3' ' HA ' ' A' ' 564' ' ' CYS . 20.6 Cg_exo -70.48 -23.41 27.55 Favored 'Trans proline' 0 CA--C 1.534 0.487 0 C-N-CA 123.379 2.719 . . . . 1.0 113.35 -177.479 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 566' ' ' ILE . . . . . 0.465 HG23 ' HB3' ' A' ' 599' ' ' CYS . 26.7 mt -71.44 -37.64 65.46 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.364 0 N-CA-C 112.041 0.385 . . . . 1.54 112.041 -174.249 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 567' ' ' CYS . . . . . . . . . . . . . 29.2 p -124.34 2.06 8.43 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.805 0.336 . . . . 0.7 111.429 178.07 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 568' ' ' LYS . . . . . . . . . . . . . 29.4 mtpp 69.65 18.01 7.7 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 113.463 0.912 . . . . 3.19 113.463 171.798 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 569' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -107.85 136.37 47.69 Favored 'General case' 0 C--O 1.238 0.46 0 C-N-CA 120.373 -0.531 . . . . 3.34 111.332 178.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 570' ' ' THR . . . . . 0.443 ' HA ' ' HA ' ' A' ' 563' ' ' LYS . 35.5 m -68.18 125.99 28.12 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 115.015 -0.993 . . . . 1.43 110.925 -178.677 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 571' ' ' VAL . . . . . 0.533 ' O ' ' HA ' ' A' ' 561' ' ' ALA . 15.9 t -95.06 117.51 39.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 115.68 -0.691 . . . . 1.39 110.602 -176.891 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 572' ' ' THR . . . . . 0.513 HG23 ' HB2' ' A' ' 561' ' ' ALA . 25.6 p -109.17 158.62 17.63 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 109.619 -0.512 . . . . 2.17 109.619 176.589 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . -129.92 156.41 21.44 Favored Glycine 0 N--CA 1.443 -0.871 0 C-N-CA 120.305 -0.95 . . . . 2.2 111.777 -177.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 574' ' ' VAL . . . . . 0.444 ' O ' HG21 ' A' ' 583' ' ' VAL . 20.1 t -113.68 149.94 15.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-O 120.832 0.348 . . . . 3.64 110.227 -173.352 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 575' ' ' TYR . . . . . 0.424 ' HA ' ' HA ' ' A' ' 582' ' ' TRP . 39.6 t80 -80.61 123.84 28.48 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 109.276 -0.639 . . . . 3.53 109.276 174.383 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 576' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -90.97 105.49 17.86 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 108.434 -0.95 . . . . 3.34 108.434 175.574 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 577' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -67.09 -27.02 67.01 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.377 -0.829 . . . . 5.59 112.083 -170.602 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 578' ' ' GLU . . . . . . . . . . . . . 23.1 mp0 -75.15 -47.06 30.33 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.537 -0.301 . . . . 5.11 111.354 -179.452 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 579' ' ' SER . . . . . . . . . . . . . 75.2 p -83.12 -21.06 33.74 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.059 0.457 . . . . 3.7 111.295 -179.449 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 580' ' ' GLY . . . . . . . . . . . . . . . 80.23 20.49 67.03 Favored Glycine 0 N--CA 1.449 -0.46 0 CA-C-N 115.863 -0.608 . . . . 2.89 112.836 177.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 581' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -130.28 148.08 52.07 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.912 0.387 . . . . 3.19 110.752 -178.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 582' ' ' TRP . . . . . 0.559 ' O ' ' HA ' ' A' ' 552' ' ' VAL . 81.1 m95 -79.12 135.19 36.76 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.313 -0.625 . . . . 2.63 109.313 174.194 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 583' ' ' VAL . . . . . 0.444 HG21 ' O ' ' A' ' 574' ' ' VAL . 29.3 m -113.4 129.33 69.35 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 N-CA-C 112.987 0.736 . . . . 1.67 112.987 -172.594 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 584' ' ' TRP . . . . . 0.572 ' CD1' HG21 ' A' ' 553' ' ' VAL . 23.3 m0 -109.4 102.31 11.21 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 108.085 -1.08 . . . . 2.74 108.085 163.108 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 585' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.99 151.51 19.49 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 110.2 -0.296 . . . . 4.27 110.2 -173.428 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 586' ' ' ASN . . . . . 0.504 ' O ' ' HA ' ' A' ' 596' ' ' HIS . 2.2 m-20 55.95 42.33 28.83 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 121.214 0.53 . . . . 1.72 109.714 -173.311 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 587' ' ' THR . . . . . . . . . . . . . 30.2 m -124.41 141.42 52.1 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.359 -0.837 . . . . 1.22 110.439 -178.015 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 588' ' ' ILE . . . . . 0.563 ' HB ' ' HB3' ' A' ' 597' ' ' SER . 16.1 tt -139.98 147.92 23.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 116.255 -0.43 . . . . 1.34 109.877 177.928 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 589' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -100.62 119.08 38.03 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.453 -0.573 . . . . 1.35 109.453 176.653 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 590' ' ' VAL . . . . . . . . . . . . . 60.0 t -130.93 127.31 61.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.563 -0.744 . . . . 1.3 109.401 179.065 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 591' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 59.05 33.21 22.83 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 121.605 0.717 . . . . 2.03 110.384 179.068 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . 84.88 0.74 89.07 Favored Glycine 0 N--CA 1.45 -0.424 0 CA-C-N 115.795 -0.639 . . . . 0.62 113.303 175.815 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 593' ' ' LYS . . . . . . . . . . . . . 45.3 mmtm -121.35 148.06 44.86 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.056 0.455 . . . . 3.3 111.482 -178.305 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 594' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -92.89 132.76 36.75 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.566 -0.743 . . . . 2.29 110.576 179.597 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 595' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -136.55 162.58 32.72 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.292 -0.867 . . . . 2.2 108.766 177.529 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 596' ' ' HIS . . . . . 0.504 ' HA ' ' O ' ' A' ' 586' ' ' ASN . 21.9 m170 -66.86 125.05 24.7 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 107.743 -1.206 . . . . 0.76 107.743 167.178 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 597' ' ' SER . . . . . 0.563 ' HB3' ' HB ' ' A' ' 588' ' ' ILE . 2.1 p -67.77 -29.79 69.08 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.256 0.55 . . . . 1.59 109.884 177.501 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 598' ' ' THR . . . . . . . . . . . . . 25.6 m -63.84 -38.27 90.46 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.258 -0.883 . . . . 1.93 110.656 174.643 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 599' ' ' CYS . . . . . 0.47 ' SG ' ' HB2' ' A' ' 596' ' ' HIS . 73.6 m -75.14 -29.92 60.64 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.971 -0.559 . . . . 0.81 110.816 177.263 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 600' ' ' TYR . . . . . . . . . . . . . 92.4 t80 -55.62 -34.52 64.98 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.617 -0.719 . . . . 2.65 111.623 -174.598 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 601' ' ' HIS . . . . . . . . . . . . . 66.9 m170 -60.16 -32.51 71.12 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 112.459 0.541 . . . . 5.16 112.459 -176.343 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 602' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -72.61 -33.52 66.73 Favored 'General case' 0 CA--C 1.528 0.099 0 C-N-CA 120.118 -0.633 . . . . 3.85 110.966 -179.141 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 603' ' ' THR . . . . . . . . . . . . . 8.8 t . . . . . 0 C--O 1.235 0.3 0 C-N-CA 120.633 -0.427 . . . . 3.3 110.837 -177.564 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 701' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.387 0 N-CA-C 112.565 -0.214 . . . . 3.2 112.565 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 549' ' ' LYS . . . . . . . . . . . . . 32.5 mmmt -70.8 143.72 51.06 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 110.038 -0.356 . . . . 5.9 110.038 178.089 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 550' ' ' TYR . . . . . 0.507 ' CE1' HG12 ' A' ' 583' ' ' VAL . 23.8 p90 -125.97 159.73 31.89 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 109.29 -0.633 . . . . 2.79 109.29 177.015 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 551' ' ' VAL . . . . . . . . . . . . . 52.6 t -118.33 133.37 65.35 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.021 0 N-CA-C 108.723 -0.843 . . . . 1.52 108.723 177.48 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 552' ' ' VAL . . . . . 0.57 ' HA ' ' O ' ' A' ' 582' ' ' TRP . 60.8 t -65.2 130.59 30.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 109.499 -0.556 . . . . 1.38 109.499 179.374 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 553' ' ' VAL . . . . . 0.6 HG22 ' CD1' ' A' ' 584' ' ' TRP . 66.0 t -59.0 121.37 54.6 Favored Pre-proline 0 CA--C 1.519 -0.243 0 O-C-N 123.618 0.574 . . . . 1.38 110.681 -175.608 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 554' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 553' ' ' VAL . 31.9 Cg_exo . . . . . 0 N--CA 1.464 -0.219 0 C-N-CA 123.041 2.494 . . . . 1.98 112.786 -177.404 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 560' ' ' MET . . . . . 0.468 ' HG3' HG11 ' A' ' 553' ' ' VAL . 1.8 mpt? . . . . . 0 N--CA 1.466 0.346 0 N-CA-C 112.397 0.518 . . . . 2.61 112.397 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 561' ' ' ALA . . . . . 0.461 ' HA ' ' O ' ' A' ' 571' ' ' VAL . . . -144.5 152.67 40.93 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.015 0.436 . . . . 0.95 111.33 -178.659 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 33.4 p90 -142.76 151.7 41.52 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.219 -0.66 . . . . 0.9 109.219 170.949 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 563' ' ' LYS . . . . . . . . . . . . . 3.6 tppp? -88.8 117.98 28.17 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 109.269 -0.641 . . . . 2.18 109.269 -178.49 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 564' ' ' CYS . . . . . 0.479 ' HA ' ' HD3' ' A' ' 565' ' ' PRO . 41.7 t -68.26 112.96 12.45 Favored Pre-proline 0 C--O 1.223 -0.316 0 N-CA-C 109.578 -0.527 . . . . 0.41 109.578 179.035 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 565' ' ' PRO . . . . . 0.479 ' HD3' ' HA ' ' A' ' 564' ' ' CYS . 15.5 Cg_exo -71.77 -18.21 28.66 Favored 'Trans proline' 0 CA--C 1.527 0.162 0 C-N-CA 122.747 2.298 . . . . 0.63 113.299 -174.583 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 566' ' ' ILE . . . . . . . . . . . . . 26.4 mt -89.18 -38.32 11.15 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 N-CA-C 112.211 0.448 . . . . 0.94 112.211 -172.233 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 567' ' ' CYS . . . . . 0.466 ' SG ' ' OE2' ' A' ' 569' ' ' GLU . 28.6 p -127.74 1.21 6.09 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.512 -0.475 . . . . 0.7 111.65 178.67 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 568' ' ' LYS . . . . . 0.421 ' HA ' ' O ' ' A' ' 564' ' ' CYS . 54.3 mtpt 70.9 31.72 2.55 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 114.576 1.324 . . . . 2.71 114.576 163.782 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 569' ' ' GLU . . . . . 0.466 ' OE2' ' SG ' ' A' ' 567' ' ' CYS . 0.0 OUTLIER -95.72 149.38 21.55 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 108.605 -0.887 . . . . 3.34 108.605 170.173 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 570' ' ' THR . . . . . . . . . . . . . 57.0 m -84.02 117.06 23.16 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 109.045 -0.724 . . . . 1.01 109.045 172.844 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 571' ' ' VAL . . . . . 0.495 HG22 ' CE1' ' A' ' 596' ' ' HIS . 34.1 t -84.89 116.56 28.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-O 120.976 0.417 . . . . 0.73 111.108 -174.214 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 23.7 p -107.03 159.24 16.44 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.748 -0.66 . . . . 1.89 109.768 177.191 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . -130.5 155.68 21.24 Favored Glycine 0 N--CA 1.442 -0.926 0 C-N-CA 119.925 -1.131 . . . . 2.2 111.732 -178.233 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 574' ' ' VAL . . . . . 0.5 ' O ' HG22 ' A' ' 583' ' ' VAL . 40.5 t -118.0 148.44 20.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 109.838 -0.43 . . . . 3.24 109.838 -174.215 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 575' ' ' TYR . . . . . 0.46 ' HA ' ' HA ' ' A' ' 582' ' ' TRP . 47.6 t80 -84.22 119.46 25.06 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.797 -0.446 . . . . 3.02 109.797 178.147 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 576' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -95.84 113.38 25.0 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.97 0.414 . . . . 3.34 110.04 176.776 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 577' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -70.43 -22.69 62.69 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.42 -0.809 . . . . 5.59 112.074 -175.262 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 578' ' ' GLU . . . . . . . . . . . . . 15.8 tp10 -74.82 -46.39 36.98 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 121.023 -0.271 . . . . 5.11 110.854 -179.233 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 579' ' ' SER . . . . . . . . . . . . . 74.0 p -82.34 -20.96 36.27 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.111 0.482 . . . . 3.28 110.608 176.013 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 580' ' ' GLY . . . . . . . . . . . . . . . 79.54 20.21 69.45 Favored Glycine 0 N--CA 1.447 -0.578 0 CA-C-N 115.667 -0.697 . . . . 2.6 112.5 175.79 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 581' ' ' GLU . . . . . 0.43 ' OE1' ' HA ' ' A' ' 581' ' ' GLU . 8.7 mm-40 -138.1 160.26 39.85 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.24 0.543 . . . . 3.19 111.048 -177.901 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 582' ' ' TRP . . . . . 0.57 ' O ' ' HA ' ' A' ' 552' ' ' VAL . 80.3 m95 -79.55 137.84 37.29 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.609 -0.723 . . . . 2.3 109.361 174.322 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 583' ' ' VAL . . . . . 0.507 HG12 ' CE1' ' A' ' 550' ' ' TYR . 19.9 m -116.53 132.43 66.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 N-CA-C 113.667 0.988 . . . . 1.11 113.667 -172.122 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 584' ' ' TRP . . . . . 0.6 ' CD1' HG22 ' A' ' 553' ' ' VAL . 31.2 m0 -113.31 102.71 10.6 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 108.17 -1.048 . . . . 2.29 108.17 162.387 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 585' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.32 154.15 18.03 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.884 -0.327 . . . . 3.95 110.869 -176.212 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 586' ' ' ASN . . . . . . . . . . . . . 22.6 m-20 56.23 43.73 26.11 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 108.615 -0.884 . . . . 1.43 108.615 -170.112 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 587' ' ' THR . . . . . . . . . . . . . 34.3 m -133.98 141.13 47.16 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.098 -0.955 . . . . 0.65 110.513 -176.019 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 588' ' ' ILE . . . . . . . . . . . . . 12.7 tt -141.58 149.41 20.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.358 -0.383 . . . . 0.71 110.095 -178.74 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 589' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -97.73 122.65 41.08 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.887 -0.412 . . . . 1.35 109.887 177.246 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 590' ' ' VAL . . . . . . . . . . . . . 35.4 t -124.64 118.44 53.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 N-CA-C 109.761 -0.459 . . . . 0.65 109.761 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 591' ' ' ASN . . . . . . . . . . . . . 3.7 t30 55.58 40.99 31.12 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.418 -0.81 . . . . 2.03 110.988 177.458 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . 85.41 5.13 85.34 Favored Glycine 0 CA--C 1.52 0.365 0 C-N-CA 120.86 -0.686 . . . . 0.62 113.778 174.455 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 593' ' ' LYS . . . . . . . . . . . . . 56.0 mttp -127.84 144.89 51.08 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 117.363 0.582 . . . . 2.78 110.958 177.481 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 594' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -91.25 132.94 35.8 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.277 0.561 . . . . 1.45 110.711 -179.516 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 595' ' ' PHE . . . . . . . . . . . . . 72.0 m-85 -132.95 156.32 47.5 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.299 -0.864 . . . . 1.32 108.962 178.441 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 596' ' ' HIS . . . . . 0.495 ' CE1' HG22 ' A' ' 571' ' ' VAL . 11.3 m170 -60.98 126.97 29.3 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 108.384 -0.969 . . . . 0.59 108.384 167.775 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 597' ' ' SER . . . . . . . . . . . . . 23.2 t -65.15 -29.31 70.14 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.859 -0.609 . . . . 1.13 109.986 -177.506 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 598' ' ' THR . . . . . . . . . . . . . 2.6 m -66.8 -39.18 87.67 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 115.522 -0.763 . . . . 1.4 110.707 178.829 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 599' ' ' CYS . . . . . . . . . . . . . 86.1 m -74.68 -32.82 62.31 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.527 -0.76 . . . . 0.81 112.152 -174.882 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 600' ' ' TYR . . . . . . . . . . . . . 73.9 t80 -57.06 -34.68 68.5 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.928 0.394 . . . . 1.88 111.471 -172.337 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 601' ' ' HIS . . . . . . . . . . . . . 14.6 m-70 -61.91 -26.82 68.4 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.786 -0.643 . . . . 4.52 112.361 -177.221 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 602' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.49 -29.13 65.57 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 121.117 0.484 . . . . 3.85 110.13 -178.646 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 603' ' ' THR . . . . . . . . . . . . . 92.2 m . . . . . 0 C--N 1.326 -0.423 0 CA-C-N 115.841 -0.618 . . . . 3.3 110.811 -178.311 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.512 -0.147 0 N-CA-C 113.274 0.07 . . . . 3.2 113.274 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 549' ' ' LYS . . . . . 0.645 ' HD2' ' N ' ' A' ' 549' ' ' LYS . 6.5 mptt -81.29 150.35 28.56 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.379 0.609 . . . . 5.9 111.467 178.95 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 550' ' ' TYR . . . . . 0.509 ' CE1' HG12 ' A' ' 583' ' ' VAL . 16.6 p90 -111.19 161.88 15.52 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 114.92 -1.036 . . . . 2.79 110.072 -174.929 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 551' ' ' VAL . . . . . . . . . . . . . 84.9 t -118.08 133.28 65.38 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 N-CA-C 109.181 -0.674 . . . . 1.52 109.181 177.762 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 552' ' ' VAL . . . . . . . . . . . . . 59.1 t -63.92 134.66 28.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.725 -0.67 . . . . 1.38 109.815 -179.731 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 553' ' ' VAL . . . . . 0.603 HG22 ' CD1' ' A' ' 584' ' ' TRP . 86.3 t -60.07 121.01 55.78 Favored Pre-proline 0 N--CA 1.454 -0.233 0 O-C-N 123.618 0.574 . . . . 1.38 111.108 -176.936 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 554' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 553' ' ' VAL . 16.6 Cg_exo . . . . . 0 N--CA 1.461 -0.431 0 C-N-CA 123.167 2.578 . . . . 1.98 112.561 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 560' ' ' MET . . . . . . . . . . . . . 67.0 mtm . . . . . 0 C--O 1.235 0.294 0 N-CA-C 111.703 0.261 . . . . 2.61 111.703 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 561' ' ' ALA . . . . . . . . . . . . . . . -145.39 157.96 43.93 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.364 -0.38 . . . . 0.95 110.54 178.387 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 35.0 p90 -153.33 158.39 41.48 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.736 -0.468 . . . . 0.9 109.736 174.977 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 563' ' ' LYS . . . . . . . . . . . . . 5.2 tppp? -89.43 127.32 35.82 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 110.191 -0.3 . . . . 2.18 110.191 179.215 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 564' ' ' CYS . . . . . 0.678 ' O ' ' HA ' ' A' ' 568' ' ' LYS . 47.7 t -71.02 114.44 27.23 Favored Pre-proline 0 C--O 1.222 -0.355 0 N-CA-C 109.48 -0.563 . . . . 0.41 109.48 175.493 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 565' ' ' PRO . . . . . 0.489 ' HD3' ' HA ' ' A' ' 564' ' ' CYS . 13.7 Cg_exo -72.21 -18.8 26.6 Favored 'Trans proline' 0 CA--C 1.528 0.208 0 C-N-CA 122.978 2.452 . . . . 0.63 113.887 -174.424 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 566' ' ' ILE . . . . . 0.483 HD12 ' HB3' ' A' ' 599' ' ' CYS . 65.9 mt -91.85 -55.14 6.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 112.191 0.441 . . . . 0.94 112.191 -172.019 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 567' ' ' CYS . . . . . 0.454 ' SG ' ' OE2' ' A' ' 569' ' ' GLU . 29.5 p -106.68 -6.35 17.94 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.251 -0.579 . . . . 0.7 111.043 178.584 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 568' ' ' LYS . . . . . 0.678 ' HA ' ' O ' ' A' ' 564' ' ' CYS . 99.4 mttt 70.98 32.92 2.22 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 114.64 1.348 . . . . 2.71 114.64 165.569 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 569' ' ' GLU . . . . . 0.454 ' OE2' ' SG ' ' A' ' 567' ' ' CYS . 0.0 OUTLIER -96.44 136.19 37.28 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 108.806 -0.813 . . . . 3.34 108.806 168.098 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 570' ' ' THR . . . . . . . . . . . . . 57.3 m -68.41 118.24 11.22 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.203 -0.453 . . . . 1.01 110.182 -179.7 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 571' ' ' VAL . . . . . 0.509 HG22 ' CE1' ' A' ' 596' ' ' HIS . 21.6 t -89.7 116.55 31.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 116.15 -0.477 . . . . 0.73 110.935 -175.66 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 29.2 p -115.18 161.37 18.52 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 109.011 -0.737 . . . . 1.89 109.011 173.987 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . -128.27 154.41 19.92 Favored Glycine 0 N--CA 1.437 -1.285 0 C-N-CA 119.468 -1.349 . . . . 2.2 111.089 -179.494 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 574' ' ' VAL . . . . . 0.412 ' O ' HG22 ' A' ' 583' ' ' VAL . 49.0 t -115.47 142.46 28.49 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-O 120.922 0.391 . . . . 3.24 110.308 -171.557 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 575' ' ' TYR . . . . . . . . . . . . . 45.3 t80 -79.96 118.93 22.15 Favored 'General case' 0 N--CA 1.443 -0.787 0 N-CA-C 109.568 -0.53 . . . . 3.02 109.568 175.688 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 576' ' ' ASP . . . . . . . . . . . . . 27.9 t0 -90.92 109.11 20.33 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.192 -0.669 . . . . 3.34 109.192 178.018 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 577' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -70.57 -23.9 62.68 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 115.008 -0.996 . . . . 5.59 111.309 -175.693 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 578' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -77.09 -34.2 56.91 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.149 -0.478 . . . . 5.11 111.056 -175.709 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 579' ' ' SER . . . . . . . . . . . . . 77.5 p -98.77 -20.66 16.78 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.351 0.595 . . . . 3.28 110.553 176.207 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 580' ' ' GLY . . . . . . . . . . . . . . . 80.43 28.04 49.54 Favored Glycine 0 N--CA 1.448 -0.506 0 CA-C-N 115.497 -0.774 . . . . 2.6 113.46 177.225 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 581' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -140.91 161.2 38.39 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 117.195 0.498 . . . . 3.19 111.48 178.15 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 582' ' ' TRP . . . . . . . . . . . . . 81.6 m95 -84.93 134.28 34.26 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.743 -0.466 . . . . 2.3 109.743 176.508 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 583' ' ' VAL . . . . . 0.509 HG12 ' CE1' ' A' ' 550' ' ' TYR . 15.6 m -115.84 136.63 52.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 N-CA-C 112.61 0.596 . . . . 1.11 112.61 -172.415 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 584' ' ' TRP . . . . . 0.603 ' CD1' HG22 ' A' ' 553' ' ' VAL . 18.9 m0 -113.59 104.42 12.23 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.478 -0.783 . . . . 2.29 108.982 165.758 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 585' ' ' LYS . . . . . 0.503 ' HG2' ' OD1' ' A' ' 586' ' ' ASN . 0.0 OUTLIER -88.77 151.25 22.51 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.639 0.257 . . . . 3.95 111.262 -175.137 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 586' ' ' ASN . . . . . 0.578 ' O ' ' HA ' ' A' ' 596' ' ' HIS . 8.0 m120 53.51 43.0 31.85 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 123.196 0.598 . . . . 1.43 110.019 -174.121 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 587' ' ' THR . . . . . . . . . . . . . 53.2 m -128.91 140.46 51.66 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.021 0.439 . . . . 0.65 111.425 -173.377 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 588' ' ' ILE . . . . . . . . . . . . . 14.8 tt -142.4 150.27 18.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.855 -0.611 . . . . 0.71 109.682 178.056 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 589' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -104.4 119.65 39.44 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.47 -0.567 . . . . 1.35 109.47 176.353 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 590' ' ' VAL . . . . . . . . . . . . . 58.5 t -125.37 117.41 49.6 Favored 'Isoleucine or valine' 0 C--O 1.239 0.552 0 CA-C-N 115.831 -0.622 . . . . 0.65 110.374 178.898 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 591' ' ' ASN . . . . . . . . . . . . . 95.0 m-20 57.36 45.8 19.4 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.379 -0.828 . . . . 2.03 112.172 176.538 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . 82.06 7.4 87.89 Favored Glycine 0 N--CA 1.45 -0.429 0 CA-C-N 115.927 -0.579 . . . . 0.62 112.329 173.318 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 593' ' ' LYS . . . . . 0.413 ' NZ ' ' HB2' ' A' ' 593' ' ' LYS . 8.1 mtmp? -129.97 137.86 50.54 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.823 0.344 . . . . 2.78 111.182 -177.557 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 594' ' ' TYR . . . . . . . . . . . . . 79.2 m-85 -94.21 132.38 38.83 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.016 -0.538 . . . . 1.45 110.567 179.514 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 595' ' ' PHE . . . . . . . . . . . . . 71.8 m-85 -138.41 159.35 42.28 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.013 -0.736 . . . . 1.32 109.013 177.053 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 596' ' ' HIS . . . . . 0.667 ' HB2' ' SG ' ' A' ' 599' ' ' CYS . 24.4 m170 -63.52 129.44 40.19 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 107.599 -1.26 . . . . 0.59 107.599 165.957 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 597' ' ' SER . . . . . . . . . . . . . 2.9 m -58.7 -32.41 69.14 Favored 'General case' 0 CA--C 1.519 -0.214 0 CA-C-O 121.577 0.703 . . . . 1.13 109.783 178.909 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 598' ' ' THR . . . . . . . . . . . . . 81.8 m -59.46 -39.9 85.14 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 114.573 -1.194 . . . . 1.4 110.534 173.606 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 599' ' ' CYS . . . . . 0.672 ' HA ' ' HG2' ' A' ' 602' ' ' GLU . 83.6 m -74.82 -34.99 62.45 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.969 -0.56 . . . . 0.81 112.329 -179.258 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 600' ' ' TYR . . . . . . . . . . . . . 79.6 t80 -61.01 -35.57 77.19 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 109.161 -0.681 . . . . 1.88 109.161 -179.142 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 601' ' ' HIS . . . . . . . . . . . . . 27.8 t60 -68.09 -42.99 79.52 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 115.581 -0.736 . . . . 4.52 110.288 177.628 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 602' ' ' GLU . . . . . 0.672 ' HG2' ' HA ' ' A' ' 599' ' ' CYS . 13.8 pt-20 -70.91 -33.74 70.84 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 111.863 0.32 . . . . 3.85 111.863 -176.447 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 603' ' ' THR . . . . . 0.468 ' HB ' HD13 ' A' ' 566' ' ' ILE . 15.3 t . . . . . 0 C--N 1.326 -0.434 0 O-C-N 122.167 -0.333 . . . . 3.3 111.243 -179.028 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.289 0 N-CA-C 113.593 0.197 . . . . 3.2 113.593 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 549' ' ' LYS . . . . . . . . . . . . . 29.6 mtpt -81.01 138.89 36.02 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.107 0.48 . . . . 5.9 110.473 177.447 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 550' ' ' TYR . . . . . 0.555 ' CE1' HG12 ' A' ' 583' ' ' VAL . 16.4 p90 -111.46 161.72 15.84 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.167 -0.924 . . . . 2.79 109.279 178.535 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 551' ' ' VAL . . . . . 0.515 HG11 ' HE1' ' A' ' 594' ' ' TYR . 57.4 t -116.47 133.52 62.79 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.992 0 N-CA-C 109.19 -0.67 . . . . 1.52 109.19 177.887 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 552' ' ' VAL . . . . . . . . . . . . . 48.3 t -67.89 130.72 33.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.912 -0.585 . . . . 1.38 110.361 -177.545 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 553' ' ' VAL . . . . . 0.637 HG22 ' CD1' ' A' ' 584' ' ' TRP . 64.1 t -59.2 122.61 64.72 Favored Pre-proline 0 C--N 1.328 -0.34 0 O-C-N 123.902 0.751 . . . . 1.38 111.048 -177.545 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 554' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_exo . . . . . 0 N--CA 1.461 -0.391 0 C-N-CA 122.706 2.271 . . . . 1.98 111.442 176.709 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 560' ' ' MET . . . . . . . . . . . . . 57.4 mtt . . . . . 0 N--CA 1.469 0.503 0 CA-C-O 121.585 0.707 . . . . 2.61 110.259 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 561' ' ' ALA . . . . . . . . . . . . . . . -144.21 161.18 39.54 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.048 -0.978 . . . . 0.95 110.517 -174.993 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 30.8 p90 -136.59 164.31 28.5 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 108.02 -1.104 . . . . 0.9 108.02 171.373 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 563' ' ' LYS . . . . . . . . . . . . . 29.2 ttpt -112.17 122.0 46.51 Favored 'General case' 0 C--N 1.32 -0.704 0 C-N-CA 120.399 -0.52 . . . . 2.18 110.675 -177.542 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 564' ' ' CYS . . . . . 0.424 ' HA ' ' HD3' ' A' ' 565' ' ' PRO . 44.2 t -74.39 111.91 14.91 Favored Pre-proline 0 N--CA 1.453 -0.322 0 CA-C-N 115.48 -0.782 . . . . 0.41 109.624 -178.49 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 565' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 564' ' ' CYS . 15.2 Cg_exo -72.34 -21.66 22.79 Favored 'Trans proline' 0 CA--C 1.528 0.202 0 C-N-CA 123.128 2.552 . . . . 0.63 113.843 -174.206 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 566' ' ' ILE . . . . . . . . . . . . . 18.4 mt -71.9 -39.19 66.93 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 CA-C-O 121.059 0.457 . . . . 0.94 110.476 -173.974 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 567' ' ' CYS . . . . . 0.594 ' SG ' ' HG3' ' A' ' 569' ' ' GLU . 27.4 p -129.81 2.53 4.9 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.873 -0.603 . . . . 0.7 112.534 -174.5 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 568' ' ' LYS . . . . . . . . . . . . . 52.5 mtpt 71.16 30.81 2.58 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 113.425 0.898 . . . . 2.71 113.425 175.047 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 569' ' ' GLU . . . . . 0.594 ' HG3' ' SG ' ' A' ' 567' ' ' CYS . 46.2 mt-10 -85.59 132.84 34.1 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 120.515 -0.474 . . . . 3.34 110.277 176.486 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 570' ' ' THR . . . . . . . . . . . . . 49.2 m -84.42 116.12 22.9 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 108.317 -0.994 . . . . 1.01 108.317 166.875 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 571' ' ' VAL . . . . . . . . . . . . . 12.7 t -98.08 116.29 40.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 115.947 -0.57 . . . . 0.73 110.856 -171.398 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 27.5 p -104.26 160.71 14.65 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.594 -0.73 . . . . 1.89 109.474 178.86 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . -128.66 157.18 21.36 Favored Glycine 0 N--CA 1.439 -1.114 0 C-N-CA 119.896 -1.145 . . . . 2.2 111.912 -176.546 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 574' ' ' VAL . . . . . . . . . . . . . 60.3 t -111.66 145.86 17.3 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-O 121.004 0.43 . . . . 3.24 110.231 -172.825 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 575' ' ' TYR . . . . . . . . . . . . . 45.3 t80 -78.52 118.49 20.7 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 108.917 -0.772 . . . . 3.02 108.917 174.771 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 576' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -91.66 102.76 15.39 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 109.154 -0.684 . . . . 3.34 109.154 -179.113 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 577' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -68.56 -23.0 64.45 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.276 -0.42 . . . . 5.59 111.635 -176.147 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 578' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -65.74 -43.98 87.35 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.409 -0.36 . . . . 5.11 110.603 -178.739 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 579' ' ' SER . . . . . . . . . . . . . 72.0 p -95.9 -20.61 18.64 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.109 0.48 . . . . 3.28 111.504 176.8 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 580' ' ' GLY . . . . . . . . . . . . . . . 80.71 21.38 63.93 Favored Glycine 0 N--CA 1.452 -0.244 0 CA-C-N 116.01 -0.541 . . . . 2.6 112.886 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 581' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -133.09 157.56 44.98 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.728 0.299 . . . . 3.19 110.597 179.676 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 582' ' ' TRP . . . . . 0.478 ' HB2' ' HB ' ' A' ' 553' ' ' VAL . 76.3 m95 -79.85 137.11 36.85 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.478 -0.328 . . . . 2.3 110.194 178.151 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 583' ' ' VAL . . . . . 0.555 HG12 ' CE1' ' A' ' 550' ' ' TYR . 20.5 m -118.81 141.48 38.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 113.251 0.834 . . . . 1.11 113.251 -173.409 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 584' ' ' TRP . . . . . 0.637 ' CD1' HG22 ' A' ' 553' ' ' VAL . 28.1 m0 -113.43 104.56 12.41 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 114.997 -1.001 . . . . 2.29 108.621 164.225 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 585' ' ' LYS . . . . . 0.497 ' HD2' ' CB ' ' A' ' 550' ' ' TYR . 10.9 mmmm -89.17 152.35 21.66 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.696 0.284 . . . . 3.95 110.491 -176.337 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 586' ' ' ASN . . . . . 0.414 ' O ' ' HA ' ' A' ' 596' ' ' HIS . 1.1 m-20 55.24 42.77 30.15 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 115.911 -0.586 . . . . 1.43 109.648 -173.601 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 587' ' ' THR . . . . . . . . . . . . . 53.3 m -126.33 140.23 52.68 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.114 0.483 . . . . 0.65 110.878 -175.491 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 588' ' ' ILE . . . . . . . . . . . . . 14.3 tt -137.25 145.3 29.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.832 -0.622 . . . . 0.71 109.644 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 589' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -103.17 121.14 42.04 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.064 0.459 . . . . 1.35 109.999 178.636 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 590' ' ' VAL . . . . . . . . . . . . . 43.5 t -131.6 127.65 59.6 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 115.594 -0.73 . . . . 0.65 109.662 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 591' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 59.63 33.26 21.93 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 121.947 0.88 . . . . 2.03 110.451 179.297 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . 77.78 9.82 86.64 Favored Glycine 0 N--CA 1.449 -0.436 0 CA-C-N 115.64 -0.709 . . . . 0.62 112.327 179.316 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 593' ' ' LYS . . . . . . . . . . . . . 70.1 mmtt -123.35 144.57 49.37 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 110.185 -0.302 . . . . 2.78 110.185 -175.676 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 594' ' ' TYR . . . . . 0.515 ' HE1' HG11 ' A' ' 551' ' ' VAL . 99.1 m-85 -96.28 134.27 39.6 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.878 0.37 . . . . 1.45 111.162 -177.2 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 595' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -139.18 162.66 34.42 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.681 -0.69 . . . . 1.32 109.631 178.258 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 596' ' ' HIS . . . . . 0.428 ' HB2' ' HB2' ' A' ' 599' ' ' CYS . 24.6 m170 -68.17 128.78 37.8 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 108.951 -0.759 . . . . 0.59 108.951 169.4 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 597' ' ' SER . . . . . . . . . . . . . 4.6 m -63.26 -36.42 83.61 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-O 121.467 0.651 . . . . 1.13 109.474 178.519 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 598' ' ' THR . . . . . . . . . . . . . 96.3 m -63.69 -44.76 92.74 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 114.704 -1.134 . . . . 1.4 111.188 177.225 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 599' ' ' CYS . . . . . 0.663 ' O ' ' HG2' ' A' ' 602' ' ' GLU . 83.3 m -76.45 -31.98 58.16 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.564 0.579 . . . . 0.81 112.564 -176.157 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 600' ' ' TYR . . . . . . . . . . . . . 87.5 t80 -57.03 -36.45 70.48 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.647 0.61 . . . . 1.88 112.647 -169.219 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 601' ' ' HIS . . . . . . . . . . . . . 18.5 m170 -64.17 -26.71 68.65 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 112.801 0.667 . . . . 4.52 112.801 -174.4 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 602' ' ' GLU . . . . . 0.663 ' HG2' ' O ' ' A' ' 599' ' ' CYS . 11.9 pt-20 -70.12 -23.48 63.03 Favored 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 120.313 -0.555 . . . . 3.85 111.077 -178.445 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 603' ' ' THR . . . . . . . . . . . . . 85.0 m . . . . . 0 C--N 1.328 -0.338 0 CA-C-O 121.31 0.576 . . . . 3.3 109.774 177.347 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.447 0 N-CA-C 112.504 -0.239 . . . . 3.2 112.504 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 549' ' ' LYS . . . . . 0.444 ' HD3' ' HA ' ' A' ' 549' ' ' LYS . 31.0 mmtp -76.13 150.86 37.14 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.615 0.721 . . . . 5.9 111.429 179.014 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 550' ' ' TYR . . . . . 0.591 ' CE1' HG12 ' A' ' 583' ' ' VAL . 46.9 p90 -114.81 162.97 16.17 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 114.594 -1.185 . . . . 2.79 110.761 -170.375 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 551' ' ' VAL . . . . . . . . . . . . . 60.5 t -117.03 134.01 61.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 N-CA-C 108.681 -0.859 . . . . 1.52 108.681 175.228 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 552' ' ' VAL . . . . . 0.595 ' HA ' ' O ' ' A' ' 582' ' ' TRP . 60.4 t -62.57 135.36 27.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.094 -0.503 . . . . 1.38 110.508 -176.622 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 553' ' ' VAL . . . . . 0.56 HG22 ' CD1' ' A' ' 584' ' ' TRP . 92.4 t -59.34 120.62 49.74 Favored Pre-proline 0 N--CA 1.455 -0.194 0 CA-C-N 116.034 -0.53 . . . . 1.38 110.464 -178.405 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 554' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 553' ' ' VAL . 33.5 Cg_exo . . . . . 0 C--O 1.232 0.21 0 C-N-CA 123.653 2.902 . . . . 1.98 113.043 -178.526 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 560' ' ' MET . . . . . . . . . . . . . 1.9 mpt? . . . . . 0 N--CA 1.467 0.421 0 N-CA-C 112.059 0.392 . . . . 2.61 112.059 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 561' ' ' ALA . . . . . 0.493 ' HA ' ' O ' ' A' ' 571' ' ' VAL . . . -144.64 154.71 43.09 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.918 0.39 . . . . 0.95 111.486 -177.634 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 34.5 p90 -141.58 159.83 41.41 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 108.884 -0.784 . . . . 0.9 108.884 170.467 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 563' ' ' LYS . . . . . . . . . . . . . 23.3 tptm -99.87 122.52 42.94 Favored 'General case' 0 C--N 1.32 -0.713 0 C-N-CA 120.98 -0.288 . . . . 2.18 110.702 -176.066 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 564' ' ' CYS . . . . . 0.515 ' HB3' ' HG2' ' A' ' 569' ' ' GLU . 49.5 t -77.38 114.72 43.07 Favored Pre-proline 0 C--N 1.326 -0.425 0 N-CA-C 109.912 -0.403 . . . . 0.41 109.912 178.102 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 565' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 564' ' ' CYS . 13.4 Cg_exo -69.42 -28.85 26.37 Favored 'Trans proline' 0 C--N 1.343 0.263 0 C-N-CA 122.998 2.465 . . . . 0.63 113.539 -173.053 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 566' ' ' ILE . . . . . . . . . . . . . 51.9 mt -72.01 -55.62 12.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 121.005 0.431 . . . . 0.94 111.577 -175.537 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 567' ' ' CYS . . . . . 0.494 ' SG ' ' OE2' ' A' ' 569' ' ' GLU . 26.7 p -107.47 2.3 24.11 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 112.262 0.467 . . . . 0.7 112.262 -174.186 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 568' ' ' LYS . . . . . . . . . . . . . 44.8 mmtm 67.34 28.7 7.81 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 115.921 -0.581 . . . . 2.71 112.186 171.117 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 569' ' ' GLU . . . . . 0.515 ' HG2' ' HB3' ' A' ' 564' ' ' CYS . 17.4 pt-20 -99.5 135.51 40.8 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.705 -0.398 . . . . 3.34 110.35 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 570' ' ' THR . . . . . . . . . . . . . 88.5 m -80.66 119.1 22.85 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.649 -0.5 . . . . 1.01 109.649 174.154 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 571' ' ' VAL . . . . . 0.493 ' O ' ' HA ' ' A' ' 561' ' ' ALA . 11.7 t -92.27 116.72 34.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 116.179 -0.464 . . . . 0.73 111.039 -174.861 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 27.8 p -107.67 159.07 16.75 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 116.1 -0.5 . . . . 1.89 109.889 176.703 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . -130.79 155.78 21.37 Favored Glycine 0 N--CA 1.442 -0.939 0 C-N-CA 119.868 -1.158 . . . . 2.2 111.835 179.496 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 574' ' ' VAL . . . . . . . . . . . . . 23.9 t -114.09 149.96 16.26 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 N-CA-C 109.761 -0.459 . . . . 3.24 109.761 -175.148 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 575' ' ' TYR . . . . . 0.406 ' HA ' ' HA ' ' A' ' 582' ' ' TRP . 54.1 t80 -82.02 119.18 23.67 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 108.717 -0.846 . . . . 3.02 108.717 174.335 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 576' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -90.57 106.36 18.45 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 109.12 -0.696 . . . . 3.34 109.12 -178.989 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 577' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -69.36 -21.8 63.78 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.956 -0.565 . . . . 5.59 111.965 -176.854 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 578' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -67.6 -44.76 77.32 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.974 0.416 . . . . 5.11 110.527 -177.69 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 579' ' ' SER . . . . . . . . . . . . . 70.1 p -96.29 -23.67 16.56 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.281 0.562 . . . . 3.28 111.119 176.202 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 580' ' ' GLY . . . . . . . . . . . . . . . 81.81 31.48 32.48 Favored Glycine 0 CA--C 1.522 0.477 0 CA-C-N 115.497 -0.774 . . . . 2.6 113.018 -178.782 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 581' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -138.15 152.52 48.77 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 116.855 0.327 . . . . 3.19 110.675 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 582' ' ' TRP . . . . . 0.595 ' O ' ' HA ' ' A' ' 552' ' ' VAL . 80.5 m95 -76.8 136.69 38.97 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 109.639 -0.504 . . . . 2.3 109.639 176.411 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 583' ' ' VAL . . . . . 0.591 HG12 ' CE1' ' A' ' 550' ' ' TYR . 19.1 m -116.0 131.55 68.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 N-CA-C 113.502 0.927 . . . . 1.11 113.502 -173.118 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 584' ' ' TRP . . . . . 0.56 ' CD1' HG22 ' A' ' 553' ' ' VAL . 17.8 m0 -114.49 103.0 10.6 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 108.497 -0.927 . . . . 2.29 108.497 162.835 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 585' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.98 151.21 22.95 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.066 0.46 . . . . 3.95 111.991 -173.426 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 586' ' ' ASN . . . . . . . . . . . . . 18.9 m-20 52.68 41.7 31.46 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 115.23 -0.896 . . . . 1.43 110.192 -174.474 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 587' ' ' THR . . . . . . . . . . . . . 32.5 m -120.34 141.0 50.46 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.015 -0.539 . . . . 0.65 110.789 -177.132 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 588' ' ' ILE . . . . . . . . . . . . . 11.7 tt -137.98 141.54 38.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 N-CA-C 109.671 -0.492 . . . . 0.71 109.671 179.767 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 589' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -97.23 120.87 38.38 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.306 -0.628 . . . . 1.35 109.306 177.812 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 590' ' ' VAL . . . . . . . . . . . . . 61.9 t -127.17 118.2 49.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.634 -0.712 . . . . 0.65 110.549 179.653 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 591' ' ' ASN . . . . . . . . . . . . . 62.8 t30 58.62 38.91 25.11 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 115.459 -0.791 . . . . 2.03 111.617 176.112 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . 86.08 5.49 83.12 Favored Glycine 0 N--CA 1.45 -0.421 0 CA-C-N 115.86 -0.609 . . . . 0.62 113.17 175.344 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 593' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -128.74 139.75 52.06 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.917 0.389 . . . . 2.78 111.151 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 594' ' ' TYR . . . . . . . . . . . . . 85.1 m-85 -91.26 129.82 37.2 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.966 -0.561 . . . . 1.45 110.478 -179.218 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 595' ' ' PHE . . . . . . . . . . . . . 63.8 m-85 -135.0 162.9 31.13 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.896 -0.593 . . . . 1.32 109.682 177.235 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 596' ' ' HIS . . . . . 0.499 ' HB2' ' SG ' ' A' ' 599' ' ' CYS . 30.5 m170 -70.68 129.36 38.93 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.68 -0.489 . . . . 0.59 109.68 172.436 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 597' ' ' SER . . . . . . . . . . . . . 23.0 t -65.47 -30.47 71.25 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.783 -0.644 . . . . 1.13 109.598 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 598' ' ' THR . . . . . . . . . . . . . 1.8 m -66.52 -42.42 87.32 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 115.464 -0.789 . . . . 1.4 110.333 175.063 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 599' ' ' CYS . . . . . 0.499 ' SG ' ' HB2' ' A' ' 596' ' ' HIS . 78.6 m -73.83 -27.45 61.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.069 -0.969 . . . . 0.81 111.906 -178.778 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 600' ' ' TYR . . . . . . . . . . . . . 79.7 t80 -56.0 -35.29 66.64 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.696 0.284 . . . . 1.88 110.98 -174.894 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 601' ' ' HIS . . . . . . . . . . . . . 31.2 m170 -62.74 -28.13 69.75 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.006 0.432 . . . . 4.52 111.01 178.823 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 602' ' ' GLU . . . . . 0.413 ' HB3' ' O ' ' A' ' 599' ' ' CYS . 8.7 tp10 -70.81 -38.37 73.3 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.018 -0.537 . . . . 3.85 110.924 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 603' ' ' THR . . . . . . . . . . . . . 10.3 t . . . . . 0 C--N 1.327 -0.392 0 CA-C-O 121.203 0.525 . . . . 3.3 110.599 -176.594 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.509 -0.321 0 CA-C-O 120.915 0.175 . . . . 3.2 113.064 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 549' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -80.18 132.72 35.95 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.135 0.493 . . . . 5.9 110.559 179.392 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 550' ' ' TYR . . . . . 0.471 ' HB3' ' HD2' ' A' ' 585' ' ' LYS . 39.0 p90 -111.18 160.56 16.82 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.58 -0.737 . . . . 2.79 109.29 174.941 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 551' ' ' VAL . . . . . . . . . . . . . 70.2 t -117.72 133.36 64.75 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 N-CA-C 108.708 -0.849 . . . . 1.52 108.708 178.137 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 552' ' ' VAL . . . . . 0.582 ' HA ' ' O ' ' A' ' 582' ' ' TRP . 74.4 t -64.86 131.67 30.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.994 -0.548 . . . . 1.38 110.487 -178.291 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 553' ' ' VAL . . . . . 0.625 ' HB ' ' HB2' ' A' ' 582' ' ' TRP . 65.9 t -59.04 123.33 68.76 Favored Pre-proline 0 C--O 1.235 0.319 0 CA-C-N 116.073 -0.512 . . . . 1.38 110.08 178.932 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 554' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_exo . . . . . 0 CA--C 1.529 0.241 0 C-N-CA 122.967 2.445 . . . . 1.98 112.577 -177.275 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 560' ' ' MET . . . . . . . . . . . . . 41.7 mtm . . . . . 0 C--O 1.235 0.298 0 CA-C-O 120.67 0.271 . . . . 2.61 110.947 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 561' ' ' ALA . . . . . . . . . . . . . . . -142.84 145.78 33.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.098 0.475 . . . . 0.95 112.231 -173.832 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 27.0 p90 -136.17 164.7 27.44 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 107.4 -1.333 . . . . 0.9 107.4 172.427 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 563' ' ' LYS . . . . . . . . . . . . . 35.5 ttmt -105.48 133.0 50.96 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 119.589 -0.844 . . . . 2.18 111.157 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 564' ' ' CYS . . . . . 0.431 ' O ' ' HA ' ' A' ' 568' ' ' LYS . 34.6 t -71.97 114.1 26.08 Favored Pre-proline 0 C--O 1.222 -0.385 0 CA-C-N 115.085 -0.961 . . . . 0.41 109.385 178.468 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 565' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -67.02 -30.79 38.45 Favored 'Trans proline' 0 CA--C 1.53 0.285 0 C-N-CA 122.588 2.192 . . . . 0.63 113.942 -172.613 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 566' ' ' ILE . . . . . . . . . . . . . 32.8 mt -71.61 -56.27 10.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.815 0.34 . . . . 0.94 111.53 -172.47 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 567' ' ' CYS . . . . . 0.521 ' SG ' ' HG3' ' A' ' 569' ' ' GLU . 28.5 p -108.05 0.71 21.91 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.99 0.424 . . . . 0.7 111.339 -177.604 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 568' ' ' LYS . . . . . 0.431 ' HA ' ' O ' ' A' ' 564' ' ' CYS . 52.7 mttp 67.57 30.56 6.6 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 113.145 0.795 . . . . 2.71 113.145 171.389 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 569' ' ' GLU . . . . . 0.521 ' HG3' ' SG ' ' A' ' 567' ' ' CYS . 35.7 mt-10 -77.96 133.44 38.03 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.78 -0.452 . . . . 3.34 109.78 171.85 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 570' ' ' THR . . . . . . . . . . . . . 52.8 m -76.16 117.31 17.73 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 108.68 -0.859 . . . . 1.01 108.68 167.278 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 571' ' ' VAL . . . . . . . . . . . . . 23.5 t -94.77 116.93 37.32 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-N 116.59 -0.277 . . . . 0.73 110.894 -172.708 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 24.1 p -111.89 159.59 18.21 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.748 -0.66 . . . . 1.89 109.536 175.532 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . -130.82 155.1 21.05 Favored Glycine 0 N--CA 1.442 -0.938 0 C-N-CA 119.933 -1.127 . . . . 2.2 111.799 -178.129 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 574' ' ' VAL . . . . . 0.465 ' O ' HG22 ' A' ' 583' ' ' VAL . 35.4 t -113.04 149.54 15.44 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 N-CA-C 109.614 -0.513 . . . . 3.24 109.614 -176.081 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 575' ' ' TYR . . . . . 0.529 ' HA ' ' HA ' ' A' ' 582' ' ' TRP . 59.8 t80 -83.76 119.41 24.78 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.593 0.235 . . . . 3.02 110.43 177.071 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 576' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -92.01 105.67 17.86 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.199 0.523 . . . . 3.34 110.024 175.236 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 577' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -63.87 -23.94 67.55 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.39 -0.823 . . . . 5.59 111.153 -178.184 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 578' ' ' GLU . . . . . . . . . . . . . 13.4 tt0 -72.25 -46.58 55.37 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.911 -0.586 . . . . 5.11 111.216 -174.422 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 579' ' ' SER . . . . . . . . . . . . . 75.7 p -87.54 -15.97 35.98 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.965 0.412 . . . . 3.28 110.743 175.102 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 580' ' ' GLY . . . . . . . . . . . . . . . 80.04 15.24 79.32 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 121.07 -0.586 . . . . 2.6 112.697 177.379 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 581' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -135.09 154.53 51.64 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.023 0.439 . . . . 3.19 110.596 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 582' ' ' TRP . . . . . 0.625 ' HB2' ' HB ' ' A' ' 553' ' ' VAL . 77.3 m95 -71.88 148.2 46.35 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.913 -0.585 . . . . 2.3 109.96 176.673 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 583' ' ' VAL . . . . . 0.465 HG22 ' O ' ' A' ' 574' ' ' VAL . 15.8 m -121.58 133.33 68.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 112.975 0.731 . . . . 1.11 112.975 -174.881 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 584' ' ' TRP . . . . . 0.612 ' CD1' HG22 ' A' ' 553' ' ' VAL . 27.0 m0 -110.31 103.79 12.5 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 108.262 -1.014 . . . . 2.29 108.262 162.868 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 585' ' ' LYS . . . . . 0.471 ' HD2' ' HB3' ' A' ' 550' ' ' TYR . 14.4 mmmm -82.08 152.0 26.78 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.877 0.37 . . . . 3.95 111.127 -175.312 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 586' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 54.76 41.9 31.57 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 115.424 -0.807 . . . . 1.43 109.632 -176.844 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 587' ' ' THR . . . . . . . . . . . . . 49.3 m -120.91 140.52 51.71 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.19 0.519 . . . . 0.65 110.628 -175.921 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 588' ' ' ILE . . . . . . . . . . . . . 15.1 tt -139.67 143.61 30.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.606 -0.725 . . . . 0.71 109.924 -177.812 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 589' ' ' GLU . . . . . 0.413 ' HA ' ' O ' ' A' ' 593' ' ' LYS . 0.8 OUTLIER -96.22 119.56 34.92 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.351 -0.611 . . . . 1.35 109.351 175.979 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 590' ' ' VAL . . . . . . . . . . . . . 27.3 t -128.36 120.75 53.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.253 -0.885 . . . . 0.65 109.343 179.028 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 591' ' ' ASN . . . . . . . . . . . . . 16.9 m120 59.36 34.66 22.9 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 121.175 0.512 . . . . 2.03 111.21 -179.004 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . 79.56 13.91 81.93 Favored Glycine 0 N--CA 1.445 -0.748 0 C-N-CA 120.981 -0.628 . . . . 0.62 112.15 177.836 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 593' ' ' LYS . . . . . 0.413 ' O ' ' HA ' ' A' ' 589' ' ' GLU . 46.7 mmtm -123.58 139.81 53.63 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.747 0.308 . . . . 2.78 110.535 -176.849 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 594' ' ' TYR . . . . . . . . . . . . . 75.5 m-85 -90.62 122.51 33.47 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.304 -0.407 . . . . 1.45 110.466 179.089 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 595' ' ' PHE . . . . . . . . . . . . . 44.8 m-85 -133.15 163.87 28.3 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.771 -0.65 . . . . 1.32 110.058 178.588 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 596' ' ' HIS . . . . . 0.412 ' HB3' HG22 ' A' ' 598' ' ' THR . 32.1 m170 -71.55 128.06 34.59 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.742 -0.836 . . . . 0.59 108.742 170.093 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 597' ' ' SER . . . . . . . . . . . . . 8.6 m -64.15 -29.99 71.08 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.159 -0.473 . . . . 1.13 110.277 -179.732 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 598' ' ' THR . . . . . 0.412 HG22 ' HB3' ' A' ' 596' ' ' HIS . 4.7 t -67.37 -38.91 85.51 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 115.376 -0.829 . . . . 1.4 110.968 179.724 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 599' ' ' CYS . . . . . . . . . . . . . 77.3 m -77.35 -34.64 55.1 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.954 -0.566 . . . . 0.81 112.495 -175.179 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 600' ' ' TYR . . . . . 0.416 ' O ' HG22 ' A' ' 603' ' ' THR . 85.0 t80 -56.75 -33.65 66.79 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 120.898 0.38 . . . . 1.88 111.92 -170.091 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 601' ' ' HIS . . . . . . . . . . . . . 28.7 m170 -59.74 -27.21 66.3 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 112.427 0.529 . . . . 4.52 112.427 -175.314 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 602' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -70.06 -31.08 68.51 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.734 0.302 . . . . 3.85 110.794 -176.959 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 603' ' ' THR . . . . . 0.416 HG22 ' O ' ' A' ' 600' ' ' TYR . 3.2 t . . . . . 0 CA--C 1.533 0.302 0 C-N-CA 120.55 -0.46 . . . . 3.3 111.66 -174.937 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.508 -0.351 0 N-CA-C 112.127 -0.389 . . . . 3.2 112.127 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 549' ' ' LYS . . . . . 0.422 ' HA ' ' HD3' ' A' ' 549' ' ' LYS . 71.3 mmtt -71.91 132.55 44.51 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.003 0.43 . . . . 5.9 110.871 -179.521 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 550' ' ' TYR . . . . . . . . . . . . . 21.2 p90 -125.66 159.63 31.73 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.232 -0.894 . . . . 2.79 109.286 177.588 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 551' ' ' VAL . . . . . . . . . . . . . 57.5 t -118.81 132.69 67.96 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 N-CA-C 109.073 -0.714 . . . . 1.52 109.073 177.917 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 552' ' ' VAL . . . . . 0.506 ' HA ' ' O ' ' A' ' 582' ' ' TRP . 67.9 t -65.19 127.04 25.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 109.642 -0.503 . . . . 1.38 109.642 178.668 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 553' ' ' VAL . . . . . 0.666 HG22 ' CD1' ' A' ' 584' ' ' TRP . 61.8 t -59.92 120.99 55.11 Favored Pre-proline 0 C--N 1.329 -0.313 0 O-C-N 123.495 0.497 . . . . 1.38 110.834 -176.238 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 554' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_exo . . . . . 0 N--CA 1.461 -0.406 0 C-N-CA 122.785 2.323 . . . . 1.98 111.764 178.907 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 560' ' ' MET . . . . . . . . . . . . . 2.0 mpt? . . . . . 0 N--CA 1.465 0.323 0 CA-C-O 121.355 0.598 . . . . 2.61 109.935 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 561' ' ' ALA . . . . . . . . . . . . . . . -145.36 161.95 38.41 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.394 -0.821 . . . . 0.95 111.722 -171.923 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 31.0 p90 -142.82 155.03 44.73 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 107.781 -1.192 . . . . 0.9 107.781 170.117 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 563' ' ' LYS . . . . . 0.411 ' HA ' ' HA ' ' A' ' 570' ' ' THR . 78.7 tttt -99.15 120.83 40.15 Favored 'General case' 0 C--N 1.32 -0.715 0 C-N-CA 120.193 -0.603 . . . . 2.18 110.536 -176.254 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 564' ' ' CYS . . . . . . . . . . . . . 42.8 t -64.7 117.29 36.8 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 115.412 -0.813 . . . . 0.41 111.944 -174.79 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 565' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_exo -68.72 -22.01 37.93 Favored 'Trans proline' 0 CA--C 1.531 0.358 0 C-N-CA 123.128 2.552 . . . . 0.63 113.085 -179.621 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 566' ' ' ILE . . . . . 0.534 HG21 ' HB3' ' A' ' 599' ' ' CYS . 36.0 mm -74.47 -42.25 49.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 120.714 0.293 . . . . 0.94 111.569 -177.041 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 567' ' ' CYS . . . . . . . . . . . . . 28.8 p -123.56 0.9 8.86 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 111.923 0.342 . . . . 0.7 111.923 -174.172 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 568' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? 62.13 27.95 16.83 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.84 -0.618 . . . . 2.71 112.008 176.425 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 569' ' ' GLU . . . . . 0.42 ' HA ' ' OE1' ' A' ' 569' ' ' GLU . 6.3 mm-40 -107.37 137.4 45.49 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 116.298 -0.41 . . . . 3.34 110.463 177.637 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 570' ' ' THR . . . . . 0.411 ' HA ' ' HA ' ' A' ' 563' ' ' LYS . 37.4 m -69.24 123.91 22.41 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.76 -0.655 . . . . 1.01 110.396 -179.257 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 571' ' ' VAL . . . . . 0.444 HG22 ' CE1' ' A' ' 596' ' ' HIS . 18.0 t -96.62 115.41 35.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 116.376 -0.374 . . . . 0.73 110.087 -179.827 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 23.6 p -106.72 159.22 16.38 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 116.053 -0.521 . . . . 1.89 110.325 178.787 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . -130.35 155.73 21.23 Favored Glycine 0 N--CA 1.44 -1.084 0 C-N-CA 119.921 -1.133 . . . . 2.2 111.384 -178.933 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 574' ' ' VAL . . . . . 0.466 ' O ' HG22 ' A' ' 583' ' ' VAL . 41.2 t -111.85 147.2 15.88 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 N-CA-C 109.644 -0.502 . . . . 3.24 109.644 -172.503 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 575' ' ' TYR . . . . . 0.492 ' HA ' ' HA ' ' A' ' 582' ' ' TRP . 48.8 t80 -82.33 121.49 26.76 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.507 -0.553 . . . . 3.02 109.507 174.668 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 576' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -89.59 108.54 19.73 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.046 -0.724 . . . . 3.34 109.046 179.45 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 577' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -69.68 -23.03 63.39 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.417 -0.81 . . . . 5.59 111.816 -172.734 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 578' ' ' GLU . . . . . . . . . . . . . 45.4 tt0 -74.87 -48.35 25.38 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 121.044 -0.262 . . . . 5.11 110.858 -178.156 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 579' ' ' SER . . . . . . . . . . . . . 74.0 p -85.64 -19.16 31.38 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.019 0.438 . . . . 3.28 111.187 179.32 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 580' ' ' GLY . . . . . . . . . . . . . . . 79.13 22.36 65.72 Favored Glycine 0 N--CA 1.448 -0.535 0 CA-C-N 115.926 -0.579 . . . . 2.6 112.818 178.554 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 581' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -135.17 152.34 51.5 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.876 0.37 . . . . 3.19 110.8 -178.394 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 582' ' ' TRP . . . . . 0.506 ' O ' ' HA ' ' A' ' 552' ' ' VAL . 74.5 m95 -78.8 144.78 34.76 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.742 -0.663 . . . . 2.3 110.013 177.778 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 583' ' ' VAL . . . . . 0.466 HG22 ' O ' ' A' ' 574' ' ' VAL . 26.7 m -124.14 134.3 66.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 N-CA-C 112.719 0.637 . . . . 1.11 112.719 -175.001 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 584' ' ' TRP . . . . . 0.666 ' CD1' HG22 ' A' ' 553' ' ' VAL . 27.8 m0 -109.5 101.98 10.88 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 108.799 -0.815 . . . . 2.29 108.799 162.761 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 585' ' ' LYS . . . . . 0.403 ' HD3' ' OD1' ' A' ' 586' ' ' ASN . 0.0 OUTLIER -89.62 152.68 21.26 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.644 -0.253 . . . . 3.95 110.904 -177.217 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 586' ' ' ASN . . . . . 0.403 ' OD1' ' HD3' ' A' ' 585' ' ' LYS . 10.4 m120 55.34 46.22 23.9 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 109.385 -0.598 . . . . 1.43 109.385 -170.615 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 587' ' ' THR . . . . . . . . . . . . . 28.6 m -135.69 140.68 44.63 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.012 -0.54 . . . . 0.65 110.593 -177.933 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 588' ' ' ILE . . . . . . . . . . . . . 15.0 tt -141.9 146.49 22.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.305 -0.407 . . . . 0.71 110.404 -179.423 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 589' ' ' GLU . . . . . 0.409 ' HB2' ' CE2' ' A' ' 594' ' ' TYR . 33.4 tt0 -94.54 119.84 33.84 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.829 -0.434 . . . . 1.35 109.829 174.722 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 590' ' ' VAL . . . . . . . . . . . . . 61.3 t -125.49 121.57 60.58 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 N-CA-C 109.491 -0.559 . . . . 0.65 109.491 178.392 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 591' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 58.2 33.71 23.42 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.083 -0.508 . . . . 2.03 111.425 -179.231 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . 84.67 -1.58 88.74 Favored Glycine 0 N--CA 1.45 -0.378 0 CA-C-N 115.797 -0.638 . . . . 0.62 113.114 177.511 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 593' ' ' LYS . . . . . . . . . . . . . 70.5 mmtt -114.49 146.22 40.95 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.782 0.325 . . . . 2.78 111.254 -179.145 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 594' ' ' TYR . . . . . 0.409 ' CE2' ' HB2' ' A' ' 589' ' ' GLU . 80.4 m-85 -98.16 127.45 44.11 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.207 -0.451 . . . . 1.45 111.46 -176.198 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 595' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -135.13 162.53 32.24 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.531 -0.759 . . . . 1.32 109.704 177.865 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 596' ' ' HIS . . . . . 0.444 ' CE1' HG22 ' A' ' 571' ' ' VAL . 10.3 m170 -61.29 128.79 38.07 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.42 -0.585 . . . . 0.59 109.42 171.403 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 597' ' ' SER . . . . . . . . . . . . . 47.7 t -64.55 -29.57 70.6 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.244 -0.65 . . . . 1.13 109.244 176.981 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 598' ' ' THR . . . . . . . . . . . . . 5.2 m -67.98 -45.98 72.63 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-O 121.64 0.734 . . . . 1.4 110.233 175.992 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 599' ' ' CYS . . . . . 0.534 ' HB3' HG21 ' A' ' 566' ' ' ILE . 74.6 m -74.67 -30.67 61.67 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.376 -0.829 . . . . 0.81 112.566 -174.618 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 600' ' ' TYR . . . . . 0.447 ' O ' HG22 ' A' ' 603' ' ' THR . 85.0 t80 -57.47 -36.08 71.0 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.045 0.45 . . . . 1.88 110.762 -174.644 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 601' ' ' HIS . . . . . . . . . . . . . 41.2 m170 -66.59 -28.47 68.53 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.213 -0.449 . . . . 4.52 111.546 179.447 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 602' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -63.56 -32.75 74.31 Favored 'General case' 0 CA--C 1.52 -0.192 0 CA-C-O 120.686 0.279 . . . . 3.85 110.315 -175.884 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 603' ' ' THR . . . . . 0.447 HG22 ' O ' ' A' ' 600' ' ' TYR . 13.0 t . . . . . 0 N--CA 1.45 -0.473 0 CA-C-O 121.065 0.459 . . . . 3.3 110.713 -178.028 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.326 0 N-CA-C 112.546 -0.222 . . . . 3.2 112.546 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 549' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -67.46 149.51 50.12 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.368 0.604 . . . . 5.9 110.67 177.04 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 550' ' ' TYR . . . . . 0.599 ' HB3' ' HD3' ' A' ' 585' ' ' LYS . 9.5 p90 -124.29 160.29 28.35 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.331 -0.849 . . . . 2.79 110.947 -173.403 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 551' ' ' VAL . . . . . . . . . . . . . 96.9 t -118.95 133.19 66.61 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 N-CA-C 108.704 -0.85 . . . . 1.52 108.704 172.726 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 552' ' ' VAL . . . . . 0.544 ' HA ' ' O ' ' A' ' 582' ' ' TRP . 47.4 t -65.34 131.74 31.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 116.238 -0.437 . . . . 1.38 110.112 -178.995 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 553' ' ' VAL . . . . . 0.683 HG22 ' CD1' ' A' ' 584' ' ' TRP . 26.3 t -63.56 120.99 67.62 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.249 -0.432 . . . . 1.38 109.967 -179.677 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 554' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 553' ' ' VAL . 44.5 Cg_exo . . . . . 0 C--O 1.231 0.171 0 C-N-CA 122.959 2.44 . . . . 1.98 113.025 -177.323 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 560' ' ' MET . . . . . . . . . . . . . 81.5 mtp . . . . . 0 N--CA 1.466 0.341 0 CA-C-O 121.168 0.509 . . . . 2.61 110.682 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 561' ' ' ALA . . . . . . . . . . . . . . . -145.82 162.2 38.23 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.897 -0.592 . . . . 0.95 109.89 -177.771 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 35.1 p90 -138.5 145.97 41.42 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 120.437 -0.505 . . . . 0.9 110.022 173.172 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 563' ' ' LYS . . . . . . . . . . . . . 50.2 tptt -88.62 111.18 21.61 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 116.134 -0.484 . . . . 2.18 110.06 -178.575 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 564' ' ' CYS . . . . . 0.411 ' HA ' ' HD3' ' A' ' 565' ' ' PRO . 42.4 t -68.72 112.09 10.25 Favored Pre-proline 0 C--N 1.333 -0.145 0 N-CA-C 109.183 -0.673 . . . . 0.41 109.183 179.266 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 565' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 564' ' ' CYS . 15.4 Cg_exo -71.57 -17.77 29.69 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 123.042 2.494 . . . . 0.63 111.751 -175.293 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 566' ' ' ILE . . . . . 0.406 HD12 ' HB3' ' A' ' 599' ' ' CYS . 45.6 mt -80.16 -51.9 15.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.233 -0.894 . . . . 0.94 111.044 -175.687 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 567' ' ' CYS . . . . . . . . . . . . . 28.9 p -105.12 -1.7 25.21 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.363 -0.381 . . . . 0.7 111.237 -176.572 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 568' ' ' LYS . . . . . . . . . . . . . 35.6 mtmm 65.41 22.54 11.95 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 112.646 0.61 . . . . 2.71 112.646 174.48 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 569' ' ' GLU . . . . . . . . . . . . . 15.9 mm-40 -105.81 135.26 47.56 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.654 0.264 . . . . 3.34 110.479 177.064 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 570' ' ' THR . . . . . . . . . . . . . 49.2 m -75.54 126.08 30.29 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.508 -0.552 . . . . 1.01 109.508 177.059 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 571' ' ' VAL . . . . . . . . . . . . . 16.2 t -100.42 115.26 41.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 116.511 -0.313 . . . . 0.73 110.888 -175.979 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 24.6 p -105.3 161.83 13.96 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.022 -0.733 . . . . 1.89 109.022 174.991 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . -127.6 154.0 19.46 Favored Glycine 0 N--CA 1.436 -1.305 0 C-N-CA 119.134 -1.508 . . . . 2.2 111.68 -179.012 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 574' ' ' VAL . . . . . . . . . . . . . 44.5 t -111.32 145.14 17.94 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 CA-C-O 120.898 0.38 . . . . 3.24 110.059 -171.1 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 575' ' ' TYR . . . . . . . . . . . . . 38.7 t80 -76.93 118.44 19.52 Favored 'General case' 0 N--CA 1.439 -1.021 0 N-CA-C 108.956 -0.757 . . . . 3.02 108.956 174.177 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 576' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -89.72 96.95 10.92 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 108.469 -0.938 . . . . 3.34 108.469 -177.948 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 577' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -63.66 -22.73 67.06 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.53 -0.759 . . . . 5.59 111.907 -175.164 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 578' ' ' GLU . . . . . . . . . . . . . 19.0 mm-40 -66.14 -43.52 86.84 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.182 -0.463 . . . . 5.11 110.547 -179.694 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 579' ' ' SER . . . . . 0.411 ' OG ' ' HG2' ' A' ' 581' ' ' GLU . 68.3 p -100.46 -19.72 16.1 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.045 -0.525 . . . . 3.28 111.696 -179.599 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 580' ' ' GLY . . . . . . . . . . . . . . . 80.66 30.49 39.62 Favored Glycine 0 CA--C 1.524 0.6 0 CA-C-N 115.85 -0.614 . . . . 2.6 113.264 179.28 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 581' ' ' GLU . . . . . 0.411 ' HG2' ' OG ' ' A' ' 579' ' ' SER . 17.3 pt-20 -139.07 156.44 47.17 Favored 'General case' 0 C--N 1.326 -0.442 0 O-C-N 122.304 -0.527 . . . . 3.19 110.682 179.837 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 582' ' ' TRP . . . . . 0.591 ' HB3' ' HB ' ' A' ' 553' ' ' VAL . 90.2 m95 -82.04 134.26 35.34 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.512 -0.551 . . . . 2.3 109.512 176.241 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 583' ' ' VAL . . . . . . . . . . . . . 33.5 m -123.0 134.03 67.33 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 N-CA-C 113.793 1.034 . . . . 1.11 113.793 -173.666 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 584' ' ' TRP . . . . . 0.683 ' CD1' HG22 ' A' ' 553' ' ' VAL . 33.5 m0 -113.85 103.76 11.51 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 107.893 -1.151 . . . . 2.29 107.893 161.914 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 585' ' ' LYS . . . . . 0.599 ' HD3' ' HB3' ' A' ' 550' ' ' TYR . 35.3 mmtp -81.56 142.67 32.62 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.777 -0.369 . . . . 3.95 110.768 -175.84 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 586' ' ' ASN . . . . . . . . . . . . . 22.1 m-20 55.23 50.0 16.02 Favored 'General case' 0 CA--C 1.516 -0.335 0 CA-C-N 115.38 -0.827 . . . . 1.43 109.889 -178.292 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 587' ' ' THR . . . . . . . . . . . . . 41.1 m -125.03 141.41 52.14 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.907 -0.588 . . . . 0.65 109.965 -179.417 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 588' ' ' ILE . . . . . . . . . . . . . 12.9 tt -140.57 144.21 27.71 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 N-CA-C 109.841 -0.429 . . . . 0.71 109.841 -178.801 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 589' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -96.78 119.13 34.69 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 108.68 -0.859 . . . . 1.35 108.68 176.953 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 590' ' ' VAL . . . . . . . . . . . . . 56.3 t -125.1 118.83 54.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.997 -0.547 . . . . 0.65 109.989 -178.764 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 591' ' ' ASN . . . . . . . . . . . . . 12.3 m120 58.1 36.57 26.05 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.932 -0.577 . . . . 2.03 112.334 176.326 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . 86.57 6.65 80.18 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 121.194 -0.527 . . . . 0.62 113.682 175.573 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 593' ' ' LYS . . . . . . . . . . . . . 27.8 mtpp -129.1 146.39 51.06 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 117.204 0.502 . . . . 2.78 110.933 176.917 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 594' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -91.16 133.97 34.92 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.895 -0.593 . . . . 1.45 110.836 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 595' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -139.12 160.46 39.73 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.829 -0.623 . . . . 1.32 109.716 176.362 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 596' ' ' HIS . . . . . 0.75 ' HB2' ' SG ' ' A' ' 599' ' ' CYS . 37.7 m80 -67.16 130.5 43.32 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.314 -0.995 . . . . 0.59 108.314 169.229 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 597' ' ' SER . . . . . . . . . . . . . 11.4 m -60.75 -31.88 71.19 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.283 -0.417 . . . . 1.13 110.252 179.471 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 598' ' ' THR . . . . . . . . . . . . . 3.6 t -69.22 -35.23 75.97 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.397 0.618 . . . . 1.4 110.33 174.973 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 599' ' ' CYS . . . . . 0.75 ' SG ' ' HB2' ' A' ' 596' ' ' HIS . 91.2 m -73.98 -29.58 62.05 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.819 -0.628 . . . . 0.81 112.595 -176.162 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 600' ' ' TYR . . . . . . . . . . . . . 43.9 t80 -57.26 -35.0 69.2 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.125 -0.695 . . . . 1.88 109.125 -178.996 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 601' ' ' HIS . . . . . . . . . . . . . 56.9 m80 -74.7 -41.16 60.71 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.638 -0.71 . . . . 4.52 111.814 176.15 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 602' ' ' GLU . . . . . 0.699 ' HG2' ' HA ' ' A' ' 599' ' ' CYS . 22.5 pt-20 -67.81 -25.72 65.71 Favored 'General case' 0 N--CA 1.467 0.411 0 O-C-N 122.094 -0.379 . . . . 3.85 110.87 -176.65 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 603' ' ' THR . . . . . . . . . . . . . 14.1 t . . . . . 0 CA--C 1.533 0.309 0 N-CA-C 111.994 0.368 . . . . 3.3 111.994 -179.639 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.452 0 N-CA-C 111.141 -0.784 . . . . 3.2 111.141 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 549' ' ' LYS . . . . . 0.433 ' HA ' ' HD3' ' A' ' 549' ' ' LYS . 37.1 mmtm -73.18 147.39 44.81 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-O 121.673 0.749 . . . . 5.9 111.061 179.82 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 550' ' ' TYR . . . . . 0.49 ' CE1' HG12 ' A' ' 583' ' ' VAL . 29.2 p90 -124.76 162.18 24.81 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 114.764 -1.107 . . . . 2.79 109.703 -175.73 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 551' ' ' VAL . . . . . 0.432 HG11 ' HE1' ' A' ' 594' ' ' TYR . 96.3 t -117.39 133.61 63.62 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 N-CA-C 109.016 -0.735 . . . . 1.52 109.016 175.863 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 552' ' ' VAL . . . . . 0.503 ' HA ' ' O ' ' A' ' 582' ' ' TRP . 56.9 t -62.99 132.15 28.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.928 -0.578 . . . . 1.38 109.802 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 553' ' ' VAL . . . . . 0.604 HG22 ' CD1' ' A' ' 584' ' ' TRP . 65.8 t -60.79 120.67 55.35 Favored Pre-proline 0 C--N 1.33 -0.247 0 O-C-N 123.74 0.65 . . . . 1.38 111.505 -175.948 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 554' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo . . . . . 0 N--CA 1.462 -0.331 0 C-N-CA 123.194 2.596 . . . . 1.98 111.939 176.169 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 560' ' ' MET . . . . . 0.512 ' HB3' HG11 ' A' ' 553' ' ' VAL . 65.3 mtt . . . . . 0 C--O 1.236 0.366 0 CA-C-O 121.553 0.692 . . . . 2.61 110.119 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 561' ' ' ALA . . . . . . . . . . . . . . . -144.98 161.73 38.65 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 115.279 -0.873 . . . . 0.95 110.902 -175.214 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 33.8 p90 -150.06 163.7 37.47 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 107.796 -1.187 . . . . 0.9 107.796 173.69 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 563' ' ' LYS . . . . . . . . . . . . . 7.7 ttmm -106.63 126.33 52.14 Favored 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 119.44 -0.904 . . . . 2.18 109.935 179.12 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 564' ' ' CYS . . . . . 0.414 ' HA ' ' HD3' ' A' ' 565' ' ' PRO . 48.6 t -69.3 112.06 10.62 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 115.523 -0.762 . . . . 0.41 109.601 -178.5 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 565' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 564' ' ' CYS . 17.2 Cg_exo -70.67 -29.9 18.87 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 123.318 2.678 . . . . 0.63 113.686 -173.525 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 566' ' ' ILE . . . . . . . . . . . . . 26.8 mt -70.74 -34.84 58.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.308 -0.405 . . . . 0.94 111.184 -172.497 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 567' ' ' CYS . . . . . 0.502 ' SG ' ' OE2' ' A' ' 569' ' ' GLU . 28.7 p -129.07 3.61 5.27 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 112.855 0.687 . . . . 0.7 112.855 -175.257 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 568' ' ' LYS . . . . . . . . . . . . . 61.9 mmtt 71.21 30.21 2.68 Favored 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 113.028 0.751 . . . . 2.71 113.028 175.45 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 569' ' ' GLU . . . . . 0.502 ' OE2' ' SG ' ' A' ' 567' ' ' CYS . 45.2 mt-10 -90.11 131.71 35.82 Favored 'General case' 0 N--CA 1.468 0.448 0 O-C-N 121.953 -0.467 . . . . 3.34 110.662 176.794 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 570' ' ' THR . . . . . . . . . . . . . 47.2 m -75.7 117.85 17.9 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 108.917 -0.772 . . . . 1.01 108.917 164.558 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 571' ' ' VAL . . . . . 0.401 HG22 ' CE1' ' A' ' 596' ' ' HIS . 20.2 t -100.66 116.49 44.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 120.808 0.337 . . . . 0.73 111.344 -172.949 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 33.4 p -110.41 160.01 16.97 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.908 -0.587 . . . . 1.89 109.914 176.994 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . -129.8 155.03 20.74 Favored Glycine 0 N--CA 1.442 -0.929 0 C-N-CA 119.761 -1.209 . . . . 2.2 111.875 -178.977 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 574' ' ' VAL . . . . . 0.488 ' O ' HG22 ' A' ' 583' ' ' VAL . 27.6 t -120.39 148.82 23.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-O 120.757 0.313 . . . . 3.24 110.234 -172.549 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 575' ' ' TYR . . . . . . . . . . . . . 66.2 t80 -83.69 119.14 24.41 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.5 -0.318 . . . . 3.02 110.261 177.079 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 576' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -94.99 114.23 26.02 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.772 -0.455 . . . . 3.34 109.772 178.133 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 577' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -69.21 -23.41 63.89 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.122 -0.49 . . . . 5.59 112.231 -174.347 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 578' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -74.7 -41.41 60.26 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.002 0.43 . . . . 5.11 110.773 -177.276 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 579' ' ' SER . . . . . . . . . . . . . 67.7 p -86.31 -25.58 25.37 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.228 -0.442 . . . . 3.28 110.938 176.46 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 580' ' ' GLY . . . . . . . . . . . . . . . 80.28 15.98 77.29 Favored Glycine 0 N--CA 1.451 -0.348 0 CA-C-N 115.865 -0.607 . . . . 2.6 112.584 179.006 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 581' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 -130.74 161.12 32.39 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.863 0.363 . . . . 3.19 110.386 -178.492 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 582' ' ' TRP . . . . . 0.503 ' O ' ' HA ' ' A' ' 552' ' ' VAL . 76.1 m95 -83.04 134.42 35.03 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.38 -0.6 . . . . 2.3 109.38 175.108 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 583' ' ' VAL . . . . . 0.49 HG12 ' CE1' ' A' ' 550' ' ' TYR . 16.9 m -113.17 133.63 58.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 N-CA-C 113.487 0.921 . . . . 1.11 113.487 -171.753 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 584' ' ' TRP . . . . . 0.604 ' CD1' HG22 ' A' ' 553' ' ' VAL . 29.0 m0 -108.44 101.35 10.54 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.114 -1.069 . . . . 2.29 108.114 161.154 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 585' ' ' LYS . . . . . 0.5 ' HD2' ' H ' ' A' ' 585' ' ' LYS . 0.0 OUTLIER -76.4 145.66 39.23 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.415 -0.357 . . . . 3.95 111.211 -174.281 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 586' ' ' ASN . . . . . . . . . . . . . 32.3 m-20 48.85 50.3 17.78 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 115.668 -0.696 . . . . 1.43 110.37 -179.692 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 587' ' ' THR . . . . . . . . . . . . . 45.5 m -127.1 142.72 51.45 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.674 -0.694 . . . . 0.65 109.948 -178.436 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 588' ' ' ILE . . . . . . . . . . . . . 13.3 tt -139.35 147.77 24.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 109.476 -0.564 . . . . 0.71 109.476 179.601 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 589' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -103.1 121.86 43.48 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.124 0.487 . . . . 1.35 109.799 178.719 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 590' ' ' VAL . . . . . . . . . . . . . 64.8 t -134.54 130.91 53.97 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.621 0 CA-C-N 115.537 -0.756 . . . . 0.65 109.144 178.762 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 591' ' ' ASN . . . . . . . . . . . . . 64.6 t30 59.19 33.24 22.63 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 121.391 0.615 . . . . 2.03 110.77 178.731 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . 77.22 11.92 85.08 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.937 -0.649 . . . . 0.62 112.487 178.332 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 593' ' ' LYS . . . . . . . . . . . . . 34.1 mmtp -126.42 139.68 53.07 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.777 0.322 . . . . 2.78 110.533 -178.057 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 594' ' ' TYR . . . . . 0.432 ' HE1' HG11 ' A' ' 551' ' ' VAL . 95.0 m-85 -89.85 132.06 35.46 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 116.067 -0.515 . . . . 1.45 110.273 177.695 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 595' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -134.94 154.63 51.63 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 108.914 -0.773 . . . . 1.32 108.914 175.405 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 596' ' ' HIS . . . . . 0.401 ' CE1' HG22 ' A' ' 571' ' ' VAL . 26.9 m170 -62.34 128.13 34.6 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 108.446 -0.946 . . . . 0.59 108.446 169.733 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 597' ' ' SER . . . . . . . . . . . . . 31.0 t -63.3 -29.96 71.18 Favored 'General case' 0 C--N 1.322 -0.592 0 O-C-N 123.701 0.626 . . . . 1.13 109.852 -177.274 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 598' ' ' THR . . . . . . . . . . . . . 1.8 t -67.09 -41.54 86.16 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 115.715 -0.675 . . . . 1.4 110.776 175.771 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 599' ' ' CYS . . . . . 0.41 ' O ' ' HG3' ' A' ' 602' ' ' GLU . 74.2 m -75.82 -31.88 59.57 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.892 -0.595 . . . . 0.81 111.574 -177.611 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 600' ' ' TYR . . . . . . . . . . . . . 72.4 t80 -57.03 -33.1 66.86 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.038 -0.528 . . . . 1.88 112.067 -173.566 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 601' ' ' HIS . . . . . . . . . . . . . 33.7 m170 -58.46 -26.4 63.33 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 112.781 0.66 . . . . 4.52 112.781 -173.276 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 602' ' ' GLU . . . . . 0.41 ' HG3' ' O ' ' A' ' 599' ' ' CYS . 3.0 pp20? -62.1 -30.54 71.08 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-O 120.949 0.404 . . . . 3.85 110.849 -178.881 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 603' ' ' THR . . . . . . . . . . . . . 1.1 m . . . . . 0 CA--C 1.537 0.469 0 CA-C-O 120.981 0.42 . . . . 3.3 111.161 -177.138 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.519 0.328 0 N-CA-C 113.676 0.231 . . . . 3.2 113.676 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 549' ' ' LYS . . . . . . . . . . . . . 28.8 mtpp -81.1 142.24 33.5 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 117.247 0.524 . . . . 5.9 110.931 177.393 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 550' ' ' TYR . . . . . 0.447 ' CE1' HG12 ' A' ' 583' ' ' VAL . 24.9 p90 -116.35 159.97 21.17 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.066 -0.716 . . . . 2.79 109.066 176.246 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 551' ' ' VAL . . . . . 0.753 HG11 ' HE1' ' A' ' 594' ' ' TYR . 39.9 t -119.97 136.58 56.59 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 N-CA-C 109.154 -0.684 . . . . 1.52 109.154 176.735 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 552' ' ' VAL . . . . . 0.557 ' HA ' ' O ' ' A' ' 582' ' ' TRP . 62.9 t -66.33 133.63 30.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 110.449 -0.204 . . . . 1.38 110.449 -178.796 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 553' ' ' VAL . . . . . 0.635 HG22 ' CD1' ' A' ' 584' ' ' TRP . 80.7 t -61.99 120.99 62.54 Favored Pre-proline 0 C--N 1.331 -0.227 0 CA-C-N 116.228 -0.442 . . . . 1.38 111.254 -177.386 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 554' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' ' 553' ' ' VAL . 7.1 Cg_exo . . . . . 0 N--CA 1.46 -0.483 0 C-N-CA 122.871 2.381 . . . . 1.98 112.45 179.19 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 560' ' ' MET . . . . . . . . . . . . . 2.1 mpt? . . . . . 0 C--O 1.234 0.266 0 CA-C-O 121.239 0.543 . . . . 2.61 110.311 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 561' ' ' ALA . . . . . . . . . . . . . . . -144.32 151.15 38.95 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 115.622 -0.717 . . . . 0.95 110.036 -176.814 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 45.9 p90 -128.2 150.27 50.09 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 110.015 -0.365 . . . . 0.9 110.015 177.953 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 563' ' ' LYS . . . . . 0.459 ' HE3' ' O ' ' A' ' 568' ' ' LYS . 47.5 tptt -89.6 113.81 25.3 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.001 -0.74 . . . . 2.18 109.001 -178.513 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 564' ' ' CYS . . . . . . . . . . . . . 47.1 t -62.56 113.55 9.29 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 116.461 -0.336 . . . . 0.41 110.902 -175.859 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 565' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -67.65 -27.95 38.03 Favored 'Trans proline' 0 CA--C 1.53 0.284 0 C-N-CA 123.074 2.516 . . . . 0.63 112.778 -176.026 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 566' ' ' ILE . . . . . . . . . . . . . 42.8 mt -71.73 -38.15 65.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 111.969 0.359 . . . . 0.94 111.969 -174.907 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 567' ' ' CYS . . . . . . . . . . . . . 28.5 p -129.2 1.08 5.18 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.427 0.528 . . . . 0.7 112.427 -174.729 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 568' ' ' LYS . . . . . 0.459 ' O ' ' HE3' ' A' ' 563' ' ' LYS . 50.3 mtpt 66.27 30.93 8.85 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 121.055 0.455 . . . . 2.71 111.753 176.105 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 569' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -105.67 135.23 47.46 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.003 -0.544 . . . . 3.34 110.933 179.215 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 570' ' ' THR . . . . . . . . . . . . . 41.4 m -71.1 118.78 14.32 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.331 -0.395 . . . . 1.01 110.598 179.217 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 571' ' ' VAL . . . . . 0.665 HG22 ' CE1' ' A' ' 596' ' ' HIS . 16.9 t -97.25 116.22 39.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 120.722 0.296 . . . . 0.73 110.635 -178.649 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 22.7 p -108.78 157.88 18.16 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.129 -0.487 . . . . 1.89 110.599 179.381 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 573' ' ' GLY . . . . . 0.5 ' HA3' ' HD1' ' A' ' 584' ' ' TRP . . . -131.24 156.06 21.61 Favored Glycine 0 N--CA 1.44 -1.069 0 N-CA-C 111.061 -0.816 . . . . 2.2 111.061 178.265 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 574' ' ' VAL . . . . . 0.581 ' O ' HG22 ' A' ' 583' ' ' VAL . 25.6 t -116.66 147.68 19.88 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 CA-C-O 120.8 0.334 . . . . 3.24 110.111 -172.9 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 575' ' ' TYR . . . . . . . . . . . . . 59.5 t80 -78.28 120.51 23.15 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.684 -0.487 . . . . 3.02 109.684 175.268 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 576' ' ' ASP . . . . . . . . . . . . . 15.4 t0 -91.16 114.67 27.25 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.071 0.462 . . . . 3.34 110.275 -179.333 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 577' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -66.98 -23.31 65.93 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.491 -0.777 . . . . 5.59 111.144 -179.574 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 578' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -75.83 -48.51 21.27 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.444 -0.344 . . . . 5.11 111.083 -174.192 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 579' ' ' SER . . . . . . . . . . . . . 75.4 p -87.37 -24.41 24.25 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.295 0.569 . . . . 3.28 110.8 177.84 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 580' ' ' GLY . . . . . . . . . . . . . . . 80.26 23.04 61.73 Favored Glycine 0 N--CA 1.447 -0.626 0 CA-C-N 115.407 -0.815 . . . . 2.6 111.86 -177.749 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 581' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -131.16 160.02 36.0 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.882 0.372 . . . . 3.19 110.157 -179.786 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 582' ' ' TRP . . . . . 0.557 ' O ' ' HA ' ' A' ' 552' ' ' VAL . 76.5 m95 -82.09 135.43 35.31 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.846 -0.427 . . . . 2.3 109.846 176.634 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 583' ' ' VAL . . . . . 0.581 HG22 ' O ' ' A' ' 574' ' ' VAL . 20.0 m -112.86 131.6 63.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 N-CA-C 112.775 0.657 . . . . 1.11 112.775 -174.841 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 584' ' ' TRP . . . . . 0.635 ' CD1' HG22 ' A' ' 553' ' ' VAL . 15.9 m0 -105.01 102.99 12.46 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 108.943 -0.762 . . . . 2.29 108.943 164.074 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 585' ' ' LYS . . . . . 0.415 ' HD2' ' H ' ' A' ' 585' ' ' LYS . 0.0 OUTLIER -93.5 151.62 19.6 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.391 -0.822 . . . . 3.95 111.43 -175.248 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 586' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 53.27 41.15 32.15 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 115.521 -0.763 . . . . 1.43 109.026 -172.314 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 587' ' ' THR . . . . . . . . . . . . . 36.1 m -128.86 140.83 51.51 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.492 -0.776 . . . . 0.65 110.203 -175.956 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 588' ' ' ILE . . . . . 0.57 ' HB ' ' HB3' ' A' ' 597' ' ' SER . 12.5 tt -131.52 144.37 37.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 N-CA-C 109.228 -0.656 . . . . 0.71 109.228 178.047 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 589' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -106.57 120.06 40.94 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.254 0.55 . . . . 1.35 109.847 178.724 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 590' ' ' VAL . . . . . . . . . . . . . 54.9 t -128.16 120.37 53.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.262 -0.881 . . . . 0.65 109.995 -179.852 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 591' ' ' ASN . . . . . . . . . . . . . 2.3 t30 59.23 40.68 21.21 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 115.969 -0.56 . . . . 2.03 111.1 177.217 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . 78.82 10.06 86.52 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.94 -0.647 . . . . 0.62 112.4 175.844 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 593' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -126.28 144.3 50.84 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-O 121.174 0.512 . . . . 2.78 110.981 -178.964 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 594' ' ' TYR . . . . . 0.753 ' HE1' HG11 ' A' ' 551' ' ' VAL . 97.5 m-85 -101.29 135.13 43.27 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.784 -0.644 . . . . 1.45 110.725 -177.848 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 595' ' ' PHE . . . . . . . . . . . . . 59.9 m-85 -139.55 158.24 44.46 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 108.548 -0.908 . . . . 1.32 108.548 177.829 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 596' ' ' HIS . . . . . 0.665 ' CE1' HG22 ' A' ' 571' ' ' VAL . 15.4 m170 -61.18 127.03 29.52 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.341 -0.985 . . . . 0.59 108.341 168.661 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 597' ' ' SER . . . . . 0.57 ' HB3' ' HB ' ' A' ' 588' ' ' ILE . 8.7 p -66.37 -29.31 69.46 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.068 0.461 . . . . 1.13 109.879 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 598' ' ' THR . . . . . . . . . . . . . 1.1 t -69.0 -32.48 72.07 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 115.273 -0.876 . . . . 1.4 109.93 176.321 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 599' ' ' CYS . . . . . 0.462 ' SG ' ' HB2' ' A' ' 596' ' ' HIS . 84.9 m -78.82 -29.06 44.56 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 113.81 1.041 . . . . 0.81 113.81 -179.323 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 600' ' ' TYR . . . . . 0.456 ' O ' HG22 ' A' ' 603' ' ' THR . 87.3 t80 -54.64 -35.98 64.06 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 113.678 0.992 . . . . 1.88 113.678 -164.304 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 601' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -60.22 -25.15 65.41 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 112.267 0.469 . . . . 4.52 112.267 -177.415 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 602' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -61.7 -38.19 86.94 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 120.981 0.419 . . . . 3.85 111.357 179.188 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 603' ' ' THR . . . . . 0.456 HG22 ' O ' ' A' ' 600' ' ' TYR . 11.5 t . . . . . 0 C--O 1.236 0.352 0 CA-C-N 116.483 -0.326 . . . . 3.3 111.344 -177.842 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.455 0 N-CA-C 111.754 -0.538 . . . . 3.2 111.754 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 549' ' ' LYS . . . . . . . . . . . . . 9.1 mtmp? -68.91 149.78 48.49 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.896 -0.409 . . . . 5.9 109.896 177.358 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 550' ' ' TYR . . . . . 0.503 ' CE1' HG12 ' A' ' 583' ' ' VAL . 38.0 p90 -114.75 160.21 19.67 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 115.941 -0.572 . . . . 2.79 110.402 -176.087 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 551' ' ' VAL . . . . . . . . . . . . . 65.5 t -117.76 133.76 63.5 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 N-CA-C 108.493 -0.928 . . . . 1.52 108.493 175.74 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 552' ' ' VAL . . . . . 0.62 ' HA ' ' O ' ' A' ' 582' ' ' TRP . 28.3 t -61.95 134.88 27.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 116.315 -0.402 . . . . 1.38 110.08 -177.573 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 553' ' ' VAL . . . . . 0.583 HG22 ' CD1' ' A' ' 584' ' ' TRP . 89.0 t -61.6 119.19 44.96 Favored Pre-proline 0 N--CA 1.451 -0.411 0 N-CA-C 109.648 -0.501 . . . . 1.38 109.648 -179.688 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 554' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo . . . . . 0 N--CA 1.46 -0.458 0 C-N-CA 122.878 2.385 . . . . 1.98 112.779 -178.509 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 560' ' ' MET . . . . . . . . . . . . . 56.9 mtm . . . . . 0 N--CA 1.469 0.478 0 CA-C-O 120.787 0.327 . . . . 2.61 111.317 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 561' ' ' ALA . . . . . . . . . . . . . . . -145.55 156.63 43.81 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.199 -0.455 . . . . 0.95 111.485 -176.901 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 24.1 p90 -141.9 156.77 45.5 Favored 'General case' 0 C--O 1.225 -0.218 0 N-CA-C 108.131 -1.063 . . . . 0.9 108.131 172.306 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 563' ' ' LYS . . . . . 0.532 ' HA ' ' HA ' ' A' ' 570' ' ' THR . 36.5 ttmt -99.83 128.04 45.95 Favored 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 119.752 -0.779 . . . . 2.18 110.444 -178.773 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 564' ' ' CYS . . . . . 0.424 ' O ' ' HA ' ' A' ' 568' ' ' LYS . 50.0 t -72.12 118.05 63.77 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 115.834 -0.621 . . . . 0.41 110.395 179.275 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 565' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -72.13 -27.62 16.69 Favored 'Trans proline' 0 CA--C 1.531 0.372 0 C-N-CA 123.026 2.484 . . . . 0.63 114.209 -173.836 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 566' ' ' ILE . . . . . 0.548 HD12 ' HB3' ' A' ' 599' ' ' CYS . 71.2 mt -82.2 -52.36 13.67 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 N-CA-C 112.271 0.471 . . . . 0.94 112.271 -172.257 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 567' ' ' CYS . . . . . . . . . . . . . 29.5 p -104.59 0.82 29.0 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 121.063 0.459 . . . . 0.7 110.787 -179.655 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 568' ' ' LYS . . . . . 0.424 ' HA ' ' O ' ' A' ' 564' ' ' CYS . 28.3 mtpp 69.93 29.27 4.0 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 113.623 0.971 . . . . 2.71 113.623 166.091 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 569' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -101.39 132.96 46.7 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.669 -0.412 . . . . 3.34 110.18 175.903 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 570' ' ' THR . . . . . 0.532 ' HA ' ' HA ' ' A' ' 563' ' ' LYS . 55.8 m -70.82 118.4 13.55 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.517 -0.549 . . . . 1.01 109.517 173.21 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 571' ' ' VAL . . . . . . . . . . . . . 22.4 t -91.02 116.18 31.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-O 121.0 0.428 . . . . 0.73 110.539 -176.389 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 30.6 p -106.68 159.5 16.16 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.504 -0.771 . . . . 1.89 109.068 175.122 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . -129.76 154.66 20.56 Favored Glycine 0 N--CA 1.439 -1.107 0 C-N-CA 119.689 -1.243 . . . . 2.2 111.599 -178.366 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 574' ' ' VAL . . . . . 0.434 ' O ' HG22 ' A' ' 583' ' ' VAL . 22.6 t -114.25 151.9 15.98 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 N-CA-C 109.874 -0.417 . . . . 3.24 109.874 -175.061 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 575' ' ' TYR . . . . . . . . . . . . . 39.8 t80 -83.73 122.47 28.68 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 116.29 -0.413 . . . . 3.02 110.077 176.954 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 576' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -91.31 112.85 24.94 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 108.674 -0.861 . . . . 3.34 108.674 175.121 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 577' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -69.73 -35.56 75.1 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.38 -0.827 . . . . 5.59 112.524 -169.035 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 578' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -75.39 -35.51 61.04 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.881 -0.328 . . . . 5.11 111.566 -174.978 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 579' ' ' SER . . . . . . . . . . . . . 77.1 p -82.53 -24.69 33.95 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.92 0.39 . . . . 3.28 110.486 179.228 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 580' ' ' GLY . . . . . . . . . . . . . . . 80.66 20.66 65.56 Favored Glycine 0 N--CA 1.452 -0.285 0 CA-C-N 115.574 -0.739 . . . . 2.6 112.914 177.147 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 581' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -145.85 154.8 42.38 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.845 0.355 . . . . 3.19 111.072 179.545 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 582' ' ' TRP . . . . . 0.62 ' O ' ' HA ' ' A' ' 552' ' ' VAL . 64.9 m95 -77.34 150.78 35.14 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.088 -0.506 . . . . 2.3 110.509 -177.833 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 583' ' ' VAL . . . . . 0.503 HG12 ' CE1' ' A' ' 550' ' ' TYR . 21.4 m -123.9 133.04 70.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 113.564 0.95 . . . . 1.11 113.564 -173.285 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 584' ' ' TRP . . . . . 0.583 ' CD1' HG22 ' A' ' 553' ' ' VAL . 24.1 m0 -116.2 103.79 10.87 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 114.854 -1.066 . . . . 2.29 108.566 164.124 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 585' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -87.25 150.2 24.06 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 120.419 -0.513 . . . . 3.95 111.136 -175.003 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 586' ' ' ASN . . . . . . . . . . . . . 14.1 m120 54.37 41.29 32.05 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 115.545 -0.752 . . . . 1.43 110.495 -175.101 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 587' ' ' THR . . . . . . . . . . . . . 44.3 m -119.76 142.53 48.47 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.756 -0.656 . . . . 0.65 110.341 -177.925 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 588' ' ' ILE . . . . . . . . . . . . . 15.3 tt -133.75 148.19 30.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 N-CA-C 109.424 -0.584 . . . . 0.71 109.424 -179.593 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 589' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -115.33 118.75 34.13 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.519 -0.548 . . . . 1.35 109.519 177.901 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 590' ' ' VAL . . . . . . . . . . . . . 44.0 t -125.14 118.84 54.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.505 -0.77 . . . . 0.65 110.019 -177.439 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 591' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 58.2 36.99 26.19 Favored 'General case' 0 C--O 1.235 0.306 0 O-C-N 123.482 0.489 . . . . 2.03 111.864 177.777 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . 85.66 8.41 80.18 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.967 -0.635 . . . . 0.62 113.271 174.932 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 593' ' ' LYS . . . . . . . . . . . . . 60.1 mttm -125.55 139.76 53.33 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.158 0.504 . . . . 2.78 111.461 178.55 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 594' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -93.67 133.28 37.19 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.165 -0.925 . . . . 1.45 110.784 -178.385 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 595' ' ' PHE . . . . . . . . . . . . . 81.2 m-85 -139.98 160.14 40.59 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.194 -0.912 . . . . 1.32 108.896 177.262 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 596' ' ' HIS . . . . . 0.534 ' HB3' HG22 ' A' ' 598' ' ' THR . 9.3 m-70 -66.32 128.69 37.12 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 108.579 -0.897 . . . . 0.59 108.579 167.849 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 597' ' ' SER . . . . . . . . . . . . . 40.2 t -61.71 -32.48 72.7 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.8 -0.637 . . . . 1.13 109.696 -178.86 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 598' ' ' THR . . . . . 0.534 HG22 ' HB3' ' A' ' 596' ' ' HIS . 11.1 t -67.82 -35.33 78.41 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-N 115.332 -0.849 . . . . 1.4 110.091 177.637 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 599' ' ' CYS . . . . . 0.603 ' HA ' ' HB3' ' A' ' 602' ' ' GLU . 72.7 m -76.13 -31.98 58.9 Favored 'General case' 0 N--CA 1.457 -0.091 0 N-CA-C 112.228 0.455 . . . . 0.81 112.228 -179.048 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 600' ' ' TYR . . . . . . . . . . . . . 71.1 t80 -67.37 -36.26 80.99 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.009 -0.737 . . . . 1.88 109.009 -178.355 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 601' ' ' HIS . . . . . . . . . . . . . 64.5 t60 -72.48 -32.06 65.9 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.134 -0.939 . . . . 4.52 109.656 174.135 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 602' ' ' GLU . . . . . 0.603 ' HB3' ' HA ' ' A' ' 599' ' ' CYS . 0.7 OUTLIER -61.83 -37.59 85.02 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 115.463 -0.79 . . . . 3.85 111.745 177.475 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 603' ' ' THR . . . . . 0.499 ' HB ' HD13 ' A' ' 566' ' ' ILE . 14.5 t . . . . . 0 C--N 1.324 -0.542 0 N-CA-C 112.391 0.515 . . . . 3.3 112.391 -173.157 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.284 0 N-CA-C 112.998 -0.041 . . . . 3.2 112.998 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 549' ' ' LYS . . . . . . . . . . . . . 89.1 mttt -80.26 144.08 33.17 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.954 0.407 . . . . 5.9 110.342 174.825 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 550' ' ' TYR . . . . . . . . . . . . . 30.2 p90 -118.5 161.03 20.69 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 108.649 -0.871 . . . . 2.79 108.649 179.495 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 551' ' ' VAL . . . . . . . . . . . . . 62.7 t -118.24 133.18 65.87 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.971 0 N-CA-C 109.485 -0.561 . . . . 1.52 109.485 177.706 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 552' ' ' VAL . . . . . 0.457 ' HA ' ' O ' ' A' ' 582' ' ' TRP . 33.1 t -67.97 126.04 26.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-O 120.666 0.27 . . . . 1.38 110.549 -177.61 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 553' ' ' VAL . . . . . 0.654 HG22 ' CD1' ' A' ' 584' ' ' TRP . 47.3 t -61.91 126.37 87.1 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 115.828 -0.624 . . . . 1.38 111.415 -176.145 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 554' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' ' 553' ' ' VAL . 16.5 Cg_exo . . . . . 0 C--O 1.233 0.27 0 C-N-CA 123.0 2.467 . . . . 1.98 111.464 175.941 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 560' ' ' MET . . . . . . . . . . . . . 4.5 mpp? . . . . . 0 N--CA 1.467 0.404 0 N-CA-C 111.935 0.346 . . . . 2.61 111.935 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 561' ' ' ALA . . . . . . . . . . . . . . . -144.29 145.75 32.2 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.314 -0.403 . . . . 0.95 110.08 178.883 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 44.5 p90 -137.42 155.32 49.49 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.315 -0.402 . . . . 0.9 109.938 178.224 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 563' ' ' LYS . . . . . . . . . . . . . 13.9 tppt? -90.01 125.55 35.43 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.771 0.32 . . . . 2.18 110.33 -179.354 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 564' ' ' CYS . . . . . . . . . . . . . 40.6 t -63.57 114.78 14.32 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 115.908 -0.587 . . . . 0.41 109.596 176.121 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 565' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -69.8 -17.61 37.3 Favored 'Trans proline' 0 CA--C 1.527 0.164 0 C-N-CA 122.588 2.192 . . . . 0.63 113.157 -172.498 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 566' ' ' ILE . . . . . 0.454 HG21 ' HG2' ' A' ' 602' ' ' GLU . 55.5 mt -81.48 -44.33 20.43 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 N-CA-C 111.807 0.299 . . . . 0.94 111.807 -176.832 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 567' ' ' CYS . . . . . 0.484 ' SG ' ' HG3' ' A' ' 569' ' ' GLU . 27.9 p -129.8 1.83 4.89 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.447 0.536 . . . . 0.7 112.447 -174.044 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 568' ' ' LYS . . . . . . . . . . . . . 40.0 mtmt 68.08 30.77 5.74 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 113.433 0.901 . . . . 2.71 113.433 173.992 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 569' ' ' GLU . . . . . 0.484 ' HG3' ' SG ' ' A' ' 567' ' ' CYS . 32.7 mt-10 -80.17 135.8 36.36 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 108.932 -0.766 . . . . 3.34 108.932 169.635 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 570' ' ' THR . . . . . . . . . . . . . 90.1 m -78.31 117.88 19.97 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 109.083 -0.71 . . . . 1.01 109.083 170.753 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 571' ' ' VAL . . . . . . . . . . . . . 39.6 t -90.03 116.12 30.8 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 N-CA-C 110.008 -0.368 . . . . 0.73 110.008 -178.492 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 32.0 p -115.19 158.0 22.87 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.984 -0.553 . . . . 1.89 110.017 179.753 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . -130.07 155.11 20.85 Favored Glycine 0 N--CA 1.436 -1.318 0 C-N-CA 120.05 -1.071 . . . . 2.2 111.529 178.944 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 574' ' ' VAL . . . . . . . . . . . . . 42.2 t -115.87 147.56 19.18 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 N-CA-C 109.63 -0.507 . . . . 3.24 109.63 -173.875 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 575' ' ' TYR . . . . . . . . . . . . . 51.5 t80 -83.76 118.32 23.83 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 108.82 -0.807 . . . . 3.02 108.82 173.26 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 576' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -95.71 107.05 19.23 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.033 -0.729 . . . . 3.34 109.033 178.988 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 577' ' ' GLU . . . . . . . . . . . . . 38.3 mp0 -68.56 -23.3 64.48 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.824 -0.625 . . . . 5.59 111.943 -173.567 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 578' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -76.05 -34.7 59.63 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.603 0.239 . . . . 5.11 111.256 -177.525 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 579' ' ' SER . . . . . . . . . . . . . 67.5 p -93.75 -23.42 18.2 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.097 0.475 . . . . 3.28 110.546 175.512 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 580' ' ' GLY . . . . . . . . . . . . . . . 80.44 26.81 53.71 Favored Glycine 0 N--CA 1.449 -0.462 0 CA-C-N 115.608 -0.723 . . . . 2.6 112.929 176.449 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 581' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -145.87 161.6 39.63 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 117.16 0.48 . . . . 3.19 111.421 -179.69 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 582' ' ' TRP . . . . . 0.513 ' CB ' ' HB ' ' A' ' 553' ' ' VAL . 80.4 m95 -83.93 139.12 32.79 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-N 115.887 -0.597 . . . . 2.3 110.37 177.605 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 583' ' ' VAL . . . . . . . . . . . . . 26.6 m -121.04 130.15 74.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 N-CA-C 112.971 0.73 . . . . 1.11 112.971 -174.773 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 584' ' ' TRP . . . . . 0.654 ' CD1' HG22 ' A' ' 553' ' ' VAL . 14.7 m0 -104.82 103.5 13.11 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 108.605 -0.887 . . . . 2.29 108.605 162.835 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 585' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -94.83 153.75 17.58 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.637 -0.711 . . . . 3.95 111.241 -175.334 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 586' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 55.56 40.75 31.14 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 108.799 -0.815 . . . . 1.43 108.799 -170.899 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 587' ' ' THR . . . . . . . . . . . . . 26.6 m -134.88 141.45 46.34 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.393 -0.821 . . . . 0.65 110.396 -173.941 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 588' ' ' ILE . . . . . . . . . . . . . 13.7 tt -141.58 148.92 20.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 109.665 -0.494 . . . . 0.71 109.665 -179.552 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 589' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -94.34 118.7 32.01 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.93 0.395 . . . . 1.35 110.016 176.209 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 590' ' ' VAL . . . . . . . . . . . . . 59.9 t -126.5 127.25 70.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.888 -0.596 . . . . 0.65 109.451 179.488 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 591' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 59.46 37.25 23.11 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-O 121.554 0.692 . . . . 2.03 110.313 -179.689 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . 73.42 12.04 80.03 Favored Glycine 0 C--N 1.333 0.364 0 CA-C-N 115.588 -0.733 . . . . 0.62 112.952 177.872 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 593' ' ' LYS . . . . . . . . . . . . . 46.3 mtmt -127.74 143.45 51.14 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.861 0.362 . . . . 2.78 110.372 -177.005 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 594' ' ' TYR . . . . . . . . . . . . . 56.0 m-85 -86.59 125.51 33.86 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.955 0.407 . . . . 1.45 110.853 -178.696 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 595' ' ' PHE . . . . . . . . . . . . . 63.7 m-85 -136.41 160.49 38.57 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.634 -0.712 . . . . 1.32 110.044 179.593 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 596' ' ' HIS . . . . . . . . . . . . . 4.2 m170 -62.34 127.16 30.02 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.476 -0.565 . . . . 0.59 109.476 172.664 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 597' ' ' SER . . . . . . . . . . . . . 31.8 t -66.55 -32.04 73.14 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.849 -0.614 . . . . 1.13 109.776 179.45 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 598' ' ' THR . . . . . . . . . . . . . 13.0 t -69.13 -35.19 76.12 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 115.274 -0.875 . . . . 1.4 110.356 179.714 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 599' ' ' CYS . . . . . . . . . . . . . 73.4 m -75.92 -29.73 58.49 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.596 -0.729 . . . . 0.81 112.591 -176.982 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 600' ' ' TYR . . . . . 0.446 ' O ' HG22 ' A' ' 603' ' ' THR . 71.0 t80 -54.54 -31.73 56.93 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.868 0.366 . . . . 1.88 111.763 -172.559 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 601' ' ' HIS . . . . . . . . . . . . . 12.6 m170 -59.43 -27.29 65.91 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 111.927 0.343 . . . . 4.52 111.927 -179.425 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 602' ' ' GLU . . . . . 0.454 ' HG2' HG21 ' A' ' 566' ' ' ILE . 1.1 pp20? -70.18 -32.83 70.94 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 120.906 -0.317 . . . . 3.85 111.384 -175.389 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 603' ' ' THR . . . . . 0.446 HG22 ' O ' ' A' ' 600' ' ' TYR . 11.4 t . . . . . 0 C--N 1.329 -0.305 0 CA-C-O 120.922 0.391 . . . . 3.3 110.977 -176.77 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.506 0 N-CA-C 112.381 -0.288 . . . . 3.2 112.381 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 549' ' ' LYS . . . . . . . . . . . . . 31.3 mmmt -80.65 137.11 36.32 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 121.113 0.482 . . . . 5.9 110.491 177.528 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 550' ' ' TYR . . . . . . . . . . . . . 49.9 p90 -109.6 159.77 16.82 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 108.405 -0.961 . . . . 2.79 108.405 176.194 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 551' ' ' VAL . . . . . . . . . . . . . 55.1 t -117.17 133.21 64.63 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.106 0 N-CA-C 109.033 -0.729 . . . . 1.52 109.033 179.632 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 552' ' ' VAL . . . . . 0.724 ' HA ' ' O ' ' A' ' 582' ' ' TRP . 39.1 t -66.98 130.09 32.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.972 -0.558 . . . . 1.38 109.612 -179.122 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 553' ' ' VAL . . . . . 0.599 HG22 ' CD1' ' A' ' 584' ' ' TRP . 59.1 t -59.0 119.44 38.09 Favored Pre-proline 0 N--CA 1.452 -0.342 0 O-C-N 123.409 0.443 . . . . 1.38 110.016 -176.655 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 554' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 553' ' ' VAL . 33.0 Cg_exo . . . . . 0 N--CA 1.459 -0.552 0 C-N-CA 122.945 2.43 . . . . 1.98 112.132 -178.192 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 560' ' ' MET . . . . . . . . . . . . . 4.3 mpp? . . . . . 0 N--CA 1.465 0.312 0 CA-C-O 120.843 0.354 . . . . 2.61 111.907 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 561' ' ' ALA . . . . . . . . . . . . . . . -144.75 155.24 43.43 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 116.258 -0.428 . . . . 0.95 110.817 -176.317 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 29.3 p90 -138.7 164.59 29.14 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.413 -0.588 . . . . 0.9 109.413 174.38 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 563' ' ' LYS . . . . . . . . . . . . . 21.9 tptm -103.06 125.07 49.63 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 109.983 -0.377 . . . . 2.18 109.983 -178.446 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 564' ' ' CYS . . . . . . . . . . . . . 48.8 t -80.09 113.38 38.01 Favored Pre-proline 0 C--N 1.327 -0.412 0 N-CA-C 109.512 -0.551 . . . . 0.41 109.512 -179.663 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 565' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -71.88 -28.67 16.24 Favored 'Trans proline' 0 CA--C 1.528 0.217 0 C-N-CA 122.667 2.245 . . . . 0.63 113.954 -172.13 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 566' ' ' ILE . . . . . . . . . . . . . 28.5 mt -72.67 -37.7 56.59 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 CA-C-O 121.069 0.462 . . . . 0.94 111.671 -172.662 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 567' ' ' CYS . . . . . 0.559 ' SG ' ' HG3' ' A' ' 569' ' ' GLU . 27.8 p -127.43 1.27 6.29 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.534 -0.303 . . . . 0.7 111.567 -175.309 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 568' ' ' LYS . . . . . . . . . . . . . 29.1 mtpp 67.45 27.45 8.01 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 115.934 -0.576 . . . . 2.71 112.429 175.272 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 569' ' ' GLU . . . . . 0.559 ' HG3' ' SG ' ' A' ' 567' ' ' CYS . 51.1 mt-10 -79.07 136.43 37.16 Favored 'General case' 0 CA--C 1.516 -0.336 0 N-CA-C 109.944 -0.391 . . . . 3.34 109.944 174.692 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 570' ' ' THR . . . . . . . . . . . . . 47.4 m -87.99 116.58 26.26 Favored 'General case' 0 C--N 1.314 -0.977 0 N-CA-C 107.835 -1.172 . . . . 1.01 107.835 171.736 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 571' ' ' VAL . . . . . 0.438 HG22 ' CE1' ' A' ' 596' ' ' HIS . 16.8 t -97.78 115.73 38.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 C-N-CA 120.668 -0.413 . . . . 0.73 110.962 -171.477 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 23.8 p -109.76 158.82 17.73 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 109.183 -0.673 . . . . 1.89 109.183 174.881 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . -131.21 155.15 21.16 Favored Glycine 0 N--CA 1.443 -0.896 0 C-N-CA 120.04 -1.076 . . . . 2.2 112.132 -178.2 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 574' ' ' VAL . . . . . 0.411 ' O ' HG22 ' A' ' 583' ' ' VAL . 39.5 t -112.35 152.81 14.1 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 N-CA-C 109.432 -0.581 . . . . 3.24 109.432 -175.632 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 575' ' ' TYR . . . . . 0.41 ' HA ' ' HA ' ' A' ' 582' ' ' TRP . 50.7 t80 -84.52 119.84 25.64 Favored 'General case' 0 C--N 1.315 -0.891 0 N-CA-C 109.953 -0.388 . . . . 3.02 109.953 176.997 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 576' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -90.3 97.96 11.49 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 108.277 -1.009 . . . . 3.34 108.277 178.99 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 577' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -65.92 -22.85 66.53 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.354 -0.839 . . . . 5.59 111.851 -172.834 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 578' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -73.32 -48.09 37.25 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.014 0.435 . . . . 5.11 110.116 -178.27 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 579' ' ' SER . . . . . . . . . . . . . 74.5 p -84.05 -19.88 33.64 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.922 0.391 . . . . 3.28 111.023 178.109 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 580' ' ' GLY . . . . . . . . . . . . . . . 80.24 22.65 62.53 Favored Glycine 0 N--CA 1.449 -0.451 0 CA-C-N 115.795 -0.639 . . . . 2.6 112.266 179.048 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 581' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -130.59 147.83 52.31 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-O 121.32 0.581 . . . . 3.19 111.009 -177.274 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 582' ' ' TRP . . . . . 0.724 ' O ' ' HA ' ' A' ' 552' ' ' VAL . 88.4 m95 -72.05 143.82 48.97 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 108.591 -0.892 . . . . 2.3 108.591 168.815 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 583' ' ' VAL . . . . . 0.6 HG21 ' HE2' ' A' ' 585' ' ' LYS . 24.4 m -124.08 133.19 69.96 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 N-CA-C 113.679 0.992 . . . . 1.11 113.679 -174.493 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 584' ' ' TRP . . . . . 0.599 ' CD1' HG22 ' A' ' 553' ' ' VAL . 30.9 m0 -110.51 104.1 12.79 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 114.912 -1.04 . . . . 2.29 108.338 163.067 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 585' ' ' LYS . . . . . 0.6 ' HE2' HG21 ' A' ' 583' ' ' VAL . 66.9 mmtt -83.38 151.49 25.5 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-O 120.495 0.188 . . . . 3.95 110.611 -176.54 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 586' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 50.27 44.86 26.36 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 115.887 -0.597 . . . . 1.43 110.124 -175.517 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 587' ' ' THR . . . . . . . . . . . . . 75.3 m -125.83 140.94 52.25 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.15 -0.477 . . . . 0.65 110.679 -176.394 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 588' ' ' ILE . . . . . 0.459 ' HB ' ' HB3' ' A' ' 597' ' ' SER . 12.7 tt -136.05 146.13 29.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 N-CA-C 109.482 -0.562 . . . . 0.71 109.482 179.025 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 589' ' ' GLU . . . . . . . . . . . . . 46.2 tt0 -100.45 121.5 41.65 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.219 -0.66 . . . . 1.35 109.219 174.329 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 590' ' ' VAL . . . . . . . . . . . . . 52.7 t -124.35 118.19 52.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 109.947 -0.39 . . . . 0.65 109.947 -179.185 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 591' ' ' ASN . . . . . . . . . . . . . 60.0 t30 58.12 37.51 26.4 Favored 'General case' 0 C--N 1.328 -0.327 0 O-C-N 123.912 0.757 . . . . 2.03 110.852 178.67 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . 85.25 0.88 88.51 Favored Glycine 0 N--CA 1.452 -0.256 0 CA-C-N 115.844 -0.616 . . . . 0.62 113.718 176.462 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 593' ' ' LYS . . . . . . . . . . . . . 61.8 mttp -118.71 147.69 43.56 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 117.245 0.523 . . . . 2.78 111.104 -179.129 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 594' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -96.53 135.64 38.14 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.018 0.437 . . . . 1.45 111.219 -175.581 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 595' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 -143.87 155.02 43.96 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.337 -0.847 . . . . 1.32 109.322 178.57 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 596' ' ' HIS . . . . . 0.438 ' CE1' HG22 ' A' ' 571' ' ' VAL . 16.7 m170 -64.66 127.24 30.69 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 107.972 -1.121 . . . . 0.59 107.972 166.579 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 597' ' ' SER . . . . . 0.459 ' HB3' ' HB ' ' A' ' 588' ' ' ILE . 7.7 p -66.02 -32.02 73.26 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.043 0.449 . . . . 1.13 110.002 -178.906 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 598' ' ' THR . . . . . . . . . . . . . 97.1 m -61.12 -43.25 99.17 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.265 -0.879 . . . . 1.4 110.345 173.694 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 599' ' ' CYS . . . . . 0.511 ' O ' ' HB3' ' A' ' 602' ' ' GLU . 83.9 m -74.74 -30.46 61.51 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.779 -0.646 . . . . 0.81 111.289 -179.775 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 600' ' ' TYR . . . . . . . . . . . . . 88.0 t80 -59.28 -35.87 74.52 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.179 0.514 . . . . 1.88 109.908 177.572 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 601' ' ' HIS . . . . . . . . . . . . . 67.3 t60 -71.22 -29.51 65.23 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.811 -0.631 . . . . 4.52 110.506 176.562 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 602' ' ' GLU . . . . . 0.511 ' HB3' ' O ' ' A' ' 599' ' ' CYS . 2.0 tp10 -61.89 -37.21 83.74 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.923 -0.581 . . . . 3.85 111.149 178.639 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 603' ' ' THR . . . . . . . . . . . . . 12.3 t . . . . . 0 C--N 1.328 -0.343 0 CA-C-N 116.447 -0.342 . . . . 3.3 111.102 -179.05 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.5 0 N-CA-C 111.818 -0.513 . . . . 3.2 111.818 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 549' ' ' LYS . . . . . . . . . . . . . 68.4 mmtt -64.01 149.37 47.57 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-O 121.338 0.589 . . . . 5.9 111.085 178.813 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 550' ' ' TYR . . . . . . . . . . . . . 39.7 p90 -122.38 159.94 26.47 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.277 -0.874 . . . . 2.79 109.745 179.181 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 551' ' ' VAL . . . . . . . . . . . . . 60.6 t -118.15 133.35 65.21 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.925 0 N-CA-C 108.527 -0.916 . . . . 1.52 108.527 177.551 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 552' ' ' VAL . . . . . 0.648 ' HA ' ' O ' ' A' ' 582' ' ' TRP . 42.0 t -67.8 134.24 30.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 116.122 -0.49 . . . . 1.38 109.741 -177.426 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 553' ' ' VAL . . . . . 0.515 HG11 ' HB3' ' A' ' 560' ' ' MET . 63.2 t -59.46 121.68 58.57 Favored Pre-proline 0 C--N 1.325 -0.461 0 O-C-N 123.682 0.613 . . . . 1.38 111.391 -175.813 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 554' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 553' ' ' VAL . 31.6 Cg_exo . . . . . 0 C--N 1.343 0.272 0 C-N-CA 123.559 2.839 . . . . 1.98 112.607 179.148 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 560' ' ' MET . . . . . 0.515 ' HB3' HG11 ' A' ' 553' ' ' VAL . 60.1 mtt . . . . . 0 C--O 1.234 0.285 0 CA-C-O 120.912 0.387 . . . . 2.61 111.266 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 561' ' ' ALA . . . . . 0.427 ' HB2' HG22 ' A' ' 572' ' ' THR . . . -144.3 161.95 37.65 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 116.072 -0.513 . . . . 0.95 111.443 -177.627 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 31.2 p90 -143.83 153.06 41.97 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.968 -0.753 . . . . 0.9 108.968 173.242 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 563' ' ' LYS . . . . . 0.529 ' HA ' ' HA ' ' A' ' 570' ' ' THR . 16.0 tppt? -88.89 126.47 35.4 Favored 'General case' 0 C--N 1.317 -0.841 0 C-N-CA 120.705 -0.398 . . . . 2.18 110.189 177.989 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 564' ' ' CYS . . . . . 0.439 ' HA ' ' HD3' ' A' ' 565' ' ' PRO . 52.7 t -79.46 113.62 38.42 Favored Pre-proline 0 N--CA 1.451 -0.379 0 N-CA-C 109.444 -0.576 . . . . 0.41 109.444 174.62 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 565' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 564' ' ' CYS . 33.4 Cg_exo -63.38 -36.37 55.98 Favored 'Trans proline' 0 CA--C 1.528 0.206 0 C-N-CA 123.146 2.564 . . . . 0.63 113.896 -173.323 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 566' ' ' ILE . . . . . 0.498 HD12 ' HB3' ' A' ' 599' ' ' CYS . 60.3 mt -72.35 -37.81 59.25 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 N-CA-C 112.088 0.403 . . . . 0.94 112.088 -173.143 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 567' ' ' CYS . . . . . . . . . . . . . 29.6 p -113.15 0.76 15.04 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.536 -0.466 . . . . 0.7 111.82 -176.281 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 568' ' ' LYS . . . . . . . . . . . . . 99.4 mttt 66.03 11.63 7.89 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 113.181 0.808 . . . . 2.71 113.181 173.522 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 569' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -100.6 134.64 43.26 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.873 0.368 . . . . 3.34 110.971 179.216 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 570' ' ' THR . . . . . 0.529 ' HA ' ' HA ' ' A' ' 563' ' ' LYS . 45.8 m -74.13 128.96 36.87 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.5 -0.773 . . . . 1.01 109.617 177.863 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 571' ' ' VAL . . . . . . . . . . . . . 17.9 t -95.76 115.09 33.97 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 N-CA-C 109.568 -0.53 . . . . 0.73 109.568 178.424 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 572' ' ' THR . . . . . 0.427 HG22 ' HB2' ' A' ' 561' ' ' ALA . 24.4 p -106.24 160.41 15.37 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.66 -0.7 . . . . 1.89 109.438 177.103 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . -129.53 153.89 20.14 Favored Glycine 0 N--CA 1.44 -1.052 0 C-N-CA 119.352 -1.404 . . . . 2.2 112.405 -178.619 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 574' ' ' VAL . . . . . . . . . . . . . 58.5 t -122.57 148.13 26.42 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 CA-C-N 114.861 -0.67 . . . . 3.24 109.395 -172.714 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 575' ' ' TYR . . . . . . . . . . . . . 53.3 t80 -80.81 118.07 22.02 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 109.356 -0.609 . . . . 3.02 109.356 175.718 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 576' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -92.96 114.89 27.58 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 109.754 -0.461 . . . . 3.34 109.754 179.756 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 577' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -68.89 -22.72 64.16 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.511 -0.768 . . . . 5.59 112.13 -174.441 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 578' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -77.08 -48.13 18.65 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.509 -0.314 . . . . 5.11 111.723 -178.276 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 579' ' ' SER . . . . . . . . . . . . . 72.4 p -86.0 -21.82 27.61 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.878 0.37 . . . . 3.28 110.859 178.961 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 580' ' ' GLY . . . . . . . . . . . . . . . 80.19 17.29 74.54 Favored Glycine 0 C--N 1.331 0.285 0 C-N-CA 121.157 -0.544 . . . . 2.6 112.725 178.48 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 581' ' ' GLU . . . . . . . . . . . . . 20.7 mm-40 -122.42 152.24 40.43 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.921 0.391 . . . . 3.19 111.292 -176.943 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 582' ' ' TRP . . . . . 0.648 ' O ' ' HA ' ' A' ' 552' ' ' VAL . 84.5 m95 -77.51 130.38 36.9 Favored 'General case' 0 CA--C 1.512 -0.491 0 N-CA-C 107.451 -1.315 . . . . 2.3 107.451 165.245 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 583' ' ' VAL . . . . . . . . . . . . . 19.3 m -115.39 133.91 60.2 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.971 0 N-CA-C 113.958 1.096 . . . . 1.11 113.958 -169.998 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 584' ' ' TRP . . . . . 0.508 ' CD1' HG22 ' A' ' 553' ' ' VAL . 30.5 m0 -113.33 103.65 11.52 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 114.795 -1.093 . . . . 2.29 108.053 162.281 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 585' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.99 145.61 27.63 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.985 0.422 . . . . 3.95 111.774 -173.104 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 586' ' ' ASN . . . . . . . . . . . . . 12.3 m120 53.2 42.93 32.13 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.282 -0.872 . . . . 1.43 110.512 -176.613 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 587' ' ' THR . . . . . . . . . . . . . 57.9 m -115.38 142.46 46.66 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.0 0.428 . . . . 0.65 110.761 -176.963 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 588' ' ' ILE . . . . . . . . . . . . . 15.3 tt -137.38 150.19 25.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.58 -0.736 . . . . 0.71 109.396 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 589' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -111.13 122.73 48.62 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.098 -0.705 . . . . 1.35 109.098 176.908 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 590' ' ' VAL . . . . . . . . . . . . . 62.1 t -126.39 117.65 49.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 115.716 -0.675 . . . . 0.65 110.06 179.324 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 591' ' ' ASN . . . . . . . . . . . . . 13.3 t-20 58.27 40.64 24.43 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 115.582 -0.735 . . . . 2.03 110.835 177.267 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . 79.98 13.67 81.81 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.91 -0.662 . . . . 0.62 112.592 176.036 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 593' ' ' LYS . . . . . . . . . . . . . 46.8 mtmt -128.47 139.92 52.08 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.036 0.446 . . . . 2.78 110.777 -178.898 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 594' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -94.9 134.88 37.06 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.054 -0.521 . . . . 1.45 111.064 -177.081 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 595' ' ' PHE . . . . . . . . . . . . . 62.7 m-85 -142.25 165.24 27.98 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.372 -0.831 . . . . 1.32 108.807 177.002 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 596' ' ' HIS . . . . . 0.701 ' HB2' ' SG ' ' A' ' 599' ' ' CYS . 24.9 m80 -68.79 130.11 41.88 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 108.273 -1.01 . . . . 0.59 108.273 166.641 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 597' ' ' SER . . . . . . . . . . . . . 40.1 t -60.83 -30.16 69.93 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.462 0.649 . . . . 1.13 109.81 179.361 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 598' ' ' THR . . . . . . . . . . . . . 93.7 m -66.39 -34.71 78.58 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.905 -1.043 . . . . 1.4 110.803 175.11 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 599' ' ' CYS . . . . . 0.701 ' SG ' ' HB2' ' A' ' 596' ' ' HIS . 75.8 m -74.77 -31.15 61.69 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.622 0.601 . . . . 0.81 112.622 -178.25 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 600' ' ' TYR . . . . . . . . . . . . . 86.0 t80 -61.8 -35.62 78.72 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 121.362 0.601 . . . . 1.88 109.842 -178.427 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 601' ' ' HIS . . . . . . . . . . . . . 78.7 t60 -66.72 -34.7 78.43 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.373 -0.83 . . . . 4.52 110.408 176.001 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 602' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -64.65 -36.57 84.69 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.145 -0.48 . . . . 3.85 110.927 179.847 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 603' ' ' THR . . . . . . . . . . . . . 15.4 t . . . . . 0 C--N 1.324 -0.507 0 CA-C-N 116.554 -0.293 . . . . 3.3 110.701 -179.266 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.418 0 N-CA-C 112.107 -0.397 . . . . 3.2 112.107 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 549' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -64.28 132.49 50.39 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.056 0.455 . . . . 5.9 110.125 176.558 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 550' ' ' TYR . . . . . 0.524 ' CE1' HG12 ' A' ' 583' ' ' VAL . 37.4 p90 -111.34 160.91 16.6 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.822 -0.626 . . . . 2.79 109.834 177.414 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 551' ' ' VAL . . . . . 0.527 HG11 ' HE1' ' A' ' 594' ' ' TYR . 52.9 t -118.53 133.26 65.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 N-CA-C 109.072 -0.714 . . . . 1.52 109.072 176.437 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 552' ' ' VAL . . . . . 0.72 ' HA ' ' O ' ' A' ' 582' ' ' TRP . 56.6 t -61.95 125.18 17.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 O-C-N 123.32 0.388 . . . . 1.38 110.287 -179.039 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 553' ' ' VAL . . . . . 0.685 HG22 ' CD1' ' A' ' 584' ' ' TRP . 66.6 t -58.91 120.41 46.32 Favored Pre-proline 0 C--N 1.33 -0.271 0 O-C-N 123.729 0.643 . . . . 1.38 111.495 -173.903 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 554' ' ' PRO . . . . . 0.458 ' HD3' ' HA ' ' A' ' 553' ' ' VAL . 7.2 Cg_exo . . . . . 0 N--CA 1.456 -0.697 0 C-N-CA 122.802 2.335 . . . . 1.98 112.06 175.78 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 560' ' ' MET . . . . . . . . . . . . . 62.1 mtt . . . . . 0 N--CA 1.468 0.471 0 CA-C-O 120.87 0.367 . . . . 2.61 110.797 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 561' ' ' ALA . . . . . . . . . . . . . . . -144.77 149.94 36.35 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.378 -0.373 . . . . 0.95 111.162 -173.908 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 26.8 p90 -133.69 164.01 28.17 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.572 -0.899 . . . . 0.9 108.572 173.605 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 563' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt -112.09 127.59 55.96 Favored 'General case' 0 C--N 1.323 -0.587 0 C-N-CA 120.456 -0.498 . . . . 2.18 110.772 -179.459 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 564' ' ' CYS . . . . . . . . . . . . . 53.4 t -73.77 113.9 27.28 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 115.416 -0.811 . . . . 0.41 109.797 -179.192 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 565' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -72.83 -19.91 23.15 Favored 'Trans proline' 0 N--CA 1.472 0.218 0 C-N-CA 122.965 2.443 . . . . 0.63 113.599 -175.633 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 566' ' ' ILE . . . . . 0.449 HD13 ' HB ' ' A' ' 603' ' ' THR . 37.7 mt -82.26 -37.86 14.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.255 -0.429 . . . . 0.94 111.616 -172.368 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 567' ' ' CYS . . . . . 0.476 ' SG ' ' OE2' ' A' ' 569' ' ' GLU . 27.9 p -129.32 5.86 5.27 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 112.22 0.452 . . . . 0.7 112.22 -179.319 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 568' ' ' LYS . . . . . . . . . . . . . 21.0 mmmt 72.82 30.59 1.72 Allowed 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 113.923 1.083 . . . . 2.71 113.923 167.346 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 569' ' ' GLU . . . . . 0.476 ' OE2' ' SG ' ' A' ' 567' ' ' CYS . 7.0 mt-10 -92.85 135.81 33.8 Favored 'General case' 0 N--CA 1.466 0.361 0 O-C-N 121.786 -0.571 . . . . 3.34 111.231 178.308 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 570' ' ' THR . . . . . . . . . . . . . 82.5 m -82.14 117.91 22.66 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 108.875 -0.787 . . . . 1.01 108.875 166.142 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 571' ' ' VAL . . . . . . . . . . . . . 21.3 t -103.13 123.27 56.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.951 0.405 . . . . 0.73 111.745 -170.883 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 24.5 p -108.94 160.96 15.59 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.87 -0.604 . . . . 1.89 110.33 177.672 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . -130.98 156.15 21.61 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.343 -0.932 . . . . 2.2 112.185 -177.97 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 574' ' ' VAL . . . . . 0.474 ' O ' HG22 ' A' ' 583' ' ' VAL . 21.8 t -112.26 149.61 14.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-O 120.888 0.375 . . . . 3.24 110.319 -173.117 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 575' ' ' TYR . . . . . 0.408 ' HA ' ' HA ' ' A' ' 582' ' ' TRP . 53.8 t80 -85.21 123.36 30.62 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.256 -0.429 . . . . 3.02 111.012 179.061 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 576' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -92.12 107.75 19.44 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.418 -0.586 . . . . 3.34 109.418 174.09 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 577' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -68.17 -26.98 66.03 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.037 -0.529 . . . . 5.59 112.424 -173.215 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 578' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -69.53 -47.95 62.06 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.76 0.314 . . . . 5.11 111.249 -178.409 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 579' ' ' SER . . . . . . . . . . . . . 77.1 p -83.31 -23.88 32.39 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.343 0.592 . . . . 3.28 110.578 -179.837 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 580' ' ' GLY . . . . . . . . . . . . . . . 79.17 18.4 74.5 Favored Glycine 0 N--CA 1.449 -0.499 0 CA-C-N 115.561 -0.745 . . . . 2.6 111.326 -176.714 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 581' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -123.32 138.85 54.52 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.295 0.569 . . . . 3.19 110.833 -176.036 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 582' ' ' TRP . . . . . 0.72 ' O ' ' HA ' ' A' ' 552' ' ' VAL . 83.7 m95 -71.45 141.06 50.25 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.975 -0.75 . . . . 2.3 108.975 173.221 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 583' ' ' VAL . . . . . 0.524 HG12 ' CE1' ' A' ' 550' ' ' TYR . 24.0 m -119.89 133.78 65.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 N-CA-C 113.352 0.871 . . . . 1.11 113.352 -173.933 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 584' ' ' TRP . . . . . 0.685 ' CD1' HG22 ' A' ' 553' ' ' VAL . 21.6 m0 -111.38 104.51 12.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.024 -0.989 . . . . 2.29 108.983 165.436 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 585' ' ' LYS . . . . . 0.408 ' HD2' ' HB3' ' A' ' 550' ' ' TYR . 26.2 mmmt -83.23 148.13 27.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.607 -0.269 . . . . 3.95 110.473 -175.041 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 586' ' ' ASN . . . . . . . . . . . . . 62.7 m-20 48.32 41.95 17.16 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 123.319 0.648 . . . . 1.43 110.337 -173.934 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 587' ' ' THR . . . . . . . . . . . . . 56.8 m -120.1 140.9 50.35 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.966 -0.561 . . . . 0.65 109.607 179.556 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 588' ' ' ILE . . . . . . . . . . . . . 15.5 tt -135.66 146.22 30.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-O 120.927 0.394 . . . . 0.71 110.123 -178.707 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 589' ' ' GLU . . . . . 0.434 ' HA ' ' O ' ' A' ' 593' ' ' LYS . 1.8 tm-20 -103.23 121.16 42.12 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.213 -0.662 . . . . 1.35 109.213 175.373 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 590' ' ' VAL . . . . . . . . . . . . . 59.1 t -125.64 118.6 52.69 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 115.776 -0.647 . . . . 0.65 109.829 -179.56 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 591' ' ' ASN . . . . . . . . . . . . . 67.1 t30 58.78 36.9 25.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.676 0.751 . . . . 2.03 110.779 178.041 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . 85.85 6.59 82.35 Favored Glycine 0 N--CA 1.446 -0.647 0 CA-C-N 115.729 -0.669 . . . . 0.62 113.214 176.38 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 593' ' ' LYS . . . . . 0.434 ' O ' ' HA ' ' A' ' 589' ' ' GLU . 30.4 mmmt -120.85 139.29 53.38 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 117.02 0.41 . . . . 2.78 111.64 -179.046 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 594' ' ' TYR . . . . . 0.527 ' HE1' HG11 ' A' ' 551' ' ' VAL . 91.8 m-85 -93.55 124.05 37.28 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.86 -0.609 . . . . 1.45 111.092 -179.864 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 595' ' ' PHE . . . . . . . . . . . . . 47.9 m-85 -137.29 164.27 28.95 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.865 -0.607 . . . . 1.32 109.662 176.872 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 596' ' ' HIS . . . . . 0.715 ' HB2' ' SG ' ' A' ' 599' ' ' CYS . 29.3 m170 -61.58 129.83 43.0 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 108.927 -0.768 . . . . 0.59 108.927 168.99 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 597' ' ' SER . . . . . . . . . . . . . 33.4 t -64.24 -30.35 71.41 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.039 -0.528 . . . . 1.13 109.65 178.929 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 598' ' ' THR . . . . . . . . . . . . . 8.7 m -61.8 -38.85 89.64 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 115.307 -0.861 . . . . 1.4 110.488 175.403 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 599' ' ' CYS . . . . . 0.715 ' SG ' ' HB2' ' A' ' 596' ' ' HIS . 83.2 m -73.98 -28.52 61.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.302 -0.863 . . . . 0.81 112.672 -175.336 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 600' ' ' TYR . . . . . . . . . . . . . 70.0 t80 -55.94 -35.89 67.16 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 120.902 0.382 . . . . 1.88 110.963 -174.62 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 601' ' ' HIS . . . . . . . . . . . . . 43.5 m-70 -73.26 -39.35 65.48 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.453 -0.339 . . . . 4.52 111.232 -178.86 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 602' ' ' GLU . . . . . 0.663 ' HG2' ' O ' ' A' ' 599' ' ' CYS . 23.3 pt-20 -70.36 -35.5 73.59 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 120.709 0.29 . . . . 3.85 111.028 -177.438 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 603' ' ' THR . . . . . 0.449 ' HB ' HD13 ' A' ' 566' ' ' ILE . 13.0 t . . . . . 0 C--N 1.327 -0.387 0 C-N-CA 120.978 -0.289 . . . . 3.3 111.557 -175.225 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.136 0 N-CA-C 113.484 0.154 . . . . 3.2 113.484 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 549' ' ' LYS . . . . . . . . . . . . . 61.6 mttm -73.43 134.79 44.07 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.906 0.384 . . . . 5.9 110.588 176.218 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 550' ' ' TYR . . . . . . . . . . . . . 31.8 p90 -111.62 159.9 17.74 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.561 -0.745 . . . . 2.79 109.584 179.322 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 551' ' ' VAL . . . . . . . . . . . . . 59.2 t -117.94 131.9 69.34 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 N-CA-C 108.556 -0.905 . . . . 1.52 108.556 175.311 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 552' ' ' VAL . . . . . 0.563 ' HA ' ' O ' ' A' ' 582' ' ' TRP . 59.0 t -63.95 134.82 28.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 116.051 -0.522 . . . . 1.38 110.075 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 553' ' ' VAL . . . . . 0.579 HG22 ' CD1' ' A' ' 584' ' ' TRP . 86.0 t -58.84 121.72 56.55 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 115.677 -0.692 . . . . 1.38 110.05 -178.489 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 554' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_exo . . . . . 0 N--CA 1.462 -0.363 0 C-N-CA 122.791 2.327 . . . . 1.98 112.496 -176.523 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 560' ' ' MET . . . . . . . . . . . . . 3.8 mpp? . . . . . 0 C--O 1.237 0.419 0 CA-C-O 120.647 0.26 . . . . 2.61 111.28 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 561' ' ' ALA . . . . . 0.59 ' HB2' HG22 ' A' ' 572' ' ' THR . . . -144.66 145.7 31.88 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-O 121.045 0.45 . . . . 0.95 111.552 -176.628 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 33.1 p90 -135.92 149.22 48.87 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 107.791 -1.189 . . . . 0.9 107.791 169.914 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 563' ' ' LYS . . . . . 0.46 ' HA ' ' HA ' ' A' ' 570' ' ' THR . 72.1 tttt -93.3 119.99 33.07 Favored 'General case' 0 C--N 1.316 -0.859 0 C-N-CA 120.093 -0.643 . . . . 2.18 110.929 -176.07 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 564' ' ' CYS . . . . . 0.48 ' HA ' ' HD3' ' A' ' 565' ' ' PRO . 10.6 t -76.91 114.26 37.76 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-N 115.348 -0.842 . . . . 0.41 110.729 -178.626 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 565' ' ' PRO . . . . . 0.48 ' HD3' ' HA ' ' A' ' 564' ' ' CYS . 20.6 Cg_exo -70.48 -23.41 27.55 Favored 'Trans proline' 0 CA--C 1.534 0.487 0 C-N-CA 123.379 2.719 . . . . 0.63 113.35 -177.479 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 566' ' ' ILE . . . . . 0.485 HG21 ' HB3' ' A' ' 599' ' ' CYS . 26.7 mt -71.44 -37.64 65.46 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.364 0 N-CA-C 112.041 0.385 . . . . 0.94 112.041 -174.249 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 567' ' ' CYS . . . . . . . . . . . . . 29.2 p -124.34 2.06 8.43 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.805 0.336 . . . . 0.7 111.429 178.07 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 568' ' ' LYS . . . . . . . . . . . . . 29.4 mtpp 69.65 18.01 7.7 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 113.463 0.912 . . . . 2.71 113.463 171.798 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 569' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -107.85 136.37 47.69 Favored 'General case' 0 C--O 1.238 0.46 0 C-N-CA 120.373 -0.531 . . . . 3.34 111.332 178.818 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 570' ' ' THR . . . . . 0.46 ' HA ' ' HA ' ' A' ' 563' ' ' LYS . 35.5 m -68.18 125.99 28.12 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 115.015 -0.993 . . . . 1.01 110.925 -178.677 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 571' ' ' VAL . . . . . 0.533 ' O ' ' HA ' ' A' ' 561' ' ' ALA . 15.9 t -95.06 117.51 39.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 115.68 -0.691 . . . . 0.73 110.602 -176.891 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 572' ' ' THR . . . . . 0.59 HG22 ' HB2' ' A' ' 561' ' ' ALA . 25.6 p -109.17 158.62 17.63 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 109.619 -0.512 . . . . 1.89 109.619 176.589 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . -129.92 156.41 21.44 Favored Glycine 0 N--CA 1.443 -0.871 0 C-N-CA 120.305 -0.95 . . . . 2.2 111.777 -177.882 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 574' ' ' VAL . . . . . 0.484 ' O ' HG22 ' A' ' 583' ' ' VAL . 20.1 t -113.68 149.94 15.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-O 120.832 0.348 . . . . 3.24 110.227 -173.352 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 575' ' ' TYR . . . . . 0.446 ' HA ' ' HA ' ' A' ' 582' ' ' TRP . 39.6 t80 -80.61 123.84 28.48 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 109.276 -0.639 . . . . 3.02 109.276 174.383 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 576' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -90.97 105.49 17.86 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 108.434 -0.95 . . . . 3.34 108.434 175.574 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 577' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -67.09 -27.02 67.01 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.377 -0.829 . . . . 5.59 112.083 -170.602 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 578' ' ' GLU . . . . . . . . . . . . . 23.1 mp0 -75.15 -47.06 30.33 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.537 -0.301 . . . . 5.11 111.354 -179.452 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 579' ' ' SER . . . . . . . . . . . . . 75.2 p -83.12 -21.06 33.74 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.059 0.457 . . . . 3.28 111.295 -179.449 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 580' ' ' GLY . . . . . . . . . . . . . . . 80.23 20.49 67.03 Favored Glycine 0 N--CA 1.449 -0.46 0 CA-C-N 115.863 -0.608 . . . . 2.6 112.836 177.924 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 581' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -130.28 148.08 52.07 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.912 0.387 . . . . 3.19 110.752 -178.869 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 582' ' ' TRP . . . . . 0.563 ' O ' ' HA ' ' A' ' 552' ' ' VAL . 81.1 m95 -79.12 135.19 36.76 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.313 -0.625 . . . . 2.3 109.313 174.194 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 583' ' ' VAL . . . . . 0.484 HG22 ' O ' ' A' ' 574' ' ' VAL . 29.3 m -113.4 129.33 69.35 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 N-CA-C 112.987 0.736 . . . . 1.11 112.987 -172.594 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 584' ' ' TRP . . . . . 0.579 ' CD1' HG22 ' A' ' 553' ' ' VAL . 23.3 m0 -109.4 102.31 11.21 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 108.085 -1.08 . . . . 2.29 108.085 163.108 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 585' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.99 151.51 19.49 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 110.2 -0.296 . . . . 3.95 110.2 -173.428 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 586' ' ' ASN . . . . . 0.501 ' O ' ' HA ' ' A' ' 596' ' ' HIS . 2.2 m-20 55.95 42.33 28.83 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 121.214 0.53 . . . . 1.43 109.714 -173.311 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 587' ' ' THR . . . . . . . . . . . . . 30.2 m -124.41 141.42 52.1 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.359 -0.837 . . . . 0.65 110.439 -178.015 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 588' ' ' ILE . . . . . 0.568 ' HB ' ' HB3' ' A' ' 597' ' ' SER . 16.1 tt -139.98 147.92 23.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 116.255 -0.43 . . . . 0.71 109.877 177.928 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 589' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -100.62 119.08 38.03 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.453 -0.573 . . . . 1.35 109.453 176.653 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 590' ' ' VAL . . . . . . . . . . . . . 60.0 t -130.93 127.31 61.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.563 -0.744 . . . . 0.65 109.401 179.065 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 591' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 59.05 33.21 22.83 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 121.605 0.717 . . . . 2.03 110.384 179.068 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . 84.88 0.74 89.07 Favored Glycine 0 N--CA 1.45 -0.424 0 CA-C-N 115.795 -0.639 . . . . 0.62 113.303 175.815 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 593' ' ' LYS . . . . . . . . . . . . . 45.3 mmtm -121.35 148.06 44.86 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.056 0.455 . . . . 2.78 111.482 -178.305 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 594' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -92.89 132.76 36.75 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.566 -0.743 . . . . 1.45 110.576 179.597 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 595' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -136.55 162.58 32.72 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.292 -0.867 . . . . 1.32 108.766 177.529 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 596' ' ' HIS . . . . . 0.512 ' CE1' HG22 ' A' ' 571' ' ' VAL . 21.9 m170 -66.86 125.05 24.7 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 107.743 -1.206 . . . . 0.59 107.743 167.178 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 597' ' ' SER . . . . . 0.568 ' HB3' ' HB ' ' A' ' 588' ' ' ILE . 2.1 p -67.77 -29.79 69.08 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.256 0.55 . . . . 1.13 109.884 177.501 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 598' ' ' THR . . . . . . . . . . . . . 25.6 m -63.84 -38.27 90.46 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.258 -0.883 . . . . 1.4 110.656 174.643 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 599' ' ' CYS . . . . . 0.485 ' HB3' HG21 ' A' ' 566' ' ' ILE . 73.6 m -75.14 -29.92 60.64 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.971 -0.559 . . . . 0.81 110.816 177.263 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 600' ' ' TYR . . . . . . . . . . . . . 92.4 t80 -55.62 -34.52 64.98 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.617 -0.719 . . . . 1.88 111.623 -174.598 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 601' ' ' HIS . . . . . . . . . . . . . 66.9 m170 -60.16 -32.51 71.12 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 112.459 0.541 . . . . 4.52 112.459 -176.343 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 602' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -72.61 -33.52 66.73 Favored 'General case' 0 CA--C 1.528 0.099 0 C-N-CA 120.118 -0.633 . . . . 3.85 110.966 -179.141 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 603' ' ' THR . . . . . . . . . . . . . 8.8 t . . . . . 0 C--O 1.235 0.3 0 C-N-CA 120.633 -0.427 . . . . 3.3 110.837 -177.564 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.387 0 N-CA-C 112.565 -0.214 . . . . 3.2 112.565 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 549' ' ' LYS . . . . . . . . . . . . . 32.5 mmmt -70.8 143.72 51.06 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 110.038 -0.356 . . . . 5.9 110.038 178.089 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 550' ' ' TYR . . . . . 0.507 ' CE1' HG12 ' A' ' 583' ' ' VAL . 23.8 p90 -125.97 159.73 31.89 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 109.29 -0.633 . . . . 2.79 109.29 177.015 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 551' ' ' VAL . . . . . . . . . . . . . 52.6 t -118.33 133.37 65.35 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.021 0 N-CA-C 108.723 -0.843 . . . . 1.52 108.723 177.48 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 552' ' ' VAL . . . . . 0.57 ' HA ' ' O ' ' A' ' 582' ' ' TRP . 60.8 t -65.2 130.59 30.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 109.499 -0.556 . . . . 1.38 109.499 179.374 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 553' ' ' VAL . . . . . 0.6 HG22 ' CD1' ' A' ' 584' ' ' TRP . 66.0 t -59.0 121.37 54.6 Favored Pre-proline 0 CA--C 1.519 -0.243 0 O-C-N 123.618 0.574 . . . . 1.38 110.681 -175.608 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 554' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 553' ' ' VAL . 31.9 Cg_exo -57.74 135.22 67.93 Favored 'Trans proline' 0 N--CA 1.464 -0.219 0 C-N-CA 123.041 2.494 . . . . 1.98 112.786 -177.404 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 555' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -91.65 -3.99 55.71 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.698 -0.683 . . . . 4.17 110.476 -179.262 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 21.6 p -86.43 -16.12 38.15 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.574 -0.739 . . . . 4.04 111.127 179.727 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 557' ' ' SER . . . . . . . . . . . . . 13.3 m -88.43 -41.14 12.98 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.179 -0.464 . . . . 3.03 110.701 179.112 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 558' ' ' GLN . . . . . . . . . . . . . 53.4 mt-30 68.76 -1.49 1.99 Allowed 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 115.396 -0.82 . . . . 5.06 113.013 175.599 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 559' ' ' ASP . . . . . . . . . . . . . 28.8 p-10 -105.7 -18.46 14.07 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.078 0.466 . . . . 3.23 110.429 176.601 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 560' ' ' MET . . . . . 0.468 ' HG3' HG11 ' A' ' 553' ' ' VAL . 1.8 mpt? 63.96 21.75 12.73 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 115.241 -0.891 . . . . 2.61 112.397 174.872 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 561' ' ' ALA . . . . . 0.461 ' HA ' ' O ' ' A' ' 571' ' ' VAL . . . -144.5 152.67 40.93 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.015 0.436 . . . . 0.95 111.33 -178.659 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 33.4 p90 -142.76 151.7 41.52 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.219 -0.66 . . . . 0.9 109.219 170.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 563' ' ' LYS . . . . . . . . . . . . . 3.6 tppp? -88.8 117.98 28.17 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 109.269 -0.641 . . . . 2.18 109.269 -178.49 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 564' ' ' CYS . . . . . 0.479 ' HA ' ' HD3' ' A' ' 565' ' ' PRO . 41.7 t -68.26 112.96 12.45 Favored Pre-proline 0 C--O 1.223 -0.316 0 N-CA-C 109.578 -0.527 . . . . 0.41 109.578 179.035 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 565' ' ' PRO . . . . . 0.479 ' HD3' ' HA ' ' A' ' 564' ' ' CYS . 15.5 Cg_exo -71.77 -18.21 28.66 Favored 'Trans proline' 0 CA--C 1.527 0.162 0 C-N-CA 122.747 2.298 . . . . 0.63 113.299 -174.583 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 566' ' ' ILE . . . . . . . . . . . . . 26.4 mt -89.18 -38.32 11.15 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 N-CA-C 112.211 0.448 . . . . 0.94 112.211 -172.233 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 567' ' ' CYS . . . . . . . . . . . . . 28.6 p -127.74 1.21 6.09 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.512 -0.475 . . . . 0.7 111.65 178.67 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 568' ' ' LYS . . . . . 0.421 ' HA ' ' O ' ' A' ' 564' ' ' CYS . 54.3 mtpt 70.9 31.72 2.55 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 114.576 1.324 . . . . 2.71 114.576 163.782 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 569' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -95.72 149.38 21.55 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 108.605 -0.887 . . . . 3.34 108.605 170.173 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 570' ' ' THR . . . . . . . . . . . . . 57.0 m -84.02 117.06 23.16 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 109.045 -0.724 . . . . 1.01 109.045 172.844 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 571' ' ' VAL . . . . . 0.495 HG22 ' CE1' ' A' ' 596' ' ' HIS . 34.1 t -84.89 116.56 28.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-O 120.976 0.417 . . . . 0.73 111.108 -174.214 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 23.7 p -107.03 159.24 16.44 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.748 -0.66 . . . . 1.89 109.768 177.191 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . -130.5 155.68 21.24 Favored Glycine 0 N--CA 1.442 -0.926 0 C-N-CA 119.925 -1.131 . . . . 2.2 111.732 -178.233 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 574' ' ' VAL . . . . . 0.5 ' O ' HG22 ' A' ' 583' ' ' VAL . 40.5 t -118.0 148.44 20.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 109.838 -0.43 . . . . 3.24 109.838 -174.215 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 575' ' ' TYR . . . . . 0.46 ' HA ' ' HA ' ' A' ' 582' ' ' TRP . 47.6 t80 -84.22 119.46 25.06 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.797 -0.446 . . . . 3.02 109.797 178.147 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 576' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -95.84 113.38 25.0 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.97 0.414 . . . . 3.34 110.04 176.776 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 577' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -70.43 -22.69 62.69 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.42 -0.809 . . . . 5.59 112.074 -175.262 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 578' ' ' GLU . . . . . . . . . . . . . 15.8 tp10 -74.82 -46.39 36.98 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 121.023 -0.271 . . . . 5.11 110.854 -179.233 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 579' ' ' SER . . . . . . . . . . . . . 74.0 p -82.34 -20.96 36.27 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.111 0.482 . . . . 3.28 110.608 176.013 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 580' ' ' GLY . . . . . . . . . . . . . . . 79.54 20.21 69.45 Favored Glycine 0 N--CA 1.447 -0.578 0 CA-C-N 115.667 -0.697 . . . . 2.6 112.5 175.79 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 581' ' ' GLU . . . . . 0.43 ' OE1' ' HA ' ' A' ' 581' ' ' GLU . 8.7 mm-40 -138.1 160.26 39.85 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.24 0.543 . . . . 3.19 111.048 -177.901 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 582' ' ' TRP . . . . . 0.57 ' O ' ' HA ' ' A' ' 552' ' ' VAL . 80.3 m95 -79.55 137.84 37.29 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.609 -0.723 . . . . 2.3 109.361 174.322 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 583' ' ' VAL . . . . . 0.507 HG12 ' CE1' ' A' ' 550' ' ' TYR . 19.9 m -116.53 132.43 66.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 N-CA-C 113.667 0.988 . . . . 1.11 113.667 -172.122 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 584' ' ' TRP . . . . . 0.6 ' CD1' HG22 ' A' ' 553' ' ' VAL . 31.2 m0 -113.31 102.71 10.6 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 108.17 -1.048 . . . . 2.29 108.17 162.387 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 585' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.32 154.15 18.03 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.884 -0.327 . . . . 3.95 110.869 -176.212 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 586' ' ' ASN . . . . . . . . . . . . . 22.6 m-20 56.23 43.73 26.11 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 108.615 -0.884 . . . . 1.43 108.615 -170.112 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 587' ' ' THR . . . . . . . . . . . . . 34.3 m -133.98 141.13 47.16 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.098 -0.955 . . . . 0.65 110.513 -176.019 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 588' ' ' ILE . . . . . . . . . . . . . 12.7 tt -141.58 149.41 20.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.358 -0.383 . . . . 0.71 110.095 -178.74 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 589' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -97.73 122.65 41.08 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.887 -0.412 . . . . 1.35 109.887 177.246 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 590' ' ' VAL . . . . . . . . . . . . . 35.4 t -124.64 118.44 53.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 N-CA-C 109.761 -0.459 . . . . 0.65 109.761 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 591' ' ' ASN . . . . . . . . . . . . . 3.7 t30 55.58 40.99 31.12 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.418 -0.81 . . . . 2.03 110.988 177.458 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . 85.41 5.13 85.34 Favored Glycine 0 CA--C 1.52 0.365 0 C-N-CA 120.86 -0.686 . . . . 0.62 113.778 174.455 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 593' ' ' LYS . . . . . . . . . . . . . 56.0 mttp -127.84 144.89 51.08 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 117.363 0.582 . . . . 2.78 110.958 177.481 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 594' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -91.25 132.94 35.8 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.277 0.561 . . . . 1.45 110.711 -179.516 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 595' ' ' PHE . . . . . . . . . . . . . 72.0 m-85 -132.95 156.32 47.5 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.299 -0.864 . . . . 1.32 108.962 178.441 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 596' ' ' HIS . . . . . 0.495 ' CE1' HG22 ' A' ' 571' ' ' VAL . 11.3 m170 -60.98 126.97 29.3 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 108.384 -0.969 . . . . 0.59 108.384 167.775 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 597' ' ' SER . . . . . . . . . . . . . 23.2 t -65.15 -29.31 70.14 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.859 -0.609 . . . . 1.13 109.986 -177.506 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 598' ' ' THR . . . . . . . . . . . . . 2.6 m -66.8 -39.18 87.67 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 115.522 -0.763 . . . . 1.4 110.707 178.829 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 599' ' ' CYS . . . . . . . . . . . . . 86.1 m -74.68 -32.82 62.31 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.527 -0.76 . . . . 0.81 112.152 -174.882 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 600' ' ' TYR . . . . . . . . . . . . . 73.9 t80 -57.06 -34.68 68.5 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.928 0.394 . . . . 1.88 111.471 -172.337 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 601' ' ' HIS . . . . . . . . . . . . . 14.6 m-70 -61.91 -26.82 68.4 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.786 -0.643 . . . . 4.52 112.361 -177.221 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 602' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.49 -29.13 65.57 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 121.117 0.484 . . . . 3.85 110.13 -178.646 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 603' ' ' THR . . . . . . . . . . . . . 92.2 m . . . . . 0 C--N 1.326 -0.423 0 CA-C-N 115.841 -0.618 . . . . 3.3 110.811 -178.311 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 701' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.512 -0.147 0 N-CA-C 113.274 0.07 . . . . 3.2 113.274 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 549' ' ' LYS . . . . . 0.645 ' HD2' ' N ' ' A' ' 549' ' ' LYS . 6.5 mptt -81.29 150.35 28.56 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.379 0.609 . . . . 5.9 111.467 178.95 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 550' ' ' TYR . . . . . 0.509 ' CE1' HG12 ' A' ' 583' ' ' VAL . 16.6 p90 -111.19 161.88 15.52 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 114.92 -1.036 . . . . 2.79 110.072 -174.929 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 551' ' ' VAL . . . . . . . . . . . . . 84.9 t -118.08 133.28 65.38 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 N-CA-C 109.181 -0.674 . . . . 1.52 109.181 177.762 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 552' ' ' VAL . . . . . . . . . . . . . 59.1 t -63.92 134.66 28.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.725 -0.67 . . . . 1.38 109.815 -179.731 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 553' ' ' VAL . . . . . 0.603 HG22 ' CD1' ' A' ' 584' ' ' TRP . 86.3 t -60.07 121.01 55.78 Favored Pre-proline 0 N--CA 1.454 -0.233 0 O-C-N 123.618 0.574 . . . . 1.38 111.108 -176.936 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 554' ' ' PRO . . . . . 0.443 ' HB2' ' OG ' ' A' ' 557' ' ' SER . 16.6 Cg_exo -64.22 138.06 59.44 Favored 'Trans proline' 0 N--CA 1.461 -0.431 0 C-N-CA 123.167 2.578 . . . . 1.98 112.561 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 555' ' ' GLU . . . . . 0.48 ' H ' ' CD ' ' A' ' 555' ' ' GLU . 0.0 OUTLIER -84.41 -32.09 24.31 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.622 -0.717 . . . . 4.17 110.57 -178.413 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 19.0 p -82.15 6.88 15.11 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.398 -0.819 . . . . 4.04 112.329 -177.868 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 557' ' ' SER . . . . . 0.443 ' OG ' ' HB2' ' A' ' 554' ' ' PRO . 60.7 m -86.2 -2.78 58.68 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.952 -0.388 . . . . 3.03 109.952 174.143 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 558' ' ' GLN . . . . . . . . . . . . . 78.1 mm-40 68.65 -70.44 0.13 Allowed 'General case' 0 N--CA 1.465 0.305 0 O-C-N 123.987 0.804 . . . . 5.06 110.771 -178.656 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 559' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -94.77 146.27 24.3 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.544 -0.539 . . . . 3.23 109.544 177.711 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 560' ' ' MET . . . . . . . . . . . . . 67.0 mtm -92.12 29.59 1.6 Allowed 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 111.703 0.261 . . . . 2.61 111.703 -173.899 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 561' ' ' ALA . . . . . . . . . . . . . . . -145.39 157.96 43.93 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.364 -0.38 . . . . 0.95 110.54 178.387 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 35.0 p90 -153.33 158.39 41.48 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.736 -0.468 . . . . 0.9 109.736 174.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 563' ' ' LYS . . . . . . . . . . . . . 5.2 tppp? -89.43 127.32 35.82 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 110.191 -0.3 . . . . 2.18 110.191 179.215 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 564' ' ' CYS . . . . . 0.678 ' O ' ' HA ' ' A' ' 568' ' ' LYS . 47.7 t -71.02 114.44 27.23 Favored Pre-proline 0 C--O 1.222 -0.355 0 N-CA-C 109.48 -0.563 . . . . 0.41 109.48 175.493 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 565' ' ' PRO . . . . . 0.489 ' HD3' ' HA ' ' A' ' 564' ' ' CYS . 13.7 Cg_exo -72.21 -18.8 26.6 Favored 'Trans proline' 0 CA--C 1.528 0.208 0 C-N-CA 122.978 2.452 . . . . 0.63 113.887 -174.424 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 566' ' ' ILE . . . . . 0.483 HD12 ' HB3' ' A' ' 599' ' ' CYS . 65.9 mt -91.85 -55.14 6.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 112.191 0.441 . . . . 0.94 112.191 -172.019 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 567' ' ' CYS . . . . . . . . . . . . . 29.5 p -106.68 -6.35 17.94 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.251 -0.579 . . . . 0.7 111.043 178.584 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 568' ' ' LYS . . . . . 0.678 ' HA ' ' O ' ' A' ' 564' ' ' CYS . 99.4 mttt 70.98 32.92 2.22 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 114.64 1.348 . . . . 2.71 114.64 165.569 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 569' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -96.44 136.19 37.28 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 108.806 -0.813 . . . . 3.34 108.806 168.098 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 570' ' ' THR . . . . . . . . . . . . . 57.3 m -68.41 118.24 11.22 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.203 -0.453 . . . . 1.01 110.182 -179.7 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 571' ' ' VAL . . . . . 0.509 HG22 ' CE1' ' A' ' 596' ' ' HIS . 21.6 t -89.7 116.55 31.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 116.15 -0.477 . . . . 0.73 110.935 -175.66 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 29.2 p -115.18 161.37 18.52 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 109.011 -0.737 . . . . 1.89 109.011 173.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . -128.27 154.41 19.92 Favored Glycine 0 N--CA 1.437 -1.285 0 C-N-CA 119.468 -1.349 . . . . 2.2 111.089 -179.494 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 574' ' ' VAL . . . . . 0.412 ' O ' HG22 ' A' ' 583' ' ' VAL . 49.0 t -115.47 142.46 28.49 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-O 120.922 0.391 . . . . 3.24 110.308 -171.557 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 575' ' ' TYR . . . . . . . . . . . . . 45.3 t80 -79.96 118.93 22.15 Favored 'General case' 0 N--CA 1.443 -0.787 0 N-CA-C 109.568 -0.53 . . . . 3.02 109.568 175.688 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 576' ' ' ASP . . . . . . . . . . . . . 27.9 t0 -90.92 109.11 20.33 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.192 -0.669 . . . . 3.34 109.192 178.018 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 577' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -70.57 -23.9 62.68 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 115.008 -0.996 . . . . 5.59 111.309 -175.693 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 578' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -77.09 -34.2 56.91 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.149 -0.478 . . . . 5.11 111.056 -175.709 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 579' ' ' SER . . . . . . . . . . . . . 77.5 p -98.77 -20.66 16.78 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.351 0.595 . . . . 3.28 110.553 176.207 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 580' ' ' GLY . . . . . . . . . . . . . . . 80.43 28.04 49.54 Favored Glycine 0 N--CA 1.448 -0.506 0 CA-C-N 115.497 -0.774 . . . . 2.6 113.46 177.225 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 581' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -140.91 161.2 38.39 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 117.195 0.498 . . . . 3.19 111.48 178.15 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 582' ' ' TRP . . . . . . . . . . . . . 81.6 m95 -84.93 134.28 34.26 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.743 -0.466 . . . . 2.3 109.743 176.508 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 583' ' ' VAL . . . . . 0.509 HG12 ' CE1' ' A' ' 550' ' ' TYR . 15.6 m -115.84 136.63 52.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 N-CA-C 112.61 0.596 . . . . 1.11 112.61 -172.415 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 584' ' ' TRP . . . . . 0.603 ' CD1' HG22 ' A' ' 553' ' ' VAL . 18.9 m0 -113.59 104.42 12.23 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.478 -0.783 . . . . 2.29 108.982 165.758 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 585' ' ' LYS . . . . . 0.503 ' HG2' ' OD1' ' A' ' 586' ' ' ASN . 0.0 OUTLIER -88.77 151.25 22.51 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.639 0.257 . . . . 3.95 111.262 -175.137 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 586' ' ' ASN . . . . . 0.578 ' O ' ' HA ' ' A' ' 596' ' ' HIS . 8.0 m120 53.51 43.0 31.85 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 123.196 0.598 . . . . 1.43 110.019 -174.121 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 587' ' ' THR . . . . . . . . . . . . . 53.2 m -128.91 140.46 51.66 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.021 0.439 . . . . 0.65 111.425 -173.377 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 588' ' ' ILE . . . . . . . . . . . . . 14.8 tt -142.4 150.27 18.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.855 -0.611 . . . . 0.71 109.682 178.056 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 589' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -104.4 119.65 39.44 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.47 -0.567 . . . . 1.35 109.47 176.353 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 590' ' ' VAL . . . . . . . . . . . . . 58.5 t -125.37 117.41 49.6 Favored 'Isoleucine or valine' 0 C--O 1.239 0.552 0 CA-C-N 115.831 -0.622 . . . . 0.65 110.374 178.898 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 591' ' ' ASN . . . . . . . . . . . . . 95.0 m-20 57.36 45.8 19.4 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.379 -0.828 . . . . 2.03 112.172 176.538 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . 82.06 7.4 87.89 Favored Glycine 0 N--CA 1.45 -0.429 0 CA-C-N 115.927 -0.579 . . . . 0.62 112.329 173.318 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 593' ' ' LYS . . . . . 0.413 ' NZ ' ' HB2' ' A' ' 593' ' ' LYS . 8.1 mtmp? -129.97 137.86 50.54 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.823 0.344 . . . . 2.78 111.182 -177.557 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 594' ' ' TYR . . . . . . . . . . . . . 79.2 m-85 -94.21 132.38 38.83 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.016 -0.538 . . . . 1.45 110.567 179.514 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 595' ' ' PHE . . . . . . . . . . . . . 71.8 m-85 -138.41 159.35 42.28 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.013 -0.736 . . . . 1.32 109.013 177.053 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 596' ' ' HIS . . . . . 0.667 ' HB2' ' SG ' ' A' ' 599' ' ' CYS . 24.4 m170 -63.52 129.44 40.19 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 107.599 -1.26 . . . . 0.59 107.599 165.957 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 597' ' ' SER . . . . . . . . . . . . . 2.9 m -58.7 -32.41 69.14 Favored 'General case' 0 CA--C 1.519 -0.214 0 CA-C-O 121.577 0.703 . . . . 1.13 109.783 178.909 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 598' ' ' THR . . . . . . . . . . . . . 81.8 m -59.46 -39.9 85.14 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 114.573 -1.194 . . . . 1.4 110.534 173.606 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 599' ' ' CYS . . . . . 0.672 ' HA ' ' HG2' ' A' ' 602' ' ' GLU . 83.6 m -74.82 -34.99 62.45 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.969 -0.56 . . . . 0.81 112.329 -179.258 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 600' ' ' TYR . . . . . . . . . . . . . 79.6 t80 -61.01 -35.57 77.19 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 109.161 -0.681 . . . . 1.88 109.161 -179.142 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 601' ' ' HIS . . . . . . . . . . . . . 27.8 t60 -68.09 -42.99 79.52 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 115.581 -0.736 . . . . 4.52 110.288 177.628 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 602' ' ' GLU . . . . . 0.672 ' HG2' ' HA ' ' A' ' 599' ' ' CYS . 13.8 pt-20 -70.91 -33.74 70.84 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 111.863 0.32 . . . . 3.85 111.863 -176.447 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 603' ' ' THR . . . . . 0.468 ' HB ' HD13 ' A' ' 566' ' ' ILE . 15.3 t . . . . . 0 C--N 1.326 -0.434 0 O-C-N 122.167 -0.333 . . . . 3.3 111.243 -179.028 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 701' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.289 0 N-CA-C 113.593 0.197 . . . . 3.2 113.593 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 549' ' ' LYS . . . . . . . . . . . . . 29.6 mtpt -81.01 138.89 36.02 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.107 0.48 . . . . 5.9 110.473 177.447 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 550' ' ' TYR . . . . . 0.555 ' CE1' HG12 ' A' ' 583' ' ' VAL . 16.4 p90 -111.46 161.72 15.84 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.167 -0.924 . . . . 2.79 109.279 178.535 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 551' ' ' VAL . . . . . 0.515 HG11 ' HE1' ' A' ' 594' ' ' TYR . 57.4 t -116.47 133.52 62.79 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.992 0 N-CA-C 109.19 -0.67 . . . . 1.52 109.19 177.887 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 552' ' ' VAL . . . . . . . . . . . . . 48.3 t -67.89 130.72 33.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.912 -0.585 . . . . 1.38 110.361 -177.545 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 553' ' ' VAL . . . . . 0.637 HG22 ' CD1' ' A' ' 584' ' ' TRP . 64.1 t -59.2 122.61 64.72 Favored Pre-proline 0 C--N 1.328 -0.34 0 O-C-N 123.902 0.751 . . . . 1.38 111.048 -177.545 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 554' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_exo -59.9 142.78 99.22 Favored 'Trans proline' 0 N--CA 1.461 -0.391 0 C-N-CA 122.706 2.271 . . . . 1.98 111.442 176.709 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 555' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -47.86 -49.05 30.67 Favored 'General case' 0 C--O 1.235 0.319 0 O-C-N 123.608 0.567 . . . . 4.17 111.949 -171.57 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 22.8 p -108.17 -76.06 0.62 Allowed 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.959 -0.564 . . . . 4.04 111.879 -178.086 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 557' ' ' SER . . . . . . . . . . . . . 21.8 t 62.8 -84.63 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 109.509 -0.552 . . . . 3.03 109.509 -173.716 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 558' ' ' GLN . . . . . . . . . . . . . 82.9 mm-40 -147.54 -84.13 0.11 Allowed 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 108.602 -0.888 . . . . 5.06 108.602 174.632 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 559' ' ' ASP . . . . . . . . . . . . . 20.9 p-10 -121.05 46.24 2.08 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.149 -0.932 . . . . 3.23 109.239 173.365 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 560' ' ' MET . . . . . . . . . . . . . 57.4 mtt 59.52 33.26 22.11 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 115.087 -0.96 . . . . 2.61 110.259 -174.297 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 561' ' ' ALA . . . . . . . . . . . . . . . -144.21 161.18 39.54 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.048 -0.978 . . . . 0.95 110.517 -174.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 30.8 p90 -136.59 164.31 28.5 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 108.02 -1.104 . . . . 0.9 108.02 171.373 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 563' ' ' LYS . . . . . . . . . . . . . 29.2 ttpt -112.17 122.0 46.51 Favored 'General case' 0 C--N 1.32 -0.704 0 C-N-CA 120.399 -0.52 . . . . 2.18 110.675 -177.542 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 564' ' ' CYS . . . . . 0.424 ' HA ' ' HD3' ' A' ' 565' ' ' PRO . 44.2 t -74.39 111.91 14.91 Favored Pre-proline 0 N--CA 1.453 -0.322 0 CA-C-N 115.48 -0.782 . . . . 0.41 109.624 -178.49 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 565' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 564' ' ' CYS . 15.2 Cg_exo -72.34 -21.66 22.79 Favored 'Trans proline' 0 CA--C 1.528 0.202 0 C-N-CA 123.128 2.552 . . . . 0.63 113.843 -174.206 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 566' ' ' ILE . . . . . . . . . . . . . 18.4 mt -71.9 -39.19 66.93 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 CA-C-O 121.059 0.457 . . . . 0.94 110.476 -173.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 567' ' ' CYS . . . . . 0.594 ' SG ' ' HG3' ' A' ' 569' ' ' GLU . 27.4 p -129.81 2.53 4.9 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.873 -0.603 . . . . 0.7 112.534 -174.5 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 568' ' ' LYS . . . . . . . . . . . . . 52.5 mtpt 71.16 30.81 2.58 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 113.425 0.898 . . . . 2.71 113.425 175.047 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 569' ' ' GLU . . . . . 0.594 ' HG3' ' SG ' ' A' ' 567' ' ' CYS . 46.2 mt-10 -85.59 132.84 34.1 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 120.515 -0.474 . . . . 3.34 110.277 176.486 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 570' ' ' THR . . . . . . . . . . . . . 49.2 m -84.42 116.12 22.9 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 108.317 -0.994 . . . . 1.01 108.317 166.875 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 571' ' ' VAL . . . . . . . . . . . . . 12.7 t -98.08 116.29 40.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 115.947 -0.57 . . . . 0.73 110.856 -171.398 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 27.5 p -104.26 160.71 14.65 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.594 -0.73 . . . . 1.89 109.474 178.86 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . -128.66 157.18 21.36 Favored Glycine 0 N--CA 1.439 -1.114 0 C-N-CA 119.896 -1.145 . . . . 2.2 111.912 -176.546 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 574' ' ' VAL . . . . . . . . . . . . . 60.3 t -111.66 145.86 17.3 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-O 121.004 0.43 . . . . 3.24 110.231 -172.825 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 575' ' ' TYR . . . . . . . . . . . . . 45.3 t80 -78.52 118.49 20.7 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 108.917 -0.772 . . . . 3.02 108.917 174.771 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 576' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -91.66 102.76 15.39 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 109.154 -0.684 . . . . 3.34 109.154 -179.113 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 577' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -68.56 -23.0 64.45 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.276 -0.42 . . . . 5.59 111.635 -176.147 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 578' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -65.74 -43.98 87.35 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.409 -0.36 . . . . 5.11 110.603 -178.739 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 579' ' ' SER . . . . . . . . . . . . . 72.0 p -95.9 -20.61 18.64 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.109 0.48 . . . . 3.28 111.504 176.8 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 580' ' ' GLY . . . . . . . . . . . . . . . 80.71 21.38 63.93 Favored Glycine 0 N--CA 1.452 -0.244 0 CA-C-N 116.01 -0.541 . . . . 2.6 112.886 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 581' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -133.09 157.56 44.98 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.728 0.299 . . . . 3.19 110.597 179.676 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 582' ' ' TRP . . . . . 0.478 ' HB2' ' HB ' ' A' ' 553' ' ' VAL . 76.3 m95 -79.85 137.11 36.85 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.478 -0.328 . . . . 2.3 110.194 178.151 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 583' ' ' VAL . . . . . 0.555 HG12 ' CE1' ' A' ' 550' ' ' TYR . 20.5 m -118.81 141.48 38.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 113.251 0.834 . . . . 1.11 113.251 -173.409 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 584' ' ' TRP . . . . . 0.637 ' CD1' HG22 ' A' ' 553' ' ' VAL . 28.1 m0 -113.43 104.56 12.41 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 114.997 -1.001 . . . . 2.29 108.621 164.225 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 585' ' ' LYS . . . . . 0.497 ' HD2' ' CB ' ' A' ' 550' ' ' TYR . 10.9 mmmm -89.17 152.35 21.66 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.696 0.284 . . . . 3.95 110.491 -176.337 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 586' ' ' ASN . . . . . 0.414 ' O ' ' HA ' ' A' ' 596' ' ' HIS . 1.1 m-20 55.24 42.77 30.15 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 115.911 -0.586 . . . . 1.43 109.648 -173.601 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 587' ' ' THR . . . . . . . . . . . . . 53.3 m -126.33 140.23 52.68 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.114 0.483 . . . . 0.65 110.878 -175.491 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 588' ' ' ILE . . . . . . . . . . . . . 14.3 tt -137.25 145.3 29.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.832 -0.622 . . . . 0.71 109.644 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 589' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -103.17 121.14 42.04 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.064 0.459 . . . . 1.35 109.999 178.636 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 590' ' ' VAL . . . . . . . . . . . . . 43.5 t -131.6 127.65 59.6 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 115.594 -0.73 . . . . 0.65 109.662 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 591' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 59.63 33.26 21.93 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 121.947 0.88 . . . . 2.03 110.451 179.297 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . 77.78 9.82 86.64 Favored Glycine 0 N--CA 1.449 -0.436 0 CA-C-N 115.64 -0.709 . . . . 0.62 112.327 179.316 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 593' ' ' LYS . . . . . . . . . . . . . 70.1 mmtt -123.35 144.57 49.37 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 110.185 -0.302 . . . . 2.78 110.185 -175.676 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 594' ' ' TYR . . . . . 0.515 ' HE1' HG11 ' A' ' 551' ' ' VAL . 99.1 m-85 -96.28 134.27 39.6 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.878 0.37 . . . . 1.45 111.162 -177.2 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 595' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -139.18 162.66 34.42 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.681 -0.69 . . . . 1.32 109.631 178.258 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 596' ' ' HIS . . . . . 0.428 ' HB2' ' HB2' ' A' ' 599' ' ' CYS . 24.6 m170 -68.17 128.78 37.8 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 108.951 -0.759 . . . . 0.59 108.951 169.4 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 597' ' ' SER . . . . . . . . . . . . . 4.6 m -63.26 -36.42 83.61 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-O 121.467 0.651 . . . . 1.13 109.474 178.519 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 598' ' ' THR . . . . . . . . . . . . . 96.3 m -63.69 -44.76 92.74 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 114.704 -1.134 . . . . 1.4 111.188 177.225 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 599' ' ' CYS . . . . . 0.663 ' O ' ' HG2' ' A' ' 602' ' ' GLU . 83.3 m -76.45 -31.98 58.16 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.564 0.579 . . . . 0.81 112.564 -176.157 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 600' ' ' TYR . . . . . . . . . . . . . 87.5 t80 -57.03 -36.45 70.48 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.647 0.61 . . . . 1.88 112.647 -169.219 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 601' ' ' HIS . . . . . . . . . . . . . 18.5 m170 -64.17 -26.71 68.65 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 112.801 0.667 . . . . 4.52 112.801 -174.4 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 602' ' ' GLU . . . . . 0.663 ' HG2' ' O ' ' A' ' 599' ' ' CYS . 11.9 pt-20 -70.12 -23.48 63.03 Favored 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 120.313 -0.555 . . . . 3.85 111.077 -178.445 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 603' ' ' THR . . . . . . . . . . . . . 85.0 m . . . . . 0 C--N 1.328 -0.338 0 CA-C-O 121.31 0.576 . . . . 3.3 109.774 177.347 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 701' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.447 0 N-CA-C 112.504 -0.239 . . . . 3.2 112.504 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 549' ' ' LYS . . . . . 0.444 ' HD3' ' HA ' ' A' ' 549' ' ' LYS . 31.0 mmtp -76.13 150.86 37.14 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.615 0.721 . . . . 5.9 111.429 179.014 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 550' ' ' TYR . . . . . 0.591 ' CE1' HG12 ' A' ' 583' ' ' VAL . 46.9 p90 -114.81 162.97 16.17 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 114.594 -1.185 . . . . 2.79 110.761 -170.375 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 551' ' ' VAL . . . . . . . . . . . . . 60.5 t -117.03 134.01 61.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 N-CA-C 108.681 -0.859 . . . . 1.52 108.681 175.228 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 552' ' ' VAL . . . . . 0.595 ' HA ' ' O ' ' A' ' 582' ' ' TRP . 60.4 t -62.57 135.36 27.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.094 -0.503 . . . . 1.38 110.508 -176.622 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 553' ' ' VAL . . . . . 0.56 HG22 ' CD1' ' A' ' 584' ' ' TRP . 92.4 t -59.34 120.62 49.74 Favored Pre-proline 0 N--CA 1.455 -0.194 0 CA-C-N 116.034 -0.53 . . . . 1.38 110.464 -178.405 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 554' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 553' ' ' VAL . 33.5 Cg_exo -57.31 143.24 94.29 Favored 'Trans proline' 0 C--O 1.232 0.21 0 C-N-CA 123.653 2.902 . . . . 1.98 113.043 -178.526 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 555' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -72.33 -15.1 61.88 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.446 -0.797 . . . . 4.17 110.341 179.721 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 23.7 p -104.67 22.06 15.74 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.454 -0.794 . . . . 4.04 110.779 177.408 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 557' ' ' SER . . . . . . . . . . . . . 29.0 t -74.3 149.75 40.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.848 -0.615 . . . . 3.03 110.763 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 558' ' ' GLN . . . . . . . . . . . . . 82.2 mm-40 -90.69 89.3 7.46 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.112 -0.495 . . . . 5.06 109.952 -178.322 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 559' ' ' ASP . . . . . . . . . . . . . 10.8 t70 64.91 35.07 8.61 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 115.217 -0.902 . . . . 3.23 110.399 -179.233 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 560' ' ' MET . . . . . . . . . . . . . 1.9 mpt? 61.09 26.56 16.47 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 115.119 -0.946 . . . . 2.61 112.059 177.083 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 561' ' ' ALA . . . . . 0.493 ' HA ' ' O ' ' A' ' 571' ' ' VAL . . . -144.64 154.71 43.09 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.918 0.39 . . . . 0.95 111.486 -177.634 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 34.5 p90 -141.58 159.83 41.41 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 108.884 -0.784 . . . . 0.9 108.884 170.467 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 563' ' ' LYS . . . . . . . . . . . . . 23.3 tptm -99.87 122.52 42.94 Favored 'General case' 0 C--N 1.32 -0.713 0 C-N-CA 120.98 -0.288 . . . . 2.18 110.702 -176.066 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 564' ' ' CYS . . . . . 0.515 ' HB3' ' HG2' ' A' ' 569' ' ' GLU . 49.5 t -77.38 114.72 43.07 Favored Pre-proline 0 C--N 1.326 -0.425 0 N-CA-C 109.912 -0.403 . . . . 0.41 109.912 178.102 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 565' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 564' ' ' CYS . 13.4 Cg_exo -69.42 -28.85 26.37 Favored 'Trans proline' 0 C--N 1.343 0.263 0 C-N-CA 122.998 2.465 . . . . 0.63 113.539 -173.053 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 566' ' ' ILE . . . . . . . . . . . . . 51.9 mt -72.01 -55.62 12.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 121.005 0.431 . . . . 0.94 111.577 -175.537 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 567' ' ' CYS . . . . . . . . . . . . . 26.7 p -107.47 2.3 24.11 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 112.262 0.467 . . . . 0.7 112.262 -174.186 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 568' ' ' LYS . . . . . . . . . . . . . 44.8 mmtm 67.34 28.7 7.81 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 115.921 -0.581 . . . . 2.71 112.186 171.117 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 569' ' ' GLU . . . . . 0.515 ' HG2' ' HB3' ' A' ' 564' ' ' CYS . 17.4 pt-20 -99.5 135.51 40.8 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.705 -0.398 . . . . 3.34 110.35 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 570' ' ' THR . . . . . . . . . . . . . 88.5 m -80.66 119.1 22.85 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.649 -0.5 . . . . 1.01 109.649 174.154 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 571' ' ' VAL . . . . . 0.493 ' O ' ' HA ' ' A' ' 561' ' ' ALA . 11.7 t -92.27 116.72 34.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 116.179 -0.464 . . . . 0.73 111.039 -174.861 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 27.8 p -107.67 159.07 16.75 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 116.1 -0.5 . . . . 1.89 109.889 176.703 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . -130.79 155.78 21.37 Favored Glycine 0 N--CA 1.442 -0.939 0 C-N-CA 119.868 -1.158 . . . . 2.2 111.835 179.496 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 574' ' ' VAL . . . . . . . . . . . . . 23.9 t -114.09 149.96 16.26 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 N-CA-C 109.761 -0.459 . . . . 3.24 109.761 -175.148 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 575' ' ' TYR . . . . . 0.406 ' HA ' ' HA ' ' A' ' 582' ' ' TRP . 54.1 t80 -82.02 119.18 23.67 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 108.717 -0.846 . . . . 3.02 108.717 174.335 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 576' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -90.57 106.36 18.45 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 109.12 -0.696 . . . . 3.34 109.12 -178.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 577' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -69.36 -21.8 63.78 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.956 -0.565 . . . . 5.59 111.965 -176.854 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 578' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -67.6 -44.76 77.32 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.974 0.416 . . . . 5.11 110.527 -177.69 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 579' ' ' SER . . . . . . . . . . . . . 70.1 p -96.29 -23.67 16.56 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.281 0.562 . . . . 3.28 111.119 176.202 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 580' ' ' GLY . . . . . . . . . . . . . . . 81.81 31.48 32.48 Favored Glycine 0 CA--C 1.522 0.477 0 CA-C-N 115.497 -0.774 . . . . 2.6 113.018 -178.782 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 581' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -138.15 152.52 48.77 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 116.855 0.327 . . . . 3.19 110.675 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 582' ' ' TRP . . . . . 0.595 ' O ' ' HA ' ' A' ' 552' ' ' VAL . 80.5 m95 -76.8 136.69 38.97 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 109.639 -0.504 . . . . 2.3 109.639 176.411 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 583' ' ' VAL . . . . . 0.591 HG12 ' CE1' ' A' ' 550' ' ' TYR . 19.1 m -116.0 131.55 68.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 N-CA-C 113.502 0.927 . . . . 1.11 113.502 -173.118 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 584' ' ' TRP . . . . . 0.56 ' CD1' HG22 ' A' ' 553' ' ' VAL . 17.8 m0 -114.49 103.0 10.6 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 108.497 -0.927 . . . . 2.29 108.497 162.835 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 585' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.98 151.21 22.95 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.066 0.46 . . . . 3.95 111.991 -173.426 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 586' ' ' ASN . . . . . . . . . . . . . 18.9 m-20 52.68 41.7 31.46 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 115.23 -0.896 . . . . 1.43 110.192 -174.474 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 587' ' ' THR . . . . . . . . . . . . . 32.5 m -120.34 141.0 50.46 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.015 -0.539 . . . . 0.65 110.789 -177.132 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 588' ' ' ILE . . . . . . . . . . . . . 11.7 tt -137.98 141.54 38.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 N-CA-C 109.671 -0.492 . . . . 0.71 109.671 179.767 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 589' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -97.23 120.87 38.38 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.306 -0.628 . . . . 1.35 109.306 177.812 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 590' ' ' VAL . . . . . . . . . . . . . 61.9 t -127.17 118.2 49.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.634 -0.712 . . . . 0.65 110.549 179.653 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 591' ' ' ASN . . . . . . . . . . . . . 62.8 t30 58.62 38.91 25.11 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 115.459 -0.791 . . . . 2.03 111.617 176.112 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . 86.08 5.49 83.12 Favored Glycine 0 N--CA 1.45 -0.421 0 CA-C-N 115.86 -0.609 . . . . 0.62 113.17 175.344 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 593' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -128.74 139.75 52.06 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.917 0.389 . . . . 2.78 111.151 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 594' ' ' TYR . . . . . . . . . . . . . 85.1 m-85 -91.26 129.82 37.2 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.966 -0.561 . . . . 1.45 110.478 -179.218 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 595' ' ' PHE . . . . . . . . . . . . . 63.8 m-85 -135.0 162.9 31.13 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.896 -0.593 . . . . 1.32 109.682 177.235 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 596' ' ' HIS . . . . . 0.499 ' HB2' ' SG ' ' A' ' 599' ' ' CYS . 30.5 m170 -70.68 129.36 38.93 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.68 -0.489 . . . . 0.59 109.68 172.436 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 597' ' ' SER . . . . . . . . . . . . . 23.0 t -65.47 -30.47 71.25 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.783 -0.644 . . . . 1.13 109.598 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 598' ' ' THR . . . . . . . . . . . . . 1.8 m -66.52 -42.42 87.32 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 115.464 -0.789 . . . . 1.4 110.333 175.063 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 599' ' ' CYS . . . . . 0.499 ' SG ' ' HB2' ' A' ' 596' ' ' HIS . 78.6 m -73.83 -27.45 61.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.069 -0.969 . . . . 0.81 111.906 -178.778 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 600' ' ' TYR . . . . . . . . . . . . . 79.7 t80 -56.0 -35.29 66.64 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.696 0.284 . . . . 1.88 110.98 -174.894 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 601' ' ' HIS . . . . . . . . . . . . . 31.2 m170 -62.74 -28.13 69.75 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.006 0.432 . . . . 4.52 111.01 178.823 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 602' ' ' GLU . . . . . 0.413 ' HB3' ' O ' ' A' ' 599' ' ' CYS . 8.7 tp10 -70.81 -38.37 73.3 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.018 -0.537 . . . . 3.85 110.924 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 603' ' ' THR . . . . . . . . . . . . . 10.3 t . . . . . 0 C--N 1.327 -0.392 0 CA-C-O 121.203 0.525 . . . . 3.3 110.599 -176.594 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 701' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.509 -0.321 0 CA-C-O 120.915 0.175 . . . . 3.2 113.064 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 549' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -80.18 132.72 35.95 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.135 0.493 . . . . 5.9 110.559 179.392 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 550' ' ' TYR . . . . . 0.471 ' HB3' ' HD2' ' A' ' 585' ' ' LYS . 39.0 p90 -111.18 160.56 16.82 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.58 -0.737 . . . . 2.79 109.29 174.941 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 551' ' ' VAL . . . . . . . . . . . . . 70.2 t -117.72 133.36 64.75 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 N-CA-C 108.708 -0.849 . . . . 1.52 108.708 178.137 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 552' ' ' VAL . . . . . 0.582 ' HA ' ' O ' ' A' ' 582' ' ' TRP . 74.4 t -64.86 131.67 30.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.994 -0.548 . . . . 1.38 110.487 -178.291 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 553' ' ' VAL . . . . . 0.625 ' HB ' ' HB2' ' A' ' 582' ' ' TRP . 65.9 t -59.04 123.33 68.76 Favored Pre-proline 0 C--O 1.235 0.319 0 CA-C-N 116.073 -0.512 . . . . 1.38 110.08 178.932 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 554' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_exo -56.18 136.58 75.96 Favored 'Trans proline' 0 CA--C 1.529 0.241 0 C-N-CA 122.967 2.445 . . . . 1.98 112.577 -177.275 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 555' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -90.23 143.76 26.47 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.817 -0.629 . . . . 4.17 110.132 -176.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 28.6 p 47.6 36.3 5.26 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 123.428 0.691 . . . . 4.04 111.997 -176.891 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 557' ' ' SER . . . . . . . . . . . . . 15.5 t -102.99 49.62 0.83 Allowed 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 116.091 -0.504 . . . . 3.03 110.04 -178.658 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 558' ' ' GLN . . . . . . . . . . . . . 17.2 mm-40 71.76 -63.5 0.42 Allowed 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 115.26 -0.882 . . . . 5.06 111.616 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 559' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -143.68 -168.03 2.73 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.393 -0.595 . . . . 3.23 109.393 -177.488 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 560' ' ' MET . . . . . . . . . . . . . 41.7 mtm -115.62 15.28 16.58 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.67 0.271 . . . . 2.61 110.947 -173.671 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 561' ' ' ALA . . . . . . . . . . . . . . . -142.84 145.78 33.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.098 0.475 . . . . 0.95 112.231 -173.832 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 27.0 p90 -136.17 164.7 27.44 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 107.4 -1.333 . . . . 0.9 107.4 172.427 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 563' ' ' LYS . . . . . . . . . . . . . 35.5 ttmt -105.48 133.0 50.96 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 119.589 -0.844 . . . . 2.18 111.157 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 564' ' ' CYS . . . . . 0.431 ' O ' ' HA ' ' A' ' 568' ' ' LYS . 34.6 t -71.97 114.1 26.08 Favored Pre-proline 0 C--O 1.222 -0.385 0 CA-C-N 115.085 -0.961 . . . . 0.41 109.385 178.468 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 565' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -67.02 -30.79 38.45 Favored 'Trans proline' 0 CA--C 1.53 0.285 0 C-N-CA 122.588 2.192 . . . . 0.63 113.942 -172.613 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 566' ' ' ILE . . . . . . . . . . . . . 32.8 mt -71.61 -56.27 10.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.815 0.34 . . . . 0.94 111.53 -172.47 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 567' ' ' CYS . . . . . 0.521 ' SG ' ' HG3' ' A' ' 569' ' ' GLU . 28.5 p -108.05 0.71 21.91 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.99 0.424 . . . . 0.7 111.339 -177.604 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 568' ' ' LYS . . . . . 0.431 ' HA ' ' O ' ' A' ' 564' ' ' CYS . 52.7 mttp 67.57 30.56 6.6 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 113.145 0.795 . . . . 2.71 113.145 171.389 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 569' ' ' GLU . . . . . 0.521 ' HG3' ' SG ' ' A' ' 567' ' ' CYS . 35.7 mt-10 -77.96 133.44 38.03 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.78 -0.452 . . . . 3.34 109.78 171.85 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 570' ' ' THR . . . . . . . . . . . . . 52.8 m -76.16 117.31 17.73 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 108.68 -0.859 . . . . 1.01 108.68 167.278 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 571' ' ' VAL . . . . . . . . . . . . . 23.5 t -94.77 116.93 37.32 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-N 116.59 -0.277 . . . . 0.73 110.894 -172.708 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 24.1 p -111.89 159.59 18.21 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.748 -0.66 . . . . 1.89 109.536 175.532 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . -130.82 155.1 21.05 Favored Glycine 0 N--CA 1.442 -0.938 0 C-N-CA 119.933 -1.127 . . . . 2.2 111.799 -178.129 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 574' ' ' VAL . . . . . 0.465 ' O ' HG22 ' A' ' 583' ' ' VAL . 35.4 t -113.04 149.54 15.44 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 N-CA-C 109.614 -0.513 . . . . 3.24 109.614 -176.081 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 575' ' ' TYR . . . . . 0.529 ' HA ' ' HA ' ' A' ' 582' ' ' TRP . 59.8 t80 -83.76 119.41 24.78 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.593 0.235 . . . . 3.02 110.43 177.071 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 576' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -92.01 105.67 17.86 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.199 0.523 . . . . 3.34 110.024 175.236 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 577' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -63.87 -23.94 67.55 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.39 -0.823 . . . . 5.59 111.153 -178.184 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 578' ' ' GLU . . . . . . . . . . . . . 13.4 tt0 -72.25 -46.58 55.37 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.911 -0.586 . . . . 5.11 111.216 -174.422 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 579' ' ' SER . . . . . . . . . . . . . 75.7 p -87.54 -15.97 35.98 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.965 0.412 . . . . 3.28 110.743 175.102 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 580' ' ' GLY . . . . . . . . . . . . . . . 80.04 15.24 79.32 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 121.07 -0.586 . . . . 2.6 112.697 177.379 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 581' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -135.09 154.53 51.64 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.023 0.439 . . . . 3.19 110.596 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 582' ' ' TRP . . . . . 0.625 ' HB2' ' HB ' ' A' ' 553' ' ' VAL . 77.3 m95 -71.88 148.2 46.35 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.913 -0.585 . . . . 2.3 109.96 176.673 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 583' ' ' VAL . . . . . 0.465 HG22 ' O ' ' A' ' 574' ' ' VAL . 15.8 m -121.58 133.33 68.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 112.975 0.731 . . . . 1.11 112.975 -174.881 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 584' ' ' TRP . . . . . 0.612 ' CD1' HG22 ' A' ' 553' ' ' VAL . 27.0 m0 -110.31 103.79 12.5 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 108.262 -1.014 . . . . 2.29 108.262 162.868 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 585' ' ' LYS . . . . . 0.471 ' HD2' ' HB3' ' A' ' 550' ' ' TYR . 14.4 mmmm -82.08 152.0 26.78 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.877 0.37 . . . . 3.95 111.127 -175.312 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 586' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 54.76 41.9 31.57 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 115.424 -0.807 . . . . 1.43 109.632 -176.844 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 587' ' ' THR . . . . . . . . . . . . . 49.3 m -120.91 140.52 51.71 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.19 0.519 . . . . 0.65 110.628 -175.921 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 588' ' ' ILE . . . . . . . . . . . . . 15.1 tt -139.67 143.61 30.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.606 -0.725 . . . . 0.71 109.924 -177.812 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 589' ' ' GLU . . . . . 0.413 ' HA ' ' O ' ' A' ' 593' ' ' LYS . 0.8 OUTLIER -96.22 119.56 34.92 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.351 -0.611 . . . . 1.35 109.351 175.979 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 590' ' ' VAL . . . . . . . . . . . . . 27.3 t -128.36 120.75 53.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.253 -0.885 . . . . 0.65 109.343 179.028 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 591' ' ' ASN . . . . . . . . . . . . . 16.9 m120 59.36 34.66 22.9 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 121.175 0.512 . . . . 2.03 111.21 -179.004 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . 79.56 13.91 81.93 Favored Glycine 0 N--CA 1.445 -0.748 0 C-N-CA 120.981 -0.628 . . . . 0.62 112.15 177.836 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 593' ' ' LYS . . . . . 0.413 ' O ' ' HA ' ' A' ' 589' ' ' GLU . 46.7 mmtm -123.58 139.81 53.63 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.747 0.308 . . . . 2.78 110.535 -176.849 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 594' ' ' TYR . . . . . . . . . . . . . 75.5 m-85 -90.62 122.51 33.47 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.304 -0.407 . . . . 1.45 110.466 179.089 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 595' ' ' PHE . . . . . . . . . . . . . 44.8 m-85 -133.15 163.87 28.3 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.771 -0.65 . . . . 1.32 110.058 178.588 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 596' ' ' HIS . . . . . 0.412 ' HB3' HG22 ' A' ' 598' ' ' THR . 32.1 m170 -71.55 128.06 34.59 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.742 -0.836 . . . . 0.59 108.742 170.093 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 597' ' ' SER . . . . . . . . . . . . . 8.6 m -64.15 -29.99 71.08 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.159 -0.473 . . . . 1.13 110.277 -179.732 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 598' ' ' THR . . . . . 0.412 HG22 ' HB3' ' A' ' 596' ' ' HIS . 4.7 t -67.37 -38.91 85.51 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 115.376 -0.829 . . . . 1.4 110.968 179.724 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 599' ' ' CYS . . . . . . . . . . . . . 77.3 m -77.35 -34.64 55.1 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.954 -0.566 . . . . 0.81 112.495 -175.179 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 600' ' ' TYR . . . . . 0.416 ' O ' HG22 ' A' ' 603' ' ' THR . 85.0 t80 -56.75 -33.65 66.79 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 120.898 0.38 . . . . 1.88 111.92 -170.091 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 601' ' ' HIS . . . . . . . . . . . . . 28.7 m170 -59.74 -27.21 66.3 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 112.427 0.529 . . . . 4.52 112.427 -175.314 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 602' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -70.06 -31.08 68.51 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.734 0.302 . . . . 3.85 110.794 -176.959 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 603' ' ' THR . . . . . 0.416 HG22 ' O ' ' A' ' 600' ' ' TYR . 3.2 t . . . . . 0 CA--C 1.533 0.302 0 C-N-CA 120.55 -0.46 . . . . 3.3 111.66 -174.937 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 701' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.508 -0.351 0 N-CA-C 112.127 -0.389 . . . . 3.2 112.127 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 549' ' ' LYS . . . . . 0.422 ' HA ' ' HD3' ' A' ' 549' ' ' LYS . 71.3 mmtt -71.91 132.55 44.51 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.003 0.43 . . . . 5.9 110.871 -179.521 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 550' ' ' TYR . . . . . . . . . . . . . 21.2 p90 -125.66 159.63 31.73 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.232 -0.894 . . . . 2.79 109.286 177.588 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 551' ' ' VAL . . . . . . . . . . . . . 57.5 t -118.81 132.69 67.96 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 N-CA-C 109.073 -0.714 . . . . 1.52 109.073 177.917 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 552' ' ' VAL . . . . . 0.506 ' HA ' ' O ' ' A' ' 582' ' ' TRP . 67.9 t -65.19 127.04 25.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 109.642 -0.503 . . . . 1.38 109.642 178.668 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 553' ' ' VAL . . . . . 0.666 HG22 ' CD1' ' A' ' 584' ' ' TRP . 61.8 t -59.92 120.99 55.11 Favored Pre-proline 0 C--N 1.329 -0.313 0 O-C-N 123.495 0.497 . . . . 1.38 110.834 -176.238 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 554' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_exo -60.93 135.91 62.38 Favored 'Trans proline' 0 N--CA 1.461 -0.406 0 C-N-CA 122.785 2.323 . . . . 1.98 111.764 178.907 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 555' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -82.06 -0.78 46.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.234 0.54 . . . . 4.17 110.858 -179.245 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 24.4 p -80.46 -27.81 37.79 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.773 -0.649 . . . . 4.04 110.278 174.933 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 557' ' ' SER . . . . . . . . . . . . . 44.5 t -81.05 109.03 15.22 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 115.478 -0.783 . . . . 3.03 109.795 177.557 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 558' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -75.81 -1.44 25.17 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.052 0.453 . . . . 5.06 110.629 179.488 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 559' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -101.73 -18.61 15.74 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.612 -0.722 . . . . 3.23 110.679 176.331 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 560' ' ' MET . . . . . . . . . . . . . 2.0 mpt? 60.58 22.38 12.16 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 115.496 -0.775 . . . . 2.61 109.935 -173.396 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 561' ' ' ALA . . . . . . . . . . . . . . . -145.36 161.95 38.41 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.394 -0.821 . . . . 0.95 111.722 -171.923 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 31.0 p90 -142.82 155.03 44.73 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 107.781 -1.192 . . . . 0.9 107.781 170.117 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 563' ' ' LYS . . . . . 0.411 ' HA ' ' HA ' ' A' ' 570' ' ' THR . 78.7 tttt -99.15 120.83 40.15 Favored 'General case' 0 C--N 1.32 -0.715 0 C-N-CA 120.193 -0.603 . . . . 2.18 110.536 -176.254 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 564' ' ' CYS . . . . . . . . . . . . . 42.8 t -64.7 117.29 36.8 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 115.412 -0.813 . . . . 0.41 111.944 -174.79 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 565' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_exo -68.72 -22.01 37.93 Favored 'Trans proline' 0 CA--C 1.531 0.358 0 C-N-CA 123.128 2.552 . . . . 0.63 113.085 -179.621 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 566' ' ' ILE . . . . . 0.534 HG21 ' HB3' ' A' ' 599' ' ' CYS . 36.0 mm -74.47 -42.25 49.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 120.714 0.293 . . . . 0.94 111.569 -177.041 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 567' ' ' CYS . . . . . . . . . . . . . 28.8 p -123.56 0.9 8.86 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 111.923 0.342 . . . . 0.7 111.923 -174.172 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 568' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? 62.13 27.95 16.83 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.84 -0.618 . . . . 2.71 112.008 176.425 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 569' ' ' GLU . . . . . 0.42 ' HA ' ' OE1' ' A' ' 569' ' ' GLU . 6.3 mm-40 -107.37 137.4 45.49 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 116.298 -0.41 . . . . 3.34 110.463 177.637 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 570' ' ' THR . . . . . 0.411 ' HA ' ' HA ' ' A' ' 563' ' ' LYS . 37.4 m -69.24 123.91 22.41 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.76 -0.655 . . . . 1.01 110.396 -179.257 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 571' ' ' VAL . . . . . 0.444 HG22 ' CE1' ' A' ' 596' ' ' HIS . 18.0 t -96.62 115.41 35.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 116.376 -0.374 . . . . 0.73 110.087 -179.827 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 23.6 p -106.72 159.22 16.38 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 116.053 -0.521 . . . . 1.89 110.325 178.787 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . -130.35 155.73 21.23 Favored Glycine 0 N--CA 1.44 -1.084 0 C-N-CA 119.921 -1.133 . . . . 2.2 111.384 -178.933 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 574' ' ' VAL . . . . . 0.466 ' O ' HG22 ' A' ' 583' ' ' VAL . 41.2 t -111.85 147.2 15.88 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 N-CA-C 109.644 -0.502 . . . . 3.24 109.644 -172.503 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 575' ' ' TYR . . . . . 0.492 ' HA ' ' HA ' ' A' ' 582' ' ' TRP . 48.8 t80 -82.33 121.49 26.76 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.507 -0.553 . . . . 3.02 109.507 174.668 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 576' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -89.59 108.54 19.73 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.046 -0.724 . . . . 3.34 109.046 179.45 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 577' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -69.68 -23.03 63.39 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.417 -0.81 . . . . 5.59 111.816 -172.734 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 578' ' ' GLU . . . . . . . . . . . . . 45.4 tt0 -74.87 -48.35 25.38 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 121.044 -0.262 . . . . 5.11 110.858 -178.156 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 579' ' ' SER . . . . . . . . . . . . . 74.0 p -85.64 -19.16 31.38 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.019 0.438 . . . . 3.28 111.187 179.32 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 580' ' ' GLY . . . . . . . . . . . . . . . 79.13 22.36 65.72 Favored Glycine 0 N--CA 1.448 -0.535 0 CA-C-N 115.926 -0.579 . . . . 2.6 112.818 178.554 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 581' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -135.17 152.34 51.5 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.876 0.37 . . . . 3.19 110.8 -178.394 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 582' ' ' TRP . . . . . 0.506 ' O ' ' HA ' ' A' ' 552' ' ' VAL . 74.5 m95 -78.8 144.78 34.76 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.742 -0.663 . . . . 2.3 110.013 177.778 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 583' ' ' VAL . . . . . 0.466 HG22 ' O ' ' A' ' 574' ' ' VAL . 26.7 m -124.14 134.3 66.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 N-CA-C 112.719 0.637 . . . . 1.11 112.719 -175.001 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 584' ' ' TRP . . . . . 0.666 ' CD1' HG22 ' A' ' 553' ' ' VAL . 27.8 m0 -109.5 101.98 10.88 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 108.799 -0.815 . . . . 2.29 108.799 162.761 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 585' ' ' LYS . . . . . 0.403 ' HD3' ' OD1' ' A' ' 586' ' ' ASN . 0.0 OUTLIER -89.62 152.68 21.26 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.644 -0.253 . . . . 3.95 110.904 -177.217 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 586' ' ' ASN . . . . . 0.403 ' OD1' ' HD3' ' A' ' 585' ' ' LYS . 10.4 m120 55.34 46.22 23.9 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 109.385 -0.598 . . . . 1.43 109.385 -170.615 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 587' ' ' THR . . . . . . . . . . . . . 28.6 m -135.69 140.68 44.63 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.012 -0.54 . . . . 0.65 110.593 -177.933 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 588' ' ' ILE . . . . . . . . . . . . . 15.0 tt -141.9 146.49 22.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.305 -0.407 . . . . 0.71 110.404 -179.423 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 589' ' ' GLU . . . . . 0.409 ' HB2' ' CE2' ' A' ' 594' ' ' TYR . 33.4 tt0 -94.54 119.84 33.84 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.829 -0.434 . . . . 1.35 109.829 174.722 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 590' ' ' VAL . . . . . . . . . . . . . 61.3 t -125.49 121.57 60.58 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 N-CA-C 109.491 -0.559 . . . . 0.65 109.491 178.392 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 591' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 58.2 33.71 23.42 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.083 -0.508 . . . . 2.03 111.425 -179.231 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . 84.67 -1.58 88.74 Favored Glycine 0 N--CA 1.45 -0.378 0 CA-C-N 115.797 -0.638 . . . . 0.62 113.114 177.511 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 593' ' ' LYS . . . . . . . . . . . . . 70.5 mmtt -114.49 146.22 40.95 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.782 0.325 . . . . 2.78 111.254 -179.145 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 594' ' ' TYR . . . . . 0.409 ' CE2' ' HB2' ' A' ' 589' ' ' GLU . 80.4 m-85 -98.16 127.45 44.11 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.207 -0.451 . . . . 1.45 111.46 -176.198 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 595' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -135.13 162.53 32.24 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.531 -0.759 . . . . 1.32 109.704 177.865 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 596' ' ' HIS . . . . . 0.444 ' CE1' HG22 ' A' ' 571' ' ' VAL . 10.3 m170 -61.29 128.79 38.07 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.42 -0.585 . . . . 0.59 109.42 171.403 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 597' ' ' SER . . . . . . . . . . . . . 47.7 t -64.55 -29.57 70.6 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.244 -0.65 . . . . 1.13 109.244 176.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 598' ' ' THR . . . . . . . . . . . . . 5.2 m -67.98 -45.98 72.63 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-O 121.64 0.734 . . . . 1.4 110.233 175.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 599' ' ' CYS . . . . . 0.534 ' HB3' HG21 ' A' ' 566' ' ' ILE . 74.6 m -74.67 -30.67 61.67 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.376 -0.829 . . . . 0.81 112.566 -174.618 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 600' ' ' TYR . . . . . 0.447 ' O ' HG22 ' A' ' 603' ' ' THR . 85.0 t80 -57.47 -36.08 71.0 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.045 0.45 . . . . 1.88 110.762 -174.644 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 601' ' ' HIS . . . . . . . . . . . . . 41.2 m170 -66.59 -28.47 68.53 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.213 -0.449 . . . . 4.52 111.546 179.447 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 602' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -63.56 -32.75 74.31 Favored 'General case' 0 CA--C 1.52 -0.192 0 CA-C-O 120.686 0.279 . . . . 3.85 110.315 -175.884 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 603' ' ' THR . . . . . 0.447 HG22 ' O ' ' A' ' 600' ' ' TYR . 13.0 t . . . . . 0 N--CA 1.45 -0.473 0 CA-C-O 121.065 0.459 . . . . 3.3 110.713 -178.028 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 701' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.326 0 N-CA-C 112.546 -0.222 . . . . 3.2 112.546 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 549' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -67.46 149.51 50.12 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.368 0.604 . . . . 5.9 110.67 177.04 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 550' ' ' TYR . . . . . 0.599 ' HB3' ' HD3' ' A' ' 585' ' ' LYS . 9.5 p90 -124.29 160.29 28.35 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.331 -0.849 . . . . 2.79 110.947 -173.403 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 551' ' ' VAL . . . . . . . . . . . . . 96.9 t -118.95 133.19 66.61 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 N-CA-C 108.704 -0.85 . . . . 1.52 108.704 172.726 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 552' ' ' VAL . . . . . 0.544 ' HA ' ' O ' ' A' ' 582' ' ' TRP . 47.4 t -65.34 131.74 31.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 116.238 -0.437 . . . . 1.38 110.112 -178.995 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 553' ' ' VAL . . . . . 0.683 HG22 ' CD1' ' A' ' 584' ' ' TRP . 26.3 t -63.56 120.99 67.62 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.249 -0.432 . . . . 1.38 109.967 -179.677 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 554' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 553' ' ' VAL . 44.5 Cg_exo -57.03 135.88 73.4 Favored 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.959 2.44 . . . . 1.98 113.025 -177.323 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 555' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -104.52 -4.77 22.24 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.416 0.627 . . . . 4.17 110.059 175.929 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 24.2 p -86.05 -4.59 59.2 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.356 -0.838 . . . . 4.04 110.116 175.897 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 557' ' ' SER . . . . . . . . . . . . . 39.5 m -100.62 138.35 37.8 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 115.193 -0.912 . . . . 3.03 110.157 -179.497 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 558' ' ' GLN . . . . . . . . . . . . . 61.7 mt-30 -73.73 -35.24 65.04 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.618 -0.719 . . . . 5.06 109.549 178.658 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 559' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -107.3 109.67 21.5 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.188 -0.915 . . . . 3.23 109.402 172.024 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 560' ' ' MET . . . . . . . . . . . . . 81.5 mtp -80.45 39.7 0.47 Allowed 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 121.168 0.509 . . . . 2.61 110.682 -176.295 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 561' ' ' ALA . . . . . . . . . . . . . . . -145.82 162.2 38.23 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.897 -0.592 . . . . 0.95 109.89 -177.771 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 35.1 p90 -138.5 145.97 41.42 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 120.437 -0.505 . . . . 0.9 110.022 173.172 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 563' ' ' LYS . . . . . . . . . . . . . 50.2 tptt -88.62 111.18 21.61 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 116.134 -0.484 . . . . 2.18 110.06 -178.575 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 564' ' ' CYS . . . . . 0.411 ' HA ' ' HD3' ' A' ' 565' ' ' PRO . 42.4 t -68.72 112.09 10.25 Favored Pre-proline 0 C--N 1.333 -0.145 0 N-CA-C 109.183 -0.673 . . . . 0.41 109.183 179.266 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 565' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 564' ' ' CYS . 15.4 Cg_exo -71.57 -17.77 29.69 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 123.042 2.494 . . . . 0.63 111.751 -175.293 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 566' ' ' ILE . . . . . 0.406 HD12 ' HB3' ' A' ' 599' ' ' CYS . 45.6 mt -80.16 -51.9 15.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.233 -0.894 . . . . 0.94 111.044 -175.687 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 567' ' ' CYS . . . . . . . . . . . . . 28.9 p -105.12 -1.7 25.21 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.363 -0.381 . . . . 0.7 111.237 -176.572 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 568' ' ' LYS . . . . . . . . . . . . . 35.6 mtmm 65.41 22.54 11.95 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 112.646 0.61 . . . . 2.71 112.646 174.48 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 569' ' ' GLU . . . . . . . . . . . . . 15.9 mm-40 -105.81 135.26 47.56 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.654 0.264 . . . . 3.34 110.479 177.064 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 570' ' ' THR . . . . . . . . . . . . . 49.2 m -75.54 126.08 30.29 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.508 -0.552 . . . . 1.01 109.508 177.059 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 571' ' ' VAL . . . . . . . . . . . . . 16.2 t -100.42 115.26 41.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 116.511 -0.313 . . . . 0.73 110.888 -175.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 24.6 p -105.3 161.83 13.96 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.022 -0.733 . . . . 1.89 109.022 174.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . -127.6 154.0 19.46 Favored Glycine 0 N--CA 1.436 -1.305 0 C-N-CA 119.134 -1.508 . . . . 2.2 111.68 -179.012 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 574' ' ' VAL . . . . . . . . . . . . . 44.5 t -111.32 145.14 17.94 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 CA-C-O 120.898 0.38 . . . . 3.24 110.059 -171.1 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 575' ' ' TYR . . . . . . . . . . . . . 38.7 t80 -76.93 118.44 19.52 Favored 'General case' 0 N--CA 1.439 -1.021 0 N-CA-C 108.956 -0.757 . . . . 3.02 108.956 174.177 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 576' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -89.72 96.95 10.92 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 108.469 -0.938 . . . . 3.34 108.469 -177.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 577' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -63.66 -22.73 67.06 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.53 -0.759 . . . . 5.59 111.907 -175.164 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 578' ' ' GLU . . . . . . . . . . . . . 19.0 mm-40 -66.14 -43.52 86.84 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.182 -0.463 . . . . 5.11 110.547 -179.694 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 579' ' ' SER . . . . . 0.411 ' OG ' ' HG2' ' A' ' 581' ' ' GLU . 68.3 p -100.46 -19.72 16.1 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.045 -0.525 . . . . 3.28 111.696 -179.599 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 580' ' ' GLY . . . . . . . . . . . . . . . 80.66 30.49 39.62 Favored Glycine 0 CA--C 1.524 0.6 0 CA-C-N 115.85 -0.614 . . . . 2.6 113.264 179.28 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 581' ' ' GLU . . . . . 0.411 ' HG2' ' OG ' ' A' ' 579' ' ' SER . 17.3 pt-20 -139.07 156.44 47.17 Favored 'General case' 0 C--N 1.326 -0.442 0 O-C-N 122.304 -0.527 . . . . 3.19 110.682 179.837 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 582' ' ' TRP . . . . . 0.591 ' HB3' ' HB ' ' A' ' 553' ' ' VAL . 90.2 m95 -82.04 134.26 35.34 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.512 -0.551 . . . . 2.3 109.512 176.241 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 583' ' ' VAL . . . . . . . . . . . . . 33.5 m -123.0 134.03 67.33 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 N-CA-C 113.793 1.034 . . . . 1.11 113.793 -173.666 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 584' ' ' TRP . . . . . 0.683 ' CD1' HG22 ' A' ' 553' ' ' VAL . 33.5 m0 -113.85 103.76 11.51 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 107.893 -1.151 . . . . 2.29 107.893 161.914 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 585' ' ' LYS . . . . . 0.599 ' HD3' ' HB3' ' A' ' 550' ' ' TYR . 35.3 mmtp -81.56 142.67 32.62 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.777 -0.369 . . . . 3.95 110.768 -175.84 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 586' ' ' ASN . . . . . . . . . . . . . 22.1 m-20 55.23 50.0 16.02 Favored 'General case' 0 CA--C 1.516 -0.335 0 CA-C-N 115.38 -0.827 . . . . 1.43 109.889 -178.292 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 587' ' ' THR . . . . . . . . . . . . . 41.1 m -125.03 141.41 52.14 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.907 -0.588 . . . . 0.65 109.965 -179.417 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 588' ' ' ILE . . . . . . . . . . . . . 12.9 tt -140.57 144.21 27.71 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 N-CA-C 109.841 -0.429 . . . . 0.71 109.841 -178.801 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 589' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -96.78 119.13 34.69 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 108.68 -0.859 . . . . 1.35 108.68 176.953 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 590' ' ' VAL . . . . . . . . . . . . . 56.3 t -125.1 118.83 54.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.997 -0.547 . . . . 0.65 109.989 -178.764 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 591' ' ' ASN . . . . . . . . . . . . . 12.3 m120 58.1 36.57 26.05 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.932 -0.577 . . . . 2.03 112.334 176.326 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . 86.57 6.65 80.18 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 121.194 -0.527 . . . . 0.62 113.682 175.573 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 593' ' ' LYS . . . . . . . . . . . . . 27.8 mtpp -129.1 146.39 51.06 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 117.204 0.502 . . . . 2.78 110.933 176.917 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 594' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -91.16 133.97 34.92 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.895 -0.593 . . . . 1.45 110.836 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 595' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -139.12 160.46 39.73 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.829 -0.623 . . . . 1.32 109.716 176.362 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 596' ' ' HIS . . . . . 0.75 ' HB2' ' SG ' ' A' ' 599' ' ' CYS . 37.7 m80 -67.16 130.5 43.32 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.314 -0.995 . . . . 0.59 108.314 169.229 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 597' ' ' SER . . . . . . . . . . . . . 11.4 m -60.75 -31.88 71.19 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.283 -0.417 . . . . 1.13 110.252 179.471 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 598' ' ' THR . . . . . . . . . . . . . 3.6 t -69.22 -35.23 75.97 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.397 0.618 . . . . 1.4 110.33 174.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 599' ' ' CYS . . . . . 0.75 ' SG ' ' HB2' ' A' ' 596' ' ' HIS . 91.2 m -73.98 -29.58 62.05 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.819 -0.628 . . . . 0.81 112.595 -176.162 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 600' ' ' TYR . . . . . . . . . . . . . 43.9 t80 -57.26 -35.0 69.2 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.125 -0.695 . . . . 1.88 109.125 -178.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 601' ' ' HIS . . . . . . . . . . . . . 56.9 m80 -74.7 -41.16 60.71 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.638 -0.71 . . . . 4.52 111.814 176.15 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 602' ' ' GLU . . . . . 0.699 ' HG2' ' HA ' ' A' ' 599' ' ' CYS . 22.5 pt-20 -67.81 -25.72 65.71 Favored 'General case' 0 N--CA 1.467 0.411 0 O-C-N 122.094 -0.379 . . . . 3.85 110.87 -176.65 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 603' ' ' THR . . . . . . . . . . . . . 14.1 t . . . . . 0 CA--C 1.533 0.309 0 N-CA-C 111.994 0.368 . . . . 3.3 111.994 -179.639 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 701' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.452 0 N-CA-C 111.141 -0.784 . . . . 3.2 111.141 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 549' ' ' LYS . . . . . 0.433 ' HA ' ' HD3' ' A' ' 549' ' ' LYS . 37.1 mmtm -73.18 147.39 44.81 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-O 121.673 0.749 . . . . 5.9 111.061 179.82 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 550' ' ' TYR . . . . . 0.49 ' CE1' HG12 ' A' ' 583' ' ' VAL . 29.2 p90 -124.76 162.18 24.81 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 114.764 -1.107 . . . . 2.79 109.703 -175.73 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 551' ' ' VAL . . . . . 0.432 HG11 ' HE1' ' A' ' 594' ' ' TYR . 96.3 t -117.39 133.61 63.62 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 N-CA-C 109.016 -0.735 . . . . 1.52 109.016 175.863 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 552' ' ' VAL . . . . . 0.503 ' HA ' ' O ' ' A' ' 582' ' ' TRP . 56.9 t -62.99 132.15 28.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.928 -0.578 . . . . 1.38 109.802 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 553' ' ' VAL . . . . . 0.604 HG22 ' CD1' ' A' ' 584' ' ' TRP . 65.8 t -60.79 120.67 55.35 Favored Pre-proline 0 C--N 1.33 -0.247 0 O-C-N 123.74 0.65 . . . . 1.38 111.505 -175.948 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 554' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo -70.15 138.16 35.94 Favored 'Trans proline' 0 N--CA 1.462 -0.331 0 C-N-CA 123.194 2.596 . . . . 1.98 111.939 176.169 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 555' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -72.81 -35.8 67.4 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.439 0.638 . . . . 4.17 110.283 179.298 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 23.1 p -94.81 85.07 4.32 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.537 -0.756 . . . . 4.04 111.565 -175.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 557' ' ' SER . . . . . . . . . . . . . 32.5 t -157.99 -100.76 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.613 -0.514 . . . . 3.03 109.613 176.204 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 558' ' ' GLN . . . . . . . . . . . . . 80.2 mt-30 -126.16 -136.76 0.26 Allowed 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.476 -0.564 . . . . 5.06 109.476 173.6 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 559' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -76.66 47.92 0.53 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.685 0.278 . . . . 3.23 110.408 178.291 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 560' ' ' MET . . . . . 0.512 ' HB3' HG11 ' A' ' 553' ' ' VAL . 65.3 mtt 58.11 29.6 18.09 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-O 121.553 0.692 . . . . 2.61 110.119 -172.514 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 561' ' ' ALA . . . . . . . . . . . . . . . -144.98 161.73 38.65 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 115.279 -0.873 . . . . 0.95 110.902 -175.214 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 33.8 p90 -150.06 163.7 37.47 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 107.796 -1.187 . . . . 0.9 107.796 173.69 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 563' ' ' LYS . . . . . . . . . . . . . 7.7 ttmm -106.63 126.33 52.14 Favored 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 119.44 -0.904 . . . . 2.18 109.935 179.12 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 564' ' ' CYS . . . . . 0.414 ' HA ' ' HD3' ' A' ' 565' ' ' PRO . 48.6 t -69.3 112.06 10.62 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 115.523 -0.762 . . . . 0.41 109.601 -178.5 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 565' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 564' ' ' CYS . 17.2 Cg_exo -70.67 -29.9 18.87 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 123.318 2.678 . . . . 0.63 113.686 -173.525 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 566' ' ' ILE . . . . . . . . . . . . . 26.8 mt -70.74 -34.84 58.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.308 -0.405 . . . . 0.94 111.184 -172.497 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 567' ' ' CYS . . . . . 0.447 ' SG ' ' HG3' ' A' ' 569' ' ' GLU . 28.7 p -129.07 3.61 5.27 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 112.855 0.687 . . . . 0.7 112.855 -175.257 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 568' ' ' LYS . . . . . . . . . . . . . 61.9 mmtt 71.21 30.21 2.68 Favored 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 113.028 0.751 . . . . 2.71 113.028 175.45 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 569' ' ' GLU . . . . . 0.447 ' HG3' ' SG ' ' A' ' 567' ' ' CYS . 45.2 mt-10 -90.11 131.71 35.82 Favored 'General case' 0 N--CA 1.468 0.448 0 O-C-N 121.953 -0.467 . . . . 3.34 110.662 176.794 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 570' ' ' THR . . . . . . . . . . . . . 47.2 m -75.7 117.85 17.9 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 108.917 -0.772 . . . . 1.01 108.917 164.558 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 571' ' ' VAL . . . . . 0.401 HG22 ' CE1' ' A' ' 596' ' ' HIS . 20.2 t -100.66 116.49 44.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 120.808 0.337 . . . . 0.73 111.344 -172.949 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 33.4 p -110.41 160.01 16.97 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.908 -0.587 . . . . 1.89 109.914 176.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . -129.8 155.03 20.74 Favored Glycine 0 N--CA 1.442 -0.929 0 C-N-CA 119.761 -1.209 . . . . 2.2 111.875 -178.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 574' ' ' VAL . . . . . 0.488 ' O ' HG22 ' A' ' 583' ' ' VAL . 27.6 t -120.39 148.82 23.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-O 120.757 0.313 . . . . 3.24 110.234 -172.549 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 575' ' ' TYR . . . . . . . . . . . . . 66.2 t80 -83.69 119.14 24.41 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.5 -0.318 . . . . 3.02 110.261 177.079 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 576' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -94.99 114.23 26.02 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.772 -0.455 . . . . 3.34 109.772 178.133 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 577' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -69.21 -23.41 63.89 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.122 -0.49 . . . . 5.59 112.231 -174.347 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 578' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -74.7 -41.41 60.26 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.002 0.43 . . . . 5.11 110.773 -177.276 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 579' ' ' SER . . . . . . . . . . . . . 67.7 p -86.31 -25.58 25.37 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.228 -0.442 . . . . 3.28 110.938 176.46 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 580' ' ' GLY . . . . . . . . . . . . . . . 80.28 15.98 77.29 Favored Glycine 0 N--CA 1.451 -0.348 0 CA-C-N 115.865 -0.607 . . . . 2.6 112.584 179.006 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 581' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 -130.74 161.12 32.39 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.863 0.363 . . . . 3.19 110.386 -178.492 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 582' ' ' TRP . . . . . 0.503 ' O ' ' HA ' ' A' ' 552' ' ' VAL . 76.1 m95 -83.04 134.42 35.03 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.38 -0.6 . . . . 2.3 109.38 175.108 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 583' ' ' VAL . . . . . 0.49 HG12 ' CE1' ' A' ' 550' ' ' TYR . 16.9 m -113.17 133.63 58.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 N-CA-C 113.487 0.921 . . . . 1.11 113.487 -171.753 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 584' ' ' TRP . . . . . 0.604 ' CD1' HG22 ' A' ' 553' ' ' VAL . 29.0 m0 -108.44 101.35 10.54 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.114 -1.069 . . . . 2.29 108.114 161.154 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 585' ' ' LYS . . . . . 0.5 ' HD2' ' H ' ' A' ' 585' ' ' LYS . 0.0 OUTLIER -76.4 145.66 39.23 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.415 -0.357 . . . . 3.95 111.211 -174.281 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 586' ' ' ASN . . . . . . . . . . . . . 32.3 m-20 48.85 50.3 17.78 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 115.668 -0.696 . . . . 1.43 110.37 -179.692 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 587' ' ' THR . . . . . . . . . . . . . 45.5 m -127.1 142.72 51.45 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.674 -0.694 . . . . 0.65 109.948 -178.436 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 588' ' ' ILE . . . . . . . . . . . . . 13.3 tt -139.35 147.77 24.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 109.476 -0.564 . . . . 0.71 109.476 179.601 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 589' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -103.1 121.86 43.48 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.124 0.487 . . . . 1.35 109.799 178.719 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 590' ' ' VAL . . . . . . . . . . . . . 64.8 t -134.54 130.91 53.97 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.621 0 CA-C-N 115.537 -0.756 . . . . 0.65 109.144 178.762 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 591' ' ' ASN . . . . . . . . . . . . . 64.6 t30 59.19 33.24 22.63 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 121.391 0.615 . . . . 2.03 110.77 178.731 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . 77.22 11.92 85.08 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.937 -0.649 . . . . 0.62 112.487 178.332 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 593' ' ' LYS . . . . . . . . . . . . . 34.1 mmtp -126.42 139.68 53.07 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.777 0.322 . . . . 2.78 110.533 -178.057 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 594' ' ' TYR . . . . . 0.432 ' HE1' HG11 ' A' ' 551' ' ' VAL . 95.0 m-85 -89.85 132.06 35.46 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 116.067 -0.515 . . . . 1.45 110.273 177.695 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 595' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -134.94 154.63 51.63 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 108.914 -0.773 . . . . 1.32 108.914 175.405 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 596' ' ' HIS . . . . . 0.401 ' CE1' HG22 ' A' ' 571' ' ' VAL . 26.9 m170 -62.34 128.13 34.6 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 108.446 -0.946 . . . . 0.59 108.446 169.733 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 597' ' ' SER . . . . . . . . . . . . . 31.0 t -63.3 -29.96 71.18 Favored 'General case' 0 C--N 1.322 -0.592 0 O-C-N 123.701 0.626 . . . . 1.13 109.852 -177.274 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 598' ' ' THR . . . . . . . . . . . . . 1.8 t -67.09 -41.54 86.16 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 115.715 -0.675 . . . . 1.4 110.776 175.771 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 599' ' ' CYS . . . . . 0.41 ' O ' ' HG3' ' A' ' 602' ' ' GLU . 74.2 m -75.82 -31.88 59.57 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.892 -0.595 . . . . 0.81 111.574 -177.611 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 600' ' ' TYR . . . . . . . . . . . . . 72.4 t80 -57.03 -33.1 66.86 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.038 -0.528 . . . . 1.88 112.067 -173.566 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 601' ' ' HIS . . . . . . . . . . . . . 33.7 m170 -58.46 -26.4 63.33 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 112.781 0.66 . . . . 4.52 112.781 -173.276 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 602' ' ' GLU . . . . . 0.41 ' HG3' ' O ' ' A' ' 599' ' ' CYS . 3.0 pp20? -62.1 -30.54 71.08 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-O 120.949 0.404 . . . . 3.85 110.849 -178.881 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 603' ' ' THR . . . . . . . . . . . . . 1.1 m . . . . . 0 CA--C 1.537 0.469 0 CA-C-O 120.981 0.42 . . . . 3.3 111.161 -177.138 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 701' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.519 0.328 0 N-CA-C 113.676 0.231 . . . . 3.2 113.676 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 549' ' ' LYS . . . . . . . . . . . . . 28.8 mtpp -81.1 142.24 33.5 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 117.247 0.524 . . . . 5.9 110.931 177.393 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 550' ' ' TYR . . . . . 0.447 ' CE1' HG12 ' A' ' 583' ' ' VAL . 24.9 p90 -116.35 159.97 21.17 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.066 -0.716 . . . . 2.79 109.066 176.246 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 551' ' ' VAL . . . . . 0.753 HG11 ' HE1' ' A' ' 594' ' ' TYR . 39.9 t -119.97 136.58 56.59 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 N-CA-C 109.154 -0.684 . . . . 1.52 109.154 176.735 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 552' ' ' VAL . . . . . 0.557 ' HA ' ' O ' ' A' ' 582' ' ' TRP . 62.9 t -66.33 133.63 30.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 110.449 -0.204 . . . . 1.38 110.449 -178.796 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 553' ' ' VAL . . . . . 0.635 HG22 ' CD1' ' A' ' 584' ' ' TRP . 80.7 t -61.99 120.99 62.54 Favored Pre-proline 0 C--N 1.331 -0.227 0 CA-C-N 116.228 -0.442 . . . . 1.38 111.254 -177.386 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 554' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' ' 553' ' ' VAL . 7.1 Cg_exo -69.1 137.43 37.36 Favored 'Trans proline' 0 N--CA 1.46 -0.483 0 C-N-CA 122.871 2.381 . . . . 1.98 112.45 179.19 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 555' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -89.94 -1.61 58.01 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.285 0.564 . . . . 4.17 109.883 176.106 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 23.2 p -81.88 40.5 0.61 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.728 0.775 . . . . 4.04 110.319 175.47 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 557' ' ' SER . . . . . . . . . . . . . 46.8 t -157.62 141.31 15.71 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-N 114.719 -1.128 . . . . 3.03 108.109 -177.37 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 558' ' ' GLN . . . . . . . . . . . . . 15.9 mm-40 -78.48 -26.32 46.01 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.976 0.417 . . . . 5.06 110.284 -179.613 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 559' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -105.23 136.24 45.11 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.63 -0.714 . . . . 3.23 109.778 176.215 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 560' ' ' MET . . . . . . . . . . . . . 2.1 mpt? -83.8 18.45 1.98 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.239 0.543 . . . . 2.61 110.311 178.352 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 561' ' ' ALA . . . . . . . . . . . . . . . -144.32 151.15 38.95 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 115.622 -0.717 . . . . 0.95 110.036 -176.814 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 45.9 p90 -128.2 150.27 50.09 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 110.015 -0.365 . . . . 0.9 110.015 177.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 563' ' ' LYS . . . . . 0.459 ' HE3' ' O ' ' A' ' 568' ' ' LYS . 47.5 tptt -89.6 113.81 25.3 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.001 -0.74 . . . . 2.18 109.001 -178.513 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 564' ' ' CYS . . . . . . . . . . . . . 47.1 t -62.56 113.55 9.29 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 116.461 -0.336 . . . . 0.41 110.902 -175.859 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 565' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -67.65 -27.95 38.03 Favored 'Trans proline' 0 CA--C 1.53 0.284 0 C-N-CA 123.074 2.516 . . . . 0.63 112.778 -176.026 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 566' ' ' ILE . . . . . . . . . . . . . 42.8 mt -71.73 -38.15 65.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 111.969 0.359 . . . . 0.94 111.969 -174.907 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 567' ' ' CYS . . . . . . . . . . . . . 28.5 p -129.2 1.08 5.18 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.427 0.528 . . . . 0.7 112.427 -174.729 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 568' ' ' LYS . . . . . 0.459 ' O ' ' HE3' ' A' ' 563' ' ' LYS . 50.3 mtpt 66.27 30.93 8.85 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 121.055 0.455 . . . . 2.71 111.753 176.105 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 569' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -105.67 135.23 47.46 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.003 -0.544 . . . . 3.34 110.933 179.215 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 570' ' ' THR . . . . . . . . . . . . . 41.4 m -71.1 118.78 14.32 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.331 -0.395 . . . . 1.01 110.598 179.217 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 571' ' ' VAL . . . . . 0.665 HG22 ' CE1' ' A' ' 596' ' ' HIS . 16.9 t -97.25 116.22 39.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 120.722 0.296 . . . . 0.73 110.635 -178.649 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 22.7 p -108.78 157.88 18.16 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.129 -0.487 . . . . 1.89 110.599 179.381 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 573' ' ' GLY . . . . . 0.5 ' HA3' ' HD1' ' A' ' 584' ' ' TRP . . . -131.24 156.06 21.61 Favored Glycine 0 N--CA 1.44 -1.069 0 N-CA-C 111.061 -0.816 . . . . 2.2 111.061 178.265 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 574' ' ' VAL . . . . . 0.581 ' O ' HG22 ' A' ' 583' ' ' VAL . 25.6 t -116.66 147.68 19.88 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 CA-C-O 120.8 0.334 . . . . 3.24 110.111 -172.9 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 575' ' ' TYR . . . . . . . . . . . . . 59.5 t80 -78.28 120.51 23.15 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.684 -0.487 . . . . 3.02 109.684 175.268 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 576' ' ' ASP . . . . . . . . . . . . . 15.4 t0 -91.16 114.67 27.25 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.071 0.462 . . . . 3.34 110.275 -179.333 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 577' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -66.98 -23.31 65.93 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.491 -0.777 . . . . 5.59 111.144 -179.574 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 578' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -75.83 -48.51 21.27 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.444 -0.344 . . . . 5.11 111.083 -174.192 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 579' ' ' SER . . . . . . . . . . . . . 75.4 p -87.37 -24.41 24.25 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.295 0.569 . . . . 3.28 110.8 177.84 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 580' ' ' GLY . . . . . . . . . . . . . . . 80.26 23.04 61.73 Favored Glycine 0 N--CA 1.447 -0.626 0 CA-C-N 115.407 -0.815 . . . . 2.6 111.86 -177.749 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 581' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -131.16 160.02 36.0 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.882 0.372 . . . . 3.19 110.157 -179.786 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 582' ' ' TRP . . . . . 0.557 ' O ' ' HA ' ' A' ' 552' ' ' VAL . 76.5 m95 -82.09 135.43 35.31 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.846 -0.427 . . . . 2.3 109.846 176.634 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 583' ' ' VAL . . . . . 0.581 HG22 ' O ' ' A' ' 574' ' ' VAL . 20.0 m -112.86 131.6 63.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 N-CA-C 112.775 0.657 . . . . 1.11 112.775 -174.841 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 584' ' ' TRP . . . . . 0.635 ' CD1' HG22 ' A' ' 553' ' ' VAL . 15.9 m0 -105.01 102.99 12.46 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 108.943 -0.762 . . . . 2.29 108.943 164.074 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 585' ' ' LYS . . . . . 0.415 ' HD2' ' H ' ' A' ' 585' ' ' LYS . 0.0 OUTLIER -93.5 151.62 19.6 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.391 -0.822 . . . . 3.95 111.43 -175.248 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 586' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 53.27 41.15 32.15 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 115.521 -0.763 . . . . 1.43 109.026 -172.314 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 587' ' ' THR . . . . . . . . . . . . . 36.1 m -128.86 140.83 51.51 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.492 -0.776 . . . . 0.65 110.203 -175.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 588' ' ' ILE . . . . . 0.57 ' HB ' ' HB3' ' A' ' 597' ' ' SER . 12.5 tt -131.52 144.37 37.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 N-CA-C 109.228 -0.656 . . . . 0.71 109.228 178.047 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 589' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -106.57 120.06 40.94 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.254 0.55 . . . . 1.35 109.847 178.724 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 590' ' ' VAL . . . . . . . . . . . . . 54.9 t -128.16 120.37 53.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.262 -0.881 . . . . 0.65 109.995 -179.852 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 591' ' ' ASN . . . . . . . . . . . . . 2.3 t30 59.23 40.68 21.21 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 115.969 -0.56 . . . . 2.03 111.1 177.217 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . 78.82 10.06 86.52 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.94 -0.647 . . . . 0.62 112.4 175.844 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 593' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -126.28 144.3 50.84 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-O 121.174 0.512 . . . . 2.78 110.981 -178.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 594' ' ' TYR . . . . . 0.753 ' HE1' HG11 ' A' ' 551' ' ' VAL . 97.5 m-85 -101.29 135.13 43.27 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.784 -0.644 . . . . 1.45 110.725 -177.848 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 595' ' ' PHE . . . . . . . . . . . . . 59.9 m-85 -139.55 158.24 44.46 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 108.548 -0.908 . . . . 1.32 108.548 177.829 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 596' ' ' HIS . . . . . 0.665 ' CE1' HG22 ' A' ' 571' ' ' VAL . 15.4 m170 -61.18 127.03 29.52 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.341 -0.985 . . . . 0.59 108.341 168.661 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 597' ' ' SER . . . . . 0.57 ' HB3' ' HB ' ' A' ' 588' ' ' ILE . 8.7 p -66.37 -29.31 69.46 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.068 0.461 . . . . 1.13 109.879 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 598' ' ' THR . . . . . . . . . . . . . 1.1 t -69.0 -32.48 72.07 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 115.273 -0.876 . . . . 1.4 109.93 176.321 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 599' ' ' CYS . . . . . 0.462 ' SG ' ' HB2' ' A' ' 596' ' ' HIS . 84.9 m -78.82 -29.06 44.56 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 113.81 1.041 . . . . 0.81 113.81 -179.323 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 600' ' ' TYR . . . . . 0.456 ' O ' HG22 ' A' ' 603' ' ' THR . 87.3 t80 -54.64 -35.98 64.06 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 113.678 0.992 . . . . 1.88 113.678 -164.304 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 601' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -60.22 -25.15 65.41 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 112.267 0.469 . . . . 4.52 112.267 -177.415 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 602' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -61.7 -38.19 86.94 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 120.981 0.419 . . . . 3.85 111.357 179.188 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 603' ' ' THR . . . . . 0.456 HG22 ' O ' ' A' ' 600' ' ' TYR . 11.5 t . . . . . 0 C--O 1.236 0.352 0 CA-C-N 116.483 -0.326 . . . . 3.3 111.344 -177.842 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 701' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.455 0 N-CA-C 111.754 -0.538 . . . . 3.2 111.754 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 549' ' ' LYS . . . . . . . . . . . . . 9.1 mtmp? -68.91 149.78 48.49 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.896 -0.409 . . . . 5.9 109.896 177.358 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 550' ' ' TYR . . . . . 0.503 ' CE1' HG12 ' A' ' 583' ' ' VAL . 38.0 p90 -114.75 160.21 19.67 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 115.941 -0.572 . . . . 2.79 110.402 -176.087 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 551' ' ' VAL . . . . . . . . . . . . . 65.5 t -117.76 133.76 63.5 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 N-CA-C 108.493 -0.928 . . . . 1.52 108.493 175.74 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 552' ' ' VAL . . . . . 0.62 ' HA ' ' O ' ' A' ' 582' ' ' TRP . 28.3 t -61.95 134.88 27.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 116.315 -0.402 . . . . 1.38 110.08 -177.573 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 553' ' ' VAL . . . . . 0.583 HG22 ' CD1' ' A' ' 584' ' ' TRP . 89.0 t -61.6 119.19 44.96 Favored Pre-proline 0 N--CA 1.451 -0.411 0 N-CA-C 109.648 -0.501 . . . . 1.38 109.648 -179.688 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 554' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -59.45 136.13 69.56 Favored 'Trans proline' 0 N--CA 1.46 -0.458 0 C-N-CA 122.878 2.385 . . . . 1.98 112.779 -178.509 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 555' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -78.36 -10.72 59.8 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.924 -0.769 . . . . 4.17 108.924 174.875 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 25.2 p -99.73 24.39 8.41 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 114.869 -1.06 . . . . 4.04 110.928 -179.621 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 557' ' ' SER . . . . . . . . . . . . . 73.8 p -95.64 179.02 5.28 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.13 -0.486 . . . . 3.03 110.513 -179.178 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 558' ' ' GLN . . . . . . . . . . . . . 24.5 mp0 -74.51 -73.12 0.25 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.993 0.425 . . . . 5.06 110.311 178.215 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 559' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -131.76 48.49 2.41 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.137 -0.483 . . . . 3.23 110.214 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 560' ' ' MET . . . . . . . . . . . . . 56.9 mtm 62.7 18.56 10.71 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 115.756 -0.656 . . . . 2.61 111.317 179.272 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 561' ' ' ALA . . . . . . . . . . . . . . . -145.55 156.63 43.81 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.199 -0.455 . . . . 0.95 111.485 -176.901 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 24.1 p90 -141.9 156.77 45.5 Favored 'General case' 0 C--O 1.225 -0.218 0 N-CA-C 108.131 -1.063 . . . . 0.9 108.131 172.306 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 563' ' ' LYS . . . . . 0.532 ' HA ' ' HA ' ' A' ' 570' ' ' THR . 36.5 ttmt -99.83 128.04 45.95 Favored 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 119.752 -0.779 . . . . 2.18 110.444 -178.773 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 564' ' ' CYS . . . . . 0.424 ' O ' ' HA ' ' A' ' 568' ' ' LYS . 50.0 t -72.12 118.05 63.77 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 115.834 -0.621 . . . . 0.41 110.395 179.275 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 565' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -72.13 -27.62 16.69 Favored 'Trans proline' 0 CA--C 1.531 0.372 0 C-N-CA 123.026 2.484 . . . . 0.63 114.209 -173.836 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 566' ' ' ILE . . . . . 0.548 HD12 ' HB3' ' A' ' 599' ' ' CYS . 71.2 mt -82.2 -52.36 13.67 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 N-CA-C 112.271 0.471 . . . . 0.94 112.271 -172.257 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 567' ' ' CYS . . . . . . . . . . . . . 29.5 p -104.59 0.82 29.0 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 121.063 0.459 . . . . 0.7 110.787 -179.655 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 568' ' ' LYS . . . . . 0.424 ' HA ' ' O ' ' A' ' 564' ' ' CYS . 28.3 mtpp 69.93 29.27 4.0 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 113.623 0.971 . . . . 2.71 113.623 166.091 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 569' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -101.39 132.96 46.7 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.669 -0.412 . . . . 3.34 110.18 175.903 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 570' ' ' THR . . . . . 0.532 ' HA ' ' HA ' ' A' ' 563' ' ' LYS . 55.8 m -70.82 118.4 13.55 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.517 -0.549 . . . . 1.01 109.517 173.21 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 571' ' ' VAL . . . . . . . . . . . . . 22.4 t -91.02 116.18 31.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-O 121.0 0.428 . . . . 0.73 110.539 -176.389 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 30.6 p -106.68 159.5 16.16 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.504 -0.771 . . . . 1.89 109.068 175.122 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . -129.76 154.66 20.56 Favored Glycine 0 N--CA 1.439 -1.107 0 C-N-CA 119.689 -1.243 . . . . 2.2 111.599 -178.366 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 574' ' ' VAL . . . . . 0.434 ' O ' HG22 ' A' ' 583' ' ' VAL . 22.6 t -114.25 151.9 15.98 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 N-CA-C 109.874 -0.417 . . . . 3.24 109.874 -175.061 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 575' ' ' TYR . . . . . . . . . . . . . 39.8 t80 -83.73 122.47 28.68 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 116.29 -0.413 . . . . 3.02 110.077 176.954 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 576' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -91.31 112.85 24.94 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 108.674 -0.861 . . . . 3.34 108.674 175.121 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 577' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -69.73 -35.56 75.1 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.38 -0.827 . . . . 5.59 112.524 -169.035 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 578' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -75.39 -35.51 61.04 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.881 -0.328 . . . . 5.11 111.566 -174.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 579' ' ' SER . . . . . . . . . . . . . 77.1 p -82.53 -24.69 33.95 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.92 0.39 . . . . 3.28 110.486 179.228 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 580' ' ' GLY . . . . . . . . . . . . . . . 80.66 20.66 65.56 Favored Glycine 0 N--CA 1.452 -0.285 0 CA-C-N 115.574 -0.739 . . . . 2.6 112.914 177.147 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 581' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -145.85 154.8 42.38 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.845 0.355 . . . . 3.19 111.072 179.545 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 582' ' ' TRP . . . . . 0.62 ' O ' ' HA ' ' A' ' 552' ' ' VAL . 64.9 m95 -77.34 150.78 35.14 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.088 -0.506 . . . . 2.3 110.509 -177.833 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 583' ' ' VAL . . . . . 0.503 HG12 ' CE1' ' A' ' 550' ' ' TYR . 21.4 m -123.9 133.04 70.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 113.564 0.95 . . . . 1.11 113.564 -173.285 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 584' ' ' TRP . . . . . 0.583 ' CD1' HG22 ' A' ' 553' ' ' VAL . 24.1 m0 -116.2 103.79 10.87 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 114.854 -1.066 . . . . 2.29 108.566 164.124 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 585' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -87.25 150.2 24.06 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 120.419 -0.513 . . . . 3.95 111.136 -175.003 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 586' ' ' ASN . . . . . . . . . . . . . 14.1 m120 54.37 41.29 32.05 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 115.545 -0.752 . . . . 1.43 110.495 -175.101 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 587' ' ' THR . . . . . . . . . . . . . 44.3 m -119.76 142.53 48.47 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.756 -0.656 . . . . 0.65 110.341 -177.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 588' ' ' ILE . . . . . . . . . . . . . 15.3 tt -133.75 148.19 30.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 N-CA-C 109.424 -0.584 . . . . 0.71 109.424 -179.593 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 589' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -115.33 118.75 34.13 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.519 -0.548 . . . . 1.35 109.519 177.901 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 590' ' ' VAL . . . . . . . . . . . . . 44.0 t -125.14 118.84 54.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.505 -0.77 . . . . 0.65 110.019 -177.439 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 591' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 58.2 36.99 26.19 Favored 'General case' 0 C--O 1.235 0.306 0 O-C-N 123.482 0.489 . . . . 2.03 111.864 177.777 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . 85.66 8.41 80.18 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.967 -0.635 . . . . 0.62 113.271 174.932 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 593' ' ' LYS . . . . . . . . . . . . . 60.1 mttm -125.55 139.76 53.33 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.158 0.504 . . . . 2.78 111.461 178.55 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 594' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -93.67 133.28 37.19 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.165 -0.925 . . . . 1.45 110.784 -178.385 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 595' ' ' PHE . . . . . . . . . . . . . 81.2 m-85 -139.98 160.14 40.59 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.194 -0.912 . . . . 1.32 108.896 177.262 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 596' ' ' HIS . . . . . 0.534 ' HB3' HG22 ' A' ' 598' ' ' THR . 9.3 m170 -66.32 128.69 37.12 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 108.579 -0.897 . . . . 0.59 108.579 167.849 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 597' ' ' SER . . . . . . . . . . . . . 40.2 t -61.71 -32.48 72.7 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.8 -0.637 . . . . 1.13 109.696 -178.86 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 598' ' ' THR . . . . . 0.534 HG22 ' HB3' ' A' ' 596' ' ' HIS . 11.1 t -67.82 -35.33 78.41 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-N 115.332 -0.849 . . . . 1.4 110.091 177.637 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 599' ' ' CYS . . . . . 0.603 ' HA ' ' HB3' ' A' ' 602' ' ' GLU . 72.7 m -76.13 -31.98 58.9 Favored 'General case' 0 N--CA 1.457 -0.091 0 N-CA-C 112.228 0.455 . . . . 0.81 112.228 -179.048 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 600' ' ' TYR . . . . . . . . . . . . . 71.1 t80 -67.37 -36.26 80.99 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.009 -0.737 . . . . 1.88 109.009 -178.355 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 601' ' ' HIS . . . . . . . . . . . . . 64.5 t60 -72.48 -32.06 65.9 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.134 -0.939 . . . . 4.52 109.656 174.135 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 602' ' ' GLU . . . . . 0.603 ' HB3' ' HA ' ' A' ' 599' ' ' CYS . 0.7 OUTLIER -61.83 -37.59 85.02 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 115.463 -0.79 . . . . 3.85 111.745 177.475 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 603' ' ' THR . . . . . 0.499 ' HB ' HD13 ' A' ' 566' ' ' ILE . 14.5 t . . . . . 0 C--N 1.324 -0.542 0 N-CA-C 112.391 0.515 . . . . 3.3 112.391 -173.157 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 701' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.284 0 N-CA-C 112.998 -0.041 . . . . 3.2 112.998 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 549' ' ' LYS . . . . . . . . . . . . . 89.1 mttt -80.26 144.08 33.17 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.954 0.407 . . . . 5.9 110.342 174.825 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 550' ' ' TYR . . . . . . . . . . . . . 30.2 p90 -118.5 161.03 20.69 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 108.649 -0.871 . . . . 2.79 108.649 179.495 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 551' ' ' VAL . . . . . . . . . . . . . 62.7 t -118.24 133.18 65.87 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.971 0 N-CA-C 109.485 -0.561 . . . . 1.52 109.485 177.706 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 552' ' ' VAL . . . . . 0.457 ' HA ' ' O ' ' A' ' 582' ' ' TRP . 33.1 t -67.97 126.04 26.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-O 120.666 0.27 . . . . 1.38 110.549 -177.61 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 553' ' ' VAL . . . . . 0.654 HG22 ' CD1' ' A' ' 584' ' ' TRP . 47.3 t -61.91 126.37 87.1 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 115.828 -0.624 . . . . 1.38 111.415 -176.145 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 554' ' ' PRO . . . . . 0.547 ' HB2' ' HB2' ' A' ' 557' ' ' SER . 16.5 Cg_exo -66.96 138.05 46.74 Favored 'Trans proline' 0 C--O 1.233 0.27 0 C-N-CA 123.0 2.467 . . . . 1.98 111.464 175.941 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 555' ' ' GLU . . . . . 0.429 ' H ' ' CD ' ' A' ' 555' ' ' GLU . 0.2 OUTLIER -79.01 -30.96 44.52 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.013 0.435 . . . . 4.17 110.728 -176.037 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 556' ' ' THR . . . . . 0.402 HG23 ' HG2' ' A' ' 555' ' ' GLU . 39.3 p -94.9 30.93 1.96 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.355 0.597 . . . . 4.04 111.139 179.442 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 557' ' ' SER . . . . . 0.547 ' HB2' ' HB2' ' A' ' 554' ' ' PRO . 21.2 t -91.6 30.1 1.39 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.905 -0.589 . . . . 3.03 110.228 -178.854 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 558' ' ' GLN . . . . . . . . . . . . . 74.7 mt-30 62.11 -83.71 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 123.576 0.75 . . . . 5.06 111.636 -179.127 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 559' ' ' ASP . . . . . . . . . . . . . 16.5 p-10 -115.37 15.24 16.85 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.975 0.417 . . . . 3.23 110.927 -178.121 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 560' ' ' MET . . . . . 0.402 ' HA ' ' HB3' ' A' ' 557' ' ' SER . 4.5 mpp? 61.8 23.98 14.19 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 115.239 -0.892 . . . . 2.61 111.935 174.884 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 561' ' ' ALA . . . . . . . . . . . . . . . -144.29 145.75 32.2 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.314 -0.403 . . . . 0.95 110.08 178.883 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 44.5 p90 -137.42 155.32 49.49 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.315 -0.402 . . . . 0.9 109.938 178.224 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 563' ' ' LYS . . . . . . . . . . . . . 13.9 tppt? -90.01 125.55 35.43 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.771 0.32 . . . . 2.18 110.33 -179.354 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 564' ' ' CYS . . . . . . . . . . . . . 40.6 t -63.57 114.78 14.32 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 115.908 -0.587 . . . . 0.41 109.596 176.121 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 565' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -69.8 -17.61 37.3 Favored 'Trans proline' 0 CA--C 1.527 0.164 0 C-N-CA 122.588 2.192 . . . . 0.63 113.157 -172.498 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 566' ' ' ILE . . . . . 0.454 HG21 ' HG2' ' A' ' 602' ' ' GLU . 55.5 mt -81.48 -44.33 20.43 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 N-CA-C 111.807 0.299 . . . . 0.94 111.807 -176.832 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 567' ' ' CYS . . . . . 0.484 ' SG ' ' HG3' ' A' ' 569' ' ' GLU . 27.9 p -129.8 1.83 4.89 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.447 0.536 . . . . 0.7 112.447 -174.044 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 568' ' ' LYS . . . . . . . . . . . . . 40.0 mtmt 68.08 30.77 5.74 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 113.433 0.901 . . . . 2.71 113.433 173.992 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 569' ' ' GLU . . . . . 0.484 ' HG3' ' SG ' ' A' ' 567' ' ' CYS . 32.7 mt-10 -80.17 135.8 36.36 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 108.932 -0.766 . . . . 3.34 108.932 169.635 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 570' ' ' THR . . . . . . . . . . . . . 90.1 m -78.31 117.88 19.97 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 109.083 -0.71 . . . . 1.01 109.083 170.753 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 571' ' ' VAL . . . . . . . . . . . . . 39.6 t -90.03 116.12 30.8 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 N-CA-C 110.008 -0.368 . . . . 0.73 110.008 -178.492 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 32.0 p -115.19 158.0 22.87 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.984 -0.553 . . . . 1.89 110.017 179.753 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . -130.07 155.11 20.85 Favored Glycine 0 N--CA 1.436 -1.318 0 C-N-CA 120.05 -1.071 . . . . 2.2 111.529 178.944 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 574' ' ' VAL . . . . . . . . . . . . . 42.2 t -115.87 147.56 19.18 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 N-CA-C 109.63 -0.507 . . . . 3.24 109.63 -173.875 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 575' ' ' TYR . . . . . . . . . . . . . 51.5 t80 -83.76 118.32 23.83 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 108.82 -0.807 . . . . 3.02 108.82 173.26 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 576' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -95.71 107.05 19.23 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.033 -0.729 . . . . 3.34 109.033 178.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 577' ' ' GLU . . . . . . . . . . . . . 38.3 mp0 -68.56 -23.3 64.48 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.824 -0.625 . . . . 5.59 111.943 -173.567 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 578' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -76.05 -34.7 59.63 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.603 0.239 . . . . 5.11 111.256 -177.525 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 579' ' ' SER . . . . . . . . . . . . . 67.5 p -93.75 -23.42 18.2 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.097 0.475 . . . . 3.28 110.546 175.512 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 580' ' ' GLY . . . . . . . . . . . . . . . 80.44 26.81 53.71 Favored Glycine 0 N--CA 1.449 -0.462 0 CA-C-N 115.608 -0.723 . . . . 2.6 112.929 176.449 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 581' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -145.87 161.6 39.63 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 117.16 0.48 . . . . 3.19 111.421 -179.69 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 582' ' ' TRP . . . . . 0.513 ' CB ' ' HB ' ' A' ' 553' ' ' VAL . 80.4 m95 -83.93 139.12 32.79 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-N 115.887 -0.597 . . . . 2.3 110.37 177.605 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 583' ' ' VAL . . . . . . . . . . . . . 26.6 m -121.04 130.15 74.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 N-CA-C 112.971 0.73 . . . . 1.11 112.971 -174.773 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 584' ' ' TRP . . . . . 0.654 ' CD1' HG22 ' A' ' 553' ' ' VAL . 14.7 m0 -104.82 103.5 13.11 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 108.605 -0.887 . . . . 2.29 108.605 162.835 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 585' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -94.83 153.75 17.58 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.637 -0.711 . . . . 3.95 111.241 -175.334 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 586' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 55.56 40.75 31.14 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 108.799 -0.815 . . . . 1.43 108.799 -170.899 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 587' ' ' THR . . . . . . . . . . . . . 26.6 m -134.88 141.45 46.34 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.393 -0.821 . . . . 0.65 110.396 -173.941 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 588' ' ' ILE . . . . . . . . . . . . . 13.7 tt -141.58 148.92 20.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 109.665 -0.494 . . . . 0.71 109.665 -179.552 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 589' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -94.34 118.7 32.01 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.93 0.395 . . . . 1.35 110.016 176.209 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 590' ' ' VAL . . . . . . . . . . . . . 59.9 t -126.5 127.25 70.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.888 -0.596 . . . . 0.65 109.451 179.488 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 591' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 59.46 37.25 23.11 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-O 121.554 0.692 . . . . 2.03 110.313 -179.689 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . 73.42 12.04 80.03 Favored Glycine 0 C--N 1.333 0.364 0 CA-C-N 115.588 -0.733 . . . . 0.62 112.952 177.872 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 593' ' ' LYS . . . . . . . . . . . . . 46.3 mtmt -127.74 143.45 51.14 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.861 0.362 . . . . 2.78 110.372 -177.005 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 594' ' ' TYR . . . . . . . . . . . . . 56.0 m-85 -86.59 125.51 33.86 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.955 0.407 . . . . 1.45 110.853 -178.696 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 595' ' ' PHE . . . . . . . . . . . . . 63.7 m-85 -136.41 160.49 38.57 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.634 -0.712 . . . . 1.32 110.044 179.593 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 596' ' ' HIS . . . . . . . . . . . . . 4.2 m170 -62.34 127.16 30.02 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.476 -0.565 . . . . 0.59 109.476 172.664 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 597' ' ' SER . . . . . . . . . . . . . 31.8 t -66.55 -32.04 73.14 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.849 -0.614 . . . . 1.13 109.776 179.45 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 598' ' ' THR . . . . . . . . . . . . . 13.0 t -69.13 -35.19 76.12 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 115.274 -0.875 . . . . 1.4 110.356 179.714 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 599' ' ' CYS . . . . . . . . . . . . . 73.4 m -75.92 -29.73 58.49 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.596 -0.729 . . . . 0.81 112.591 -176.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 600' ' ' TYR . . . . . 0.446 ' O ' HG22 ' A' ' 603' ' ' THR . 71.0 t80 -54.54 -31.73 56.93 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.868 0.366 . . . . 1.88 111.763 -172.559 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 601' ' ' HIS . . . . . . . . . . . . . 12.6 m170 -59.43 -27.29 65.91 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 111.927 0.343 . . . . 4.52 111.927 -179.425 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 602' ' ' GLU . . . . . 0.454 ' HG2' HG21 ' A' ' 566' ' ' ILE . 1.1 pp20? -70.18 -32.83 70.94 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 120.906 -0.317 . . . . 3.85 111.384 -175.389 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 603' ' ' THR . . . . . 0.446 HG22 ' O ' ' A' ' 600' ' ' TYR . 11.4 t . . . . . 0 C--N 1.329 -0.305 0 CA-C-O 120.922 0.391 . . . . 3.3 110.977 -176.77 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 701' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.506 0 N-CA-C 112.381 -0.288 . . . . 3.2 112.381 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 549' ' ' LYS . . . . . . . . . . . . . 31.3 mmmt -80.65 137.11 36.32 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 121.113 0.482 . . . . 5.9 110.491 177.528 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 550' ' ' TYR . . . . . . . . . . . . . 49.9 p90 -109.6 159.77 16.82 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 108.405 -0.961 . . . . 2.79 108.405 176.194 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 551' ' ' VAL . . . . . . . . . . . . . 55.1 t -117.17 133.21 64.63 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.106 0 N-CA-C 109.033 -0.729 . . . . 1.52 109.033 179.632 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 552' ' ' VAL . . . . . 0.724 ' HA ' ' O ' ' A' ' 582' ' ' TRP . 39.1 t -66.98 130.09 32.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.972 -0.558 . . . . 1.38 109.612 -179.122 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 553' ' ' VAL . . . . . 0.599 HG22 ' CD1' ' A' ' 584' ' ' TRP . 59.1 t -59.0 119.44 38.09 Favored Pre-proline 0 N--CA 1.452 -0.342 0 O-C-N 123.409 0.443 . . . . 1.38 110.016 -176.655 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 554' ' ' PRO . . . . . 0.569 ' HB2' ' HB2' ' A' ' 557' ' ' SER . 33.0 Cg_exo -59.5 135.92 67.98 Favored 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 122.945 2.43 . . . . 1.98 112.132 -178.192 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 555' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -77.32 -21.57 53.23 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.64 -0.709 . . . . 4.17 110.031 179.341 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 21.5 p -89.56 3.53 52.2 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 115.382 -0.827 . . . . 4.04 110.835 176.241 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 557' ' ' SER . . . . . 0.569 ' HB2' ' HB2' ' A' ' 554' ' ' PRO . 15.5 t -98.03 120.07 37.77 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.047 -0.723 . . . . 3.03 109.047 175.162 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 558' ' ' GLN . . . . . . . . . . . . . 78.4 mm-40 -69.71 138.22 52.69 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.093 -0.503 . . . . 5.06 111.564 -174.866 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 559' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 68.34 6.0 5.07 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 115.341 -0.845 . . . . 3.23 112.204 175.787 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 560' ' ' MET . . . . . . . . . . . . . 4.3 mpp? 58.09 27.34 14.8 Favored 'General case' 0 N--CA 1.465 0.312 0 O-C-N 123.451 0.469 . . . . 2.61 111.907 176.899 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 561' ' ' ALA . . . . . . . . . . . . . . . -144.75 155.24 43.43 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 116.258 -0.428 . . . . 0.95 110.817 -176.317 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 29.3 p90 -138.7 164.59 29.14 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.413 -0.588 . . . . 0.9 109.413 174.38 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 563' ' ' LYS . . . . . . . . . . . . . 21.9 tptm -103.06 125.07 49.63 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 109.983 -0.377 . . . . 2.18 109.983 -178.446 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 564' ' ' CYS . . . . . . . . . . . . . 48.8 t -80.09 113.38 38.01 Favored Pre-proline 0 C--N 1.327 -0.412 0 N-CA-C 109.512 -0.551 . . . . 0.41 109.512 -179.663 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 565' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -71.88 -28.67 16.24 Favored 'Trans proline' 0 CA--C 1.528 0.217 0 C-N-CA 122.667 2.245 . . . . 0.63 113.954 -172.13 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 566' ' ' ILE . . . . . . . . . . . . . 28.5 mt -72.67 -37.7 56.59 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 CA-C-O 121.069 0.462 . . . . 0.94 111.671 -172.662 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 567' ' ' CYS . . . . . 0.559 ' SG ' ' HG3' ' A' ' 569' ' ' GLU . 27.8 p -127.43 1.27 6.29 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.534 -0.303 . . . . 0.7 111.567 -175.309 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 568' ' ' LYS . . . . . . . . . . . . . 29.1 mtpp 67.45 27.45 8.01 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 115.934 -0.576 . . . . 2.71 112.429 175.272 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 569' ' ' GLU . . . . . 0.559 ' HG3' ' SG ' ' A' ' 567' ' ' CYS . 51.1 mt-10 -79.07 136.43 37.16 Favored 'General case' 0 CA--C 1.516 -0.336 0 N-CA-C 109.944 -0.391 . . . . 3.34 109.944 174.692 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 570' ' ' THR . . . . . . . . . . . . . 47.4 m -87.99 116.58 26.26 Favored 'General case' 0 C--N 1.314 -0.977 0 N-CA-C 107.835 -1.172 . . . . 1.01 107.835 171.736 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 571' ' ' VAL . . . . . 0.438 HG22 ' CE1' ' A' ' 596' ' ' HIS . 16.8 t -97.78 115.73 38.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 C-N-CA 120.668 -0.413 . . . . 0.73 110.962 -171.477 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 23.8 p -109.76 158.82 17.73 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 109.183 -0.673 . . . . 1.89 109.183 174.881 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . -131.21 155.15 21.16 Favored Glycine 0 N--CA 1.443 -0.896 0 C-N-CA 120.04 -1.076 . . . . 2.2 112.132 -178.2 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 574' ' ' VAL . . . . . 0.411 ' O ' HG22 ' A' ' 583' ' ' VAL . 39.5 t -112.35 152.81 14.1 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 N-CA-C 109.432 -0.581 . . . . 3.24 109.432 -175.632 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 575' ' ' TYR . . . . . 0.41 ' HA ' ' HA ' ' A' ' 582' ' ' TRP . 50.7 t80 -84.52 119.84 25.64 Favored 'General case' 0 C--N 1.315 -0.891 0 N-CA-C 109.953 -0.388 . . . . 3.02 109.953 176.997 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 576' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -90.3 97.96 11.49 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 108.277 -1.009 . . . . 3.34 108.277 178.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 577' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -65.92 -22.85 66.53 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.354 -0.839 . . . . 5.59 111.851 -172.834 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 578' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -73.32 -48.09 37.25 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.014 0.435 . . . . 5.11 110.116 -178.27 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 579' ' ' SER . . . . . . . . . . . . . 74.5 p -84.05 -19.88 33.64 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.922 0.391 . . . . 3.28 111.023 178.109 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 580' ' ' GLY . . . . . . . . . . . . . . . 80.24 22.65 62.53 Favored Glycine 0 N--CA 1.449 -0.451 0 CA-C-N 115.795 -0.639 . . . . 2.6 112.266 179.048 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 581' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -130.59 147.83 52.31 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-O 121.32 0.581 . . . . 3.19 111.009 -177.274 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 582' ' ' TRP . . . . . 0.724 ' O ' ' HA ' ' A' ' 552' ' ' VAL . 88.4 m95 -72.05 143.82 48.97 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 108.591 -0.892 . . . . 2.3 108.591 168.815 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 583' ' ' VAL . . . . . 0.6 HG21 ' HE2' ' A' ' 585' ' ' LYS . 24.4 m -124.08 133.19 69.96 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 N-CA-C 113.679 0.992 . . . . 1.11 113.679 -174.493 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 584' ' ' TRP . . . . . 0.599 ' CD1' HG22 ' A' ' 553' ' ' VAL . 30.9 m0 -110.51 104.1 12.79 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 114.912 -1.04 . . . . 2.29 108.338 163.067 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 585' ' ' LYS . . . . . 0.6 ' HE2' HG21 ' A' ' 583' ' ' VAL . 66.9 mmtt -83.38 151.49 25.5 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-O 120.495 0.188 . . . . 3.95 110.611 -176.54 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 586' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 50.27 44.86 26.36 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 115.887 -0.597 . . . . 1.43 110.124 -175.517 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 587' ' ' THR . . . . . . . . . . . . . 75.3 m -125.83 140.94 52.25 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.15 -0.477 . . . . 0.65 110.679 -176.394 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 588' ' ' ILE . . . . . 0.459 ' HB ' ' HB3' ' A' ' 597' ' ' SER . 12.7 tt -136.05 146.13 29.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 N-CA-C 109.482 -0.562 . . . . 0.71 109.482 179.025 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 589' ' ' GLU . . . . . . . . . . . . . 46.2 tt0 -100.45 121.5 41.65 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.219 -0.66 . . . . 1.35 109.219 174.329 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 590' ' ' VAL . . . . . . . . . . . . . 52.7 t -124.35 118.19 52.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 109.947 -0.39 . . . . 0.65 109.947 -179.185 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 591' ' ' ASN . . . . . . . . . . . . . 60.0 t30 58.12 37.51 26.4 Favored 'General case' 0 C--N 1.328 -0.327 0 O-C-N 123.912 0.757 . . . . 2.03 110.852 178.67 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . 85.25 0.88 88.51 Favored Glycine 0 N--CA 1.452 -0.256 0 CA-C-N 115.844 -0.616 . . . . 0.62 113.718 176.462 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 593' ' ' LYS . . . . . . . . . . . . . 61.8 mttp -118.71 147.69 43.56 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 117.245 0.523 . . . . 2.78 111.104 -179.129 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 594' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -96.53 135.64 38.14 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.018 0.437 . . . . 1.45 111.219 -175.581 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 595' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 -143.87 155.02 43.96 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.337 -0.847 . . . . 1.32 109.322 178.57 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 596' ' ' HIS . . . . . 0.438 ' CE1' HG22 ' A' ' 571' ' ' VAL . 16.7 m170 -64.66 127.24 30.69 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 107.972 -1.121 . . . . 0.59 107.972 166.579 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 597' ' ' SER . . . . . 0.459 ' HB3' ' HB ' ' A' ' 588' ' ' ILE . 7.7 p -66.02 -32.02 73.26 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.043 0.449 . . . . 1.13 110.002 -178.906 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 598' ' ' THR . . . . . . . . . . . . . 97.1 m -61.12 -43.25 99.17 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.265 -0.879 . . . . 1.4 110.345 173.694 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 599' ' ' CYS . . . . . 0.511 ' O ' ' HB3' ' A' ' 602' ' ' GLU . 83.9 m -74.74 -30.46 61.51 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.779 -0.646 . . . . 0.81 111.289 -179.775 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 600' ' ' TYR . . . . . . . . . . . . . 88.0 t80 -59.28 -35.87 74.52 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.179 0.514 . . . . 1.88 109.908 177.572 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 601' ' ' HIS . . . . . . . . . . . . . 67.3 t60 -71.22 -29.51 65.23 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.811 -0.631 . . . . 4.52 110.506 176.562 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 602' ' ' GLU . . . . . 0.511 ' HB3' ' O ' ' A' ' 599' ' ' CYS . 2.0 tp10 -61.89 -37.21 83.74 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.923 -0.581 . . . . 3.85 111.149 178.639 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 603' ' ' THR . . . . . . . . . . . . . 12.3 t . . . . . 0 C--N 1.328 -0.343 0 CA-C-N 116.447 -0.342 . . . . 3.3 111.102 -179.05 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 701' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.5 0 N-CA-C 111.818 -0.513 . . . . 3.2 111.818 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 549' ' ' LYS . . . . . . . . . . . . . 68.4 mmtt -64.01 149.37 47.57 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-O 121.338 0.589 . . . . 5.9 111.085 178.813 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 550' ' ' TYR . . . . . . . . . . . . . 39.7 p90 -122.38 159.94 26.47 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.277 -0.874 . . . . 2.79 109.745 179.181 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 551' ' ' VAL . . . . . . . . . . . . . 60.6 t -118.15 133.35 65.21 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.925 0 N-CA-C 108.527 -0.916 . . . . 1.52 108.527 177.551 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 552' ' ' VAL . . . . . 0.648 ' HA ' ' O ' ' A' ' 582' ' ' TRP . 42.0 t -67.8 134.24 30.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 116.122 -0.49 . . . . 1.38 109.741 -177.426 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 553' ' ' VAL . . . . . 0.515 HG11 ' HB3' ' A' ' 560' ' ' MET . 63.2 t -59.46 121.68 58.57 Favored Pre-proline 0 C--N 1.325 -0.461 0 O-C-N 123.682 0.613 . . . . 1.38 111.391 -175.813 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 554' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 553' ' ' VAL . 31.6 Cg_exo -58.74 143.13 99.1 Favored 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 123.559 2.839 . . . . 1.98 112.607 179.148 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 555' ' ' GLU . . . . . . . . . . . . . 19.9 tp10 -62.05 -38.36 88.45 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.165 -0.925 . . . . 4.17 111.094 -179.562 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 24.1 p -96.26 45.01 1.07 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.238 -0.437 . . . . 4.04 111.848 -176.68 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 557' ' ' SER . . . . . 0.586 ' OG ' ' HA ' ' A' ' 560' ' ' MET . 59.4 p -107.25 124.37 49.66 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.99 0.424 . . . . 3.03 110.438 179.003 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 558' ' ' GLN . . . . . . . . . . . . . 89.3 mt-30 -66.11 112.84 4.1 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.18 -0.463 . . . . 5.06 109.86 179.312 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 559' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 66.44 12.98 9.04 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 115.867 -0.606 . . . . 3.23 111.71 -177.467 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 560' ' ' MET . . . . . 0.586 ' HA ' ' OG ' ' A' ' 557' ' ' SER . 60.1 mtt 57.18 37.03 28.2 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 116.248 -0.433 . . . . 2.61 111.266 -179.789 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 561' ' ' ALA . . . . . 0.427 ' HB2' HG22 ' A' ' 572' ' ' THR . . . -144.3 161.95 37.65 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 116.072 -0.513 . . . . 0.95 111.443 -177.627 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 31.2 p90 -143.83 153.06 41.97 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.968 -0.753 . . . . 0.9 108.968 173.242 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 563' ' ' LYS . . . . . 0.529 ' HA ' ' HA ' ' A' ' 570' ' ' THR . 16.0 tppt? -88.89 126.47 35.4 Favored 'General case' 0 C--N 1.317 -0.841 0 C-N-CA 120.705 -0.398 . . . . 2.18 110.189 177.989 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 564' ' ' CYS . . . . . 0.439 ' HA ' ' HD3' ' A' ' 565' ' ' PRO . 52.7 t -79.46 113.62 38.42 Favored Pre-proline 0 N--CA 1.451 -0.379 0 N-CA-C 109.444 -0.576 . . . . 0.41 109.444 174.62 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 565' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 564' ' ' CYS . 33.4 Cg_exo -63.38 -36.37 55.98 Favored 'Trans proline' 0 CA--C 1.528 0.206 0 C-N-CA 123.146 2.564 . . . . 0.63 113.896 -173.323 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 566' ' ' ILE . . . . . 0.498 HD12 ' HB3' ' A' ' 599' ' ' CYS . 60.3 mt -72.35 -37.81 59.25 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 N-CA-C 112.088 0.403 . . . . 0.94 112.088 -173.143 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 567' ' ' CYS . . . . . . . . . . . . . 29.6 p -113.15 0.76 15.04 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.536 -0.466 . . . . 0.7 111.82 -176.281 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 568' ' ' LYS . . . . . . . . . . . . . 99.4 mttt 66.03 11.63 7.89 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 113.181 0.808 . . . . 2.71 113.181 173.522 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 569' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -100.6 134.64 43.26 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.873 0.368 . . . . 3.34 110.971 179.216 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 570' ' ' THR . . . . . 0.529 ' HA ' ' HA ' ' A' ' 563' ' ' LYS . 45.8 m -74.13 128.96 36.87 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.5 -0.773 . . . . 1.01 109.617 177.863 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 571' ' ' VAL . . . . . . . . . . . . . 17.9 t -95.76 115.09 33.97 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 N-CA-C 109.568 -0.53 . . . . 0.73 109.568 178.424 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 572' ' ' THR . . . . . 0.427 HG22 ' HB2' ' A' ' 561' ' ' ALA . 24.4 p -106.24 160.41 15.37 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.66 -0.7 . . . . 1.89 109.438 177.103 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . -129.53 153.89 20.14 Favored Glycine 0 N--CA 1.44 -1.052 0 C-N-CA 119.352 -1.404 . . . . 2.2 112.405 -178.619 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 574' ' ' VAL . . . . . . . . . . . . . 58.5 t -122.57 148.13 26.42 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 CA-C-N 114.861 -0.67 . . . . 3.24 109.395 -172.714 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 575' ' ' TYR . . . . . . . . . . . . . 53.3 t80 -80.81 118.07 22.02 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 109.356 -0.609 . . . . 3.02 109.356 175.718 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 576' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -92.96 114.89 27.58 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 109.754 -0.461 . . . . 3.34 109.754 179.756 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 577' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -68.89 -22.72 64.16 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.511 -0.768 . . . . 5.59 112.13 -174.441 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 578' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -77.08 -48.13 18.65 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.509 -0.314 . . . . 5.11 111.723 -178.276 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 579' ' ' SER . . . . . . . . . . . . . 72.4 p -86.0 -21.82 27.61 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.878 0.37 . . . . 3.28 110.859 178.961 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 580' ' ' GLY . . . . . . . . . . . . . . . 80.19 17.29 74.54 Favored Glycine 0 C--N 1.331 0.285 0 C-N-CA 121.157 -0.544 . . . . 2.6 112.725 178.48 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 581' ' ' GLU . . . . . . . . . . . . . 20.7 mm-40 -122.42 152.24 40.43 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.921 0.391 . . . . 3.19 111.292 -176.943 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 582' ' ' TRP . . . . . 0.648 ' O ' ' HA ' ' A' ' 552' ' ' VAL . 84.5 m95 -77.51 130.38 36.9 Favored 'General case' 0 CA--C 1.512 -0.491 0 N-CA-C 107.451 -1.315 . . . . 2.3 107.451 165.245 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 583' ' ' VAL . . . . . . . . . . . . . 19.3 m -115.39 133.91 60.2 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.971 0 N-CA-C 113.958 1.096 . . . . 1.11 113.958 -169.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 584' ' ' TRP . . . . . 0.508 ' CD1' HG22 ' A' ' 553' ' ' VAL . 30.5 m0 -113.33 103.65 11.52 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 114.795 -1.093 . . . . 2.29 108.053 162.281 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 585' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.99 145.61 27.63 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.985 0.422 . . . . 3.95 111.774 -173.104 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 586' ' ' ASN . . . . . . . . . . . . . 12.3 m120 53.2 42.93 32.13 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.282 -0.872 . . . . 1.43 110.512 -176.613 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 587' ' ' THR . . . . . . . . . . . . . 57.9 m -115.38 142.46 46.66 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.0 0.428 . . . . 0.65 110.761 -176.963 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 588' ' ' ILE . . . . . . . . . . . . . 15.3 tt -137.38 150.19 25.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.58 -0.736 . . . . 0.71 109.396 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 589' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -111.13 122.73 48.62 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.098 -0.705 . . . . 1.35 109.098 176.908 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 590' ' ' VAL . . . . . . . . . . . . . 62.1 t -126.39 117.65 49.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 115.716 -0.675 . . . . 0.65 110.06 179.324 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 591' ' ' ASN . . . . . . . . . . . . . 13.3 t-20 58.27 40.64 24.43 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 115.582 -0.735 . . . . 2.03 110.835 177.267 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . 79.98 13.67 81.81 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.91 -0.662 . . . . 0.62 112.592 176.036 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 593' ' ' LYS . . . . . . . . . . . . . 46.8 mtmt -128.47 139.92 52.08 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.036 0.446 . . . . 2.78 110.777 -178.898 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 594' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -94.9 134.88 37.06 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.054 -0.521 . . . . 1.45 111.064 -177.081 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 595' ' ' PHE . . . . . . . . . . . . . 62.7 m-85 -142.25 165.24 27.98 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.372 -0.831 . . . . 1.32 108.807 177.002 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 596' ' ' HIS . . . . . 0.701 ' HB2' ' SG ' ' A' ' 599' ' ' CYS . 24.9 m80 -68.79 130.11 41.88 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 108.273 -1.01 . . . . 0.59 108.273 166.641 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 597' ' ' SER . . . . . . . . . . . . . 40.1 t -60.83 -30.16 69.93 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.462 0.649 . . . . 1.13 109.81 179.361 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 598' ' ' THR . . . . . . . . . . . . . 93.7 m -66.39 -34.71 78.58 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.905 -1.043 . . . . 1.4 110.803 175.11 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 599' ' ' CYS . . . . . 0.701 ' SG ' ' HB2' ' A' ' 596' ' ' HIS . 75.8 m -74.77 -31.15 61.69 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.622 0.601 . . . . 0.81 112.622 -178.25 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 600' ' ' TYR . . . . . . . . . . . . . 86.0 t80 -61.8 -35.62 78.72 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 121.362 0.601 . . . . 1.88 109.842 -178.427 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 601' ' ' HIS . . . . . . . . . . . . . 78.7 t60 -66.72 -34.7 78.43 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.373 -0.83 . . . . 4.52 110.408 176.001 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 602' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -64.65 -36.57 84.69 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.145 -0.48 . . . . 3.85 110.927 179.847 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 603' ' ' THR . . . . . . . . . . . . . 15.4 t . . . . . 0 C--N 1.324 -0.507 0 CA-C-N 116.554 -0.293 . . . . 3.3 110.701 -179.266 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 701' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.418 0 N-CA-C 112.107 -0.397 . . . . 3.2 112.107 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 549' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -64.28 132.49 50.39 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.056 0.455 . . . . 5.9 110.125 176.558 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 550' ' ' TYR . . . . . 0.524 ' CE1' HG12 ' A' ' 583' ' ' VAL . 37.4 p90 -111.34 160.91 16.6 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.822 -0.626 . . . . 2.79 109.834 177.414 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 551' ' ' VAL . . . . . 0.527 HG11 ' HE1' ' A' ' 594' ' ' TYR . 52.9 t -118.53 133.26 65.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 N-CA-C 109.072 -0.714 . . . . 1.52 109.072 176.437 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 552' ' ' VAL . . . . . 0.72 ' HA ' ' O ' ' A' ' 582' ' ' TRP . 56.6 t -61.95 125.18 17.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 O-C-N 123.32 0.388 . . . . 1.38 110.287 -179.039 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 553' ' ' VAL . . . . . 0.685 HG22 ' CD1' ' A' ' 584' ' ' TRP . 66.6 t -58.91 120.41 46.32 Favored Pre-proline 0 C--N 1.33 -0.271 0 O-C-N 123.729 0.643 . . . . 1.38 111.495 -173.903 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 554' ' ' PRO . . . . . 0.458 ' HD3' ' HA ' ' A' ' 553' ' ' VAL . 7.2 Cg_exo -72.4 136.91 27.21 Favored 'Trans proline' 0 N--CA 1.456 -0.697 0 C-N-CA 122.802 2.335 . . . . 1.98 112.06 175.78 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 555' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 -76.93 -15.35 59.7 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.593 -0.73 . . . . 4.17 110.055 179.357 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 22.7 p -84.43 -13.34 52.38 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.389 -0.823 . . . . 4.04 111.862 -177.71 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 557' ' ' SER . . . . . . . . . . . . . 47.2 m -80.68 78.07 7.46 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.615 -0.266 . . . . 3.03 111.532 -177.64 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 558' ' ' GLN . . . . . 0.426 ' HA ' ' OE1' ' A' ' 558' ' ' GLN . 10.4 mm-40 56.25 -89.66 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 123.512 0.725 . . . . 5.06 111.703 176.39 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 559' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -137.05 61.07 1.63 Allowed 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.022 -0.733 . . . . 3.23 109.022 176.784 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 560' ' ' MET . . . . . . . . . . . . . 62.1 mtt 62.22 24.63 14.68 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 115.273 -0.876 . . . . 2.61 110.797 -178.302 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 561' ' ' ALA . . . . . . . . . . . . . . . -144.77 149.94 36.35 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.378 -0.373 . . . . 0.95 111.162 -173.908 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 26.8 p90 -133.69 164.01 28.17 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.572 -0.899 . . . . 0.9 108.572 173.605 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 563' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt -112.09 127.59 55.96 Favored 'General case' 0 C--N 1.323 -0.587 0 C-N-CA 120.456 -0.498 . . . . 2.18 110.772 -179.459 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 564' ' ' CYS . . . . . . . . . . . . . 53.4 t -73.77 113.9 27.28 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 115.416 -0.811 . . . . 0.41 109.797 -179.192 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 565' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -72.83 -19.91 23.15 Favored 'Trans proline' 0 N--CA 1.472 0.218 0 C-N-CA 122.965 2.443 . . . . 0.63 113.599 -175.633 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 566' ' ' ILE . . . . . 0.449 HD13 ' HB ' ' A' ' 603' ' ' THR . 37.7 mt -82.26 -37.86 14.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.255 -0.429 . . . . 0.94 111.616 -172.368 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 567' ' ' CYS . . . . . . . . . . . . . 27.9 p -129.32 5.86 5.27 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 112.22 0.452 . . . . 0.7 112.22 -179.319 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 568' ' ' LYS . . . . . . . . . . . . . 21.0 mmmt 72.82 30.59 1.72 Allowed 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 113.923 1.083 . . . . 2.71 113.923 167.346 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 569' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -92.85 135.81 33.8 Favored 'General case' 0 N--CA 1.466 0.361 0 O-C-N 121.786 -0.571 . . . . 3.34 111.231 178.308 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 570' ' ' THR . . . . . . . . . . . . . 82.5 m -82.14 117.91 22.66 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 108.875 -0.787 . . . . 1.01 108.875 166.142 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 571' ' ' VAL . . . . . . . . . . . . . 21.3 t -103.13 123.27 56.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.951 0.405 . . . . 0.73 111.745 -170.883 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 24.5 p -108.94 160.96 15.59 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.87 -0.604 . . . . 1.89 110.33 177.672 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . -130.98 156.15 21.61 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.343 -0.932 . . . . 2.2 112.185 -177.97 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 574' ' ' VAL . . . . . 0.474 ' O ' HG22 ' A' ' 583' ' ' VAL . 21.8 t -112.26 149.61 14.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-O 120.888 0.375 . . . . 3.24 110.319 -173.117 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 575' ' ' TYR . . . . . 0.408 ' HA ' ' HA ' ' A' ' 582' ' ' TRP . 53.8 t80 -85.21 123.36 30.62 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.256 -0.429 . . . . 3.02 111.012 179.061 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 576' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -92.12 107.75 19.44 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.418 -0.586 . . . . 3.34 109.418 174.09 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 577' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -68.17 -26.98 66.03 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.037 -0.529 . . . . 5.59 112.424 -173.215 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 578' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -69.53 -47.95 62.06 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.76 0.314 . . . . 5.11 111.249 -178.409 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 579' ' ' SER . . . . . . . . . . . . . 77.1 p -83.31 -23.88 32.39 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.343 0.592 . . . . 3.28 110.578 -179.837 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 580' ' ' GLY . . . . . . . . . . . . . . . 79.17 18.4 74.5 Favored Glycine 0 N--CA 1.449 -0.499 0 CA-C-N 115.561 -0.745 . . . . 2.6 111.326 -176.714 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 581' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -123.32 138.85 54.52 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.295 0.569 . . . . 3.19 110.833 -176.036 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 582' ' ' TRP . . . . . 0.72 ' O ' ' HA ' ' A' ' 552' ' ' VAL . 83.7 m95 -71.45 141.06 50.25 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.975 -0.75 . . . . 2.3 108.975 173.221 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 583' ' ' VAL . . . . . 0.524 HG12 ' CE1' ' A' ' 550' ' ' TYR . 24.0 m -119.89 133.78 65.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 N-CA-C 113.352 0.871 . . . . 1.11 113.352 -173.933 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 584' ' ' TRP . . . . . 0.685 ' CD1' HG22 ' A' ' 553' ' ' VAL . 21.6 m0 -111.38 104.51 12.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.024 -0.989 . . . . 2.29 108.983 165.436 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 585' ' ' LYS . . . . . 0.408 ' HD2' ' HB3' ' A' ' 550' ' ' TYR . 26.2 mmmt -83.23 148.13 27.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.607 -0.269 . . . . 3.95 110.473 -175.041 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 586' ' ' ASN . . . . . . . . . . . . . 62.7 m-20 48.32 41.95 17.16 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 123.319 0.648 . . . . 1.43 110.337 -173.934 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 587' ' ' THR . . . . . . . . . . . . . 56.8 m -120.1 140.9 50.35 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.966 -0.561 . . . . 0.65 109.607 179.556 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 588' ' ' ILE . . . . . . . . . . . . . 15.5 tt -135.66 146.22 30.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-O 120.927 0.394 . . . . 0.71 110.123 -178.707 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 589' ' ' GLU . . . . . 0.434 ' HA ' ' O ' ' A' ' 593' ' ' LYS . 1.8 tm-20 -103.23 121.16 42.12 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.213 -0.662 . . . . 1.35 109.213 175.373 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 590' ' ' VAL . . . . . . . . . . . . . 59.1 t -125.64 118.6 52.69 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 115.776 -0.647 . . . . 0.65 109.829 -179.56 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 591' ' ' ASN . . . . . . . . . . . . . 67.1 t30 58.78 36.9 25.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.676 0.751 . . . . 2.03 110.779 178.041 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . 85.85 6.59 82.35 Favored Glycine 0 N--CA 1.446 -0.647 0 CA-C-N 115.729 -0.669 . . . . 0.62 113.214 176.38 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 593' ' ' LYS . . . . . 0.434 ' O ' ' HA ' ' A' ' 589' ' ' GLU . 30.4 mmmt -120.85 139.29 53.38 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 117.02 0.41 . . . . 2.78 111.64 -179.046 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 594' ' ' TYR . . . . . 0.527 ' HE1' HG11 ' A' ' 551' ' ' VAL . 91.8 m-85 -93.55 124.05 37.28 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.86 -0.609 . . . . 1.45 111.092 -179.864 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 595' ' ' PHE . . . . . . . . . . . . . 47.9 m-85 -137.29 164.27 28.95 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.865 -0.607 . . . . 1.32 109.662 176.872 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 596' ' ' HIS . . . . . 0.715 ' HB2' ' SG ' ' A' ' 599' ' ' CYS . 29.3 m170 -61.58 129.83 43.0 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 108.927 -0.768 . . . . 0.59 108.927 168.99 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 597' ' ' SER . . . . . . . . . . . . . 33.4 t -64.24 -30.35 71.41 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.039 -0.528 . . . . 1.13 109.65 178.929 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 598' ' ' THR . . . . . . . . . . . . . 8.7 m -61.8 -38.85 89.64 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 115.307 -0.861 . . . . 1.4 110.488 175.403 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 599' ' ' CYS . . . . . 0.715 ' SG ' ' HB2' ' A' ' 596' ' ' HIS . 83.2 m -73.98 -28.52 61.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.302 -0.863 . . . . 0.81 112.672 -175.336 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 600' ' ' TYR . . . . . . . . . . . . . 70.0 t80 -55.94 -35.89 67.16 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 120.902 0.382 . . . . 1.88 110.963 -174.62 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 601' ' ' HIS . . . . . . . . . . . . . 43.5 m-70 -73.26 -39.35 65.48 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.453 -0.339 . . . . 4.52 111.232 -178.86 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 602' ' ' GLU . . . . . 0.663 ' HG2' ' O ' ' A' ' 599' ' ' CYS . 23.3 pt-20 -70.36 -35.5 73.59 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 120.709 0.29 . . . . 3.85 111.028 -177.438 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 603' ' ' THR . . . . . 0.449 ' HB ' HD13 ' A' ' 566' ' ' ILE . 13.0 t . . . . . 0 C--N 1.327 -0.387 0 C-N-CA 120.978 -0.289 . . . . 3.3 111.557 -175.225 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 701' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.136 0 N-CA-C 113.484 0.154 . . . . 3.2 113.484 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 549' ' ' LYS . . . . . . . . . . . . . 61.6 mttm -73.43 134.79 44.07 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.906 0.384 . . . . 5.9 110.588 176.218 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 550' ' ' TYR . . . . . . . . . . . . . 31.8 p90 -111.62 159.9 17.74 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.561 -0.745 . . . . 2.79 109.584 179.322 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 551' ' ' VAL . . . . . . . . . . . . . 59.2 t -117.94 131.9 69.34 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 N-CA-C 108.556 -0.905 . . . . 1.52 108.556 175.311 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 552' ' ' VAL . . . . . 0.563 ' HA ' ' O ' ' A' ' 582' ' ' TRP . 59.0 t -63.95 134.82 28.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 116.051 -0.522 . . . . 1.38 110.075 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 553' ' ' VAL . . . . . 0.579 HG22 ' CD1' ' A' ' 584' ' ' TRP . 86.0 t -58.84 121.72 56.55 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 115.677 -0.692 . . . . 1.38 110.05 -178.489 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 554' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_exo -55.65 135.89 71.55 Favored 'Trans proline' 0 N--CA 1.462 -0.363 0 C-N-CA 122.791 2.327 . . . . 1.98 112.496 -176.523 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 555' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -82.59 -6.32 59.28 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.979 -0.555 . . . . 4.17 110.2 -178.843 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 23.0 p -83.23 -6.39 59.46 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.567 -0.742 . . . . 4.04 111.037 179.111 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 557' ' ' SER . . . . . . . . . . . . . 32.6 t -109.02 143.1 38.75 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 115.977 -0.556 . . . . 3.03 110.28 -179.066 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 558' ' ' GLN . . . . . . . . . . . . . 80.0 mt-30 -100.31 5.3 44.49 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.089 -0.505 . . . . 5.06 110.229 177.199 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 559' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -133.05 120.55 21.47 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 108.938 -0.764 . . . . 3.23 108.938 176.837 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 560' ' ' MET . . . . . . . . . . . . . 3.8 mpp? -78.45 37.4 0.27 Allowed 'General case' 0 C--O 1.237 0.419 0 CA-C-N 116.587 -0.279 . . . . 2.61 111.28 -174.824 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 561' ' ' ALA . . . . . 0.59 ' HB2' HG22 ' A' ' 572' ' ' THR . . . -144.66 145.7 31.88 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-O 121.045 0.45 . . . . 0.95 111.552 -176.628 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 33.1 p90 -135.92 149.22 48.87 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 107.791 -1.189 . . . . 0.9 107.791 169.914 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 563' ' ' LYS . . . . . 0.46 ' HA ' ' HA ' ' A' ' 570' ' ' THR . 72.1 tttt -93.3 119.99 33.07 Favored 'General case' 0 C--N 1.316 -0.859 0 C-N-CA 120.093 -0.643 . . . . 2.18 110.929 -176.07 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 564' ' ' CYS . . . . . 0.48 ' HA ' ' HD3' ' A' ' 565' ' ' PRO . 10.6 t -76.91 114.26 37.76 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-N 115.348 -0.842 . . . . 0.41 110.729 -178.626 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 565' ' ' PRO . . . . . 0.48 ' HD3' ' HA ' ' A' ' 564' ' ' CYS . 20.6 Cg_exo -70.48 -23.41 27.55 Favored 'Trans proline' 0 CA--C 1.534 0.487 0 C-N-CA 123.379 2.719 . . . . 0.63 113.35 -177.479 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 566' ' ' ILE . . . . . 0.485 HG21 ' HB3' ' A' ' 599' ' ' CYS . 26.7 mt -71.44 -37.64 65.46 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.364 0 N-CA-C 112.041 0.385 . . . . 0.94 112.041 -174.249 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 567' ' ' CYS . . . . . . . . . . . . . 29.2 p -124.34 2.06 8.43 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.805 0.336 . . . . 0.7 111.429 178.07 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 568' ' ' LYS . . . . . . . . . . . . . 29.4 mtpp 69.65 18.01 7.7 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 113.463 0.912 . . . . 2.71 113.463 171.798 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 569' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -107.85 136.37 47.69 Favored 'General case' 0 C--O 1.238 0.46 0 C-N-CA 120.373 -0.531 . . . . 3.34 111.332 178.818 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 570' ' ' THR . . . . . 0.46 ' HA ' ' HA ' ' A' ' 563' ' ' LYS . 35.5 m -68.18 125.99 28.12 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 115.015 -0.993 . . . . 1.01 110.925 -178.677 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 571' ' ' VAL . . . . . 0.533 ' O ' ' HA ' ' A' ' 561' ' ' ALA . 15.9 t -95.06 117.51 39.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 115.68 -0.691 . . . . 0.73 110.602 -176.891 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 572' ' ' THR . . . . . 0.59 HG22 ' HB2' ' A' ' 561' ' ' ALA . 25.6 p -109.17 158.62 17.63 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 109.619 -0.512 . . . . 1.89 109.619 176.589 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . -129.92 156.41 21.44 Favored Glycine 0 N--CA 1.443 -0.871 0 C-N-CA 120.305 -0.95 . . . . 2.2 111.777 -177.882 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 574' ' ' VAL . . . . . 0.484 ' O ' HG22 ' A' ' 583' ' ' VAL . 20.1 t -113.68 149.94 15.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-O 120.832 0.348 . . . . 3.24 110.227 -173.352 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 575' ' ' TYR . . . . . 0.446 ' HA ' ' HA ' ' A' ' 582' ' ' TRP . 39.6 t80 -80.61 123.84 28.48 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 109.276 -0.639 . . . . 3.02 109.276 174.383 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 576' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -90.97 105.49 17.86 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 108.434 -0.95 . . . . 3.34 108.434 175.574 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 577' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -67.09 -27.02 67.01 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.377 -0.829 . . . . 5.59 112.083 -170.602 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 578' ' ' GLU . . . . . . . . . . . . . 23.1 mp0 -75.15 -47.06 30.33 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.537 -0.301 . . . . 5.11 111.354 -179.452 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 579' ' ' SER . . . . . . . . . . . . . 75.2 p -83.12 -21.06 33.74 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.059 0.457 . . . . 3.28 111.295 -179.449 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 580' ' ' GLY . . . . . . . . . . . . . . . 80.23 20.49 67.03 Favored Glycine 0 N--CA 1.449 -0.46 0 CA-C-N 115.863 -0.608 . . . . 2.6 112.836 177.924 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 581' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -130.28 148.08 52.07 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.912 0.387 . . . . 3.19 110.752 -178.869 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 582' ' ' TRP . . . . . 0.563 ' O ' ' HA ' ' A' ' 552' ' ' VAL . 81.1 m95 -79.12 135.19 36.76 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.313 -0.625 . . . . 2.3 109.313 174.194 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 583' ' ' VAL . . . . . 0.484 HG22 ' O ' ' A' ' 574' ' ' VAL . 29.3 m -113.4 129.33 69.35 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 N-CA-C 112.987 0.736 . . . . 1.11 112.987 -172.594 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 584' ' ' TRP . . . . . 0.579 ' CD1' HG22 ' A' ' 553' ' ' VAL . 23.3 m0 -109.4 102.31 11.21 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 108.085 -1.08 . . . . 2.29 108.085 163.108 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 585' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.99 151.51 19.49 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 110.2 -0.296 . . . . 3.95 110.2 -173.428 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 586' ' ' ASN . . . . . 0.501 ' O ' ' HA ' ' A' ' 596' ' ' HIS . 2.2 m-20 55.95 42.33 28.83 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 121.214 0.53 . . . . 1.43 109.714 -173.311 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 587' ' ' THR . . . . . . . . . . . . . 30.2 m -124.41 141.42 52.1 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.359 -0.837 . . . . 0.65 110.439 -178.015 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 588' ' ' ILE . . . . . 0.568 ' HB ' ' HB3' ' A' ' 597' ' ' SER . 16.1 tt -139.98 147.92 23.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 116.255 -0.43 . . . . 0.71 109.877 177.928 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 589' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -100.62 119.08 38.03 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.453 -0.573 . . . . 1.35 109.453 176.653 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 590' ' ' VAL . . . . . . . . . . . . . 60.0 t -130.93 127.31 61.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.563 -0.744 . . . . 0.65 109.401 179.065 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 591' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 59.05 33.21 22.83 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 121.605 0.717 . . . . 2.03 110.384 179.068 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . 84.88 0.74 89.07 Favored Glycine 0 N--CA 1.45 -0.424 0 CA-C-N 115.795 -0.639 . . . . 0.62 113.303 175.815 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 593' ' ' LYS . . . . . . . . . . . . . 45.3 mmtm -121.35 148.06 44.86 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.056 0.455 . . . . 2.78 111.482 -178.305 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 594' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -92.89 132.76 36.75 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.566 -0.743 . . . . 1.45 110.576 179.597 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 595' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -136.55 162.58 32.72 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.292 -0.867 . . . . 1.32 108.766 177.529 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 596' ' ' HIS . . . . . 0.512 ' CE1' HG22 ' A' ' 571' ' ' VAL . 21.9 m170 -66.86 125.05 24.7 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 107.743 -1.206 . . . . 0.59 107.743 167.178 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 597' ' ' SER . . . . . 0.568 ' HB3' ' HB ' ' A' ' 588' ' ' ILE . 2.1 p -67.77 -29.79 69.08 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.256 0.55 . . . . 1.13 109.884 177.501 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 598' ' ' THR . . . . . . . . . . . . . 25.6 m -63.84 -38.27 90.46 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.258 -0.883 . . . . 1.4 110.656 174.643 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 599' ' ' CYS . . . . . 0.485 ' HB3' HG21 ' A' ' 566' ' ' ILE . 73.6 m -75.14 -29.92 60.64 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.971 -0.559 . . . . 0.81 110.816 177.263 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 600' ' ' TYR . . . . . . . . . . . . . 92.4 t80 -55.62 -34.52 64.98 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.617 -0.719 . . . . 1.88 111.623 -174.598 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 601' ' ' HIS . . . . . . . . . . . . . 66.9 m170 -60.16 -32.51 71.12 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 112.459 0.541 . . . . 4.52 112.459 -176.343 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 602' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -72.61 -33.52 66.73 Favored 'General case' 0 CA--C 1.528 0.099 0 C-N-CA 120.118 -0.633 . . . . 3.85 110.966 -179.141 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 603' ' ' THR . . . . . . . . . . . . . 8.8 t . . . . . 0 C--O 1.235 0.3 0 C-N-CA 120.633 -0.427 . . . . 3.3 110.837 -177.564 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 701' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.387 0 N-CA-C 112.565 -0.214 . . . . 3.2000000000000002 112.565 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 549' ' ' LYS . . . . . . . . . . . . . 32.5 mmmt -70.8 143.72 51.06 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 110.038 -0.356 . . . . 5.9000000000000004 110.038 178.089 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 550' ' ' TYR . . . . . 0.507 ' CE1' HG12 ' A' ' 583' ' ' VAL . 23.8 p90 -125.97 159.73 31.89 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 109.29 -0.633 . . . . 2.79 109.29 177.015 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 551' ' ' VAL . . . . . . . . . . . . . 52.6 t -118.33 133.37 65.35 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.021 0 N-CA-C 108.723 -0.843 . . . . 1.52 108.723 177.48 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 552' ' ' VAL . . . . . 0.57 ' HA ' ' O ' ' A' ' 582' ' ' TRP . 60.8 t -65.2 130.59 30.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 109.499 -0.556 . . . . 1.3799999999999999 109.499 179.374 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 553' ' ' VAL . . . . . 0.6 HG22 ' CD1' ' A' ' 584' ' ' TRP . 66.0 t -59.0 121.37 54.6 Favored Pre-proline 0 CA--C 1.519 -0.243 0 O-C-N 123.618 0.574 . . . . 1.3799999999999999 110.681 -175.608 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 554' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 553' ' ' VAL . 31.9 Cg_exo . . . . . 0 N--CA 1.464 -0.219 0 C-N-CA 123.041 2.494 . . . . 1.98 112.786 -177.404 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 560' ' ' MET . . . . . 0.468 ' HG3' HG11 ' A' ' 553' ' ' VAL . 1.8 mpt? . . . . . 0 N--CA 1.466 0.346 0 N-CA-C 112.397 0.518 . . . . 2.6099999999999999 112.397 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 561' ' ' ALA . . . . . 0.461 ' HA ' ' O ' ' A' ' 571' ' ' VAL . . . -144.5 152.67 40.93 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.015 0.436 . . . . 0.94999999999999996 111.33 -178.659 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 33.4 p90 -142.76 151.7 41.52 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.219 -0.66 . . . . 0.90000000000000002 109.219 170.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 563' ' ' LYS . . . . . . . . . . . . . 3.6 tppp? -88.8 117.98 28.17 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 109.269 -0.641 . . . . 2.1800000000000002 109.269 -178.49 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 564' ' ' CYS . . . . . 0.479 ' HA ' ' HD3' ' A' ' 565' ' ' PRO . 41.7 t -68.26 112.96 12.45 Favored Pre-proline 0 C--O 1.223 -0.316 0 N-CA-C 109.578 -0.527 . . . . 0.40999999999999998 109.578 179.035 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 565' ' ' PRO . . . . . 0.479 ' HD3' ' HA ' ' A' ' 564' ' ' CYS . 15.5 Cg_exo -71.77 -18.21 28.66 Favored 'Trans proline' 0 CA--C 1.527 0.162 0 C-N-CA 122.747 2.298 . . . . 0.63 113.299 -174.583 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 566' ' ' ILE . . . . . . . . . . . . . 26.4 mt -89.18 -38.32 11.15 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 N-CA-C 112.211 0.448 . . . . 0.93999999999999995 112.211 -172.233 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 567' ' ' CYS . . . . . 0.466 ' SG ' ' OE2' ' A' ' 569' ' ' GLU . 28.6 p -127.74 1.21 6.09 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.512 -0.475 . . . . 0.69999999999999996 111.65 178.67 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 568' ' ' LYS . . . . . 0.421 ' HA ' ' O ' ' A' ' 564' ' ' CYS . 54.3 mtpt 70.9 31.72 2.55 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 114.576 1.324 . . . . 2.71 114.576 163.782 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 569' ' ' GLU . . . . . 0.466 ' OE2' ' SG ' ' A' ' 567' ' ' CYS . 0.0 OUTLIER -95.72 149.38 21.55 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 108.605 -0.887 . . . . 3.3399999999999999 108.605 170.173 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 570' ' ' THR . . . . . . . . . . . . . 57.0 m -84.02 117.06 23.16 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 109.045 -0.724 . . . . 1.01 109.045 172.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 571' ' ' VAL . . . . . 0.495 HG22 ' CE1' ' A' ' 596' ' ' HIS . 34.1 t -84.89 116.56 28.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-O 120.976 0.417 . . . . 0.72999999999999998 111.108 -174.214 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 23.7 p -107.03 159.24 16.44 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.748 -0.66 . . . . 1.8899999999999999 109.768 177.191 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . -130.5 155.68 21.24 Favored Glycine 0 N--CA 1.442 -0.926 0 C-N-CA 119.925 -1.131 . . . . 2.2000000000000002 111.732 -178.233 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 574' ' ' VAL . . . . . 0.5 ' O ' HG22 ' A' ' 583' ' ' VAL . 40.5 t -118.0 148.44 20.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 109.838 -0.43 . . . . 3.2400000000000002 109.838 -174.215 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 575' ' ' TYR . . . . . 0.46 ' HA ' ' HA ' ' A' ' 582' ' ' TRP . 47.6 t80 -84.22 119.46 25.06 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.797 -0.446 . . . . 3.02 109.797 178.147 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 576' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -95.84 113.38 25.0 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.97 0.414 . . . . 3.3399999999999999 110.04 176.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 577' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -70.43 -22.69 62.69 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.42 -0.809 . . . . 5.5899999999999999 112.074 -175.262 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 578' ' ' GLU . . . . . . . . . . . . . 15.8 tp10 -74.82 -46.39 36.98 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 121.023 -0.271 . . . . 5.1100000000000003 110.854 -179.233 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 579' ' ' SER . . . . . . . . . . . . . 74.0 p -82.34 -20.96 36.27 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.111 0.482 . . . . 3.2799999999999998 110.608 176.013 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 580' ' ' GLY . . . . . . . . . . . . . . . 79.54 20.21 69.45 Favored Glycine 0 N--CA 1.447 -0.578 0 CA-C-N 115.667 -0.697 . . . . 2.6000000000000001 112.5 175.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 581' ' ' GLU . . . . . 0.43 ' HA ' ' OE1' ' A' ' 581' ' ' GLU . 8.7 mm-40 -138.1 160.26 39.85 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.24 0.543 . . . . 3.1899999999999999 111.048 -177.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 582' ' ' TRP . . . . . 0.57 ' O ' ' HA ' ' A' ' 552' ' ' VAL . 80.3 m95 -79.55 137.84 37.29 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.609 -0.723 . . . . 2.2999999999999998 109.361 174.322 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 583' ' ' VAL . . . . . 0.507 HG12 ' CE1' ' A' ' 550' ' ' TYR . 19.9 m -116.53 132.43 66.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 N-CA-C 113.667 0.988 . . . . 1.1100000000000001 113.667 -172.122 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 584' ' ' TRP . . . . . 0.6 ' CD1' HG22 ' A' ' 553' ' ' VAL . 31.2 m0 -113.31 102.71 10.6 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 108.17 -1.048 . . . . 2.29 108.17 162.387 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 585' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.32 154.15 18.03 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.884 -0.327 . . . . 3.9500000000000002 110.869 -176.212 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 586' ' ' ASN . . . . . . . . . . . . . 22.6 m-20 56.23 43.73 26.11 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 108.615 -0.884 . . . . 1.4299999999999999 108.615 -170.112 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 587' ' ' THR . . . . . . . . . . . . . 34.3 m -133.98 141.13 47.16 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.098 -0.955 . . . . 0.65000000000000002 110.513 -176.019 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 588' ' ' ILE . . . . . . . . . . . . . 12.7 tt -141.58 149.41 20.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.358 -0.383 . . . . 0.70999999999999996 110.095 -178.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 589' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -97.73 122.65 41.08 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.887 -0.412 . . . . 1.3500000000000001 109.887 177.246 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 590' ' ' VAL . . . . . . . . . . . . . 35.4 t -124.64 118.44 53.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 N-CA-C 109.761 -0.459 . . . . 0.65000000000000002 109.761 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 591' ' ' ASN . . . . . . . . . . . . . 3.7 t30 55.58 40.99 31.12 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.418 -0.81 . . . . 2.0299999999999998 110.988 177.458 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . 85.41 5.13 85.34 Favored Glycine 0 CA--C 1.52 0.365 0 C-N-CA 120.86 -0.686 . . . . 0.62 113.778 174.455 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 593' ' ' LYS . . . . . . . . . . . . . 56.0 mttp -127.84 144.89 51.08 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 117.363 0.582 . . . . 2.7799999999999998 110.958 177.481 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 594' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -91.25 132.94 35.8 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.277 0.561 . . . . 1.45 110.711 -179.516 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 595' ' ' PHE . . . . . . . . . . . . . 72.0 m-85 -132.95 156.32 47.5 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.299 -0.864 . . . . 1.3200000000000001 108.962 178.441 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 596' ' ' HIS . . . . . 0.495 ' CE1' HG22 ' A' ' 571' ' ' VAL . 11.3 m170 -60.98 126.97 29.3 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 108.384 -0.969 . . . . 0.58999999999999997 108.384 167.775 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 597' ' ' SER . . . . . . . . . . . . . 23.2 t -65.15 -29.31 70.14 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.859 -0.609 . . . . 1.1299999999999999 109.986 -177.506 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 598' ' ' THR . . . . . . . . . . . . . 2.6 m -66.8 -39.18 87.67 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 115.522 -0.763 . . . . 1.3999999999999999 110.707 178.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 599' ' ' CYS . . . . . . . . . . . . . 86.1 m -74.68 -32.82 62.31 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.527 -0.76 . . . . 0.81000000000000005 112.152 -174.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 600' ' ' TYR . . . . . . . . . . . . . 73.9 t80 -57.06 -34.68 68.5 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.928 0.394 . . . . 1.8799999999999999 111.471 -172.337 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 601' ' ' HIS . . . . . . . . . . . . . 14.6 m-70 -61.91 -26.82 68.4 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.786 -0.643 . . . . 4.5199999999999996 112.361 -177.221 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 602' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.49 -29.13 65.57 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 121.117 0.484 . . . . 3.8500000000000001 110.13 -178.646 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 603' ' ' THR . . . . . . . . . . . . . 92.2 m . . . . . 0 C--N 1.326 -0.423 0 CA-C-N 115.841 -0.618 . . . . 3.2999999999999998 110.811 -178.311 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.512 -0.147 0 N-CA-C 113.274 0.07 . . . . 3.2000000000000002 113.274 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 549' ' ' LYS . . . . . 0.645 ' N ' ' HD2' ' A' ' 549' ' ' LYS . 6.5 mptt -81.29 150.35 28.56 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.379 0.609 . . . . 5.9000000000000004 111.467 178.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 550' ' ' TYR . . . . . 0.509 ' CE1' HG12 ' A' ' 583' ' ' VAL . 16.6 p90 -111.19 161.88 15.52 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 114.92 -1.036 . . . . 2.79 110.072 -174.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 551' ' ' VAL . . . . . . . . . . . . . 84.9 t -118.08 133.28 65.38 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 N-CA-C 109.181 -0.674 . . . . 1.52 109.181 177.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 552' ' ' VAL . . . . . . . . . . . . . 59.1 t -63.92 134.66 28.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.725 -0.67 . . . . 1.3799999999999999 109.815 -179.731 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 553' ' ' VAL . . . . . 0.603 HG22 ' CD1' ' A' ' 584' ' ' TRP . 86.3 t -60.07 121.01 55.78 Favored Pre-proline 0 N--CA 1.454 -0.233 0 O-C-N 123.618 0.574 . . . . 1.3799999999999999 111.108 -176.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 554' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 553' ' ' VAL . 16.6 Cg_exo . . . . . 0 N--CA 1.461 -0.431 0 C-N-CA 123.167 2.578 . . . . 1.98 112.561 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 560' ' ' MET . . . . . . . . . . . . . 67.0 mtm . . . . . 0 C--O 1.235 0.294 0 N-CA-C 111.703 0.261 . . . . 2.6099999999999999 111.703 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 561' ' ' ALA . . . . . . . . . . . . . . . -145.39 157.96 43.93 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.364 -0.38 . . . . 0.94999999999999996 110.54 178.387 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 35.0 p90 -153.33 158.39 41.48 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.736 -0.468 . . . . 0.90000000000000002 109.736 174.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 563' ' ' LYS . . . . . . . . . . . . . 5.2 tppp? -89.43 127.32 35.82 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 110.191 -0.3 . . . . 2.1800000000000002 110.191 179.215 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 564' ' ' CYS . . . . . 0.678 ' O ' ' HA ' ' A' ' 568' ' ' LYS . 47.7 t -71.02 114.44 27.23 Favored Pre-proline 0 C--O 1.222 -0.355 0 N-CA-C 109.48 -0.563 . . . . 0.40999999999999998 109.48 175.493 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 565' ' ' PRO . . . . . 0.489 ' HD3' ' HA ' ' A' ' 564' ' ' CYS . 13.7 Cg_exo -72.21 -18.8 26.6 Favored 'Trans proline' 0 CA--C 1.528 0.208 0 C-N-CA 122.978 2.452 . . . . 0.63 113.887 -174.424 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 566' ' ' ILE . . . . . 0.483 HD12 ' HB3' ' A' ' 599' ' ' CYS . 65.9 mt -91.85 -55.14 6.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 112.191 0.441 . . . . 0.93999999999999995 112.191 -172.019 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 567' ' ' CYS . . . . . 0.454 ' SG ' ' OE2' ' A' ' 569' ' ' GLU . 29.5 p -106.68 -6.35 17.94 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.251 -0.579 . . . . 0.69999999999999996 111.043 178.584 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 568' ' ' LYS . . . . . 0.678 ' HA ' ' O ' ' A' ' 564' ' ' CYS . 99.4 mttt 70.98 32.92 2.22 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 114.64 1.348 . . . . 2.71 114.64 165.569 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 569' ' ' GLU . . . . . 0.454 ' OE2' ' SG ' ' A' ' 567' ' ' CYS . 0.0 OUTLIER -96.44 136.19 37.28 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 108.806 -0.813 . . . . 3.3399999999999999 108.806 168.098 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 570' ' ' THR . . . . . . . . . . . . . 57.3 m -68.41 118.24 11.22 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.203 -0.453 . . . . 1.01 110.182 -179.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 571' ' ' VAL . . . . . 0.509 HG22 ' CE1' ' A' ' 596' ' ' HIS . 21.6 t -89.7 116.55 31.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 116.15 -0.477 . . . . 0.72999999999999998 110.935 -175.66 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 29.2 p -115.18 161.37 18.52 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 109.011 -0.737 . . . . 1.8899999999999999 109.011 173.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . -128.27 154.41 19.92 Favored Glycine 0 N--CA 1.437 -1.285 0 C-N-CA 119.468 -1.349 . . . . 2.2000000000000002 111.089 -179.494 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 574' ' ' VAL . . . . . 0.412 ' O ' HG22 ' A' ' 583' ' ' VAL . 49.0 t -115.47 142.46 28.49 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-O 120.922 0.391 . . . . 3.2400000000000002 110.308 -171.557 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 575' ' ' TYR . . . . . . . . . . . . . 45.3 t80 -79.96 118.93 22.15 Favored 'General case' 0 N--CA 1.443 -0.787 0 N-CA-C 109.568 -0.53 . . . . 3.02 109.568 175.688 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 576' ' ' ASP . . . . . . . . . . . . . 27.9 t0 -90.92 109.11 20.33 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.192 -0.669 . . . . 3.3399999999999999 109.192 178.018 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 577' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -70.57 -23.9 62.68 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 115.008 -0.996 . . . . 5.5899999999999999 111.309 -175.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 578' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -77.09 -34.2 56.91 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.149 -0.478 . . . . 5.1100000000000003 111.056 -175.709 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 579' ' ' SER . . . . . . . . . . . . . 77.5 p -98.77 -20.66 16.78 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.351 0.595 . . . . 3.2799999999999998 110.553 176.207 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 580' ' ' GLY . . . . . . . . . . . . . . . 80.43 28.04 49.54 Favored Glycine 0 N--CA 1.448 -0.506 0 CA-C-N 115.497 -0.774 . . . . 2.6000000000000001 113.46 177.225 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 581' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -140.91 161.2 38.39 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 117.195 0.498 . . . . 3.1899999999999999 111.48 178.15 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 582' ' ' TRP . . . . . . . . . . . . . 81.6 m95 -84.93 134.28 34.26 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.743 -0.466 . . . . 2.2999999999999998 109.743 176.508 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 583' ' ' VAL . . . . . 0.509 HG12 ' CE1' ' A' ' 550' ' ' TYR . 15.6 m -115.84 136.63 52.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 N-CA-C 112.61 0.596 . . . . 1.1100000000000001 112.61 -172.415 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 584' ' ' TRP . . . . . 0.603 ' CD1' HG22 ' A' ' 553' ' ' VAL . 18.9 m0 -113.59 104.42 12.23 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.478 -0.783 . . . . 2.29 108.982 165.758 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 585' ' ' LYS . . . . . 0.503 ' HG2' ' OD1' ' A' ' 586' ' ' ASN . 0.0 OUTLIER -88.77 151.25 22.51 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.639 0.257 . . . . 3.9500000000000002 111.262 -175.137 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 586' ' ' ASN . . . . . 0.578 ' O ' ' HA ' ' A' ' 596' ' ' HIS . 8.0 m120 53.51 43.0 31.85 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 123.196 0.598 . . . . 1.4299999999999999 110.019 -174.121 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 587' ' ' THR . . . . . . . . . . . . . 53.2 m -128.91 140.46 51.66 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.021 0.439 . . . . 0.65000000000000002 111.425 -173.377 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 588' ' ' ILE . . . . . . . . . . . . . 14.8 tt -142.4 150.27 18.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.855 -0.611 . . . . 0.70999999999999996 109.682 178.056 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 589' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -104.4 119.65 39.44 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.47 -0.567 . . . . 1.3500000000000001 109.47 176.353 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 590' ' ' VAL . . . . . . . . . . . . . 58.5 t -125.37 117.41 49.6 Favored 'Isoleucine or valine' 0 C--O 1.239 0.552 0 CA-C-N 115.831 -0.622 . . . . 0.65000000000000002 110.374 178.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 591' ' ' ASN . . . . . . . . . . . . . 95.0 m-20 57.36 45.8 19.4 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.379 -0.828 . . . . 2.0299999999999998 112.172 176.538 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . 82.06 7.4 87.89 Favored Glycine 0 N--CA 1.45 -0.429 0 CA-C-N 115.927 -0.579 . . . . 0.62 112.329 173.318 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 593' ' ' LYS . . . . . 0.413 ' HB2' ' NZ ' ' A' ' 593' ' ' LYS . 8.1 mtmp? -129.97 137.86 50.54 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.823 0.344 . . . . 2.7799999999999998 111.182 -177.557 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 594' ' ' TYR . . . . . . . . . . . . . 79.2 m-85 -94.21 132.38 38.83 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.016 -0.538 . . . . 1.45 110.567 179.514 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 595' ' ' PHE . . . . . . . . . . . . . 71.8 m-85 -138.41 159.35 42.28 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.013 -0.736 . . . . 1.3200000000000001 109.013 177.053 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 596' ' ' HIS . . . . . 0.667 ' HB2' ' SG ' ' A' ' 599' ' ' CYS . 24.4 m170 -63.52 129.44 40.19 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 107.599 -1.26 . . . . 0.58999999999999997 107.599 165.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 597' ' ' SER . . . . . . . . . . . . . 2.9 m -58.7 -32.41 69.14 Favored 'General case' 0 CA--C 1.519 -0.214 0 CA-C-O 121.577 0.703 . . . . 1.1299999999999999 109.783 178.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 598' ' ' THR . . . . . . . . . . . . . 81.8 m -59.46 -39.9 85.14 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 114.573 -1.194 . . . . 1.3999999999999999 110.534 173.606 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 599' ' ' CYS . . . . . 0.672 ' HA ' ' HG2' ' A' ' 602' ' ' GLU . 83.6 m -74.82 -34.99 62.45 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.969 -0.56 . . . . 0.81000000000000005 112.329 -179.258 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 600' ' ' TYR . . . . . . . . . . . . . 79.6 t80 -61.01 -35.57 77.19 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 109.161 -0.681 . . . . 1.8799999999999999 109.161 -179.142 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 601' ' ' HIS . . . . . . . . . . . . . 27.8 t60 -68.09 -42.99 79.52 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 115.581 -0.736 . . . . 4.5199999999999996 110.288 177.628 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 602' ' ' GLU . . . . . 0.672 ' HG2' ' HA ' ' A' ' 599' ' ' CYS . 13.8 pt-20 -70.91 -33.74 70.84 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 111.863 0.32 . . . . 3.8500000000000001 111.863 -176.447 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 603' ' ' THR . . . . . 0.468 ' HB ' HD13 ' A' ' 566' ' ' ILE . 15.3 t . . . . . 0 C--N 1.326 -0.434 0 O-C-N 122.167 -0.333 . . . . 3.2999999999999998 111.243 -179.028 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.289 0 N-CA-C 113.593 0.197 . . . . 3.2000000000000002 113.593 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 549' ' ' LYS . . . . . . . . . . . . . 29.6 mtpt -81.01 138.89 36.02 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.107 0.48 . . . . 5.9000000000000004 110.473 177.447 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 550' ' ' TYR . . . . . 0.555 ' CE1' HG12 ' A' ' 583' ' ' VAL . 16.4 p90 -111.46 161.72 15.84 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.167 -0.924 . . . . 2.79 109.279 178.535 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 551' ' ' VAL . . . . . 0.515 HG11 ' HE1' ' A' ' 594' ' ' TYR . 57.4 t -116.47 133.52 62.79 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.992 0 N-CA-C 109.19 -0.67 . . . . 1.52 109.19 177.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 552' ' ' VAL . . . . . . . . . . . . . 48.3 t -67.89 130.72 33.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.912 -0.585 . . . . 1.3799999999999999 110.361 -177.545 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 553' ' ' VAL . . . . . 0.637 HG22 ' CD1' ' A' ' 584' ' ' TRP . 64.1 t -59.2 122.61 64.72 Favored Pre-proline 0 C--N 1.328 -0.34 0 O-C-N 123.902 0.751 . . . . 1.3799999999999999 111.048 -177.545 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 554' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_exo . . . . . 0 N--CA 1.461 -0.391 0 C-N-CA 122.706 2.271 . . . . 1.98 111.442 176.709 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 560' ' ' MET . . . . . . . . . . . . . 57.4 mtt . . . . . 0 N--CA 1.469 0.503 0 CA-C-O 121.585 0.707 . . . . 2.6099999999999999 110.259 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 561' ' ' ALA . . . . . . . . . . . . . . . -144.21 161.18 39.54 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.048 -0.978 . . . . 0.94999999999999996 110.517 -174.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 30.8 p90 -136.59 164.31 28.5 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 108.02 -1.104 . . . . 0.90000000000000002 108.02 171.373 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 563' ' ' LYS . . . . . . . . . . . . . 29.2 ttpt -112.17 122.0 46.51 Favored 'General case' 0 C--N 1.32 -0.704 0 C-N-CA 120.399 -0.52 . . . . 2.1800000000000002 110.675 -177.542 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 564' ' ' CYS . . . . . 0.424 ' HA ' ' HD3' ' A' ' 565' ' ' PRO . 44.2 t -74.39 111.91 14.91 Favored Pre-proline 0 N--CA 1.453 -0.322 0 CA-C-N 115.48 -0.782 . . . . 0.40999999999999998 109.624 -178.49 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 565' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 564' ' ' CYS . 15.2 Cg_exo -72.34 -21.66 22.79 Favored 'Trans proline' 0 CA--C 1.528 0.202 0 C-N-CA 123.128 2.552 . . . . 0.63 113.843 -174.206 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 566' ' ' ILE . . . . . . . . . . . . . 18.4 mt -71.9 -39.19 66.93 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 CA-C-O 121.059 0.457 . . . . 0.93999999999999995 110.476 -173.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 567' ' ' CYS . . . . . 0.594 ' SG ' ' HG3' ' A' ' 569' ' ' GLU . 27.4 p -129.81 2.53 4.9 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.873 -0.603 . . . . 0.69999999999999996 112.534 -174.5 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 568' ' ' LYS . . . . . . . . . . . . . 52.5 mtpt 71.16 30.81 2.58 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 113.425 0.898 . . . . 2.71 113.425 175.047 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 569' ' ' GLU . . . . . 0.594 ' HG3' ' SG ' ' A' ' 567' ' ' CYS . 46.2 mt-10 -85.59 132.84 34.1 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 120.515 -0.474 . . . . 3.3399999999999999 110.277 176.486 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 570' ' ' THR . . . . . . . . . . . . . 49.2 m -84.42 116.12 22.9 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 108.317 -0.994 . . . . 1.01 108.317 166.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 571' ' ' VAL . . . . . . . . . . . . . 12.7 t -98.08 116.29 40.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 115.947 -0.57 . . . . 0.72999999999999998 110.856 -171.398 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 27.5 p -104.26 160.71 14.65 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.594 -0.73 . . . . 1.8899999999999999 109.474 178.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . -128.66 157.18 21.36 Favored Glycine 0 N--CA 1.439 -1.114 0 C-N-CA 119.896 -1.145 . . . . 2.2000000000000002 111.912 -176.546 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 574' ' ' VAL . . . . . . . . . . . . . 60.3 t -111.66 145.86 17.3 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-O 121.004 0.43 . . . . 3.2400000000000002 110.231 -172.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 575' ' ' TYR . . . . . . . . . . . . . 45.3 t80 -78.52 118.49 20.7 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 108.917 -0.772 . . . . 3.02 108.917 174.771 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 576' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -91.66 102.76 15.39 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 109.154 -0.684 . . . . 3.3399999999999999 109.154 -179.113 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 577' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -68.56 -23.0 64.45 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.276 -0.42 . . . . 5.5899999999999999 111.635 -176.147 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 578' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -65.74 -43.98 87.35 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.409 -0.36 . . . . 5.1100000000000003 110.603 -178.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 579' ' ' SER . . . . . . . . . . . . . 72.0 p -95.9 -20.61 18.64 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.109 0.48 . . . . 3.2799999999999998 111.504 176.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 580' ' ' GLY . . . . . . . . . . . . . . . 80.71 21.38 63.93 Favored Glycine 0 N--CA 1.452 -0.244 0 CA-C-N 116.01 -0.541 . . . . 2.6000000000000001 112.886 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 581' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -133.09 157.56 44.98 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.728 0.299 . . . . 3.1899999999999999 110.597 179.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 582' ' ' TRP . . . . . 0.478 ' HB2' ' HB ' ' A' ' 553' ' ' VAL . 76.3 m95 -79.85 137.11 36.85 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.478 -0.328 . . . . 2.2999999999999998 110.194 178.151 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 583' ' ' VAL . . . . . 0.555 HG12 ' CE1' ' A' ' 550' ' ' TYR . 20.5 m -118.81 141.48 38.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 113.251 0.834 . . . . 1.1100000000000001 113.251 -173.409 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 584' ' ' TRP . . . . . 0.637 ' CD1' HG22 ' A' ' 553' ' ' VAL . 28.1 m0 -113.43 104.56 12.41 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 114.997 -1.001 . . . . 2.29 108.621 164.225 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 585' ' ' LYS . . . . . 0.497 ' HD2' ' CB ' ' A' ' 550' ' ' TYR . 10.9 mmmm -89.17 152.35 21.66 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.696 0.284 . . . . 3.9500000000000002 110.491 -176.337 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 586' ' ' ASN . . . . . 0.414 ' O ' ' HA ' ' A' ' 596' ' ' HIS . 1.1 m-20 55.24 42.77 30.15 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 115.911 -0.586 . . . . 1.4299999999999999 109.648 -173.601 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 587' ' ' THR . . . . . . . . . . . . . 53.3 m -126.33 140.23 52.68 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.114 0.483 . . . . 0.65000000000000002 110.878 -175.491 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 588' ' ' ILE . . . . . . . . . . . . . 14.3 tt -137.25 145.3 29.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.832 -0.622 . . . . 0.70999999999999996 109.644 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 589' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -103.17 121.14 42.04 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.064 0.459 . . . . 1.3500000000000001 109.999 178.636 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 590' ' ' VAL . . . . . . . . . . . . . 43.5 t -131.6 127.65 59.6 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 115.594 -0.73 . . . . 0.65000000000000002 109.662 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 591' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 59.63 33.26 21.93 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 121.947 0.88 . . . . 2.0299999999999998 110.451 179.297 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . 77.78 9.82 86.64 Favored Glycine 0 N--CA 1.449 -0.436 0 CA-C-N 115.64 -0.709 . . . . 0.62 112.327 179.316 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 593' ' ' LYS . . . . . . . . . . . . . 70.1 mmtt -123.35 144.57 49.37 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 110.185 -0.302 . . . . 2.7799999999999998 110.185 -175.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 594' ' ' TYR . . . . . 0.515 ' HE1' HG11 ' A' ' 551' ' ' VAL . 99.1 m-85 -96.28 134.27 39.6 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.878 0.37 . . . . 1.45 111.162 -177.2 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 595' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -139.18 162.66 34.42 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.681 -0.69 . . . . 1.3200000000000001 109.631 178.258 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 596' ' ' HIS . . . . . 0.428 ' HB2' ' HB2' ' A' ' 599' ' ' CYS . 24.6 m170 -68.17 128.78 37.8 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 108.951 -0.759 . . . . 0.58999999999999997 108.951 169.4 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 597' ' ' SER . . . . . . . . . . . . . 4.6 m -63.26 -36.42 83.61 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-O 121.467 0.651 . . . . 1.1299999999999999 109.474 178.519 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 598' ' ' THR . . . . . . . . . . . . . 96.3 m -63.69 -44.76 92.74 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 114.704 -1.134 . . . . 1.3999999999999999 111.188 177.225 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 599' ' ' CYS . . . . . 0.663 ' O ' ' HG2' ' A' ' 602' ' ' GLU . 83.3 m -76.45 -31.98 58.16 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.564 0.579 . . . . 0.81000000000000005 112.564 -176.157 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 600' ' ' TYR . . . . . . . . . . . . . 87.5 t80 -57.03 -36.45 70.48 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.647 0.61 . . . . 1.8799999999999999 112.647 -169.219 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 601' ' ' HIS . . . . . . . . . . . . . 18.5 m170 -64.17 -26.71 68.65 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 112.801 0.667 . . . . 4.5199999999999996 112.801 -174.4 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 602' ' ' GLU . . . . . 0.663 ' HG2' ' O ' ' A' ' 599' ' ' CYS . 11.9 pt-20 -70.12 -23.48 63.03 Favored 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 120.313 -0.555 . . . . 3.8500000000000001 111.077 -178.445 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 603' ' ' THR . . . . . . . . . . . . . 85.0 m . . . . . 0 C--N 1.328 -0.338 0 CA-C-O 121.31 0.576 . . . . 3.2999999999999998 109.774 177.347 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.447 0 N-CA-C 112.504 -0.239 . . . . 3.2000000000000002 112.504 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 549' ' ' LYS . . . . . 0.444 ' HD3' ' HA ' ' A' ' 549' ' ' LYS . 31.0 mmtp -76.13 150.86 37.14 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.615 0.721 . . . . 5.9000000000000004 111.429 179.014 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 550' ' ' TYR . . . . . 0.591 ' CE1' HG12 ' A' ' 583' ' ' VAL . 46.9 p90 -114.81 162.97 16.17 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 114.594 -1.185 . . . . 2.79 110.761 -170.375 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 551' ' ' VAL . . . . . . . . . . . . . 60.5 t -117.03 134.01 61.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 N-CA-C 108.681 -0.859 . . . . 1.52 108.681 175.228 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 552' ' ' VAL . . . . . 0.595 ' HA ' ' O ' ' A' ' 582' ' ' TRP . 60.4 t -62.57 135.36 27.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.094 -0.503 . . . . 1.3799999999999999 110.508 -176.622 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 553' ' ' VAL . . . . . 0.56 HG22 ' CD1' ' A' ' 584' ' ' TRP . 92.4 t -59.34 120.62 49.74 Favored Pre-proline 0 N--CA 1.455 -0.194 0 CA-C-N 116.034 -0.53 . . . . 1.3799999999999999 110.464 -178.405 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 554' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 553' ' ' VAL . 33.5 Cg_exo . . . . . 0 C--O 1.232 0.21 0 C-N-CA 123.653 2.902 . . . . 1.98 113.043 -178.526 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 560' ' ' MET . . . . . . . . . . . . . 1.9 mpt? . . . . . 0 N--CA 1.467 0.421 0 N-CA-C 112.059 0.392 . . . . 2.6099999999999999 112.059 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 561' ' ' ALA . . . . . 0.493 ' HA ' ' O ' ' A' ' 571' ' ' VAL . . . -144.64 154.71 43.09 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.918 0.39 . . . . 0.94999999999999996 111.486 -177.634 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 34.5 p90 -141.58 159.83 41.41 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 108.884 -0.784 . . . . 0.90000000000000002 108.884 170.467 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 563' ' ' LYS . . . . . . . . . . . . . 23.3 tptm -99.87 122.52 42.94 Favored 'General case' 0 C--N 1.32 -0.713 0 C-N-CA 120.98 -0.288 . . . . 2.1800000000000002 110.702 -176.066 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 564' ' ' CYS . . . . . 0.515 ' HB3' ' HG2' ' A' ' 569' ' ' GLU . 49.5 t -77.38 114.72 43.07 Favored Pre-proline 0 C--N 1.326 -0.425 0 N-CA-C 109.912 -0.403 . . . . 0.40999999999999998 109.912 178.102 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 565' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 564' ' ' CYS . 13.4 Cg_exo -69.42 -28.85 26.37 Favored 'Trans proline' 0 C--N 1.343 0.263 0 C-N-CA 122.998 2.465 . . . . 0.63 113.539 -173.053 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 566' ' ' ILE . . . . . . . . . . . . . 51.9 mt -72.01 -55.62 12.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 121.005 0.431 . . . . 0.93999999999999995 111.577 -175.537 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 567' ' ' CYS . . . . . 0.494 ' SG ' ' OE2' ' A' ' 569' ' ' GLU . 26.7 p -107.47 2.3 24.11 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 112.262 0.467 . . . . 0.69999999999999996 112.262 -174.186 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 568' ' ' LYS . . . . . . . . . . . . . 44.8 mmtm 67.34 28.7 7.81 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 115.921 -0.581 . . . . 2.71 112.186 171.117 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 569' ' ' GLU . . . . . 0.515 ' HG2' ' HB3' ' A' ' 564' ' ' CYS . 17.4 pt-20 -99.5 135.51 40.8 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.705 -0.398 . . . . 3.3399999999999999 110.35 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 570' ' ' THR . . . . . . . . . . . . . 88.5 m -80.66 119.1 22.85 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.649 -0.5 . . . . 1.01 109.649 174.154 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 571' ' ' VAL . . . . . 0.493 ' O ' ' HA ' ' A' ' 561' ' ' ALA . 11.7 t -92.27 116.72 34.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 116.179 -0.464 . . . . 0.72999999999999998 111.039 -174.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 27.8 p -107.67 159.07 16.75 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 116.1 -0.5 . . . . 1.8899999999999999 109.889 176.703 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . -130.79 155.78 21.37 Favored Glycine 0 N--CA 1.442 -0.939 0 C-N-CA 119.868 -1.158 . . . . 2.2000000000000002 111.835 179.496 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 574' ' ' VAL . . . . . . . . . . . . . 23.9 t -114.09 149.96 16.26 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 N-CA-C 109.761 -0.459 . . . . 3.2400000000000002 109.761 -175.148 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 575' ' ' TYR . . . . . 0.406 ' HA ' ' HA ' ' A' ' 582' ' ' TRP . 54.1 t80 -82.02 119.18 23.67 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 108.717 -0.846 . . . . 3.02 108.717 174.335 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 576' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -90.57 106.36 18.45 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 109.12 -0.696 . . . . 3.3399999999999999 109.12 -178.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 577' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -69.36 -21.8 63.78 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.956 -0.565 . . . . 5.5899999999999999 111.965 -176.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 578' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -67.6 -44.76 77.32 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.974 0.416 . . . . 5.1100000000000003 110.527 -177.69 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 579' ' ' SER . . . . . . . . . . . . . 70.1 p -96.29 -23.67 16.56 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.281 0.562 . . . . 3.2799999999999998 111.119 176.202 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 580' ' ' GLY . . . . . . . . . . . . . . . 81.81 31.48 32.48 Favored Glycine 0 CA--C 1.522 0.477 0 CA-C-N 115.497 -0.774 . . . . 2.6000000000000001 113.018 -178.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 581' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -138.15 152.52 48.77 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 116.855 0.327 . . . . 3.1899999999999999 110.675 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 582' ' ' TRP . . . . . 0.595 ' O ' ' HA ' ' A' ' 552' ' ' VAL . 80.5 m95 -76.8 136.69 38.97 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 109.639 -0.504 . . . . 2.2999999999999998 109.639 176.411 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 583' ' ' VAL . . . . . 0.591 HG12 ' CE1' ' A' ' 550' ' ' TYR . 19.1 m -116.0 131.55 68.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 N-CA-C 113.502 0.927 . . . . 1.1100000000000001 113.502 -173.118 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 584' ' ' TRP . . . . . 0.56 ' CD1' HG22 ' A' ' 553' ' ' VAL . 17.8 m0 -114.49 103.0 10.6 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 108.497 -0.927 . . . . 2.29 108.497 162.835 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 585' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.98 151.21 22.95 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.066 0.46 . . . . 3.9500000000000002 111.991 -173.426 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 586' ' ' ASN . . . . . . . . . . . . . 18.9 m-20 52.68 41.7 31.46 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 115.23 -0.896 . . . . 1.4299999999999999 110.192 -174.474 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 587' ' ' THR . . . . . . . . . . . . . 32.5 m -120.34 141.0 50.46 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.015 -0.539 . . . . 0.65000000000000002 110.789 -177.132 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 588' ' ' ILE . . . . . . . . . . . . . 11.7 tt -137.98 141.54 38.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 N-CA-C 109.671 -0.492 . . . . 0.70999999999999996 109.671 179.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 589' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -97.23 120.87 38.38 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.306 -0.628 . . . . 1.3500000000000001 109.306 177.812 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 590' ' ' VAL . . . . . . . . . . . . . 61.9 t -127.17 118.2 49.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.634 -0.712 . . . . 0.65000000000000002 110.549 179.653 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 591' ' ' ASN . . . . . . . . . . . . . 62.8 t30 58.62 38.91 25.11 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 115.459 -0.791 . . . . 2.0299999999999998 111.617 176.112 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . 86.08 5.49 83.12 Favored Glycine 0 N--CA 1.45 -0.421 0 CA-C-N 115.86 -0.609 . . . . 0.62 113.17 175.344 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 593' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -128.74 139.75 52.06 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.917 0.389 . . . . 2.7799999999999998 111.151 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 594' ' ' TYR . . . . . . . . . . . . . 85.1 m-85 -91.26 129.82 37.2 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.966 -0.561 . . . . 1.45 110.478 -179.218 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 595' ' ' PHE . . . . . . . . . . . . . 63.8 m-85 -135.0 162.9 31.13 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.896 -0.593 . . . . 1.3200000000000001 109.682 177.235 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 596' ' ' HIS . . . . . 0.499 ' HB2' ' SG ' ' A' ' 599' ' ' CYS . 30.5 m170 -70.68 129.36 38.93 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.68 -0.489 . . . . 0.58999999999999997 109.68 172.436 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 597' ' ' SER . . . . . . . . . . . . . 23.0 t -65.47 -30.47 71.25 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.783 -0.644 . . . . 1.1299999999999999 109.598 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 598' ' ' THR . . . . . . . . . . . . . 1.8 m -66.52 -42.42 87.32 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 115.464 -0.789 . . . . 1.3999999999999999 110.333 175.063 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 599' ' ' CYS . . . . . 0.499 ' SG ' ' HB2' ' A' ' 596' ' ' HIS . 78.6 m -73.83 -27.45 61.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.069 -0.969 . . . . 0.81000000000000005 111.906 -178.778 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 600' ' ' TYR . . . . . . . . . . . . . 79.7 t80 -56.0 -35.29 66.64 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.696 0.284 . . . . 1.8799999999999999 110.98 -174.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 601' ' ' HIS . . . . . . . . . . . . . 31.2 m170 -62.74 -28.13 69.75 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.006 0.432 . . . . 4.5199999999999996 111.01 178.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 602' ' ' GLU . . . . . 0.413 ' HB3' ' O ' ' A' ' 599' ' ' CYS . 8.7 tp10 -70.81 -38.37 73.3 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.018 -0.537 . . . . 3.8500000000000001 110.924 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 603' ' ' THR . . . . . . . . . . . . . 10.3 t . . . . . 0 C--N 1.327 -0.392 0 CA-C-O 121.203 0.525 . . . . 3.2999999999999998 110.599 -176.594 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.509 -0.321 0 CA-C-O 120.915 0.175 . . . . 3.2000000000000002 113.064 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 549' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -80.18 132.72 35.95 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.135 0.493 . . . . 5.9000000000000004 110.559 179.392 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 550' ' ' TYR . . . . . 0.471 ' HB3' ' HD2' ' A' ' 585' ' ' LYS . 39.0 p90 -111.18 160.56 16.82 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.58 -0.737 . . . . 2.79 109.29 174.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 551' ' ' VAL . . . . . . . . . . . . . 70.2 t -117.72 133.36 64.75 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 N-CA-C 108.708 -0.849 . . . . 1.52 108.708 178.137 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 552' ' ' VAL . . . . . 0.582 ' HA ' ' O ' ' A' ' 582' ' ' TRP . 74.4 t -64.86 131.67 30.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.994 -0.548 . . . . 1.3799999999999999 110.487 -178.291 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 553' ' ' VAL . . . . . 0.625 ' HB ' ' HB2' ' A' ' 582' ' ' TRP . 65.9 t -59.04 123.33 68.76 Favored Pre-proline 0 C--O 1.235 0.319 0 CA-C-N 116.073 -0.512 . . . . 1.3799999999999999 110.08 178.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 554' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_exo . . . . . 0 CA--C 1.529 0.241 0 C-N-CA 122.967 2.445 . . . . 1.98 112.577 -177.275 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 560' ' ' MET . . . . . . . . . . . . . 41.7 mtm . . . . . 0 C--O 1.235 0.298 0 CA-C-O 120.67 0.271 . . . . 2.6099999999999999 110.947 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 561' ' ' ALA . . . . . . . . . . . . . . . -142.84 145.78 33.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.098 0.475 . . . . 0.94999999999999996 112.231 -173.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 27.0 p90 -136.17 164.7 27.44 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 107.4 -1.333 . . . . 0.90000000000000002 107.4 172.427 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 563' ' ' LYS . . . . . . . . . . . . . 35.5 ttmt -105.48 133.0 50.96 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 119.589 -0.844 . . . . 2.1800000000000002 111.157 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 564' ' ' CYS . . . . . 0.431 ' O ' ' HA ' ' A' ' 568' ' ' LYS . 34.6 t -71.97 114.1 26.08 Favored Pre-proline 0 C--O 1.222 -0.385 0 CA-C-N 115.085 -0.961 . . . . 0.40999999999999998 109.385 178.468 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 565' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -67.02 -30.79 38.45 Favored 'Trans proline' 0 CA--C 1.53 0.285 0 C-N-CA 122.588 2.192 . . . . 0.63 113.942 -172.613 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 566' ' ' ILE . . . . . . . . . . . . . 32.8 mt -71.61 -56.27 10.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.815 0.34 . . . . 0.93999999999999995 111.53 -172.47 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 567' ' ' CYS . . . . . 0.521 ' SG ' ' HG3' ' A' ' 569' ' ' GLU . 28.5 p -108.05 0.71 21.91 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.99 0.424 . . . . 0.69999999999999996 111.339 -177.604 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 568' ' ' LYS . . . . . 0.431 ' HA ' ' O ' ' A' ' 564' ' ' CYS . 52.7 mttp 67.57 30.56 6.6 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 113.145 0.795 . . . . 2.71 113.145 171.389 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 569' ' ' GLU . . . . . 0.521 ' HG3' ' SG ' ' A' ' 567' ' ' CYS . 35.7 mt-10 -77.96 133.44 38.03 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.78 -0.452 . . . . 3.3399999999999999 109.78 171.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 570' ' ' THR . . . . . . . . . . . . . 52.8 m -76.16 117.31 17.73 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 108.68 -0.859 . . . . 1.01 108.68 167.278 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 571' ' ' VAL . . . . . . . . . . . . . 23.5 t -94.77 116.93 37.32 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-N 116.59 -0.277 . . . . 0.72999999999999998 110.894 -172.708 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 24.1 p -111.89 159.59 18.21 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.748 -0.66 . . . . 1.8899999999999999 109.536 175.532 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . -130.82 155.1 21.05 Favored Glycine 0 N--CA 1.442 -0.938 0 C-N-CA 119.933 -1.127 . . . . 2.2000000000000002 111.799 -178.129 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 574' ' ' VAL . . . . . 0.465 ' O ' HG22 ' A' ' 583' ' ' VAL . 35.4 t -113.04 149.54 15.44 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 N-CA-C 109.614 -0.513 . . . . 3.2400000000000002 109.614 -176.081 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 575' ' ' TYR . . . . . 0.529 ' HA ' ' HA ' ' A' ' 582' ' ' TRP . 59.8 t80 -83.76 119.41 24.78 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.593 0.235 . . . . 3.02 110.43 177.071 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 576' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -92.01 105.67 17.86 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.199 0.523 . . . . 3.3399999999999999 110.024 175.236 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 577' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -63.87 -23.94 67.55 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.39 -0.823 . . . . 5.5899999999999999 111.153 -178.184 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 578' ' ' GLU . . . . . . . . . . . . . 13.4 tt0 -72.25 -46.58 55.37 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.911 -0.586 . . . . 5.1100000000000003 111.216 -174.422 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 579' ' ' SER . . . . . . . . . . . . . 75.7 p -87.54 -15.97 35.98 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.965 0.412 . . . . 3.2799999999999998 110.743 175.102 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 580' ' ' GLY . . . . . . . . . . . . . . . 80.04 15.24 79.32 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 121.07 -0.586 . . . . 2.6000000000000001 112.697 177.379 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 581' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -135.09 154.53 51.64 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.023 0.439 . . . . 3.1899999999999999 110.596 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 582' ' ' TRP . . . . . 0.625 ' HB2' ' HB ' ' A' ' 553' ' ' VAL . 77.3 m95 -71.88 148.2 46.35 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.913 -0.585 . . . . 2.2999999999999998 109.96 176.673 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 583' ' ' VAL . . . . . 0.465 HG22 ' O ' ' A' ' 574' ' ' VAL . 15.8 m -121.58 133.33 68.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 112.975 0.731 . . . . 1.1100000000000001 112.975 -174.881 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 584' ' ' TRP . . . . . 0.612 ' CD1' HG22 ' A' ' 553' ' ' VAL . 27.0 m0 -110.31 103.79 12.5 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 108.262 -1.014 . . . . 2.29 108.262 162.868 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 585' ' ' LYS . . . . . 0.471 ' HD2' ' HB3' ' A' ' 550' ' ' TYR . 14.4 mmmm -82.08 152.0 26.78 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.877 0.37 . . . . 3.9500000000000002 111.127 -175.312 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 586' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 54.76 41.9 31.57 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 115.424 -0.807 . . . . 1.4299999999999999 109.632 -176.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 587' ' ' THR . . . . . . . . . . . . . 49.3 m -120.91 140.52 51.71 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.19 0.519 . . . . 0.65000000000000002 110.628 -175.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 588' ' ' ILE . . . . . . . . . . . . . 15.1 tt -139.67 143.61 30.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.606 -0.725 . . . . 0.70999999999999996 109.924 -177.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 589' ' ' GLU . . . . . 0.413 ' HA ' ' O ' ' A' ' 593' ' ' LYS . 0.8 OUTLIER -96.22 119.56 34.92 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.351 -0.611 . . . . 1.3500000000000001 109.351 175.979 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 590' ' ' VAL . . . . . . . . . . . . . 27.3 t -128.36 120.75 53.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.253 -0.885 . . . . 0.65000000000000002 109.343 179.028 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 591' ' ' ASN . . . . . . . . . . . . . 16.9 m120 59.36 34.66 22.9 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 121.175 0.512 . . . . 2.0299999999999998 111.21 -179.004 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . 79.56 13.91 81.93 Favored Glycine 0 N--CA 1.445 -0.748 0 C-N-CA 120.981 -0.628 . . . . 0.62 112.15 177.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 593' ' ' LYS . . . . . 0.413 ' O ' ' HA ' ' A' ' 589' ' ' GLU . 46.7 mmtm -123.58 139.81 53.63 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.747 0.308 . . . . 2.7799999999999998 110.535 -176.849 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 594' ' ' TYR . . . . . . . . . . . . . 75.5 m-85 -90.62 122.51 33.47 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.304 -0.407 . . . . 1.45 110.466 179.089 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 595' ' ' PHE . . . . . . . . . . . . . 44.8 m-85 -133.15 163.87 28.3 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.771 -0.65 . . . . 1.3200000000000001 110.058 178.588 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 596' ' ' HIS . . . . . 0.412 ' HB3' HG22 ' A' ' 598' ' ' THR . 32.1 m170 -71.55 128.06 34.59 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.742 -0.836 . . . . 0.58999999999999997 108.742 170.093 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 597' ' ' SER . . . . . . . . . . . . . 8.6 m -64.15 -29.99 71.08 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.159 -0.473 . . . . 1.1299999999999999 110.277 -179.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 598' ' ' THR . . . . . 0.412 HG22 ' HB3' ' A' ' 596' ' ' HIS . 4.7 t -67.37 -38.91 85.51 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 115.376 -0.829 . . . . 1.3999999999999999 110.968 179.724 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 599' ' ' CYS . . . . . . . . . . . . . 77.3 m -77.35 -34.64 55.1 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.954 -0.566 . . . . 0.81000000000000005 112.495 -175.179 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 600' ' ' TYR . . . . . 0.416 ' O ' HG22 ' A' ' 603' ' ' THR . 85.0 t80 -56.75 -33.65 66.79 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 120.898 0.38 . . . . 1.8799999999999999 111.92 -170.091 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 601' ' ' HIS . . . . . . . . . . . . . 28.7 m170 -59.74 -27.21 66.3 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 112.427 0.529 . . . . 4.5199999999999996 112.427 -175.314 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 602' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -70.06 -31.08 68.51 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.734 0.302 . . . . 3.8500000000000001 110.794 -176.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 603' ' ' THR . . . . . 0.416 HG22 ' O ' ' A' ' 600' ' ' TYR . 3.2 t . . . . . 0 CA--C 1.533 0.302 0 C-N-CA 120.55 -0.46 . . . . 3.2999999999999998 111.66 -174.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.508 -0.351 0 N-CA-C 112.127 -0.389 . . . . 3.2000000000000002 112.127 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 549' ' ' LYS . . . . . 0.422 ' HA ' ' HD3' ' A' ' 549' ' ' LYS . 71.3 mmtt -71.91 132.55 44.51 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.003 0.43 . . . . 5.9000000000000004 110.871 -179.521 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 550' ' ' TYR . . . . . . . . . . . . . 21.2 p90 -125.66 159.63 31.73 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.232 -0.894 . . . . 2.79 109.286 177.588 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 551' ' ' VAL . . . . . . . . . . . . . 57.5 t -118.81 132.69 67.96 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 N-CA-C 109.073 -0.714 . . . . 1.52 109.073 177.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 552' ' ' VAL . . . . . 0.506 ' HA ' ' O ' ' A' ' 582' ' ' TRP . 67.9 t -65.19 127.04 25.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 109.642 -0.503 . . . . 1.3799999999999999 109.642 178.668 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 553' ' ' VAL . . . . . 0.666 HG22 ' CD1' ' A' ' 584' ' ' TRP . 61.8 t -59.92 120.99 55.11 Favored Pre-proline 0 C--N 1.329 -0.313 0 O-C-N 123.495 0.497 . . . . 1.3799999999999999 110.834 -176.238 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 554' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_exo . . . . . 0 N--CA 1.461 -0.406 0 C-N-CA 122.785 2.323 . . . . 1.98 111.764 178.907 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 560' ' ' MET . . . . . . . . . . . . . 2.0 mpt? . . . . . 0 N--CA 1.465 0.323 0 CA-C-O 121.355 0.598 . . . . 2.6099999999999999 109.935 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 561' ' ' ALA . . . . . . . . . . . . . . . -145.36 161.95 38.41 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.394 -0.821 . . . . 0.94999999999999996 111.722 -171.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 31.0 p90 -142.82 155.03 44.73 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 107.781 -1.192 . . . . 0.90000000000000002 107.781 170.117 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 563' ' ' LYS . . . . . 0.411 ' HA ' ' HA ' ' A' ' 570' ' ' THR . 78.7 tttt -99.15 120.83 40.15 Favored 'General case' 0 C--N 1.32 -0.715 0 C-N-CA 120.193 -0.603 . . . . 2.1800000000000002 110.536 -176.254 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 564' ' ' CYS . . . . . . . . . . . . . 42.8 t -64.7 117.29 36.8 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 115.412 -0.813 . . . . 0.40999999999999998 111.944 -174.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 565' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_exo -68.72 -22.01 37.93 Favored 'Trans proline' 0 CA--C 1.531 0.358 0 C-N-CA 123.128 2.552 . . . . 0.63 113.085 -179.621 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 566' ' ' ILE . . . . . 0.534 HG21 ' HB3' ' A' ' 599' ' ' CYS . 36.0 mm -74.47 -42.25 49.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 120.714 0.293 . . . . 0.93999999999999995 111.569 -177.041 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 567' ' ' CYS . . . . . . . . . . . . . 28.8 p -123.56 0.9 8.86 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 111.923 0.342 . . . . 0.69999999999999996 111.923 -174.172 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 568' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? 62.13 27.95 16.83 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.84 -0.618 . . . . 2.71 112.008 176.425 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 569' ' ' GLU . . . . . 0.42 ' HA ' ' OE1' ' A' ' 569' ' ' GLU . 6.3 mm-40 -107.37 137.4 45.49 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 116.298 -0.41 . . . . 3.3399999999999999 110.463 177.637 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 570' ' ' THR . . . . . 0.411 ' HA ' ' HA ' ' A' ' 563' ' ' LYS . 37.4 m -69.24 123.91 22.41 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.76 -0.655 . . . . 1.01 110.396 -179.257 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 571' ' ' VAL . . . . . 0.444 HG22 ' CE1' ' A' ' 596' ' ' HIS . 18.0 t -96.62 115.41 35.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 116.376 -0.374 . . . . 0.72999999999999998 110.087 -179.827 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 23.6 p -106.72 159.22 16.38 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 116.053 -0.521 . . . . 1.8899999999999999 110.325 178.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . -130.35 155.73 21.23 Favored Glycine 0 N--CA 1.44 -1.084 0 C-N-CA 119.921 -1.133 . . . . 2.2000000000000002 111.384 -178.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 574' ' ' VAL . . . . . 0.466 ' O ' HG22 ' A' ' 583' ' ' VAL . 41.2 t -111.85 147.2 15.88 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 N-CA-C 109.644 -0.502 . . . . 3.2400000000000002 109.644 -172.503 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 575' ' ' TYR . . . . . 0.492 ' HA ' ' HA ' ' A' ' 582' ' ' TRP . 48.8 t80 -82.33 121.49 26.76 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.507 -0.553 . . . . 3.02 109.507 174.668 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 576' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -89.59 108.54 19.73 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.046 -0.724 . . . . 3.3399999999999999 109.046 179.45 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 577' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -69.68 -23.03 63.39 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.417 -0.81 . . . . 5.5899999999999999 111.816 -172.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 578' ' ' GLU . . . . . . . . . . . . . 45.4 tt0 -74.87 -48.35 25.38 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 121.044 -0.262 . . . . 5.1100000000000003 110.858 -178.156 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 579' ' ' SER . . . . . . . . . . . . . 74.0 p -85.64 -19.16 31.38 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.019 0.438 . . . . 3.2799999999999998 111.187 179.32 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 580' ' ' GLY . . . . . . . . . . . . . . . 79.13 22.36 65.72 Favored Glycine 0 N--CA 1.448 -0.535 0 CA-C-N 115.926 -0.579 . . . . 2.6000000000000001 112.818 178.554 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 581' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -135.17 152.34 51.5 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.876 0.37 . . . . 3.1899999999999999 110.8 -178.394 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 582' ' ' TRP . . . . . 0.506 ' O ' ' HA ' ' A' ' 552' ' ' VAL . 74.5 m95 -78.8 144.78 34.76 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.742 -0.663 . . . . 2.2999999999999998 110.013 177.778 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 583' ' ' VAL . . . . . 0.466 HG22 ' O ' ' A' ' 574' ' ' VAL . 26.7 m -124.14 134.3 66.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 N-CA-C 112.719 0.637 . . . . 1.1100000000000001 112.719 -175.001 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 584' ' ' TRP . . . . . 0.666 ' CD1' HG22 ' A' ' 553' ' ' VAL . 27.8 m0 -109.5 101.98 10.88 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 108.799 -0.815 . . . . 2.29 108.799 162.761 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 585' ' ' LYS . . . . . 0.403 ' HD3' ' OD1' ' A' ' 586' ' ' ASN . 0.0 OUTLIER -89.62 152.68 21.26 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.644 -0.253 . . . . 3.9500000000000002 110.904 -177.217 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 586' ' ' ASN . . . . . 0.403 ' OD1' ' HD3' ' A' ' 585' ' ' LYS . 10.4 m120 55.34 46.22 23.9 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 109.385 -0.598 . . . . 1.4299999999999999 109.385 -170.615 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 587' ' ' THR . . . . . . . . . . . . . 28.6 m -135.69 140.68 44.63 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.012 -0.54 . . . . 0.65000000000000002 110.593 -177.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 588' ' ' ILE . . . . . . . . . . . . . 15.0 tt -141.9 146.49 22.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.305 -0.407 . . . . 0.70999999999999996 110.404 -179.423 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 589' ' ' GLU . . . . . 0.409 ' HB2' ' CE2' ' A' ' 594' ' ' TYR . 33.4 tt0 -94.54 119.84 33.84 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.829 -0.434 . . . . 1.3500000000000001 109.829 174.722 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 590' ' ' VAL . . . . . . . . . . . . . 61.3 t -125.49 121.57 60.58 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 N-CA-C 109.491 -0.559 . . . . 0.65000000000000002 109.491 178.392 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 591' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 58.2 33.71 23.42 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.083 -0.508 . . . . 2.0299999999999998 111.425 -179.231 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . 84.67 -1.58 88.74 Favored Glycine 0 N--CA 1.45 -0.378 0 CA-C-N 115.797 -0.638 . . . . 0.62 113.114 177.511 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 593' ' ' LYS . . . . . . . . . . . . . 70.5 mmtt -114.49 146.22 40.95 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.782 0.325 . . . . 2.7799999999999998 111.254 -179.145 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 594' ' ' TYR . . . . . 0.409 ' CE2' ' HB2' ' A' ' 589' ' ' GLU . 80.4 m-85 -98.16 127.45 44.11 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.207 -0.451 . . . . 1.45 111.46 -176.198 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 595' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -135.13 162.53 32.24 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.531 -0.759 . . . . 1.3200000000000001 109.704 177.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 596' ' ' HIS . . . . . 0.444 ' CE1' HG22 ' A' ' 571' ' ' VAL . 10.3 m170 -61.29 128.79 38.07 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.42 -0.585 . . . . 0.58999999999999997 109.42 171.403 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 597' ' ' SER . . . . . . . . . . . . . 47.7 t -64.55 -29.57 70.6 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.244 -0.65 . . . . 1.1299999999999999 109.244 176.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 598' ' ' THR . . . . . . . . . . . . . 5.2 m -67.98 -45.98 72.63 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-O 121.64 0.734 . . . . 1.3999999999999999 110.233 175.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 599' ' ' CYS . . . . . 0.534 ' HB3' HG21 ' A' ' 566' ' ' ILE . 74.6 m -74.67 -30.67 61.67 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.376 -0.829 . . . . 0.81000000000000005 112.566 -174.618 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 600' ' ' TYR . . . . . 0.447 ' O ' HG22 ' A' ' 603' ' ' THR . 85.0 t80 -57.47 -36.08 71.0 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.045 0.45 . . . . 1.8799999999999999 110.762 -174.644 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 601' ' ' HIS . . . . . . . . . . . . . 41.2 m170 -66.59 -28.47 68.53 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.213 -0.449 . . . . 4.5199999999999996 111.546 179.447 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 602' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -63.56 -32.75 74.31 Favored 'General case' 0 CA--C 1.52 -0.192 0 CA-C-O 120.686 0.279 . . . . 3.8500000000000001 110.315 -175.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 603' ' ' THR . . . . . 0.447 HG22 ' O ' ' A' ' 600' ' ' TYR . 13.0 t . . . . . 0 N--CA 1.45 -0.473 0 CA-C-O 121.065 0.459 . . . . 3.2999999999999998 110.713 -178.028 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.326 0 N-CA-C 112.546 -0.222 . . . . 3.2000000000000002 112.546 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 549' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -67.46 149.51 50.12 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.368 0.604 . . . . 5.9000000000000004 110.67 177.04 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 550' ' ' TYR . . . . . 0.599 ' HB3' ' HD3' ' A' ' 585' ' ' LYS . 9.5 p90 -124.29 160.29 28.35 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.331 -0.849 . . . . 2.79 110.947 -173.403 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 551' ' ' VAL . . . . . . . . . . . . . 96.9 t -118.95 133.19 66.61 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 N-CA-C 108.704 -0.85 . . . . 1.52 108.704 172.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 552' ' ' VAL . . . . . 0.544 ' HA ' ' O ' ' A' ' 582' ' ' TRP . 47.4 t -65.34 131.74 31.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 116.238 -0.437 . . . . 1.3799999999999999 110.112 -178.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 553' ' ' VAL . . . . . 0.683 HG22 ' CD1' ' A' ' 584' ' ' TRP . 26.3 t -63.56 120.99 67.62 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.249 -0.432 . . . . 1.3799999999999999 109.967 -179.677 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 554' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 553' ' ' VAL . 44.5 Cg_exo . . . . . 0 C--O 1.231 0.171 0 C-N-CA 122.959 2.44 . . . . 1.98 113.025 -177.323 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 560' ' ' MET . . . . . . . . . . . . . 81.5 mtp . . . . . 0 N--CA 1.466 0.341 0 CA-C-O 121.168 0.509 . . . . 2.6099999999999999 110.682 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 561' ' ' ALA . . . . . . . . . . . . . . . -145.82 162.2 38.23 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.897 -0.592 . . . . 0.94999999999999996 109.89 -177.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 35.1 p90 -138.5 145.97 41.42 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 120.437 -0.505 . . . . 0.90000000000000002 110.022 173.172 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 563' ' ' LYS . . . . . . . . . . . . . 50.2 tptt -88.62 111.18 21.61 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 116.134 -0.484 . . . . 2.1800000000000002 110.06 -178.575 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 564' ' ' CYS . . . . . 0.411 ' HA ' ' HD3' ' A' ' 565' ' ' PRO . 42.4 t -68.72 112.09 10.25 Favored Pre-proline 0 C--N 1.333 -0.145 0 N-CA-C 109.183 -0.673 . . . . 0.40999999999999998 109.183 179.266 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 565' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 564' ' ' CYS . 15.4 Cg_exo -71.57 -17.77 29.69 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 123.042 2.494 . . . . 0.63 111.751 -175.293 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 566' ' ' ILE . . . . . 0.406 HD12 ' HB3' ' A' ' 599' ' ' CYS . 45.6 mt -80.16 -51.9 15.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.233 -0.894 . . . . 0.93999999999999995 111.044 -175.687 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 567' ' ' CYS . . . . . . . . . . . . . 28.9 p -105.12 -1.7 25.21 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.363 -0.381 . . . . 0.69999999999999996 111.237 -176.572 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 568' ' ' LYS . . . . . . . . . . . . . 35.6 mtmm 65.41 22.54 11.95 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 112.646 0.61 . . . . 2.71 112.646 174.48 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 569' ' ' GLU . . . . . . . . . . . . . 15.9 mm-40 -105.81 135.26 47.56 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.654 0.264 . . . . 3.3399999999999999 110.479 177.064 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 570' ' ' THR . . . . . . . . . . . . . 49.2 m -75.54 126.08 30.29 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.508 -0.552 . . . . 1.01 109.508 177.059 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 571' ' ' VAL . . . . . . . . . . . . . 16.2 t -100.42 115.26 41.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 116.511 -0.313 . . . . 0.72999999999999998 110.888 -175.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 24.6 p -105.3 161.83 13.96 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.022 -0.733 . . . . 1.8899999999999999 109.022 174.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . -127.6 154.0 19.46 Favored Glycine 0 N--CA 1.436 -1.305 0 C-N-CA 119.134 -1.508 . . . . 2.2000000000000002 111.68 -179.012 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 574' ' ' VAL . . . . . . . . . . . . . 44.5 t -111.32 145.14 17.94 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 CA-C-O 120.898 0.38 . . . . 3.2400000000000002 110.059 -171.1 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 575' ' ' TYR . . . . . . . . . . . . . 38.7 t80 -76.93 118.44 19.52 Favored 'General case' 0 N--CA 1.439 -1.021 0 N-CA-C 108.956 -0.757 . . . . 3.02 108.956 174.177 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 576' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -89.72 96.95 10.92 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 108.469 -0.938 . . . . 3.3399999999999999 108.469 -177.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 577' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -63.66 -22.73 67.06 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.53 -0.759 . . . . 5.5899999999999999 111.907 -175.164 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 578' ' ' GLU . . . . . . . . . . . . . 19.0 mm-40 -66.14 -43.52 86.84 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.182 -0.463 . . . . 5.1100000000000003 110.547 -179.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 579' ' ' SER . . . . . 0.411 ' OG ' ' HG2' ' A' ' 581' ' ' GLU . 68.3 p -100.46 -19.72 16.1 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.045 -0.525 . . . . 3.2799999999999998 111.696 -179.599 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 580' ' ' GLY . . . . . . . . . . . . . . . 80.66 30.49 39.62 Favored Glycine 0 CA--C 1.524 0.6 0 CA-C-N 115.85 -0.614 . . . . 2.6000000000000001 113.264 179.28 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 581' ' ' GLU . . . . . 0.411 ' HG2' ' OG ' ' A' ' 579' ' ' SER . 17.3 pt-20 -139.07 156.44 47.17 Favored 'General case' 0 C--N 1.326 -0.442 0 O-C-N 122.304 -0.527 . . . . 3.1899999999999999 110.682 179.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 582' ' ' TRP . . . . . 0.591 ' HB3' ' HB ' ' A' ' 553' ' ' VAL . 90.2 m95 -82.04 134.26 35.34 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.512 -0.551 . . . . 2.2999999999999998 109.512 176.241 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 583' ' ' VAL . . . . . . . . . . . . . 33.5 m -123.0 134.03 67.33 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 N-CA-C 113.793 1.034 . . . . 1.1100000000000001 113.793 -173.666 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 584' ' ' TRP . . . . . 0.683 ' CD1' HG22 ' A' ' 553' ' ' VAL . 33.5 m0 -113.85 103.76 11.51 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 107.893 -1.151 . . . . 2.29 107.893 161.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 585' ' ' LYS . . . . . 0.599 ' HD3' ' HB3' ' A' ' 550' ' ' TYR . 35.3 mmtp -81.56 142.67 32.62 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.777 -0.369 . . . . 3.9500000000000002 110.768 -175.84 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 586' ' ' ASN . . . . . . . . . . . . . 22.1 m-20 55.23 50.0 16.02 Favored 'General case' 0 CA--C 1.516 -0.335 0 CA-C-N 115.38 -0.827 . . . . 1.4299999999999999 109.889 -178.292 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 587' ' ' THR . . . . . . . . . . . . . 41.1 m -125.03 141.41 52.14 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.907 -0.588 . . . . 0.65000000000000002 109.965 -179.417 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 588' ' ' ILE . . . . . . . . . . . . . 12.9 tt -140.57 144.21 27.71 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 N-CA-C 109.841 -0.429 . . . . 0.70999999999999996 109.841 -178.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 589' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -96.78 119.13 34.69 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 108.68 -0.859 . . . . 1.3500000000000001 108.68 176.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 590' ' ' VAL . . . . . . . . . . . . . 56.3 t -125.1 118.83 54.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.997 -0.547 . . . . 0.65000000000000002 109.989 -178.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 591' ' ' ASN . . . . . . . . . . . . . 12.3 m120 58.1 36.57 26.05 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.932 -0.577 . . . . 2.0299999999999998 112.334 176.326 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . 86.57 6.65 80.18 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 121.194 -0.527 . . . . 0.62 113.682 175.573 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 593' ' ' LYS . . . . . . . . . . . . . 27.8 mtpp -129.1 146.39 51.06 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 117.204 0.502 . . . . 2.7799999999999998 110.933 176.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 594' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -91.16 133.97 34.92 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.895 -0.593 . . . . 1.45 110.836 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 595' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -139.12 160.46 39.73 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.829 -0.623 . . . . 1.3200000000000001 109.716 176.362 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 596' ' ' HIS . . . . . 0.75 ' HB2' ' SG ' ' A' ' 599' ' ' CYS . 37.7 m80 -67.16 130.5 43.32 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.314 -0.995 . . . . 0.58999999999999997 108.314 169.229 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 597' ' ' SER . . . . . . . . . . . . . 11.4 m -60.75 -31.88 71.19 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.283 -0.417 . . . . 1.1299999999999999 110.252 179.471 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 598' ' ' THR . . . . . . . . . . . . . 3.6 t -69.22 -35.23 75.97 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.397 0.618 . . . . 1.3999999999999999 110.33 174.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 599' ' ' CYS . . . . . 0.75 ' SG ' ' HB2' ' A' ' 596' ' ' HIS . 91.2 m -73.98 -29.58 62.05 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.819 -0.628 . . . . 0.81000000000000005 112.595 -176.162 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 600' ' ' TYR . . . . . . . . . . . . . 43.9 t80 -57.26 -35.0 69.2 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.125 -0.695 . . . . 1.8799999999999999 109.125 -178.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 601' ' ' HIS . . . . . . . . . . . . . 45.4 m-70 -74.7 -41.16 60.71 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.638 -0.71 . . . . 4.5199999999999996 111.814 176.15 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 602' ' ' GLU . . . . . 0.699 ' HG2' ' HA ' ' A' ' 599' ' ' CYS . 22.5 pt-20 -67.81 -25.72 65.71 Favored 'General case' 0 N--CA 1.467 0.411 0 O-C-N 122.094 -0.379 . . . . 3.8500000000000001 110.87 -176.65 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 603' ' ' THR . . . . . . . . . . . . . 14.1 t . . . . . 0 CA--C 1.533 0.309 0 N-CA-C 111.994 0.368 . . . . 3.2999999999999998 111.994 -179.639 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.452 0 N-CA-C 111.141 -0.784 . . . . 3.2000000000000002 111.141 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 549' ' ' LYS . . . . . 0.433 ' HA ' ' HD3' ' A' ' 549' ' ' LYS . 37.1 mmtm -73.18 147.39 44.81 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-O 121.673 0.749 . . . . 5.9000000000000004 111.061 179.82 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 550' ' ' TYR . . . . . 0.49 ' CE1' HG12 ' A' ' 583' ' ' VAL . 29.2 p90 -124.76 162.18 24.81 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 114.764 -1.107 . . . . 2.79 109.703 -175.73 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 551' ' ' VAL . . . . . 0.432 HG11 ' HE1' ' A' ' 594' ' ' TYR . 96.3 t -117.39 133.61 63.62 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 N-CA-C 109.016 -0.735 . . . . 1.52 109.016 175.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 552' ' ' VAL . . . . . 0.503 ' HA ' ' O ' ' A' ' 582' ' ' TRP . 56.9 t -62.99 132.15 28.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.928 -0.578 . . . . 1.3799999999999999 109.802 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 553' ' ' VAL . . . . . 0.604 HG22 ' CD1' ' A' ' 584' ' ' TRP . 65.8 t -60.79 120.67 55.35 Favored Pre-proline 0 C--N 1.33 -0.247 0 O-C-N 123.74 0.65 . . . . 1.3799999999999999 111.505 -175.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 554' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo . . . . . 0 N--CA 1.462 -0.331 0 C-N-CA 123.194 2.596 . . . . 1.98 111.939 176.169 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 560' ' ' MET . . . . . 0.512 ' HB3' HG11 ' A' ' 553' ' ' VAL . 65.3 mtt . . . . . 0 C--O 1.236 0.366 0 CA-C-O 121.553 0.692 . . . . 2.6099999999999999 110.119 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 561' ' ' ALA . . . . . . . . . . . . . . . -144.98 161.73 38.65 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 115.279 -0.873 . . . . 0.94999999999999996 110.902 -175.214 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 33.8 p90 -150.06 163.7 37.47 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 107.796 -1.187 . . . . 0.90000000000000002 107.796 173.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 563' ' ' LYS . . . . . . . . . . . . . 7.7 ttmm -106.63 126.33 52.14 Favored 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 119.44 -0.904 . . . . 2.1800000000000002 109.935 179.12 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 564' ' ' CYS . . . . . 0.414 ' HA ' ' HD3' ' A' ' 565' ' ' PRO . 48.6 t -69.3 112.06 10.62 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 115.523 -0.762 . . . . 0.40999999999999998 109.601 -178.5 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 565' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 564' ' ' CYS . 17.2 Cg_exo -70.67 -29.9 18.87 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 123.318 2.678 . . . . 0.63 113.686 -173.525 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 566' ' ' ILE . . . . . . . . . . . . . 26.8 mt -70.74 -34.84 58.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.308 -0.405 . . . . 0.93999999999999995 111.184 -172.497 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 567' ' ' CYS . . . . . 0.502 ' SG ' ' OE2' ' A' ' 569' ' ' GLU . 28.7 p -129.07 3.61 5.27 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 112.855 0.687 . . . . 0.69999999999999996 112.855 -175.257 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 568' ' ' LYS . . . . . . . . . . . . . 61.9 mmtt 71.21 30.21 2.68 Favored 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 113.028 0.751 . . . . 2.71 113.028 175.45 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 569' ' ' GLU . . . . . 0.502 ' OE2' ' SG ' ' A' ' 567' ' ' CYS . 45.2 mt-10 -90.11 131.71 35.82 Favored 'General case' 0 N--CA 1.468 0.448 0 O-C-N 121.953 -0.467 . . . . 3.3399999999999999 110.662 176.794 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 570' ' ' THR . . . . . . . . . . . . . 47.2 m -75.7 117.85 17.9 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 108.917 -0.772 . . . . 1.01 108.917 164.558 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 571' ' ' VAL . . . . . 0.401 HG22 ' CE1' ' A' ' 596' ' ' HIS . 20.2 t -100.66 116.49 44.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 120.808 0.337 . . . . 0.72999999999999998 111.344 -172.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 33.4 p -110.41 160.01 16.97 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.908 -0.587 . . . . 1.8899999999999999 109.914 176.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . -129.8 155.03 20.74 Favored Glycine 0 N--CA 1.442 -0.929 0 C-N-CA 119.761 -1.209 . . . . 2.2000000000000002 111.875 -178.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 574' ' ' VAL . . . . . 0.488 ' O ' HG22 ' A' ' 583' ' ' VAL . 27.6 t -120.39 148.82 23.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-O 120.757 0.313 . . . . 3.2400000000000002 110.234 -172.549 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 575' ' ' TYR . . . . . . . . . . . . . 66.2 t80 -83.69 119.14 24.41 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.5 -0.318 . . . . 3.02 110.261 177.079 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 576' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -94.99 114.23 26.02 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.772 -0.455 . . . . 3.3399999999999999 109.772 178.133 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 577' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -69.21 -23.41 63.89 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.122 -0.49 . . . . 5.5899999999999999 112.231 -174.347 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 578' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -74.7 -41.41 60.26 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.002 0.43 . . . . 5.1100000000000003 110.773 -177.276 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 579' ' ' SER . . . . . . . . . . . . . 67.7 p -86.31 -25.58 25.37 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.228 -0.442 . . . . 3.2799999999999998 110.938 176.46 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 580' ' ' GLY . . . . . . . . . . . . . . . 80.28 15.98 77.29 Favored Glycine 0 N--CA 1.451 -0.348 0 CA-C-N 115.865 -0.607 . . . . 2.6000000000000001 112.584 179.006 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 581' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 -130.74 161.12 32.39 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.863 0.363 . . . . 3.1899999999999999 110.386 -178.492 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 582' ' ' TRP . . . . . 0.503 ' O ' ' HA ' ' A' ' 552' ' ' VAL . 76.1 m95 -83.04 134.42 35.03 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.38 -0.6 . . . . 2.2999999999999998 109.38 175.108 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 583' ' ' VAL . . . . . 0.49 HG12 ' CE1' ' A' ' 550' ' ' TYR . 16.9 m -113.17 133.63 58.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 N-CA-C 113.487 0.921 . . . . 1.1100000000000001 113.487 -171.753 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 584' ' ' TRP . . . . . 0.604 ' CD1' HG22 ' A' ' 553' ' ' VAL . 29.0 m0 -108.44 101.35 10.54 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.114 -1.069 . . . . 2.29 108.114 161.154 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 585' ' ' LYS . . . . . 0.5 ' HD2' ' H ' ' A' ' 585' ' ' LYS . 0.0 OUTLIER -76.4 145.66 39.23 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.415 -0.357 . . . . 3.9500000000000002 111.211 -174.281 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 586' ' ' ASN . . . . . . . . . . . . . 32.3 m-20 48.85 50.3 17.78 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 115.668 -0.696 . . . . 1.4299999999999999 110.37 -179.692 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 587' ' ' THR . . . . . . . . . . . . . 45.5 m -127.1 142.72 51.45 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.674 -0.694 . . . . 0.65000000000000002 109.948 -178.436 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 588' ' ' ILE . . . . . . . . . . . . . 13.3 tt -139.35 147.77 24.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 109.476 -0.564 . . . . 0.70999999999999996 109.476 179.601 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 589' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -103.1 121.86 43.48 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.124 0.487 . . . . 1.3500000000000001 109.799 178.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 590' ' ' VAL . . . . . . . . . . . . . 64.8 t -134.54 130.91 53.97 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.621 0 CA-C-N 115.537 -0.756 . . . . 0.65000000000000002 109.144 178.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 591' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 59.19 33.24 22.63 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 121.391 0.615 . . . . 2.0299999999999998 110.77 178.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . 77.22 11.92 85.08 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.937 -0.649 . . . . 0.62 112.487 178.332 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 593' ' ' LYS . . . . . . . . . . . . . 34.1 mmtp -126.42 139.68 53.07 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.777 0.322 . . . . 2.7799999999999998 110.533 -178.057 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 594' ' ' TYR . . . . . 0.432 ' HE1' HG11 ' A' ' 551' ' ' VAL . 95.0 m-85 -89.85 132.06 35.46 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 116.067 -0.515 . . . . 1.45 110.273 177.695 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 595' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -134.94 154.63 51.63 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 108.914 -0.773 . . . . 1.3200000000000001 108.914 175.405 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 596' ' ' HIS . . . . . 0.401 ' CE1' HG22 ' A' ' 571' ' ' VAL . 26.9 m170 -62.34 128.13 34.6 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 108.446 -0.946 . . . . 0.58999999999999997 108.446 169.733 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 597' ' ' SER . . . . . . . . . . . . . 31.0 t -63.3 -29.96 71.18 Favored 'General case' 0 C--N 1.322 -0.592 0 O-C-N 123.701 0.626 . . . . 1.1299999999999999 109.852 -177.274 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 598' ' ' THR . . . . . . . . . . . . . 1.8 t -67.09 -41.54 86.16 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 115.715 -0.675 . . . . 1.3999999999999999 110.776 175.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 599' ' ' CYS . . . . . 0.41 ' O ' ' HG3' ' A' ' 602' ' ' GLU . 74.2 m -75.82 -31.88 59.57 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.892 -0.595 . . . . 0.81000000000000005 111.574 -177.611 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 600' ' ' TYR . . . . . . . . . . . . . 72.4 t80 -57.03 -33.1 66.86 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.038 -0.528 . . . . 1.8799999999999999 112.067 -173.566 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 601' ' ' HIS . . . . . . . . . . . . . 33.7 m170 -58.46 -26.4 63.33 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 112.781 0.66 . . . . 4.5199999999999996 112.781 -173.276 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 602' ' ' GLU . . . . . 0.41 ' HG3' ' O ' ' A' ' 599' ' ' CYS . 3.0 pp20? -62.1 -30.54 71.08 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-O 120.949 0.404 . . . . 3.8500000000000001 110.849 -178.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 603' ' ' THR . . . . . . . . . . . . . 1.1 m . . . . . 0 CA--C 1.537 0.469 0 CA-C-O 120.981 0.42 . . . . 3.2999999999999998 111.161 -177.138 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.519 0.328 0 N-CA-C 113.676 0.231 . . . . 3.2000000000000002 113.676 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 549' ' ' LYS . . . . . . . . . . . . . 28.8 mtpp -81.1 142.24 33.5 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 117.247 0.524 . . . . 5.9000000000000004 110.931 177.393 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 550' ' ' TYR . . . . . 0.447 ' CE1' HG12 ' A' ' 583' ' ' VAL . 24.9 p90 -116.35 159.97 21.17 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.066 -0.716 . . . . 2.79 109.066 176.246 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 551' ' ' VAL . . . . . 0.753 HG11 ' HE1' ' A' ' 594' ' ' TYR . 39.9 t -119.97 136.58 56.59 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 N-CA-C 109.154 -0.684 . . . . 1.52 109.154 176.735 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 552' ' ' VAL . . . . . 0.557 ' HA ' ' O ' ' A' ' 582' ' ' TRP . 62.9 t -66.33 133.63 30.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 110.449 -0.204 . . . . 1.3799999999999999 110.449 -178.796 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 553' ' ' VAL . . . . . 0.635 HG22 ' CD1' ' A' ' 584' ' ' TRP . 80.7 t -61.99 120.99 62.54 Favored Pre-proline 0 C--N 1.331 -0.227 0 CA-C-N 116.228 -0.442 . . . . 1.3799999999999999 111.254 -177.386 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 554' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' ' 553' ' ' VAL . 7.1 Cg_exo . . . . . 0 N--CA 1.46 -0.483 0 C-N-CA 122.871 2.381 . . . . 1.98 112.45 179.19 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 560' ' ' MET . . . . . . . . . . . . . 2.1 mpt? . . . . . 0 C--O 1.234 0.266 0 CA-C-O 121.239 0.543 . . . . 2.6099999999999999 110.311 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 561' ' ' ALA . . . . . . . . . . . . . . . -144.32 151.15 38.95 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 115.622 -0.717 . . . . 0.94999999999999996 110.036 -176.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 45.9 p90 -128.2 150.27 50.09 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 110.015 -0.365 . . . . 0.90000000000000002 110.015 177.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 563' ' ' LYS . . . . . 0.459 ' HE3' ' O ' ' A' ' 568' ' ' LYS . 47.5 tptt -89.6 113.81 25.3 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.001 -0.74 . . . . 2.1800000000000002 109.001 -178.513 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 564' ' ' CYS . . . . . . . . . . . . . 47.1 t -62.56 113.55 9.29 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 116.461 -0.336 . . . . 0.40999999999999998 110.902 -175.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 565' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -67.65 -27.95 38.03 Favored 'Trans proline' 0 CA--C 1.53 0.284 0 C-N-CA 123.074 2.516 . . . . 0.63 112.778 -176.026 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 566' ' ' ILE . . . . . . . . . . . . . 42.8 mt -71.73 -38.15 65.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 111.969 0.359 . . . . 0.93999999999999995 111.969 -174.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 567' ' ' CYS . . . . . . . . . . . . . 28.5 p -129.2 1.08 5.18 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.427 0.528 . . . . 0.69999999999999996 112.427 -174.729 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 568' ' ' LYS . . . . . 0.459 ' O ' ' HE3' ' A' ' 563' ' ' LYS . 50.3 mtpt 66.27 30.93 8.85 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 121.055 0.455 . . . . 2.71 111.753 176.105 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 569' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -105.67 135.23 47.46 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.003 -0.544 . . . . 3.3399999999999999 110.933 179.215 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 570' ' ' THR . . . . . . . . . . . . . 41.4 m -71.1 118.78 14.32 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.331 -0.395 . . . . 1.01 110.598 179.217 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 571' ' ' VAL . . . . . 0.665 HG22 ' CE1' ' A' ' 596' ' ' HIS . 16.9 t -97.25 116.22 39.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 120.722 0.296 . . . . 0.72999999999999998 110.635 -178.649 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 22.7 p -108.78 157.88 18.16 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.129 -0.487 . . . . 1.8899999999999999 110.599 179.381 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 573' ' ' GLY . . . . . 0.5 ' HA3' ' HD1' ' A' ' 584' ' ' TRP . . . -131.24 156.06 21.61 Favored Glycine 0 N--CA 1.44 -1.069 0 N-CA-C 111.061 -0.816 . . . . 2.2000000000000002 111.061 178.265 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 574' ' ' VAL . . . . . 0.581 ' O ' HG22 ' A' ' 583' ' ' VAL . 25.6 t -116.66 147.68 19.88 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 CA-C-O 120.8 0.334 . . . . 3.2400000000000002 110.111 -172.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 575' ' ' TYR . . . . . . . . . . . . . 59.5 t80 -78.28 120.51 23.15 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.684 -0.487 . . . . 3.02 109.684 175.268 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 576' ' ' ASP . . . . . . . . . . . . . 15.4 t0 -91.16 114.67 27.25 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.071 0.462 . . . . 3.3399999999999999 110.275 -179.333 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 577' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -66.98 -23.31 65.93 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.491 -0.777 . . . . 5.5899999999999999 111.144 -179.574 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 578' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -75.83 -48.51 21.27 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.444 -0.344 . . . . 5.1100000000000003 111.083 -174.192 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 579' ' ' SER . . . . . . . . . . . . . 75.4 p -87.37 -24.41 24.25 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.295 0.569 . . . . 3.2799999999999998 110.8 177.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 580' ' ' GLY . . . . . . . . . . . . . . . 80.26 23.04 61.73 Favored Glycine 0 N--CA 1.447 -0.626 0 CA-C-N 115.407 -0.815 . . . . 2.6000000000000001 111.86 -177.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 581' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -131.16 160.02 36.0 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.882 0.372 . . . . 3.1899999999999999 110.157 -179.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 582' ' ' TRP . . . . . 0.557 ' O ' ' HA ' ' A' ' 552' ' ' VAL . 76.5 m95 -82.09 135.43 35.31 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.846 -0.427 . . . . 2.2999999999999998 109.846 176.634 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 583' ' ' VAL . . . . . 0.581 HG22 ' O ' ' A' ' 574' ' ' VAL . 20.0 m -112.86 131.6 63.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 N-CA-C 112.775 0.657 . . . . 1.1100000000000001 112.775 -174.841 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 584' ' ' TRP . . . . . 0.635 ' CD1' HG22 ' A' ' 553' ' ' VAL . 15.9 m0 -105.01 102.99 12.46 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 108.943 -0.762 . . . . 2.29 108.943 164.074 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 585' ' ' LYS . . . . . 0.415 ' HD2' ' H ' ' A' ' 585' ' ' LYS . 0.0 OUTLIER -93.5 151.62 19.6 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.391 -0.822 . . . . 3.9500000000000002 111.43 -175.248 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 586' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 53.27 41.15 32.15 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 115.521 -0.763 . . . . 1.4299999999999999 109.026 -172.314 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 587' ' ' THR . . . . . . . . . . . . . 36.1 m -128.86 140.83 51.51 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.492 -0.776 . . . . 0.65000000000000002 110.203 -175.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 588' ' ' ILE . . . . . 0.57 ' HB ' ' HB3' ' A' ' 597' ' ' SER . 12.5 tt -131.52 144.37 37.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 N-CA-C 109.228 -0.656 . . . . 0.70999999999999996 109.228 178.047 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 589' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -106.57 120.06 40.94 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.254 0.55 . . . . 1.3500000000000001 109.847 178.724 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 590' ' ' VAL . . . . . . . . . . . . . 54.9 t -128.16 120.37 53.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.262 -0.881 . . . . 0.65000000000000002 109.995 -179.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 591' ' ' ASN . . . . . . . . . . . . . 2.3 t30 59.23 40.68 21.21 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 115.969 -0.56 . . . . 2.0299999999999998 111.1 177.217 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . 78.82 10.06 86.52 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.94 -0.647 . . . . 0.62 112.4 175.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 593' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -126.28 144.3 50.84 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-O 121.174 0.512 . . . . 2.7799999999999998 110.981 -178.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 594' ' ' TYR . . . . . 0.753 ' HE1' HG11 ' A' ' 551' ' ' VAL . 97.5 m-85 -101.29 135.13 43.27 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.784 -0.644 . . . . 1.45 110.725 -177.848 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 595' ' ' PHE . . . . . . . . . . . . . 59.9 m-85 -139.55 158.24 44.46 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 108.548 -0.908 . . . . 1.3200000000000001 108.548 177.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 596' ' ' HIS . . . . . 0.665 ' CE1' HG22 ' A' ' 571' ' ' VAL . 15.4 m170 -61.18 127.03 29.52 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.341 -0.985 . . . . 0.58999999999999997 108.341 168.661 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 597' ' ' SER . . . . . 0.57 ' HB3' ' HB ' ' A' ' 588' ' ' ILE . 8.7 p -66.37 -29.31 69.46 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.068 0.461 . . . . 1.1299999999999999 109.879 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 598' ' ' THR . . . . . . . . . . . . . 1.1 t -69.0 -32.48 72.07 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 115.273 -0.876 . . . . 1.3999999999999999 109.93 176.321 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 599' ' ' CYS . . . . . 0.462 ' SG ' ' HB2' ' A' ' 596' ' ' HIS . 84.9 m -78.82 -29.06 44.56 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 113.81 1.041 . . . . 0.81000000000000005 113.81 -179.323 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 600' ' ' TYR . . . . . 0.456 ' O ' HG22 ' A' ' 603' ' ' THR . 87.3 t80 -54.64 -35.98 64.06 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 113.678 0.992 . . . . 1.8799999999999999 113.678 -164.304 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 601' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -60.22 -25.15 65.41 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 112.267 0.469 . . . . 4.5199999999999996 112.267 -177.415 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 602' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -61.7 -38.19 86.94 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 120.981 0.419 . . . . 3.8500000000000001 111.357 179.188 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 603' ' ' THR . . . . . 0.456 HG22 ' O ' ' A' ' 600' ' ' TYR . 11.5 t . . . . . 0 C--O 1.236 0.352 0 CA-C-N 116.483 -0.326 . . . . 3.2999999999999998 111.344 -177.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.455 0 N-CA-C 111.754 -0.538 . . . . 3.2000000000000002 111.754 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 549' ' ' LYS . . . . . . . . . . . . . 9.1 mtmp? -68.91 149.78 48.49 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.896 -0.409 . . . . 5.9000000000000004 109.896 177.358 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 550' ' ' TYR . . . . . 0.503 ' CE1' HG12 ' A' ' 583' ' ' VAL . 38.0 p90 -114.75 160.21 19.67 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 115.941 -0.572 . . . . 2.79 110.402 -176.087 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 551' ' ' VAL . . . . . . . . . . . . . 65.5 t -117.76 133.76 63.5 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 N-CA-C 108.493 -0.928 . . . . 1.52 108.493 175.74 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 552' ' ' VAL . . . . . 0.62 ' HA ' ' O ' ' A' ' 582' ' ' TRP . 28.3 t -61.95 134.88 27.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 116.315 -0.402 . . . . 1.3799999999999999 110.08 -177.573 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 553' ' ' VAL . . . . . 0.583 HG22 ' CD1' ' A' ' 584' ' ' TRP . 89.0 t -61.6 119.19 44.96 Favored Pre-proline 0 N--CA 1.451 -0.411 0 N-CA-C 109.648 -0.501 . . . . 1.3799999999999999 109.648 -179.688 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 554' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo . . . . . 0 N--CA 1.46 -0.458 0 C-N-CA 122.878 2.385 . . . . 1.98 112.779 -178.509 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 560' ' ' MET . . . . . . . . . . . . . 56.9 mtm . . . . . 0 N--CA 1.469 0.478 0 CA-C-O 120.787 0.327 . . . . 2.6099999999999999 111.317 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 561' ' ' ALA . . . . . . . . . . . . . . . -145.55 156.63 43.81 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.199 -0.455 . . . . 0.94999999999999996 111.485 -176.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 24.1 p90 -141.9 156.77 45.5 Favored 'General case' 0 C--O 1.225 -0.218 0 N-CA-C 108.131 -1.063 . . . . 0.90000000000000002 108.131 172.306 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 563' ' ' LYS . . . . . 0.532 ' HA ' ' HA ' ' A' ' 570' ' ' THR . 36.5 ttmt -99.83 128.04 45.95 Favored 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 119.752 -0.779 . . . . 2.1800000000000002 110.444 -178.773 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 564' ' ' CYS . . . . . 0.424 ' O ' ' HA ' ' A' ' 568' ' ' LYS . 50.0 t -72.12 118.05 63.77 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 115.834 -0.621 . . . . 0.40999999999999998 110.395 179.275 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 565' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -72.13 -27.62 16.69 Favored 'Trans proline' 0 CA--C 1.531 0.372 0 C-N-CA 123.026 2.484 . . . . 0.63 114.209 -173.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 566' ' ' ILE . . . . . 0.548 HD12 ' HB3' ' A' ' 599' ' ' CYS . 71.2 mt -82.2 -52.36 13.67 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 N-CA-C 112.271 0.471 . . . . 0.93999999999999995 112.271 -172.257 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 567' ' ' CYS . . . . . . . . . . . . . 29.5 p -104.59 0.82 29.0 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 121.063 0.459 . . . . 0.69999999999999996 110.787 -179.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 568' ' ' LYS . . . . . 0.424 ' HA ' ' O ' ' A' ' 564' ' ' CYS . 28.3 mtpp 69.93 29.27 4.0 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 113.623 0.971 . . . . 2.71 113.623 166.091 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 569' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -101.39 132.96 46.7 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.669 -0.412 . . . . 3.3399999999999999 110.18 175.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 570' ' ' THR . . . . . 0.532 ' HA ' ' HA ' ' A' ' 563' ' ' LYS . 55.8 m -70.82 118.4 13.55 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.517 -0.549 . . . . 1.01 109.517 173.21 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 571' ' ' VAL . . . . . . . . . . . . . 22.4 t -91.02 116.18 31.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-O 121.0 0.428 . . . . 0.72999999999999998 110.539 -176.389 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 30.6 p -106.68 159.5 16.16 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.504 -0.771 . . . . 1.8899999999999999 109.068 175.122 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . -129.76 154.66 20.56 Favored Glycine 0 N--CA 1.439 -1.107 0 C-N-CA 119.689 -1.243 . . . . 2.2000000000000002 111.599 -178.366 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 574' ' ' VAL . . . . . 0.434 ' O ' HG22 ' A' ' 583' ' ' VAL . 22.6 t -114.25 151.9 15.98 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 N-CA-C 109.874 -0.417 . . . . 3.2400000000000002 109.874 -175.061 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 575' ' ' TYR . . . . . . . . . . . . . 39.8 t80 -83.73 122.47 28.68 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 116.29 -0.413 . . . . 3.02 110.077 176.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 576' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -91.31 112.85 24.94 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 108.674 -0.861 . . . . 3.3399999999999999 108.674 175.121 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 577' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -69.73 -35.56 75.1 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.38 -0.827 . . . . 5.5899999999999999 112.524 -169.035 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 578' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -75.39 -35.51 61.04 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.881 -0.328 . . . . 5.1100000000000003 111.566 -174.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 579' ' ' SER . . . . . . . . . . . . . 77.1 p -82.53 -24.69 33.95 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.92 0.39 . . . . 3.2799999999999998 110.486 179.228 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 580' ' ' GLY . . . . . . . . . . . . . . . 80.66 20.66 65.56 Favored Glycine 0 N--CA 1.452 -0.285 0 CA-C-N 115.574 -0.739 . . . . 2.6000000000000001 112.914 177.147 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 581' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -145.85 154.8 42.38 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.845 0.355 . . . . 3.1899999999999999 111.072 179.545 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 582' ' ' TRP . . . . . 0.62 ' O ' ' HA ' ' A' ' 552' ' ' VAL . 64.9 m95 -77.34 150.78 35.14 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.088 -0.506 . . . . 2.2999999999999998 110.509 -177.833 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 583' ' ' VAL . . . . . 0.503 HG12 ' CE1' ' A' ' 550' ' ' TYR . 21.4 m -123.9 133.04 70.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 113.564 0.95 . . . . 1.1100000000000001 113.564 -173.285 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 584' ' ' TRP . . . . . 0.583 ' CD1' HG22 ' A' ' 553' ' ' VAL . 24.1 m0 -116.2 103.79 10.87 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 114.854 -1.066 . . . . 2.29 108.566 164.124 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 585' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -87.25 150.2 24.06 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 120.419 -0.513 . . . . 3.9500000000000002 111.136 -175.003 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 586' ' ' ASN . . . . . . . . . . . . . 14.1 m120 54.37 41.29 32.05 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 115.545 -0.752 . . . . 1.4299999999999999 110.495 -175.101 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 587' ' ' THR . . . . . . . . . . . . . 44.3 m -119.76 142.53 48.47 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.756 -0.656 . . . . 0.65000000000000002 110.341 -177.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 588' ' ' ILE . . . . . . . . . . . . . 15.3 tt -133.75 148.19 30.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 N-CA-C 109.424 -0.584 . . . . 0.70999999999999996 109.424 -179.593 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 589' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -115.33 118.75 34.13 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.519 -0.548 . . . . 1.3500000000000001 109.519 177.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 590' ' ' VAL . . . . . . . . . . . . . 44.0 t -125.14 118.84 54.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.505 -0.77 . . . . 0.65000000000000002 110.019 -177.439 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 591' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 58.2 36.99 26.19 Favored 'General case' 0 C--O 1.235 0.306 0 O-C-N 123.482 0.489 . . . . 2.0299999999999998 111.864 177.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . 85.66 8.41 80.18 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.967 -0.635 . . . . 0.62 113.271 174.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 593' ' ' LYS . . . . . . . . . . . . . 60.1 mttm -125.55 139.76 53.33 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.158 0.504 . . . . 2.7799999999999998 111.461 178.55 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 594' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -93.67 133.28 37.19 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.165 -0.925 . . . . 1.45 110.784 -178.385 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 595' ' ' PHE . . . . . . . . . . . . . 81.2 m-85 -139.98 160.14 40.59 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.194 -0.912 . . . . 1.3200000000000001 108.896 177.262 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 596' ' ' HIS . . . . . 0.534 ' HB3' HG22 ' A' ' 598' ' ' THR . 9.3 m170 -66.32 128.69 37.12 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 108.579 -0.897 . . . . 0.58999999999999997 108.579 167.849 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 597' ' ' SER . . . . . . . . . . . . . 40.2 t -61.71 -32.48 72.7 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.8 -0.637 . . . . 1.1299999999999999 109.696 -178.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 598' ' ' THR . . . . . 0.534 HG22 ' HB3' ' A' ' 596' ' ' HIS . 11.1 t -67.82 -35.33 78.41 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-N 115.332 -0.849 . . . . 1.3999999999999999 110.091 177.637 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 599' ' ' CYS . . . . . 0.603 ' HA ' ' HB3' ' A' ' 602' ' ' GLU . 72.7 m -76.13 -31.98 58.9 Favored 'General case' 0 N--CA 1.457 -0.091 0 N-CA-C 112.228 0.455 . . . . 0.81000000000000005 112.228 -179.048 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 600' ' ' TYR . . . . . . . . . . . . . 71.1 t80 -67.37 -36.26 80.99 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.009 -0.737 . . . . 1.8799999999999999 109.009 -178.355 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 601' ' ' HIS . . . . . . . . . . . . . 64.5 t60 -72.48 -32.06 65.9 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.134 -0.939 . . . . 4.5199999999999996 109.656 174.135 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 602' ' ' GLU . . . . . 0.603 ' HB3' ' HA ' ' A' ' 599' ' ' CYS . 0.7 OUTLIER -61.83 -37.59 85.02 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 115.463 -0.79 . . . . 3.8500000000000001 111.745 177.475 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 603' ' ' THR . . . . . 0.499 ' HB ' HD13 ' A' ' 566' ' ' ILE . 14.5 t . . . . . 0 C--N 1.324 -0.542 0 N-CA-C 112.391 0.515 . . . . 3.2999999999999998 112.391 -173.157 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.284 0 N-CA-C 112.998 -0.041 . . . . 3.2000000000000002 112.998 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 549' ' ' LYS . . . . . . . . . . . . . 89.1 mttt -80.26 144.08 33.17 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.954 0.407 . . . . 5.9000000000000004 110.342 174.825 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 550' ' ' TYR . . . . . . . . . . . . . 30.2 p90 -118.5 161.03 20.69 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 108.649 -0.871 . . . . 2.79 108.649 179.495 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 551' ' ' VAL . . . . . . . . . . . . . 62.7 t -118.24 133.18 65.87 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.971 0 N-CA-C 109.485 -0.561 . . . . 1.52 109.485 177.706 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 552' ' ' VAL . . . . . 0.457 ' HA ' ' O ' ' A' ' 582' ' ' TRP . 33.1 t -67.97 126.04 26.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-O 120.666 0.27 . . . . 1.3799999999999999 110.549 -177.61 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 553' ' ' VAL . . . . . 0.654 HG22 ' CD1' ' A' ' 584' ' ' TRP . 47.3 t -61.91 126.37 87.1 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 115.828 -0.624 . . . . 1.3799999999999999 111.415 -176.145 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 554' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' ' 553' ' ' VAL . 16.5 Cg_exo . . . . . 0 C--O 1.233 0.27 0 C-N-CA 123.0 2.467 . . . . 1.98 111.464 175.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 560' ' ' MET . . . . . . . . . . . . . 4.5 mpp? . . . . . 0 N--CA 1.467 0.404 0 N-CA-C 111.935 0.346 . . . . 2.6099999999999999 111.935 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 561' ' ' ALA . . . . . . . . . . . . . . . -144.29 145.75 32.2 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.314 -0.403 . . . . 0.94999999999999996 110.08 178.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 44.5 p90 -137.42 155.32 49.49 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.315 -0.402 . . . . 0.90000000000000002 109.938 178.224 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 563' ' ' LYS . . . . . . . . . . . . . 13.9 tppt? -90.01 125.55 35.43 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.771 0.32 . . . . 2.1800000000000002 110.33 -179.354 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 564' ' ' CYS . . . . . . . . . . . . . 40.6 t -63.57 114.78 14.32 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 115.908 -0.587 . . . . 0.40999999999999998 109.596 176.121 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 565' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -69.8 -17.61 37.3 Favored 'Trans proline' 0 CA--C 1.527 0.164 0 C-N-CA 122.588 2.192 . . . . 0.63 113.157 -172.498 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 566' ' ' ILE . . . . . 0.454 HG21 ' HG2' ' A' ' 602' ' ' GLU . 55.5 mt -81.48 -44.33 20.43 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 N-CA-C 111.807 0.299 . . . . 0.93999999999999995 111.807 -176.832 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 567' ' ' CYS . . . . . 0.484 ' SG ' ' HG3' ' A' ' 569' ' ' GLU . 27.9 p -129.8 1.83 4.89 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.447 0.536 . . . . 0.69999999999999996 112.447 -174.044 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 568' ' ' LYS . . . . . . . . . . . . . 40.0 mtmt 68.08 30.77 5.74 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 113.433 0.901 . . . . 2.71 113.433 173.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 569' ' ' GLU . . . . . 0.484 ' HG3' ' SG ' ' A' ' 567' ' ' CYS . 32.7 mt-10 -80.17 135.8 36.36 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 108.932 -0.766 . . . . 3.3399999999999999 108.932 169.635 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 570' ' ' THR . . . . . . . . . . . . . 90.1 m -78.31 117.88 19.97 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 109.083 -0.71 . . . . 1.01 109.083 170.753 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 571' ' ' VAL . . . . . . . . . . . . . 39.6 t -90.03 116.12 30.8 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 N-CA-C 110.008 -0.368 . . . . 0.72999999999999998 110.008 -178.492 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 32.0 p -115.19 158.0 22.87 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.984 -0.553 . . . . 1.8899999999999999 110.017 179.753 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . -130.07 155.11 20.85 Favored Glycine 0 N--CA 1.436 -1.318 0 C-N-CA 120.05 -1.071 . . . . 2.2000000000000002 111.529 178.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 574' ' ' VAL . . . . . . . . . . . . . 42.2 t -115.87 147.56 19.18 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 N-CA-C 109.63 -0.507 . . . . 3.2400000000000002 109.63 -173.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 575' ' ' TYR . . . . . . . . . . . . . 51.5 t80 -83.76 118.32 23.83 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 108.82 -0.807 . . . . 3.02 108.82 173.26 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 576' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -95.71 107.05 19.23 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.033 -0.729 . . . . 3.3399999999999999 109.033 178.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 577' ' ' GLU . . . . . . . . . . . . . 38.3 mp0 -68.56 -23.3 64.48 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.824 -0.625 . . . . 5.5899999999999999 111.943 -173.567 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 578' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -76.05 -34.7 59.63 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.603 0.239 . . . . 5.1100000000000003 111.256 -177.525 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 579' ' ' SER . . . . . . . . . . . . . 67.5 p -93.75 -23.42 18.2 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.097 0.475 . . . . 3.2799999999999998 110.546 175.512 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 580' ' ' GLY . . . . . . . . . . . . . . . 80.44 26.81 53.71 Favored Glycine 0 N--CA 1.449 -0.462 0 CA-C-N 115.608 -0.723 . . . . 2.6000000000000001 112.929 176.449 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 581' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -145.87 161.6 39.63 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 117.16 0.48 . . . . 3.1899999999999999 111.421 -179.69 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 582' ' ' TRP . . . . . 0.513 ' CB ' ' HB ' ' A' ' 553' ' ' VAL . 80.4 m95 -83.93 139.12 32.79 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-N 115.887 -0.597 . . . . 2.2999999999999998 110.37 177.605 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 583' ' ' VAL . . . . . . . . . . . . . 26.6 m -121.04 130.15 74.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 N-CA-C 112.971 0.73 . . . . 1.1100000000000001 112.971 -174.773 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 584' ' ' TRP . . . . . 0.654 ' CD1' HG22 ' A' ' 553' ' ' VAL . 14.7 m0 -104.82 103.5 13.11 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 108.605 -0.887 . . . . 2.29 108.605 162.835 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 585' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -94.83 153.75 17.58 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.637 -0.711 . . . . 3.9500000000000002 111.241 -175.334 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 586' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 55.56 40.75 31.14 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 108.799 -0.815 . . . . 1.4299999999999999 108.799 -170.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 587' ' ' THR . . . . . . . . . . . . . 26.6 m -134.88 141.45 46.34 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.393 -0.821 . . . . 0.65000000000000002 110.396 -173.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 588' ' ' ILE . . . . . . . . . . . . . 13.7 tt -141.58 148.92 20.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 109.665 -0.494 . . . . 0.70999999999999996 109.665 -179.552 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 589' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -94.34 118.7 32.01 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.93 0.395 . . . . 1.3500000000000001 110.016 176.209 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 590' ' ' VAL . . . . . . . . . . . . . 59.9 t -126.5 127.25 70.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.888 -0.596 . . . . 0.65000000000000002 109.451 179.488 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 591' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 59.46 37.25 23.11 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-O 121.554 0.692 . . . . 2.0299999999999998 110.313 -179.689 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . 73.42 12.04 80.03 Favored Glycine 0 C--N 1.333 0.364 0 CA-C-N 115.588 -0.733 . . . . 0.62 112.952 177.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 593' ' ' LYS . . . . . . . . . . . . . 46.3 mtmt -127.74 143.45 51.14 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.861 0.362 . . . . 2.7799999999999998 110.372 -177.005 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 594' ' ' TYR . . . . . . . . . . . . . 56.0 m-85 -86.59 125.51 33.86 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.955 0.407 . . . . 1.45 110.853 -178.696 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 595' ' ' PHE . . . . . . . . . . . . . 63.7 m-85 -136.41 160.49 38.57 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.634 -0.712 . . . . 1.3200000000000001 110.044 179.593 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 596' ' ' HIS . . . . . . . . . . . . . 4.2 m170 -62.34 127.16 30.02 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.476 -0.565 . . . . 0.58999999999999997 109.476 172.664 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 597' ' ' SER . . . . . . . . . . . . . 31.8 t -66.55 -32.04 73.14 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.849 -0.614 . . . . 1.1299999999999999 109.776 179.45 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 598' ' ' THR . . . . . . . . . . . . . 13.0 t -69.13 -35.19 76.12 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 115.274 -0.875 . . . . 1.3999999999999999 110.356 179.714 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 599' ' ' CYS . . . . . . . . . . . . . 73.4 m -75.92 -29.73 58.49 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.596 -0.729 . . . . 0.81000000000000005 112.591 -176.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 600' ' ' TYR . . . . . 0.446 ' O ' HG22 ' A' ' 603' ' ' THR . 71.0 t80 -54.54 -31.73 56.93 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.868 0.366 . . . . 1.8799999999999999 111.763 -172.559 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 601' ' ' HIS . . . . . . . . . . . . . 12.6 m170 -59.43 -27.29 65.91 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 111.927 0.343 . . . . 4.5199999999999996 111.927 -179.425 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 602' ' ' GLU . . . . . 0.454 ' HG2' HG21 ' A' ' 566' ' ' ILE . 1.1 pp20? -70.18 -32.83 70.94 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 120.906 -0.317 . . . . 3.8500000000000001 111.384 -175.389 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 603' ' ' THR . . . . . 0.446 HG22 ' O ' ' A' ' 600' ' ' TYR . 11.4 t . . . . . 0 C--N 1.329 -0.305 0 CA-C-O 120.922 0.391 . . . . 3.2999999999999998 110.977 -176.77 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.506 0 N-CA-C 112.381 -0.288 . . . . 3.2000000000000002 112.381 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 549' ' ' LYS . . . . . . . . . . . . . 31.3 mmmt -80.65 137.11 36.32 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 121.113 0.482 . . . . 5.9000000000000004 110.491 177.528 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 550' ' ' TYR . . . . . . . . . . . . . 49.9 p90 -109.6 159.77 16.82 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 108.405 -0.961 . . . . 2.79 108.405 176.194 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 551' ' ' VAL . . . . . . . . . . . . . 55.1 t -117.17 133.21 64.63 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.106 0 N-CA-C 109.033 -0.729 . . . . 1.52 109.033 179.632 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 552' ' ' VAL . . . . . 0.724 ' HA ' ' O ' ' A' ' 582' ' ' TRP . 39.1 t -66.98 130.09 32.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.972 -0.558 . . . . 1.3799999999999999 109.612 -179.122 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 553' ' ' VAL . . . . . 0.599 HG22 ' CD1' ' A' ' 584' ' ' TRP . 59.1 t -59.0 119.44 38.09 Favored Pre-proline 0 N--CA 1.452 -0.342 0 O-C-N 123.409 0.443 . . . . 1.3799999999999999 110.016 -176.655 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 554' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 553' ' ' VAL . 33.0 Cg_exo . . . . . 0 N--CA 1.459 -0.552 0 C-N-CA 122.945 2.43 . . . . 1.98 112.132 -178.192 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 560' ' ' MET . . . . . . . . . . . . . 4.3 mpp? . . . . . 0 N--CA 1.465 0.312 0 CA-C-O 120.843 0.354 . . . . 2.6099999999999999 111.907 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 561' ' ' ALA . . . . . . . . . . . . . . . -144.75 155.24 43.43 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 116.258 -0.428 . . . . 0.94999999999999996 110.817 -176.317 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 29.3 p90 -138.7 164.59 29.14 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.413 -0.588 . . . . 0.90000000000000002 109.413 174.38 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 563' ' ' LYS . . . . . . . . . . . . . 21.9 tptm -103.06 125.07 49.63 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 109.983 -0.377 . . . . 2.1800000000000002 109.983 -178.446 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 564' ' ' CYS . . . . . . . . . . . . . 48.8 t -80.09 113.38 38.01 Favored Pre-proline 0 C--N 1.327 -0.412 0 N-CA-C 109.512 -0.551 . . . . 0.40999999999999998 109.512 -179.663 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 565' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -71.88 -28.67 16.24 Favored 'Trans proline' 0 CA--C 1.528 0.217 0 C-N-CA 122.667 2.245 . . . . 0.63 113.954 -172.13 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 566' ' ' ILE . . . . . . . . . . . . . 28.5 mt -72.67 -37.7 56.59 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 CA-C-O 121.069 0.462 . . . . 0.93999999999999995 111.671 -172.662 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 567' ' ' CYS . . . . . 0.559 ' SG ' ' HG3' ' A' ' 569' ' ' GLU . 27.8 p -127.43 1.27 6.29 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.534 -0.303 . . . . 0.69999999999999996 111.567 -175.309 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 568' ' ' LYS . . . . . . . . . . . . . 29.1 mtpp 67.45 27.45 8.01 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 115.934 -0.576 . . . . 2.71 112.429 175.272 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 569' ' ' GLU . . . . . 0.559 ' HG3' ' SG ' ' A' ' 567' ' ' CYS . 51.1 mt-10 -79.07 136.43 37.16 Favored 'General case' 0 CA--C 1.516 -0.336 0 N-CA-C 109.944 -0.391 . . . . 3.3399999999999999 109.944 174.692 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 570' ' ' THR . . . . . . . . . . . . . 47.4 m -87.99 116.58 26.26 Favored 'General case' 0 C--N 1.314 -0.977 0 N-CA-C 107.835 -1.172 . . . . 1.01 107.835 171.736 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 571' ' ' VAL . . . . . 0.438 HG22 ' CE1' ' A' ' 596' ' ' HIS . 16.8 t -97.78 115.73 38.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 C-N-CA 120.668 -0.413 . . . . 0.72999999999999998 110.962 -171.477 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 23.8 p -109.76 158.82 17.73 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 109.183 -0.673 . . . . 1.8899999999999999 109.183 174.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . -131.21 155.15 21.16 Favored Glycine 0 N--CA 1.443 -0.896 0 C-N-CA 120.04 -1.076 . . . . 2.2000000000000002 112.132 -178.2 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 574' ' ' VAL . . . . . 0.411 ' O ' HG22 ' A' ' 583' ' ' VAL . 39.5 t -112.35 152.81 14.1 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 N-CA-C 109.432 -0.581 . . . . 3.2400000000000002 109.432 -175.632 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 575' ' ' TYR . . . . . 0.41 ' HA ' ' HA ' ' A' ' 582' ' ' TRP . 50.7 t80 -84.52 119.84 25.64 Favored 'General case' 0 C--N 1.315 -0.891 0 N-CA-C 109.953 -0.388 . . . . 3.02 109.953 176.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 576' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -90.3 97.96 11.49 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 108.277 -1.009 . . . . 3.3399999999999999 108.277 178.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 577' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -65.92 -22.85 66.53 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.354 -0.839 . . . . 5.5899999999999999 111.851 -172.834 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 578' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -73.32 -48.09 37.25 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.014 0.435 . . . . 5.1100000000000003 110.116 -178.27 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 579' ' ' SER . . . . . . . . . . . . . 74.5 p -84.05 -19.88 33.64 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.922 0.391 . . . . 3.2799999999999998 111.023 178.109 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 580' ' ' GLY . . . . . . . . . . . . . . . 80.24 22.65 62.53 Favored Glycine 0 N--CA 1.449 -0.451 0 CA-C-N 115.795 -0.639 . . . . 2.6000000000000001 112.266 179.048 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 581' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -130.59 147.83 52.31 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-O 121.32 0.581 . . . . 3.1899999999999999 111.009 -177.274 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 582' ' ' TRP . . . . . 0.724 ' O ' ' HA ' ' A' ' 552' ' ' VAL . 88.4 m95 -72.05 143.82 48.97 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 108.591 -0.892 . . . . 2.2999999999999998 108.591 168.815 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 583' ' ' VAL . . . . . 0.6 HG21 ' HE2' ' A' ' 585' ' ' LYS . 24.4 m -124.08 133.19 69.96 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 N-CA-C 113.679 0.992 . . . . 1.1100000000000001 113.679 -174.493 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 584' ' ' TRP . . . . . 0.599 ' CD1' HG22 ' A' ' 553' ' ' VAL . 30.9 m0 -110.51 104.1 12.79 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 114.912 -1.04 . . . . 2.29 108.338 163.067 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 585' ' ' LYS . . . . . 0.6 ' HE2' HG21 ' A' ' 583' ' ' VAL . 66.9 mmtt -83.38 151.49 25.5 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-O 120.495 0.188 . . . . 3.9500000000000002 110.611 -176.54 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 586' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 50.27 44.86 26.36 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 115.887 -0.597 . . . . 1.4299999999999999 110.124 -175.517 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 587' ' ' THR . . . . . . . . . . . . . 75.3 m -125.83 140.94 52.25 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.15 -0.477 . . . . 0.65000000000000002 110.679 -176.394 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 588' ' ' ILE . . . . . 0.459 ' HB ' ' HB3' ' A' ' 597' ' ' SER . 12.7 tt -136.05 146.13 29.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 N-CA-C 109.482 -0.562 . . . . 0.70999999999999996 109.482 179.025 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 589' ' ' GLU . . . . . . . . . . . . . 46.2 tt0 -100.45 121.5 41.65 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.219 -0.66 . . . . 1.3500000000000001 109.219 174.329 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 590' ' ' VAL . . . . . . . . . . . . . 52.7 t -124.35 118.19 52.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 109.947 -0.39 . . . . 0.65000000000000002 109.947 -179.185 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 591' ' ' ASN . . . . . . . . . . . . . 60.0 t30 58.12 37.51 26.4 Favored 'General case' 0 C--N 1.328 -0.327 0 O-C-N 123.912 0.757 . . . . 2.0299999999999998 110.852 178.67 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . 85.25 0.88 88.51 Favored Glycine 0 N--CA 1.452 -0.256 0 CA-C-N 115.844 -0.616 . . . . 0.62 113.718 176.462 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 593' ' ' LYS . . . . . . . . . . . . . 61.8 mttp -118.71 147.69 43.56 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 117.245 0.523 . . . . 2.7799999999999998 111.104 -179.129 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 594' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -96.53 135.64 38.14 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.018 0.437 . . . . 1.45 111.219 -175.581 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 595' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 -143.87 155.02 43.96 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.337 -0.847 . . . . 1.3200000000000001 109.322 178.57 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 596' ' ' HIS . . . . . 0.438 ' CE1' HG22 ' A' ' 571' ' ' VAL . 16.7 m170 -64.66 127.24 30.69 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 107.972 -1.121 . . . . 0.58999999999999997 107.972 166.579 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 597' ' ' SER . . . . . 0.459 ' HB3' ' HB ' ' A' ' 588' ' ' ILE . 7.7 p -66.02 -32.02 73.26 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.043 0.449 . . . . 1.1299999999999999 110.002 -178.906 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 598' ' ' THR . . . . . . . . . . . . . 97.1 m -61.12 -43.25 99.17 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.265 -0.879 . . . . 1.3999999999999999 110.345 173.694 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 599' ' ' CYS . . . . . 0.511 ' O ' ' HB3' ' A' ' 602' ' ' GLU . 83.9 m -74.74 -30.46 61.51 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.779 -0.646 . . . . 0.81000000000000005 111.289 -179.775 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 600' ' ' TYR . . . . . . . . . . . . . 88.0 t80 -59.28 -35.87 74.52 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.179 0.514 . . . . 1.8799999999999999 109.908 177.572 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 601' ' ' HIS . . . . . . . . . . . . . 67.3 t60 -71.22 -29.51 65.23 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.811 -0.631 . . . . 4.5199999999999996 110.506 176.562 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 602' ' ' GLU . . . . . 0.511 ' HB3' ' O ' ' A' ' 599' ' ' CYS . 2.0 tp10 -61.89 -37.21 83.74 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.923 -0.581 . . . . 3.8500000000000001 111.149 178.639 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 603' ' ' THR . . . . . . . . . . . . . 12.3 t . . . . . 0 C--N 1.328 -0.343 0 CA-C-N 116.447 -0.342 . . . . 3.2999999999999998 111.102 -179.05 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.5 0 N-CA-C 111.818 -0.513 . . . . 3.2000000000000002 111.818 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 549' ' ' LYS . . . . . . . . . . . . . 68.4 mmtt -64.01 149.37 47.57 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-O 121.338 0.589 . . . . 5.9000000000000004 111.085 178.813 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 550' ' ' TYR . . . . . . . . . . . . . 39.7 p90 -122.38 159.94 26.47 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.277 -0.874 . . . . 2.79 109.745 179.181 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 551' ' ' VAL . . . . . . . . . . . . . 60.6 t -118.15 133.35 65.21 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.925 0 N-CA-C 108.527 -0.916 . . . . 1.52 108.527 177.551 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 552' ' ' VAL . . . . . 0.648 ' HA ' ' O ' ' A' ' 582' ' ' TRP . 42.0 t -67.8 134.24 30.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 116.122 -0.49 . . . . 1.3799999999999999 109.741 -177.426 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 553' ' ' VAL . . . . . 0.515 HG11 ' HB3' ' A' ' 560' ' ' MET . 63.2 t -59.46 121.68 58.57 Favored Pre-proline 0 C--N 1.325 -0.461 0 O-C-N 123.682 0.613 . . . . 1.3799999999999999 111.391 -175.813 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 554' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 553' ' ' VAL . 31.6 Cg_exo . . . . . 0 C--N 1.343 0.272 0 C-N-CA 123.559 2.839 . . . . 1.98 112.607 179.148 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 560' ' ' MET . . . . . 0.515 ' HB3' HG11 ' A' ' 553' ' ' VAL . 60.1 mtt . . . . . 0 C--O 1.234 0.285 0 CA-C-O 120.912 0.387 . . . . 2.6099999999999999 111.266 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 561' ' ' ALA . . . . . 0.427 ' HB2' HG22 ' A' ' 572' ' ' THR . . . -144.3 161.95 37.65 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 116.072 -0.513 . . . . 0.94999999999999996 111.443 -177.627 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 31.2 p90 -143.83 153.06 41.97 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.968 -0.753 . . . . 0.90000000000000002 108.968 173.242 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 563' ' ' LYS . . . . . 0.529 ' HA ' ' HA ' ' A' ' 570' ' ' THR . 16.0 tppt? -88.89 126.47 35.4 Favored 'General case' 0 C--N 1.317 -0.841 0 C-N-CA 120.705 -0.398 . . . . 2.1800000000000002 110.189 177.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 564' ' ' CYS . . . . . 0.439 ' HA ' ' HD3' ' A' ' 565' ' ' PRO . 52.7 t -79.46 113.62 38.42 Favored Pre-proline 0 N--CA 1.451 -0.379 0 N-CA-C 109.444 -0.576 . . . . 0.40999999999999998 109.444 174.62 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 565' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 564' ' ' CYS . 33.4 Cg_exo -63.38 -36.37 55.98 Favored 'Trans proline' 0 CA--C 1.528 0.206 0 C-N-CA 123.146 2.564 . . . . 0.63 113.896 -173.323 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 566' ' ' ILE . . . . . 0.498 HD12 ' HB3' ' A' ' 599' ' ' CYS . 60.3 mt -72.35 -37.81 59.25 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 N-CA-C 112.088 0.403 . . . . 0.93999999999999995 112.088 -173.143 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 567' ' ' CYS . . . . . . . . . . . . . 29.6 p -113.15 0.76 15.04 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.536 -0.466 . . . . 0.69999999999999996 111.82 -176.281 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 568' ' ' LYS . . . . . . . . . . . . . 99.4 mttt 66.03 11.63 7.89 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 113.181 0.808 . . . . 2.71 113.181 173.522 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 569' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -100.6 134.64 43.26 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.873 0.368 . . . . 3.3399999999999999 110.971 179.216 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 570' ' ' THR . . . . . 0.529 ' HA ' ' HA ' ' A' ' 563' ' ' LYS . 45.8 m -74.13 128.96 36.87 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.5 -0.773 . . . . 1.01 109.617 177.863 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 571' ' ' VAL . . . . . . . . . . . . . 17.9 t -95.76 115.09 33.97 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 N-CA-C 109.568 -0.53 . . . . 0.72999999999999998 109.568 178.424 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 572' ' ' THR . . . . . 0.427 HG22 ' HB2' ' A' ' 561' ' ' ALA . 24.4 p -106.24 160.41 15.37 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.66 -0.7 . . . . 1.8899999999999999 109.438 177.103 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . -129.53 153.89 20.14 Favored Glycine 0 N--CA 1.44 -1.052 0 C-N-CA 119.352 -1.404 . . . . 2.2000000000000002 112.405 -178.619 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 574' ' ' VAL . . . . . . . . . . . . . 58.5 t -122.57 148.13 26.42 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 CA-C-N 114.861 -0.67 . . . . 3.2400000000000002 109.395 -172.714 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 575' ' ' TYR . . . . . . . . . . . . . 53.3 t80 -80.81 118.07 22.02 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 109.356 -0.609 . . . . 3.02 109.356 175.718 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 576' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -92.96 114.89 27.58 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 109.754 -0.461 . . . . 3.3399999999999999 109.754 179.756 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 577' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -68.89 -22.72 64.16 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.511 -0.768 . . . . 5.5899999999999999 112.13 -174.441 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 578' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -77.08 -48.13 18.65 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.509 -0.314 . . . . 5.1100000000000003 111.723 -178.276 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 579' ' ' SER . . . . . . . . . . . . . 72.4 p -86.0 -21.82 27.61 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.878 0.37 . . . . 3.2799999999999998 110.859 178.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 580' ' ' GLY . . . . . . . . . . . . . . . 80.19 17.29 74.54 Favored Glycine 0 C--N 1.331 0.285 0 C-N-CA 121.157 -0.544 . . . . 2.6000000000000001 112.725 178.48 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 581' ' ' GLU . . . . . . . . . . . . . 20.7 mm-40 -122.42 152.24 40.43 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.921 0.391 . . . . 3.1899999999999999 111.292 -176.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 582' ' ' TRP . . . . . 0.648 ' O ' ' HA ' ' A' ' 552' ' ' VAL . 84.5 m95 -77.51 130.38 36.9 Favored 'General case' 0 CA--C 1.512 -0.491 0 N-CA-C 107.451 -1.315 . . . . 2.2999999999999998 107.451 165.245 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 583' ' ' VAL . . . . . . . . . . . . . 19.3 m -115.39 133.91 60.2 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.971 0 N-CA-C 113.958 1.096 . . . . 1.1100000000000001 113.958 -169.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 584' ' ' TRP . . . . . 0.508 ' CD1' HG22 ' A' ' 553' ' ' VAL . 30.5 m0 -113.33 103.65 11.52 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 114.795 -1.093 . . . . 2.29 108.053 162.281 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 585' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.99 145.61 27.63 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.985 0.422 . . . . 3.9500000000000002 111.774 -173.104 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 586' ' ' ASN . . . . . . . . . . . . . 12.3 m120 53.2 42.93 32.13 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.282 -0.872 . . . . 1.4299999999999999 110.512 -176.613 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 587' ' ' THR . . . . . . . . . . . . . 57.9 m -115.38 142.46 46.66 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.0 0.428 . . . . 0.65000000000000002 110.761 -176.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 588' ' ' ILE . . . . . . . . . . . . . 15.3 tt -137.38 150.19 25.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.58 -0.736 . . . . 0.70999999999999996 109.396 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 589' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -111.13 122.73 48.62 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.098 -0.705 . . . . 1.3500000000000001 109.098 176.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 590' ' ' VAL . . . . . . . . . . . . . 62.1 t -126.39 117.65 49.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 115.716 -0.675 . . . . 0.65000000000000002 110.06 179.324 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 591' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 58.27 40.64 24.43 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 115.582 -0.735 . . . . 2.0299999999999998 110.835 177.267 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . 79.98 13.67 81.81 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.91 -0.662 . . . . 0.62 112.592 176.036 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 593' ' ' LYS . . . . . . . . . . . . . 46.8 mtmt -128.47 139.92 52.08 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.036 0.446 . . . . 2.7799999999999998 110.777 -178.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 594' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -94.9 134.88 37.06 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.054 -0.521 . . . . 1.45 111.064 -177.081 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 595' ' ' PHE . . . . . . . . . . . . . 62.7 m-85 -142.25 165.24 27.98 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.372 -0.831 . . . . 1.3200000000000001 108.807 177.002 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 596' ' ' HIS . . . . . 0.701 ' HB2' ' SG ' ' A' ' 599' ' ' CYS . 24.9 m80 -68.79 130.11 41.88 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 108.273 -1.01 . . . . 0.58999999999999997 108.273 166.641 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 597' ' ' SER . . . . . . . . . . . . . 40.1 t -60.83 -30.16 69.93 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.462 0.649 . . . . 1.1299999999999999 109.81 179.361 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 598' ' ' THR . . . . . . . . . . . . . 93.7 m -66.39 -34.71 78.58 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.905 -1.043 . . . . 1.3999999999999999 110.803 175.11 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 599' ' ' CYS . . . . . 0.701 ' SG ' ' HB2' ' A' ' 596' ' ' HIS . 75.8 m -74.77 -31.15 61.69 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.622 0.601 . . . . 0.81000000000000005 112.622 -178.25 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 600' ' ' TYR . . . . . . . . . . . . . 86.0 t80 -61.8 -35.62 78.72 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 121.362 0.601 . . . . 1.8799999999999999 109.842 -178.427 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 601' ' ' HIS . . . . . . . . . . . . . 78.7 t60 -66.72 -34.7 78.43 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.373 -0.83 . . . . 4.5199999999999996 110.408 176.001 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 602' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -64.65 -36.57 84.69 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.145 -0.48 . . . . 3.8500000000000001 110.927 179.847 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 603' ' ' THR . . . . . . . . . . . . . 15.4 t . . . . . 0 C--N 1.324 -0.507 0 CA-C-N 116.554 -0.293 . . . . 3.2999999999999998 110.701 -179.266 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.418 0 N-CA-C 112.107 -0.397 . . . . 3.2000000000000002 112.107 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 549' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -64.28 132.49 50.39 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.056 0.455 . . . . 5.9000000000000004 110.125 176.558 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 550' ' ' TYR . . . . . 0.524 ' CE1' HG12 ' A' ' 583' ' ' VAL . 37.4 p90 -111.34 160.91 16.6 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.822 -0.626 . . . . 2.79 109.834 177.414 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 551' ' ' VAL . . . . . 0.527 HG11 ' HE1' ' A' ' 594' ' ' TYR . 52.9 t -118.53 133.26 65.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 N-CA-C 109.072 -0.714 . . . . 1.52 109.072 176.437 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 552' ' ' VAL . . . . . 0.72 ' HA ' ' O ' ' A' ' 582' ' ' TRP . 56.6 t -61.95 125.18 17.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 O-C-N 123.32 0.388 . . . . 1.3799999999999999 110.287 -179.039 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 553' ' ' VAL . . . . . 0.685 HG22 ' CD1' ' A' ' 584' ' ' TRP . 66.6 t -58.91 120.41 46.32 Favored Pre-proline 0 C--N 1.33 -0.271 0 O-C-N 123.729 0.643 . . . . 1.3799999999999999 111.495 -173.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 554' ' ' PRO . . . . . 0.458 ' HD3' ' HA ' ' A' ' 553' ' ' VAL . 7.2 Cg_exo . . . . . 0 N--CA 1.456 -0.697 0 C-N-CA 122.802 2.335 . . . . 1.98 112.06 175.78 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 560' ' ' MET . . . . . . . . . . . . . 62.1 mtt . . . . . 0 N--CA 1.468 0.471 0 CA-C-O 120.87 0.367 . . . . 2.6099999999999999 110.797 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 561' ' ' ALA . . . . . . . . . . . . . . . -144.77 149.94 36.35 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.378 -0.373 . . . . 0.94999999999999996 111.162 -173.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 26.8 p90 -133.69 164.01 28.17 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.572 -0.899 . . . . 0.90000000000000002 108.572 173.605 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 563' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt -112.09 127.59 55.96 Favored 'General case' 0 C--N 1.323 -0.587 0 C-N-CA 120.456 -0.498 . . . . 2.1800000000000002 110.772 -179.459 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 564' ' ' CYS . . . . . . . . . . . . . 53.4 t -73.77 113.9 27.28 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 115.416 -0.811 . . . . 0.40999999999999998 109.797 -179.192 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 565' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -72.83 -19.91 23.15 Favored 'Trans proline' 0 N--CA 1.472 0.218 0 C-N-CA 122.965 2.443 . . . . 0.63 113.599 -175.633 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 566' ' ' ILE . . . . . 0.449 HD13 ' HB ' ' A' ' 603' ' ' THR . 37.7 mt -82.26 -37.86 14.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.255 -0.429 . . . . 0.93999999999999995 111.616 -172.368 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 567' ' ' CYS . . . . . 0.476 ' SG ' ' OE2' ' A' ' 569' ' ' GLU . 27.9 p -129.32 5.86 5.27 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 112.22 0.452 . . . . 0.69999999999999996 112.22 -179.319 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 568' ' ' LYS . . . . . . . . . . . . . 21.0 mmmt 72.82 30.59 1.72 Allowed 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 113.923 1.083 . . . . 2.71 113.923 167.346 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 569' ' ' GLU . . . . . 0.476 ' OE2' ' SG ' ' A' ' 567' ' ' CYS . 7.0 mt-10 -92.85 135.81 33.8 Favored 'General case' 0 N--CA 1.466 0.361 0 O-C-N 121.786 -0.571 . . . . 3.3399999999999999 111.231 178.308 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 570' ' ' THR . . . . . . . . . . . . . 82.5 m -82.14 117.91 22.66 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 108.875 -0.787 . . . . 1.01 108.875 166.142 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 571' ' ' VAL . . . . . . . . . . . . . 21.3 t -103.13 123.27 56.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.951 0.405 . . . . 0.72999999999999998 111.745 -170.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 24.5 p -108.94 160.96 15.59 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.87 -0.604 . . . . 1.8899999999999999 110.33 177.672 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . -130.98 156.15 21.61 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.343 -0.932 . . . . 2.2000000000000002 112.185 -177.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 574' ' ' VAL . . . . . 0.474 ' O ' HG22 ' A' ' 583' ' ' VAL . 21.8 t -112.26 149.61 14.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-O 120.888 0.375 . . . . 3.2400000000000002 110.319 -173.117 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 575' ' ' TYR . . . . . 0.408 ' HA ' ' HA ' ' A' ' 582' ' ' TRP . 53.8 t80 -85.21 123.36 30.62 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.256 -0.429 . . . . 3.02 111.012 179.061 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 576' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -92.12 107.75 19.44 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.418 -0.586 . . . . 3.3399999999999999 109.418 174.09 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 577' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -68.17 -26.98 66.03 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.037 -0.529 . . . . 5.5899999999999999 112.424 -173.215 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 578' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -69.53 -47.95 62.06 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.76 0.314 . . . . 5.1100000000000003 111.249 -178.409 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 579' ' ' SER . . . . . . . . . . . . . 77.1 p -83.31 -23.88 32.39 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.343 0.592 . . . . 3.2799999999999998 110.578 -179.837 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 580' ' ' GLY . . . . . . . . . . . . . . . 79.17 18.4 74.5 Favored Glycine 0 N--CA 1.449 -0.499 0 CA-C-N 115.561 -0.745 . . . . 2.6000000000000001 111.326 -176.714 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 581' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -123.32 138.85 54.52 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.295 0.569 . . . . 3.1899999999999999 110.833 -176.036 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 582' ' ' TRP . . . . . 0.72 ' O ' ' HA ' ' A' ' 552' ' ' VAL . 83.7 m95 -71.45 141.06 50.25 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.975 -0.75 . . . . 2.2999999999999998 108.975 173.221 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 583' ' ' VAL . . . . . 0.524 HG12 ' CE1' ' A' ' 550' ' ' TYR . 24.0 m -119.89 133.78 65.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 N-CA-C 113.352 0.871 . . . . 1.1100000000000001 113.352 -173.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 584' ' ' TRP . . . . . 0.685 ' CD1' HG22 ' A' ' 553' ' ' VAL . 21.6 m0 -111.38 104.51 12.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.024 -0.989 . . . . 2.29 108.983 165.436 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 585' ' ' LYS . . . . . 0.408 ' HD2' ' HB3' ' A' ' 550' ' ' TYR . 26.2 mmmt -83.23 148.13 27.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.607 -0.269 . . . . 3.9500000000000002 110.473 -175.041 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 586' ' ' ASN . . . . . . . . . . . . . 62.7 m-20 48.32 41.95 17.16 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 123.319 0.648 . . . . 1.4299999999999999 110.337 -173.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 587' ' ' THR . . . . . . . . . . . . . 56.8 m -120.1 140.9 50.35 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.966 -0.561 . . . . 0.65000000000000002 109.607 179.556 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 588' ' ' ILE . . . . . . . . . . . . . 15.5 tt -135.66 146.22 30.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-O 120.927 0.394 . . . . 0.70999999999999996 110.123 -178.707 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 589' ' ' GLU . . . . . 0.434 ' HA ' ' O ' ' A' ' 593' ' ' LYS . 1.8 tm-20 -103.23 121.16 42.12 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.213 -0.662 . . . . 1.3500000000000001 109.213 175.373 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 590' ' ' VAL . . . . . . . . . . . . . 59.1 t -125.64 118.6 52.69 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 115.776 -0.647 . . . . 0.65000000000000002 109.829 -179.56 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 591' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 58.78 36.9 25.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.676 0.751 . . . . 2.0299999999999998 110.779 178.041 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . 85.85 6.59 82.35 Favored Glycine 0 N--CA 1.446 -0.647 0 CA-C-N 115.729 -0.669 . . . . 0.62 113.214 176.38 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 593' ' ' LYS . . . . . 0.434 ' O ' ' HA ' ' A' ' 589' ' ' GLU . 30.4 mmmt -120.85 139.29 53.38 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 117.02 0.41 . . . . 2.7799999999999998 111.64 -179.046 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 594' ' ' TYR . . . . . 0.527 ' HE1' HG11 ' A' ' 551' ' ' VAL . 91.8 m-85 -93.55 124.05 37.28 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.86 -0.609 . . . . 1.45 111.092 -179.864 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 595' ' ' PHE . . . . . . . . . . . . . 47.9 m-85 -137.29 164.27 28.95 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.865 -0.607 . . . . 1.3200000000000001 109.662 176.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 596' ' ' HIS . . . . . 0.715 ' HB2' ' SG ' ' A' ' 599' ' ' CYS . 29.3 m170 -61.58 129.83 43.0 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 108.927 -0.768 . . . . 0.58999999999999997 108.927 168.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 597' ' ' SER . . . . . . . . . . . . . 33.4 t -64.24 -30.35 71.41 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.039 -0.528 . . . . 1.1299999999999999 109.65 178.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 598' ' ' THR . . . . . . . . . . . . . 8.7 m -61.8 -38.85 89.64 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 115.307 -0.861 . . . . 1.3999999999999999 110.488 175.403 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 599' ' ' CYS . . . . . 0.715 ' SG ' ' HB2' ' A' ' 596' ' ' HIS . 83.2 m -73.98 -28.52 61.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.302 -0.863 . . . . 0.81000000000000005 112.672 -175.336 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 600' ' ' TYR . . . . . . . . . . . . . 70.0 t80 -55.94 -35.89 67.16 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 120.902 0.382 . . . . 1.8799999999999999 110.963 -174.62 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 601' ' ' HIS . . . . . . . . . . . . . 43.5 m-70 -73.26 -39.35 65.48 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.453 -0.339 . . . . 4.5199999999999996 111.232 -178.86 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 602' ' ' GLU . . . . . 0.663 ' HG2' ' O ' ' A' ' 599' ' ' CYS . 23.3 pt-20 -70.36 -35.5 73.59 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 120.709 0.29 . . . . 3.8500000000000001 111.028 -177.438 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 603' ' ' THR . . . . . 0.449 ' HB ' HD13 ' A' ' 566' ' ' ILE . 13.0 t . . . . . 0 C--N 1.327 -0.387 0 C-N-CA 120.978 -0.289 . . . . 3.2999999999999998 111.557 -175.225 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.136 0 N-CA-C 113.484 0.154 . . . . 3.2000000000000002 113.484 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 549' ' ' LYS . . . . . . . . . . . . . 61.6 mttm -73.43 134.79 44.07 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.906 0.384 . . . . 5.9000000000000004 110.588 176.218 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 550' ' ' TYR . . . . . . . . . . . . . 31.8 p90 -111.62 159.9 17.74 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.561 -0.745 . . . . 2.79 109.584 179.322 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 551' ' ' VAL . . . . . . . . . . . . . 59.2 t -117.94 131.9 69.34 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 N-CA-C 108.556 -0.905 . . . . 1.52 108.556 175.311 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 552' ' ' VAL . . . . . 0.563 ' HA ' ' O ' ' A' ' 582' ' ' TRP . 59.0 t -63.95 134.82 28.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 116.051 -0.522 . . . . 1.3799999999999999 110.075 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 553' ' ' VAL . . . . . 0.579 HG22 ' CD1' ' A' ' 584' ' ' TRP . 86.0 t -58.84 121.72 56.55 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 115.677 -0.692 . . . . 1.3799999999999999 110.05 -178.489 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 554' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_exo . . . . . 0 N--CA 1.462 -0.363 0 C-N-CA 122.791 2.327 . . . . 1.98 112.496 -176.523 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 560' ' ' MET . . . . . . . . . . . . . 3.8 mpp? . . . . . 0 C--O 1.237 0.419 0 CA-C-O 120.647 0.26 . . . . 2.6099999999999999 111.28 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 561' ' ' ALA . . . . . 0.59 ' HB2' HG22 ' A' ' 572' ' ' THR . . . -144.66 145.7 31.88 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-O 121.045 0.45 . . . . 0.94999999999999996 111.552 -176.628 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 33.1 p90 -135.92 149.22 48.87 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 107.791 -1.189 . . . . 0.90000000000000002 107.791 169.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 563' ' ' LYS . . . . . 0.46 ' HA ' ' HA ' ' A' ' 570' ' ' THR . 72.1 tttt -93.3 119.99 33.07 Favored 'General case' 0 C--N 1.316 -0.859 0 C-N-CA 120.093 -0.643 . . . . 2.1800000000000002 110.929 -176.07 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 564' ' ' CYS . . . . . 0.48 ' HA ' ' HD3' ' A' ' 565' ' ' PRO . 10.6 t -76.91 114.26 37.76 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-N 115.348 -0.842 . . . . 0.40999999999999998 110.729 -178.626 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 565' ' ' PRO . . . . . 0.48 ' HD3' ' HA ' ' A' ' 564' ' ' CYS . 20.6 Cg_exo -70.48 -23.41 27.55 Favored 'Trans proline' 0 CA--C 1.534 0.487 0 C-N-CA 123.379 2.719 . . . . 0.63 113.35 -177.479 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 566' ' ' ILE . . . . . 0.485 HG21 ' HB3' ' A' ' 599' ' ' CYS . 26.7 mt -71.44 -37.64 65.46 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.364 0 N-CA-C 112.041 0.385 . . . . 0.93999999999999995 112.041 -174.249 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 567' ' ' CYS . . . . . . . . . . . . . 29.2 p -124.34 2.06 8.43 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.805 0.336 . . . . 0.69999999999999996 111.429 178.07 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 568' ' ' LYS . . . . . . . . . . . . . 29.4 mtpp 69.65 18.01 7.7 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 113.463 0.912 . . . . 2.71 113.463 171.798 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 569' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -107.85 136.37 47.69 Favored 'General case' 0 C--O 1.238 0.46 0 C-N-CA 120.373 -0.531 . . . . 3.3399999999999999 111.332 178.818 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 570' ' ' THR . . . . . 0.46 ' HA ' ' HA ' ' A' ' 563' ' ' LYS . 35.5 m -68.18 125.99 28.12 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 115.015 -0.993 . . . . 1.01 110.925 -178.677 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 571' ' ' VAL . . . . . 0.533 ' O ' ' HA ' ' A' ' 561' ' ' ALA . 15.9 t -95.06 117.51 39.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 115.68 -0.691 . . . . 0.72999999999999998 110.602 -176.891 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 572' ' ' THR . . . . . 0.59 HG22 ' HB2' ' A' ' 561' ' ' ALA . 25.6 p -109.17 158.62 17.63 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 109.619 -0.512 . . . . 1.8899999999999999 109.619 176.589 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . -129.92 156.41 21.44 Favored Glycine 0 N--CA 1.443 -0.871 0 C-N-CA 120.305 -0.95 . . . . 2.2000000000000002 111.777 -177.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 574' ' ' VAL . . . . . 0.484 ' O ' HG22 ' A' ' 583' ' ' VAL . 20.1 t -113.68 149.94 15.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-O 120.832 0.348 . . . . 3.2400000000000002 110.227 -173.352 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 575' ' ' TYR . . . . . 0.446 ' HA ' ' HA ' ' A' ' 582' ' ' TRP . 39.6 t80 -80.61 123.84 28.48 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 109.276 -0.639 . . . . 3.02 109.276 174.383 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 576' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -90.97 105.49 17.86 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 108.434 -0.95 . . . . 3.3399999999999999 108.434 175.574 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 577' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -67.09 -27.02 67.01 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.377 -0.829 . . . . 5.5899999999999999 112.083 -170.602 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 578' ' ' GLU . . . . . . . . . . . . . 23.1 mp0 -75.15 -47.06 30.33 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.537 -0.301 . . . . 5.1100000000000003 111.354 -179.452 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 579' ' ' SER . . . . . . . . . . . . . 75.2 p -83.12 -21.06 33.74 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.059 0.457 . . . . 3.2799999999999998 111.295 -179.449 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 580' ' ' GLY . . . . . . . . . . . . . . . 80.23 20.49 67.03 Favored Glycine 0 N--CA 1.449 -0.46 0 CA-C-N 115.863 -0.608 . . . . 2.6000000000000001 112.836 177.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 581' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -130.28 148.08 52.07 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.912 0.387 . . . . 3.1899999999999999 110.752 -178.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 582' ' ' TRP . . . . . 0.563 ' O ' ' HA ' ' A' ' 552' ' ' VAL . 81.1 m95 -79.12 135.19 36.76 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.313 -0.625 . . . . 2.2999999999999998 109.313 174.194 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 583' ' ' VAL . . . . . 0.484 HG22 ' O ' ' A' ' 574' ' ' VAL . 29.3 m -113.4 129.33 69.35 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 N-CA-C 112.987 0.736 . . . . 1.1100000000000001 112.987 -172.594 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 584' ' ' TRP . . . . . 0.579 ' CD1' HG22 ' A' ' 553' ' ' VAL . 23.3 m0 -109.4 102.31 11.21 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 108.085 -1.08 . . . . 2.29 108.085 163.108 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 585' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.99 151.51 19.49 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 110.2 -0.296 . . . . 3.9500000000000002 110.2 -173.428 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 586' ' ' ASN . . . . . 0.501 ' O ' ' HA ' ' A' ' 596' ' ' HIS . 2.2 m-20 55.95 42.33 28.83 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 121.214 0.53 . . . . 1.4299999999999999 109.714 -173.311 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 587' ' ' THR . . . . . . . . . . . . . 30.2 m -124.41 141.42 52.1 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.359 -0.837 . . . . 0.65000000000000002 110.439 -178.015 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 588' ' ' ILE . . . . . 0.568 ' HB ' ' HB3' ' A' ' 597' ' ' SER . 16.1 tt -139.98 147.92 23.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 116.255 -0.43 . . . . 0.70999999999999996 109.877 177.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 589' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -100.62 119.08 38.03 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.453 -0.573 . . . . 1.3500000000000001 109.453 176.653 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 590' ' ' VAL . . . . . . . . . . . . . 60.0 t -130.93 127.31 61.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.563 -0.744 . . . . 0.65000000000000002 109.401 179.065 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 591' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 59.05 33.21 22.83 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 121.605 0.717 . . . . 2.0299999999999998 110.384 179.068 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . 84.88 0.74 89.07 Favored Glycine 0 N--CA 1.45 -0.424 0 CA-C-N 115.795 -0.639 . . . . 0.62 113.303 175.815 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 593' ' ' LYS . . . . . . . . . . . . . 45.3 mmtm -121.35 148.06 44.86 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.056 0.455 . . . . 2.7799999999999998 111.482 -178.305 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 594' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -92.89 132.76 36.75 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.566 -0.743 . . . . 1.45 110.576 179.597 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 595' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -136.55 162.58 32.72 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.292 -0.867 . . . . 1.3200000000000001 108.766 177.529 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 596' ' ' HIS . . . . . 0.512 ' CE1' HG22 ' A' ' 571' ' ' VAL . 21.9 m170 -66.86 125.05 24.7 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 107.743 -1.206 . . . . 0.58999999999999997 107.743 167.178 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 597' ' ' SER . . . . . 0.568 ' HB3' ' HB ' ' A' ' 588' ' ' ILE . 2.1 p -67.77 -29.79 69.08 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.256 0.55 . . . . 1.1299999999999999 109.884 177.501 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 598' ' ' THR . . . . . . . . . . . . . 25.6 m -63.84 -38.27 90.46 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.258 -0.883 . . . . 1.3999999999999999 110.656 174.643 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 599' ' ' CYS . . . . . 0.485 ' HB3' HG21 ' A' ' 566' ' ' ILE . 73.6 m -75.14 -29.92 60.64 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.971 -0.559 . . . . 0.81000000000000005 110.816 177.263 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 600' ' ' TYR . . . . . . . . . . . . . 92.4 t80 -55.62 -34.52 64.98 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.617 -0.719 . . . . 1.8799999999999999 111.623 -174.598 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 601' ' ' HIS . . . . . . . . . . . . . 66.9 m170 -60.16 -32.51 71.12 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 112.459 0.541 . . . . 4.5199999999999996 112.459 -176.343 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 602' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -72.61 -33.52 66.73 Favored 'General case' 0 CA--C 1.528 0.099 0 C-N-CA 120.118 -0.633 . . . . 3.8500000000000001 110.966 -179.141 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 603' ' ' THR . . . . . . . . . . . . . 8.8 t . . . . . 0 C--O 1.235 0.3 0 C-N-CA 120.633 -0.427 . . . . 3.2999999999999998 110.837 -177.564 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.387 0 N-CA-C 112.565 -0.214 . . . . 3.2000000000000002 112.565 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 549' ' ' LYS . . . . . . . . . . . . . 32.5 mmmt -70.8 143.72 51.06 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 110.038 -0.356 . . . . 5.9000000000000004 110.038 178.089 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 550' ' ' TYR . . . . . 0.507 ' CE1' HG12 ' A' ' 583' ' ' VAL . 23.8 p90 -125.97 159.73 31.89 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 109.29 -0.633 . . . . 2.79 109.29 177.015 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 551' ' ' VAL . . . . . . . . . . . . . 52.6 t -118.33 133.37 65.35 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.021 0 N-CA-C 108.723 -0.843 . . . . 1.52 108.723 177.48 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 552' ' ' VAL . . . . . 0.57 ' HA ' ' O ' ' A' ' 582' ' ' TRP . 60.8 t -65.2 130.59 30.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 109.499 -0.556 . . . . 1.3799999999999999 109.499 179.374 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 553' ' ' VAL . . . . . 0.6 HG22 ' CD1' ' A' ' 584' ' ' TRP . 66.0 t -59.0 121.37 54.6 Favored Pre-proline 0 CA--C 1.519 -0.243 0 O-C-N 123.618 0.574 . . . . 1.3799999999999999 110.681 -175.608 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 554' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 553' ' ' VAL . 31.9 Cg_exo -57.74 135.22 67.93 Favored 'Trans proline' 0 N--CA 1.464 -0.219 0 C-N-CA 123.041 2.494 . . . . 1.98 112.786 -177.404 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 555' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -91.65 -3.99 55.71 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.698 -0.683 . . . . 4.1699999999999999 110.476 -179.262 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 21.6 p -86.43 -16.12 38.15 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.574 -0.739 . . . . 4.04 111.127 179.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 557' ' ' SER . . . . . . . . . . . . . 13.3 m -88.43 -41.14 12.98 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.179 -0.464 . . . . 3.0299999999999998 110.701 179.112 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 558' ' ' GLN . . . . . . . . . . . . . 53.4 mt-30 68.76 -1.49 1.99 Allowed 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 115.396 -0.82 . . . . 5.0599999999999996 113.013 175.599 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 559' ' ' ASP . . . . . . . . . . . . . 28.8 p-10 -105.7 -18.46 14.07 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.078 0.466 . . . . 3.23 110.429 176.601 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 560' ' ' MET . . . . . 0.468 ' HG3' HG11 ' A' ' 553' ' ' VAL . 1.8 mpt? 63.96 21.75 12.73 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 115.241 -0.891 . . . . 2.6099999999999999 112.397 174.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 561' ' ' ALA . . . . . 0.461 ' HA ' ' O ' ' A' ' 571' ' ' VAL . . . -144.5 152.67 40.93 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.015 0.436 . . . . 0.94999999999999996 111.33 -178.659 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 33.4 p90 -142.76 151.7 41.52 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.219 -0.66 . . . . 0.90000000000000002 109.219 170.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 563' ' ' LYS . . . . . . . . . . . . . 3.6 tppp? -88.8 117.98 28.17 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 109.269 -0.641 . . . . 2.1800000000000002 109.269 -178.49 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 564' ' ' CYS . . . . . 0.479 ' HA ' ' HD3' ' A' ' 565' ' ' PRO . 41.7 t -68.26 112.96 12.45 Favored Pre-proline 0 C--O 1.223 -0.316 0 N-CA-C 109.578 -0.527 . . . . 0.40999999999999998 109.578 179.035 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 565' ' ' PRO . . . . . 0.479 ' HD3' ' HA ' ' A' ' 564' ' ' CYS . 15.5 Cg_exo -71.77 -18.21 28.66 Favored 'Trans proline' 0 CA--C 1.527 0.162 0 C-N-CA 122.747 2.298 . . . . 0.63 113.299 -174.583 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 566' ' ' ILE . . . . . . . . . . . . . 26.4 mt -89.18 -38.32 11.15 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 N-CA-C 112.211 0.448 . . . . 0.93999999999999995 112.211 -172.233 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 567' ' ' CYS . . . . . . . . . . . . . 28.6 p -127.74 1.21 6.09 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.512 -0.475 . . . . 0.69999999999999996 111.65 178.67 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 568' ' ' LYS . . . . . 0.421 ' HA ' ' O ' ' A' ' 564' ' ' CYS . 54.3 mtpt 70.9 31.72 2.55 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 114.576 1.324 . . . . 2.71 114.576 163.782 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 569' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -95.72 149.38 21.55 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 108.605 -0.887 . . . . 3.3399999999999999 108.605 170.173 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 570' ' ' THR . . . . . . . . . . . . . 57.0 m -84.02 117.06 23.16 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 109.045 -0.724 . . . . 1.01 109.045 172.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 571' ' ' VAL . . . . . 0.495 HG22 ' CE1' ' A' ' 596' ' ' HIS . 34.1 t -84.89 116.56 28.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-O 120.976 0.417 . . . . 0.72999999999999998 111.108 -174.214 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 23.7 p -107.03 159.24 16.44 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.748 -0.66 . . . . 1.8899999999999999 109.768 177.191 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . -130.5 155.68 21.24 Favored Glycine 0 N--CA 1.442 -0.926 0 C-N-CA 119.925 -1.131 . . . . 2.2000000000000002 111.732 -178.233 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 574' ' ' VAL . . . . . 0.5 ' O ' HG22 ' A' ' 583' ' ' VAL . 40.5 t -118.0 148.44 20.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 109.838 -0.43 . . . . 3.2400000000000002 109.838 -174.215 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 575' ' ' TYR . . . . . 0.46 ' HA ' ' HA ' ' A' ' 582' ' ' TRP . 47.6 t80 -84.22 119.46 25.06 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.797 -0.446 . . . . 3.02 109.797 178.147 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 576' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -95.84 113.38 25.0 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.97 0.414 . . . . 3.3399999999999999 110.04 176.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 577' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -70.43 -22.69 62.69 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.42 -0.809 . . . . 5.5899999999999999 112.074 -175.262 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 578' ' ' GLU . . . . . . . . . . . . . 15.8 tp10 -74.82 -46.39 36.98 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 121.023 -0.271 . . . . 5.1100000000000003 110.854 -179.233 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 579' ' ' SER . . . . . . . . . . . . . 74.0 p -82.34 -20.96 36.27 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.111 0.482 . . . . 3.2799999999999998 110.608 176.013 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 580' ' ' GLY . . . . . . . . . . . . . . . 79.54 20.21 69.45 Favored Glycine 0 N--CA 1.447 -0.578 0 CA-C-N 115.667 -0.697 . . . . 2.6000000000000001 112.5 175.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 581' ' ' GLU . . . . . 0.43 ' HA ' ' OE1' ' A' ' 581' ' ' GLU . 8.7 mm-40 -138.1 160.26 39.85 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.24 0.543 . . . . 3.1899999999999999 111.048 -177.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 582' ' ' TRP . . . . . 0.57 ' O ' ' HA ' ' A' ' 552' ' ' VAL . 80.3 m95 -79.55 137.84 37.29 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.609 -0.723 . . . . 2.2999999999999998 109.361 174.322 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 583' ' ' VAL . . . . . 0.507 HG12 ' CE1' ' A' ' 550' ' ' TYR . 19.9 m -116.53 132.43 66.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 N-CA-C 113.667 0.988 . . . . 1.1100000000000001 113.667 -172.122 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 584' ' ' TRP . . . . . 0.6 ' CD1' HG22 ' A' ' 553' ' ' VAL . 31.2 m0 -113.31 102.71 10.6 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 108.17 -1.048 . . . . 2.29 108.17 162.387 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 585' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.32 154.15 18.03 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.884 -0.327 . . . . 3.9500000000000002 110.869 -176.212 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 586' ' ' ASN . . . . . . . . . . . . . 22.6 m-20 56.23 43.73 26.11 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 108.615 -0.884 . . . . 1.4299999999999999 108.615 -170.112 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 587' ' ' THR . . . . . . . . . . . . . 34.3 m -133.98 141.13 47.16 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.098 -0.955 . . . . 0.65000000000000002 110.513 -176.019 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 588' ' ' ILE . . . . . . . . . . . . . 12.7 tt -141.58 149.41 20.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.358 -0.383 . . . . 0.70999999999999996 110.095 -178.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 589' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -97.73 122.65 41.08 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.887 -0.412 . . . . 1.3500000000000001 109.887 177.246 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 590' ' ' VAL . . . . . . . . . . . . . 35.4 t -124.64 118.44 53.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 N-CA-C 109.761 -0.459 . . . . 0.65000000000000002 109.761 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 591' ' ' ASN . . . . . . . . . . . . . 3.7 t30 55.58 40.99 31.12 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.418 -0.81 . . . . 2.0299999999999998 110.988 177.458 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . 85.41 5.13 85.34 Favored Glycine 0 CA--C 1.52 0.365 0 C-N-CA 120.86 -0.686 . . . . 0.62 113.778 174.455 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 593' ' ' LYS . . . . . . . . . . . . . 56.0 mttp -127.84 144.89 51.08 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 117.363 0.582 . . . . 2.7799999999999998 110.958 177.481 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 594' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -91.25 132.94 35.8 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.277 0.561 . . . . 1.45 110.711 -179.516 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 595' ' ' PHE . . . . . . . . . . . . . 72.0 m-85 -132.95 156.32 47.5 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.299 -0.864 . . . . 1.3200000000000001 108.962 178.441 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 596' ' ' HIS . . . . . 0.495 ' CE1' HG22 ' A' ' 571' ' ' VAL . 11.3 m170 -60.98 126.97 29.3 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 108.384 -0.969 . . . . 0.58999999999999997 108.384 167.775 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 597' ' ' SER . . . . . . . . . . . . . 23.2 t -65.15 -29.31 70.14 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.859 -0.609 . . . . 1.1299999999999999 109.986 -177.506 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 598' ' ' THR . . . . . . . . . . . . . 2.6 m -66.8 -39.18 87.67 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 115.522 -0.763 . . . . 1.3999999999999999 110.707 178.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 599' ' ' CYS . . . . . . . . . . . . . 86.1 m -74.68 -32.82 62.31 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.527 -0.76 . . . . 0.81000000000000005 112.152 -174.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 600' ' ' TYR . . . . . . . . . . . . . 73.9 t80 -57.06 -34.68 68.5 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.928 0.394 . . . . 1.8799999999999999 111.471 -172.337 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 601' ' ' HIS . . . . . . . . . . . . . 14.6 m-70 -61.91 -26.82 68.4 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.786 -0.643 . . . . 4.5199999999999996 112.361 -177.221 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 602' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.49 -29.13 65.57 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 121.117 0.484 . . . . 3.8500000000000001 110.13 -178.646 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 603' ' ' THR . . . . . . . . . . . . . 92.2 m . . . . . 0 C--N 1.326 -0.423 0 CA-C-N 115.841 -0.618 . . . . 3.2999999999999998 110.811 -178.311 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 701' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.512 -0.147 0 N-CA-C 113.274 0.07 . . . . 3.2000000000000002 113.274 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 549' ' ' LYS . . . . . 0.645 ' N ' ' HD2' ' A' ' 549' ' ' LYS . 6.5 mptt -81.29 150.35 28.56 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.379 0.609 . . . . 5.9000000000000004 111.467 178.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 550' ' ' TYR . . . . . 0.509 ' CE1' HG12 ' A' ' 583' ' ' VAL . 16.6 p90 -111.19 161.88 15.52 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 114.92 -1.036 . . . . 2.79 110.072 -174.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 551' ' ' VAL . . . . . . . . . . . . . 84.9 t -118.08 133.28 65.38 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 N-CA-C 109.181 -0.674 . . . . 1.52 109.181 177.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 552' ' ' VAL . . . . . . . . . . . . . 59.1 t -63.92 134.66 28.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.725 -0.67 . . . . 1.3799999999999999 109.815 -179.731 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 553' ' ' VAL . . . . . 0.603 HG22 ' CD1' ' A' ' 584' ' ' TRP . 86.3 t -60.07 121.01 55.78 Favored Pre-proline 0 N--CA 1.454 -0.233 0 O-C-N 123.618 0.574 . . . . 1.3799999999999999 111.108 -176.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 554' ' ' PRO . . . . . 0.443 ' HB2' ' OG ' ' A' ' 557' ' ' SER . 16.6 Cg_exo -64.22 138.06 59.44 Favored 'Trans proline' 0 N--CA 1.461 -0.431 0 C-N-CA 123.167 2.578 . . . . 1.98 112.561 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 555' ' ' GLU . . . . . 0.48 ' H ' ' CD ' ' A' ' 555' ' ' GLU . 0.0 OUTLIER -84.41 -32.09 24.31 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.622 -0.717 . . . . 4.1699999999999999 110.57 -178.413 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 19.0 p -82.15 6.88 15.11 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.398 -0.819 . . . . 4.04 112.329 -177.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 557' ' ' SER . . . . . 0.443 ' OG ' ' HB2' ' A' ' 554' ' ' PRO . 60.7 m -86.2 -2.78 58.68 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.952 -0.388 . . . . 3.0299999999999998 109.952 174.143 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 558' ' ' GLN . . . . . . . . . . . . . 78.1 mm-40 68.65 -70.44 0.13 Allowed 'General case' 0 N--CA 1.465 0.305 0 O-C-N 123.987 0.804 . . . . 5.0599999999999996 110.771 -178.656 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 559' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -94.77 146.27 24.3 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.544 -0.539 . . . . 3.23 109.544 177.711 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 560' ' ' MET . . . . . . . . . . . . . 67.0 mtm -92.12 29.59 1.6 Allowed 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 111.703 0.261 . . . . 2.6099999999999999 111.703 -173.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 561' ' ' ALA . . . . . . . . . . . . . . . -145.39 157.96 43.93 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.364 -0.38 . . . . 0.94999999999999996 110.54 178.387 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 35.0 p90 -153.33 158.39 41.48 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.736 -0.468 . . . . 0.90000000000000002 109.736 174.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 563' ' ' LYS . . . . . . . . . . . . . 5.2 tppp? -89.43 127.32 35.82 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 110.191 -0.3 . . . . 2.1800000000000002 110.191 179.215 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 564' ' ' CYS . . . . . 0.678 ' O ' ' HA ' ' A' ' 568' ' ' LYS . 47.7 t -71.02 114.44 27.23 Favored Pre-proline 0 C--O 1.222 -0.355 0 N-CA-C 109.48 -0.563 . . . . 0.40999999999999998 109.48 175.493 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 565' ' ' PRO . . . . . 0.489 ' HD3' ' HA ' ' A' ' 564' ' ' CYS . 13.7 Cg_exo -72.21 -18.8 26.6 Favored 'Trans proline' 0 CA--C 1.528 0.208 0 C-N-CA 122.978 2.452 . . . . 0.63 113.887 -174.424 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 566' ' ' ILE . . . . . 0.483 HD12 ' HB3' ' A' ' 599' ' ' CYS . 65.9 mt -91.85 -55.14 6.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 112.191 0.441 . . . . 0.93999999999999995 112.191 -172.019 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 567' ' ' CYS . . . . . . . . . . . . . 29.5 p -106.68 -6.35 17.94 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.251 -0.579 . . . . 0.69999999999999996 111.043 178.584 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 568' ' ' LYS . . . . . 0.678 ' HA ' ' O ' ' A' ' 564' ' ' CYS . 99.4 mttt 70.98 32.92 2.22 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 114.64 1.348 . . . . 2.71 114.64 165.569 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 569' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -96.44 136.19 37.28 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 108.806 -0.813 . . . . 3.3399999999999999 108.806 168.098 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 570' ' ' THR . . . . . . . . . . . . . 57.3 m -68.41 118.24 11.22 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.203 -0.453 . . . . 1.01 110.182 -179.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 571' ' ' VAL . . . . . 0.509 HG22 ' CE1' ' A' ' 596' ' ' HIS . 21.6 t -89.7 116.55 31.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 116.15 -0.477 . . . . 0.72999999999999998 110.935 -175.66 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 29.2 p -115.18 161.37 18.52 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 109.011 -0.737 . . . . 1.8899999999999999 109.011 173.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . -128.27 154.41 19.92 Favored Glycine 0 N--CA 1.437 -1.285 0 C-N-CA 119.468 -1.349 . . . . 2.2000000000000002 111.089 -179.494 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 574' ' ' VAL . . . . . 0.412 ' O ' HG22 ' A' ' 583' ' ' VAL . 49.0 t -115.47 142.46 28.49 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-O 120.922 0.391 . . . . 3.2400000000000002 110.308 -171.557 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 575' ' ' TYR . . . . . . . . . . . . . 45.3 t80 -79.96 118.93 22.15 Favored 'General case' 0 N--CA 1.443 -0.787 0 N-CA-C 109.568 -0.53 . . . . 3.02 109.568 175.688 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 576' ' ' ASP . . . . . . . . . . . . . 27.9 t0 -90.92 109.11 20.33 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.192 -0.669 . . . . 3.3399999999999999 109.192 178.018 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 577' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -70.57 -23.9 62.68 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 115.008 -0.996 . . . . 5.5899999999999999 111.309 -175.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 578' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -77.09 -34.2 56.91 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.149 -0.478 . . . . 5.1100000000000003 111.056 -175.709 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 579' ' ' SER . . . . . . . . . . . . . 77.5 p -98.77 -20.66 16.78 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.351 0.595 . . . . 3.2799999999999998 110.553 176.207 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 580' ' ' GLY . . . . . . . . . . . . . . . 80.43 28.04 49.54 Favored Glycine 0 N--CA 1.448 -0.506 0 CA-C-N 115.497 -0.774 . . . . 2.6000000000000001 113.46 177.225 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 581' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -140.91 161.2 38.39 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 117.195 0.498 . . . . 3.1899999999999999 111.48 178.15 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 582' ' ' TRP . . . . . . . . . . . . . 81.6 m95 -84.93 134.28 34.26 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.743 -0.466 . . . . 2.2999999999999998 109.743 176.508 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 583' ' ' VAL . . . . . 0.509 HG12 ' CE1' ' A' ' 550' ' ' TYR . 15.6 m -115.84 136.63 52.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 N-CA-C 112.61 0.596 . . . . 1.1100000000000001 112.61 -172.415 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 584' ' ' TRP . . . . . 0.603 ' CD1' HG22 ' A' ' 553' ' ' VAL . 18.9 m0 -113.59 104.42 12.23 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.478 -0.783 . . . . 2.29 108.982 165.758 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 585' ' ' LYS . . . . . 0.503 ' HG2' ' OD1' ' A' ' 586' ' ' ASN . 0.0 OUTLIER -88.77 151.25 22.51 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.639 0.257 . . . . 3.9500000000000002 111.262 -175.137 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 586' ' ' ASN . . . . . 0.578 ' O ' ' HA ' ' A' ' 596' ' ' HIS . 8.0 m120 53.51 43.0 31.85 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 123.196 0.598 . . . . 1.4299999999999999 110.019 -174.121 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 587' ' ' THR . . . . . . . . . . . . . 53.2 m -128.91 140.46 51.66 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.021 0.439 . . . . 0.65000000000000002 111.425 -173.377 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 588' ' ' ILE . . . . . . . . . . . . . 14.8 tt -142.4 150.27 18.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.855 -0.611 . . . . 0.70999999999999996 109.682 178.056 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 589' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -104.4 119.65 39.44 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.47 -0.567 . . . . 1.3500000000000001 109.47 176.353 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 590' ' ' VAL . . . . . . . . . . . . . 58.5 t -125.37 117.41 49.6 Favored 'Isoleucine or valine' 0 C--O 1.239 0.552 0 CA-C-N 115.831 -0.622 . . . . 0.65000000000000002 110.374 178.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 591' ' ' ASN . . . . . . . . . . . . . 95.0 m-20 57.36 45.8 19.4 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.379 -0.828 . . . . 2.0299999999999998 112.172 176.538 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . 82.06 7.4 87.89 Favored Glycine 0 N--CA 1.45 -0.429 0 CA-C-N 115.927 -0.579 . . . . 0.62 112.329 173.318 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 593' ' ' LYS . . . . . 0.413 ' HB2' ' NZ ' ' A' ' 593' ' ' LYS . 8.1 mtmp? -129.97 137.86 50.54 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.823 0.344 . . . . 2.7799999999999998 111.182 -177.557 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 594' ' ' TYR . . . . . . . . . . . . . 79.2 m-85 -94.21 132.38 38.83 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.016 -0.538 . . . . 1.45 110.567 179.514 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 595' ' ' PHE . . . . . . . . . . . . . 71.8 m-85 -138.41 159.35 42.28 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.013 -0.736 . . . . 1.3200000000000001 109.013 177.053 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 596' ' ' HIS . . . . . 0.667 ' HB2' ' SG ' ' A' ' 599' ' ' CYS . 24.4 m170 -63.52 129.44 40.19 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 107.599 -1.26 . . . . 0.58999999999999997 107.599 165.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 597' ' ' SER . . . . . . . . . . . . . 2.9 m -58.7 -32.41 69.14 Favored 'General case' 0 CA--C 1.519 -0.214 0 CA-C-O 121.577 0.703 . . . . 1.1299999999999999 109.783 178.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 598' ' ' THR . . . . . . . . . . . . . 81.8 m -59.46 -39.9 85.14 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 114.573 -1.194 . . . . 1.3999999999999999 110.534 173.606 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 599' ' ' CYS . . . . . 0.672 ' HA ' ' HG2' ' A' ' 602' ' ' GLU . 83.6 m -74.82 -34.99 62.45 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.969 -0.56 . . . . 0.81000000000000005 112.329 -179.258 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 600' ' ' TYR . . . . . . . . . . . . . 79.6 t80 -61.01 -35.57 77.19 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 109.161 -0.681 . . . . 1.8799999999999999 109.161 -179.142 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 601' ' ' HIS . . . . . . . . . . . . . 27.8 t60 -68.09 -42.99 79.52 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 115.581 -0.736 . . . . 4.5199999999999996 110.288 177.628 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 602' ' ' GLU . . . . . 0.672 ' HG2' ' HA ' ' A' ' 599' ' ' CYS . 13.8 pt-20 -70.91 -33.74 70.84 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 111.863 0.32 . . . . 3.8500000000000001 111.863 -176.447 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 603' ' ' THR . . . . . 0.468 ' HB ' HD13 ' A' ' 566' ' ' ILE . 15.3 t . . . . . 0 C--N 1.326 -0.434 0 O-C-N 122.167 -0.333 . . . . 3.2999999999999998 111.243 -179.028 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 701' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.289 0 N-CA-C 113.593 0.197 . . . . 3.2000000000000002 113.593 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 549' ' ' LYS . . . . . . . . . . . . . 29.6 mtpt -81.01 138.89 36.02 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.107 0.48 . . . . 5.9000000000000004 110.473 177.447 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 550' ' ' TYR . . . . . 0.555 ' CE1' HG12 ' A' ' 583' ' ' VAL . 16.4 p90 -111.46 161.72 15.84 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.167 -0.924 . . . . 2.79 109.279 178.535 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 551' ' ' VAL . . . . . 0.515 HG11 ' HE1' ' A' ' 594' ' ' TYR . 57.4 t -116.47 133.52 62.79 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.992 0 N-CA-C 109.19 -0.67 . . . . 1.52 109.19 177.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 552' ' ' VAL . . . . . . . . . . . . . 48.3 t -67.89 130.72 33.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.912 -0.585 . . . . 1.3799999999999999 110.361 -177.545 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 553' ' ' VAL . . . . . 0.637 HG22 ' CD1' ' A' ' 584' ' ' TRP . 64.1 t -59.2 122.61 64.72 Favored Pre-proline 0 C--N 1.328 -0.34 0 O-C-N 123.902 0.751 . . . . 1.3799999999999999 111.048 -177.545 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 554' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_exo -59.9 142.78 99.22 Favored 'Trans proline' 0 N--CA 1.461 -0.391 0 C-N-CA 122.706 2.271 . . . . 1.98 111.442 176.709 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 555' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -47.86 -49.05 30.67 Favored 'General case' 0 C--O 1.235 0.319 0 O-C-N 123.608 0.567 . . . . 4.1699999999999999 111.949 -171.57 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 22.8 p -108.17 -76.06 0.62 Allowed 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.959 -0.564 . . . . 4.04 111.879 -178.086 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 557' ' ' SER . . . . . . . . . . . . . 21.8 t 62.8 -84.63 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 109.509 -0.552 . . . . 3.0299999999999998 109.509 -173.716 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 558' ' ' GLN . . . . . . . . . . . . . 13.0 mm100 -147.54 -84.13 0.11 Allowed 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 108.602 -0.888 . . . . 5.0599999999999996 108.602 174.632 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 559' ' ' ASP . . . . . . . . . . . . . 20.9 p-10 -121.05 46.24 2.08 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.149 -0.932 . . . . 3.23 109.239 173.365 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 560' ' ' MET . . . . . . . . . . . . . 57.4 mtt 59.52 33.26 22.11 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 115.087 -0.96 . . . . 2.6099999999999999 110.259 -174.297 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 561' ' ' ALA . . . . . . . . . . . . . . . -144.21 161.18 39.54 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.048 -0.978 . . . . 0.94999999999999996 110.517 -174.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 30.8 p90 -136.59 164.31 28.5 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 108.02 -1.104 . . . . 0.90000000000000002 108.02 171.373 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 563' ' ' LYS . . . . . . . . . . . . . 29.2 ttpt -112.17 122.0 46.51 Favored 'General case' 0 C--N 1.32 -0.704 0 C-N-CA 120.399 -0.52 . . . . 2.1800000000000002 110.675 -177.542 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 564' ' ' CYS . . . . . 0.424 ' HA ' ' HD3' ' A' ' 565' ' ' PRO . 44.2 t -74.39 111.91 14.91 Favored Pre-proline 0 N--CA 1.453 -0.322 0 CA-C-N 115.48 -0.782 . . . . 0.40999999999999998 109.624 -178.49 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 565' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 564' ' ' CYS . 15.2 Cg_exo -72.34 -21.66 22.79 Favored 'Trans proline' 0 CA--C 1.528 0.202 0 C-N-CA 123.128 2.552 . . . . 0.63 113.843 -174.206 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 566' ' ' ILE . . . . . . . . . . . . . 18.4 mt -71.9 -39.19 66.93 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 CA-C-O 121.059 0.457 . . . . 0.93999999999999995 110.476 -173.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 567' ' ' CYS . . . . . 0.594 ' SG ' ' HG3' ' A' ' 569' ' ' GLU . 27.4 p -129.81 2.53 4.9 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.873 -0.603 . . . . 0.69999999999999996 112.534 -174.5 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 568' ' ' LYS . . . . . . . . . . . . . 52.5 mtpt 71.16 30.81 2.58 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 113.425 0.898 . . . . 2.71 113.425 175.047 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 569' ' ' GLU . . . . . 0.594 ' HG3' ' SG ' ' A' ' 567' ' ' CYS . 46.2 mt-10 -85.59 132.84 34.1 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 120.515 -0.474 . . . . 3.3399999999999999 110.277 176.486 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 570' ' ' THR . . . . . . . . . . . . . 49.2 m -84.42 116.12 22.9 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 108.317 -0.994 . . . . 1.01 108.317 166.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 571' ' ' VAL . . . . . . . . . . . . . 12.7 t -98.08 116.29 40.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 115.947 -0.57 . . . . 0.72999999999999998 110.856 -171.398 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 27.5 p -104.26 160.71 14.65 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.594 -0.73 . . . . 1.8899999999999999 109.474 178.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . -128.66 157.18 21.36 Favored Glycine 0 N--CA 1.439 -1.114 0 C-N-CA 119.896 -1.145 . . . . 2.2000000000000002 111.912 -176.546 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 574' ' ' VAL . . . . . . . . . . . . . 60.3 t -111.66 145.86 17.3 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-O 121.004 0.43 . . . . 3.2400000000000002 110.231 -172.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 575' ' ' TYR . . . . . . . . . . . . . 45.3 t80 -78.52 118.49 20.7 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 108.917 -0.772 . . . . 3.02 108.917 174.771 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 576' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -91.66 102.76 15.39 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 109.154 -0.684 . . . . 3.3399999999999999 109.154 -179.113 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 577' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -68.56 -23.0 64.45 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.276 -0.42 . . . . 5.5899999999999999 111.635 -176.147 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 578' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -65.74 -43.98 87.35 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.409 -0.36 . . . . 5.1100000000000003 110.603 -178.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 579' ' ' SER . . . . . . . . . . . . . 72.0 p -95.9 -20.61 18.64 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.109 0.48 . . . . 3.2799999999999998 111.504 176.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 580' ' ' GLY . . . . . . . . . . . . . . . 80.71 21.38 63.93 Favored Glycine 0 N--CA 1.452 -0.244 0 CA-C-N 116.01 -0.541 . . . . 2.6000000000000001 112.886 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 581' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -133.09 157.56 44.98 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.728 0.299 . . . . 3.1899999999999999 110.597 179.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 582' ' ' TRP . . . . . 0.478 ' HB2' ' HB ' ' A' ' 553' ' ' VAL . 76.3 m95 -79.85 137.11 36.85 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.478 -0.328 . . . . 2.2999999999999998 110.194 178.151 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 583' ' ' VAL . . . . . 0.555 HG12 ' CE1' ' A' ' 550' ' ' TYR . 20.5 m -118.81 141.48 38.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 113.251 0.834 . . . . 1.1100000000000001 113.251 -173.409 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 584' ' ' TRP . . . . . 0.637 ' CD1' HG22 ' A' ' 553' ' ' VAL . 28.1 m0 -113.43 104.56 12.41 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 114.997 -1.001 . . . . 2.29 108.621 164.225 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 585' ' ' LYS . . . . . 0.497 ' HD2' ' CB ' ' A' ' 550' ' ' TYR . 10.9 mmmm -89.17 152.35 21.66 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.696 0.284 . . . . 3.9500000000000002 110.491 -176.337 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 586' ' ' ASN . . . . . 0.414 ' O ' ' HA ' ' A' ' 596' ' ' HIS . 1.1 m-20 55.24 42.77 30.15 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 115.911 -0.586 . . . . 1.4299999999999999 109.648 -173.601 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 587' ' ' THR . . . . . . . . . . . . . 53.3 m -126.33 140.23 52.68 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.114 0.483 . . . . 0.65000000000000002 110.878 -175.491 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 588' ' ' ILE . . . . . . . . . . . . . 14.3 tt -137.25 145.3 29.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.832 -0.622 . . . . 0.70999999999999996 109.644 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 589' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -103.17 121.14 42.04 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.064 0.459 . . . . 1.3500000000000001 109.999 178.636 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 590' ' ' VAL . . . . . . . . . . . . . 43.5 t -131.6 127.65 59.6 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 115.594 -0.73 . . . . 0.65000000000000002 109.662 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 591' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 59.63 33.26 21.93 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 121.947 0.88 . . . . 2.0299999999999998 110.451 179.297 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . 77.78 9.82 86.64 Favored Glycine 0 N--CA 1.449 -0.436 0 CA-C-N 115.64 -0.709 . . . . 0.62 112.327 179.316 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 593' ' ' LYS . . . . . . . . . . . . . 70.1 mmtt -123.35 144.57 49.37 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 110.185 -0.302 . . . . 2.7799999999999998 110.185 -175.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 594' ' ' TYR . . . . . 0.515 ' HE1' HG11 ' A' ' 551' ' ' VAL . 99.1 m-85 -96.28 134.27 39.6 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.878 0.37 . . . . 1.45 111.162 -177.2 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 595' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -139.18 162.66 34.42 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.681 -0.69 . . . . 1.3200000000000001 109.631 178.258 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 596' ' ' HIS . . . . . 0.428 ' HB2' ' HB2' ' A' ' 599' ' ' CYS . 24.6 m170 -68.17 128.78 37.8 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 108.951 -0.759 . . . . 0.58999999999999997 108.951 169.4 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 597' ' ' SER . . . . . . . . . . . . . 4.6 m -63.26 -36.42 83.61 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-O 121.467 0.651 . . . . 1.1299999999999999 109.474 178.519 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 598' ' ' THR . . . . . . . . . . . . . 96.3 m -63.69 -44.76 92.74 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 114.704 -1.134 . . . . 1.3999999999999999 111.188 177.225 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 599' ' ' CYS . . . . . 0.663 ' O ' ' HG2' ' A' ' 602' ' ' GLU . 83.3 m -76.45 -31.98 58.16 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.564 0.579 . . . . 0.81000000000000005 112.564 -176.157 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 600' ' ' TYR . . . . . . . . . . . . . 87.5 t80 -57.03 -36.45 70.48 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.647 0.61 . . . . 1.8799999999999999 112.647 -169.219 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 601' ' ' HIS . . . . . . . . . . . . . 18.5 m170 -64.17 -26.71 68.65 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 112.801 0.667 . . . . 4.5199999999999996 112.801 -174.4 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 602' ' ' GLU . . . . . 0.663 ' HG2' ' O ' ' A' ' 599' ' ' CYS . 11.9 pt-20 -70.12 -23.48 63.03 Favored 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 120.313 -0.555 . . . . 3.8500000000000001 111.077 -178.445 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 603' ' ' THR . . . . . . . . . . . . . 85.0 m . . . . . 0 C--N 1.328 -0.338 0 CA-C-O 121.31 0.576 . . . . 3.2999999999999998 109.774 177.347 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 701' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.447 0 N-CA-C 112.504 -0.239 . . . . 3.2000000000000002 112.504 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 549' ' ' LYS . . . . . 0.444 ' HD3' ' HA ' ' A' ' 549' ' ' LYS . 31.0 mmtp -76.13 150.86 37.14 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.615 0.721 . . . . 5.9000000000000004 111.429 179.014 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 550' ' ' TYR . . . . . 0.591 ' CE1' HG12 ' A' ' 583' ' ' VAL . 46.9 p90 -114.81 162.97 16.17 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 114.594 -1.185 . . . . 2.79 110.761 -170.375 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 551' ' ' VAL . . . . . . . . . . . . . 60.5 t -117.03 134.01 61.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 N-CA-C 108.681 -0.859 . . . . 1.52 108.681 175.228 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 552' ' ' VAL . . . . . 0.595 ' HA ' ' O ' ' A' ' 582' ' ' TRP . 60.4 t -62.57 135.36 27.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.094 -0.503 . . . . 1.3799999999999999 110.508 -176.622 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 553' ' ' VAL . . . . . 0.56 HG22 ' CD1' ' A' ' 584' ' ' TRP . 92.4 t -59.34 120.62 49.74 Favored Pre-proline 0 N--CA 1.455 -0.194 0 CA-C-N 116.034 -0.53 . . . . 1.3799999999999999 110.464 -178.405 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 554' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 553' ' ' VAL . 33.5 Cg_exo -57.31 143.24 94.29 Favored 'Trans proline' 0 C--O 1.232 0.21 0 C-N-CA 123.653 2.902 . . . . 1.98 113.043 -178.526 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 555' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -72.33 -15.1 61.88 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.446 -0.797 . . . . 4.1699999999999999 110.341 179.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 23.7 p -104.67 22.06 15.74 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.454 -0.794 . . . . 4.04 110.779 177.408 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 557' ' ' SER . . . . . . . . . . . . . 29.0 t -74.3 149.75 40.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.848 -0.615 . . . . 3.0299999999999998 110.763 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 558' ' ' GLN . . . . . . . . . . . . . 14.5 mm100 -90.69 89.3 7.46 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.112 -0.495 . . . . 5.0599999999999996 109.952 -178.322 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 559' ' ' ASP . . . . . . . . . . . . . 10.8 t70 64.91 35.07 8.61 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 115.217 -0.902 . . . . 3.23 110.399 -179.233 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 560' ' ' MET . . . . . . . . . . . . . 1.9 mpt? 61.09 26.56 16.47 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 115.119 -0.946 . . . . 2.6099999999999999 112.059 177.083 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 561' ' ' ALA . . . . . 0.493 ' HA ' ' O ' ' A' ' 571' ' ' VAL . . . -144.64 154.71 43.09 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.918 0.39 . . . . 0.94999999999999996 111.486 -177.634 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 34.5 p90 -141.58 159.83 41.41 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 108.884 -0.784 . . . . 0.90000000000000002 108.884 170.467 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 563' ' ' LYS . . . . . . . . . . . . . 23.3 tptm -99.87 122.52 42.94 Favored 'General case' 0 C--N 1.32 -0.713 0 C-N-CA 120.98 -0.288 . . . . 2.1800000000000002 110.702 -176.066 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 564' ' ' CYS . . . . . 0.515 ' HB3' ' HG2' ' A' ' 569' ' ' GLU . 49.5 t -77.38 114.72 43.07 Favored Pre-proline 0 C--N 1.326 -0.425 0 N-CA-C 109.912 -0.403 . . . . 0.40999999999999998 109.912 178.102 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 565' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 564' ' ' CYS . 13.4 Cg_exo -69.42 -28.85 26.37 Favored 'Trans proline' 0 C--N 1.343 0.263 0 C-N-CA 122.998 2.465 . . . . 0.63 113.539 -173.053 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 566' ' ' ILE . . . . . . . . . . . . . 51.9 mt -72.01 -55.62 12.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 121.005 0.431 . . . . 0.93999999999999995 111.577 -175.537 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 567' ' ' CYS . . . . . . . . . . . . . 26.7 p -107.47 2.3 24.11 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 112.262 0.467 . . . . 0.69999999999999996 112.262 -174.186 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 568' ' ' LYS . . . . . . . . . . . . . 44.8 mmtm 67.34 28.7 7.81 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 115.921 -0.581 . . . . 2.71 112.186 171.117 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 569' ' ' GLU . . . . . 0.515 ' HG2' ' HB3' ' A' ' 564' ' ' CYS . 17.4 pt-20 -99.5 135.51 40.8 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.705 -0.398 . . . . 3.3399999999999999 110.35 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 570' ' ' THR . . . . . . . . . . . . . 88.5 m -80.66 119.1 22.85 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.649 -0.5 . . . . 1.01 109.649 174.154 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 571' ' ' VAL . . . . . 0.493 ' O ' ' HA ' ' A' ' 561' ' ' ALA . 11.7 t -92.27 116.72 34.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 116.179 -0.464 . . . . 0.72999999999999998 111.039 -174.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 27.8 p -107.67 159.07 16.75 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 116.1 -0.5 . . . . 1.8899999999999999 109.889 176.703 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . -130.79 155.78 21.37 Favored Glycine 0 N--CA 1.442 -0.939 0 C-N-CA 119.868 -1.158 . . . . 2.2000000000000002 111.835 179.496 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 574' ' ' VAL . . . . . . . . . . . . . 23.9 t -114.09 149.96 16.26 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 N-CA-C 109.761 -0.459 . . . . 3.2400000000000002 109.761 -175.148 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 575' ' ' TYR . . . . . 0.406 ' HA ' ' HA ' ' A' ' 582' ' ' TRP . 54.1 t80 -82.02 119.18 23.67 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 108.717 -0.846 . . . . 3.02 108.717 174.335 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 576' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -90.57 106.36 18.45 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 109.12 -0.696 . . . . 3.3399999999999999 109.12 -178.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 577' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -69.36 -21.8 63.78 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.956 -0.565 . . . . 5.5899999999999999 111.965 -176.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 578' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -67.6 -44.76 77.32 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.974 0.416 . . . . 5.1100000000000003 110.527 -177.69 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 579' ' ' SER . . . . . . . . . . . . . 70.1 p -96.29 -23.67 16.56 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.281 0.562 . . . . 3.2799999999999998 111.119 176.202 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 580' ' ' GLY . . . . . . . . . . . . . . . 81.81 31.48 32.48 Favored Glycine 0 CA--C 1.522 0.477 0 CA-C-N 115.497 -0.774 . . . . 2.6000000000000001 113.018 -178.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 581' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -138.15 152.52 48.77 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 116.855 0.327 . . . . 3.1899999999999999 110.675 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 582' ' ' TRP . . . . . 0.595 ' O ' ' HA ' ' A' ' 552' ' ' VAL . 80.5 m95 -76.8 136.69 38.97 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 109.639 -0.504 . . . . 2.2999999999999998 109.639 176.411 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 583' ' ' VAL . . . . . 0.591 HG12 ' CE1' ' A' ' 550' ' ' TYR . 19.1 m -116.0 131.55 68.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 N-CA-C 113.502 0.927 . . . . 1.1100000000000001 113.502 -173.118 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 584' ' ' TRP . . . . . 0.56 ' CD1' HG22 ' A' ' 553' ' ' VAL . 17.8 m0 -114.49 103.0 10.6 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 108.497 -0.927 . . . . 2.29 108.497 162.835 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 585' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.98 151.21 22.95 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.066 0.46 . . . . 3.9500000000000002 111.991 -173.426 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 586' ' ' ASN . . . . . . . . . . . . . 18.9 m-20 52.68 41.7 31.46 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 115.23 -0.896 . . . . 1.4299999999999999 110.192 -174.474 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 587' ' ' THR . . . . . . . . . . . . . 32.5 m -120.34 141.0 50.46 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.015 -0.539 . . . . 0.65000000000000002 110.789 -177.132 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 588' ' ' ILE . . . . . . . . . . . . . 11.7 tt -137.98 141.54 38.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 N-CA-C 109.671 -0.492 . . . . 0.70999999999999996 109.671 179.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 589' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -97.23 120.87 38.38 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.306 -0.628 . . . . 1.3500000000000001 109.306 177.812 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 590' ' ' VAL . . . . . . . . . . . . . 61.9 t -127.17 118.2 49.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.634 -0.712 . . . . 0.65000000000000002 110.549 179.653 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 591' ' ' ASN . . . . . . . . . . . . . 62.8 t30 58.62 38.91 25.11 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 115.459 -0.791 . . . . 2.0299999999999998 111.617 176.112 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . 86.08 5.49 83.12 Favored Glycine 0 N--CA 1.45 -0.421 0 CA-C-N 115.86 -0.609 . . . . 0.62 113.17 175.344 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 593' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -128.74 139.75 52.06 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.917 0.389 . . . . 2.7799999999999998 111.151 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 594' ' ' TYR . . . . . . . . . . . . . 85.1 m-85 -91.26 129.82 37.2 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.966 -0.561 . . . . 1.45 110.478 -179.218 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 595' ' ' PHE . . . . . . . . . . . . . 63.8 m-85 -135.0 162.9 31.13 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.896 -0.593 . . . . 1.3200000000000001 109.682 177.235 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 596' ' ' HIS . . . . . 0.499 ' HB2' ' SG ' ' A' ' 599' ' ' CYS . 30.5 m170 -70.68 129.36 38.93 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.68 -0.489 . . . . 0.58999999999999997 109.68 172.436 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 597' ' ' SER . . . . . . . . . . . . . 23.0 t -65.47 -30.47 71.25 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.783 -0.644 . . . . 1.1299999999999999 109.598 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 598' ' ' THR . . . . . . . . . . . . . 1.8 m -66.52 -42.42 87.32 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 115.464 -0.789 . . . . 1.3999999999999999 110.333 175.063 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 599' ' ' CYS . . . . . 0.499 ' SG ' ' HB2' ' A' ' 596' ' ' HIS . 78.6 m -73.83 -27.45 61.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.069 -0.969 . . . . 0.81000000000000005 111.906 -178.778 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 600' ' ' TYR . . . . . . . . . . . . . 79.7 t80 -56.0 -35.29 66.64 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.696 0.284 . . . . 1.8799999999999999 110.98 -174.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 601' ' ' HIS . . . . . . . . . . . . . 31.2 m170 -62.74 -28.13 69.75 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.006 0.432 . . . . 4.5199999999999996 111.01 178.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 602' ' ' GLU . . . . . 0.413 ' HB3' ' O ' ' A' ' 599' ' ' CYS . 8.7 tp10 -70.81 -38.37 73.3 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.018 -0.537 . . . . 3.8500000000000001 110.924 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 603' ' ' THR . . . . . . . . . . . . . 10.3 t . . . . . 0 C--N 1.327 -0.392 0 CA-C-O 121.203 0.525 . . . . 3.2999999999999998 110.599 -176.594 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 701' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.509 -0.321 0 CA-C-O 120.915 0.175 . . . . 3.2000000000000002 113.064 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 549' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -80.18 132.72 35.95 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.135 0.493 . . . . 5.9000000000000004 110.559 179.392 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 550' ' ' TYR . . . . . 0.471 ' HB3' ' HD2' ' A' ' 585' ' ' LYS . 39.0 p90 -111.18 160.56 16.82 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.58 -0.737 . . . . 2.79 109.29 174.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 551' ' ' VAL . . . . . . . . . . . . . 70.2 t -117.72 133.36 64.75 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 N-CA-C 108.708 -0.849 . . . . 1.52 108.708 178.137 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 552' ' ' VAL . . . . . 0.582 ' HA ' ' O ' ' A' ' 582' ' ' TRP . 74.4 t -64.86 131.67 30.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.994 -0.548 . . . . 1.3799999999999999 110.487 -178.291 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 553' ' ' VAL . . . . . 0.625 ' HB ' ' HB2' ' A' ' 582' ' ' TRP . 65.9 t -59.04 123.33 68.76 Favored Pre-proline 0 C--O 1.235 0.319 0 CA-C-N 116.073 -0.512 . . . . 1.3799999999999999 110.08 178.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 554' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_exo -56.18 136.58 75.96 Favored 'Trans proline' 0 CA--C 1.529 0.241 0 C-N-CA 122.967 2.445 . . . . 1.98 112.577 -177.275 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 555' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -90.23 143.76 26.47 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.817 -0.629 . . . . 4.1699999999999999 110.132 -176.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 28.6 p 47.6 36.3 5.26 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 123.428 0.691 . . . . 4.04 111.997 -176.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 557' ' ' SER . . . . . . . . . . . . . 15.5 t -102.99 49.62 0.83 Allowed 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 116.091 -0.504 . . . . 3.0299999999999998 110.04 -178.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 558' ' ' GLN . . . . . 0.905 ' HA ' HE21 ' A' ' 558' ' ' GLN . 0.0 OUTLIER 71.76 -63.5 0.42 Allowed 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 115.26 -0.882 . . . . 5.0599999999999996 111.616 -179.953 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 559' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -143.68 -168.03 2.73 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.393 -0.595 . . . . 3.23 109.393 -177.488 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 560' ' ' MET . . . . . . . . . . . . . 41.7 mtm -115.62 15.28 16.58 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.67 0.271 . . . . 2.6099999999999999 110.947 -173.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 561' ' ' ALA . . . . . . . . . . . . . . . -142.84 145.78 33.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.098 0.475 . . . . 0.94999999999999996 112.231 -173.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 27.0 p90 -136.17 164.7 27.44 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 107.4 -1.333 . . . . 0.90000000000000002 107.4 172.427 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 563' ' ' LYS . . . . . . . . . . . . . 35.5 ttmt -105.48 133.0 50.96 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 119.589 -0.844 . . . . 2.1800000000000002 111.157 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 564' ' ' CYS . . . . . 0.431 ' O ' ' HA ' ' A' ' 568' ' ' LYS . 34.6 t -71.97 114.1 26.08 Favored Pre-proline 0 C--O 1.222 -0.385 0 CA-C-N 115.085 -0.961 . . . . 0.40999999999999998 109.385 178.468 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 565' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -67.02 -30.79 38.45 Favored 'Trans proline' 0 CA--C 1.53 0.285 0 C-N-CA 122.588 2.192 . . . . 0.63 113.942 -172.613 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 566' ' ' ILE . . . . . . . . . . . . . 32.8 mt -71.61 -56.27 10.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.815 0.34 . . . . 0.93999999999999995 111.53 -172.47 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 567' ' ' CYS . . . . . 0.521 ' SG ' ' HG3' ' A' ' 569' ' ' GLU . 28.5 p -108.05 0.71 21.91 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.99 0.424 . . . . 0.69999999999999996 111.339 -177.604 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 568' ' ' LYS . . . . . 0.431 ' HA ' ' O ' ' A' ' 564' ' ' CYS . 52.7 mttp 67.57 30.56 6.6 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 113.145 0.795 . . . . 2.71 113.145 171.389 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 569' ' ' GLU . . . . . 0.521 ' HG3' ' SG ' ' A' ' 567' ' ' CYS . 35.7 mt-10 -77.96 133.44 38.03 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.78 -0.452 . . . . 3.3399999999999999 109.78 171.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 570' ' ' THR . . . . . . . . . . . . . 52.8 m -76.16 117.31 17.73 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 108.68 -0.859 . . . . 1.01 108.68 167.278 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 571' ' ' VAL . . . . . . . . . . . . . 23.5 t -94.77 116.93 37.32 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-N 116.59 -0.277 . . . . 0.72999999999999998 110.894 -172.708 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 24.1 p -111.89 159.59 18.21 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.748 -0.66 . . . . 1.8899999999999999 109.536 175.532 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . -130.82 155.1 21.05 Favored Glycine 0 N--CA 1.442 -0.938 0 C-N-CA 119.933 -1.127 . . . . 2.2000000000000002 111.799 -178.129 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 574' ' ' VAL . . . . . 0.465 ' O ' HG22 ' A' ' 583' ' ' VAL . 35.4 t -113.04 149.54 15.44 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 N-CA-C 109.614 -0.513 . . . . 3.2400000000000002 109.614 -176.081 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 575' ' ' TYR . . . . . 0.529 ' HA ' ' HA ' ' A' ' 582' ' ' TRP . 59.8 t80 -83.76 119.41 24.78 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.593 0.235 . . . . 3.02 110.43 177.071 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 576' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -92.01 105.67 17.86 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.199 0.523 . . . . 3.3399999999999999 110.024 175.236 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 577' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -63.87 -23.94 67.55 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.39 -0.823 . . . . 5.5899999999999999 111.153 -178.184 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 578' ' ' GLU . . . . . . . . . . . . . 13.4 tt0 -72.25 -46.58 55.37 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.911 -0.586 . . . . 5.1100000000000003 111.216 -174.422 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 579' ' ' SER . . . . . . . . . . . . . 75.7 p -87.54 -15.97 35.98 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.965 0.412 . . . . 3.2799999999999998 110.743 175.102 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 580' ' ' GLY . . . . . . . . . . . . . . . 80.04 15.24 79.32 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 121.07 -0.586 . . . . 2.6000000000000001 112.697 177.379 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 581' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -135.09 154.53 51.64 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.023 0.439 . . . . 3.1899999999999999 110.596 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 582' ' ' TRP . . . . . 0.625 ' HB2' ' HB ' ' A' ' 553' ' ' VAL . 77.3 m95 -71.88 148.2 46.35 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.913 -0.585 . . . . 2.2999999999999998 109.96 176.673 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 583' ' ' VAL . . . . . 0.465 HG22 ' O ' ' A' ' 574' ' ' VAL . 15.8 m -121.58 133.33 68.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 112.975 0.731 . . . . 1.1100000000000001 112.975 -174.881 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 584' ' ' TRP . . . . . 0.612 ' CD1' HG22 ' A' ' 553' ' ' VAL . 27.0 m0 -110.31 103.79 12.5 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 108.262 -1.014 . . . . 2.29 108.262 162.868 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 585' ' ' LYS . . . . . 0.471 ' HD2' ' HB3' ' A' ' 550' ' ' TYR . 14.4 mmmm -82.08 152.0 26.78 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.877 0.37 . . . . 3.9500000000000002 111.127 -175.312 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 586' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 54.76 41.9 31.57 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 115.424 -0.807 . . . . 1.4299999999999999 109.632 -176.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 587' ' ' THR . . . . . . . . . . . . . 49.3 m -120.91 140.52 51.71 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.19 0.519 . . . . 0.65000000000000002 110.628 -175.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 588' ' ' ILE . . . . . . . . . . . . . 15.1 tt -139.67 143.61 30.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.606 -0.725 . . . . 0.70999999999999996 109.924 -177.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 589' ' ' GLU . . . . . 0.413 ' HA ' ' O ' ' A' ' 593' ' ' LYS . 0.8 OUTLIER -96.22 119.56 34.92 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.351 -0.611 . . . . 1.3500000000000001 109.351 175.979 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 590' ' ' VAL . . . . . . . . . . . . . 27.3 t -128.36 120.75 53.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.253 -0.885 . . . . 0.65000000000000002 109.343 179.028 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 591' ' ' ASN . . . . . . . . . . . . . 16.9 m120 59.36 34.66 22.9 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 121.175 0.512 . . . . 2.0299999999999998 111.21 -179.004 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . 79.56 13.91 81.93 Favored Glycine 0 N--CA 1.445 -0.748 0 C-N-CA 120.981 -0.628 . . . . 0.62 112.15 177.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 593' ' ' LYS . . . . . 0.413 ' O ' ' HA ' ' A' ' 589' ' ' GLU . 46.7 mmtm -123.58 139.81 53.63 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.747 0.308 . . . . 2.7799999999999998 110.535 -176.849 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 594' ' ' TYR . . . . . . . . . . . . . 75.5 m-85 -90.62 122.51 33.47 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.304 -0.407 . . . . 1.45 110.466 179.089 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 595' ' ' PHE . . . . . . . . . . . . . 44.8 m-85 -133.15 163.87 28.3 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.771 -0.65 . . . . 1.3200000000000001 110.058 178.588 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 596' ' ' HIS . . . . . 0.412 ' HB3' HG22 ' A' ' 598' ' ' THR . 32.1 m170 -71.55 128.06 34.59 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.742 -0.836 . . . . 0.58999999999999997 108.742 170.093 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 597' ' ' SER . . . . . . . . . . . . . 8.6 m -64.15 -29.99 71.08 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.159 -0.473 . . . . 1.1299999999999999 110.277 -179.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 598' ' ' THR . . . . . 0.412 HG22 ' HB3' ' A' ' 596' ' ' HIS . 4.7 t -67.37 -38.91 85.51 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 115.376 -0.829 . . . . 1.3999999999999999 110.968 179.724 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 599' ' ' CYS . . . . . . . . . . . . . 77.3 m -77.35 -34.64 55.1 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.954 -0.566 . . . . 0.81000000000000005 112.495 -175.179 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 600' ' ' TYR . . . . . 0.416 ' O ' HG22 ' A' ' 603' ' ' THR . 85.0 t80 -56.75 -33.65 66.79 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 120.898 0.38 . . . . 1.8799999999999999 111.92 -170.091 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 601' ' ' HIS . . . . . . . . . . . . . 28.7 m170 -59.74 -27.21 66.3 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 112.427 0.529 . . . . 4.5199999999999996 112.427 -175.314 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 602' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -70.06 -31.08 68.51 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.734 0.302 . . . . 3.8500000000000001 110.794 -176.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 603' ' ' THR . . . . . 0.416 HG22 ' O ' ' A' ' 600' ' ' TYR . 3.2 t . . . . . 0 CA--C 1.533 0.302 0 C-N-CA 120.55 -0.46 . . . . 3.2999999999999998 111.66 -174.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 701' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.508 -0.351 0 N-CA-C 112.127 -0.389 . . . . 3.2000000000000002 112.127 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 549' ' ' LYS . . . . . 0.422 ' HA ' ' HD3' ' A' ' 549' ' ' LYS . 71.3 mmtt -71.91 132.55 44.51 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.003 0.43 . . . . 5.9000000000000004 110.871 -179.521 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 550' ' ' TYR . . . . . . . . . . . . . 21.2 p90 -125.66 159.63 31.73 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.232 -0.894 . . . . 2.79 109.286 177.588 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 551' ' ' VAL . . . . . . . . . . . . . 57.5 t -118.81 132.69 67.96 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 N-CA-C 109.073 -0.714 . . . . 1.52 109.073 177.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 552' ' ' VAL . . . . . 0.506 ' HA ' ' O ' ' A' ' 582' ' ' TRP . 67.9 t -65.19 127.04 25.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 109.642 -0.503 . . . . 1.3799999999999999 109.642 178.668 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 553' ' ' VAL . . . . . 0.666 HG22 ' CD1' ' A' ' 584' ' ' TRP . 61.8 t -59.92 120.99 55.11 Favored Pre-proline 0 C--N 1.329 -0.313 0 O-C-N 123.495 0.497 . . . . 1.3799999999999999 110.834 -176.238 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 554' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_exo -60.93 135.91 62.38 Favored 'Trans proline' 0 N--CA 1.461 -0.406 0 C-N-CA 122.785 2.323 . . . . 1.98 111.764 178.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 555' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -82.06 -0.78 46.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.234 0.54 . . . . 4.1699999999999999 110.858 -179.245 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 24.4 p -80.46 -27.81 37.79 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.773 -0.649 . . . . 4.04 110.278 174.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 557' ' ' SER . . . . . . . . . . . . . 44.5 t -81.05 109.03 15.22 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 115.478 -0.783 . . . . 3.0299999999999998 109.795 177.557 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 558' ' ' GLN . . . . . . . . . . . . . 24.3 mt-30 -75.81 -1.44 25.17 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.052 0.453 . . . . 5.0599999999999996 110.629 179.488 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 559' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -101.73 -18.61 15.74 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.612 -0.722 . . . . 3.23 110.679 176.331 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 560' ' ' MET . . . . . . . . . . . . . 2.0 mpt? 60.58 22.38 12.16 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 115.496 -0.775 . . . . 2.6099999999999999 109.935 -173.396 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 561' ' ' ALA . . . . . . . . . . . . . . . -145.36 161.95 38.41 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.394 -0.821 . . . . 0.94999999999999996 111.722 -171.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 31.0 p90 -142.82 155.03 44.73 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 107.781 -1.192 . . . . 0.90000000000000002 107.781 170.117 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 563' ' ' LYS . . . . . 0.411 ' HA ' ' HA ' ' A' ' 570' ' ' THR . 78.7 tttt -99.15 120.83 40.15 Favored 'General case' 0 C--N 1.32 -0.715 0 C-N-CA 120.193 -0.603 . . . . 2.1800000000000002 110.536 -176.254 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 564' ' ' CYS . . . . . . . . . . . . . 42.8 t -64.7 117.29 36.8 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 115.412 -0.813 . . . . 0.40999999999999998 111.944 -174.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 565' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_exo -68.72 -22.01 37.93 Favored 'Trans proline' 0 CA--C 1.531 0.358 0 C-N-CA 123.128 2.552 . . . . 0.63 113.085 -179.621 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 566' ' ' ILE . . . . . 0.534 HG21 ' HB3' ' A' ' 599' ' ' CYS . 36.0 mm -74.47 -42.25 49.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 120.714 0.293 . . . . 0.93999999999999995 111.569 -177.041 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 567' ' ' CYS . . . . . . . . . . . . . 28.8 p -123.56 0.9 8.86 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 111.923 0.342 . . . . 0.69999999999999996 111.923 -174.172 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 568' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? 62.13 27.95 16.83 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.84 -0.618 . . . . 2.71 112.008 176.425 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 569' ' ' GLU . . . . . 0.42 ' HA ' ' OE1' ' A' ' 569' ' ' GLU . 6.3 mm-40 -107.37 137.4 45.49 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 116.298 -0.41 . . . . 3.3399999999999999 110.463 177.637 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 570' ' ' THR . . . . . 0.411 ' HA ' ' HA ' ' A' ' 563' ' ' LYS . 37.4 m -69.24 123.91 22.41 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.76 -0.655 . . . . 1.01 110.396 -179.257 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 571' ' ' VAL . . . . . 0.444 HG22 ' CE1' ' A' ' 596' ' ' HIS . 18.0 t -96.62 115.41 35.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 116.376 -0.374 . . . . 0.72999999999999998 110.087 -179.827 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 23.6 p -106.72 159.22 16.38 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 116.053 -0.521 . . . . 1.8899999999999999 110.325 178.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . -130.35 155.73 21.23 Favored Glycine 0 N--CA 1.44 -1.084 0 C-N-CA 119.921 -1.133 . . . . 2.2000000000000002 111.384 -178.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 574' ' ' VAL . . . . . 0.466 ' O ' HG22 ' A' ' 583' ' ' VAL . 41.2 t -111.85 147.2 15.88 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 N-CA-C 109.644 -0.502 . . . . 3.2400000000000002 109.644 -172.503 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 575' ' ' TYR . . . . . 0.492 ' HA ' ' HA ' ' A' ' 582' ' ' TRP . 48.8 t80 -82.33 121.49 26.76 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.507 -0.553 . . . . 3.02 109.507 174.668 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 576' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -89.59 108.54 19.73 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.046 -0.724 . . . . 3.3399999999999999 109.046 179.45 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 577' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -69.68 -23.03 63.39 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.417 -0.81 . . . . 5.5899999999999999 111.816 -172.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 578' ' ' GLU . . . . . . . . . . . . . 45.4 tt0 -74.87 -48.35 25.38 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 121.044 -0.262 . . . . 5.1100000000000003 110.858 -178.156 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 579' ' ' SER . . . . . . . . . . . . . 74.0 p -85.64 -19.16 31.38 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.019 0.438 . . . . 3.2799999999999998 111.187 179.32 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 580' ' ' GLY . . . . . . . . . . . . . . . 79.13 22.36 65.72 Favored Glycine 0 N--CA 1.448 -0.535 0 CA-C-N 115.926 -0.579 . . . . 2.6000000000000001 112.818 178.554 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 581' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -135.17 152.34 51.5 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.876 0.37 . . . . 3.1899999999999999 110.8 -178.394 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 582' ' ' TRP . . . . . 0.506 ' O ' ' HA ' ' A' ' 552' ' ' VAL . 74.5 m95 -78.8 144.78 34.76 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.742 -0.663 . . . . 2.2999999999999998 110.013 177.778 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 583' ' ' VAL . . . . . 0.466 HG22 ' O ' ' A' ' 574' ' ' VAL . 26.7 m -124.14 134.3 66.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 N-CA-C 112.719 0.637 . . . . 1.1100000000000001 112.719 -175.001 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 584' ' ' TRP . . . . . 0.666 ' CD1' HG22 ' A' ' 553' ' ' VAL . 27.8 m0 -109.5 101.98 10.88 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 108.799 -0.815 . . . . 2.29 108.799 162.761 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 585' ' ' LYS . . . . . 0.403 ' HD3' ' OD1' ' A' ' 586' ' ' ASN . 0.0 OUTLIER -89.62 152.68 21.26 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.644 -0.253 . . . . 3.9500000000000002 110.904 -177.217 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 586' ' ' ASN . . . . . 0.403 ' OD1' ' HD3' ' A' ' 585' ' ' LYS . 10.4 m120 55.34 46.22 23.9 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 109.385 -0.598 . . . . 1.4299999999999999 109.385 -170.615 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 587' ' ' THR . . . . . . . . . . . . . 28.6 m -135.69 140.68 44.63 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.012 -0.54 . . . . 0.65000000000000002 110.593 -177.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 588' ' ' ILE . . . . . . . . . . . . . 15.0 tt -141.9 146.49 22.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.305 -0.407 . . . . 0.70999999999999996 110.404 -179.423 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 589' ' ' GLU . . . . . 0.409 ' HB2' ' CE2' ' A' ' 594' ' ' TYR . 33.4 tt0 -94.54 119.84 33.84 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.829 -0.434 . . . . 1.3500000000000001 109.829 174.722 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 590' ' ' VAL . . . . . . . . . . . . . 61.3 t -125.49 121.57 60.58 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 N-CA-C 109.491 -0.559 . . . . 0.65000000000000002 109.491 178.392 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 591' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 58.2 33.71 23.42 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.083 -0.508 . . . . 2.0299999999999998 111.425 -179.231 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . 84.67 -1.58 88.74 Favored Glycine 0 N--CA 1.45 -0.378 0 CA-C-N 115.797 -0.638 . . . . 0.62 113.114 177.511 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 593' ' ' LYS . . . . . . . . . . . . . 70.5 mmtt -114.49 146.22 40.95 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.782 0.325 . . . . 2.7799999999999998 111.254 -179.145 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 594' ' ' TYR . . . . . 0.409 ' CE2' ' HB2' ' A' ' 589' ' ' GLU . 80.4 m-85 -98.16 127.45 44.11 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.207 -0.451 . . . . 1.45 111.46 -176.198 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 595' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -135.13 162.53 32.24 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.531 -0.759 . . . . 1.3200000000000001 109.704 177.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 596' ' ' HIS . . . . . 0.444 ' CE1' HG22 ' A' ' 571' ' ' VAL . 10.3 m170 -61.29 128.79 38.07 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.42 -0.585 . . . . 0.58999999999999997 109.42 171.403 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 597' ' ' SER . . . . . . . . . . . . . 47.7 t -64.55 -29.57 70.6 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.244 -0.65 . . . . 1.1299999999999999 109.244 176.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 598' ' ' THR . . . . . . . . . . . . . 5.2 m -67.98 -45.98 72.63 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-O 121.64 0.734 . . . . 1.3999999999999999 110.233 175.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 599' ' ' CYS . . . . . 0.534 ' HB3' HG21 ' A' ' 566' ' ' ILE . 74.6 m -74.67 -30.67 61.67 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.376 -0.829 . . . . 0.81000000000000005 112.566 -174.618 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 600' ' ' TYR . . . . . 0.447 ' O ' HG22 ' A' ' 603' ' ' THR . 85.0 t80 -57.47 -36.08 71.0 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.045 0.45 . . . . 1.8799999999999999 110.762 -174.644 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 601' ' ' HIS . . . . . . . . . . . . . 41.2 m170 -66.59 -28.47 68.53 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.213 -0.449 . . . . 4.5199999999999996 111.546 179.447 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 602' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -63.56 -32.75 74.31 Favored 'General case' 0 CA--C 1.52 -0.192 0 CA-C-O 120.686 0.279 . . . . 3.8500000000000001 110.315 -175.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 603' ' ' THR . . . . . 0.447 HG22 ' O ' ' A' ' 600' ' ' TYR . 13.0 t . . . . . 0 N--CA 1.45 -0.473 0 CA-C-O 121.065 0.459 . . . . 3.2999999999999998 110.713 -178.028 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 701' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.326 0 N-CA-C 112.546 -0.222 . . . . 3.2000000000000002 112.546 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 549' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -67.46 149.51 50.12 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.368 0.604 . . . . 5.9000000000000004 110.67 177.04 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 550' ' ' TYR . . . . . 0.599 ' HB3' ' HD3' ' A' ' 585' ' ' LYS . 9.5 p90 -124.29 160.29 28.35 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.331 -0.849 . . . . 2.79 110.947 -173.403 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 551' ' ' VAL . . . . . . . . . . . . . 96.9 t -118.95 133.19 66.61 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 N-CA-C 108.704 -0.85 . . . . 1.52 108.704 172.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 552' ' ' VAL . . . . . 0.544 ' HA ' ' O ' ' A' ' 582' ' ' TRP . 47.4 t -65.34 131.74 31.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 116.238 -0.437 . . . . 1.3799999999999999 110.112 -178.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 553' ' ' VAL . . . . . 0.683 HG22 ' CD1' ' A' ' 584' ' ' TRP . 26.3 t -63.56 120.99 67.62 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.249 -0.432 . . . . 1.3799999999999999 109.967 -179.677 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 554' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 553' ' ' VAL . 44.5 Cg_exo -57.03 135.88 73.4 Favored 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.959 2.44 . . . . 1.98 113.025 -177.323 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 555' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -104.52 -4.77 22.24 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.416 0.627 . . . . 4.1699999999999999 110.059 175.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 24.2 p -86.05 -4.59 59.2 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.356 -0.838 . . . . 4.04 110.116 175.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 557' ' ' SER . . . . . . . . . . . . . 39.5 m -100.62 138.35 37.8 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 115.193 -0.912 . . . . 3.0299999999999998 110.157 -179.497 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 558' ' ' GLN . . . . . . . . . . . . . 61.7 mt-30 -73.73 -35.24 65.04 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.618 -0.719 . . . . 5.0599999999999996 109.549 178.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 559' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -107.3 109.67 21.5 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.188 -0.915 . . . . 3.23 109.402 172.024 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 560' ' ' MET . . . . . . . . . . . . . 81.5 mtp -80.45 39.7 0.47 Allowed 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 121.168 0.509 . . . . 2.6099999999999999 110.682 -176.295 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 561' ' ' ALA . . . . . . . . . . . . . . . -145.82 162.2 38.23 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.897 -0.592 . . . . 0.94999999999999996 109.89 -177.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 35.1 p90 -138.5 145.97 41.42 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 120.437 -0.505 . . . . 0.90000000000000002 110.022 173.172 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 563' ' ' LYS . . . . . . . . . . . . . 50.2 tptt -88.62 111.18 21.61 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 116.134 -0.484 . . . . 2.1800000000000002 110.06 -178.575 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 564' ' ' CYS . . . . . 0.411 ' HA ' ' HD3' ' A' ' 565' ' ' PRO . 42.4 t -68.72 112.09 10.25 Favored Pre-proline 0 C--N 1.333 -0.145 0 N-CA-C 109.183 -0.673 . . . . 0.40999999999999998 109.183 179.266 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 565' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 564' ' ' CYS . 15.4 Cg_exo -71.57 -17.77 29.69 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 123.042 2.494 . . . . 0.63 111.751 -175.293 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 566' ' ' ILE . . . . . 0.406 HD12 ' HB3' ' A' ' 599' ' ' CYS . 45.6 mt -80.16 -51.9 15.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.233 -0.894 . . . . 0.93999999999999995 111.044 -175.687 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 567' ' ' CYS . . . . . . . . . . . . . 28.9 p -105.12 -1.7 25.21 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.363 -0.381 . . . . 0.69999999999999996 111.237 -176.572 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 568' ' ' LYS . . . . . . . . . . . . . 35.6 mtmm 65.41 22.54 11.95 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 112.646 0.61 . . . . 2.71 112.646 174.48 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 569' ' ' GLU . . . . . . . . . . . . . 15.9 mm-40 -105.81 135.26 47.56 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.654 0.264 . . . . 3.3399999999999999 110.479 177.064 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 570' ' ' THR . . . . . . . . . . . . . 49.2 m -75.54 126.08 30.29 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.508 -0.552 . . . . 1.01 109.508 177.059 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 571' ' ' VAL . . . . . . . . . . . . . 16.2 t -100.42 115.26 41.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 116.511 -0.313 . . . . 0.72999999999999998 110.888 -175.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 24.6 p -105.3 161.83 13.96 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.022 -0.733 . . . . 1.8899999999999999 109.022 174.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . -127.6 154.0 19.46 Favored Glycine 0 N--CA 1.436 -1.305 0 C-N-CA 119.134 -1.508 . . . . 2.2000000000000002 111.68 -179.012 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 574' ' ' VAL . . . . . . . . . . . . . 44.5 t -111.32 145.14 17.94 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 CA-C-O 120.898 0.38 . . . . 3.2400000000000002 110.059 -171.1 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 575' ' ' TYR . . . . . . . . . . . . . 38.7 t80 -76.93 118.44 19.52 Favored 'General case' 0 N--CA 1.439 -1.021 0 N-CA-C 108.956 -0.757 . . . . 3.02 108.956 174.177 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 576' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -89.72 96.95 10.92 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 108.469 -0.938 . . . . 3.3399999999999999 108.469 -177.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 577' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -63.66 -22.73 67.06 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.53 -0.759 . . . . 5.5899999999999999 111.907 -175.164 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 578' ' ' GLU . . . . . . . . . . . . . 19.0 mm-40 -66.14 -43.52 86.84 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.182 -0.463 . . . . 5.1100000000000003 110.547 -179.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 579' ' ' SER . . . . . 0.411 ' OG ' ' HG2' ' A' ' 581' ' ' GLU . 68.3 p -100.46 -19.72 16.1 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.045 -0.525 . . . . 3.2799999999999998 111.696 -179.599 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 580' ' ' GLY . . . . . . . . . . . . . . . 80.66 30.49 39.62 Favored Glycine 0 CA--C 1.524 0.6 0 CA-C-N 115.85 -0.614 . . . . 2.6000000000000001 113.264 179.28 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 581' ' ' GLU . . . . . 0.411 ' HG2' ' OG ' ' A' ' 579' ' ' SER . 17.3 pt-20 -139.07 156.44 47.17 Favored 'General case' 0 C--N 1.326 -0.442 0 O-C-N 122.304 -0.527 . . . . 3.1899999999999999 110.682 179.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 582' ' ' TRP . . . . . 0.591 ' HB3' ' HB ' ' A' ' 553' ' ' VAL . 90.2 m95 -82.04 134.26 35.34 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.512 -0.551 . . . . 2.2999999999999998 109.512 176.241 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 583' ' ' VAL . . . . . . . . . . . . . 33.5 m -123.0 134.03 67.33 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 N-CA-C 113.793 1.034 . . . . 1.1100000000000001 113.793 -173.666 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 584' ' ' TRP . . . . . 0.683 ' CD1' HG22 ' A' ' 553' ' ' VAL . 33.5 m0 -113.85 103.76 11.51 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 107.893 -1.151 . . . . 2.29 107.893 161.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 585' ' ' LYS . . . . . 0.599 ' HD3' ' HB3' ' A' ' 550' ' ' TYR . 35.3 mmtp -81.56 142.67 32.62 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.777 -0.369 . . . . 3.9500000000000002 110.768 -175.84 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 586' ' ' ASN . . . . . . . . . . . . . 22.1 m-20 55.23 50.0 16.02 Favored 'General case' 0 CA--C 1.516 -0.335 0 CA-C-N 115.38 -0.827 . . . . 1.4299999999999999 109.889 -178.292 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 587' ' ' THR . . . . . . . . . . . . . 41.1 m -125.03 141.41 52.14 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.907 -0.588 . . . . 0.65000000000000002 109.965 -179.417 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 588' ' ' ILE . . . . . . . . . . . . . 12.9 tt -140.57 144.21 27.71 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 N-CA-C 109.841 -0.429 . . . . 0.70999999999999996 109.841 -178.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 589' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -96.78 119.13 34.69 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 108.68 -0.859 . . . . 1.3500000000000001 108.68 176.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 590' ' ' VAL . . . . . . . . . . . . . 56.3 t -125.1 118.83 54.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.997 -0.547 . . . . 0.65000000000000002 109.989 -178.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 591' ' ' ASN . . . . . . . . . . . . . 12.3 m120 58.1 36.57 26.05 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.932 -0.577 . . . . 2.0299999999999998 112.334 176.326 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . 86.57 6.65 80.18 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 121.194 -0.527 . . . . 0.62 113.682 175.573 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 593' ' ' LYS . . . . . . . . . . . . . 27.8 mtpp -129.1 146.39 51.06 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 117.204 0.502 . . . . 2.7799999999999998 110.933 176.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 594' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -91.16 133.97 34.92 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.895 -0.593 . . . . 1.45 110.836 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 595' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -139.12 160.46 39.73 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.829 -0.623 . . . . 1.3200000000000001 109.716 176.362 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 596' ' ' HIS . . . . . 0.75 ' HB2' ' SG ' ' A' ' 599' ' ' CYS . 37.7 m80 -67.16 130.5 43.32 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.314 -0.995 . . . . 0.58999999999999997 108.314 169.229 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 597' ' ' SER . . . . . . . . . . . . . 11.4 m -60.75 -31.88 71.19 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.283 -0.417 . . . . 1.1299999999999999 110.252 179.471 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 598' ' ' THR . . . . . . . . . . . . . 3.6 t -69.22 -35.23 75.97 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.397 0.618 . . . . 1.3999999999999999 110.33 174.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 599' ' ' CYS . . . . . 0.75 ' SG ' ' HB2' ' A' ' 596' ' ' HIS . 91.2 m -73.98 -29.58 62.05 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.819 -0.628 . . . . 0.81000000000000005 112.595 -176.162 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 600' ' ' TYR . . . . . . . . . . . . . 43.9 t80 -57.26 -35.0 69.2 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.125 -0.695 . . . . 1.8799999999999999 109.125 -178.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 601' ' ' HIS . . . . . . . . . . . . . 45.4 m-70 -74.7 -41.16 60.71 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.638 -0.71 . . . . 4.5199999999999996 111.814 176.15 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 602' ' ' GLU . . . . . 0.699 ' HG2' ' HA ' ' A' ' 599' ' ' CYS . 22.5 pt-20 -67.81 -25.72 65.71 Favored 'General case' 0 N--CA 1.467 0.411 0 O-C-N 122.094 -0.379 . . . . 3.8500000000000001 110.87 -176.65 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 603' ' ' THR . . . . . . . . . . . . . 14.1 t . . . . . 0 CA--C 1.533 0.309 0 N-CA-C 111.994 0.368 . . . . 3.2999999999999998 111.994 -179.639 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 701' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.452 0 N-CA-C 111.141 -0.784 . . . . 3.2000000000000002 111.141 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 549' ' ' LYS . . . . . 0.433 ' HA ' ' HD3' ' A' ' 549' ' ' LYS . 37.1 mmtm -73.18 147.39 44.81 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-O 121.673 0.749 . . . . 5.9000000000000004 111.061 179.82 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 550' ' ' TYR . . . . . 0.49 ' CE1' HG12 ' A' ' 583' ' ' VAL . 29.2 p90 -124.76 162.18 24.81 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 114.764 -1.107 . . . . 2.79 109.703 -175.73 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 551' ' ' VAL . . . . . 0.432 HG11 ' HE1' ' A' ' 594' ' ' TYR . 96.3 t -117.39 133.61 63.62 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 N-CA-C 109.016 -0.735 . . . . 1.52 109.016 175.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 552' ' ' VAL . . . . . 0.503 ' HA ' ' O ' ' A' ' 582' ' ' TRP . 56.9 t -62.99 132.15 28.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.928 -0.578 . . . . 1.3799999999999999 109.802 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 553' ' ' VAL . . . . . 0.604 HG22 ' CD1' ' A' ' 584' ' ' TRP . 65.8 t -60.79 120.67 55.35 Favored Pre-proline 0 C--N 1.33 -0.247 0 O-C-N 123.74 0.65 . . . . 1.3799999999999999 111.505 -175.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 554' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo -70.15 138.16 35.94 Favored 'Trans proline' 0 N--CA 1.462 -0.331 0 C-N-CA 123.194 2.596 . . . . 1.98 111.939 176.169 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 555' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -72.81 -35.8 67.4 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.439 0.638 . . . . 4.1699999999999999 110.283 179.298 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 23.1 p -94.81 85.07 4.32 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.537 -0.756 . . . . 4.04 111.565 -175.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 557' ' ' SER . . . . . . . . . . . . . 32.5 t -157.99 -100.76 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.613 -0.514 . . . . 3.0299999999999998 109.613 176.204 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 558' ' ' GLN . . . . . . . . . . . . . 80.2 mt-30 -126.16 -136.76 0.26 Allowed 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.476 -0.564 . . . . 5.0599999999999996 109.476 173.6 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 559' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -76.66 47.92 0.53 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.685 0.278 . . . . 3.23 110.408 178.291 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 560' ' ' MET . . . . . 0.512 ' HB3' HG11 ' A' ' 553' ' ' VAL . 65.3 mtt 58.11 29.6 18.09 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-O 121.553 0.692 . . . . 2.6099999999999999 110.119 -172.514 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 561' ' ' ALA . . . . . . . . . . . . . . . -144.98 161.73 38.65 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 115.279 -0.873 . . . . 0.94999999999999996 110.902 -175.214 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 33.8 p90 -150.06 163.7 37.47 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 107.796 -1.187 . . . . 0.90000000000000002 107.796 173.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 563' ' ' LYS . . . . . . . . . . . . . 7.7 ttmm -106.63 126.33 52.14 Favored 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 119.44 -0.904 . . . . 2.1800000000000002 109.935 179.12 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 564' ' ' CYS . . . . . 0.414 ' HA ' ' HD3' ' A' ' 565' ' ' PRO . 48.6 t -69.3 112.06 10.62 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 115.523 -0.762 . . . . 0.40999999999999998 109.601 -178.5 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 565' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 564' ' ' CYS . 17.2 Cg_exo -70.67 -29.9 18.87 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 123.318 2.678 . . . . 0.63 113.686 -173.525 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 566' ' ' ILE . . . . . . . . . . . . . 26.8 mt -70.74 -34.84 58.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.308 -0.405 . . . . 0.93999999999999995 111.184 -172.497 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 567' ' ' CYS . . . . . 0.447 ' SG ' ' HG3' ' A' ' 569' ' ' GLU . 28.7 p -129.07 3.61 5.27 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 112.855 0.687 . . . . 0.69999999999999996 112.855 -175.257 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 568' ' ' LYS . . . . . . . . . . . . . 61.9 mmtt 71.21 30.21 2.68 Favored 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 113.028 0.751 . . . . 2.71 113.028 175.45 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 569' ' ' GLU . . . . . 0.447 ' HG3' ' SG ' ' A' ' 567' ' ' CYS . 45.2 mt-10 -90.11 131.71 35.82 Favored 'General case' 0 N--CA 1.468 0.448 0 O-C-N 121.953 -0.467 . . . . 3.3399999999999999 110.662 176.794 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 570' ' ' THR . . . . . . . . . . . . . 47.2 m -75.7 117.85 17.9 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 108.917 -0.772 . . . . 1.01 108.917 164.558 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 571' ' ' VAL . . . . . 0.401 HG22 ' CE1' ' A' ' 596' ' ' HIS . 20.2 t -100.66 116.49 44.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 120.808 0.337 . . . . 0.72999999999999998 111.344 -172.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 33.4 p -110.41 160.01 16.97 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.908 -0.587 . . . . 1.8899999999999999 109.914 176.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . -129.8 155.03 20.74 Favored Glycine 0 N--CA 1.442 -0.929 0 C-N-CA 119.761 -1.209 . . . . 2.2000000000000002 111.875 -178.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 574' ' ' VAL . . . . . 0.488 ' O ' HG22 ' A' ' 583' ' ' VAL . 27.6 t -120.39 148.82 23.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-O 120.757 0.313 . . . . 3.2400000000000002 110.234 -172.549 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 575' ' ' TYR . . . . . . . . . . . . . 66.2 t80 -83.69 119.14 24.41 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.5 -0.318 . . . . 3.02 110.261 177.079 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 576' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -94.99 114.23 26.02 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.772 -0.455 . . . . 3.3399999999999999 109.772 178.133 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 577' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -69.21 -23.41 63.89 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.122 -0.49 . . . . 5.5899999999999999 112.231 -174.347 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 578' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -74.7 -41.41 60.26 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.002 0.43 . . . . 5.1100000000000003 110.773 -177.276 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 579' ' ' SER . . . . . . . . . . . . . 67.7 p -86.31 -25.58 25.37 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.228 -0.442 . . . . 3.2799999999999998 110.938 176.46 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 580' ' ' GLY . . . . . . . . . . . . . . . 80.28 15.98 77.29 Favored Glycine 0 N--CA 1.451 -0.348 0 CA-C-N 115.865 -0.607 . . . . 2.6000000000000001 112.584 179.006 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 581' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 -130.74 161.12 32.39 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.863 0.363 . . . . 3.1899999999999999 110.386 -178.492 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 582' ' ' TRP . . . . . 0.503 ' O ' ' HA ' ' A' ' 552' ' ' VAL . 76.1 m95 -83.04 134.42 35.03 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.38 -0.6 . . . . 2.2999999999999998 109.38 175.108 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 583' ' ' VAL . . . . . 0.49 HG12 ' CE1' ' A' ' 550' ' ' TYR . 16.9 m -113.17 133.63 58.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 N-CA-C 113.487 0.921 . . . . 1.1100000000000001 113.487 -171.753 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 584' ' ' TRP . . . . . 0.604 ' CD1' HG22 ' A' ' 553' ' ' VAL . 29.0 m0 -108.44 101.35 10.54 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.114 -1.069 . . . . 2.29 108.114 161.154 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 585' ' ' LYS . . . . . 0.5 ' HD2' ' H ' ' A' ' 585' ' ' LYS . 0.0 OUTLIER -76.4 145.66 39.23 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.415 -0.357 . . . . 3.9500000000000002 111.211 -174.281 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 586' ' ' ASN . . . . . . . . . . . . . 32.3 m-20 48.85 50.3 17.78 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 115.668 -0.696 . . . . 1.4299999999999999 110.37 -179.692 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 587' ' ' THR . . . . . . . . . . . . . 45.5 m -127.1 142.72 51.45 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.674 -0.694 . . . . 0.65000000000000002 109.948 -178.436 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 588' ' ' ILE . . . . . . . . . . . . . 13.3 tt -139.35 147.77 24.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 109.476 -0.564 . . . . 0.70999999999999996 109.476 179.601 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 589' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -103.1 121.86 43.48 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.124 0.487 . . . . 1.3500000000000001 109.799 178.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 590' ' ' VAL . . . . . . . . . . . . . 64.8 t -134.54 130.91 53.97 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.621 0 CA-C-N 115.537 -0.756 . . . . 0.65000000000000002 109.144 178.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 591' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 59.19 33.24 22.63 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 121.391 0.615 . . . . 2.0299999999999998 110.77 178.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . 77.22 11.92 85.08 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.937 -0.649 . . . . 0.62 112.487 178.332 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 593' ' ' LYS . . . . . . . . . . . . . 34.1 mmtp -126.42 139.68 53.07 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.777 0.322 . . . . 2.7799999999999998 110.533 -178.057 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 594' ' ' TYR . . . . . 0.432 ' HE1' HG11 ' A' ' 551' ' ' VAL . 95.0 m-85 -89.85 132.06 35.46 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 116.067 -0.515 . . . . 1.45 110.273 177.695 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 595' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -134.94 154.63 51.63 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 108.914 -0.773 . . . . 1.3200000000000001 108.914 175.405 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 596' ' ' HIS . . . . . 0.401 ' CE1' HG22 ' A' ' 571' ' ' VAL . 26.9 m170 -62.34 128.13 34.6 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 108.446 -0.946 . . . . 0.58999999999999997 108.446 169.733 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 597' ' ' SER . . . . . . . . . . . . . 31.0 t -63.3 -29.96 71.18 Favored 'General case' 0 C--N 1.322 -0.592 0 O-C-N 123.701 0.626 . . . . 1.1299999999999999 109.852 -177.274 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 598' ' ' THR . . . . . . . . . . . . . 1.8 t -67.09 -41.54 86.16 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 115.715 -0.675 . . . . 1.3999999999999999 110.776 175.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 599' ' ' CYS . . . . . 0.41 ' O ' ' HG3' ' A' ' 602' ' ' GLU . 74.2 m -75.82 -31.88 59.57 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.892 -0.595 . . . . 0.81000000000000005 111.574 -177.611 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 600' ' ' TYR . . . . . . . . . . . . . 72.4 t80 -57.03 -33.1 66.86 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.038 -0.528 . . . . 1.8799999999999999 112.067 -173.566 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 601' ' ' HIS . . . . . . . . . . . . . 33.7 m170 -58.46 -26.4 63.33 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 112.781 0.66 . . . . 4.5199999999999996 112.781 -173.276 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 602' ' ' GLU . . . . . 0.41 ' HG3' ' O ' ' A' ' 599' ' ' CYS . 3.0 pp20? -62.1 -30.54 71.08 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-O 120.949 0.404 . . . . 3.8500000000000001 110.849 -178.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 603' ' ' THR . . . . . . . . . . . . . 1.1 m . . . . . 0 CA--C 1.537 0.469 0 CA-C-O 120.981 0.42 . . . . 3.2999999999999998 111.161 -177.138 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 701' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.519 0.328 0 N-CA-C 113.676 0.231 . . . . 3.2000000000000002 113.676 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 549' ' ' LYS . . . . . . . . . . . . . 28.8 mtpp -81.1 142.24 33.5 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 117.247 0.524 . . . . 5.9000000000000004 110.931 177.393 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 550' ' ' TYR . . . . . 0.447 ' CE1' HG12 ' A' ' 583' ' ' VAL . 24.9 p90 -116.35 159.97 21.17 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.066 -0.716 . . . . 2.79 109.066 176.246 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 551' ' ' VAL . . . . . 0.753 HG11 ' HE1' ' A' ' 594' ' ' TYR . 39.9 t -119.97 136.58 56.59 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 N-CA-C 109.154 -0.684 . . . . 1.52 109.154 176.735 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 552' ' ' VAL . . . . . 0.557 ' HA ' ' O ' ' A' ' 582' ' ' TRP . 62.9 t -66.33 133.63 30.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 110.449 -0.204 . . . . 1.3799999999999999 110.449 -178.796 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 553' ' ' VAL . . . . . 0.635 HG22 ' CD1' ' A' ' 584' ' ' TRP . 80.7 t -61.99 120.99 62.54 Favored Pre-proline 0 C--N 1.331 -0.227 0 CA-C-N 116.228 -0.442 . . . . 1.3799999999999999 111.254 -177.386 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 554' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' ' 553' ' ' VAL . 7.1 Cg_exo -69.1 137.43 37.36 Favored 'Trans proline' 0 N--CA 1.46 -0.483 0 C-N-CA 122.871 2.381 . . . . 1.98 112.45 179.19 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 555' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -89.94 -1.61 58.01 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.285 0.564 . . . . 4.1699999999999999 109.883 176.106 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 23.2 p -81.88 40.5 0.61 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.728 0.775 . . . . 4.04 110.319 175.47 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 557' ' ' SER . . . . . . . . . . . . . 46.8 t -157.62 141.31 15.71 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-N 114.719 -1.128 . . . . 3.0299999999999998 108.109 -177.37 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 558' ' ' GLN . . . . . 0.918 ' HA ' HE21 ' A' ' 558' ' ' GLN . 0.0 OUTLIER -78.48 -26.32 46.01 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.976 0.417 . . . . 5.0599999999999996 110.284 -179.613 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 559' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -105.23 136.24 45.11 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.63 -0.714 . . . . 3.23 109.778 176.215 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 560' ' ' MET . . . . . . . . . . . . . 2.1 mpt? -83.8 18.45 1.98 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.239 0.543 . . . . 2.6099999999999999 110.311 178.352 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 561' ' ' ALA . . . . . . . . . . . . . . . -144.32 151.15 38.95 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 115.622 -0.717 . . . . 0.94999999999999996 110.036 -176.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 45.9 p90 -128.2 150.27 50.09 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 110.015 -0.365 . . . . 0.90000000000000002 110.015 177.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 563' ' ' LYS . . . . . 0.459 ' HE3' ' O ' ' A' ' 568' ' ' LYS . 47.5 tptt -89.6 113.81 25.3 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.001 -0.74 . . . . 2.1800000000000002 109.001 -178.513 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 564' ' ' CYS . . . . . . . . . . . . . 47.1 t -62.56 113.55 9.29 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 116.461 -0.336 . . . . 0.40999999999999998 110.902 -175.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 565' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -67.65 -27.95 38.03 Favored 'Trans proline' 0 CA--C 1.53 0.284 0 C-N-CA 123.074 2.516 . . . . 0.63 112.778 -176.026 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 566' ' ' ILE . . . . . . . . . . . . . 42.8 mt -71.73 -38.15 65.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 111.969 0.359 . . . . 0.93999999999999995 111.969 -174.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 567' ' ' CYS . . . . . . . . . . . . . 28.5 p -129.2 1.08 5.18 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.427 0.528 . . . . 0.69999999999999996 112.427 -174.729 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 568' ' ' LYS . . . . . 0.459 ' O ' ' HE3' ' A' ' 563' ' ' LYS . 50.3 mtpt 66.27 30.93 8.85 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 121.055 0.455 . . . . 2.71 111.753 176.105 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 569' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -105.67 135.23 47.46 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.003 -0.544 . . . . 3.3399999999999999 110.933 179.215 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 570' ' ' THR . . . . . . . . . . . . . 41.4 m -71.1 118.78 14.32 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.331 -0.395 . . . . 1.01 110.598 179.217 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 571' ' ' VAL . . . . . 0.665 HG22 ' CE1' ' A' ' 596' ' ' HIS . 16.9 t -97.25 116.22 39.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 120.722 0.296 . . . . 0.72999999999999998 110.635 -178.649 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 22.7 p -108.78 157.88 18.16 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.129 -0.487 . . . . 1.8899999999999999 110.599 179.381 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 573' ' ' GLY . . . . . 0.5 ' HA3' ' HD1' ' A' ' 584' ' ' TRP . . . -131.24 156.06 21.61 Favored Glycine 0 N--CA 1.44 -1.069 0 N-CA-C 111.061 -0.816 . . . . 2.2000000000000002 111.061 178.265 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 574' ' ' VAL . . . . . 0.581 ' O ' HG22 ' A' ' 583' ' ' VAL . 25.6 t -116.66 147.68 19.88 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 CA-C-O 120.8 0.334 . . . . 3.2400000000000002 110.111 -172.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 575' ' ' TYR . . . . . . . . . . . . . 59.5 t80 -78.28 120.51 23.15 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.684 -0.487 . . . . 3.02 109.684 175.268 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 576' ' ' ASP . . . . . . . . . . . . . 15.4 t0 -91.16 114.67 27.25 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.071 0.462 . . . . 3.3399999999999999 110.275 -179.333 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 577' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -66.98 -23.31 65.93 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.491 -0.777 . . . . 5.5899999999999999 111.144 -179.574 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 578' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -75.83 -48.51 21.27 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.444 -0.344 . . . . 5.1100000000000003 111.083 -174.192 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 579' ' ' SER . . . . . . . . . . . . . 75.4 p -87.37 -24.41 24.25 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.295 0.569 . . . . 3.2799999999999998 110.8 177.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 580' ' ' GLY . . . . . . . . . . . . . . . 80.26 23.04 61.73 Favored Glycine 0 N--CA 1.447 -0.626 0 CA-C-N 115.407 -0.815 . . . . 2.6000000000000001 111.86 -177.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 581' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -131.16 160.02 36.0 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.882 0.372 . . . . 3.1899999999999999 110.157 -179.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 582' ' ' TRP . . . . . 0.557 ' O ' ' HA ' ' A' ' 552' ' ' VAL . 76.5 m95 -82.09 135.43 35.31 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.846 -0.427 . . . . 2.2999999999999998 109.846 176.634 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 583' ' ' VAL . . . . . 0.581 HG22 ' O ' ' A' ' 574' ' ' VAL . 20.0 m -112.86 131.6 63.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 N-CA-C 112.775 0.657 . . . . 1.1100000000000001 112.775 -174.841 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 584' ' ' TRP . . . . . 0.635 ' CD1' HG22 ' A' ' 553' ' ' VAL . 15.9 m0 -105.01 102.99 12.46 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 108.943 -0.762 . . . . 2.29 108.943 164.074 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 585' ' ' LYS . . . . . 0.415 ' HD2' ' H ' ' A' ' 585' ' ' LYS . 0.0 OUTLIER -93.5 151.62 19.6 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.391 -0.822 . . . . 3.9500000000000002 111.43 -175.248 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 586' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 53.27 41.15 32.15 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 115.521 -0.763 . . . . 1.4299999999999999 109.026 -172.314 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 587' ' ' THR . . . . . . . . . . . . . 36.1 m -128.86 140.83 51.51 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.492 -0.776 . . . . 0.65000000000000002 110.203 -175.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 588' ' ' ILE . . . . . 0.57 ' HB ' ' HB3' ' A' ' 597' ' ' SER . 12.5 tt -131.52 144.37 37.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 N-CA-C 109.228 -0.656 . . . . 0.70999999999999996 109.228 178.047 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 589' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -106.57 120.06 40.94 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.254 0.55 . . . . 1.3500000000000001 109.847 178.724 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 590' ' ' VAL . . . . . . . . . . . . . 54.9 t -128.16 120.37 53.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.262 -0.881 . . . . 0.65000000000000002 109.995 -179.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 591' ' ' ASN . . . . . . . . . . . . . 2.3 t30 59.23 40.68 21.21 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 115.969 -0.56 . . . . 2.0299999999999998 111.1 177.217 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . 78.82 10.06 86.52 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.94 -0.647 . . . . 0.62 112.4 175.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 593' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -126.28 144.3 50.84 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-O 121.174 0.512 . . . . 2.7799999999999998 110.981 -178.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 594' ' ' TYR . . . . . 0.753 ' HE1' HG11 ' A' ' 551' ' ' VAL . 97.5 m-85 -101.29 135.13 43.27 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.784 -0.644 . . . . 1.45 110.725 -177.848 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 595' ' ' PHE . . . . . . . . . . . . . 59.9 m-85 -139.55 158.24 44.46 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 108.548 -0.908 . . . . 1.3200000000000001 108.548 177.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 596' ' ' HIS . . . . . 0.665 ' CE1' HG22 ' A' ' 571' ' ' VAL . 15.4 m170 -61.18 127.03 29.52 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.341 -0.985 . . . . 0.58999999999999997 108.341 168.661 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 597' ' ' SER . . . . . 0.57 ' HB3' ' HB ' ' A' ' 588' ' ' ILE . 8.7 p -66.37 -29.31 69.46 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.068 0.461 . . . . 1.1299999999999999 109.879 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 598' ' ' THR . . . . . . . . . . . . . 1.1 t -69.0 -32.48 72.07 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 115.273 -0.876 . . . . 1.3999999999999999 109.93 176.321 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 599' ' ' CYS . . . . . 0.462 ' SG ' ' HB2' ' A' ' 596' ' ' HIS . 84.9 m -78.82 -29.06 44.56 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 113.81 1.041 . . . . 0.81000000000000005 113.81 -179.323 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 600' ' ' TYR . . . . . 0.456 ' O ' HG22 ' A' ' 603' ' ' THR . 87.3 t80 -54.64 -35.98 64.06 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 113.678 0.992 . . . . 1.8799999999999999 113.678 -164.304 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 601' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -60.22 -25.15 65.41 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 112.267 0.469 . . . . 4.5199999999999996 112.267 -177.415 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 602' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -61.7 -38.19 86.94 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 120.981 0.419 . . . . 3.8500000000000001 111.357 179.188 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 603' ' ' THR . . . . . 0.456 HG22 ' O ' ' A' ' 600' ' ' TYR . 11.5 t . . . . . 0 C--O 1.236 0.352 0 CA-C-N 116.483 -0.326 . . . . 3.2999999999999998 111.344 -177.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 701' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.455 0 N-CA-C 111.754 -0.538 . . . . 3.2000000000000002 111.754 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 549' ' ' LYS . . . . . . . . . . . . . 9.1 mtmp? -68.91 149.78 48.49 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.896 -0.409 . . . . 5.9000000000000004 109.896 177.358 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 550' ' ' TYR . . . . . 0.503 ' CE1' HG12 ' A' ' 583' ' ' VAL . 38.0 p90 -114.75 160.21 19.67 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 115.941 -0.572 . . . . 2.79 110.402 -176.087 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 551' ' ' VAL . . . . . . . . . . . . . 65.5 t -117.76 133.76 63.5 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 N-CA-C 108.493 -0.928 . . . . 1.52 108.493 175.74 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 552' ' ' VAL . . . . . 0.62 ' HA ' ' O ' ' A' ' 582' ' ' TRP . 28.3 t -61.95 134.88 27.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 116.315 -0.402 . . . . 1.3799999999999999 110.08 -177.573 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 553' ' ' VAL . . . . . 0.583 HG22 ' CD1' ' A' ' 584' ' ' TRP . 89.0 t -61.6 119.19 44.96 Favored Pre-proline 0 N--CA 1.451 -0.411 0 N-CA-C 109.648 -0.501 . . . . 1.3799999999999999 109.648 -179.688 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 554' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -59.45 136.13 69.56 Favored 'Trans proline' 0 N--CA 1.46 -0.458 0 C-N-CA 122.878 2.385 . . . . 1.98 112.779 -178.509 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 555' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -78.36 -10.72 59.8 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.924 -0.769 . . . . 4.1699999999999999 108.924 174.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 25.2 p -99.73 24.39 8.41 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 114.869 -1.06 . . . . 4.04 110.928 -179.621 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 557' ' ' SER . . . . . . . . . . . . . 73.8 p -95.64 179.02 5.28 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.13 -0.486 . . . . 3.0299999999999998 110.513 -179.178 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 558' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -74.51 -73.12 0.25 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.993 0.425 . . . . 5.0599999999999996 110.311 178.215 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 559' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -131.76 48.49 2.41 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.137 -0.483 . . . . 3.23 110.214 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 560' ' ' MET . . . . . . . . . . . . . 56.9 mtm 62.7 18.56 10.71 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 115.756 -0.656 . . . . 2.6099999999999999 111.317 179.272 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 561' ' ' ALA . . . . . . . . . . . . . . . -145.55 156.63 43.81 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.199 -0.455 . . . . 0.94999999999999996 111.485 -176.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 24.1 p90 -141.9 156.77 45.5 Favored 'General case' 0 C--O 1.225 -0.218 0 N-CA-C 108.131 -1.063 . . . . 0.90000000000000002 108.131 172.306 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 563' ' ' LYS . . . . . 0.532 ' HA ' ' HA ' ' A' ' 570' ' ' THR . 36.5 ttmt -99.83 128.04 45.95 Favored 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 119.752 -0.779 . . . . 2.1800000000000002 110.444 -178.773 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 564' ' ' CYS . . . . . 0.424 ' O ' ' HA ' ' A' ' 568' ' ' LYS . 50.0 t -72.12 118.05 63.77 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 115.834 -0.621 . . . . 0.40999999999999998 110.395 179.275 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 565' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -72.13 -27.62 16.69 Favored 'Trans proline' 0 CA--C 1.531 0.372 0 C-N-CA 123.026 2.484 . . . . 0.63 114.209 -173.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 566' ' ' ILE . . . . . 0.548 HD12 ' HB3' ' A' ' 599' ' ' CYS . 71.2 mt -82.2 -52.36 13.67 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 N-CA-C 112.271 0.471 . . . . 0.93999999999999995 112.271 -172.257 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 567' ' ' CYS . . . . . . . . . . . . . 29.5 p -104.59 0.82 29.0 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 121.063 0.459 . . . . 0.69999999999999996 110.787 -179.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 568' ' ' LYS . . . . . 0.424 ' HA ' ' O ' ' A' ' 564' ' ' CYS . 28.3 mtpp 69.93 29.27 4.0 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 113.623 0.971 . . . . 2.71 113.623 166.091 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 569' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -101.39 132.96 46.7 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.669 -0.412 . . . . 3.3399999999999999 110.18 175.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 570' ' ' THR . . . . . 0.532 ' HA ' ' HA ' ' A' ' 563' ' ' LYS . 55.8 m -70.82 118.4 13.55 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.517 -0.549 . . . . 1.01 109.517 173.21 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 571' ' ' VAL . . . . . . . . . . . . . 22.4 t -91.02 116.18 31.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-O 121.0 0.428 . . . . 0.72999999999999998 110.539 -176.389 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 30.6 p -106.68 159.5 16.16 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.504 -0.771 . . . . 1.8899999999999999 109.068 175.122 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . -129.76 154.66 20.56 Favored Glycine 0 N--CA 1.439 -1.107 0 C-N-CA 119.689 -1.243 . . . . 2.2000000000000002 111.599 -178.366 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 574' ' ' VAL . . . . . 0.434 ' O ' HG22 ' A' ' 583' ' ' VAL . 22.6 t -114.25 151.9 15.98 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 N-CA-C 109.874 -0.417 . . . . 3.2400000000000002 109.874 -175.061 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 575' ' ' TYR . . . . . . . . . . . . . 39.8 t80 -83.73 122.47 28.68 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 116.29 -0.413 . . . . 3.02 110.077 176.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 576' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -91.31 112.85 24.94 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 108.674 -0.861 . . . . 3.3399999999999999 108.674 175.121 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 577' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -69.73 -35.56 75.1 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.38 -0.827 . . . . 5.5899999999999999 112.524 -169.035 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 578' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -75.39 -35.51 61.04 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.881 -0.328 . . . . 5.1100000000000003 111.566 -174.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 579' ' ' SER . . . . . . . . . . . . . 77.1 p -82.53 -24.69 33.95 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.92 0.39 . . . . 3.2799999999999998 110.486 179.228 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 580' ' ' GLY . . . . . . . . . . . . . . . 80.66 20.66 65.56 Favored Glycine 0 N--CA 1.452 -0.285 0 CA-C-N 115.574 -0.739 . . . . 2.6000000000000001 112.914 177.147 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 581' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -145.85 154.8 42.38 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.845 0.355 . . . . 3.1899999999999999 111.072 179.545 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 582' ' ' TRP . . . . . 0.62 ' O ' ' HA ' ' A' ' 552' ' ' VAL . 64.9 m95 -77.34 150.78 35.14 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.088 -0.506 . . . . 2.2999999999999998 110.509 -177.833 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 583' ' ' VAL . . . . . 0.503 HG12 ' CE1' ' A' ' 550' ' ' TYR . 21.4 m -123.9 133.04 70.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 113.564 0.95 . . . . 1.1100000000000001 113.564 -173.285 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 584' ' ' TRP . . . . . 0.583 ' CD1' HG22 ' A' ' 553' ' ' VAL . 24.1 m0 -116.2 103.79 10.87 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 114.854 -1.066 . . . . 2.29 108.566 164.124 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 585' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -87.25 150.2 24.06 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 120.419 -0.513 . . . . 3.9500000000000002 111.136 -175.003 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 586' ' ' ASN . . . . . . . . . . . . . 14.1 m120 54.37 41.29 32.05 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 115.545 -0.752 . . . . 1.4299999999999999 110.495 -175.101 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 587' ' ' THR . . . . . . . . . . . . . 44.3 m -119.76 142.53 48.47 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.756 -0.656 . . . . 0.65000000000000002 110.341 -177.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 588' ' ' ILE . . . . . . . . . . . . . 15.3 tt -133.75 148.19 30.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 N-CA-C 109.424 -0.584 . . . . 0.70999999999999996 109.424 -179.593 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 589' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -115.33 118.75 34.13 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.519 -0.548 . . . . 1.3500000000000001 109.519 177.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 590' ' ' VAL . . . . . . . . . . . . . 44.0 t -125.14 118.84 54.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.505 -0.77 . . . . 0.65000000000000002 110.019 -177.439 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 591' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 58.2 36.99 26.19 Favored 'General case' 0 C--O 1.235 0.306 0 O-C-N 123.482 0.489 . . . . 2.0299999999999998 111.864 177.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . 85.66 8.41 80.18 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.967 -0.635 . . . . 0.62 113.271 174.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 593' ' ' LYS . . . . . . . . . . . . . 60.1 mttm -125.55 139.76 53.33 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.158 0.504 . . . . 2.7799999999999998 111.461 178.55 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 594' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -93.67 133.28 37.19 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.165 -0.925 . . . . 1.45 110.784 -178.385 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 595' ' ' PHE . . . . . . . . . . . . . 81.2 m-85 -139.98 160.14 40.59 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.194 -0.912 . . . . 1.3200000000000001 108.896 177.262 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 596' ' ' HIS . . . . . 0.534 ' HB3' HG22 ' A' ' 598' ' ' THR . 9.3 m170 -66.32 128.69 37.12 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 108.579 -0.897 . . . . 0.58999999999999997 108.579 167.849 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 597' ' ' SER . . . . . . . . . . . . . 40.2 t -61.71 -32.48 72.7 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.8 -0.637 . . . . 1.1299999999999999 109.696 -178.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 598' ' ' THR . . . . . 0.534 HG22 ' HB3' ' A' ' 596' ' ' HIS . 11.1 t -67.82 -35.33 78.41 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-N 115.332 -0.849 . . . . 1.3999999999999999 110.091 177.637 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 599' ' ' CYS . . . . . 0.603 ' HA ' ' HB3' ' A' ' 602' ' ' GLU . 72.7 m -76.13 -31.98 58.9 Favored 'General case' 0 N--CA 1.457 -0.091 0 N-CA-C 112.228 0.455 . . . . 0.81000000000000005 112.228 -179.048 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 600' ' ' TYR . . . . . . . . . . . . . 71.1 t80 -67.37 -36.26 80.99 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.009 -0.737 . . . . 1.8799999999999999 109.009 -178.355 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 601' ' ' HIS . . . . . . . . . . . . . 64.5 t60 -72.48 -32.06 65.9 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.134 -0.939 . . . . 4.5199999999999996 109.656 174.135 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 602' ' ' GLU . . . . . 0.603 ' HB3' ' HA ' ' A' ' 599' ' ' CYS . 0.7 OUTLIER -61.83 -37.59 85.02 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 115.463 -0.79 . . . . 3.8500000000000001 111.745 177.475 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 603' ' ' THR . . . . . 0.499 ' HB ' HD13 ' A' ' 566' ' ' ILE . 14.5 t . . . . . 0 C--N 1.324 -0.542 0 N-CA-C 112.391 0.515 . . . . 3.2999999999999998 112.391 -173.157 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 701' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.284 0 N-CA-C 112.998 -0.041 . . . . 3.2000000000000002 112.998 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 549' ' ' LYS . . . . . . . . . . . . . 89.1 mttt -80.26 144.08 33.17 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.954 0.407 . . . . 5.9000000000000004 110.342 174.825 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 550' ' ' TYR . . . . . . . . . . . . . 30.2 p90 -118.5 161.03 20.69 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 108.649 -0.871 . . . . 2.79 108.649 179.495 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 551' ' ' VAL . . . . . . . . . . . . . 62.7 t -118.24 133.18 65.87 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.971 0 N-CA-C 109.485 -0.561 . . . . 1.52 109.485 177.706 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 552' ' ' VAL . . . . . 0.457 ' HA ' ' O ' ' A' ' 582' ' ' TRP . 33.1 t -67.97 126.04 26.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-O 120.666 0.27 . . . . 1.3799999999999999 110.549 -177.61 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 553' ' ' VAL . . . . . 0.654 HG22 ' CD1' ' A' ' 584' ' ' TRP . 47.3 t -61.91 126.37 87.1 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 115.828 -0.624 . . . . 1.3799999999999999 111.415 -176.145 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 554' ' ' PRO . . . . . 0.547 ' HB2' ' HB2' ' A' ' 557' ' ' SER . 16.5 Cg_exo -66.96 138.05 46.74 Favored 'Trans proline' 0 C--O 1.233 0.27 0 C-N-CA 123.0 2.467 . . . . 1.98 111.464 175.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 555' ' ' GLU . . . . . 0.429 ' H ' ' CD ' ' A' ' 555' ' ' GLU . 0.2 OUTLIER -79.01 -30.96 44.52 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.013 0.435 . . . . 4.1699999999999999 110.728 -176.037 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 556' ' ' THR . . . . . 0.402 HG23 ' HG2' ' A' ' 555' ' ' GLU . 39.3 p -94.9 30.93 1.96 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.355 0.597 . . . . 4.04 111.139 179.442 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 557' ' ' SER . . . . . 0.547 ' HB2' ' HB2' ' A' ' 554' ' ' PRO . 21.2 t -91.6 30.1 1.39 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.905 -0.589 . . . . 3.0299999999999998 110.228 -178.854 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 558' ' ' GLN . . . . . . . . . . . . . 22.6 mt-30 62.11 -83.71 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 123.576 0.75 . . . . 5.0599999999999996 111.636 -179.127 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 559' ' ' ASP . . . . . . . . . . . . . 16.5 p-10 -115.37 15.24 16.85 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.975 0.417 . . . . 3.23 110.927 -178.121 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 560' ' ' MET . . . . . 0.402 ' HA ' ' HB3' ' A' ' 557' ' ' SER . 4.5 mpp? 61.8 23.98 14.19 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 115.239 -0.892 . . . . 2.6099999999999999 111.935 174.884 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 561' ' ' ALA . . . . . . . . . . . . . . . -144.29 145.75 32.2 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.314 -0.403 . . . . 0.94999999999999996 110.08 178.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 44.5 p90 -137.42 155.32 49.49 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.315 -0.402 . . . . 0.90000000000000002 109.938 178.224 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 563' ' ' LYS . . . . . . . . . . . . . 13.9 tppt? -90.01 125.55 35.43 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.771 0.32 . . . . 2.1800000000000002 110.33 -179.354 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 564' ' ' CYS . . . . . . . . . . . . . 40.6 t -63.57 114.78 14.32 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 115.908 -0.587 . . . . 0.40999999999999998 109.596 176.121 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 565' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -69.8 -17.61 37.3 Favored 'Trans proline' 0 CA--C 1.527 0.164 0 C-N-CA 122.588 2.192 . . . . 0.63 113.157 -172.498 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 566' ' ' ILE . . . . . 0.454 HG21 ' HG2' ' A' ' 602' ' ' GLU . 55.5 mt -81.48 -44.33 20.43 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 N-CA-C 111.807 0.299 . . . . 0.93999999999999995 111.807 -176.832 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 567' ' ' CYS . . . . . 0.484 ' SG ' ' HG3' ' A' ' 569' ' ' GLU . 27.9 p -129.8 1.83 4.89 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.447 0.536 . . . . 0.69999999999999996 112.447 -174.044 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 568' ' ' LYS . . . . . . . . . . . . . 40.0 mtmt 68.08 30.77 5.74 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 113.433 0.901 . . . . 2.71 113.433 173.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 569' ' ' GLU . . . . . 0.484 ' HG3' ' SG ' ' A' ' 567' ' ' CYS . 32.7 mt-10 -80.17 135.8 36.36 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 108.932 -0.766 . . . . 3.3399999999999999 108.932 169.635 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 570' ' ' THR . . . . . . . . . . . . . 90.1 m -78.31 117.88 19.97 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 109.083 -0.71 . . . . 1.01 109.083 170.753 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 571' ' ' VAL . . . . . . . . . . . . . 39.6 t -90.03 116.12 30.8 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 N-CA-C 110.008 -0.368 . . . . 0.72999999999999998 110.008 -178.492 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 32.0 p -115.19 158.0 22.87 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.984 -0.553 . . . . 1.8899999999999999 110.017 179.753 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . -130.07 155.11 20.85 Favored Glycine 0 N--CA 1.436 -1.318 0 C-N-CA 120.05 -1.071 . . . . 2.2000000000000002 111.529 178.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 574' ' ' VAL . . . . . . . . . . . . . 42.2 t -115.87 147.56 19.18 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 N-CA-C 109.63 -0.507 . . . . 3.2400000000000002 109.63 -173.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 575' ' ' TYR . . . . . . . . . . . . . 51.5 t80 -83.76 118.32 23.83 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 108.82 -0.807 . . . . 3.02 108.82 173.26 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 576' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -95.71 107.05 19.23 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.033 -0.729 . . . . 3.3399999999999999 109.033 178.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 577' ' ' GLU . . . . . . . . . . . . . 38.3 mp0 -68.56 -23.3 64.48 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.824 -0.625 . . . . 5.5899999999999999 111.943 -173.567 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 578' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -76.05 -34.7 59.63 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.603 0.239 . . . . 5.1100000000000003 111.256 -177.525 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 579' ' ' SER . . . . . . . . . . . . . 67.5 p -93.75 -23.42 18.2 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.097 0.475 . . . . 3.2799999999999998 110.546 175.512 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 580' ' ' GLY . . . . . . . . . . . . . . . 80.44 26.81 53.71 Favored Glycine 0 N--CA 1.449 -0.462 0 CA-C-N 115.608 -0.723 . . . . 2.6000000000000001 112.929 176.449 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 581' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -145.87 161.6 39.63 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 117.16 0.48 . . . . 3.1899999999999999 111.421 -179.69 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 582' ' ' TRP . . . . . 0.513 ' CB ' ' HB ' ' A' ' 553' ' ' VAL . 80.4 m95 -83.93 139.12 32.79 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-N 115.887 -0.597 . . . . 2.2999999999999998 110.37 177.605 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 583' ' ' VAL . . . . . . . . . . . . . 26.6 m -121.04 130.15 74.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 N-CA-C 112.971 0.73 . . . . 1.1100000000000001 112.971 -174.773 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 584' ' ' TRP . . . . . 0.654 ' CD1' HG22 ' A' ' 553' ' ' VAL . 14.7 m0 -104.82 103.5 13.11 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 108.605 -0.887 . . . . 2.29 108.605 162.835 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 585' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -94.83 153.75 17.58 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.637 -0.711 . . . . 3.9500000000000002 111.241 -175.334 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 586' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 55.56 40.75 31.14 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 108.799 -0.815 . . . . 1.4299999999999999 108.799 -170.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 587' ' ' THR . . . . . . . . . . . . . 26.6 m -134.88 141.45 46.34 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.393 -0.821 . . . . 0.65000000000000002 110.396 -173.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 588' ' ' ILE . . . . . . . . . . . . . 13.7 tt -141.58 148.92 20.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 109.665 -0.494 . . . . 0.70999999999999996 109.665 -179.552 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 589' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -94.34 118.7 32.01 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.93 0.395 . . . . 1.3500000000000001 110.016 176.209 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 590' ' ' VAL . . . . . . . . . . . . . 59.9 t -126.5 127.25 70.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.888 -0.596 . . . . 0.65000000000000002 109.451 179.488 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 591' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 59.46 37.25 23.11 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-O 121.554 0.692 . . . . 2.0299999999999998 110.313 -179.689 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . 73.42 12.04 80.03 Favored Glycine 0 C--N 1.333 0.364 0 CA-C-N 115.588 -0.733 . . . . 0.62 112.952 177.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 593' ' ' LYS . . . . . . . . . . . . . 46.3 mtmt -127.74 143.45 51.14 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.861 0.362 . . . . 2.7799999999999998 110.372 -177.005 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 594' ' ' TYR . . . . . . . . . . . . . 56.0 m-85 -86.59 125.51 33.86 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.955 0.407 . . . . 1.45 110.853 -178.696 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 595' ' ' PHE . . . . . . . . . . . . . 63.7 m-85 -136.41 160.49 38.57 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.634 -0.712 . . . . 1.3200000000000001 110.044 179.593 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 596' ' ' HIS . . . . . . . . . . . . . 4.2 m170 -62.34 127.16 30.02 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.476 -0.565 . . . . 0.58999999999999997 109.476 172.664 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 597' ' ' SER . . . . . . . . . . . . . 31.8 t -66.55 -32.04 73.14 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.849 -0.614 . . . . 1.1299999999999999 109.776 179.45 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 598' ' ' THR . . . . . . . . . . . . . 13.0 t -69.13 -35.19 76.12 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 115.274 -0.875 . . . . 1.3999999999999999 110.356 179.714 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 599' ' ' CYS . . . . . . . . . . . . . 73.4 m -75.92 -29.73 58.49 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.596 -0.729 . . . . 0.81000000000000005 112.591 -176.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 600' ' ' TYR . . . . . 0.446 ' O ' HG22 ' A' ' 603' ' ' THR . 71.0 t80 -54.54 -31.73 56.93 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.868 0.366 . . . . 1.8799999999999999 111.763 -172.559 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 601' ' ' HIS . . . . . . . . . . . . . 12.6 m170 -59.43 -27.29 65.91 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 111.927 0.343 . . . . 4.5199999999999996 111.927 -179.425 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 602' ' ' GLU . . . . . 0.454 ' HG2' HG21 ' A' ' 566' ' ' ILE . 1.1 pp20? -70.18 -32.83 70.94 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 120.906 -0.317 . . . . 3.8500000000000001 111.384 -175.389 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 603' ' ' THR . . . . . 0.446 HG22 ' O ' ' A' ' 600' ' ' TYR . 11.4 t . . . . . 0 C--N 1.329 -0.305 0 CA-C-O 120.922 0.391 . . . . 3.2999999999999998 110.977 -176.77 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 701' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.506 0 N-CA-C 112.381 -0.288 . . . . 3.2000000000000002 112.381 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 549' ' ' LYS . . . . . . . . . . . . . 31.3 mmmt -80.65 137.11 36.32 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 121.113 0.482 . . . . 5.9000000000000004 110.491 177.528 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 550' ' ' TYR . . . . . . . . . . . . . 49.9 p90 -109.6 159.77 16.82 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 108.405 -0.961 . . . . 2.79 108.405 176.194 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 551' ' ' VAL . . . . . . . . . . . . . 55.1 t -117.17 133.21 64.63 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.106 0 N-CA-C 109.033 -0.729 . . . . 1.52 109.033 179.632 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 552' ' ' VAL . . . . . 0.724 ' HA ' ' O ' ' A' ' 582' ' ' TRP . 39.1 t -66.98 130.09 32.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.972 -0.558 . . . . 1.3799999999999999 109.612 -179.122 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 553' ' ' VAL . . . . . 0.599 HG22 ' CD1' ' A' ' 584' ' ' TRP . 59.1 t -59.0 119.44 38.09 Favored Pre-proline 0 N--CA 1.452 -0.342 0 O-C-N 123.409 0.443 . . . . 1.3799999999999999 110.016 -176.655 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 554' ' ' PRO . . . . . 0.569 ' HB2' ' HB2' ' A' ' 557' ' ' SER . 33.0 Cg_exo -59.5 135.92 67.98 Favored 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 122.945 2.43 . . . . 1.98 112.132 -178.192 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 555' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -77.32 -21.57 53.23 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.64 -0.709 . . . . 4.1699999999999999 110.031 179.341 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 21.5 p -89.56 3.53 52.2 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 115.382 -0.827 . . . . 4.04 110.835 176.241 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 557' ' ' SER . . . . . 0.569 ' HB2' ' HB2' ' A' ' 554' ' ' PRO . 15.5 t -98.03 120.07 37.77 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.047 -0.723 . . . . 3.0299999999999998 109.047 175.162 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 558' ' ' GLN . . . . . . . . . . . . . 78.4 mm-40 -69.71 138.22 52.69 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.093 -0.503 . . . . 5.0599999999999996 111.564 -174.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 559' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 68.34 6.0 5.07 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 115.341 -0.845 . . . . 3.23 112.204 175.787 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 560' ' ' MET . . . . . . . . . . . . . 4.3 mpp? 58.09 27.34 14.8 Favored 'General case' 0 N--CA 1.465 0.312 0 O-C-N 123.451 0.469 . . . . 2.6099999999999999 111.907 176.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 561' ' ' ALA . . . . . . . . . . . . . . . -144.75 155.24 43.43 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 116.258 -0.428 . . . . 0.94999999999999996 110.817 -176.317 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 29.3 p90 -138.7 164.59 29.14 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.413 -0.588 . . . . 0.90000000000000002 109.413 174.38 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 563' ' ' LYS . . . . . . . . . . . . . 21.9 tptm -103.06 125.07 49.63 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 109.983 -0.377 . . . . 2.1800000000000002 109.983 -178.446 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 564' ' ' CYS . . . . . . . . . . . . . 48.8 t -80.09 113.38 38.01 Favored Pre-proline 0 C--N 1.327 -0.412 0 N-CA-C 109.512 -0.551 . . . . 0.40999999999999998 109.512 -179.663 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 565' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -71.88 -28.67 16.24 Favored 'Trans proline' 0 CA--C 1.528 0.217 0 C-N-CA 122.667 2.245 . . . . 0.63 113.954 -172.13 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 566' ' ' ILE . . . . . . . . . . . . . 28.5 mt -72.67 -37.7 56.59 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 CA-C-O 121.069 0.462 . . . . 0.93999999999999995 111.671 -172.662 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 567' ' ' CYS . . . . . 0.559 ' SG ' ' HG3' ' A' ' 569' ' ' GLU . 27.8 p -127.43 1.27 6.29 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.534 -0.303 . . . . 0.69999999999999996 111.567 -175.309 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 568' ' ' LYS . . . . . . . . . . . . . 29.1 mtpp 67.45 27.45 8.01 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 115.934 -0.576 . . . . 2.71 112.429 175.272 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 569' ' ' GLU . . . . . 0.559 ' HG3' ' SG ' ' A' ' 567' ' ' CYS . 51.1 mt-10 -79.07 136.43 37.16 Favored 'General case' 0 CA--C 1.516 -0.336 0 N-CA-C 109.944 -0.391 . . . . 3.3399999999999999 109.944 174.692 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 570' ' ' THR . . . . . . . . . . . . . 47.4 m -87.99 116.58 26.26 Favored 'General case' 0 C--N 1.314 -0.977 0 N-CA-C 107.835 -1.172 . . . . 1.01 107.835 171.736 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 571' ' ' VAL . . . . . 0.438 HG22 ' CE1' ' A' ' 596' ' ' HIS . 16.8 t -97.78 115.73 38.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 C-N-CA 120.668 -0.413 . . . . 0.72999999999999998 110.962 -171.477 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 23.8 p -109.76 158.82 17.73 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 109.183 -0.673 . . . . 1.8899999999999999 109.183 174.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . -131.21 155.15 21.16 Favored Glycine 0 N--CA 1.443 -0.896 0 C-N-CA 120.04 -1.076 . . . . 2.2000000000000002 112.132 -178.2 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 574' ' ' VAL . . . . . 0.411 ' O ' HG22 ' A' ' 583' ' ' VAL . 39.5 t -112.35 152.81 14.1 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 N-CA-C 109.432 -0.581 . . . . 3.2400000000000002 109.432 -175.632 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 575' ' ' TYR . . . . . 0.41 ' HA ' ' HA ' ' A' ' 582' ' ' TRP . 50.7 t80 -84.52 119.84 25.64 Favored 'General case' 0 C--N 1.315 -0.891 0 N-CA-C 109.953 -0.388 . . . . 3.02 109.953 176.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 576' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -90.3 97.96 11.49 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 108.277 -1.009 . . . . 3.3399999999999999 108.277 178.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 577' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -65.92 -22.85 66.53 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.354 -0.839 . . . . 5.5899999999999999 111.851 -172.834 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 578' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -73.32 -48.09 37.25 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.014 0.435 . . . . 5.1100000000000003 110.116 -178.27 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 579' ' ' SER . . . . . . . . . . . . . 74.5 p -84.05 -19.88 33.64 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.922 0.391 . . . . 3.2799999999999998 111.023 178.109 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 580' ' ' GLY . . . . . . . . . . . . . . . 80.24 22.65 62.53 Favored Glycine 0 N--CA 1.449 -0.451 0 CA-C-N 115.795 -0.639 . . . . 2.6000000000000001 112.266 179.048 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 581' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -130.59 147.83 52.31 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-O 121.32 0.581 . . . . 3.1899999999999999 111.009 -177.274 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 582' ' ' TRP . . . . . 0.724 ' O ' ' HA ' ' A' ' 552' ' ' VAL . 88.4 m95 -72.05 143.82 48.97 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 108.591 -0.892 . . . . 2.2999999999999998 108.591 168.815 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 583' ' ' VAL . . . . . 0.6 HG21 ' HE2' ' A' ' 585' ' ' LYS . 24.4 m -124.08 133.19 69.96 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 N-CA-C 113.679 0.992 . . . . 1.1100000000000001 113.679 -174.493 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 584' ' ' TRP . . . . . 0.599 ' CD1' HG22 ' A' ' 553' ' ' VAL . 30.9 m0 -110.51 104.1 12.79 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 114.912 -1.04 . . . . 2.29 108.338 163.067 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 585' ' ' LYS . . . . . 0.6 ' HE2' HG21 ' A' ' 583' ' ' VAL . 66.9 mmtt -83.38 151.49 25.5 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-O 120.495 0.188 . . . . 3.9500000000000002 110.611 -176.54 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 586' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 50.27 44.86 26.36 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 115.887 -0.597 . . . . 1.4299999999999999 110.124 -175.517 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 587' ' ' THR . . . . . . . . . . . . . 75.3 m -125.83 140.94 52.25 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.15 -0.477 . . . . 0.65000000000000002 110.679 -176.394 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 588' ' ' ILE . . . . . 0.459 ' HB ' ' HB3' ' A' ' 597' ' ' SER . 12.7 tt -136.05 146.13 29.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 N-CA-C 109.482 -0.562 . . . . 0.70999999999999996 109.482 179.025 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 589' ' ' GLU . . . . . . . . . . . . . 46.2 tt0 -100.45 121.5 41.65 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.219 -0.66 . . . . 1.3500000000000001 109.219 174.329 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 590' ' ' VAL . . . . . . . . . . . . . 52.7 t -124.35 118.19 52.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 109.947 -0.39 . . . . 0.65000000000000002 109.947 -179.185 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 591' ' ' ASN . . . . . . . . . . . . . 60.0 t30 58.12 37.51 26.4 Favored 'General case' 0 C--N 1.328 -0.327 0 O-C-N 123.912 0.757 . . . . 2.0299999999999998 110.852 178.67 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . 85.25 0.88 88.51 Favored Glycine 0 N--CA 1.452 -0.256 0 CA-C-N 115.844 -0.616 . . . . 0.62 113.718 176.462 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 593' ' ' LYS . . . . . . . . . . . . . 61.8 mttp -118.71 147.69 43.56 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 117.245 0.523 . . . . 2.7799999999999998 111.104 -179.129 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 594' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -96.53 135.64 38.14 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.018 0.437 . . . . 1.45 111.219 -175.581 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 595' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 -143.87 155.02 43.96 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.337 -0.847 . . . . 1.3200000000000001 109.322 178.57 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 596' ' ' HIS . . . . . 0.438 ' CE1' HG22 ' A' ' 571' ' ' VAL . 16.7 m170 -64.66 127.24 30.69 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 107.972 -1.121 . . . . 0.58999999999999997 107.972 166.579 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 597' ' ' SER . . . . . 0.459 ' HB3' ' HB ' ' A' ' 588' ' ' ILE . 7.7 p -66.02 -32.02 73.26 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.043 0.449 . . . . 1.1299999999999999 110.002 -178.906 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 598' ' ' THR . . . . . . . . . . . . . 97.1 m -61.12 -43.25 99.17 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.265 -0.879 . . . . 1.3999999999999999 110.345 173.694 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 599' ' ' CYS . . . . . 0.511 ' O ' ' HB3' ' A' ' 602' ' ' GLU . 83.9 m -74.74 -30.46 61.51 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.779 -0.646 . . . . 0.81000000000000005 111.289 -179.775 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 600' ' ' TYR . . . . . . . . . . . . . 88.0 t80 -59.28 -35.87 74.52 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.179 0.514 . . . . 1.8799999999999999 109.908 177.572 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 601' ' ' HIS . . . . . . . . . . . . . 67.3 t60 -71.22 -29.51 65.23 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.811 -0.631 . . . . 4.5199999999999996 110.506 176.562 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 602' ' ' GLU . . . . . 0.511 ' HB3' ' O ' ' A' ' 599' ' ' CYS . 2.0 tp10 -61.89 -37.21 83.74 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.923 -0.581 . . . . 3.8500000000000001 111.149 178.639 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 603' ' ' THR . . . . . . . . . . . . . 12.3 t . . . . . 0 C--N 1.328 -0.343 0 CA-C-N 116.447 -0.342 . . . . 3.2999999999999998 111.102 -179.05 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 701' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.5 0 N-CA-C 111.818 -0.513 . . . . 3.2000000000000002 111.818 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 549' ' ' LYS . . . . . . . . . . . . . 68.4 mmtt -64.01 149.37 47.57 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-O 121.338 0.589 . . . . 5.9000000000000004 111.085 178.813 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 550' ' ' TYR . . . . . . . . . . . . . 39.7 p90 -122.38 159.94 26.47 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.277 -0.874 . . . . 2.79 109.745 179.181 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 551' ' ' VAL . . . . . . . . . . . . . 60.6 t -118.15 133.35 65.21 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.925 0 N-CA-C 108.527 -0.916 . . . . 1.52 108.527 177.551 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 552' ' ' VAL . . . . . 0.648 ' HA ' ' O ' ' A' ' 582' ' ' TRP . 42.0 t -67.8 134.24 30.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 116.122 -0.49 . . . . 1.3799999999999999 109.741 -177.426 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 553' ' ' VAL . . . . . 0.515 HG11 ' HB3' ' A' ' 560' ' ' MET . 63.2 t -59.46 121.68 58.57 Favored Pre-proline 0 C--N 1.325 -0.461 0 O-C-N 123.682 0.613 . . . . 1.3799999999999999 111.391 -175.813 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 554' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 553' ' ' VAL . 31.6 Cg_exo -58.74 143.13 99.1 Favored 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 123.559 2.839 . . . . 1.98 112.607 179.148 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 555' ' ' GLU . . . . . . . . . . . . . 19.9 tp10 -62.05 -38.36 88.45 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.165 -0.925 . . . . 4.1699999999999999 111.094 -179.562 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 24.1 p -96.26 45.01 1.07 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.238 -0.437 . . . . 4.04 111.848 -176.68 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 557' ' ' SER . . . . . 0.586 ' OG ' ' HA ' ' A' ' 560' ' ' MET . 59.4 p -107.25 124.37 49.66 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.99 0.424 . . . . 3.0299999999999998 110.438 179.003 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 558' ' ' GLN . . . . . . . . . . . . . 89.3 mt-30 -66.11 112.84 4.1 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.18 -0.463 . . . . 5.0599999999999996 109.86 179.312 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 559' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 66.44 12.98 9.04 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 115.867 -0.606 . . . . 3.23 111.71 -177.467 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 560' ' ' MET . . . . . 0.586 ' HA ' ' OG ' ' A' ' 557' ' ' SER . 60.1 mtt 57.18 37.03 28.2 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 116.248 -0.433 . . . . 2.6099999999999999 111.266 -179.789 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 561' ' ' ALA . . . . . 0.427 ' HB2' HG22 ' A' ' 572' ' ' THR . . . -144.3 161.95 37.65 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 116.072 -0.513 . . . . 0.94999999999999996 111.443 -177.627 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 31.2 p90 -143.83 153.06 41.97 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.968 -0.753 . . . . 0.90000000000000002 108.968 173.242 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 563' ' ' LYS . . . . . 0.529 ' HA ' ' HA ' ' A' ' 570' ' ' THR . 16.0 tppt? -88.89 126.47 35.4 Favored 'General case' 0 C--N 1.317 -0.841 0 C-N-CA 120.705 -0.398 . . . . 2.1800000000000002 110.189 177.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 564' ' ' CYS . . . . . 0.439 ' HA ' ' HD3' ' A' ' 565' ' ' PRO . 52.7 t -79.46 113.62 38.42 Favored Pre-proline 0 N--CA 1.451 -0.379 0 N-CA-C 109.444 -0.576 . . . . 0.40999999999999998 109.444 174.62 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 565' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 564' ' ' CYS . 33.4 Cg_exo -63.38 -36.37 55.98 Favored 'Trans proline' 0 CA--C 1.528 0.206 0 C-N-CA 123.146 2.564 . . . . 0.63 113.896 -173.323 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 566' ' ' ILE . . . . . 0.498 HD12 ' HB3' ' A' ' 599' ' ' CYS . 60.3 mt -72.35 -37.81 59.25 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 N-CA-C 112.088 0.403 . . . . 0.93999999999999995 112.088 -173.143 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 567' ' ' CYS . . . . . . . . . . . . . 29.6 p -113.15 0.76 15.04 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.536 -0.466 . . . . 0.69999999999999996 111.82 -176.281 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 568' ' ' LYS . . . . . . . . . . . . . 99.4 mttt 66.03 11.63 7.89 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 113.181 0.808 . . . . 2.71 113.181 173.522 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 569' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -100.6 134.64 43.26 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.873 0.368 . . . . 3.3399999999999999 110.971 179.216 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 570' ' ' THR . . . . . 0.529 ' HA ' ' HA ' ' A' ' 563' ' ' LYS . 45.8 m -74.13 128.96 36.87 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.5 -0.773 . . . . 1.01 109.617 177.863 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 571' ' ' VAL . . . . . . . . . . . . . 17.9 t -95.76 115.09 33.97 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 N-CA-C 109.568 -0.53 . . . . 0.72999999999999998 109.568 178.424 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 572' ' ' THR . . . . . 0.427 HG22 ' HB2' ' A' ' 561' ' ' ALA . 24.4 p -106.24 160.41 15.37 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.66 -0.7 . . . . 1.8899999999999999 109.438 177.103 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . -129.53 153.89 20.14 Favored Glycine 0 N--CA 1.44 -1.052 0 C-N-CA 119.352 -1.404 . . . . 2.2000000000000002 112.405 -178.619 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 574' ' ' VAL . . . . . . . . . . . . . 58.5 t -122.57 148.13 26.42 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 CA-C-N 114.861 -0.67 . . . . 3.2400000000000002 109.395 -172.714 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 575' ' ' TYR . . . . . . . . . . . . . 53.3 t80 -80.81 118.07 22.02 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 109.356 -0.609 . . . . 3.02 109.356 175.718 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 576' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -92.96 114.89 27.58 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 109.754 -0.461 . . . . 3.3399999999999999 109.754 179.756 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 577' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -68.89 -22.72 64.16 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.511 -0.768 . . . . 5.5899999999999999 112.13 -174.441 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 578' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -77.08 -48.13 18.65 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.509 -0.314 . . . . 5.1100000000000003 111.723 -178.276 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 579' ' ' SER . . . . . . . . . . . . . 72.4 p -86.0 -21.82 27.61 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.878 0.37 . . . . 3.2799999999999998 110.859 178.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 580' ' ' GLY . . . . . . . . . . . . . . . 80.19 17.29 74.54 Favored Glycine 0 C--N 1.331 0.285 0 C-N-CA 121.157 -0.544 . . . . 2.6000000000000001 112.725 178.48 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 581' ' ' GLU . . . . . . . . . . . . . 20.7 mm-40 -122.42 152.24 40.43 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.921 0.391 . . . . 3.1899999999999999 111.292 -176.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 582' ' ' TRP . . . . . 0.648 ' O ' ' HA ' ' A' ' 552' ' ' VAL . 84.5 m95 -77.51 130.38 36.9 Favored 'General case' 0 CA--C 1.512 -0.491 0 N-CA-C 107.451 -1.315 . . . . 2.2999999999999998 107.451 165.245 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 583' ' ' VAL . . . . . . . . . . . . . 19.3 m -115.39 133.91 60.2 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.971 0 N-CA-C 113.958 1.096 . . . . 1.1100000000000001 113.958 -169.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 584' ' ' TRP . . . . . 0.508 ' CD1' HG22 ' A' ' 553' ' ' VAL . 30.5 m0 -113.33 103.65 11.52 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 114.795 -1.093 . . . . 2.29 108.053 162.281 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 585' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.99 145.61 27.63 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.985 0.422 . . . . 3.9500000000000002 111.774 -173.104 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 586' ' ' ASN . . . . . . . . . . . . . 12.3 m120 53.2 42.93 32.13 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.282 -0.872 . . . . 1.4299999999999999 110.512 -176.613 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 587' ' ' THR . . . . . . . . . . . . . 57.9 m -115.38 142.46 46.66 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.0 0.428 . . . . 0.65000000000000002 110.761 -176.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 588' ' ' ILE . . . . . . . . . . . . . 15.3 tt -137.38 150.19 25.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.58 -0.736 . . . . 0.70999999999999996 109.396 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 589' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -111.13 122.73 48.62 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.098 -0.705 . . . . 1.3500000000000001 109.098 176.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 590' ' ' VAL . . . . . . . . . . . . . 62.1 t -126.39 117.65 49.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 115.716 -0.675 . . . . 0.65000000000000002 110.06 179.324 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 591' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 58.27 40.64 24.43 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 115.582 -0.735 . . . . 2.0299999999999998 110.835 177.267 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . 79.98 13.67 81.81 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.91 -0.662 . . . . 0.62 112.592 176.036 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 593' ' ' LYS . . . . . . . . . . . . . 46.8 mtmt -128.47 139.92 52.08 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.036 0.446 . . . . 2.7799999999999998 110.777 -178.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 594' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -94.9 134.88 37.06 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.054 -0.521 . . . . 1.45 111.064 -177.081 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 595' ' ' PHE . . . . . . . . . . . . . 62.7 m-85 -142.25 165.24 27.98 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.372 -0.831 . . . . 1.3200000000000001 108.807 177.002 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 596' ' ' HIS . . . . . 0.701 ' HB2' ' SG ' ' A' ' 599' ' ' CYS . 24.9 m80 -68.79 130.11 41.88 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 108.273 -1.01 . . . . 0.58999999999999997 108.273 166.641 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 597' ' ' SER . . . . . . . . . . . . . 40.1 t -60.83 -30.16 69.93 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.462 0.649 . . . . 1.1299999999999999 109.81 179.361 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 598' ' ' THR . . . . . . . . . . . . . 93.7 m -66.39 -34.71 78.58 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.905 -1.043 . . . . 1.3999999999999999 110.803 175.11 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 599' ' ' CYS . . . . . 0.701 ' SG ' ' HB2' ' A' ' 596' ' ' HIS . 75.8 m -74.77 -31.15 61.69 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.622 0.601 . . . . 0.81000000000000005 112.622 -178.25 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 600' ' ' TYR . . . . . . . . . . . . . 86.0 t80 -61.8 -35.62 78.72 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 121.362 0.601 . . . . 1.8799999999999999 109.842 -178.427 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 601' ' ' HIS . . . . . . . . . . . . . 78.7 t60 -66.72 -34.7 78.43 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.373 -0.83 . . . . 4.5199999999999996 110.408 176.001 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 602' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -64.65 -36.57 84.69 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.145 -0.48 . . . . 3.8500000000000001 110.927 179.847 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 603' ' ' THR . . . . . . . . . . . . . 15.4 t . . . . . 0 C--N 1.324 -0.507 0 CA-C-N 116.554 -0.293 . . . . 3.2999999999999998 110.701 -179.266 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 701' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.418 0 N-CA-C 112.107 -0.397 . . . . 3.2000000000000002 112.107 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 549' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -64.28 132.49 50.39 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.056 0.455 . . . . 5.9000000000000004 110.125 176.558 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 550' ' ' TYR . . . . . 0.524 ' CE1' HG12 ' A' ' 583' ' ' VAL . 37.4 p90 -111.34 160.91 16.6 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.822 -0.626 . . . . 2.79 109.834 177.414 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 551' ' ' VAL . . . . . 0.527 HG11 ' HE1' ' A' ' 594' ' ' TYR . 52.9 t -118.53 133.26 65.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 N-CA-C 109.072 -0.714 . . . . 1.52 109.072 176.437 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 552' ' ' VAL . . . . . 0.72 ' HA ' ' O ' ' A' ' 582' ' ' TRP . 56.6 t -61.95 125.18 17.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 O-C-N 123.32 0.388 . . . . 1.3799999999999999 110.287 -179.039 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 553' ' ' VAL . . . . . 0.685 HG22 ' CD1' ' A' ' 584' ' ' TRP . 66.6 t -58.91 120.41 46.32 Favored Pre-proline 0 C--N 1.33 -0.271 0 O-C-N 123.729 0.643 . . . . 1.3799999999999999 111.495 -173.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 554' ' ' PRO . . . . . 0.458 ' HD3' ' HA ' ' A' ' 553' ' ' VAL . 7.2 Cg_exo -72.4 136.91 27.21 Favored 'Trans proline' 0 N--CA 1.456 -0.697 0 C-N-CA 122.802 2.335 . . . . 1.98 112.06 175.78 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 555' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 -76.93 -15.35 59.7 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.593 -0.73 . . . . 4.1699999999999999 110.055 179.357 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 22.7 p -84.43 -13.34 52.38 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.389 -0.823 . . . . 4.04 111.862 -177.71 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 557' ' ' SER . . . . . . . . . . . . . 47.2 m -80.68 78.07 7.46 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.615 -0.266 . . . . 3.0299999999999998 111.532 -177.64 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 558' ' ' GLN . . . . . 0.426 ' OE1' ' HA ' ' A' ' 558' ' ' GLN . 10.4 mm-40 56.25 -89.66 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 123.512 0.725 . . . . 5.0599999999999996 111.703 176.39 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 559' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -137.05 61.07 1.63 Allowed 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.022 -0.733 . . . . 3.23 109.022 176.784 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 560' ' ' MET . . . . . . . . . . . . . 62.1 mtt 62.22 24.63 14.68 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 115.273 -0.876 . . . . 2.6099999999999999 110.797 -178.302 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 561' ' ' ALA . . . . . . . . . . . . . . . -144.77 149.94 36.35 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.378 -0.373 . . . . 0.94999999999999996 111.162 -173.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 26.8 p90 -133.69 164.01 28.17 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.572 -0.899 . . . . 0.90000000000000002 108.572 173.605 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 563' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt -112.09 127.59 55.96 Favored 'General case' 0 C--N 1.323 -0.587 0 C-N-CA 120.456 -0.498 . . . . 2.1800000000000002 110.772 -179.459 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 564' ' ' CYS . . . . . . . . . . . . . 53.4 t -73.77 113.9 27.28 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 115.416 -0.811 . . . . 0.40999999999999998 109.797 -179.192 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 565' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -72.83 -19.91 23.15 Favored 'Trans proline' 0 N--CA 1.472 0.218 0 C-N-CA 122.965 2.443 . . . . 0.63 113.599 -175.633 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 566' ' ' ILE . . . . . 0.449 HD13 ' HB ' ' A' ' 603' ' ' THR . 37.7 mt -82.26 -37.86 14.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.255 -0.429 . . . . 0.93999999999999995 111.616 -172.368 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 567' ' ' CYS . . . . . . . . . . . . . 27.9 p -129.32 5.86 5.27 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 112.22 0.452 . . . . 0.69999999999999996 112.22 -179.319 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 568' ' ' LYS . . . . . . . . . . . . . 21.0 mmmt 72.82 30.59 1.72 Allowed 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 113.923 1.083 . . . . 2.71 113.923 167.346 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 569' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -92.85 135.81 33.8 Favored 'General case' 0 N--CA 1.466 0.361 0 O-C-N 121.786 -0.571 . . . . 3.3399999999999999 111.231 178.308 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 570' ' ' THR . . . . . . . . . . . . . 82.5 m -82.14 117.91 22.66 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 108.875 -0.787 . . . . 1.01 108.875 166.142 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 571' ' ' VAL . . . . . . . . . . . . . 21.3 t -103.13 123.27 56.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.951 0.405 . . . . 0.72999999999999998 111.745 -170.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 24.5 p -108.94 160.96 15.59 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.87 -0.604 . . . . 1.8899999999999999 110.33 177.672 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . -130.98 156.15 21.61 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.343 -0.932 . . . . 2.2000000000000002 112.185 -177.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 574' ' ' VAL . . . . . 0.474 ' O ' HG22 ' A' ' 583' ' ' VAL . 21.8 t -112.26 149.61 14.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-O 120.888 0.375 . . . . 3.2400000000000002 110.319 -173.117 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 575' ' ' TYR . . . . . 0.408 ' HA ' ' HA ' ' A' ' 582' ' ' TRP . 53.8 t80 -85.21 123.36 30.62 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.256 -0.429 . . . . 3.02 111.012 179.061 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 576' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -92.12 107.75 19.44 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.418 -0.586 . . . . 3.3399999999999999 109.418 174.09 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 577' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -68.17 -26.98 66.03 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.037 -0.529 . . . . 5.5899999999999999 112.424 -173.215 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 578' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -69.53 -47.95 62.06 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.76 0.314 . . . . 5.1100000000000003 111.249 -178.409 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 579' ' ' SER . . . . . . . . . . . . . 77.1 p -83.31 -23.88 32.39 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.343 0.592 . . . . 3.2799999999999998 110.578 -179.837 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 580' ' ' GLY . . . . . . . . . . . . . . . 79.17 18.4 74.5 Favored Glycine 0 N--CA 1.449 -0.499 0 CA-C-N 115.561 -0.745 . . . . 2.6000000000000001 111.326 -176.714 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 581' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -123.32 138.85 54.52 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.295 0.569 . . . . 3.1899999999999999 110.833 -176.036 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 582' ' ' TRP . . . . . 0.72 ' O ' ' HA ' ' A' ' 552' ' ' VAL . 83.7 m95 -71.45 141.06 50.25 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.975 -0.75 . . . . 2.2999999999999998 108.975 173.221 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 583' ' ' VAL . . . . . 0.524 HG12 ' CE1' ' A' ' 550' ' ' TYR . 24.0 m -119.89 133.78 65.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 N-CA-C 113.352 0.871 . . . . 1.1100000000000001 113.352 -173.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 584' ' ' TRP . . . . . 0.685 ' CD1' HG22 ' A' ' 553' ' ' VAL . 21.6 m0 -111.38 104.51 12.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.024 -0.989 . . . . 2.29 108.983 165.436 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 585' ' ' LYS . . . . . 0.408 ' HD2' ' HB3' ' A' ' 550' ' ' TYR . 26.2 mmmt -83.23 148.13 27.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.607 -0.269 . . . . 3.9500000000000002 110.473 -175.041 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 586' ' ' ASN . . . . . . . . . . . . . 62.7 m-20 48.32 41.95 17.16 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 123.319 0.648 . . . . 1.4299999999999999 110.337 -173.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 587' ' ' THR . . . . . . . . . . . . . 56.8 m -120.1 140.9 50.35 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.966 -0.561 . . . . 0.65000000000000002 109.607 179.556 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 588' ' ' ILE . . . . . . . . . . . . . 15.5 tt -135.66 146.22 30.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-O 120.927 0.394 . . . . 0.70999999999999996 110.123 -178.707 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 589' ' ' GLU . . . . . 0.434 ' HA ' ' O ' ' A' ' 593' ' ' LYS . 1.8 tm-20 -103.23 121.16 42.12 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.213 -0.662 . . . . 1.3500000000000001 109.213 175.373 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 590' ' ' VAL . . . . . . . . . . . . . 59.1 t -125.64 118.6 52.69 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 115.776 -0.647 . . . . 0.65000000000000002 109.829 -179.56 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 591' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 58.78 36.9 25.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.676 0.751 . . . . 2.0299999999999998 110.779 178.041 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . 85.85 6.59 82.35 Favored Glycine 0 N--CA 1.446 -0.647 0 CA-C-N 115.729 -0.669 . . . . 0.62 113.214 176.38 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 593' ' ' LYS . . . . . 0.434 ' O ' ' HA ' ' A' ' 589' ' ' GLU . 30.4 mmmt -120.85 139.29 53.38 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 117.02 0.41 . . . . 2.7799999999999998 111.64 -179.046 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 594' ' ' TYR . . . . . 0.527 ' HE1' HG11 ' A' ' 551' ' ' VAL . 91.8 m-85 -93.55 124.05 37.28 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.86 -0.609 . . . . 1.45 111.092 -179.864 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 595' ' ' PHE . . . . . . . . . . . . . 47.9 m-85 -137.29 164.27 28.95 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.865 -0.607 . . . . 1.3200000000000001 109.662 176.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 596' ' ' HIS . . . . . 0.715 ' HB2' ' SG ' ' A' ' 599' ' ' CYS . 29.3 m170 -61.58 129.83 43.0 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 108.927 -0.768 . . . . 0.58999999999999997 108.927 168.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 597' ' ' SER . . . . . . . . . . . . . 33.4 t -64.24 -30.35 71.41 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.039 -0.528 . . . . 1.1299999999999999 109.65 178.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 598' ' ' THR . . . . . . . . . . . . . 8.7 m -61.8 -38.85 89.64 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 115.307 -0.861 . . . . 1.3999999999999999 110.488 175.403 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 599' ' ' CYS . . . . . 0.715 ' SG ' ' HB2' ' A' ' 596' ' ' HIS . 83.2 m -73.98 -28.52 61.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.302 -0.863 . . . . 0.81000000000000005 112.672 -175.336 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 600' ' ' TYR . . . . . . . . . . . . . 70.0 t80 -55.94 -35.89 67.16 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 120.902 0.382 . . . . 1.8799999999999999 110.963 -174.62 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 601' ' ' HIS . . . . . . . . . . . . . 43.5 m-70 -73.26 -39.35 65.48 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.453 -0.339 . . . . 4.5199999999999996 111.232 -178.86 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 602' ' ' GLU . . . . . 0.663 ' HG2' ' O ' ' A' ' 599' ' ' CYS . 23.3 pt-20 -70.36 -35.5 73.59 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 120.709 0.29 . . . . 3.8500000000000001 111.028 -177.438 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 603' ' ' THR . . . . . 0.449 ' HB ' HD13 ' A' ' 566' ' ' ILE . 13.0 t . . . . . 0 C--N 1.327 -0.387 0 C-N-CA 120.978 -0.289 . . . . 3.2999999999999998 111.557 -175.225 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 701' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.136 0 N-CA-C 113.484 0.154 . . . . 3.2000000000000002 113.484 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 549' ' ' LYS . . . . . . . . . . . . . 61.6 mttm -73.43 134.79 44.07 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.906 0.384 . . . . 5.9000000000000004 110.588 176.218 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 550' ' ' TYR . . . . . . . . . . . . . 31.8 p90 -111.62 159.9 17.74 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.561 -0.745 . . . . 2.79 109.584 179.322 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 551' ' ' VAL . . . . . . . . . . . . . 59.2 t -117.94 131.9 69.34 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 N-CA-C 108.556 -0.905 . . . . 1.52 108.556 175.311 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 552' ' ' VAL . . . . . 0.563 ' HA ' ' O ' ' A' ' 582' ' ' TRP . 59.0 t -63.95 134.82 28.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 116.051 -0.522 . . . . 1.3799999999999999 110.075 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 553' ' ' VAL . . . . . 0.579 HG22 ' CD1' ' A' ' 584' ' ' TRP . 86.0 t -58.84 121.72 56.55 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 115.677 -0.692 . . . . 1.3799999999999999 110.05 -178.489 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 554' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_exo -55.65 135.89 71.55 Favored 'Trans proline' 0 N--CA 1.462 -0.363 0 C-N-CA 122.791 2.327 . . . . 1.98 112.496 -176.523 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 555' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -82.59 -6.32 59.28 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.979 -0.555 . . . . 4.1699999999999999 110.2 -178.843 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 23.0 p -83.23 -6.39 59.46 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.567 -0.742 . . . . 4.04 111.037 179.111 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 557' ' ' SER . . . . . . . . . . . . . 32.6 t -109.02 143.1 38.75 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 115.977 -0.556 . . . . 3.0299999999999998 110.28 -179.066 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 558' ' ' GLN . . . . . . . . . . . . . 27.5 mt-30 -100.31 5.3 44.49 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.089 -0.505 . . . . 5.0599999999999996 110.229 177.199 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 559' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -133.05 120.55 21.47 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 108.938 -0.764 . . . . 3.23 108.938 176.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 560' ' ' MET . . . . . . . . . . . . . 3.8 mpp? -78.45 37.4 0.27 Allowed 'General case' 0 C--O 1.237 0.419 0 CA-C-N 116.587 -0.279 . . . . 2.6099999999999999 111.28 -174.824 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 561' ' ' ALA . . . . . 0.59 ' HB2' HG22 ' A' ' 572' ' ' THR . . . -144.66 145.7 31.88 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-O 121.045 0.45 . . . . 0.94999999999999996 111.552 -176.628 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 33.1 p90 -135.92 149.22 48.87 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 107.791 -1.189 . . . . 0.90000000000000002 107.791 169.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 563' ' ' LYS . . . . . 0.46 ' HA ' ' HA ' ' A' ' 570' ' ' THR . 72.1 tttt -93.3 119.99 33.07 Favored 'General case' 0 C--N 1.316 -0.859 0 C-N-CA 120.093 -0.643 . . . . 2.1800000000000002 110.929 -176.07 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 564' ' ' CYS . . . . . 0.48 ' HA ' ' HD3' ' A' ' 565' ' ' PRO . 10.6 t -76.91 114.26 37.76 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-N 115.348 -0.842 . . . . 0.40999999999999998 110.729 -178.626 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 565' ' ' PRO . . . . . 0.48 ' HD3' ' HA ' ' A' ' 564' ' ' CYS . 20.6 Cg_exo -70.48 -23.41 27.55 Favored 'Trans proline' 0 CA--C 1.534 0.487 0 C-N-CA 123.379 2.719 . . . . 0.63 113.35 -177.479 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 566' ' ' ILE . . . . . 0.485 HG21 ' HB3' ' A' ' 599' ' ' CYS . 26.7 mt -71.44 -37.64 65.46 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.364 0 N-CA-C 112.041 0.385 . . . . 0.93999999999999995 112.041 -174.249 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 567' ' ' CYS . . . . . . . . . . . . . 29.2 p -124.34 2.06 8.43 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.805 0.336 . . . . 0.69999999999999996 111.429 178.07 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 568' ' ' LYS . . . . . . . . . . . . . 29.4 mtpp 69.65 18.01 7.7 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 113.463 0.912 . . . . 2.71 113.463 171.798 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 569' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -107.85 136.37 47.69 Favored 'General case' 0 C--O 1.238 0.46 0 C-N-CA 120.373 -0.531 . . . . 3.3399999999999999 111.332 178.818 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 570' ' ' THR . . . . . 0.46 ' HA ' ' HA ' ' A' ' 563' ' ' LYS . 35.5 m -68.18 125.99 28.12 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 115.015 -0.993 . . . . 1.01 110.925 -178.677 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 571' ' ' VAL . . . . . 0.533 ' O ' ' HA ' ' A' ' 561' ' ' ALA . 15.9 t -95.06 117.51 39.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 115.68 -0.691 . . . . 0.72999999999999998 110.602 -176.891 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 572' ' ' THR . . . . . 0.59 HG22 ' HB2' ' A' ' 561' ' ' ALA . 25.6 p -109.17 158.62 17.63 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 109.619 -0.512 . . . . 1.8899999999999999 109.619 176.589 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . -129.92 156.41 21.44 Favored Glycine 0 N--CA 1.443 -0.871 0 C-N-CA 120.305 -0.95 . . . . 2.2000000000000002 111.777 -177.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 574' ' ' VAL . . . . . 0.484 ' O ' HG22 ' A' ' 583' ' ' VAL . 20.1 t -113.68 149.94 15.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-O 120.832 0.348 . . . . 3.2400000000000002 110.227 -173.352 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 575' ' ' TYR . . . . . 0.446 ' HA ' ' HA ' ' A' ' 582' ' ' TRP . 39.6 t80 -80.61 123.84 28.48 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 109.276 -0.639 . . . . 3.02 109.276 174.383 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 576' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -90.97 105.49 17.86 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 108.434 -0.95 . . . . 3.3399999999999999 108.434 175.574 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 577' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -67.09 -27.02 67.01 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.377 -0.829 . . . . 5.5899999999999999 112.083 -170.602 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 578' ' ' GLU . . . . . . . . . . . . . 23.1 mp0 -75.15 -47.06 30.33 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.537 -0.301 . . . . 5.1100000000000003 111.354 -179.452 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 579' ' ' SER . . . . . . . . . . . . . 75.2 p -83.12 -21.06 33.74 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.059 0.457 . . . . 3.2799999999999998 111.295 -179.449 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 580' ' ' GLY . . . . . . . . . . . . . . . 80.23 20.49 67.03 Favored Glycine 0 N--CA 1.449 -0.46 0 CA-C-N 115.863 -0.608 . . . . 2.6000000000000001 112.836 177.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 581' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -130.28 148.08 52.07 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.912 0.387 . . . . 3.1899999999999999 110.752 -178.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 582' ' ' TRP . . . . . 0.563 ' O ' ' HA ' ' A' ' 552' ' ' VAL . 81.1 m95 -79.12 135.19 36.76 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.313 -0.625 . . . . 2.2999999999999998 109.313 174.194 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 583' ' ' VAL . . . . . 0.484 HG22 ' O ' ' A' ' 574' ' ' VAL . 29.3 m -113.4 129.33 69.35 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 N-CA-C 112.987 0.736 . . . . 1.1100000000000001 112.987 -172.594 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 584' ' ' TRP . . . . . 0.579 ' CD1' HG22 ' A' ' 553' ' ' VAL . 23.3 m0 -109.4 102.31 11.21 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 108.085 -1.08 . . . . 2.29 108.085 163.108 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 585' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.99 151.51 19.49 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 110.2 -0.296 . . . . 3.9500000000000002 110.2 -173.428 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 586' ' ' ASN . . . . . 0.501 ' O ' ' HA ' ' A' ' 596' ' ' HIS . 2.2 m-20 55.95 42.33 28.83 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 121.214 0.53 . . . . 1.4299999999999999 109.714 -173.311 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 587' ' ' THR . . . . . . . . . . . . . 30.2 m -124.41 141.42 52.1 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.359 -0.837 . . . . 0.65000000000000002 110.439 -178.015 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 588' ' ' ILE . . . . . 0.568 ' HB ' ' HB3' ' A' ' 597' ' ' SER . 16.1 tt -139.98 147.92 23.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 116.255 -0.43 . . . . 0.70999999999999996 109.877 177.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 589' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -100.62 119.08 38.03 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.453 -0.573 . . . . 1.3500000000000001 109.453 176.653 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 590' ' ' VAL . . . . . . . . . . . . . 60.0 t -130.93 127.31 61.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.563 -0.744 . . . . 0.65000000000000002 109.401 179.065 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 591' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 59.05 33.21 22.83 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 121.605 0.717 . . . . 2.0299999999999998 110.384 179.068 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . 84.88 0.74 89.07 Favored Glycine 0 N--CA 1.45 -0.424 0 CA-C-N 115.795 -0.639 . . . . 0.62 113.303 175.815 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 593' ' ' LYS . . . . . . . . . . . . . 45.3 mmtm -121.35 148.06 44.86 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.056 0.455 . . . . 2.7799999999999998 111.482 -178.305 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 594' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -92.89 132.76 36.75 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.566 -0.743 . . . . 1.45 110.576 179.597 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 595' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -136.55 162.58 32.72 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.292 -0.867 . . . . 1.3200000000000001 108.766 177.529 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 596' ' ' HIS . . . . . 0.512 ' CE1' HG22 ' A' ' 571' ' ' VAL . 21.9 m170 -66.86 125.05 24.7 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 107.743 -1.206 . . . . 0.58999999999999997 107.743 167.178 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 597' ' ' SER . . . . . 0.568 ' HB3' ' HB ' ' A' ' 588' ' ' ILE . 2.1 p -67.77 -29.79 69.08 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.256 0.55 . . . . 1.1299999999999999 109.884 177.501 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 598' ' ' THR . . . . . . . . . . . . . 25.6 m -63.84 -38.27 90.46 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.258 -0.883 . . . . 1.3999999999999999 110.656 174.643 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 599' ' ' CYS . . . . . 0.485 ' HB3' HG21 ' A' ' 566' ' ' ILE . 73.6 m -75.14 -29.92 60.64 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.971 -0.559 . . . . 0.81000000000000005 110.816 177.263 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 600' ' ' TYR . . . . . . . . . . . . . 92.4 t80 -55.62 -34.52 64.98 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.617 -0.719 . . . . 1.8799999999999999 111.623 -174.598 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 601' ' ' HIS . . . . . . . . . . . . . 66.9 m170 -60.16 -32.51 71.12 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 112.459 0.541 . . . . 4.5199999999999996 112.459 -176.343 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 602' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -72.61 -33.52 66.73 Favored 'General case' 0 CA--C 1.528 0.099 0 C-N-CA 120.118 -0.633 . . . . 3.8500000000000001 110.966 -179.141 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 603' ' ' THR . . . . . . . . . . . . . 8.8 t . . . . . 0 C--O 1.235 0.3 0 C-N-CA 120.633 -0.427 . . . . 3.2999999999999998 110.837 -177.564 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 701' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 stop_ save_